18.12.2012 Views

Floor plan - 2013 Annual Meeting - American Association for Hand ...

Floor plan - 2013 Annual Meeting - American Association for Hand ...

Floor plan - 2013 Annual Meeting - American Association for Hand ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

HYATT REGENCY CENTURY PLAZA<br />

FLOOR PLAN


TABLE OF CONTENTS<br />

AAHS Board of Directors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1<br />

AAHS Committees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2<br />

AAHS Historical In<strong>for</strong>mation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3<br />

ASPN Council Members . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4<br />

ASPN Committees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5<br />

ASPN Historical In<strong>for</strong>mation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6<br />

ASRM Council Members . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7<br />

ASRM Committees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8<br />

ASRM Historical In<strong>for</strong>mation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9<br />

Messages from the Program Chairs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10<br />

General Announcements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11<br />

Networking Events . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12<br />

2008 Exhibitor Listing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13-17<br />

CME In<strong>for</strong>mation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18-20<br />

Presenters’ Disclosure Listing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21<br />

Future <strong>Annual</strong> <strong>Meeting</strong> Locations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22<br />

AAHS Wednesday Day-at-a-Glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23<br />

Specialty Day Program . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24<br />

AAHS Thursday Day-at-a-Glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25<br />

Keynote Speaker: Ramez Naam . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27-28<br />

AAHS Friday Day-at-a-Glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29<br />

J. Joseph Danyo Presidential Invited Lecturer: Allen Van Beek, MD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30<br />

Comprehensive <strong>Hand</strong> Surgery Review Course . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32<br />

AAHS/ASPN/ASRM Saturday Day-at-a-Glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33<br />

AAHS/ASPN/ASRM Presidents’ Invited Lecturer: Aaron Vinik, MD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34<br />

ASPN Friday Day-at-a-Glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35<br />

Invited Speaker: Prof. Andrew Schwartz, PhD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36-37<br />

ASPN Saturday Day-at-a-Glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38<br />

Invited Speaker: Jeff Licthman, MD, PhD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39<br />

ASPN Sunday Day-at-a-Glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40<br />

Invited Speaker: Prof. Neville Hogan, PhD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42<br />

ASRM Saturday Day-at-a-Glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43<br />

ASRM Sunday Day-at-a-Glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45<br />

Presidents Address: Lawrence B. Colen, MD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46<br />

Presidents Invited Lecture: Luis Vasconez, MD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48<br />

Godina Lecture: Peirong Yu, MD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48<br />

ASRM Monday Day-at-a-Glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49<br />

Buncke Lecture: Berish Strauch, MD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50<br />

ASRM Master Series in Microsurgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52<br />

ASRM CTA Update Session . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52<br />

ASRM Tuesday Day-at-a-Glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53<br />

Introductional Lecturer: Hans Steinau, MD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56<br />

Abstract Table of Contents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57


2007-2008 AAHS BOARD OF DIRECTORS<br />

President N. Bradly Meland, MD<br />

President-Elect Scott H. Kozin, MD<br />

Vice-President Nicholas Vedder, MD<br />

Secretary Keith Brandt, MD<br />

Treasurer Richard E. Brown, MD<br />

Treasurer-Elect Mark Baratz, MD<br />

Historian Matthew Concannon, MD<br />

Parliamentarian Warren Schubert, MD<br />

Past Presidents Susan Mackinnon, MD<br />

Ronald Palmer, MD<br />

Directors At Large James Chang, MD<br />

Steven McCabe, MD<br />

Peter Murray, MD<br />

Nash Naam, MD<br />

Affiliate Directors Julianne Howell, PT MS CHT<br />

Christine Novak, PT MS<br />

Rebecca von der Heyde, MS, ORT/L, CHT<br />

1


AAHS COMMITTEES<br />

Please join us in thanking the AAHS committees <strong>for</strong> their work in 2007<br />

BYLAWS COMMITTEE<br />

Warren Schubert, MD<br />

Brian Adams, MD<br />

EDUCATION COMMITTEE<br />

Jaiyoung Ryu, MD, FACS, Chair<br />

Timothy J. Best, MD, MSc, FRCSC<br />

Kevin Chung, MD<br />

Paula Galaviz, OT<br />

Kevin Plancher, MD<br />

Renata Weber, MD<br />

Aviva Wolff, BSc, OTR/L, CHT<br />

FINANCE COMMITTEE<br />

Richard E. Brown, MD, Chair<br />

Mark Baratz, MD<br />

Scott Kozin, MD<br />

N. Bradly Meland, MD<br />

Ronald Palmer, MD<br />

MEMBERSHIP: ACTIVE COMMITTEE<br />

Steven McCabe, MD, Chair<br />

Amy L. Ladd, MD<br />

Steven L. Moran, MD<br />

Raj Sood, MD<br />

Robert Spinner, MD<br />

MEMBERSHIP: AFFILIATE COMMITTEE<br />

Carin Jean Wulf, OT, CHT, Chair<br />

Rebecca von der Heyde, MS, OTR/L, CHT<br />

NOMINATING COMMITTEE<br />

Ronald Palmer, MD<br />

Paul Brach, MS, PT, CHT<br />

William Dzwierzynski, MD<br />

M. Ather Mirza, MD<br />

Roger Simpson, MD<br />

Dean Sotereanos, MD<br />

2<br />

PROGRAM COMMITTEE<br />

Michael Neumeister, MD, Co-Chairperson<br />

Craig Johnson, MD, Co-Chairperson<br />

Christine Novak, PT, MS, Co-Chairperson<br />

Randipsingh Bindra, MD<br />

Diana D. Carr, MD<br />

Kevin Chung, MD<br />

Gail Groth, OTR/L, CHT, MHS<br />

M. Ather Mirza, MD<br />

Jorge Orbay, MD<br />

A. Lee Osterman, MD, FACS<br />

Miguel Pirela-Cruz, MD<br />

RESEARCH GRANTS COMMITTEE<br />

Michael Neumeister, MD, Chair<br />

Loree K. Kalliainen, MD, FACS<br />

Steven Moran, MD<br />

Jorge Orbay, MD<br />

TECHNOLOGY COMMITTEE<br />

George Landis, MD, Chairman<br />

Paul Brach, MS, PT, CHT<br />

Coleen T. Gately, PT, DPT, MS<br />

Steven McCabe, MD<br />

Eric Rothenberg, MD, FACS<br />

Stephen Schnall, MD<br />

Hugh L. Vu, MD, MPH


AAHS HISTORICAL INFORMATION<br />

AAHS PAST PRESIDENTS<br />

J. Joseph Danyo, MD 1970-1972<br />

Henry Burns, MD 1972-1973<br />

Ray A. Elliott, Jr., MD 1973-1974<br />

James Borden, MD 1974-1975<br />

Kim K. Lie, MD 1975-1976<br />

Frank L. Thorne, MD 1976-1977<br />

Lawrence R. Werschky, MD 1977-1978 deceased<br />

Robert T. Love, MD 1978-1979<br />

Arnis Freiberg, MD 1979-1980<br />

Thomas J. Krizek, MD 1980-1981<br />

George L. Lucas, MD 1981-1982<br />

Garry S. Brody, MD 1982-1983<br />

James G. Hoehn, MD 1983-1984<br />

Peter C. Linton, MD 1984-1985<br />

Wallace H.J. Chang, MD 1985-1986<br />

Austin D. Potenza, MD 1986-1987<br />

Lee E. Edstrom, MD 1987-1988<br />

C. Lin Puckett, MD 1988-1989<br />

Robert J. Demuth, MD 1989-1990<br />

Wyndell H. Merritt, MD 1990-1991<br />

Frederick R. Heckler, MD 1991-1992<br />

Robert D. Beckenbaugh, MD 1992-1993<br />

David J. Smith, Jr., MD 1993-1995<br />

James W. May, Jr., MD 1995-1996<br />

Robert H. Brumfield, Jr., MD 1996-1997<br />

Robert C. Russell, MD 1997-1998<br />

Peter C. Amadio, MD 1998-1999<br />

William M. Swartz, MD 1999-2000<br />

William Blair, MD 2000-2001<br />

Robert Buchanan, MD 2001-2002<br />

Alan Freeland, MD 2002-2003<br />

Allen Van Beek, MD 2003-2004<br />

Richard Berger, MD 2004-2005<br />

Susan Mackinnon, MD 2005-2006<br />

Ronald Palmer, MD 2006-2007<br />

PRESIDENTIAL INVITED LECTURERS<br />

Harold E. Kleinert, MD 1989<br />

Arthur C. Rettig, MD 1990<br />

Paul W. Brand, MD 1991<br />

Ronald L. Linschied, MD 1993<br />

Guy Foucher, MD 1995<br />

Michael R. Harrison, MD 1996<br />

Dallas D. Raines 1997<br />

John Texter, MD 1998<br />

Vincent R. Hentz, MD 1999<br />

Nancy Dickey, MD 2000<br />

Michael Wood, MD 2001<br />

Francisco Rosas 2002<br />

Arnold-Peter Weiss, MD 2003<br />

Susan Mackinnon, MD 2004<br />

Elvin Zook, MD 2004<br />

Gavin Menzies 2005<br />

Peter Amadio, MD 2006<br />

Robert Beckenbaugh, MD 2007<br />

3<br />

KEYNOTE SPEAKERS<br />

William L. White, MD 1978<br />

John W. Madden, MD 1979<br />

Harold E. Kleinert, MD 1980<br />

J. William Littler, MD 1981<br />

Clif<strong>for</strong>d C. Snyder, MD 1982<br />

Robert A. Chase, MD 1983<br />

Richard J. Smith, MD 1984<br />

James M. Hunter, MD 1985<br />

Bernard McC. O’Brien, MD 1986<br />

Erle E. Peacock, Jr., MD 1988<br />

Michael Jabelay, MD 1989<br />

Robert M. McFarlane, MD 1990<br />

James H. Dobyns, MD 1991<br />

Adrian E. Flatt, MD 1992<br />

John B. Carlson, PhD 1993<br />

Pat Clyne 1995<br />

David M. Evans, FRCS 1996<br />

Eugene Nelson, MD 1997<br />

Fritz Klein 1998<br />

Janet L.Babb 1999<br />

Frank E. Jones, MD 2000<br />

Joseph Buckwalter, MD 2001<br />

Linda Cendales, MD 2002<br />

Arnold-Peter Weiss, MD 2003<br />

Terry L. Whipple, MD, FACS 2005<br />

Jeff Lictman, MD, PhD 2006<br />

Richard Kogan, MD 2007<br />

Bob Jamieson 2007<br />

CLINICIAN/TEACHER OF THE YEAR<br />

Forst Brown, MD 1995<br />

Robert Beckenbaugh, MD 1996<br />

James Hoehn, MD 1997<br />

Alan Freeland, MD 1998<br />

Wyndell Merritt, MD 1999<br />

Peteramadio, MD 2000<br />

Anthony DeSantolo, MD 2002<br />

Michael Jabaley, MD 2002<br />

Maureen Hardy, PT, MS, CHT 2002<br />

Sterling Mutz, MD 2002<br />

Richard E. Brown, MD 2003<br />

Nash Naam, MD 2004


2007-2008 ASPN COUNCIL<br />

President Gregory R. D. Evans, MD, FACS<br />

President-Elect Robert C. Russell, MD<br />

Vice President Howard M. Clarke, MD, PhD<br />

Secretary Ivica Ducic, MD, PhD<br />

Treasurer Paul S. Cederna, MD<br />

Immediate Past President Rajiv Midha, MD,<br />

Past President Maria Siemionow, MD, PhD<br />

Historian Robert Spinner, MD<br />

Council Member at Large Loree K. Kalliainen, MD<br />

David T. J. Netscher, MD<br />

Gedge D. Rosson, MD<br />

4


ASPN COMMITTEES<br />

Please join us in thanking the following ASPN committees who have helped make the 2007 year successful.<br />

ASPN BOARD REPRESENTATIVE<br />

Paul S. Cederna, MD<br />

BYLAWS COMMITTEE<br />

Melanie Urbanchek, MD, Chairperson<br />

Paul Cederna, MD<br />

William Kuzon, Jr., MD<br />

Warren Schubert, MD<br />

Gregory R.D. Evans, MD, FACS, Ex-Officio<br />

CODING AND REIMBURSEMENT COMMITTEE<br />

Keith E. Brandt, MD, Chairperson<br />

Brandon J. Wilhelmi, MD<br />

William A. Zamboni, MD<br />

EDUCATION COMMITTEE<br />

David T.J. Netscher, MD, Chairperson<br />

Steven McCabe, MD<br />

Wyndell H. Merritt, MD<br />

Gregory R.D. Evans, MD, FACS, Ex-Officio<br />

FINANCE COMMITTEE<br />

Thomas H.H. Tung, MD, Chairperson<br />

David W. Chang, MD<br />

Robert C. Russell, MD<br />

Gregory R.D. Evans, MD, FACS, Ex-Officio<br />

AD-HOC GRANT GENERATION COMMITTEE<br />

Gregory R.D. Evans, MD, FACS, Chairperson<br />

Keith E. Brandt, MD<br />

Paul S. Cederna, MD<br />

Howard M. Clarke, MD<br />

Rajiv Midha, MD<br />

Robert Spinner, MD<br />

MEMBERSHIP COMMITTEE<br />

Robert C. Russell, MD, Chairperson<br />

Paul S. Cederna, MD<br />

Warren C. Hammert, DDS, MD<br />

Thomas H.H. Hung, MD<br />

Renata V. Weber, MD<br />

Gregory R. D. Evans, MD, FACS, Ex-Officio<br />

NEWSLETTER COMMITTEE<br />

Nash H. Naam, MD, Editor<br />

Robert Spinner, MD, Assistant Editor<br />

Christine Novak, PT, MS, Assistant Editor<br />

5<br />

NOMINATING COMMITTEE<br />

Rajiv Midha, MD, Chairperson<br />

Keith E. Brandt, MD<br />

David T.W. Chiu, MD<br />

William Kuzon, Jr., MD<br />

Eric L. Zager, MD<br />

Maria Siemionow, MD, PhD, Ex-Officio<br />

PROGRAM COMMITTEE<br />

Jonathan M. Winograd, MD, Chairperson<br />

Gregory M. Buncke, MD<br />

Ranjan Gupta, MD<br />

William Lineaweaver, MD<br />

Nancy McKee, MD, FRCSC<br />

David Netscher, MD<br />

Joseph M. Rosen, MD<br />

Gedge Rosson, MD<br />

Warren Schubert, MD<br />

Gregory R.D. Evans, MD, FACS, Ex-Officio<br />

TIME AND PLACE COMMITTEE<br />

Howard Clarke, MD, PhD, Chairperson<br />

Paul S. Cederna, MD<br />

Ivica Ducic, MD, PhD<br />

Gregory R. D. Evans, MD, FACS<br />

Loree K. Kalliainen, MD<br />

Rajiv Midha, MD<br />

David T.J. Netscher, MD<br />

Gedge D. Rosson, MD<br />

Robert C. Russell, MD<br />

Maria Siemionow, MD, PhD<br />

Robert Spinner, MD<br />

WEBSITE COMMITTEE<br />

Paul Cederna, MD, Chairperson<br />

William Kuzon, Jr., MD<br />

Rajiv Midha, MD<br />

Gregory R.D. Evans, MD, FACS, Ex-Officio


ASPN HISTORICAL INFORMATION<br />

FOUNDING COUNCIL (Established April 19, 1990)<br />

Warren Breidenbach, MD<br />

Thomas Brushart, MD<br />

David Chiu, MD<br />

A. Lee Dellon, MD<br />

Richard Ehrlichman, MD<br />

Nelson Goldberg, MD<br />

Roger Khouri, MD<br />

Howard Klein, MD<br />

Susan Mackinnon, MD<br />

Hallene Maragh, MD<br />

Wyndell Merritt, MD<br />

Michael Orgel, MD<br />

Elliot Rose, MD<br />

Joseph Rosen, MD<br />

Brooke Seckel, MD<br />

Saleh Shenaq, MD<br />

Thomas Stevenson, MD<br />

Berish Strauch, MD<br />

Julia K.Terzis, MD, PhD<br />

Allen Van Beek, MD<br />

Bruce Williams, MD<br />

ASPN PAST PRESIDENTS<br />

Julia K. Terzis, MD, PhD 1990-1992<br />

A. Lee Dellon, MD 1992-1993<br />

Berish Strauch, MD 1993-1994<br />

H. Bruce Williams, MD 1994-1995<br />

Susan E. Mackinnon, MD 1995-1996<br />

Wyndell Merritt, MD 1996-1997<br />

Allen Van Beek, MD 1997-1998<br />

Saleh Shenaq, MD 1998-1999<br />

David T. W. Chiu, MD 1999-2001<br />

Nancy H. McKee, MD 2001-2002<br />

William M. Kuzon, Jr., MD, PhD 2002-2003<br />

Keith E. Brandt, MD 2003-2004<br />

Steven McCabe, MD 2004-2005<br />

Maria Siemionow, MD, PhD 2005-2006<br />

Rajiv Midha, MD 2006-2007<br />

6


2007-2008 ASRM EXECUTIVE COUNCIL MEMBERS<br />

President Lawrence B. Colen, MD<br />

President-Elect Neil F. Jones, MD<br />

Vice-President William A. Zamboni, MD<br />

Secretary Peter C. Neligan, MD<br />

Treasurer Keith E. Brandt, MD<br />

Treasurer-Elect Joseph M. Serletti, MD, FACS<br />

Immediate Past President L. Scott Levin, MD, FACS<br />

Senior Members-At-Large Geoffrey L. Robb, MD<br />

Michael W. Neumeister, MD<br />

Junior Members-At-Large Elisabeth K. Beahm, MD<br />

Alexander Y. Shin, MD<br />

Historian William Lineaweaver, MD<br />

7


ASRM COMMITTEES<br />

Please join us in thanking the following ASRM committees who have helped make the 2007 year successful.<br />

AD HOC – JRM<br />

L. Scott Levin, MD, FACS, Chairperson<br />

AD HOC MICRO FELLOWSHIP<br />

Charles Butler, MD, Chairperson<br />

Gregory Buncke, MD<br />

Joseph Serletti, MD<br />

Joseph Disa, MD<br />

Peter Neligan, MD<br />

William Zamboni, MD<br />

AUDIT COMMITTEE<br />

David Chang, MD, Chairperson<br />

Joseph Disa, MD<br />

Raymond Dunn, MD<br />

BYLAWS COMMITTEE<br />

Elisabeth Beahm, MD, Chairperson<br />

Gregory M. Buncke, MD<br />

Anthony Smith, MD<br />

BUNCKE LECTURESHIP COMMITTEE<br />

L. Scott Levin, MD, FACS, Chairperson<br />

Lawrence Colen, MD<br />

Ming Huei Cheng, MD<br />

Guenter Germann, MD<br />

A. Lee Dellon, MD<br />

CLINICAL GUIDELINES & OUTCOMES COMMITTEE<br />

Raymond Dunn, MD, Chairperson<br />

James Higgins, MD<br />

Howard N. Langstein, MD<br />

Michael W. Neumeister, MD<br />

CPT/RUC COMMITTEE<br />

Keith E. Brandt, MD, Chairperson<br />

Gregory M. Buncke, MD<br />

Raymond M. Dunn, MD<br />

Daniel J. Nagle, MD<br />

William C. Pederson, MD<br />

Michael R. Zenn, MD<br />

EDUCATION COMMITTEE<br />

Howard N. Langstein, MD, Chairperson<br />

Maurice Nahabedian, MD<br />

Maria Siemionow, MD, Ph.D<br />

Peirong Yu, MD<br />

ELECTRONIC COMMUNICATIONS COMMITTEE<br />

Charles Butler, MD, Chairperson<br />

William Dzwierzynski, MD<br />

Howard N. Langstein, MD<br />

Peter Murray, MD<br />

Keith E. Brandt, MD, Ex-Officio<br />

ENDOWMENT COMMITTEE<br />

Robert L. Walton, MD, FACS, Chairperson<br />

Keith E. Brandt, MD<br />

Joseph J. Disa, MD<br />

William A. Zamboni, MD<br />

8<br />

FINANCE COMMITTEE<br />

Neil Jones, MD, Chairperson<br />

Joseph M. Serletti, MD, FACS<br />

William Zamboni, MD<br />

Keith E. Brandt, MD, Ex-Officio<br />

GODINA FELLOWSHIP SELECTION COMMITTEE<br />

Neil Jones, MD, Chairperson<br />

Zoran M. Arnez, MD, PhD<br />

Ming Huei Cheng, MD<br />

Lawrence Colen, MD<br />

Lawrence Gottlieb, MD<br />

MASTER SERIES SYMPOSIUM<br />

Milan Stevanovic, MD, Chairperson<br />

MEMBERSHIP COMMITTEE<br />

Neil Jones, MD, Chairperson<br />

Charles Butler, MD<br />

Joseph Disa, MD<br />

Milan Stevanovic, MD<br />

Michael Zenn, MD<br />

William Zamboni, MD, Ex-Officio<br />

NOMINATING COMMITTEE<br />

L. Scott Levin, MD, FACS, Chairperson<br />

Elisabeth Beahm, MD<br />

Gregory Buncke, MD<br />

Jeffrey Friedman, MD<br />

Howard Langstein, MD<br />

PROGRAM COMMITTEE<br />

Guenter Germann, MD, Chairperson<br />

Michael R. Zenn, MD, Ex-Officio<br />

Rudolf Buntic, MD<br />

R. Jobe Fix, MD<br />

James Higgins, MD<br />

Neil Jones, MD<br />

Howard Langstein, MD<br />

Charles Lee, MD<br />

TECHNICAL EXHIBITS COMMITTEE<br />

Peter C. Neligan, MD, Chairperson<br />

L. Scott Levin, MD, FACS<br />

William Lineaweaver, MD<br />

TIME & PLACE COMMITTEE<br />

L. Scott Levin, MD, FACS, Chairperson<br />

William Pederson, MD<br />

Robert Walton, MD, FACS<br />

ASPS REPRESENTATIVE<br />

Robert Walton, MD<br />

PSEF REPRESENTATIVE<br />

Gregory R.D. Evans, MD


ASRM HISTORICAL INFORMATION<br />

1983 FOUNDING COUNCIL<br />

James B. Steichen, MD, Berish Strauch, MD, Julia K. Terzis, MD, PhD, James R. Urbaniak, MD, Allen L. Van Beek, MD<br />

YEAR PRESIDENT ANNUAL MEETING SITE FOUNDERS/GODINA/BUNCKE LECTURERS<br />

1985 Berish Strauch, MD Las Vegas, NV Henry J. Buncke, MD Founders’ Lecturer<br />

1986 James R. Urbaniak, MD New Orleans, LA Harold E. Kleinert, MD Founders’ Lecturer<br />

1987 Joseph E. Kutz, MD San Antonio, TX Robert D. Acland, MD Founders’ Lecturer<br />

1988 H. Bruce Williams, MD Baltimore, MD Berish Strauch, MD Founders’ Lecturer<br />

1989 James B. Steichen, MD Seattle, WA G. Ian Taylor, FRCS, FRACS Founders’ Lecturer<br />

1990 Allen L. Van Beek, MD Toronto, Ontario, Canada Andrew Lightbody Founders’ Lecturer<br />

1991 Michael B. Wood, MD Orlando, FL Alain Gilbert, MD Founders’ Lecturer<br />

1992 Andrew J. Weiland, MD Scottsdale, AZ Edgar Biemer, MD Founders’ Lecturer<br />

1993 Graham Lister, MD Kansas City, MO Algimantas Narakas Founders’ Lecturer<br />

Lawrence B. Colen, MD Godina Lecturer<br />

1994-95 Robert C. Russell, MD Marco Island, FL Nguyen Huy Phan, MD Founders’ Lecturer<br />

Mark A. Schusterman, MD Godina Lecturer<br />

1995-96 Ralph T. Manktelow, MD Tucson, AZ Fu Chan Wei, MD Founders’ Lecturer<br />

Randy Sherman, MD Godina Lecturer<br />

1996-97 James A. Nunley, MD Boca Raton, FL James R. Urbaniak, MD Founders’ Lecturer<br />

Zoran M. Arnez, MD Godina Lecturer<br />

1997-98 William M. Swartz, MD Scottsdale, AZ H. Bruce Williams, MD Founders’ Lecturer<br />

L. Scott Levin, MD Godina Lecturer<br />

1998-99 David T. W. Chiu, MD Waikoloa, HI Julia K. Terzis, MD Founders’ Lecturer<br />

Phillip Blondeel, MD Godina Lecturer<br />

1999-2000 Daniel Nagle, MD Miami, FL Allen Van Beek, MD Founders’ Lecturer<br />

Gregory R. D. Evans, MD Godina Lecturer<br />

2000-2001 Saleh M. Shenaq, MD San Diego, CA Wayne Morrision, MD, FRACS Founders’ Lecturer<br />

Roger Khouri, MD Godina Lecturer<br />

2001-2002 Randy Sherman, MD Cancun, Mexico Robert Russell, MD Founders’ Lecturer<br />

William Zamboni, MD Godina Lecturer<br />

2002-2003 Julia K. Terzis, MD, PhD Kauai, HI Panayotis Soucacos, MD Founders’ Lecturer<br />

Raymond Dunn, MD Godina Lecturer<br />

2003-2004 Ronald M. Zuker, MD Palm Springs, CA Ralph Manktelow, MD Founders’ Lecturer<br />

Milomir Ninkovic, MD, PhD Godina Lecturer<br />

2004-2005 Robert L. Walton, MD, FACS Fajardo, Puerto Rico Isao Koshima, MD Founders’ Lecturer<br />

Michael Neumeister, MD, FRCSC, FACS Godina Lecturer<br />

G. Ian Taylor, MD, FACS Buncke Lecturer<br />

2005-2006 William C. Pederson, MD Tucson, AZ David Chang, MD, FACS Godina Lecturer<br />

Fu Chan Wei, MD, FACS Buncke Lecturer<br />

2006-2007 L. Scott Levin, MD, FACS Rio Grande, Puerto Rico Ming Huei Cheng, MD, MHA Godina Lecturer<br />

9<br />

James Urbaniak, MD Buncke Lecturer


MESSAGES FROM THE PROGRAM CHAIRS<br />

AAHS<br />

Welcome to Hollywood. As Ed Sullivan would say, “We have a really big Shoooo” <strong>for</strong> you in tinsel town. The 2008 <strong>Annual</strong> <strong>Meeting</strong> of the AAHS promises<br />

to be a colorful combination of science and entertainment meshed together with interactive dialogue designed to stimulate the minds of the old and new.<br />

Christine Novak and Dr. Craig Johnson have worked diligently to arrange a captivating opening session on Wednesday with a focus on the management of<br />

our arthritic conditions of the hand. A <strong>for</strong>um of lectures, discussions, and panel experts will update participants on medical, surgical and rehabilitation management<br />

of rheumatoid arthritis. Instructional courses in the afternoon will provide an opportunity <strong>for</strong> attendees to learn the current practices on various topics<br />

in hand surgery.<br />

The opening ceremonies will be held on Thursday morning followed immediately by a panel on one of the latest advancements in hand surgery “Wide Awake<br />

Approach to <strong>Hand</strong> Surgery” moderated by Dr. Brad Meland. The keynote speaker Ramez Naam will discuss his latest book in a lecture entitled “More Than<br />

Human”. Dr. Joe Slade will end the days’ scientific session with an update panel on the current issues of the Management of Scaphoid Fractures.<br />

On Friday, following early bird instructional courses, a controversial panel chaired by Dr. Susan Mackinnon entitled “Cubital Tunnel: Defend Your Operation”<br />

promises to provide an interesting debate from the panelists and the audience. Our president Dr. Brad Meland, has scripted a riveting presidential address<br />

to enlighten us on his views of the future of hand surgery. The consummate enthusiast, Dr. Allen Van Beek, is this year’s Joseph Danyo Presidential Lecturer.<br />

The conjoint session on Saturday with the ASRM and ASPN is highlighted by presentation of the top papers from each society as well as two panels.<br />

The combination of exciting speakers, panels and scientific paper presentations shall truly make this years’ AAHS a very memorable experience. Thank you<br />

to all of the participants and attendees and in the words of one of Hollywoods finest stars, Edward G. Robinson “Look you mugs….. It’s going to be swell<br />

see…. swell”.<br />

Michael Neumeister, MD<br />

AAHS Program Chairman<br />

It is my distinct pleasure to welcome you to the 17th annual meeting of the <strong>American</strong> Society <strong>for</strong> Peripheral Nerve. The meeting will be held on Friday, Saturday<br />

and Sunday January 11, 12th and 13th, 2008 at the Hyatt Regency Century Plaza Hotel & Spa in Beverly Hills, Cali<strong>for</strong>nia. The scientific program will offer both<br />

clinical and basic science advances in the field of peripheral nerve surgery in an exciting venue located in the heart of Century City, convenient to the many<br />

attractions of the magnificent City of Los Angeles.<br />

The program will start mid-day on Friday to allow <strong>for</strong> a longer program than in past meetings. The first invited speaker, Professor Andrew Schwartz, PhD of the<br />

University of Pittsburgh, will give an address entitled “Useful Signals from Motor Cortex“ on the exciting field of cortical neural prosthetics. As in the past,<br />

Saturday morning will consist of a shared session with the <strong>American</strong> <strong>Association</strong> <strong>for</strong> <strong>Hand</strong> Surgery and <strong>American</strong> Society <strong>for</strong> Reconstructive Microsurgery meetings.<br />

Two combined panels on “Treatment of Scleroderma with Sympathectomy” and “Tendon and Nerve Transfers <strong>for</strong> Common Upper Extremity Palsies:<br />

Consensus and Controversies” will be given. The Presidents Invited Lecture, Arthur Vinik, MD, will also give an address on Neurovascular Dysfunction in<br />

Diabetes. Outstanding papers selected by the 3 groups will then be presented.<br />

The ASPN will meet Saturday afternoon and Sunday. Professor Jeff Lichtman, MD, PhD will begin the ASPN program after lunch with a scientific lecture on the<br />

rapidly evolving topic of “Peripheral Nerve Growth Branching and Retraction: Studies in Fluorescent Mice.” Instructional courses Sunday morning will cover<br />

intraoperative monitoring, obstetrical brachial plexus palsy, peripheral nerve tumors, reinnervating muscle, and brain-body interfacing. A combined<br />

ASRM/ASPN panel on the treatment of the mangled hand will be held Sunday morning. Scientific and clinical papers will be given throughout the three day<br />

program. The final invited speaker <strong>for</strong> the meeting, Professor Neville Hogan, PhD, an expert on contact robotics, will give a fascinating lecture on “Robotics<br />

<strong>for</strong> Neurorecovery.” The ASPN welcome reception will be held in conjunction with the ASRM on Saturday evening.<br />

I encourage you to attend and participate in this meeting. It promises to be an exciting, rewarding and enjoyable experience, and I am looking <strong>for</strong>ward to seeing<br />

you there.<br />

Jonathan M. Winograd, MD<br />

ASPN Program Chairman<br />

The annual meeting is here, although the great days of Puerto Rico are still in our minds. For the first time, the remoteness and tranquility of a resort have been<br />

changed to a congress venue in the heart of a vibrant city. The newly remodeled hotel with its excellent facilities should provide precisely the atmosphere <strong>for</strong><br />

a meeting that guarantees familiarity, an excellent scientific program, many fun things to do and enough time to meet old and new friends.<br />

The goal of the program is to combine basic science, which has always been the basis <strong>for</strong> clinical progress, with very interesting topics <strong>for</strong> the practicing clinical<br />

micro-surgeon. Highlights from last year’s program such as the “Best Case” and the “Best Save” have been kept and several new features have been added.<br />

The “Big Debate” focuses on the question: Do we still need flaps to salvage a lower extremity or does the VAC do the job <strong>for</strong> us? “Grill the experts” will test<br />

the various strategic solutions of acknowledged experts in identical cases. “Voodoo in Micro” will address questions that have been discussed since the early<br />

age of Microsurgery: When can an extremity be mobilized? When can an extremity with a flap reconstruction be trained by lowering the extremity? How do<br />

we immobilize after flap reconstruction? When can a flap be debulked? When is it randomized, if so at all?<br />

These new features will be embraced by several interesting panels, some of them in cooperation with AAHS, ASPN and concurrent scientific sessions. Excellent<br />

lectures will be other highlights of the meeting; some sessions will be opened by “state of the art” introductions. The instructional courses feature topics that<br />

are both clinically relevant and future oriented at the same time. As it is almost custom, a CTA update will be included in our time table with as little as possible<br />

overlapping of sessions.<br />

In the movie city, a little “Voodoo” and some “magic” by the presenters should create a great program that is as exciting as the city itself. So come to LA to<br />

be part of the experience.<br />

We are glad you are here.<br />

Guenter Germann, MD<br />

ASRM Program Chairman<br />

10<br />

ASPN<br />

ASRM


GENERAL ANNOUNCEMENTS<br />

<strong>Meeting</strong> Service Hours (subject to change)<br />

Wednesday, January 9 6:30am – 2:30pm; 5:00pm – 7:00pm<br />

Thursday, January 10 6:30am – 3:00pm<br />

Friday, January 11 6:30am – 7:00pm<br />

Saturday, January 12 6:30am – 6:30pm<br />

Sunday, January 13 6:30am – 4:00pm<br />

Monday, January 14 6:30am – 3:00pm; 6:30pm – 8:00pm<br />

Tuesday, January 15 6:30am – 9:30am<br />

AAHS POSTER PRESENTATION VIEWING HOURS<br />

The AAHS Poster Presentations will be placed in the Cali<strong>for</strong>nia Showroom. Posters will be available <strong>for</strong> viewing Wednesday - Friday. If you are a presenter,<br />

please have your poster set up prior to 12:00pm on Wednesday and taken down prior to 11:00am on Friday. The <strong>American</strong> <strong>Association</strong> <strong>for</strong><br />

<strong>Hand</strong> Surgery will not be responsible <strong>for</strong> any poster that is not removed within the time allotted.<br />

ASPN POSTER PRESENTATION VIEWING HOURS<br />

The ASPN Poster Presentations will be placed in the Cali<strong>for</strong>nia Showroom. Posters will be available <strong>for</strong> viewing Friday - Sunday. If you are a presenter,<br />

please have your poster set up prior to 1:00pm on Friday and taken down prior to 5:00pm on Sunday. The <strong>American</strong> Society <strong>for</strong> Peripheral Nerve<br />

will not be responsible <strong>for</strong> any poster that is not removed within the time allotted.<br />

ASRM POSTER PRESENTATION VIEWING HOURS<br />

The ASRM Poster Presentations will be placed in the Cali<strong>for</strong>nia Showroom. Posters will be presented digitally on a continuous loop in the Cali<strong>for</strong>nia<br />

Showroom on Sunday, January 13th and Monday, January 14th.<br />

COMMERCIAL EXHIBITS<br />

The commercial exhibits will be located in Cali<strong>for</strong>nia Showroom. A variety of commercial exhibits are featured at the meeting, enabling the attendees<br />

to learn about the technological advances pertaining to upper extremity surgery, neurosurgery and reconstructive microsurgery, and to meet<br />

key suppliers. Please refer to the Exhibit Listing in this book.<br />

EXHIBIT HOURS<br />

Thursday, January 10 7:00am – 3:30pm<br />

Friday, January 11 7:00am – 6:00pm<br />

Saturday, January 12 7:00am – 6:00pm<br />

Sunday, January 13 7:00am – 5:30pm<br />

Monday, January 14 7:00am – 4:30pm<br />

SPEAKER READY ROOM HOURS<br />

The Speaker Ready Room will be located in the Cali<strong>for</strong>nia Showroom.<br />

Wednesday, January 9 6:00am – 5:00pm<br />

Thursday, January 10 6:30am – 3:30pm<br />

Friday, January 11 6:00am – 5:00pm<br />

Saturday, January 12 6:00am – 5:00pm<br />

Sunday, January 13 6:00am – 4:00pm<br />

Monday, January 14 6:00am – 3:30pm<br />

Tuesday, January 15 6:00am – 11:30am<br />

DRESS CODE<br />

We encourage meeting attendees to dress casually and com<strong>for</strong>tably. Jackets and ties are not required <strong>for</strong> any business or networking events. If you<br />

<strong>plan</strong> to be outdoors in the evening, a jacket may be preferred.<br />

MESSAGE BOARD<br />

A message board will be set up near <strong>Meeting</strong> Services. Please refer to the message board <strong>for</strong> meeting notices and general announcements.<br />

11


NETWORKING EVENTS<br />

Networking events are offered to promote collaboration in a social environment, and to enhance your meeting experience. Many of the events are<br />

included in your registration fee, and we encourage you to purchase tickets <strong>for</strong> your guests <strong>for</strong> all networking events. We recommend that you purchase<br />

guest tickets in advance, as they will be available on a very limited basis at the meeting. Name badges will be required to attend all social events.<br />

AAHS Welcome Reception<br />

Wednesday, January 9 – 6:00pm – 8:00pm<br />

Cost: One admission included in AAHS registration. Additional tickets available @ $50 each.<br />

Reconnect with fellow meeting-goers at the Hyatt’s fabulous new X Bar. So trendy, you may want to come dressed Hollywood-Hip, and don’t <strong>for</strong>get to<br />

bring your Bling. This event is indoor and outdoor. Tickets include beverages and light hors d’oeuvres. Not recommended <strong>for</strong> guests under age 21.<br />

AAHS Salsa Sensation Awards Dinner and Dance<br />

Friday, January 11 – 7:00pm – 10:00pm<br />

Cost: One admission included in AAHS registration.<br />

Additional adult tickets available @ $100 each; tickets <strong>for</strong> children and young adults ages 5 - 20 available @<br />

$50 each.<br />

Can you Rumba, Samba, Salsa, Mambo, Merengue? You will if you attend our sizzling hot Salsa Sensation party.<br />

After a brief awards presentation, move to the beat of Latin rhythms with the pros and discover what the dance<br />

craze is about. A Latin inspired casual dinner buffet, refreshments and entertainment are all included in your ticket.<br />

Dress casual or Latin chic and prepare yourself <strong>for</strong> an electro-charged, scintillating night to remember. Cha cha cha.<br />

ASPN-ASRM Welcome Reception<br />

Saturday, January 12 – 6:30pm – 8:00pm<br />

Cost: One admission included in ASPN and ASRM registration. Additional tickets available @ $50 each.<br />

Reconnect with fellow meeting-goers at the Hyatt’s fabulous new X Bar. This event is indoor and outdoor. Tickets include beverages and light hors d’oeuvres.<br />

We thank ASSI <strong>for</strong> their generous sponsorship of this reception.<br />

ASRM Cocktail Reception and Dinner – Theater of the Imagination<br />

Monday, January 14 – 7:00pm – 10:30pm<br />

Cost: One admission included in ASRM registration. Additional tickets available @ $100 each; tickets <strong>for</strong> children and young adults ages 5 - 20 @ $50 each.<br />

Journey beyond the depths of your imagination during this elegant and entertaining evening. From the sparkling flutes of champagne, to delectable<br />

gourmet dining, each one of your senses will be stirred. Your perception of the abilities of the human body will be <strong>for</strong>ever changed. Through a fusion<br />

of strength, flexibility and technical skill, a cast of Cirque Du Soleil-inspired per<strong>for</strong>mances will dazzle, as suspenseful aerial acrobatics and ground level<br />

feats of dexterity are per<strong>for</strong>med be<strong>for</strong>e your very eyes. Adult admission includes a reception with beverages and hors d’oeuvres, 3 course dinner, wine<br />

and Cirque Du Soleil per<strong>for</strong>mances throughout dinner.<br />

The ASRM would like to thank ASSI <strong>for</strong> their generous sponsorship of the cocktail reception.<br />

ASRM Day At The Links<br />

Monday, January 14 - 12:30pm shotgun (depart hotel at 11:15am)<br />

Cost: $225 per player. Tickets are non-refundable.<br />

The ASRM day at the links will take place at the private Mountain Gate Country Club. By special privilege, ASRM has been granted an opportunity to<br />

play this exclusive Ted Robinson designed course that boasts a challenging play that’s as inviting as the scenery. Gorgeous views of the Santa Monica<br />

Mountains and rolling elevation changes makes <strong>for</strong> a truly unique golf outing. (Prizes will be awarded) Tournament registration will officially close on<br />

Sunday, January 13 at 12:00pm. If you prefer to be paired with specific players, requests must be submitted to our <strong>Meeting</strong> Services staff by this time.<br />

Tournament costs include transportation, lunch at the course, hosted beverage cart during play, greens fees, cart, tournament coordination, prizes and<br />

range balls. Limited club rentals are available to rent with advance reservation at $45 per set.<br />

ASRM Guest Fee<br />

Have your guest or spouse join you <strong>for</strong> ASRM social events, breakfasts and lunches Saturday – Tuesday at a reduced price. Please see ASRM daily<br />

schedules <strong>for</strong> details. These individuals will not receive CME credit. Any attendee that intends to attend general sessions and receive CME credit<br />

must register as a regular attendee.<br />

The All Inclusive Registration Packages<br />

Receive the following benefits <strong>for</strong> the meeting or meetings that you are registering <strong>for</strong>.<br />

AAHS, ASRM or ASPN: Admission to all instructional courses ● Access to speaker presentations ● Admission <strong>for</strong> each evening<br />

networking event Breakfast & lunch served per the agenda ● Refreshment breaks ● Access to the Exhibit Hall<br />

Free internet access in Exhibit Hall ● Self-Guided computerized CME courses (ASRM only)<br />

Valuable CME Hours ● 2008 Program Book complete with abstracts ● Discounted hotel rates.<br />

The AAHS Comprehensive Review Course and the ASRM Master Series require an additional admission purchase. Additional<br />

evening network event admission is available <strong>for</strong> your guests at an additional cost.<br />

12


2008 EXHIBITOR LISTING<br />

AMERICAN SOCIETY OF<br />

PLASTIC SURGEONS<br />

Booth: 50<br />

Emily Matzelle<br />

<strong>American</strong> Society of Plastic Surgery<br />

444 East Algonquian Road<br />

Arlington Heights, IL 60005<br />

phone: 847-228-9900<br />

fax: 847-981-5482<br />

email: ejm@plasticsurgery.org<br />

www.plasticsurgery.org<br />

The <strong>American</strong> Society of Plastic Surgeons is the largest organization of board-certified<br />

plastic surgeons in the world. With 6,000 members, the society is recognized as<br />

a leading authority and in<strong>for</strong>mation source on cosmetic and reconstructive plastic<br />

surgery. The society represents physicians certified by The <strong>American</strong> Board of<br />

Plastic Surgery or The Royal College of Physicians and Surgeons of Canada.<br />

AM SURGICAL<br />

Booth: 47<br />

Marc Binnick<br />

290 East Main Street, Ste. 200<br />

Smithtown, NY 11787<br />

phone: 800-437-9653<br />

fax: 631-980-4369<br />

email: mbinnick@amsurgical.com<br />

www.amsurgical.com<br />

Visit A.M. Surgical at booth # 47 to learn about our single-incision, scope-assisted<br />

carpal and cubital tunnel release procedures. We will also be hosting sawbones<br />

demonstrations at our booth <strong>for</strong> our novel, non-spanning fixator (The CPX) <strong>for</strong> distal<br />

radius fractures. The CPX provides multi<strong>plan</strong>ar fixation through an external, unilateral<br />

frame resulting in early mobilization and return to ADL.<br />

APTIS MEDICAL LLC.<br />

Booth: 45<br />

Bill Sandbach<br />

5 River Hill Road<br />

Louisville, KY 40207<br />

phone: 502.500.7000<br />

fax: 502.897.9007<br />

email: bills@aptismedical.com<br />

www.aptistmedical.com<br />

Aptis Medical has invented and developed upper extremity prosthesis including<br />

the Scheker Distal Radio-Ulnar Joint. The Scheker DRUJ Prosthesis has none of<br />

the widely known weaknesses associated with alternative procedures:<br />

1) Soft Tissue Arthroplasty: short-lived<br />

2) Single Bone Forearm: innobility<br />

3) Salvage procedures: impingement<br />

4) Allograft procedures: high cost of anti-rejection drugs/steriod risk<br />

5) Other prosthetic devices: replace only one of the three primary<br />

components of the DRUJ.<br />

ASCENSION ORTHOPEDICS<br />

Booth: 7<br />

Leigh Lovato<br />

8700 Cameron Road<br />

Suite 100<br />

Austin, TX 78754<br />

phone: 512-836-5001<br />

fax: 512-836-5145<br />

email: llovato@ascensionortho.com<br />

www.ascensionortho.com<br />

Ascension Orthopedics is dedicated to combining advanced materials with innovative<br />

designs, focusing on extremity surgery, and leading the field in surgeon<br />

education. Our founders are pioneers in using advanced materials to combat the<br />

debilitating effects of arthritis. Our goal is to provide solutions <strong>for</strong> all areas of surgery<br />

– reconstruction, trauma and tissue regeneration.<br />

13<br />

ASSI - ACCURATE SURGICAL<br />

Booth: 14<br />

Marie Bonazinga<br />

300 Shames Drive<br />

Westbury, NY 11590<br />

phone: 800-645-3569<br />

fax: 516-997-4948<br />

email: assi@accuratesurgical.com<br />

www.accuratesurgical.com<br />

ASSI will feature the Engler Breast Retractor, the Stanger C Breast Retractors and<br />

the new Lalonde Breast Sizers, the Lalonde Percutaneous Bone Clamp with K-wire<br />

guide, Face Lift Retractors, Campbell Lip Awl, Matarasso Lipo Roller and<br />

SuperCut Face Lift Scissors, ASSI’s Bipolar Scissors, Micro Monopolar Forceps,<br />

the Surex Sural Nerve Extractor and Nerve Holding/Cutting Forceps. ASSI’s <strong>Hand</strong><br />

Crafted Microsurgical Instruments and Clinical Microvascular Clamps.<br />

AXOGEN, INC.<br />

Booth: 20<br />

Douglas Silber<br />

13859 Progress Boulevard<br />

Suite 100<br />

Alachua, FL 32615<br />

phone: 386-462-6816<br />

fax: 386-462-6801<br />

email: dsilber@axogeninc.com<br />

www.axogeninc.com<br />

AxoGen Nerve Regeneration provides surgeons with solutions to repair and<br />

regenerate peripheral nerves, bringing relief and restoring function to patients<br />

who suffer peripheral nerve injuries. AxoGen is a leader in the advancement of<br />

peripheral nerve repair – creating a unique combination of patented technologies<br />

and a rich pipeline of new products.<br />

BIOMET TRAUMA<br />

Booth: 23<br />

Steven Rassner<br />

100 Interpace Parkway<br />

Parsippany, NJ 07054<br />

phone: 973-299-9300<br />

fax: 973-316-2452<br />

email: steven.rassner@ebimed.com<br />

www.biomedtrauma.com<br />

Biomet Trauma develops and markets a full range of internal/external orthopedic<br />

devices used <strong>for</strong> upper extremity fracture fixation. This includes the OptiLockâ<br />

Distal Radius Plating System with SphereLockTM technology, UNIFLEXâ Humeral<br />

Nails, Variable Pitch Compression Screws, OptiROMâ Elbow Fixators and a variety<br />

of distal radius fixators.<br />

BIO PRO, INCORPORATED<br />

Booth: 40<br />

Jason Schneider<br />

17 Seventeenth Street<br />

Port Huron, MI 48060<br />

phone: 810-982-7777<br />

fax: 810-982-7794<br />

email: jschneider@bioproim<strong>plan</strong>ts.com<br />

www.bioproim<strong>plan</strong>ts.com<br />

BioPro manufactures the Modular Thumb Im<strong>plan</strong>t <strong>for</strong> the CMC joint, Nitinol<br />

Memory Staples <strong>for</strong> arthrodesis and fracture fixation, and the Digital Compression<br />

Screw <strong>for</strong> digital IP joint fusion.


BME<br />

Booth: 8<br />

Lisa May<br />

14785 Omicon Drive<br />

Suite 205<br />

San Antonio, TX 78245<br />

phone: 800-880-6528<br />

fax: 210-677-0355<br />

email: lisamay@bme-tx.com<br />

www.bme-tx.com<br />

The BME OSStaple and OSSPlate are changing the way surgeons manage<br />

fractures, fusions and osteotomies. The OSS<strong>for</strong>ce offers controlled compression<br />

of Nitinol im<strong>plan</strong>ts, which provide continual compression throughout the<br />

healing process. This controllable residual compression is what sets the<br />

OSStaple and OSSplate fixation system in a category of its own.<br />

COOK MEDICAL<br />

Booth: 17<br />

750 Daniels Way<br />

Bloomington, IN 47404<br />

Fax: 800-554-8335<br />

phone: 800-468-1379<br />

email: info@cookmedical.com<br />

www.cookmedical.com<br />

Cook ® Medical presents two unique products: The Cook-Swartz im<strong>plan</strong>table<br />

Doppler Blood Flow probe with new DP-M250 Monitor offers the latest technology<br />

<strong>for</strong> continuous confirmation of vascular patency. Surgisis ® , a resorbable<br />

porcine small intestinal submucosa biomaterial provides a scaffold <strong>for</strong> host tissue<br />

remodeling, creating natural, cost-effective alternative to surgical repair.<br />

DEPUY ORTHOPEDICS,<br />

INCORPORATED<br />

Booth: 36<br />

Lynn Best<br />

700 Orthopaedic Drive<br />

Warsaw, IN 46580<br />

phone: 574-371-4979<br />

fax: 574-372-7382<br />

email: dpyus@.jnj.com<br />

DePuy Orthopaedics Inc., a Johnson and Johnson Company, is the world’s oldest<br />

and largest orthopaedic company and is a leading designer, manufacturer and distributor<br />

of orthopaedic devices and supplies. DePuy products are used in both surgical<br />

and non-surgical therapies to treat patients with musculoskeletal conditions<br />

resulting from degenerative diseases, de<strong>for</strong>mities, trauma and sports related injuries.<br />

ELESVIER/SAUNDERS/MOSBY<br />

Booth: 9<br />

Matt Fee<br />

11363 Dulcet Avenue<br />

Northridge, CA 91326<br />

phone: 818-831-6717<br />

fax: 818-360-5903<br />

email: m.fee@elsevier.com<br />

www.elsevier.com<br />

Elsevier-Saunders-Mosby- is the world’s largest medical book publisher. The latest<br />

hand therapy and surgery textbooks will be available <strong>for</strong> viewing.<br />

HAND REHABILITATION FOUNDATION<br />

Booth: 19<br />

Leslie Ristine<br />

834 Chestnut Street, G114<br />

Philadelphia, PA 19107<br />

phone: 215-925-4579<br />

fax: 215-925-2386<br />

email: lristine@handfoundation.org<br />

The <strong>Hand</strong> Rehabilitation Foundation, established in 1975, is a 501(c)3 non profit<br />

corporation <strong>for</strong>med to promote research and education, and disseminate in<strong>for</strong>mation<br />

to physicians and therapists who work with children and adults with hand<br />

disorders caused by injury, disease or present at birth.<br />

14<br />

HOLOGIC, INCORPORATED<br />

Booth: 15<br />

Laura L. DiGangi<br />

35 Cosby Drive<br />

Bed<strong>for</strong>d, MA 01730<br />

phone: 781-999-7667<br />

fax: 781-280-0668<br />

email: ldigangi@hologic.com<br />

www.hologic.com<br />

Fluoroscan ® mini C-arm X-ray systems from Hologic are designed <strong>for</strong> orthopedic<br />

surgeons per<strong>for</strong>ming minimally invasive surgical procedures of the extremities, as<br />

well as <strong>for</strong> low-dose, in-office imaging.<br />

HOODMAN CORPORATION<br />

Booth: 2<br />

Lou Schmidt<br />

20445 Gramercy Place #201<br />

Torrance, CA 90501<br />

phone: 310-222-8608<br />

fax: 310-222-8623<br />

email: lou@hoodmanusa.com<br />

www.hoodmanusa.com<br />

Introduces its United States Ergonomics Certified ThermalRest ® ThermalRest ® is a<br />

Heated Computer Keyboard Wrist Pad which relieves wrist and hand pain associated<br />

with keyboard operating. CSA Safety Certified.<br />

INNOMED, INC.<br />

Booth 43<br />

Shannon Willhite<br />

HR Manager<br />

103 Estus Drive<br />

Savannah, GA 31404<br />

phone: 913-236-0000/109<br />

fax: 912-236-7766<br />

email: shannon@innomed.net<br />

www.innomed.net<br />

Innomed, Inc., a developer of instruments <strong>for</strong> orthopedic surgery, continues to<br />

introduce new and innovative products. We offer an array of unique instruments<br />

and patient positioning devices, designed by or in conjunction with orthopedic<br />

surgeons and surgical professionals.<br />

INTEGRA<br />

Booth: 12<br />

Jon Trout<br />

311 Enterprise Drive<br />

Plainsboro, NJ 08536<br />

phone: 609-275-0500<br />

fax: 609-799-3297<br />

email: jtrout@integra-ls.com<br />

www.integra-ls.com<br />

Integra develops, manufactures, and markets medical devices <strong>for</strong> neuro-trauma<br />

and neurosurgery, plastic and reconstructive surgery and general surgery. Integra’s<br />

peripheral nerve surgery products include NeuraGen <strong>for</strong> completely severed<br />

nerves and NeuraWrap <strong>for</strong> compressed, scarred or partially injured nerves


LIPPINCOTT, WILLIAMS & WILKINS<br />

Booth: 39<br />

Sean Fee<br />

11636 Andasol Avenue<br />

Granda Hills, CA 91344-2203<br />

phone: 818-363-0477<br />

fax: 603-372-0007<br />

email: sean.fee@woltersklower.com<br />

www.lww.com<br />

Lippincott Williams & Wilkins (LWW) is a leading international publisher of professional<br />

health in<strong>for</strong>mation <strong>for</strong> physicians, nurses, specialized clinicians and students.<br />

The latest <strong>Hand</strong> surgery books from Lippincott, Thieme, and Springer will<br />

be on display.<br />

MAST BIOSURGERY<br />

Booth: 46<br />

David Goodman<br />

6749 Top Gun St., Suite 108<br />

San Diego, CA 92121<br />

phone: 858-550-8050<br />

fax: 858-550-8060<br />

email: dgoodman@mastbio.com<br />

www.mastbio.com<br />

The OrthoWrap Bioresorbable Protective Sheet is designed to protect tendons and<br />

minimize soft tissue attachments (STAs) to the device. MAST Biosurgery is a leader<br />

in the design, development, and production of bioresorbable polymer im<strong>plan</strong>ts,<br />

and emerging new technologies <strong>for</strong> use in a variety of surgical applications.<br />

MEDARTIS, INC.<br />

Booth: 18<br />

Norman Eckley<br />

127 W. Street Road<br />

Suite 203<br />

Kennett Square, PA 19348<br />

phone: 610-961-6101<br />

fax: 610-961-6108<br />

email: Norman.eckley@medartis.com<br />

www.medartis.com<br />

Medartis is recognized around the world as an innovator in the use of Polyaxial screw<br />

fixation <strong>for</strong> the treatment of Distal Radius and <strong>Hand</strong> fractures. Since 2001, MEDAR-<br />

TIS has continued to develop exceptional im<strong>plan</strong>ts and elegant instrumentation,<br />

finely crafted in the Swiss tradition of Orthopaedics.<br />

MEDICAL COMMUNICATIONS MEDIA<br />

Booth: 4<br />

Linda Hopkins<br />

54 Friends Lane, Suite 125<br />

Newtown, PA 18940<br />

phone: 267-364-0556<br />

fax: 267-364-0567<br />

www.cmecorner.com<br />

The CME Corner center is a unique service of Medical Communications Media,<br />

Incorporated and is intended to provide AAHS members with access to a free CME<br />

monograph on the topic of Dupuytren’s Contracture. Free copies of the monograph<br />

will be available at the exhibit.<br />

MEDLINK USA, INC.<br />

Booth: 5<br />

Tod Kellen<br />

PO BOX 42483<br />

Des Moines, IA 50323<br />

phone: 800-762-7921<br />

fax: 800-329-5990<br />

email: tkellen@medlinkusa.com<br />

www.medlinkusa.com<br />

15<br />

MEDTRONIC ENT<br />

Booth: 22<br />

6743 Southpoint Drive North<br />

Jacksonville, FL 32216<br />

phone: 904-296-9600<br />

fax: 904-281-0966<br />

Medtronic ENT is a leading developer, manufacturer and marketer of surgical products<br />

<strong>for</strong> use by ENT specialists. Medtronic ENT markets over 5,000 surgical products<br />

worldwide addressing the major ENT subspecialties – Sinus, Rhinology,<br />

Laryngology, Otology, Pediatric ENT. and Image Guided Surgery.<br />

MICRINS SURGICAL, INC.<br />

Booth: 11<br />

Bern Teitz<br />

28438 Ballard Drive<br />

Lake Forest, IL 60048<br />

phone: 847-549-1410<br />

fax: 847-549-1510<br />

email: bern@micrins.com<br />

www.micrins.com<br />

MICRINS is featuring some of our most popular instruments and accessories <strong>for</strong><br />

<strong>Hand</strong> surgery, Micro-reconstructive surgery and Aesthetic surgery. With over 3500<br />

different patterns we are certain that we will have just the right instrument that you<br />

are looking <strong>for</strong>. Make a point to reserve some time and stop by the MICRINS booth.<br />

MICROSURGERY INSTRUMENTS, INC.<br />

Booth: 6<br />

Nancy Kang<br />

7211 Regency Sq. Blvd, #223<br />

Houston, TX 77036<br />

phone: 713-664-4707<br />

MICROSURGERY INSTRUMENTS, INC.<br />

fax: 713-664-8873<br />

email: microusa@microsurgeryusa.com<br />

Microsurgery Instruments, Inc. is one of the leading suppliers of instruments and surgical<br />

loupes in the United States. We are well known in a large number of surgical<br />

fields. Apart from high-quality loupes (from 2.5x to 11x), we also have super-cut scissors,<br />

titanium instruments, vascular clamps, headlights, sutures, microscopes and<br />

other surgical instruments<br />

MMI<br />

Booth: 33<br />

Melissa Rattle<br />

6000 Poplar Avenue<br />

Memphis, TN 38119<br />

phone: 901-685-7557<br />

fax: 901-683-7077<br />

email: mrattle@mmi-usa.com<br />

www.mmi-usa.com<br />

MMI is the U.S. Subsidiary of Memometal Technologies. Founded in 1992,<br />

Memometal Technologies is one of the only fully integrated manufacturers of<br />

Nitinol (NiTi) in the world. Memometal produces their Nitinol products from raw<br />

material (melting) to the final sterile im<strong>plan</strong>t. In 2002, Memometal Technologies<br />

began a strategic ef<strong>for</strong>t to concentrate its core technology and ef<strong>for</strong>ts in the<br />

extremity market (hand/wrist/elbow and foot/ankle).<br />

NEUROMETRIX<br />

Booth 44<br />

Leli Ng<br />

Marketing Specialist<br />

62 Fourth Ave<br />

Waltham, MA 02451<br />

phone: 981-890-9989<br />

fax: 981-890-1556<br />

email: info@neurometrix.com<br />

www.neurometrix.com<br />

The NC-stat® Nerve Conduction System enables all physicians to measure neuropathies<br />

related to diabetes and common conditions such as radiculopathy,<br />

spinal stenosis, sciatica, and carpal tunnel syndrome. Physicians order tests & staff<br />

administers under guidance. NC-stat has been clinically validated in 45 peerreviewed<br />

journal articles and abstracts.


NORTH COAST MEDICAL<br />

Booth: 1<br />

Roy Beckham<br />

18305 Sutter Boulevard<br />

Morgan Hill, CA 95037<br />

phone: 408-776-5000<br />

fax: 408-776-5087<br />

email: rbeckham@ncmedical.com<br />

www.ncmedical.com<br />

North Coast Medical specializes in the manufacture and wholesale distribution of<br />

occupational, physical and hand therapy products. For over 30 years, North Coast<br />

has established itself as the premier supplier of clinical supplies by providing outstanding<br />

customer service, exceptional quality products and competitive pricing.<br />

NOVADAQ TECHNOLOGIES<br />

INCORPORATED<br />

Booth: 41<br />

Mary Kay Baggs<br />

6473 Saddlewood Lane<br />

Fairhope, AL 36532<br />

phone: 772-559-9902<br />

fax: 772-929-0992<br />

email: mbaggs@novadaq.com<br />

www.novadaq.com<br />

Novadaq commercializes medical imaging systems and real-time image guided therapies<br />

<strong>for</strong> use in the operating room. Novadaq's proprietary imaging systems can be<br />

used to visualize blood vessels, nerves and the lymphatic system during a variety of surgical<br />

procedures. Novadaq's SPY ® Imaging System enables surgeons to visually assess<br />

blood flow and tissue perfusion during the course of plastic reconstructive surgery.<br />

NUTEK<br />

Booth: 38<br />

Jim Tyson<br />

301 SW 7th Street<br />

Fort Lauderdale, FL 33315<br />

phone: 954-779-1400<br />

fax: 954-779-1900<br />

email: jim@nutekortho.com<br />

www.nutekortho.com<br />

Nutek Orthopaedics, INC, was <strong>for</strong>med in Sep. 2006. Its first products are the NBX<br />

non-bridging external fixator and the First Assistant wrist fracture reduction<br />

device. Used in tandem these two products provide the surgeon with a combined<br />

MIS surgical and rehab. solution <strong>for</strong> distal radius fractures.<br />

ORFIT ® INDUSTRIES AMERICA<br />

Booth: Hall – Wednesday Only<br />

Debby Schwartz<br />

350 Jericho Turnpike, Suite 101<br />

Jericho, NY 11753<br />

phone: 516-935-8500<br />

fax: 516-935-8505<br />

email: debby.schwartz@orfit.com<br />

www.orfit.com<br />

Orfit ® Industries America is a world leader in the <strong>for</strong>mulation, development and manufacture<br />

of low temperature thermoplastic materials <strong>for</strong> over 20 years. There is a wide<br />

range of Orfit ® splinting materials available to meet all therapy requirements and personal<br />

preferences. Orfit ® splinting materials are available in an unmatched number of<br />

thicknesses and per<strong>for</strong>ation styles. Orfit ® offers innovative splinting materials that<br />

enable you to create elegant solutions <strong>for</strong> all of your splinting challenges.<br />

ORTHOSCAN, INC.<br />

Booth: 27<br />

Tiffany Townsend<br />

8212 E. Evans Road<br />

Scottsdale, AZ 85260<br />

phone: 480-503-8010<br />

fax: 480-503-8011<br />

email: tiffany.townsend@orthoscan.com<br />

www.orthoscan.com<br />

OrthoScan re-invented the Mini C-Arm with the goal of bringing “Mini” back to<br />

Mini C-arms, with a light weight, easy to use, high definition image. In addition to<br />

this improved resolution, we have the largest image on the market and the most<br />

contrasted image. OrthoScan is 100% dedicated to the orthopedic surgeon and<br />

100% dedicated to the Mini C-Arm.<br />

16<br />

ROBBINS INSTRUMENTS<br />

Booth: 16<br />

William Sabella<br />

2 North Passiac Avenue<br />

Chatham, NJ 07928<br />

phone: 800-206-8649<br />

fax: 973-635-8732<br />

email: williamsabella@cox.net<br />

www.robbinsinstruments.com<br />

Robbins Instruments will have on display our “High Torque” Micromotor Surgical<br />

System with surgical hand pieces <strong>for</strong> K-Wire placement, cutting and contouring<br />

bone and skin grafting.<br />

SMALL BONE INNOVATIONS<br />

Booth: 10<br />

Caralyn Foster<br />

1380 South Pennsylvania Avenue<br />

Morrisville, PA 19067<br />

phone: 215-428-1791<br />

fax: 215-428-1805<br />

email: cfoster@totalsmallbone.com<br />

www.totalsmallbone.com<br />

Small Bone Innovations, Inc. (SBi), is a single-source provider of products, technology<br />

and education <strong>for</strong> the small bone and joint sector of the orthopedic market. Please<br />

come visit us at Booth #10 at the 2008 AAHS <strong>Meeting</strong>.<br />

SPRINGER<br />

Booth: 26<br />

Acasia Dalmau<br />

233 Spring Street<br />

New York, NY 10013<br />

phone: 212-460-1600<br />

fax: 201-272-1832<br />

email: exhibits-ny@springer.com<br />

www.springer.com<br />

Stop by and browse Springer’s selection of <strong>Hand</strong> Surgery publications, and pick<br />

up your free sample copy of HAND, the new official journal of the <strong>American</strong><br />

<strong>Association</strong> <strong>for</strong> <strong>Hand</strong> Surgery.<br />

STRYKER ORTHOPAEDICS<br />

Booth: 13<br />

Peter Valente<br />

325 Corporate Drive<br />

Mahwah, NJ 07430<br />

phone: 201-831-5276<br />

fax: 201-831-6453<br />

email: peter.valente@stryker.com<br />

www.stryker.com<br />

Stryker range of Upper Extremities and <strong>Hand</strong> Products offers a full range of options<br />

from Intramedullary nails, external fixation devices, screws, pins, plates and new<br />

orthobiologic solutions <strong>for</strong> fracture treatment. Industry recognized product lines<br />

such as T2 ® , Hoffmann, Asnis III, Variax and Profyle <strong>Hand</strong> Products.<br />

SYNOVIS MCA<br />

Booth: 30<br />

Terry Harrell<br />

739 Industrial Lane<br />

Birmingham, AL 35211<br />

phone: 205-941-0111<br />

fax: 205-941-1522<br />

email: terry.harrell@synovis.com<br />

www.synovis.com<br />

Synovis MCA, “the microsurgeon’s most trusted resource, provides innovative<br />

advanced technologies <strong>for</strong> microsurgeons. Come see our products: The<br />

Micorvascular Anastomotic COUPLER, GEM Neurotube ® - the proven choice in<br />

nerve conduits, S&T ® Collagen Matrix – <strong>for</strong> soft tissue repair, Biover disposable<br />

microvascular clamps, and the Life optics Varioscope ® - the world’s smallest headmounted<br />

operating microscope.


SYNTHES CMF<br />

Booth: 21<br />

Angela Obzud<br />

1301 Goshen Parkway<br />

West Chester, PA 19380<br />

phone: 610-719-6552<br />

fax: 610-719-6533<br />

email: obzud.angela@synthes.com<br />

www.synthes.com<br />

Synthes CMF is the sole authorized North <strong>American</strong> manufacturer and distributor<br />

of AO ASIF instruments and im<strong>plan</strong>ts <strong>for</strong> internal fixation of craniomaxillofacial and<br />

mandibular trauma and reconstruction. Our product offering includes distraction<br />

osteogenesis devices, resorbable plating, and bone graft substitutes. Synthes<br />

CMF also supports North <strong>American</strong> AO ASIF Continuing Education courses.<br />

THE GUATEMALA HEALING<br />

HANDS FOUNDATION<br />

Booth: 52<br />

Mona Lipson<br />

290 6th Avenue<br />

Brooklyn, NY 11215<br />

phone: 718-768-5927<br />

email: monalipson@hotmail.com<br />

www.guatemalahands.org<br />

GHHF is a nonprofit organization dedicated to improving the quality and availability<br />

of hand care in Guatemala through education, surgery, and therapy.<br />

Specializing in the treatment of congenital and hand injuries, we aim to reach the<br />

Guatemalan population through medical missions led by a volunteer team of<br />

specialized and skilled surgeons, therapists, and dedicated volunteers.<br />

TORNIER<br />

Booth: 37<br />

Caroline Muigai<br />

10750 Cash Road<br />

Staf<strong>for</strong>d, TX 77477<br />

phone: 281-494-7900<br />

fax: 281-494-0206<br />

email: cmuigai@tornier.com<br />

www.tornier-us.com<br />

The TORNIER Company is a global orthopaedic medical device company specializing<br />

in the design, manufacture and marketing of reconstructive joint devices.<br />

Please visit our booth and see our comprehensive portfolio of innovative products<br />

<strong>for</strong> upper extremity applications including the CoverLoc Volar Plate.<br />

TRIMED, INC.<br />

Booth: 3<br />

Jim Fassett<br />

25864 Tournament Road<br />

Valencia, CA 91355<br />

phone: 508-668-0988<br />

fax: 508-668-0212<br />

email: Tania@trimedortho.com<br />

www.trimedortho.com<br />

Founded in 1995, TriMed revolutionized the treatment of distal radius fractures.<br />

TriMed® is one of the most dynamic companies in the field of orthopaedics with<br />

its Advanced Fixation Technologies. The company specializes in small fragment<br />

and peri-articular fractures fixation and holds numerous patents on its innovative<br />

fracture fixation products<br />

17<br />

TRUEVISION SYSTEMS, INC.<br />

Booth: 29<br />

Latifa McQuiggan<br />

114 East Haley Street, Suite L<br />

Santa Barbara, CA 93101<br />

phone: 805-963-9700<br />

fax: 805-963-9719<br />

email: latifa@truevisionsys.com<br />

www.truevisionsys.com<br />

TrueVision is a revolutionary 3HDH vision system <strong>for</strong> microsurgery. The True<br />

Vision System converts the optical 3D image viewed through the microscope to<br />

a digital 3D high-definition image displayed to a projection screen or monitor in<br />

real time. It’s an ideal tool in surgery, teaching and collaboration.<br />

UPEX<br />

Booth: 24<br />

Dipak Rajhansa<br />

1300 Minnesota Avenue #101<br />

Winter Park, FL 32789<br />

phone: 407-539-2704<br />

fax: 407-539-2765<br />

email: info@upexco.com<br />

www.upexco.com<br />

VIOPTIX, INC.<br />

Booth: 28<br />

Denise Yarmlak<br />

44061-B Old Warm Springs Blvd.<br />

Fremont, CA 94538<br />

phone: 510-226-5806 x 217<br />

fax: 510-226-5864<br />

email: yarmlakd@vioptix.com<br />

www.vioptix.com<br />

The ViOptix Tissue Oximeter provides continuous, non-invasive, direct, real-time<br />

measurements of local tissue oxygen saturation. It is used <strong>for</strong> post-operative monitoring<br />

of flaps and digit re<strong>plan</strong>ts to assess and monitor tissue, thereby improving<br />

medical outcomes and decreasing cost. The system consists of a monitor and sterile<br />

single-use optical sensors.


AAHS CONTINUING MEDICAL EDUCATION<br />

AAHS MEETING OBJECTIVES:<br />

1. To arrange clinical and basic science panels, special speakers, instructional courses and skill workshops on a variety of hand and upper extremity problems including<br />

therapy issues.<br />

2. To assemble a specialty day with experts in the field reviewing all aspects of the current medical treatments of arthritis, as well as new techniques in joint replacement,<br />

fusion and therapy techniques <strong>for</strong> the complete care of the arthritic hand patient, both osteo and rheumatoid.<br />

3. To contrast and compare the intellectual discourses of the annual meeting through an integrated program with the ASRM and ASPN.<br />

4. To learn and apply new skills during courses on hands <strong>for</strong> the replacement of new joints, plates, fracture management, hand soft tissue reconstruction <strong>for</strong> the<br />

upper extremity patient.<br />

5. Debate panel presentations on the following topics: the wide awake approach to hand surgery in an office setting with local anesthesia, the problem of ulnar<br />

nerve compression, neuropathies of the elbow, cubital tunnel syndrome, scaphoid fractures and management both non-operative and operative with newer techniques<br />

and compression screws.<br />

6. To appraise a presidential guest speaker, who is a Micorsoft engineer, will discuss new techniques in genetic engineering and im<strong>plan</strong>table computer chips in the<br />

brain to help patients with paralysis, stroke, blindness and hearing deficits.<br />

7. To define current practices in wrist and hand fracture management.<br />

8. To demonstrate new surgical techniques in tendon, nerve and soft tissue repair.<br />

9. To acquire evidence based knowledge of current trends in the management of arthritis of the hand and wrist.<br />

10. To critique and appraise the latest basic science research in tissue engineering, composite tissue allografts and joint replacements.<br />

11. To discuss challenges and management issues in peripheral nerve surgery.<br />

METHODS TO ACHIEVE THESE OBJECTIVES WILL BE:<br />

1. Original research papers will be presented and discussed throughout the meeting.<br />

2. Poster presentations that were not selected <strong>for</strong> podium presentation will be presented and available <strong>for</strong> all members to review.<br />

3. All of the panelists are recognized experts and published in the international literature, in regards to those topics of nerve, out patient, local anesthetic surgery,<br />

patient safety issues ands- scaphoid and wrist fractures with problems discussed completely including therapy.<br />

4. Specialty day will include hand therapists as well as expert surgeons discussing an entire day on the treatment of the patient with osteo and rheumatoid arthritis,<br />

including a medical rheumatologist discussing current treatment protocols, as well as an entire review of all the new arthropplasty’s, fusions and a therapist will be<br />

included in every topic to discuss patient outcome, rapid recovery and patient safety issues in regards to therapy.<br />

5. Skills courses will be presented using cadaver related techniques to improve the hand surgeon and therapist understanding of newer techniques in joint arthroplasty,<br />

plating <strong>for</strong> fractures and soft tissue related issues <strong>for</strong> coverage of wounds.<br />

6. All attendees will have the opportunity to take a board review course which covers the entire aspect of board examination <strong>for</strong> the upper extremity surgeon, presented by a series<br />

of experts.<br />

7. Instructional courses will be offered throughout the program and will avail attendees with in<strong>for</strong>mation related to all aspects of hand surgery.<br />

ACCREDITATION/CME<br />

This activity has been <strong>plan</strong>ned and implemented in accordance with the Essential Areas and policies of the Accreditation Council <strong>for</strong> Continuing Medical Education<br />

through the joint sponsorship of the <strong>American</strong> Society of Plastic Surgeons and <strong>American</strong> Society <strong>for</strong> Peripheral Nerve. The <strong>American</strong> Society of Plastic Surgeons is accredited<br />

by the ACCME to provide continuing medical education <strong>for</strong> physicians.<br />

The <strong>American</strong> Society of Plastic Surgeons designates this educational activity <strong>for</strong> a maximum of 13.75 AMA PRA Category 1 credits. Physicians should only claim credit<br />

commensurate with the extent of their participation in the activity. (Credit hours subject to change):<br />

AAHS ANNUAL MEETING<br />

January 9-12, 2008 13.75 hours<br />

COMPREHENSIVE HAND SURGERY REVIEW COURSE<br />

January 11, 2008 4.5 hours<br />

AAHS/ASPN/ASRM COMBINED DAY<br />

January 12, 2008 4.0 hours<br />

Additional CME hours are available <strong>for</strong> Instructional/Bioskills Courses on an hour-<strong>for</strong>-hour basis, awarded solely based on registration lists, as follows:<br />

COURSE # CME COURSE # CME<br />

101-104 1.0 hours 112-116 1.0 hours<br />

105 2.0 hours 117-122 1.0 hours<br />

106 1.5 hours<br />

107-111 1.0 hour<br />

Credit hours are subject to program changes.<br />

COPYRIGHT<br />

All of the proceedings of the annual meeting, including the presentations of scientific papers, are intended solely <strong>for</strong> the benefit of the membership of the <strong>American</strong><br />

<strong>Association</strong> <strong>for</strong> <strong>Hand</strong> Surgery. No statement or presentation made at the meeting is to be regarded as dedicated to the public domain. Any statement or presentation<br />

is to be regarded as limited publication only and all property rights in the material presented, including common law copyright, are expressly reserved to the speaker or<br />

to the <strong>American</strong> <strong>Association</strong> <strong>for</strong> <strong>Hand</strong> Surgery. Any sound reproduction, transcript, or other use of material presented at the meeting without the permission of the speaker<br />

or the <strong>American</strong> <strong>Association</strong> <strong>for</strong> <strong>Hand</strong> Surgery is prohibited to thef ull extent of common law copyright in such material.<br />

THE USE OF CAMERAS OR PHOTOGRAPHIC EQUIPMENT IS NOT PERMITTED DURING THE PRESENTATION OF SCIENTIFIC PAPERS.<br />

18


ASPN CONTINUING MEDICAL EDUCATION<br />

ASPN MEETING OBJECTIVES:<br />

ASPN's commitment to research and education has encouraged the organization to add an additional day of programming to the regular two day schedule. New <strong>for</strong> 2008,<br />

ASPN attendees will meet on Friday, Saturday and Sunday to enhance their educational experience.<br />

1. Describe and discuss experimental techniques in nerve research.<br />

2. Identify emerging technologies in the management of nerve and extremity injuries.<br />

3. To explain electrodiagnostic evaluation of acute and chronic nerve injuries.<br />

4. To identify and describe the management of nerve injury and nerve tumors.<br />

5. To describe and discuss evolving management of nerve injury causing pain.<br />

6. To explain the physiology of the neuromuscular junction and muscle reinnervation.<br />

METHODS TO ACHIEVE THESE OBJECTIVES WILL BE:<br />

1. Scientific presentations on current and recent advances in research on nerve injury and repair.<br />

2. Seminars from invited experts on specialized topics related to reinnervation, reconstruction and nerve tumors.<br />

3. Invited lectures from clinical scientists and researchers in nerve biology, pathophysiology and injury.<br />

ACCREDITATION/CME<br />

This activity has been <strong>plan</strong>ned and implemented in accordance with the Essential Areas and policies of the Accreditation Council <strong>for</strong> Continuing Medical Education<br />

through the joint sponsorship of the <strong>American</strong> Society of Plastic Surgeons and <strong>American</strong> Society <strong>for</strong> Peripheral Nerve. The <strong>American</strong> Society of Plastic Surgeons is accredited<br />

by the ACCME to provide continuing medical education <strong>for</strong> physicians.<br />

The <strong>American</strong> Society of Plastic Surgeons designates this educational activity <strong>for</strong> a maximum of 12.75 AMA PRA Category 1 credits. Physicians should only claim credit<br />

commensurate with the extent of their participation in the activity. (Credit hours subject to change)<br />

ASPN ANNUAL MEETING<br />

January 11 – 13, 2008 12.75 hours<br />

AAHS/ASPN/ASRM COMBINED DAY<br />

January 12, 2008 4.0 hours<br />

Additional CME hours are available <strong>for</strong> Instructional Courses on an hour-<strong>for</strong>-hour basis, awarded solely based on registration lists, as follows:<br />

COURSE # CME<br />

Instructional Courses 301 – 305 1.00 hour each<br />

Credit hours are subject to program changes.<br />

COPYRIGHT<br />

All of the proceedings of the annual meeting, including the presentations of scientific papers, are intended solely <strong>for</strong> the benefit of the membership of the <strong>American</strong><br />

Society <strong>for</strong> Peripheral Nerve. No statement or presentation made at the meeting is to be regarded as dedicated to the public domain. Any statement or presentation<br />

is to be regarded as limited publication only and all property rights in the material presented, including common law copyright, are expressly reserved to the speaker or<br />

to the <strong>American</strong> Society <strong>for</strong> Peripheral Nerve. Any sound reproduction, transcript, or other use of material presented at the meeting without the permission of the speaker<br />

or the <strong>American</strong> Society <strong>for</strong> Peripheral Nerve is prohibited to the full extent of common law copyright in such material.<br />

DISCLAIMER<br />

The views expressed and the subject material presented in the course of any activities sponsored by the <strong>American</strong> Society <strong>for</strong> Peripheral Nerve including lectures, seminars,<br />

instructional courses, or otherwise, represent the personal views of the individual participants and do not represent the opinion of the <strong>American</strong> Society <strong>for</strong> Peripheral<br />

Nerve. The Society assumes no responsibility <strong>for</strong> such views or materials, or implied, <strong>for</strong> the content of any Society sponsored presentations. Further, the Society hereby<br />

acknowledges that while its broad purpose is to promote the development and exchange of knowledge pertaining to the practice of microsurgery; it does so only in<br />

the context of a private <strong>for</strong>um without making any representation to the public whatsoever. Accordingly, the Society declares that its primary purpose is to benefit only<br />

its members, and responsibility of the Society <strong>for</strong> acts or omissions of Society members dealing with the public is hereby expressly disclaimed.<br />

THE USE OF CAMERAS OR PHOTOGRAPHIC EQUIPMENT IS NOT PERMITTED DURING THE PRESENTATION OF SCIENTIFIC PAPERS.<br />

19


ASRM CONTINUING MEDICAL EDUCATION<br />

ASRM MEETING OBJECTIVES:<br />

1. To recognize and express updates on the state of the art techniques <strong>for</strong> microsurgical and complex reconstruction via peer reviewed scientific presentations<br />

on clinical and basic science research.<br />

2. To assemble scientific and academic interaction and foster collaboration amongst the <strong>American</strong> <strong>Association</strong> <strong>for</strong> <strong>Hand</strong> Surgery, the <strong>American</strong> Society <strong>for</strong> Peripheral<br />

Nerve and the <strong>American</strong> Society <strong>for</strong> Reconstructive Microsurgery.<br />

3. To arrange education opportunities <strong>for</strong> practicing surgeons, residents and fellows.<br />

4. To define and provide the attendees a focused update on specific topics in the <strong>for</strong>m of expert panel presentations.<br />

5. To integrate participation by colleagues from around the world.<br />

METHODS TO ACHIEVE THESE OBJECTIVES WILL BE:<br />

1. Free papers to be presented in the open <strong>for</strong>um that allows audience discussion.<br />

2. National and international experts will provide different instructional courses on each day of the meeting.<br />

3. Panels by national and international experts will discuss conventional, new and controversial aspects of microsurgery and complex reconstruction.<br />

4. Patient Safety CME will be available by meeting participation and specialized computer modules available throughout the program.<br />

5. Specific mailing and invitations will increase participation of colleagues from around the world.<br />

6. Daily social events will provide interaction amongst colleagues, societies, and trainees.<br />

7. A conjoint scientific session including panels, instructional courses will be maintained on Saturday with the AAHS and on Sunday with the ASPN.<br />

ACCREDITATION/CME<br />

This activity has been <strong>plan</strong>ned and implemented in accordance with the Essential Areas and policies of the Accreditation Council <strong>for</strong> Continuing Medical Education through<br />

the joint sponsorship of the <strong>American</strong> Society of Plastic Surgeons and <strong>American</strong> Society <strong>for</strong> Reconstructive Microsurgery. The <strong>American</strong> Society of Plastic Surgeons is accredited<br />

by the ACCME to provide continuing medical education <strong>for</strong> physicians.<br />

The <strong>American</strong> Society of Plastic Surgeons designates this educational activity <strong>for</strong> a maximum of 26 AMA PRA Category 1 credits. Physicians should only claim credit<br />

commensurate with the extent of their participation in the activity. (Credit hours subject to change):<br />

AAHS/ASRM/ASPN Combined Day<br />

January 12, 2008 4.0 hours<br />

ASRM Master Series in Microsurgery<br />

January 13, 2008 4.0 hours<br />

ASRM <strong>Annual</strong> <strong>Meeting</strong><br />

January 12 – 15, 2008 22 hours<br />

Additional CME hours are available <strong>for</strong> Instructional Courses on an hour-<strong>for</strong>-hour basis, awarded solely based on registration lists, as follows:<br />

Course # CME<br />

Instructional Courses 201 – 204 1.00 hour each<br />

Instructional Coruses 205 – 208 1.00 hour each<br />

Instructional Courses 209 – 212 1.00 hour each<br />

Instructional Courses 213 – 216 1.00 hour each<br />

Patient Safety Modules<br />

January 12 – 15, 2008 1.00 hour each<br />

Credit hours are subject to program changes.<br />

COPYRIGHT<br />

All of the proceedings of the annual meeting, including the presentations of scientific papers, are intended solely <strong>for</strong> the benefit of the membership of the <strong>American</strong><br />

Society <strong>for</strong> Reconstructive Microsurgery. No statement or presentation made at the meeting is to be regarded as dedicated to the public domain. Any statement or<br />

presentation is to be regarded as limited publication only and all property rights in the material presented, including common law copyright, are expressly reserved to<br />

the speaker or to the <strong>American</strong> Society <strong>for</strong> Reconstructive Microsurgery. Any sound reproduction, transcript, or other use of material presented at the meeting without<br />

the permission of the speaker or the <strong>American</strong> Society <strong>for</strong> Reconstructive Microsurgery is prohibited to the full extent of common law copyright in such material.<br />

DISCLAIMER<br />

The views expressed and the subject material presented in the course of any activities sponsored by the <strong>American</strong> Society <strong>for</strong> Reconstructive Microsurgery including lectures,<br />

seminars, instructional courses, or otherwise, represent the personal views of the individual participants and do not represent the opinion of the <strong>American</strong> Society<br />

<strong>for</strong> Reconstructive Microsurgery. The Society assumes no responsibility <strong>for</strong> such views or materials, or implied, <strong>for</strong> the content of any Society sponsored presentations.<br />

Further, the Society hereby acknowledges that while its broad purpose is to promote the development and exchange of knowledge pertaining to the practice of microsurgery;<br />

it does so only in the context of a private <strong>for</strong>um without making any representation to the public whatsoever. Accordingly, the Society declares that its primary<br />

purpose is to benefit only its members, and responsibility of the Society <strong>for</strong> acts or omissions of Society members dealing with the public is hereby expressly disclaimed.<br />

THE USE OF CAMERAS OR PHOTOGRAPHIC EQUIPMENT IS NOT PERMITTED DURING THE PRESENTATION OF SCIENTIFIC PAPERS.<br />

20


<strong>Association</strong> <strong>for</strong> <strong>Hand</strong> Surgery<br />

<strong>American</strong> Society <strong>for</strong> Peripheral Nerve<br />

<strong>American</strong> Society <strong>for</strong> Reconstructive Microsurgery<br />

2008 <strong>Annual</strong> <strong>Meeting</strong><br />

PRESENTERS’ DISCLOSURES<br />

THE FOLLOWING ANNUAL MEETING PRESENTERS HAVE INDICATED THE FOLLOWING DISCLOSURES:<br />

Brian Adams, MD, serves as a consultant to Ascension Orthopedics.<br />

Chris Attinger, MD, is on the speaker bureau <strong>for</strong> KCI, J&J, Novadsig, Insigon, and Smith &Nephew. He is also on the advisory panel of RCI and Smith & Nephew.<br />

Marie Badalamente, PhD, is a consultant <strong>for</strong> Auxilium Pharmaceuticals Inc.<br />

Robert Beckenbaugh, MD, receives royalties and travel assistance <strong>for</strong> laboratory from Ascension Orthopedics.<br />

Allan J. Belzberg, MD, receives grant support from DOD.<br />

Randy R. Bindra, MD, receives research support, non income support, and serves as consultant <strong>for</strong> DVO Tornier.<br />

Brandon M. Boyce, MD, receives WVU Dept of Orthopaedics.<br />

Charles Butler, MD, speaks <strong>for</strong> and receives clinical & research grant support from Life Cell Inc.<br />

Edward I. Chang, MD, receives stock support from Synvascular INC.<br />

Constance M. Chen, MD, receives research support from Allergan Corporation.<br />

Tyson Cobb, MD, receives research support from Wright Medical. He has also served as a consultant <strong>for</strong> SBI.<br />

William Cooney, MD, serves as a consultant to Small Bone Innovations.<br />

Vishal Didwania, BA, receives research and non income support from Integra Neurosciences.<br />

Haluk Duman, receives research support from Gulhane Military Medical Academy & Medical School.<br />

Gregory A. Dumanian, receives research support and non income support from Defense Department Research (DARPA), and DEKA Engineering.<br />

Michael Charles Edwards, MD, PhD, receives research support from the Michael Charles Edwards center, non income support from Medtronic, Inc.,<br />

and stock support from Human Electric, Inc.<br />

Neville Hogan, PhD, holds equity in Interactive Motion Tech., Inc., which manufactures robots <strong>for</strong> physiotherapy.<br />

Wei-Chao Huang, receives research support from Chang Gung Memorial Hospital.<br />

Jeffery M. Jacobson, MD, receives stock support <strong>for</strong> Allergan, Inc.<br />

Phillip Johnston, MA, MRCS, receives research support from Action Arthritis.<br />

Alex Keller, MD, is a consultant <strong>for</strong> ViOptix.<br />

Tosca Kinchelow, MD, receives research support, royalties, and is a consultant <strong>for</strong> Wright Medical.<br />

Lukasz Krokowicz, MD, receives research support and is a consultant <strong>for</strong> SanuWave.<br />

Amy L. Ladd, MD, receives research support from Packard Children’s Foundation grant, and OREF grant.<br />

Donald, Lalonde, MD, serves as a consultant to ASSI instruments.<br />

Wyndell Merritt, MD, serves as a consultant to Micro Aire, and receives royalties <strong>for</strong> their Epicut Knife.<br />

Ather Mirza, MD, holds stock with AM Surgical.<br />

Jose Monsivais, MD, receives research support from the University of Texas at El Paso.<br />

Wong Moon, MD, receives research support and non income support from Cleveland Clinic<br />

Arash Moradzadeh, MD, receives non income support from Axogen, Inc.<br />

Afshin Mosabebi, receives research support <strong>for</strong> Allergan Corporation<br />

Tanya M. Oswald, MD, receives research support from the University of Mississippi Medical Center.<br />

Jeff Rodgers, MD, receives research support from Integra Life Sciences.<br />

Laura Rummler, MS, receives research support from NIH and ASSH. She also is a consultant <strong>for</strong> the University of Cali<strong>for</strong>nia, Irvine.<br />

Michel C. Samson, MD, is a consultant <strong>for</strong> Novadaq.<br />

Robert Spinner, MD, receive royalties <strong>for</strong> work licensed through Mayo Clinic to a privately held company <strong>for</strong> contributions related to the use of nerve signal modulation<br />

to treat central, autonomic, and peripheral nervous system disorders, including pain. Mayo Clinic receives royalties and owns equity in this company. The company does<br />

not currently license or manufacture any drug or device in the medical field.<br />

Mario G. Solari, MD, received research support from AAHS, NIH, and PSEF.<br />

William Swartz, MD, receives royalties from Cook Vascular <strong>for</strong> his patent of the Cook Doppler Monitor.<br />

Shian Chao Tay, MBBS, FRCS, FAMS, receives research support from Siemens Medical Solutions, National Medical Research Council, and Mayo Foundation.<br />

Charles Y. Tseng, MD, receives non income support from ViOptix, Inc.<br />

Sami H. Tuffah, BA, receives research support from AxoGen, Inc.<br />

Robert Whitfield, MD, receives research support from Life Cell and Integra, and receives non income support from Alloderm.<br />

The following presenters will include a discussion of an “off-label” or other non-FDA-approved, investigational use of medical devices or pharmaceutical products during<br />

their presentation. They will disclose that the product is not labeled <strong>for</strong> use under discussion or that the product is still investigational.<br />

Peter B. Arnold, MD, PhD Candice O. McDaniel, MD<br />

Marie Badalamente, PhD Wong Moon, MD<br />

Rachel Bluebond-Langner, MD Peirong Yu, MD<br />

Alex Keller, MD<br />

All other faculty members responded to PSEF that they did not have a conflict of interest.<br />

21


FUTURE ANNUAL MEETING LOCATIONS<br />

AAHS<br />

2009 ANNUAL MEETING<br />

January 7 – 10, 2009<br />

Grand Wailea Resort Hotel and Spa<br />

Maui, Hawaii<br />

2010 ANNUAL MEETING<br />

January 6 – 9, 2010<br />

Boca Raton Resort and Club<br />

Boca Raton, Florida<br />

2011 ANNUAL MEETING<br />

January 12 – 15, 2011<br />

Ritz Carlton Cancun<br />

Cancun, Mexico<br />

2012 ANNUAL MEETING<br />

January 11 – 14, 2012<br />

Red Rock Casino Resort & Spa<br />

Las Vegas, Nevada<br />

ASPN<br />

2009 ANNUAL MEETING<br />

January 9 – 11, 2009<br />

Grand Wailea Resort Hotel and Club<br />

Maui, Hawaii<br />

2010 ANNUAL MEETING<br />

January 9 – 10, 2010<br />

Boca Raton Resort and Spa<br />

Boca Raton, Florida<br />

2011 ANNUAL MEETING<br />

January 15 – 16, 2011<br />

Ritz Carlton Cancun<br />

Cancun, Mexico<br />

2012 ANNUAL MEETING<br />

January 14 – 15, 2012<br />

Red Rock Casino Resort & Spa<br />

Las Vegas, Nevada<br />

22<br />

ASRM<br />

2009 ANNUAL MEETING<br />

January 10 – 13, 2009<br />

Grand Wailea Resort Hotel and Spa<br />

Maui, Hawaii<br />

2010 ANNUAL MEETING<br />

January 9 – 12, 2010<br />

Boca Raton Resort and Club<br />

Boca Raton, Florida<br />

2011 ANNUAL MEETING<br />

January 15 – 18, 2011<br />

Ritz Carlton Cancun<br />

Cancun, Mexico<br />

2012 ANNUAL MEETING<br />

January 14 – 17, 2012<br />

Red Rock Casino Resort & Spa<br />

Las Vegas, Nevada


AAHS<br />

DAY-AT-A-GLANCE<br />

Wednesday, January 9, 2008<br />

6:30am – 5:00pm Speaker Ready Room Cali<strong>for</strong>nia Showroom<br />

6:30am – 2:00pm <strong>Meeting</strong> Services Cali<strong>for</strong>nia Lounge<br />

6:30am – 7:30am Continental Breakfast Los Angeles<br />

7:00am – 4:30pm Specialty Day Program: Arthritis Los Angeles<br />

9:05am – 9:25am Break Cali<strong>for</strong>nia Showroom<br />

12:34pm – 12:55pm Lunch Cali<strong>for</strong>nia Showroom<br />

2:30pm – 3:30pm <strong>Hand</strong> Surgery Endowment Board of Governors <strong>Meeting</strong> Director’s Boardroom<br />

2:00pm – 3:00pm AAHS Instructional Courses<br />

101 Distal Radius Fracture Encino<br />

102 DRUJ Pacific<br />

103 Flexor Tendon Repair Palisades<br />

104 Extensor Tendon Injuries Brentwood<br />

2:00pm – 4:00pm 105 Treatment of Thumb CMC Arthritis Sherman Oaks<br />

3:00pm – 4:30pm 106 Splinting Challenges – Practical Pearls Westwood<br />

5:00pm – 7:00pm <strong>Meeting</strong> Services Cali<strong>for</strong>nia Lounge<br />

5:00pm – 6:00pm Therapists’ Reception Meland Suite<br />

6:00pm – 8:00pm AAHS Welcome Reception X Bar<br />

23


MEETING AGENDAS<br />

AAHS<br />

Wednesday, January 9, 2008<br />

6:30am – 7:30am Continental Breakfast<br />

7:00am – 7:15am President/Program Chair Welcome<br />

N. Bradley Meland, MD, President<br />

Michael Neumeister, MD, Program Chair<br />

Craig Johnson, MD, Program Chair<br />

Christine Novak, PT, MS, Program Chair<br />

7:15am – 9:05am MEDICAL/SURGICAL MANAGEMENT<br />

Craig Johnson, MD, Moderator<br />

7:15am Pathogenesis & Medical Management<br />

Steven Ytterberg, MD<br />

DIP/PIP<br />

7:40am PIP Arthroplasty<br />

Robert Beckenbaugh, MD<br />

8:05am Post Op Management Following PIP Arthroplasty<br />

Ann Lund, OTR, CHT<br />

MP<br />

8:20am MP Arthroplasty<br />

Steve Moran, MD<br />

8:40am Post Op Management Following MP Arthroplasty<br />

Paul Brach, MS, PT, CHT<br />

8:55am Discussion & Questions<br />

9:05am BREAK<br />

9:25am – 10:45am SOFT TISSUE RECONSTRUCTION<br />

Christine Novak, PT, MS, Moderator<br />

9:25am Tendon Reconstruction<br />

James Chang, MD<br />

9:45am Post Op Management Following Tendon Reconstruction<br />

Rebecca von der Heyde, MS, OTR/L, CHT<br />

10:00am Surgical Management of Raynaud’s Phenomenon<br />

Michael Neumeister, MD<br />

10:20am Post Op Management<br />

Julianne Howell, PT, MS, CHT<br />

10:35am Discussion and Questions<br />

10:45am PANEL: Wrist Reconstruction<br />

Mark Baratz, MD, Moderator<br />

Brian Adams, MD<br />

A. Bobby Chhabra, MD<br />

Bill Cooney, MD<br />

11:30am – 1:00pm Past President’s Lunch<br />

11:40am PANEL: Thumb Arthritis: Challenges & Management<br />

Peter Murray, MD, Moderator<br />

James Chang, MD<br />

Peter Jebson, MD<br />

Matthew Tomaino, MD<br />

12:35pm LUNCH<br />

24<br />

12:55pm PANEL: When Bad Things Happen to Good People<br />

Nicholas Vedder, MD, Moderator<br />

Peter Amadio, MD<br />

Daniel Nagle, MD<br />

A. Lee Osterman, MD<br />

William Swartz, MD<br />

2:30pm – 3:30pm <strong>Hand</strong> Surgery Endowment Board of<br />

Governors <strong>Meeting</strong><br />

2:00pm – 3:00pm Instructional Courses<br />

2:00pm – 4:00pm<br />

3:00pm – 4:30pm<br />

101 Distal Radius Fracture<br />

Current techniques <strong>for</strong> operative treatment and postoperative<br />

rehabilitation will be presented through a<br />

case-based <strong>for</strong>mat. Indications <strong>for</strong> volar plating, including<br />

comminuted fractures and elderly patients will be<br />

discussed. Associated injuries to the distal radioulnar<br />

joint and treatment options will also be included.<br />

Brian Adams, MD, Moderator<br />

William Geissler, MD<br />

Ronald Palmer, MD<br />

Ann Kammien, PT, CHT<br />

102 DRUJ<br />

Mark Baratz, MD, Moderator<br />

Daniel Nagle, MD<br />

Maureen Hardy, PT, MS, CHT<br />

103 Flexor Tendon Repair<br />

This course will focus on the current issues of flexor tendon<br />

repair including anatomy, pathophysiology, type of<br />

repair, and recent advances in rehabilitation. Material<br />

will represent evidence-based practice.<br />

Michael Neumeister, MD, Moderator<br />

Peter Amadio, MD<br />

Donald Lalonde, MD<br />

Aviva Wolff, BSc, OTR/L, CHT<br />

104 Extensor Tendon Injuries<br />

Surgical and non-surgical management of acute and<br />

chronic common extensor injuries are reviewed with<br />

emphasis on newer methods that permit immediate<br />

active motion and function, including long extensor<br />

laceration’s boutonniere de<strong>for</strong>mity, sagittal band rupture<br />

and mallet de<strong>for</strong>mity.<br />

Wyndell Merritt, MD, Moderator<br />

Julianne Howell, PT, MS, CHT<br />

105 Treatment of Thumb CMC Arthritis<br />

A number of different methods can be successfully used<br />

<strong>for</strong> treatment of osteoarthritis of the CMC joint. This<br />

workshop will focus on strategies <strong>for</strong> the use of a less<br />

invasive approach to treat earlier stage OA utilizing a<br />

degradable resurfacing im<strong>plan</strong>t. The faculty will discuss<br />

im<strong>plan</strong>tation using an open surgical approach as well as a<br />

minimally invasive, arthroscopic approach.<br />

Alejandro Badia, MD<br />

Randy Bindra, MD<br />

Sponsored by:<br />

Tyson Cobb, MD<br />

A. Lee Osterman, MD<br />

106 Splinting Challenges – Practical Pearls<br />

In this course, practical splinting pearls, techniques and<br />

demonstrations will be presented. The course will<br />

include immediate controlled active motion program<br />

<strong>for</strong> extensor tendon repairs, intra-articular dynamic traction<br />

splint <strong>for</strong> phalangeal fractures and unique splinting<br />

<strong>for</strong> flexor tendon repairs.<br />

Julianne Howell, PT, MS, CHT, Moderator<br />

James Gyovai, PT, CHT<br />

Rebecca von der Heyde, MS, OTR/L, CHT<br />

5:00pm – 6:00pm Therapists’ Reception<br />

6:00pm – 8:00pm Welcome Reception


AAHS<br />

DAY-AT-A-GLANCE<br />

Thursday, January 10, 2008<br />

6:30am – 3:30pm Speaker Ready Room Cali<strong>for</strong>nia Showroom<br />

6:30am – 3:00pm <strong>Meeting</strong> Services Cali<strong>for</strong>nia Lounge<br />

7:00am – 8:00am Continental Breakfast with Exhibitors Cali<strong>for</strong>nia Showroom<br />

7:00am – 8:00am Instructional Courses<br />

107 Fractures of the <strong>Hand</strong> Pacific<br />

108 PIP Joint Stiffness Palisades<br />

109 Vascularized Bone Grafts Westwood<br />

110 Scapho-Lunate Injuries Sherman Oaks<br />

111 Cost-Effective and Tax-Efficient Managed Money Encino<br />

<strong>for</strong> Physicians<br />

8:10am – 8:45am President/Program Chair Welcome Los Angeles<br />

AAHS Presidential Welcome<br />

Program Chair Welcome<br />

ASSH Presidential Welcome<br />

ASPS Preidential Welcome<br />

Vargas Recipient Welcome<br />

8:45am – 10:15am PANEL: Wide Awake <strong>Hand</strong> Surgery Los Angeles<br />

10:15am – 10:45am Break with Exhibitors Cali<strong>for</strong>nia Showroom<br />

10:30am – 11:30am <strong>Hand</strong> Journal – Editorial Board <strong>Meeting</strong> Bel Air<br />

10:45am – 12:35pm Concurrent Scientific Paper Session A Los Angeles<br />

10:45am – 12:35pm Concurrent Scientific Paper Session B Beverly Hills<br />

12:35pm – 1:00pm Lunch with Exhibitors Cali<strong>for</strong>nia Showroom<br />

1:10pm – 1:40pm Keynote Speaker: Ramez Naam Los Angeles<br />

1:45pm – 2:15pm PANEL: Scaphoid Fractures Los Angeles<br />

2:30pm – 3:30pm AAHS Instructional Courses<br />

112 Complex <strong>Hand</strong> Trauma Pacific<br />

113 Tumors of the Upper Extremity Palisades<br />

114 Nerve and Tendon Transfer Westwood<br />

115 The Assessment and Treatment of Peripheral Brentwood<br />

Nerve Injuries in Children<br />

116 Anatomy and Care of the Perionychium Sherman Oaks<br />

116A Partial Ulnar Head Replacement Arthroplasty: Encino<br />

Why Resect the Entire Head?<br />

25


AAHS<br />

Thursday, January 10, 2008<br />

7:00am – 8:00am Continental Breakfast with Exhibitors<br />

7:00am – 8:00am Instructional Courses<br />

107 Fractures of the <strong>Hand</strong><br />

This course will review treatment options to get the best<br />

results <strong>for</strong> the various common finger and metacarpal<br />

fractures, with emphasis on the difficult ones. New concepts<br />

in early protected movement in finger fractures<br />

will be explored.<br />

Donald Lalonde, MD<br />

Stephen Trigg, MD<br />

Mary Burns, OT<br />

108 PIP Joint Stiffness<br />

This course will review the treatment options <strong>for</strong> the stiff<br />

finger. Therapy measures, soft tissue surgical and manipulation<br />

treatment, and mobilization techniques <strong>for</strong> the<br />

stiff PIP after arthroplasty will be discussed.<br />

Robert Beckenbaugh, MD, Moderator<br />

Ann Lund, OTR, CHT<br />

Joseph Slade, MD<br />

109 Vascularized Bone Grafts<br />

Steven Moran, MD<br />

Michael Saurbier, MD<br />

110 Scapho-Lunate Injuries<br />

This course will review current concepts on the diagnosis,<br />

evaluation and management of acute and chronic<br />

scapholunate injuries. Indications, technical pearls and<br />

outcomes of surgical procedures <strong>for</strong> repair or reconstruction<br />

of radial-sided wrist instability will be discussed.<br />

Randy Bindra, MD, Moderator<br />

Michael Hayton, MD<br />

Jai Ryu, MD<br />

111 Cost Effective and Tax<br />

Efficient Managed Money<br />

<strong>for</strong> Physicians<br />

Physicians are busy individuals that require specialized services<br />

<strong>for</strong> their wealth management needs. This discussion<br />

will focus on managed money <strong>for</strong> physicians—the most<br />

cost-effective and tax-efficient way to manage money <strong>for</strong><br />

high income earning individuals. We will discuss current<br />

investment opportunities and markets, maximizing the use<br />

of tax-free investments. This year’s talk features special<br />

guests the Nexus Group of portfolio managers. The Nexus<br />

Group seeks to achieve higher returns but with significantly<br />

lower risk. The portfolio managers employ a disciplined<br />

and balanced strategy; they have a goal of producing consistent<br />

above market returns. Come learn valuable insights<br />

into how to maximize your returns.<br />

Patrick Donnelly- Smith Barney Consulting Group<br />

Jeff Palmer- Smith Barney Consulting Group<br />

Bimal Sheth- Smith Barney Nexus Group<br />

Sanjeev Arora- Smith Barney Nexus Group<br />

Aziz Ihani- Smith Barney Nexus Group<br />

8:10am – 8:45am Welcome<br />

N. Bradly Meland, MD, President<br />

Michael Neumeister, MD, Program Chair<br />

Craig Johnson, MD, Program Chair<br />

Christine Novak, PT, MS, Program Chair<br />

Steven Glickel, MD, ASSH President<br />

Richard D’Amico, MD, ASPS President<br />

Roberta Finley Morris, OTR/L, 2007 Vargas Recipient<br />

8:45am – 10:15am PANEL: Wide Awake <strong>Hand</strong> Surgery<br />

N. Bradly Meland, MD, Moderator<br />

Donald Lalonde, MD<br />

Wyndell Merritt, MD<br />

Matthew Concannon, MD<br />

10:15am – 10:45am Break with Exhibitors<br />

10:30am – 11:30am <strong>Hand</strong> Journal – Editorial Board <strong>Meeting</strong><br />

Sponsored by Springer<br />

26<br />

10:45am – 12:45pm Concurrent Scientific Paper Session A<br />

*Designates resident/fellow paper presentations<br />

Moderators: Keith E. Brandt, MD<br />

Michael Neumeister, MD<br />

10:45am – 10:51am<br />

Long Term Outcome Following Scaphoidectomy and Four-Corner Fusion<br />

Institution where the work was prepared: Mayo Clinic, Rochester, MN, USA<br />

David Dennison, MD; Coen Wijdicks; Justin Strickland; Steven Moran;<br />

Alexander Shin<br />

10:51am – 10:57am<br />

Reconstruction of the TFCC using ECU Half-Slip and Interference Screw<br />

Institution where the work was prepared: Department of Orthopaedic Surgery,<br />

Keio University, Tokyo, Japan<br />

Toshiyasu Nakamura, MD, PhD; Kazuki Sato; Noriaki Nakamichi; Yoshiaki Toyama;<br />

Hiroyasu Ikegami<br />

10:57am – 11:03am<br />

*Expression of TGF beta and IL-10 in Rat Hindlimb Composite Tissue Allografts<br />

Institution where the work was prepared: Plastic Surgery, Southern Illniois University<br />

School of Medicine, P.O. Box 19653, Sprignfield, IL, USA<br />

Damon Cooney MD, PhD; Chris Chambers; Michael Neumeister<br />

11:03am – 11:09am<br />

*Is There More Translational Motion after Proximal Row Carpectomy?<br />

Institution where the work was prepared: University of Pittsburgh Medical Center,<br />

Pittsburgh, PA, USA<br />

Peter Tang, MD, MPH; Jean Gauvin, PhD; Muturi Muriuki, PhD; Jamie Pfaeffle,<br />

MD, PhD; Joseph Imbriglia, MD; Robert Goitz, MD<br />

11:09am – 11:15am<br />

A Novel Approach <strong>for</strong> Treating Fractures of the Distal Radius<br />

Institution where the work was prepared: Dr Ather Mirza, Smithtown, NY, USA<br />

M. Ather Mirza, MD; Mary Kate Reinhart, CNP<br />

11:15am – 11:21am<br />

Discussion<br />

Moderators: Allen T. Bishop, MD<br />

Guenter Germann, MD<br />

11:21am – 11:27am<br />

*Radiographic Evaluation of the Distal Radius Using Two Novel Bi<strong>plan</strong>ar<br />

"Pitch-And-Roll" Views: A Cadaveric Study<br />

Institution where the work was prepared: West Virginia University Department of<br />

Orthopaedics, Morgantown, WV, USA, Brandon M. Boyce, MD; Jaiyoung Ryu<br />

11:27am – 11:33am<br />

*Repair of Distal Radial Malunions with Intramedullary Fixation<br />

Institution where the work was prepared: UMDNJ- NJ Medical School, Newark,<br />

NJ, USA<br />

John Capo; Damon Ng, MD; Tosca Kinchelow, MD; Virak Tan, MD<br />

11:33am – 11:39am<br />

Transosseous Repair of the Triangular Fibrocartilage Complex in Ulnar Sided<br />

Lesions; Cadaver Model and Clinical Series<br />

Institution where the work was prepared: Miami <strong>Hand</strong> Center, Miami, FL, USA<br />

Eduardo Gonzalez-Hernandez, MD; Ignacio Garcia-Cepeda, MD<br />

11:39am – 11:45am<br />

*Wrist Arthrodesis as a Salvage Operation <strong>for</strong> Failed Wrist Im<strong>plan</strong>t Arthroplasty<br />

Institution where the work was prepared: Mayo Clinic, Rochester, MN, USA<br />

Duncan B. Ackerman, MD; Marco Rizzo; Robert Rodrigues; Robert D.<br />

Beckenbaugh<br />

11:45am – 11:51am<br />

*Osteochondral Resurfacing of Capitate Chondrosis in Proximal Row Carpectomy<br />

Institution where the work was prepared: Western Pennsylvania <strong>Hand</strong> and<br />

UpperEx Center, Wex<strong>for</strong>d, PA, USA<br />

Peter Tang, MD, MPH; Joseph E. Imbriglia, MD<br />

11:51am – 11:57am<br />

Discussion<br />

Moderators: James Chang, MD<br />

Steven McCabe, MD<br />

11:57am – 12:03am<br />

*Post-Operative Complications Of Arthroscopic TFCC Repair<br />

Institution where the work was prepared: University of Toledo, Toledo, OH, USA<br />

Ian Rodway, MD; Martin C Skie; Despina E Ciocanel<br />

12:03am – 12:09pm<br />

Scaphoid Excision and Limited Wrist Fusion: A Comparison of K-wire and<br />

Circular Plate Fixation<br />

Institution where the work was prepared: Des Moines Orthopaedic Surgeons,<br />

West DesMoines, IA, USA<br />

Jeff Rodgers, MD; Gary Holt, MD; Edward Finnerty, PhD; Blake Miller, BS


12:09pm -12:15pm<br />

*The Volar Approach <strong>for</strong> Fractures of the Distal Radius: 100 Patients Analysis<br />

Institution where the work was prepared: Faculdade de Medicina do ABC, Santo<br />

Andre, Brazil<br />

Marcio A. Aita, MD; Gustavo M. Ruggiero, MD; Alvaro B. Cho, MD; Walter Y.<br />

Fukushima, MD; W. Lino Jr, MD; Fabiano N. Faria, MD<br />

12:15pm – 12:21pm<br />

Mechanical Effect of Metaphyseal Plate Stand-off in Radius Volar Plates<br />

Institution where the work was prepared: University of Arkansas, Little Rock, AR, USA<br />

Randy R. Bindra, MD, FRCS; Sivathan Kumar; William R Hogue<br />

12:21pm – 12:27pm<br />

*Surgical Management of Post-traumatic Elbow Contractures in the Adolescent<br />

Patient Population: Principles and Outcome<br />

Institution where the work was prepared: Allegheny General Hospital, Pittsburgh, PA,<br />

USA<br />

Alexander H. Payatakes, MD; Nickolaos A Darlis; Robert W Kaufmann; Dean G<br />

Sotereanos<br />

12:27pm – 12:42pm<br />

Discussion<br />

10:45am – 12:45pm Concurrent Scientific Paper Session B<br />

*Designates resident/fellow paper presentations<br />

Moderators: Loree K. Kalliainen, MD, FACS<br />

Steven L. Moran, MD<br />

10:45am – 10:51am<br />

Injectable Collagenase Enzyme (AA4500) in Dupuytren's Contracture: Clinical<br />

Success in Patients with Concomitant Diabetes<br />

Institution where the work was prepared: SUNY at Stony Brook, Stony Brook, NY, USA<br />

Marie Badalamente, PhD; Lawrence C. Hurst<br />

10:51am – 10:57am<br />

*Clinical Outcome in Dupuytren's Disease Correlates with Proteinase Gene<br />

Expression<br />

Institution where the work was prepared: University of East Anglia and Norfolk &<br />

Norwich Hospital, Norwich, United Kingdom<br />

Phillip Johnston, MA, MRCS; Debbie Larson; Adrian J. Chojnowski, MA, FRCS,<br />

(Orth); Ian M. Clark, PhD<br />

10:57am – 11:03am<br />

Amputation Versus Reconstruction in Severe Crush Injuries of the Upper Limb<br />

Institution where the work was prepared: UMF Iuliu Hatieganu, Plastic and<br />

Reconstructive Microsurgery Clinic, Cluj Napoca, Romania<br />

Alexandru Georgescu, Prof, MD, PhD; Filip Ardelean MD; Ileana Matei; Irina<br />

Capota MD<br />

11:03am – 11:09am<br />

A Comparison Study of Preliminary Soft Tissue Distraction vs. Check Rein<br />

Ligament Release in the Treatment of Dupuytren's PIP Joint Contracture<br />

Institution where the work was prepared: Mayo Clinic Hospital Arizona, Phoenix, AZ, USA<br />

Aaron Klomp, MD; Grant Fankhauser; Anthony Smith; Alanna Rebecca; Scott Duncan<br />

11:09am – 11:15am<br />

*The Spiral Flap <strong>for</strong> Fingertip Resurfacing: Short- and Long-Term Results<br />

Institution where the work was prepared: Singapore General Hospital, Singapore,<br />

Singapore<br />

Gale Lim, MBBS, MRCS, MMed; Andrew Yam, MBBS, MRCSEd, MM; Jonthan YL<br />

Lee, MBBS, MRCSEd, MM; Lc Teoh, MBBS, FRCS, FAMS<br />

11:15am – 11:21am<br />

Discussion<br />

Moderators: Matthew Concannon, MD<br />

Jaiyoung Ryu, MD, FACS<br />

11:21am – 11:27am<br />

*Analysis of Limited Wyndell Merritt Splint <strong>for</strong> Extensor Tendon Injuries to<br />

<strong>Hand</strong> Immobilization<br />

Institution where the work was prepared: SIU School of Medicine, Springfield, IL, USA<br />

Nada Berry, MD; Michael Neumeister<br />

11:27am – 11:33am<br />

*Comparison of FiberLoop and Supramid in Zone II Flexor Tendon Repair<br />

Using a Cyclic Protocol<br />

Institution where the work was prepared: Cleveland Clinic, Cleveland, OH, USA<br />

Aaron Anderson, MD; S. Chase Donnelly; Richard Drake, PhD; Kathleen Derwin,<br />

PhD; Jeff Lawton, MD<br />

27<br />

11:33am – 11:39am<br />

Graft-on flap Method <strong>for</strong> Fingertip Nail Reconstruction<br />

Institution where the work was prepared: Yuichi Hirase, Saitama, Japan<br />

Yuichi Hirase, MD<br />

11:39am – 11:45am<br />

Deep Inferior Epigastric Artery Graft <strong>for</strong> Raynaud's Disease<br />

Institution where the work was prepared: Hee Chang Ahn, Seoul, South Korea<br />

Hee-Chang Ahn, MD; Steven Bates, MD; Scott L. Hansen; Neil F. Jones<br />

11:45am – 11:51am<br />

The Use of Dermal Substitutes in Burn Scar Contracture Releases to the <strong>Hand</strong><br />

and Upper Extremity<br />

Institution where the work was prepared: Indiana University, Indianapolis, IN, USA<br />

Madeline Zieger, PA; David Roggy, RN; Rajiv Sood, MD, FACS<br />

11:51am – 11:57am<br />

Discussion<br />

Moderators: Nash Naam, MD<br />

Michel Saint-Cyr, MD<br />

11:57am – 12:03pm<br />

Treatment of Distal Biceps Ruptures Using a One-Incision Technique and<br />

Biotenodesis Screw Fixation: A Preliminary Report on Patient-Oriented<br />

Outcomes<br />

Institution where the work was prepared: UMass Memorial Medical Center,<br />

Worcester, MA, USA<br />

Mark Eskander, MD; Jonathan Eskander; Douglass Weiss; Nicola DeAngelis<br />

12:03pm – 12:09pm<br />

*Flexor Tendon Repair with Barbed Suture<br />

Institution where the work was prepared: UT SouthWestern Medical center,<br />

Dallas, TX, USA<br />

Fatemeh Abtahi, MD; Michel Saint-Cyr; Spencer A. Brown; Debby Noble, BS;<br />

Dan Hatef, MD; Jordan Farkas, MD<br />

12:09pm – 12:15pm<br />

*Management of the Central Extensor Tendon on the Surgical Approach <strong>for</strong><br />

Exposure of the Proximal Interphalangeal Joint: A Biomechanical Study<br />

Institution where the work was prepared: University of New Mexico, Department<br />

of Orthopaedics, Albuquerque, NM, USA<br />

Deana Mercer; Keikhosrow Firoozbakhsh; Alex Carvalho; Moheb S. Moneim<br />

12:15pm – 12:21pm<br />

Treatment of Chronic Digital Ischemia with Direct Microsurgical Revascularization<br />

Institution where the work was prepared: Northwestern University, Chicago, IL, USA<br />

Zol Kryger, MD; Vinay Rawlani; Gregory A. Dumanian<br />

12:21pm – 12:27pm<br />

*Modified Allen's Test Using Near Infrared Spectroscopy: Clincal and Anatomic<br />

Study<br />

Institution where the work was prepared: University of Texas Southwestern<br />

Medical Center, Dallas, TX, USA<br />

Daniel A. Hatef, MD; Dallas Alvey; Li Ngov; Michel Saint-Cyr; Spencer A. Brown;<br />

Rod J. Rohrich<br />

12:27pm – 12:35pm<br />

Discussion<br />

12:35pm – 1:00pm Lunch With Exhibitors<br />

1:10pm – 1:40pm Keynote Speaker<br />

Ramez Naam<br />

“More Than Human: From Therapy to Enhancement”<br />

At the edge of medicine, researchers are demonstration that<br />

it’s possible to enhance human abilities beyond the health<br />

norm. Should we? Ramez Naam is an author and professional<br />

technologist who has spent his career seeking ways to<br />

empower people through software. He helped develop<br />

two of the most widely used pieces of software in the<br />

world – Microsoft Internet Explorer and Microsoft Nano<br />

Technologies, developing software <strong>for</strong> nanotechnology<br />

researchers. He is currently the Group Program Manager <strong>for</strong><br />

Windows Live Search, where he leads ef<strong>for</strong>ts to develop new<br />

and smarter technologies <strong>for</strong> searching the internet. Naam is<br />

also the author of More than Human: How Technology Wil<br />

l Trans<strong>for</strong>m Us and Why We Should Embrace It


(Broadway Books, 2004). In the book, Naam explores how<br />

new technologies can serve as powerful tools in humans’<br />

quest to improve themselves. Naam is regularly invited to<br />

speak at software and nanotechnology conferences. He<br />

is a fellow of the Institute <strong>for</strong> Ethics and Emerging<br />

Technologies and the recipient of the 2005 H.G. Wells Award<br />

<strong>for</strong> Contributions to Transhumanism. Naam recently<br />

appeared in the PBS television show “The 22nd Century”<br />

and has been profiled or reviewed in the New York Times,<br />

Scientific <strong>American</strong>, Fast Company, Discover Magazine,<br />

Business Week and numerous other publications.<br />

He is a graduate of the University of Illinois at<br />

Champaign-Urbana.<br />

1:45pm – 2:15pm PANEL: Scaphoid Fractures<br />

Joseph Slade, MD, Moderator<br />

2:30pm – 3:30pm Instructional Courses<br />

112 Complex <strong>Hand</strong> Trauma<br />

This course will focus on the treatment of complex hand<br />

trauma, including assessment and <strong>plan</strong>ning, initial treatment,<br />

and delayed reconstruction and rehabilitation.<br />

Treatment algorithms <strong>for</strong> managing vascular, nerve, skeletal,<br />

and soft tissue injuries will be presented and discussed.<br />

Nicholas Vedder, MD, Moderator<br />

Steven Moran, MD<br />

W. P. Andrew Lee, MD<br />

113 Tumors of the Upper Extremity<br />

Gene Deune, MD<br />

114 Nerve and Tendon Transfer<br />

This course will review nerve and tendon transfer options<br />

<strong>for</strong> isolated and complex upper extremity injuries. Pre-<br />

Operative evaluation, timing and <strong>plan</strong>ning, operative<br />

technique and motor and sensory re-education will be<br />

reviewed.<br />

Susan Mackinnon, MD, Moderator<br />

Neil Ford Jones, MD<br />

Christine Novak, PT, MS<br />

115 The Assessment and Treatment<br />

of Peripheral Nerve Injuries in Children<br />

This course will cover the gamut of peripheral nerve injuries<br />

in children. The principles of diagnosis and assessment of<br />

nerve injuries in children will be discussed. Subsequently,<br />

the treatment of both acute nerve trauma and of late presentations<br />

of nerve injuries will be highlighted. Importantly,<br />

the role of the therapist on the evaluation process and during<br />

the time of nerve recovery will be reviewed. Case<br />

presentations will conclude the course with audience participation.<br />

Scott Kozin, MD, Moderator<br />

Howard Clarke, MD<br />

Lynn Bassini, OTR, CHT<br />

116 Anatomy and Care of the Perionychium<br />

A summary of the anatomy of the perionychium and the<br />

care of injury, reconstruction, and other conditions of the nail.<br />

Elvin Zook, MD, Moderator<br />

116-A Partial Ulnar Head Replacement<br />

Arthroplasty: Why Resect the Entire Head?<br />

This course will introduce a new Partial Ulnar Head replacement,<br />

designed to allow preservation of the native ulnar styloid<br />

and keep the critical soft tissue structures intact. This<br />

workshop will provide a comprehensive overview of DRUJ<br />

disorders, design rationale, patient selection, surgical technique<br />

and post-op therapy. Cadaveric models will be used<br />

to demonstrate the Ascension® First Choice® Partial Ulnar<br />

Head Replacement surgical technique.<br />

Brian Adams, MD<br />

Sponsored by Ascension Orthopedics<br />

28


AAHS<br />

DAY-AT-A-GLANCE<br />

Friday, January 11, 2008<br />

6:00am – 5:00pm Speaker Ready Room Cali<strong>for</strong>nia Showroom<br />

6:30am – 7:00am <strong>Meeting</strong> Services Cali<strong>for</strong>nia Lounge<br />

7:00am – 7:30am <strong>Annual</strong> Business <strong>Meeting</strong> Breakfast Encino<br />

7:00am – 8:30am Continental Breakfast w/Exhibitors Cali<strong>for</strong>nia Showroom<br />

7:30am – 8:30am Instructional Courses<br />

117 Thumb Reconstruction Palisades<br />

118 Outcomes of Nerve Decompression Pacific<br />

119 NCS Nerve Electrophysiology Brentwood<br />

120 Basilar Joint Arthritis Westwood<br />

121 Periarticular Elbow Fracture Dislocations: Will My Sherman Oaks<br />

Elbow Bend Again?<br />

122 Financial Planning <strong>for</strong> the Newly Established Surgeon Director’s Dining Room<br />

8:35am – 9:35am PANEL: Cubital Tunnel: Defend Your Operation Los Angeles<br />

9:35am – 10:00am Presidential Address Los Angeles<br />

10:00am – 10:30am Joseph Danyo Presidential Invited Lecturer: Allen Van Beek Los Angeles<br />

10:30am – 11:00am Break with Exhibitors Cali<strong>for</strong>nia Showroom<br />

11:00am – 12:45pm Concurrent Scientific Paper Session C Los Angeles<br />

11:00am – 12:45pm Concurrent Scientific Paper Session D Palisades/Pacific<br />

12:00pm – 2:30pm AAHS Board of Directors Luncheon/<strong>Meeting</strong> Governor’s Boardroom<br />

12:45pm– 6:10pm Comprehensive <strong>Hand</strong> Surgery Review Course Beverly Hills<br />

7:00pm – 10:00pm AAHS Salsa Sensation Awards Dinner & Dance Plaza Pavilion<br />

29


AAHS<br />

Friday, January 11, 2008<br />

7:00am – 7:30am <strong>Annual</strong> Business <strong>Meeting</strong><br />

(Attendance is limited to AAHS members only)<br />

7:00am – 8:30am Continental Breakfast<br />

7:30am – 8:30am Instructional Courses<br />

117 Thumb Reconstruction<br />

This case-oriented panel will review simple to complex<br />

methods of thumb reconstruction <strong>for</strong> congenital and<br />

post-traumatic thumb absence. The cases presented<br />

will illustrate key principles in thumb reconstruction.<br />

Algorithms <strong>for</strong> optimal thumb reconstruction will be<br />

presented.<br />

James Chang, MD, Moderator<br />

Rudy Buntic, MD<br />

Neil Ford Jones, MD<br />

118 Outcomes of Neve Decompression<br />

This course will combine a review of outcomes<br />

measurements <strong>for</strong> nerve decompression surgery and an evidence<br />

based review of the outcomes that are achieved. It<br />

will be of interest to the surgeon, therapists, others providing<br />

care, and to the clinical researcher.<br />

Steven McCabe, MD, Moderator<br />

Kevin Chung, MD<br />

119 NCS Nerve Electrophysiology<br />

This course’s objective is to teach participants<br />

understanding of NCS and the clinical use of intraoperative<br />

use of Nerve Stimulation and Recording<br />

techniques during complex reconstructive surgery.<br />

Allen Van Beek, MD, Moderator<br />

120 Basilar Joint Arthritis<br />

This course deals with the etiology, diagnosis and<br />

treatment of degenerative arthritis of the basal joint of<br />

the thumb. Treatment modalities will be discussed<br />

including arthroscopy, metacarpal osteotomy, arthrodesis,<br />

interposition arthroplasty and total joint replacement.<br />

Nash Naam, MD, Moderator<br />

Miguel Saldana, MD<br />

Jennifer Thompson, PT<br />

121 Periarticular Elbow Fracture Dislocations:<br />

Will My Elbow Bend Again?<br />

This course will review surgical and therapeutic<br />

treatment principles related to periarticular elbow<br />

fractures and dislocations. Emphasis will be placed on<br />

factors that ultimately lead to optimal outcome and<br />

patient satisfaction.<br />

Robert Goitz, MD, Moderator<br />

Paul Brach, PT, MS, CHT<br />

Dean Sotereanos, MD<br />

122 Financial Planning <strong>for</strong> the<br />

Newly Established Surgeon<br />

As a physician, you have worked hard <strong>for</strong> your wealth.<br />

However, accumulating wealth is just one aspect of<br />

managing your assets. If you are like most busy physicians,<br />

you may lack the time needed to select the right<br />

investments that best meet your specific financial needs.<br />

This discussion will focus on the basic things residents or<br />

new physicians need to do in order to begin investing<br />

<strong>for</strong> themselves and their practices, and how to select the<br />

right investment program. This year’s talk features special<br />

guests the Nexus Group of professional portfolio managers,<br />

who seek to achieve higher returns with significantly<br />

lower risk. Come ask your investment and<br />

market related questions and gain wisdom <strong>for</strong><br />

the future.<br />

Patrick Donnelly- Smith Barney Consulting Group<br />

Jeff Palmer- Smith Barney Consulting Group<br />

Bimal Sheth- Smith Barney Nexus Group<br />

Sanjeev Arora- Smith Barney Nexus Group<br />

Aziz Ihani- Smith Barney Nexus Group<br />

8:35am – 9:35am PANEL: Cubital Tunnel: Defend Your Operation<br />

This panel will cover z plasty/submuscular, learmonth<br />

submuscular, medial epicondylectomy and endoscopic<br />

operations.<br />

Susan Mackinnon, MD, Moderator<br />

Daniel Nagle, MD<br />

A. Lee Osterman, MD<br />

Dean Sotereanos, MD<br />

Tyson Cobb, MD<br />

30<br />

9:35am – 10:00am Presidential Address<br />

N. Bradly Meland, MD<br />

10:00am – 10:30am Joseph Danyo Presidential Invited Lecturer<br />

Allen Van Beek, MD<br />

“<strong>Hand</strong>ing Back Options”<br />

The surgical outreach to help children in third world<br />

countries provides children with new options <strong>for</strong> their<br />

futures. It provides inspiration, challenges and meaning<br />

<strong>for</strong> the <strong>Hand</strong> Surgeon.<br />

Dr. Van Beek has served as President of the AAHS,<br />

ASPN, ASRM and PSEF. He has traveled to numerous<br />

countries and locations per<strong>for</strong>ming <strong>Hand</strong> and<br />

Reconstructive Plastic Surgery in under served areas or<br />

teaching centers. His experience serves as an impetus<br />

<strong>for</strong> him to encourage others to help provide care <strong>for</strong><br />

children whose futures are altered because of their<br />

hands. His challenge is <strong>for</strong> health care providers to go<br />

beyond their “com<strong>for</strong>t zone” something he considers<br />

the “danger zone”.<br />

10:30am – 11:00am Break with Exhibitors<br />

11:00am – 12:45pm Concurrent Scientific Paper Session C<br />

*Designates resident/fellow paper presentations<br />

Moderators: Peter Murray, MD<br />

Christine Novak, PT MS<br />

11:00am – 11:06am<br />

*Evaluating the Efficacy of Combining Clinical Signs of Scaphoid Fracture to<br />

Decrease Unnecessary Immobilization: A Prospective Multi-Institutional Study<br />

Supporting the Early Use of Advanced Imaging<br />

Institution where the work was prepared: Naval Medical Center San Diego, San<br />

Diego, CA, USA<br />

Joseph R. Carney, MD; Eric Hofmeister; John Paul Rhue; Brian Fitzgerald;<br />

Michael Thompson<br />

11:06am – 11:12am<br />

*Long-term Outcomes of Dorsal Intercarpal Ligament Capsulodesis <strong>for</strong><br />

Chronic Scapholunate Dissociation<br />

Institution where the work was prepared: University of Cali<strong>for</strong>nia, Davis,<br />

Sacramento, CA, USA<br />

Varun Gajendran, MS; Brett Peterson, MD; Robert R. Slater, MD, FACS; Robert<br />

Szabo, MD, MPH<br />

11:12am – 11:18am<br />

*Treatment of Scaphoid Fractures and Nonunions with a Cannulated AO<br />

Screw and Threaded Washer: Report of 99 Cases<br />

Institution where the work was prepared: University of Cali<strong>for</strong>nia San Diego, San<br />

Diego, CA, USA WITHDRAW<br />

Andrew Pennock, MD; Todd Horton, MD; William Tontz, MD; Reid Abrams, MD<br />

11:18am – 11:24am<br />

*Outcome Assessment after Treatment of Scaphoid Nonunion in the Middle<br />

Third (Herbert Type D2) with Conventional Bone Grafting and Screw Fixation<br />

from a Palmar Approach<br />

Institution where the work was prepared: Department of <strong>Hand</strong>, Plastic and<br />

Reconstructive Surgery, Ludwigshafen, Germany<br />

Miriam Mueller, MD; Andre Otto; Christiane Hitzigrath; Rainer Simon; Günter<br />

Germann; Michael Sauerbier<br />

11:24am – 11:30am<br />

*Open Reduction <strong>for</strong> Perilunate Injuries - Long Term Results and Patients Content<br />

Institution where the work was prepared: BG Trauma Center Ludwigshafen,<br />

Ludwigshafen, Germany<br />

Thomas Kremer, MD; Michael Wendt; Michael Sauerbier; Guenter Germann<br />

11:30am – 11:35am<br />

Discussion<br />

Moderators: Daniel Nagle, MD<br />

Michael Sauerbier, MD


11:35am – 11:41am<br />

Thumb Metacarpal Phalangeal Joint Capsulodesis at the Time of Basal Joint<br />

Arthroplasty: a Surgical Technique Utilizing Suture Anchors<br />

Institution where the work was prepared: Mayo Clinic, Phoenix, AZ, USA<br />

Scott F.M. Duncan, MD, MPH; Smith Anthony, MD; Merritt Marianne, RNFA; Ivy<br />

Cindy, OT, CHT; Renfree Kevin, MD; Kousuke Iba, MD<br />

11:41am – 11:47am<br />

Biotenodesis Screw in Basilar Thumb Arthritis: A Biomechanical Study<br />

Institution where the work was prepared: Tripler Army Medical Center, Honolulu, HI, USA<br />

John Faillace, MD; Shawn Hermenau, MD<br />

11:47am – 11:53am<br />

*Partial Ulnar Head Resurfacing Im<strong>plan</strong>t Arthroplasty<br />

Institution where the work was prepared: University of Iowa, Iowa City, IA, USA<br />

Danielle A. Conaway, MD; Brian D Adams<br />

11:53am – 11:59am<br />

*Dynamic (4D) Computed Tomography of the Wrist : Proof of Feasibility in a<br />

Cadaveric Model<br />

Institution where the work was prepared: Mayo Clinic College of Medicine,<br />

Rochester, MN, USA<br />

Shian Chao Tay, MBBS, FRCS, FAMS; Andrew N. Primak, PhD; Joel G. Fletcher,<br />

MD; Bernhard Schmidt, PhD; Kimberly K.amrami, MD; Cynthia H. McCollough,<br />

PhD; Richard A. Berger, MD, PhD<br />

11:59am – 12:05pm<br />

Preliminary Experience with Fat Grafting of Dupuytren's Contracture<br />

Following Complete Percutaneous Release<br />

Institution where the work was prepared: Miami <strong>Hand</strong> Center, Miami, FL, USA<br />

Roger K. Khouri, MD; Jorge L. Orbay, MD; Steven E.R. Hovius<br />

12:05pm – 12:10pm<br />

Discussion<br />

Moderators: Donald H. Lalonde, MD<br />

Thomas Tung, MD<br />

12:10pm – 12:16pm<br />

Ulnohumeral Arthroplasty in the Management of the Arthritic Elbow<br />

Institution where the work was prepared: Wrightington Hospital Centre For<br />

Upper Limb Surgery, Wigan, United Kingdom<br />

M. J. Hayton; Sumedh C Talwalkar; Ian A Trail; Niloy Roy; John K Stanley<br />

12:16pm – 12:22pm<br />

Isolated Proximal Pole Hamate Arthritis<br />

Institution where the work was prepared: Thomas Jefferson University,<br />

Philadelphia, PA, USA<br />

A. Lee Osterman, MD; Randall Culp<br />

12:22pm – 12:28pm<br />

*In-Vivo Kinematic Analysis of the Forearm<br />

Institution where the work was prepared: Mayo Clinic College of Medicine,<br />

Rochester, MN, USA<br />

Shian Chao Tay, MD, MS; Kazunari Tomita, MD; Roger P. Van Riet, MD; Kimberly<br />

K.amrami; Kai-Nan An, PhD; Richard Berger, MD, PhD<br />

12:28pm – 12:34pm<br />

Mesh Im<strong>plan</strong>t Arthroplasty <strong>for</strong> Treatment of Basilar Joint Arthritis<br />

Institution where the work was prepared: Methodist Hospital, Houston, TX, USA<br />

Evan Collins, MD; Kimberly Staines; John Thornby<br />

12:34pm – 12:40pm<br />

*Combining a Clinical Software Program, Research Databases, and Novel<br />

Teaching Software with the Use of Medical In<strong>for</strong>matics in a Resource Limited<br />

Environment<br />

Institution where the work was prepared: Baylor College of Medicine, Houston, TX,<br />

USA<br />

Brian A. Janz, MD; Anthony Echo; Morgan E. Norris, MD, DDS; Nicholas A. Fiore II<br />

12:40pm – 12:45pm<br />

Discussion<br />

11:00am – 12:45pm Concurrent Scientific Paper Session D<br />

*Designates resident/fellow paper presentations<br />

Moderators: Miguel Saldana, MD<br />

Patrick Stewart, MD, FACS<br />

11:00am – 11:06am<br />

*Chimerism Induction and Maintenance in Composite Tissue Allograft<br />

Trans<strong>plan</strong>ts after Augmentation with Donor Specific BMT<br />

Institution where the work was prepared: Cleveland Clinic, Cleveland, OH, USA<br />

Wioleta Luszczek, PhD; Aleksandra Klimczak, PhD; Maria Siemionow, MD, PhD<br />

31<br />

11:06am – 11:12am<br />

Fifteen Year Follow-up of the Distal Single Scope Assisted Carpal Tunnel<br />

Release<br />

Institution where the work was prepared: Dr Ather Mirza, Smithtown, NY, USA<br />

M. Ather Mirza, MD; Mary Kate Reinhart, CNP<br />

11:12am – 11:18am<br />

*A Simple Method to Demonstrate Collateral Sprouting of An Intact Axon at<br />

End-to-side Neurorrhaphy Site<br />

Institution where the work was prepared: The First Affilated Hospital of Sun Yat-<br />

Sen University, Guangzhou, China<br />

Qing Tang Zhu, MD, PhD; Jia Kai Zhu, MD; Zhen Guo Lao, MD; Xiao Lin Liu, MD,<br />

PhD; Gary Chen, MD<br />

11:18am – 11:24am<br />

*Real Time in Vivo Imaging of Neural Microarchitecture with Coherent Antistokes<br />

Raman Scattering (CARS) Microscopy<br />

Institution where the work was prepared: Massachusetts General Hospital,<br />

Harvard Medical School, Boston, MA, USA<br />

Francis Patrick Henry, MD; Daniel Cote, PhD; M.A. Randolph, MAS; Irene E.<br />

Kochevar, PhD; Charles P. Lin, PhD; Jonathan M. Winograd, MD<br />

11:24am – 11:30am<br />

Innervations of the Medial Head of the Triceps by the Ulnar Nerve<br />

Institution where the work was prepared: Department of Orthopaedic Surgery<br />

Columbia Uni. Medical Cen., New York, NY, USA<br />

Halil I. Bekler, MD; Joy Christiane Vroemen; Jason M. McKean; Melvin P<br />

Rosenwasser<br />

11:30am – 11:35am<br />

Discussion<br />

Moderators: Rocco Barbier, MD<br />

David Netscher, MD<br />

11:35am – 11:41am<br />

*Endoscopic Revision of Carpal Tunnel Release<br />

Institution where the work was prepared: University of Washington, Seattle, WA,<br />

USA<br />

Shai Luria, MD; Thanapong Waitayawinyu; Thomas E. Trumble<br />

11:41am – 11:47am<br />

Practical Clinical Guide <strong>for</strong> the Management of Chronic Pain Secondary to<br />

Neuropathic Conditions<br />

Institution where the work was prepared: <strong>Hand</strong> and Microsurgery Center of El<br />

Paso and UTEP, El Paso, TX, USA<br />

Jose Monsivais, MD; Kris Robinson, PhD, FNP<br />

11:47am – 11:53am<br />

An Upper Limb Reach and Grasp Cycle <strong>for</strong> Children<br />

Institution where the work was prepared: Stan<strong>for</strong>d University, Stan<strong>for</strong>d, CA, USA<br />

Amy L. Ladd, MD; Erin Butler; Stephanie Louie; Wendy Wong; Andrew Rogers;<br />

Jessica Rose<br />

11:53am – 11:59am<br />

*Anticoagulation in Digital Revascularization and Reim<strong>plan</strong>tation Surgery: a<br />

Complete Analysis of Beneficial and Detrimental Effects<br />

Institution where the work was prepared: Montreal University Health Care Center,<br />

Montreal, Canada<br />

Youssef Tahiri, medical, student; Patrick Harris, MD; Genevieve Landes, MD;<br />

Valerie Lemaine, MD; Andreas Nikolis, MD<br />

11:59am – 12:04pm<br />

Discussion<br />

Moderators: William Dzwierzynski, MD<br />

A. Lee Osterman, MD FACS<br />

12:04pm – 12:10pm<br />

*Local Immunotherapy Inhibits Skin Rejection in Composite Tissue Allotrans<strong>plan</strong>tation<br />

Institution where the work was prepared: University of Pittsburgh, Pittsburgh, PA,<br />

USA<br />

Mario G. Solari, MD; Kia M. McLean; Justin M. Sacks; Theresa Hautz; Jignesh V.<br />

Unadkat; Elaine K. Horibe; Vijay S. Gorantla; Stefan Schneeberger; Angus W.<br />

Thomson; W.P. Andrew Lee<br />

12:10pm – 12:16pm<br />

*Rate of Reoperation Following Digital Re<strong>plan</strong>tation and Revascularization<br />

Surgery in a Designated Provincial University Re<strong>plan</strong>tation Program<br />

Institution where the work was prepared: Centre hospitalier de l'Universite de<br />

Montreal, Montreal, QC, Canada<br />

Valerie Lemaine, MD; Geneviève Landes; Patrick Harris; André Chollet; Youssef<br />

Tahiri; Andreas Nikolis


12:16pm – 12:22pm<br />

Survey of The Current State of Upper Extremity Re<strong>plan</strong>tation in Northamerica<br />

Institution where the work was prepared: University of Texas Southwestern,<br />

Dallas, TX, USA<br />

David W. Mathes, MD; Dan Hatef; Michel Saint-Cyr<br />

12:22pm – 12:28pm<br />

*The Effect of Donor Presensitization on the Immunotolerance in Composite<br />

Tissue Trans<strong>plan</strong>tation in Rat Groin Flap Model<br />

Institution where the work was prepared: Cleveland Clinic, Cleveland, OH, USA<br />

Mehmet Bozkurt, MD; Serdar Nasir; Aleksandra Klimczak; Lukasz Krokowicz;<br />

Wioleta Luszczek; Maria Siemionow<br />

12:28pm – 12:34pm<br />

Pedicled radial artery removal does not compromise palmar microcirculationamong<br />

arteriosclerotic patients<br />

Institution where the work was prepared: Hannover Medical School, Hannover,<br />

Germany<br />

Karsten Knobloch, MD, PhD; Sandra Tomaszek; Marcus Spies; Kay H. Busch;<br />

Peter M. Vogt<br />

12:34pm – 12:40pm<br />

Discussion<br />

12:00pm – 2:30pm AAHS Board of Directors Luncheon/<strong>Meeting</strong><br />

12:45pm – 6:10pm Comprehensive <strong>Hand</strong> Surgery Review Course<br />

Randy Bindra, MD, Chairman<br />

The expert faculty of this Comprehensive <strong>Hand</strong> Surgery Review Course will address the<br />

important principles of common topics covered on board examinations, the hand surgery<br />

certification examination and resident in-training examinations. The exciting new<br />

<strong>for</strong>mat will be more interactive using an “audience response system”. From infection<br />

to arthritis, nerve to bone, the child to the adult, this course will truly cover it all and you<br />

will consider it an afternoon well spent.<br />

Additional registration required.<br />

Sponsored by:<br />

12:45pm – 1:00pm Vascular Disorders of the <strong>Hand</strong>/Reim<strong>plan</strong>tation<br />

William C. Pederson, MD<br />

Vascular disorders of the hand are uncommon and the<br />

indications <strong>for</strong> reim<strong>plan</strong>tation narrow. This presentation<br />

will discuss the various diagnostic and treatment challenges<br />

encountered in vascular disorders of the hand.<br />

Techniques and indication <strong>for</strong> im<strong>plan</strong>tation will be<br />

reviewed.<br />

1:00pm – 1:20pm Compressive Neuropathies & CRPS<br />

Daniel Nagle, MD<br />

In this lecture carpal tunnel syndrome and cubital tunnel<br />

syndrome will be reviewed. Physical examination and<br />

diagnostic modalities will be emphasized. The last portion<br />

of the presentation will review the diagnosis, treatment<br />

and long-term sequelae of complex regional pain<br />

syndrome.<br />

1:20pm – 1:40pm Thumb Basal Joint Arthritis and Wrist Arthritis<br />

Alejandro Badia, MD<br />

This lecture will address the fundamentals of diagnosis<br />

and treatment <strong>for</strong> thumb basal joint arthritis, SLAC/SNAC<br />

degeneration of the wrist. Critical success factors necessary<br />

to obtain favorable outcomes will be emphasized.<br />

1:40pm – 2:00pm Inflammatory Arthritis of the <strong>Hand</strong> and Wrist<br />

Matt Tomaino, MD<br />

Indications and various reconstructive options <strong>for</strong> hand<br />

and wrist de<strong>for</strong>mities secondary to rheumatoid arthritis<br />

and other inflammatory conditions will be discussed.<br />

Indications and techniques <strong>for</strong> synovectomy, arthroplasty<br />

of the MCP and wrist and small joint fusions will be<br />

reviewed.<br />

2:00pm – 2:15pm Distal Radius Fractures<br />

Peter J. L. Jebson, MD<br />

A review of adult distal radius fractures including the clinical<br />

evaluation, diagnostic imaging options and interpretation,<br />

indications <strong>for</strong> operative versus non-operative<br />

treatment and the current strategies and indications <strong>for</strong><br />

the various operative treatment techniques.<br />

32<br />

2:15pm – 2:30pm Distal Radioulnar Joint<br />

Brian Adams, MD<br />

Anatomy, biomechanics and patterns of injury will be discussed.<br />

Bone and soft tissue salvage reconstructive<br />

options will be illustrated.<br />

2:30pm – 2:45pm Scaphoid Fractures and Non-Unions<br />

Mike Hayton, FRCS<br />

A review of the clinical features, diagnostic challenges,<br />

operative and non-operative treatment options, and a<br />

contemporary approach to the patient with an acute<br />

scaphoid fracture or established non-union.<br />

2:45pm – 3:00pm Brachial Plexus Injuries<br />

Randy Bindra, MD<br />

A simplification of this complex injury focusing on principles<br />

of acute management to include clinical assessment,<br />

investigations and indications <strong>for</strong> surgery.<br />

3:00pm – 3:15pm Carpal Instability<br />

Peter Amadio, MD<br />

A review of the anatomy and mechanics of the wrist as it<br />

relates to carpal instability, including a review of the diagnostics<br />

and treatment of common patterns of instability.<br />

3:15pm – 3:35pm Fractures of the Metacarpals and Phalanges<br />

David Dennison, MD<br />

Metacarpal and phalangeal fractures are among the<br />

most common injuries seen in the hand. A thorough<br />

review of the anatomy and biomechanics of these<br />

injuries will be provided. The treatment choices of<br />

closed management, percutaneous pinning and plate<br />

fixation will be reviewed along with surgical approaches.<br />

3:35pm – 3:55pm Flexor Tendon Injuries<br />

Kevin J. Renfree, MD<br />

This presentation will review the basic science of tendon<br />

healing, physical examination and techniques of exposure<br />

and of flexor tendon injuries. The biomechanical<br />

rationale behind the development of current post op<br />

rehab protocols will be discussed.<br />

3:55pm – 4:10pm Infections of the <strong>Hand</strong><br />

Kevin D. Plancher, MD, MS, FACS, FAAOS<br />

Comprehensive review of infections of the hand with up<br />

to date in<strong>for</strong>mation on antibiotics to allow the participant<br />

to feel com<strong>for</strong>table treating patients with these maladies.<br />

4:10pm – 4:30pm Congenital <strong>Hand</strong> Differences<br />

Scott H. Kozin, MD<br />

Discuss congenital anomalies of the upper extremity<br />

including embryology, diagnosis, and treatment. Focus<br />

on associated syndromes that require accurate diagnosis<br />

and management. Review surgical techniques, outcomes,<br />

and complications of selected conditions.<br />

4:30pm – 4:50pm Tumors of the <strong>Hand</strong> and Wrist<br />

Michael Bednar, MD<br />

Discussion of the pathology, radiology and treatment of<br />

benign and malignant bone and soft tissue tumors affecting<br />

the hand and wrist.<br />

4:50pm – 5:10pm Soft Tissue Coverage in the <strong>Hand</strong>s<br />

Loree Kallianen, MD<br />

A variety of pedicled flaps and free flaps of are available<br />

<strong>for</strong> coverage of the soft tissue defects of the hand. These<br />

flaps will be reviewed and technical tips provided. A spectrum<br />

of cases will be reviewed to illustrate the utility of<br />

each soft tissue coverage procedure.<br />

5:10pm – 5:30pm Tendon Transfers <strong>for</strong> the <strong>Hand</strong><br />

Randy Bindra, MD<br />

Palsy of the median, ulnar or radial nerves can be devastating<br />

to hand and wrist function. Tendon transfers can<br />

provide predictable restoration of function. The more<br />

commonly chosen tendon transfers will be discussed<br />

along with the technical challenges unique to each set of transfers.<br />

5:30pm – 5:50pm Tendonopathies and Dupuytren’s Contracture<br />

Peter Murray, MD<br />

Tendonopathies of the hand and wrist and Dupuytrens<br />

Contracture are among the most common problems<br />

seen in hand surgery. An overview of the pathophysiology<br />

of these conditions will be provided as well as specific<br />

treatment recommendations.<br />

5:50pm – 6:10pm Questions/Adjourn<br />

7:00pm AAHS Salsa Sensation Awards Dinner & Dance


AAHS/ASPN/ASRM<br />

DAY-AT-A-GLANCE<br />

Saturday, January 12, 2008<br />

6:00am – 5:00pm Speaker Ready Room Cali<strong>for</strong>nia Showroom<br />

6:30am – 6:30pm <strong>Meeting</strong> Services Cali<strong>for</strong>nia Lounge<br />

6:30am – 7:00am AAHS/ASRM/ASPN Coffee Break Cali<strong>for</strong>nia Lounge<br />

7:00am – 6:00pm ASRM Patient Safety Computerized Presentations Cali<strong>for</strong>nia Showroom<br />

7:00am – 7:15am AAHS/ASRM/ASPN Presidents’ Welcome Los Angeles<br />

7:15am – 8:15am PANEL: Treatment of the Ischemic Limb Los Angeles<br />

8:15am – 8:45am AAHS/ASRM/ASPN Breakfast with Exhibitors Cali<strong>for</strong>nia Showroom<br />

8:45am – 9:45am PANEL: Tendon and Nerve Transfers <strong>for</strong> Common Los Angeles<br />

Upper Extremity Palsies: Consensus and Controversies<br />

9:45am – 10:45am AAHS/ASPN/ASRM Presidents Invited Lecturer: Aaron Vinik, MD Los Angeles<br />

10:45am – 11:30am AAHS/ASPN/ASRM Outstanding Paper Presentations Los Angeles<br />

11:30am – 12:30pm ASRM/ASPN Lunch with Exhibitors Cali<strong>for</strong>nia Showroom<br />

12:30pm – 3:00pm ASPN Programming Santa Monica<br />

12:30pm – 6:00pm ASRM Programming Los Angeles<br />

33


AAHS-ASPN-ASRM<br />

Saturday, January 12, 2008<br />

6:30am – 7:00am Coffee<br />

7:00am – 6:00pm ASRM Patient Safety Computerized Presentations<br />

7:00am – 7:15am Presidents’ Welcome<br />

N. Bradly Meland, MD, AAHS President<br />

Gregory R. D. Evans, MD, ASPN President<br />

Lawrence B. Colen, MD, ASRM President<br />

7:15am – 8:15am Panel: Treatment of the<br />

Ischemic Limb<br />

This panel will cover treatment of ischemic feet hypothenar<br />

hammer syndrome and treatment with botox.<br />

William C. Pederson, MD, Moderator<br />

Chris Attinger, MD<br />

Craig Johnson, MD<br />

Michael Neumeister, MD<br />

8:15am – 8:45am Breakfast with Exhibitors<br />

8:45am – 9:45am Panel: Tendon and Nerve Transfers <strong>for</strong> Common<br />

Upper Extremity Palsies: Consensus and Controversies<br />

Nerve transfers and tendon transfers <strong>for</strong> radial nerve palsy<br />

will be discussed.<br />

Jonathan Winograd, MD, Moderator<br />

Allen T. Bishop, MD<br />

Guenter Germann, MD<br />

Thomas Tung, MD<br />

9:45am – 10:45am AAHS/ASPN/ASRM Presidents Invited Lecture<br />

Aaron Vinik, MD<br />

Neurovascular Dysfunction in Diabetes<br />

Dr. Aaron I. Vinik will present the in<strong>for</strong>mation on the role<br />

of the microvasculature in providing nutritive support <strong>for</strong><br />

the nervous system, to illustrate the functional as well as<br />

the organic causes of microvascular insufficiency, to show<br />

the mechanistic aspects thereof and highlight potential <strong>for</strong><br />

medical intervention to improve function.<br />

Dr. Vinik is one of the leading diabetes researchers in<br />

the world and leads the quest <strong>for</strong> a cure to diabetes at<br />

the Strelitz Diabetes Institute at Eastern Virginia Medical<br />

School. Dr. Vinik went to EVMS from the University of<br />

Michigan where he was a professor of both Internal<br />

Medicine and Surgery. He is a leader in research<br />

on the diagnosis and treatment of diabetic neuropathy<br />

and has particular expertise in the area of autonomic<br />

diabetic neuropathy. Dr. Vinik has been a leader in<br />

research on new approaches to generate islet cell tissue<br />

from pancreatic duct tissue.<br />

34<br />

10:45am – 11:30am AAHS/ASPN/ASRM Outstanding<br />

Paper Presentations<br />

*Designates resident/fellow paper presentations<br />

Moderator: Michael Neumeister, MD<br />

10:45am – 10:50am<br />

*Aberrant Anatomy Does Not Preclude Safe Carpal Tunnel Release Via a<br />

Limited-Open Approach<br />

Institution where the work was prepared: Allegheny General Hospital, Pittsburgh, PA,<br />

USA<br />

Caitlin Gannon, BS; Mark E. Baratz<br />

10:50am – 10:55am<br />

Efficacy of Endoscopic Cubital Tunnel Release<br />

Institution where the work was prepared: Orthopaedic Specialists, PC,<br />

Davenport, IA, USA<br />

Tyson Cobb, MD; Jon Lemke, PhD; Jennifer Tyler, PA; Patrick Sterbank, PA<br />

10:45am – 11:00am<br />

Discussion<br />

Moderator: Jonathan Winograd, MD<br />

11:00am – 11:05am<br />

Rodent Facial Nerve: A Model <strong>for</strong> the Study of Synkinesis<br />

Institution where the work was prepared: Massachusetts Eye and Ear Infirmary,<br />

Boston, MA, USA<br />

Tessa A. Hadlock, MD; Jeffrey Kowaleski; David Lo; Susan Mackinnon; James T.<br />

Heaton, PhD<br />

11:05am – 11:10am<br />

*Enhancement of Regeneration of Peripheral Nerve Defects by Application of<br />

Epineural Tubes Filled with Donor Derived Bone Marrow Stromal Cells<br />

Institution where the work was prepared: Cleveland Clinic, Cleveland, OH, USA<br />

Mehmet Bozkurt; Christopher Grykien; Lukasz Krokowicz; Aleksandra Klimczak;<br />

Jill Froimson; Dileep Nair; Maria Siemionow<br />

11:10am – 11:15am<br />

Discussion<br />

Moderator: Guenter Germann, MD<br />

11:15am – 11:20am<br />

*Extended Applications of Vascularized Preauricular and Helical Rim Flaps in<br />

Reconstruction of Nasal Defects<br />

Institution where the work was prepared: Duke University Medical Center,<br />

Durham, NC, USA<br />

Yi Xin Zhang, MD; Keith E. Follmar; Danru Wang, MD; Yee Siang Ong, MRCS,<br />

(Edin); Yunliang Qian, MD; Detlev Erdmann; Michael R. Zenn; L. Scott Levin<br />

11:20am – 11:25am<br />

*Microvascular Free Flaps: A Novel Delivery Vehicle <strong>for</strong> Local Immunotherapy<br />

with Minimal Systemic Toxicity<br />

Institution where the work was prepared: Stan<strong>for</strong>d University, Stan<strong>for</strong>d, CA, USA<br />

Marlese P. Dempsey, MD; Cynthia Hamou, MD; Leila Jazayeri, BS, BA; Edward I.<br />

Chang, MD; Hariharan Thangarajah, MD; Shadi Ghali, MD; Raymon Grogan, MD;<br />

Geoffrey C. Gurtner, MD<br />

11:25am – 11:30am<br />

Discussion<br />

11:30am – 12:30pm<br />

ASRM/ASPN Lunch with Exhibitors


ASPN<br />

DAY-AT-A-GLANCE<br />

Friday, January 11, 2008<br />

6:00am – 5:00pm Speaker Ready Room Cali<strong>for</strong>nia Showroom<br />

6:30am – 7:00am <strong>Meeting</strong> Services Cali<strong>for</strong>nia Lounge<br />

9:00am – 11:00am ASPN Council <strong>Meeting</strong> Governor’s Boardroom<br />

12:00pm – 12:10pm Presidents/ Program Chair Welcome Santa Monica<br />

Gregory R.D. Evans, MD, ASPN President<br />

Jonathan Winograd, MD, ASPN Program Chair<br />

12:10pm – 1:30pm Scientific Paper Session A Santa Monica<br />

1:30pm – 3:00pm ASPN Invited Speaker: Prof. Andrew Schwartz, PhD Santa Monica<br />

3:00pm – 3:30pm Break with Exhibitors Cali<strong>for</strong>nia Showroom<br />

3:30pm – 5:00pm Scientific Paper Session B Santa Monica<br />

35


ASPN<br />

Friday, January 11, 2008<br />

9:00am – 11:00am ASPN Council <strong>Meeting</strong><br />

12:00pm – 12:10pm Presidents/Program Chair Welcome<br />

Gregory R.D. Evans, MD, ASPN President<br />

Jonathan Winograd, MD, ASPN Program Chair<br />

12:10pm – 1:30pm Scientific Paper Session A<br />

*Designates resident/fellow paper presentations<br />

Moderators: Joseph M. Rosen, MD<br />

Jonathan M. Winograd, MD<br />

12:10pm – 12:15pm<br />

Maintainance of Neuronal Differentiated Adipose-derived Stem Cells in Long<br />

Term Culture<br />

Institution where the work was prepared: University of Cali<strong>for</strong>nia, Irvine Medical<br />

Center, Orange, CA, USA<br />

Suraj Kachgal, MS; Sanjay Dhar, PhD; Eul Sik Yoon, MD; Gregory R.D. Evans, MD<br />

12:15pm – 12:18pm<br />

Discussion<br />

12:18pm – 12:25pm<br />

*Repair of Partial Nerve Injury by Bypass Nerve Grafting with End-to-side<br />

Neurorrhaphy<br />

Institution where the work was prepared: University of Mississippi Medical Center,<br />

Jackson, MS, USA<br />

Tanya M. Oswald, MD; Feng Zhang; William C Lineaweaver<br />

12:23pm – 12:26pm<br />

Discussion<br />

12:26pm – 12:31pm<br />

*The Effect of In Vivo Delivery of Nerve Growth Factor (NGF) Through a Novel<br />

T-tube Chamber on Behavioural Recovery in a Rat Model of Peripheral Nerve<br />

Injury<br />

Institution where the work was prepared: University of Calgary, Calgary, AB, Canada<br />

Stephen W.P. Kemp, BSc(Hons), MSc; Aubrey A. Webb; Rajiv Midha<br />

12:31pm – 12:34pm<br />

Discussion<br />

12:34pm – 12:39pm<br />

Nerve Repair with Introduction of a MEMS-Based Neural Electrode is Not<br />

Detrimental to Muscle Reinnervation<br />

Institution where the work was prepared: University of Michigan, Ann Arbor, MI, USA<br />

Melanie G. Urbanchek, MS, PhD; Antonio P. Peramo, PhD; Daryl R. Kipke, PhD;<br />

William M. Kuzon Jr, MD, PhD; Paul S. Cederna, PhD<br />

12:39pm – 12:42pm<br />

Discussion<br />

12:42pm – 12:47pm<br />

Nerve Regeneration through Nerve Autografts after Local Administration of<br />

Brain Derived Neurotrophic Factor (Bdnf) with Osmotic Pumps<br />

Institution where the work was prepared: Clinica Universitaria. Universidad de<br />

Navarra, Pamplona, Spain<br />

Bernardo Hontanilla, MD, PhD; Cristina Aubá; Oscar Gorria<br />

36<br />

12:47pm – 12:50pm<br />

Discussion<br />

12:50pm – 12:55pm<br />

Peripheral Nerve Surgery: Pre-operative Variables Associated With Outcome<br />

Failures<br />

Institution where the work was prepared: Georgetwon University Hospital,<br />

Washington, DC, USA<br />

Ivica Ducic, MD, PhD; Emily Hartmann<br />

12:55pm – 12:58pm<br />

Discussion<br />

12:58pm – 1:03pm<br />

The Dynamic Phases of Peroneal and Tibial Intraneural Ganglion Formation: A<br />

New Dimension Added to the Unifying Articular Theory<br />

Institution where the work was prepared: Mayo Clinic, Rochester, MN, USA<br />

Robert J. Spinner, MD; Huan Wang; Kimberly K. Amrami<br />

1:03pm – 1:06pm<br />

Discussion<br />

1:06pm – 1:11pm<br />

*Delay of Denervation Atrophy by Sensory Protection in an End-to-Side<br />

Neurorrhaphy Model<br />

Institution where the work was prepared: Erasmus MC, Rotterdam, Netherlands<br />

H.M. Zuijdendorp; W. Tra; J. van Neck; J.H. Coert<br />

1:11pm – 1:14pm<br />

Discussion<br />

1:14pm – 1:19pm<br />

Insulin-Like-Growth Factor 1 Improves Nerve Regeneration in Aged Rats<br />

Institution where the work was prepared: Wake Forest University, Winston-Salem,<br />

NC, USA<br />

Peter Apel, MD; Timothy Alton, BS; Jianjun Ma, MD, PhD; Zhongyu Li, MD, PhD<br />

1:19pm – 1:22pm<br />

Discussion<br />

1:30pm – 3:00pm ASPN Invited Speaker<br />

Sponsored by:<br />

Prof. Andrew Schwartz, PhD<br />

Useful Signals from Motor Cortex<br />

Recent scientific progress has led to a better understanding<br />

of the representation of arm movement in<br />

the motor cortex. This knowledge has been used to<br />

build neural prosthetic devices capable of operating<br />

a prosthetic arm and gripper in a self-feeding task.<br />

Dr. Schwartz received his Ph.D. from the University of<br />

Minnesota in 1984 with a thesis entitled “Activity in the<br />

Deep Cerebellar Nuclei During Normal and Perturbed<br />

Locomotion.” He then went on to a postdoctoral<br />

fellowship at the Johns Hopkins School of Medicine<br />

where he worked with Dr. Apostolos Georgopoulos,<br />

who was developing the concept of directional tuning<br />

and popuation-based movement representation in the<br />

motor cortex While there, Dr. Schwartz was instrumental<br />

in developing the basis <strong>for</strong> three-dimensional trajectory<br />

representation in the motor cortex.<br />

In 1988, Dr. Schwartz began his independent research<br />

career at the Barrow Neurological Institute in Phoenix.<br />

There, he developed a paradigm to explore the continuous<br />

cortical signals generated throughout volitional<br />

arm-movements. This was done using monkeys<br />

trained to draw shapes while recording single-cell<br />

activity from their motor cortices. After developing the<br />

ability to capture a high fidelity representation of<br />

movement intention from the motor cortex, Dr.<br />

Schwartz teamed up with engineering colleagues at<br />

Arizona State University to develop cortical neural prosthetics.<br />

The work has progressed to the point that<br />

monkeys can now use these recorded signals to<br />

control motorized arm prostheses to reach out grasp a<br />

piece of food and return it to the mouth.


Dr. Schwartz moved from the Barrow Neurological<br />

Institute to the Neurosciences Institute in San Diego in<br />

1995 and then to the University of Pittsburgh in 2002.<br />

In addition to the prosthetics work, he has continued<br />

to utilize the neural trajectory representation to better<br />

understand the trans<strong>for</strong>mation from intended to actual<br />

movement using motor illusions in a virtual reality<br />

environment.<br />

3:00pm – 3:30pm Break with Exhibitors<br />

3:30pm – 5:00pm Scientific Paper Session B<br />

*Designates resident/fellow paper presentations<br />

Moderators: Ranjan Gupta, MD<br />

Gedge D. Rosson, MD<br />

3:30pm – 3:35pm<br />

*In Vivo Microscopy of the Peripheral Nerve, a Quantitative Analysis Following<br />

Injury using Optical Coherence Tomography (OCT)<br />

Institution where the work was prepared: Massachusetts General Hospital,<br />

Harvard Medical School, Boston, MA, USA<br />

Francis Patrick Henry, MD; Hyle Boris Park, PhD; Esther A. Z. Rust; M.A.<br />

Randolph, MAS; Johannes F. DeBoer, PhD; Jonathan M. Winograd, MD<br />

3:35pm – 3:38pm<br />

Discussion<br />

3:38pm – 3:43pm<br />

*Comparative Analysis of Holding Strength of Available “Nerve Glues”<br />

Institution where the work was prepared: Candice McDaniel, Richmond, VA, USA<br />

Jonathan Isaacs, MD; Candice O. McDaniel, MD; John R. Owen, PE; Jennifer S.<br />

Wayne<br />

3:43pm – 3:46pm<br />

Discussion<br />

3:46pm – 3:51pm<br />

Sensory Protection of Rat Muscle Spindles Following Peripheral Nerve Injury<br />

and Reinnervation<br />

Institution where the work was prepared: McMaster University, Hamilton, ON, Canada<br />

Margaret Fahnestock, PhD; Amal S. Elsohemy, BSc; Richard G. Butler, PhD;<br />

James R. Bain, MSc, MD<br />

3:51pm – 3:54pm<br />

Discussion<br />

3:54pm – 3:59pm<br />

*The Efficacy of Subcutaneous Transposition of the Ulnar Nerve in Surgical<br />

Treatment of Cubital Tunnel Syndrome<br />

Institution where the work was prepared: Dept. of Plastic Surgery,University of<br />

Tuebingen, Tuebingen, Germany<br />

Armin Kraus, MD; Nektarios Sinis; Frank Werdin; Hans-Eberhard Schaller<br />

3:59pm – 4:02pm<br />

Discussion<br />

4:02pm – 4:07pm<br />

Health Related Quality of Life and Disability in Patients Following Peripheral<br />

Nerve Injury<br />

Institution where the work was prepared: University Health Network, Toronto,<br />

ON, Canada<br />

Christine B. Novak, PT, MS, PhD(c); Dimitri J. Anastakis<br />

4:07pm – 4:10pm<br />

Discussion<br />

4:10pm – 4:15pm<br />

The Mechanisms of Axonal Sprouting With End-to-Side Neurorrhaphy<br />

Institution where the work was prepared: Washington University in St Louis, St<br />

Louis, MO, USA<br />

Ayato Hayashi, MD, PhD; Daniel A. Hunter, RA; Alice Y. Tong, MS; David H.<br />

Kawamura, MD; Arash Moradzadeh, MD; Sami H. Tuffaha, BA; Christina B.<br />

Kenney, MD; Janina Luciano, BS; Thomas H. Tung, MD; Susan E. Mackinnon,<br />

MD; Terence M. Myckatyn, MD<br />

4:15pm – 4:18pm<br />

Discussion<br />

37<br />

4:18pm – 4:23pm<br />

Comparison of Psychosocial Outcomes of Patients with Neuropathic<br />

Conditions Treated With and Without Surgery<br />

Institution where the work was prepared: <strong>Hand</strong> and Microsurgery Center of El<br />

Paso, El Paso, TX, USA<br />

Jose Monsivais, MD; Kris Robinson, PhD, FNP<br />

4:23pm – 4:26pm<br />

Discussion<br />

4:26pm – 4:31pm<br />

*Delivery Strategy Significantly Affects the Number and Phenotype of<br />

Schwann Cells in Seeded Decellularized Allografts<br />

Institution where the work was prepared: Washington University School of<br />

Medicine, Saint Louis, MO, USA<br />

Arash Moradzadeh, MD; Sami H. Tuffaha, BA; Ryan D. Luginbuhl; Jason Gustin;<br />

Gregory H. Borschel; Alice Y. Tong; Jeffery Milbrandt, MD, PhD; Susan E.<br />

Mackinnon, MD; Terence M. Myckatyn, MD<br />

4:31pm – 4:34pm<br />

Discussion<br />

4:34pm – 4:39pm<br />

*Saphenous Nerve Neuropathy: Treatment Options and Outcomes<br />

Institution where the work was prepared: Georgetwon University Hospital,<br />

Washington, DC, USA<br />

Ethan Larson, MD; Ivica Ducic, MD, PhD<br />

4:39pm – 4:42pm<br />

Discussion<br />

4:42pm – 4:47pm<br />

Caspase 3 Knockout Mice Show Partial Protection of Skeletal Muscle Atrophy<br />

following Denervation<br />

Institution where the work was prepared: McMaster University, Hamilton, ON,<br />

Canada<br />

James Bain, MD, MSc; Jane AE Batt, MD, PhD, FRCPC; Pam Plant; Minna Woo<br />

4:47pm – 4:50pm<br />

Discussion


ASPN<br />

DAY-AT-A-GLANCE<br />

Saturday, January 12, 2008<br />

6:00am – 3:00pm Speaker Ready Room Cali<strong>for</strong>nia Showroom<br />

6:30am – 6:30pm <strong>Meeting</strong> Services Cali<strong>for</strong>nia Lounge<br />

6:30am – 7:00am AAHS/ASPN/ASRM Coffee Break Cali<strong>for</strong>nia Lounge<br />

7:00am – 11:30am AAHS/ASPN/ASRM Combined Programming Los Angeles<br />

11:30am – 12:30pm ASPN/ASRM Lunch with Exhibitors Cali<strong>for</strong>nia Showroom<br />

12:30pm – 1:30pm ASPN Invited Speaker: Prof. Jeff Lichtman, MD, PhD Santa Monica<br />

1:30pm – 3:00pm Scientific Paper Session C Santa Monica<br />

6:30pm – 8:00pm ASPN/ASRM Welcome Reception X Bar<br />

38


ASPN<br />

Saturday, January 12, 2008<br />

11:30am – 12:30pm Lunch with Exhibitors<br />

12:30pm – 1:30pm ASPN Invited Speaker<br />

Prof. Jeff Lichtman, MD, PhD<br />

Peripheral Nerve Growth Branching and<br />

Retraction: Studies in Fluorescent Mice<br />

Description: Mice in which axons express a variety of<br />

different colored fluorescent proteins allow in vivo<br />

studies of peripheral nerve development and reorganization<br />

in trauma and aging.<br />

Jeff Lichtman, MD, PhD is Professor of Molecular and<br />

Cellular Biology at Harvard University. He received his<br />

MD and PhD in Neurobiology at Washington University<br />

in St. Louis. Dr. Lichtman currently serves as Advisory<br />

Editor <strong>for</strong> Anatomy and Embryology and is on the<br />

Editorial Board <strong>for</strong> the Journal of Neuroscience, Journal<br />

of Neurobiology, Molecular and Cellular Neuroscience<br />

and Cells and Systems.<br />

1:30pm – 3:00pm Scientific Paper Session C<br />

*Designates resident/fellow paper presentations<br />

Moderator: Gregory R. D. Evans, MD, FACS<br />

David T. J. Netscher, MD<br />

1:30pm – 1:35pm<br />

Grip Strength and CMAP Amplitude in Median Nerve Injury of the Rats<br />

Institution where the work was prepared: Mayo Clinic, Rochester, MN, USA<br />

Huan Wang, MD, PhD; Eric J. Sorenson; Robert J. Spinner; Anthony J.<br />

Windebank<br />

1:35pm – 1:38pm<br />

Discussion<br />

1:38pm – 1:42pm<br />

Nerve Transfers For Paralysis Of The Tibialis Anterior Muscle (Foot-Drop)—A<br />

Cadaveric Feasibility Study<br />

Institution where the work was prepared: Teaxs Tech University Health Science<br />

Center, El Paso, TX, USA<br />

Miguel Pirela-Cruz, MD; D.A. Terreros; U.D. Hansen, MD; P. West, MD; A.D.<br />

Rossum, MD<br />

1:43pm – 1:46pm<br />

Discussion<br />

1:46pm – 1:51pm<br />

*Soleus Arch as Compression Site <strong>for</strong> Proximal Tibial Nerve: Cadaver Study<br />

Institution where the work was prepared: Union Memorial Hospital, Baltimore,<br />

MD, USA<br />

Eric H. Williams, MD; Gedge D. Rosson, MD; A. Lee Dellon, MD<br />

1:51pm – 1:54pm<br />

Discussion<br />

1:54pm – 1:59pm<br />

*Anatomical Landmarks <strong>for</strong> the Nerve Branch to the Masseter Muscle in Facial<br />

Reanimation<br />

Institution where the work was prepared: SIU School of Medicine, Springfield, IL, USA<br />

Nada Berry, MD; Margo Herron; Rebuen Bueno; Ronald Zuker, MD; Michael W.<br />

Neumeister<br />

1:59pm – 2:02pm<br />

Discussion<br />

Sponsored by:<br />

2:02pm – 2:07pm<br />

*Novel Model <strong>for</strong> End-Neuroma Formation in the Amputated Rabbit Forelimb<br />

Institution where the work was prepared: Northwestern University, Feinberg<br />

School of Medicine, Chicago, IL, USA<br />

Peter S. Kim, MD; Kristina O'Shaughnessy, MD; Todd A. Kuiken, MD, PhD;<br />

Gregory A. Dumanian<br />

39<br />

2:07pm – 2:10pm<br />

Discussion<br />

2:10pm – 2:15pm<br />

*Antibodies to Galactocerebroside Enhance Nerve Regeneration after Acute<br />

Contusion and Transection Injuries in the Adult Rat Sciatic Nerve<br />

Institution where the work was prepared: University of Cali<strong>for</strong>nia, Irvine, Orange,<br />

CA, USA<br />

Aaron M. Kosins, MD, MBA; Charles Mendoza; Michael P. McConnell, MD;<br />

Brandon Shepard; Sanjay Dhar, PhD; Gregory RD Evans, MD, FACS; Hans S.<br />

Keirstead, PhD<br />

2:15pm – 2:18pm<br />

Discussion<br />

2:18pm – 2:23pm<br />

*Sympathetic Nerves in the Tarsal Tunnel: Implications <strong>for</strong> Blood Flow in the<br />

Diabetic Foot<br />

Institution where the work was prepared: University of Arizona School of<br />

Medicine, Tucson, AZ, USA<br />

Andrew Blount, BS; Erika Dexter; Raymond Nagle; Christopher Maloney; Lee<br />

Dellon; Ziv Peled<br />

2:23pm – 2:26pm<br />

Discussion<br />

2:26pm – 2:31pm<br />

*A Study of Modality Specific Nerve Regeneration in the Rat Femoral Nerve<br />

Institution where the work was prepared: Washington University, St. Louis, MO,<br />

USA<br />

David H. Kawamura, MD; Gregory H Borschel; Daniel A Hunter; Susan E<br />

Mackinnon; Thomas HH Tung<br />

2:31pm – 2:34pm<br />

Discussion<br />

2:34pm – 2:39pm<br />

Limb Length Discrepancy in Obstetrical Brachial Plexus Injury<br />

Institution where the work was prepared: McMaster Children's Hospital,<br />

Hamilton, ON, Canada<br />

James Bain, MD, MSc; Carol DeMatteo; Deborah Agro<br />

2:39pm – 2:42pm<br />

Discussion<br />

2:42pm – 2:47pm<br />

*Regeneration in an Enzyme-Treated Decellularized Nerve Allograft<br />

Institution where the work was prepared: Washington University School of<br />

Medicine, St. Louis, MO, USA<br />

Sami H. Tuffaha, BA; Daniel A. Hunter; Ying Yan; Janina P. Luciano; Susan E.<br />

Mackinnon; Gregory H. Borschel<br />

2:47pm – 2:50pm<br />

Discussion<br />

2:50pm – 2:55pm<br />

*Increase of Neuronal Camp by Electrical Stimulation or Rolipram Administration<br />

and/or Local Application of Chonodrioitinase<br />

ABC Accelerates Motor Axon Outgrowth Across the Surgical Repair Site of<br />

Sectioned Rat Peripheral Nerve<br />

Institution where the work was prepared: University of Alberta, Edmonton, AB,<br />

Canada<br />

T. Gordon; M Furey; N Tyreman; E Udina<br />

2:55pm – 2:58pm<br />

Discussion<br />

6:30pm – 8:00pm ASPN/ASRM Welcome Reception<br />

The ASPN & ASRM would like to thank ASSI<br />

<strong>for</strong> their generous sponsorship of this reception.


ASPN<br />

DAY-AT-A-GLANCE<br />

Sunday, January 13, 2008<br />

6:00am – 3:00pm Speaker Ready Room Cali<strong>for</strong>nia Showroom<br />

6:30am – 7:30am ASPN Breakfast with Exhibitors Cali<strong>for</strong>nia Showroom<br />

6:30am – 4:00pm <strong>Meeting</strong> Services Cali<strong>for</strong>nia Lounge<br />

7:00am – 8:00am ASPN Instructional Courses<br />

301 Interoperative Monitoring Palisades<br />

302 Obstetrical Brachial Plexus Palsy Pacific<br />

303 Peripheral Nerve Tumors Sherman Oaks<br />

304 Peinnervating Muscle Westwood<br />

305 Working Toward a Brain-Body Interface: Brentwood<br />

Intelligent Functional Electrical Stimulations<br />

For The Upper Extremity<br />

8:15am – 9:15am ASRM/ASPN Panel: Treatment of the Mangled <strong>Hand</strong>: Los Angeles<br />

A Multidisciplinary Approach<br />

9:15am – 9:45am Break with Exhibitors Cali<strong>for</strong>nia Showroom<br />

9:45am – 11:30am Scientific Paper Presentations D Santa Monica<br />

11:30am – 12:00pm ASPN Poster Presentations Cali<strong>for</strong>nia Showroom<br />

12:00pm – 1:00pm Lunch with Exhibitors Cali<strong>for</strong>nia Showroom<br />

1:00pm – 2:15pm Scientific Paper Presentations E Santa Monica<br />

2:15pm – 3:15pm ASPN Invited Speaker: Prof. Neville Hogan Santa Monica<br />

3:15pm – 3:30pm Closing Remarks & Presentation of Awards Santa Monica<br />

3:30pm – 4:00pm ASPN Business <strong>Meeting</strong> Santa Monica<br />

4:00pm – 4:30pm ASPN Council <strong>Meeting</strong> Santa Monica<br />

40


ASPN<br />

Sunday, January 13, 2008<br />

6:30am – 7:30am Breakfast with Exhibitors<br />

7:00am – 8:00am Instructional Courses<br />

301 Intraoperative Monitoring<br />

Intraoperative neurophysiological techniques help guide<br />

decision making during nerve surgery so that outcome<br />

may be optimized. Background to these techniques, and<br />

their usefulness, will be explored by classical and case<br />

studies. Practical applications will also be emphasized.<br />

David Houlden, PhD<br />

Robert Tiel, MD<br />

Allen Van Beek, MD<br />

302 Obstetrical Brachial Plexus Palsy<br />

Current thinking concerning timing of surgery versus<br />

natural history will be explored. Techniques of nerve transfers<br />

will be described.<br />

Allan Belzberg, MD<br />

Howard M. Clarke, MD, PhD<br />

Scott Kozin, MD<br />

303 Peripheral Nerve Tumors<br />

Diagnosis and treatment of benign and malignant peripheral<br />

nerve tumors.<br />

Ab Guha, MD<br />

Rajiv Midha, MD<br />

Robert Spinner, MD<br />

304 Reinnervating Muscle<br />

The course will focus on the consequence of muscle denervation,<br />

physiologic responses during reinnervation, and<br />

the potential techniques to optimize the recovery of function.<br />

Paul Cederna, MD<br />

Tessa Gordon, PhD<br />

William Kuzon, Jr, MD<br />

305 Working Toward a Brain-Body Interface:<br />

Intelligent Functional Electrical Stimulation<br />

For The Upper Extremity<br />

The course will focus on the development of a brain-body<br />

interface, including implementation of existing technologies<br />

to link functional electrical stimulation of the upper<br />

extremity to cortical movement inention.<br />

Robert Ajemian, PhD<br />

Jonathan Winograd, MD<br />

8:15am – 9:15am ASRM/ASPN Panel: Treatment of the Mangled<br />

<strong>Hand</strong>: A Multidisciplinary Approach<br />

This panel will focus on the surgical approach to the<br />

complex wounds of the upper extremity. Aspects of discussion<br />

will include acute management of soft tissue,<br />

nerve loss, bony instability and revascularization. The<br />

multidisciplinary approach should captivate peripheral<br />

nerve surgeons, microsurgeons and hand surgeons.<br />

Michael W. Neumeister, MD; Moderator<br />

David Chwei-Chin Chuang, MD<br />

L. Scott Levin, MD<br />

Michael Sauerbier, MD, PhD<br />

9:15am – 9:45am Break with Exhibitors<br />

9:45am – 11:30am Scientific Paper Session D<br />

*Designates resident/fellow paper presentations<br />

Moderators: Gregory M. Buncke, MD<br />

Warren Schubert, MD<br />

9:45am – 9:50am<br />

*Brachial Plexus Surgery in a German Center <strong>for</strong> Peripheral Nerve Surgery<br />

Institution where the work was prepared: University of Tuebingen, Tuebingen,<br />

Germany<br />

Nektarios Sinis, MD; Tatjana Lanaras; Hans-Eberhard Schaller, MD<br />

41<br />

9:50am – 9:53am<br />

Discussion<br />

9:53am – 9:58am<br />

*Effect Of Nerve Growth Factor (NGF) Releasing Polylactic-Co-Glycolic Acid<br />

(PLGA) Microspheres On Peripheral Nerve Regeneration<br />

Institution where the work was prepared: Mayo Clinic, Rochester, MN, USA<br />

Ralph De Boer, MD; Huan Wang, MD, PhD; Andrew M. Knight, PhD; Robert J.<br />

Spinner; M.J.A. Malessy; Michael J. Yaszemski, MD, PhD; Anthony J. Windebank,<br />

MD<br />

9:58am – 10:01am<br />

Discussion<br />

10:01am – 10:06am<br />

Nerve Transfers to Reanimate Elbow Flexion in Obstetric Brachial Plexus<br />

Lesions<br />

Institution where the work was prepared: Leiden University Medical Center,<br />

Leiden, Netherlands<br />

Willem Pondaag, MD; Martijn J.A. Malessy<br />

10:06am – 10:09am<br />

Discussion<br />

10:09am – 10:14am<br />

Specialty of the Phrenic Nerve <strong>for</strong> Modified End-to-Side Nerve Repair -<br />

Experiment and Clinical Implications<br />

Institution where the work was prepared: Medical College of Wisconsin,<br />

Milwaukee, WI, USA<br />

ji-Geng Yan, MD; Lin-Ling Zhang; Hani S Matloub; James R Sanger; Yu-Hui Yan<br />

10:14am – 10:17am<br />

Discussion<br />

10:17am – 10:22am<br />

Spontaneous Gait Recovery in Denervated Rats May Impair the Evaluation of<br />

Artificial Nerve Guides<br />

Institution where the work was prepared: The Catholic University, Rome, Italy<br />

Antonio Merolli, MD; Lorenzo Rocchi; Maria Silvia Spinelli; Rocco De Vitis;<br />

Francesco Catalano<br />

10:22am – 10:25am<br />

Discussion<br />

10:25am – 10:30am<br />

*Suppression of Fibrous Scar Improves Peripheral Nerve Regeneration After<br />

Primary Nerve Suture<br />

Institution where the work was prepared: University of Tuebingen and University<br />

of Duesseldorf, Tuebingen and Duesseldorf, Germany<br />

Nektarios Sinis, MD; Philip Schoenle; Tatjana Lanaras; Frank Werdin, MD; Armin<br />

Kraus, MD; Max Haerle, MD; Timm Danker, PhD; Elke Guenther, Phd; Federica Di<br />

Scipio, Phd; Stefano Geuna, MD; Hans-Werner Mueller, PhD; Daniela Mueller;<br />

Carmen Masannek; Susanne Hermanns, Phd; Hans-Eberhard Schaller, MD<br />

10:30am – 10:33am<br />

Discussion<br />

10:33am – 10:38am<br />

*Extending the Indications <strong>for</strong> Primary Nerve Surgery in Obstetrical Brachial<br />

Plexus Palsy<br />

Institution where the work was prepared: The Hospital <strong>for</strong> Sick Children,<br />

University of Toronto, Toronto, ON, Canada<br />

Jenny C. Lin, MD, PhD; Christine G. Curtis, BScPT; Howard M. Clarke, MD, PhD,<br />

FRCS(C)<br />

10:38am – 10:41am<br />

Discussion<br />

10:41am – 10:46am<br />

*The Effects of Inflammation on GFAP Expression in Satellite Cells of the<br />

Dorsal Root Ganglion<br />

Institution where the work was prepared: Cleveland Clinic, Cleveland, OH, USA<br />

Krzysztof Siemionow, MD; Alexandra Klimczak, PhD; Maria Siemionow, MD, PhD;<br />

Robert F. McLain, MD<br />

10:46am – 10:49am<br />

Discussion


10:49am – 10:54am<br />

Actual Delivery Location of Carpal Tunnel Injections: A Cadaveric Study<br />

Institution where the work was prepared: The Cleveland Clinic, Cleveland, OH, USA<br />

Joseph E. Robison, MD; Peter J. Evans, MD, PhD; Jeffrey N. Lawton, MD<br />

10:54am – 10:57am<br />

Discussion<br />

10:57am – 11:02am<br />

Understanding Pain Associated with Chronic Nerve Compression Injuries<br />

Institution where the work was prepared: University of Cali<strong>for</strong>nia Irvine, Irvine, CA, USA<br />

Laura Rummler, BS; Winnie Palispis; Ranjan Gupta<br />

11:02am – 11:05am<br />

Discussion<br />

11:05am – 11:10am<br />

Surgical Treatment of Post-operative or Post-traumatic Chronic Headaches:<br />

Indications and Outcome<br />

Institution where the work was prepared: Georgetown University Hospital,<br />

Washington, DC, USA<br />

Ivica Ducic, MD, PhD<br />

11:10am – 11:13am<br />

Discussion<br />

11:13am – 11:18am<br />

*Morphological Analysis of the Carpal Tunnel and Median Nerve Following<br />

Endoscopic and Open Carpal Tunnel Release<br />

Institution where the work was prepared: University of Manitoba, Winnipeg, MB, Canada<br />

Avinash Islur, MD, FRCSC; Kenneth A. Murray, MD, FRCPS(C)<br />

11:18am – 11:21am<br />

Discussion<br />

11:21am – 11:26am<br />

*Does Mode of Minocycline Delivery Affect Recovery From Partial Nerve Injury?<br />

Institution where the work was prepared: Rush University Medical Center,<br />

Chicago, IL, USA<br />

Vishal Didwania, BA; Mark Gonzalez, MD; Jeffrey S. Kroin, PhD; Susan Shott,<br />

PhD; Sara Beddow, BA; James M. Kerns, PhD<br />

11:26am – 11:29am<br />

Discussion<br />

11:30am – 12:00pm Poster Presentations<br />

12:00pm – 1:00pm Lunch with Exhibitors<br />

1:00pm – 2:15pm Scientific Paper Session E<br />

*Designates resident/fellow paper presentations<br />

Moderator: Nancy H. McKee, MD, FRCSC<br />

Thomas H. H. Tung, MD<br />

1:00pm – 1:05pm<br />

Nonviral HVJ (Hemagglutinating Virus of Japan) Liposome Mediated<br />

Retrograde Gene Transfer of Human Hepatocyte Growth Factor Improves<br />

Neuropathic Pain-Related Phenomena in Rats<br />

Institution where the work was prepared: National Defense Medical College,<br />

Tokorozawa, Japan<br />

Toyokazu Tsuchihara; Koichi Nemoto; Hiroshi Arino; Masatoshi Amako; Kuniaki<br />

Nakanishi; Morishita Ryuichi<br />

1:05pm – 1:08pm<br />

Discussion<br />

1:08pm – 1:13pm<br />

*Repairing Peripheral Nerve Injuries Using Skin-Derived Precursor Cells<br />

Institution where the work was prepared: University of Calgary, Hotchkiss Brain<br />

Institute, Calgary, AB, Canada<br />

Sarah K. Walsh, BSc; Raj Midha, MD, MSc<br />

1:13pm – 1:16pm<br />

Discussion<br />

1:16pm – 1:21pm<br />

DASH as a Measurement of Outcome in Adult Brachial Plexus Reconstruction<br />

Institution where the work was prepared: Mayo Clinic, Rochester, MN, USA<br />

Keith A. Bengtson; Alexander Shin; Robert Spinner; Allen Bishop; Michelle Kircher<br />

1:21pm – 1:24pm<br />

Discussion<br />

1:24pm – 1:29pm<br />

Reversal of Distal Symmetric Polyneuropathy by Microsurgical Decompression<br />

of Localized Nerve Entrapments<br />

Institution where the work was prepared: International Neuropathy Microsurgery<br />

Institute, Sonora, CA, USA<br />

Michael Charles Edwards, MD/PhD; Joseph Paul Day, PhD<br />

1:29pm – 1:32pm<br />

Discussion<br />

42<br />

1:32pm – 1:37pm<br />

*Evaluation of Function of Composite Osseomusculocutaneous Nose, Lower Lip<br />

and Premaxilla Allograft Trans<strong>plan</strong>ts via Somatosensory Evoked Potentials<br />

Institution where the work was prepared: Cleveland Clinic, Cleveland, OH, USA<br />

Mehmet Bozkurt; Erhan Sonmez; Christopher Grykien; Lukasz Krokowicz; Serdar<br />

Nasir; Klimczak Aleksandra; Jill Froimson; Dileep Nair; Maria Siemionow<br />

1:37pm – 1:40pm<br />

Discussion<br />

1:40pm – 1:45pm<br />

Pressure Changes in the Medial and Lateral Plantar and Tarsal Tunnels Related to<br />

Ankle Position: a Prospective Intra-Operative Study in Patients with Underlying<br />

Neuropathy<br />

Institution where the work was prepared: Johns Hopkins University School of Medicine,<br />

Baltimore, MD, USA<br />

Gedge D. Rosson, MD; Eric H. Williams, MD; Allison R. Barker, BA; A. Lee Dellon, MD<br />

1:45pm – 1:48pm<br />

Discussion<br />

1:48pm – 1:53pm<br />

Inducible Nerve Growth Factor Delivery by HEK-293 Cells <strong>for</strong> Peripheral Nerve<br />

Regeneration in Vivo<br />

Institution where the work was prepared: University of Cali<strong>for</strong>nia, Irvine, CA, USA<br />

Thomas Scholz, MD; James M. Rogers; Alisa Krichev; Sanjay Dhar; Gregory R. D. Evans<br />

1:53pm – 1:56pm<br />

Discussion<br />

1:56pm – 2:01pm<br />

Restoration of Elbow Function Using Inverse End-to-Side Anastomosis between<br />

Ulnar Fascicles and Musculocutaneous Nerve in Late Incomplete Obstetrical<br />

Erb's Palsy<br />

Institution where the work was prepared: Tel Aviv Medical Center, Tel Aviv University,<br />

Tel Aviv, Israel<br />

Shimon Rochkind, MD; Mohamed Shafi; Malvina Alon; Hagar Patish<br />

2:01pm – 2:04pm<br />

Discussion<br />

2:04pm – 2:09pm<br />

*The Feasibility of Using Side-to-Side Nerve Grafts to “Protect” Nerve Pathways<br />

during Axon Regeneration from Surgically Repaired Proximal Nerve Injuries<br />

Institution where the work was prepared: University of Alberta, Edmonton, AB, Canada<br />

P. Schembri, BSc, MD; A Ladak; N. Tyreman; J Olson; T. Gordon<br />

2:09pm – 2:12pm<br />

Discussion<br />

2:15pm – 3:15pm ASPN Invited Speaker<br />

Sponsored by:<br />

Professor Neville Hogan, PhD<br />

Robotics <strong>for</strong> Neurorecovery<br />

Robots are well on their way to becoming commonplace<br />

domestic appliances but to realize their full potential<br />

requires the perfection of contact robotics, machines that<br />

physically cooperate with humans. Robots capable of safe<br />

physical cooperation with humans enable entirely new<br />

ways <strong>for</strong> technology to help people. One pioneering<br />

application of contact robotics is the delivery of physiotherapy<br />

to facilitate recovery after neurological injury. I will<br />

review recent success with interactive robotic treatment of<br />

upper-extremity motor disorders. It has proven to af<strong>for</strong>d<br />

lasting benefits, both an increase of motor ability and a<br />

reduction of paretic arm pain, <strong>for</strong> persons in both the<br />

acute phase and the chronic phase of recovery after stroke.<br />

Neville Hogan is Professor of Mechanical Engineering<br />

and Professor of Brain and Cognitive Sciences at the<br />

Massachusetts Institute of Technology. He is Director of<br />

the Newman Laboratory <strong>for</strong> Biomechanics and Human<br />

rehabilitation and a founder and director of Interactive<br />

Motion Technologies, Inc., a company offering innovative<br />

robotic tools to study and treat neuro-motor impairments.<br />

Born in Dublin, Ireland, he obtained a Dip. Eng.<br />

(with distinction) from Dublin Institute of Technology and<br />

M.S., M.E. and Ph.D. degrees from the Massachusetts<br />

Institute of Technology. Following industrial experience in<br />

engineering design, he joined MIT’s school of<br />

Engineering faculty in 1979 and has served as Head and<br />

Associate Head of the MIT Mechanical Engineering<br />

Department’s System Dynamics and Control Division. He<br />

has been awarded Honorary Doctorates from the Delft<br />

University of Technology and the Dublin Institute of<br />

Technology and the Silver Medal of the Royal Academy<br />

of Medicine in Ireland.<br />

3:15pm – 3:30pm Closing Remarks & Presentation of Awards<br />

3:30pm – 4:00pm ASPN Business <strong>Meeting</strong> (attendance is limited to ASPN members only)<br />

4:00pm – 4:30pm ASPN Council <strong>Meeting</strong>


ASRM<br />

DAY-AT-A-GLANCE<br />

Saturday, January 12, 2008<br />

6:00am – 5:00pm Speaker Ready Room Cali<strong>for</strong>nia Showroom<br />

6:30am – 6:30pm <strong>Meeting</strong> Services Cali<strong>for</strong>nia Lounge<br />

6:30am – 7:00am AAHS/ASPN/ASRM Coffee Break Cali<strong>for</strong>nia Lounge<br />

7:00am – 11:30am AAHS/ASPN/ASRM Combined Programming Los Angeles<br />

11:30am – 12:30pm Lunch with Exhibitors Cali<strong>for</strong>nia Showroom<br />

12:30pm – 1:30pm Scientific Paper Presentations: Research II Los Angeles<br />

1:30pm – 2:30pm ASRM Instructional Courses<br />

201 Pedicle and Microsurgical Per<strong>for</strong>ator<br />

Flaps in Upper Extremity Reconstruction<br />

Palisades<br />

202 Venous Flow Through Flaps Pacific<br />

203 Microsurgical Salvage of the Chronic Wound Sherman Oaks<br />

204 Breast Reconstruction – What has evolved<br />

as the Clinical Standard?<br />

Westwood<br />

2:30 – 3:00pm Coffee Break with Exhibitors Cali<strong>for</strong>nia Showroom<br />

3:00pm – 4:00pm PANEL: Grill the Expert Los Angeles<br />

4:00pm – 6:00pm Best Microsurgical Case/Best Microsurgical<br />

Save Presentations<br />

Los Angeles<br />

6:30pm – 8:00pm ASPN/ASRM Welcome Reception X Bar<br />

43


ASRM<br />

Saturday, January 12, 2008<br />

11:30am – 12:30pm Lunch with Exhibitors<br />

12:30pm – 1:30pm Scientific Paper Presentations: Research II<br />

*Designates resident/fellow paper presentations<br />

Moderator: Paul Cederna, MD<br />

12:30pm – 12:34pm<br />

*Changes in the Nitric Oxide Pathway During Free Flap Failure<br />

Institution where the work was prepared: R Adams Cowley Shock Trauma Center,<br />

Baltimore, MD, USA<br />

Suhail K. Mithani, MD; Rachel Bluebond-Langner, MD; Hunter C. Champion, MD,<br />

PhD; Eduardo D. Rodriguez<br />

12:34pm – 12:38pm<br />

Regenerative Acellular Collagen Tube Matrix as a Microvascular Conduit<br />

Institution where the work was prepared: Cleveland Clinic Foundation,<br />

Cleveland, OH, USA<br />

Wong Moon, MD<br />

12:38pm – 12:41pm<br />

Discussion<br />

12:41pm – 12:45pm<br />

*Thermoreversible Poloxamers and Applications <strong>for</strong> Vascular Biology<br />

Institution where the work was prepared: Stan<strong>for</strong>d University, Stan<strong>for</strong>d, CA, USA<br />

Edward I. Chang, MD; Cynthia D. Hamou; Michael G. Galvez; Michael T.<br />

Longaker; Geoffrey C. Gurtner<br />

12:45pm – 12:49pm<br />

*Brain Plasticity after Facial Reanimation Imaged by fMRI<br />

Institution where the work was prepared: Dep of Plastic Surgery, Helsinki<br />

University Hospital, Helsinki, Finland<br />

Tuija M. Ylä-Kotola, MD; Antti Korvenoja, MD, PhD; M Susanna C Kauhanen;<br />

Sinikka Suominen; Erkki Tukiainen; Sirpa Asko-Seljavaara<br />

12:49pm – 12:53pm<br />

Postoperative Changes in Blood Velocity Following Microvascular Free Tissue<br />

Transfer<br />

Institution where the work was prepared: University of Texas M. D. Anderson<br />

Cancer Center, Houston, TX, USA<br />

Olubunmi Ogunleye, MD; Michael J. Miller, MD; Craig J. Hartley, PhD; Matthew<br />

M. Hanasono, MD<br />

12:53pm – 12:56pm<br />

Discussion<br />

12:56pm – 1:00pm<br />

*Correlation of Chimerism with Size of Vascularized and Non Vascularized<br />

Allograft Trans<strong>plan</strong>ts<br />

Institution where the work was prepared: Cleveland Clinic, Cleveland, OH, USA<br />

Serdar Nasir; Mehmet Bozkurt; Lukasz Krokowicz; Aleksandra Klimczak; Maria Siemionow<br />

1:00pm – 1:04pm<br />

*Supportive Therapy with Donor Bone Marrow Trans<strong>plan</strong>tation and Role of<br />

Regulatory T-cell <strong>for</strong> Allograft Survival in Facial Allograft Model<br />

Institution where the work was prepared: Cleveland Clinic, Cleveland, OH, USA<br />

Aleksandra Klimczak, PhD; Mehmet Bekir Unal; Yavuz Demir; Maria Siemionow<br />

1:04pm – 1:08pm<br />

*Involvement of Notch1 Signals in Osteoinduction and Proliferation of Adipose<br />

Derived Adult Stem Cells<br />

Institution where the work was prepared: SIU SOM, springfield, IL, USA<br />

Damon Cooney, MD, PhD; Chris Chambers; Minh-Doan Nguyen; Michael Neumeister<br />

1:08pm – 1:11pm<br />

Discussion<br />

1:11pm – 1:15pm<br />

*The Use of Thrombolytics in Microvascular Free Flaps<br />

Institution where the work was prepared: NYU Medical Center, New York, NY, USA<br />

Otway Louie; Pierre Saadeh; Jamie Levine<br />

44<br />

1:15pm – 1:19pm<br />

Ischemia/reperfusion-induced Apoptotic Endothelial Cells Isolated from Rat<br />

Skeletal Muscle<br />

Institution where the work was prepared: University of Nevada School of Medicine, Las<br />

Vegas, NV, USA<br />

Wei Z. Wang, MD; Xin-Hua Fang, MT; Linda L. Stephenson, MT; Kayvan T. Khiabani,<br />

MD; William A. Zamboni, MD<br />

1:19pm – 1:23pm<br />

*A Prefabricated Neo-Endocrine Pancreas Using a Muscle Flap to Maximize‚-cell Mass<br />

in Pancreatic Trans<strong>plan</strong>ts – Pilot Study in a Rat Model<br />

Institution where the work was prepared: Singapore General Hospital, Singapore, Singapore<br />

Eky Woo, MBBS, MRCSEd; Bien-Keem Tan, FRCS; Kok Chai Tan, FRCS; Pk Chow,<br />

FRCS, PHD<br />

1:23pm – 1:26pm<br />

Discussion<br />

1:30pm – 2:30pm Instructional Courses<br />

201 Pedicle and Microsurgical Per<strong>for</strong>ator Flaps in<br />

Upper Extremity Reconstruction<br />

This course will cover the anatomy, dissection technique<br />

and applications in pedicle and microsurgical<br />

per<strong>for</strong>ator flaps in upper extremity reconstruction.<br />

Alexandru Georgescu, MD<br />

Ming Huei-Cheng, MD<br />

Yixin Zhang, MD<br />

202 Venous Flow Through Flaps<br />

Venous flow through flaps are defined as composite<br />

flaps of skin and subcutaneous vein that uses the subcutaneous<br />

venous system <strong>for</strong> the nutrient support. The<br />

inflow can be arterial blood or venous blood. The outflow<br />

can be artery or vein.<br />

Rudolf Buntic, MD<br />

Tsu Min Tsai, MD<br />

203 Microsurgical Salvage of the Chronic Wound<br />

Chronic venous ulcer disease remains a highly prevalent<br />

condition <strong>for</strong> which no medical or surgical solution<br />

has resulted in definitive cure without a high prevalence<br />

<strong>for</strong> recurrence. The purpose of this instructional course<br />

is to review our experience in the rationale, technical<br />

per<strong>for</strong>mance and the results of microvascular flap<br />

treatment of chronic venous ulcer disease and lower<br />

extremity chronic osteomyelitis. Details of wide subfascial<br />

excision of ulcer, or wounds, bony debridement<br />

resection and grafting and details of post-operative<br />

care, patient and flap selection <strong>for</strong> surgery will be discussed<br />

in detail.<br />

Raymond Dunn, MD<br />

Koenraad Landuyt, MD<br />

204 Breast Reconstruction – What has<br />

evolved as the Clinical Standard?<br />

This instructional course will cover the current strategies<br />

in autogenous breast reconstruction and when to use<br />

Free Tram, DIEP and SIEA flaps <strong>for</strong> reliable results. The<br />

use of internal mammary vessels and patient selection<br />

will be covered as well.<br />

Joseph Serletti, MD<br />

Michael Zenn, MD<br />

David Chang, MD<br />

2:30pm – 3:00pm Coffee Break with Exhibitors<br />

3:00pm – 4:00pm Panel: Grill the Expert<br />

Experts grilled on the management of complex reconstructive<br />

problems including complications and salvage<br />

procedures.<br />

Julian Pribaz, MD, Co-Moderator<br />

Robert Walton, MD, Co-Moderator<br />

William C. Pederson, MD<br />

L. Scott Levin, MD, FACS<br />

Julia K. Terzis, MD, PhD<br />

Randy Sherman, MD<br />

4:00pm – 6:00pm Best Microsurgical Case/ Best Microsurgical<br />

Save Presentations<br />

The Best Microsurgical Save of the Year Award and the Best<br />

Microsurgical Case of the Year Award will be presented, based<br />

on submissions from the membership of microsurgical salvage<br />

cases per<strong>for</strong>med during the last year. A panel of experts will<br />

critique submitted cases and the attendees will vote <strong>for</strong> the best<br />

case and the best save<br />

Michael Zenn, MD, Co-Moderator<br />

Robert Russell, MD, Co-Moderator<br />

The ASRM would like to thank Synovis MCA<br />

<strong>for</strong> their generous sponsorship of this event.<br />

6:30pm – 8:00pm ASPN/ASRM Welcome Reception


ASRM<br />

DAY-AT-A-GLANCE<br />

Sunday, January 13, 2008<br />

6:30am – 7:30am Breakfast with Exhibitors Cali<strong>for</strong>nia Showroom<br />

6:00am – 3:00pm Speaker Ready Room Cali<strong>for</strong>nia Showroom<br />

6:30am – 4:00pm <strong>Meeting</strong> Services Cali<strong>for</strong>nia Lounge<br />

7:00am – 5:00pm Patient Safety Computerized Presentations Cali<strong>for</strong>nia Showroom<br />

7:00am – 7:15am Welcome: Los Angeles<br />

Lawrence B. Colen, MD<br />

Guenter Germann, MD<br />

7:15am – 8:15am Scientific Paper Presentations: Breast Los Angeles<br />

8:15am – 9:15am ASRM/ASPN PANEL: Treatment of the Mangled <strong>Hand</strong>: Los Angeles<br />

A Multidisciplinary Approach<br />

9:15am – 9:45am Break with Exhibitors Cali<strong>for</strong>nia Showroom<br />

9:45am – 10:45am PANEL: Basic Science <strong>for</strong> Clinical Microsurgeons Los Angeles<br />

Current Status and Clinical Relevance<br />

9:45am – 10:45am PANEL: GU Reconstruction Beverly Hills<br />

10:45am – 11:45am PANEL: Voodoo in Microsurgery? Los Angeles<br />

11:45am – 12:15pm Presidents Address: Lawrence B. Colen, MD Los Angeles<br />

12:15pm – 1:00pm Lunch with Exhibitors Cali<strong>for</strong>nia Showroom<br />

12:15pm – 1:00pm Mentor Luncheon (Invitation Only) Director’s Dining<br />

1:00pm – 2:00pm ASRM Instructional Courses<br />

205 Reconstruction of a Weight Bearing Sole Palisades<br />

206 Pedicled and Microsurgical Flaps in Pacific<br />

Lower Extremity Reconstruction – What has<br />

Evolved as the Routine State of the Art?<br />

207 Monitoring Free Flaps – What should be Sherman Oaks<br />

the standard of care?<br />

208 Head and Neck Reconstruction - Westwood<br />

What’s new in hard and soft tissue transfer?<br />

2:00pm – 3:00pm Concurrent Scientific Paper Presentations: Other Beverly Hills<br />

2:00pm - 3:00pm Concurrent Scientific Paper Presentations: Upper Extremity Los Angeles<br />

3:00pm – 3:30pm Break with Exhibitors Cali<strong>for</strong>nia Showroom<br />

3:30pm – 4:30pm Presidents Invited Lecturer: Luis Vasconez, MD Los Angeles<br />

4:30pm – 5:30pm Godina Lecture: Peirong Yu, MD Los Angeles<br />

45


ASRM<br />

Sunday, January 13, 2008<br />

6:30am – 7:30am Breakfast with Exhibitors<br />

7:00am – 5:00pm Patient Safety Computerized Presentations<br />

7:00am -7:15am Welcome<br />

Lawrence B. Colen, MD<br />

Guenter Germann, MD<br />

7:15am – 8:15am Scientific Paper Presentations: Breast<br />

*Designates resident/fellow paper presentations<br />

Moderator: Michael Zenn, MD<br />

7:15am – 7:19am<br />

Redesigned Gluteal Artery Per<strong>for</strong>ator Flap <strong>for</strong> Breast Reconstruction<br />

Institution where the work was prepared: Univ. of Texas, M.D. Anderson Cancer<br />

Center, Houston, TX, USA<br />

Steven J. Kronowitz, MD<br />

7:19am – 7:23am<br />

*DIEP Flaps in Patients with Abdominal Scars: Are Complication Rates Affected?<br />

Institution where the work was prepared: Beth Israel Deaconess Medical Center,<br />

Harvard Medical School, Boston, MA, USA<br />

Brian M. Parrett, MD; Stephanie A. Caterson, MD; Adam M. Tobias; Bernard T. Lee<br />

7:23am – 7:27am<br />

Laser-Assisted ICG Angiography; Applications in Per<strong>for</strong>ator Flap Surgery<br />

Institution where the work was prepared: Cleveland Clinic Florida, Weston, FL,<br />

USA<br />

Michel C. Samson, MD; Martin I. Newman, MD<br />

7:27am – 7:30am<br />

Discussion<br />

7:30am – 7:34am<br />

*Comparison Of Superior Gluteal Artery Per<strong>for</strong>ator Flaps and Myocutaneous<br />

Flaps For Breast Reconstruction<br />

Institution where the work was prepared: University of Cali<strong>for</strong>nia at Los Angeles,<br />

Los Angeles, CA, USA<br />

Mark Gelfand, MD; Brian Boyd, MD; William Shaw, MD; James Watson, MD;<br />

Andrew Da Lio, MD<br />

7:34am – 7:38am<br />

*Advanced Age as a Risk Factor <strong>for</strong> Free Tissue Transfer Breast Reconstructions:<br />

A Review of 372 Operations<br />

Institution where the work was prepared: UCLA (University of Cali<strong>for</strong>nia, Los<br />

Angeles), Los Angeles, CA, USA<br />

Maura Reinblatt, MD; Luis Vaca; Jaco Festekjian, MD; James Watson, MD;<br />

Andrew Da Lio, MD; Christopher Crisera, MD<br />

7:38am – 7:42am<br />

Late Venous Thrombosis in Free Flap Breast Reconstruction<br />

Institution where the work was prepared: Hospital of the University of Pennsylvania,<br />

Philadelphia, PA, USA<br />

Elizabeth M. Kim, MD; Liza C. Wu; Joseph M. Serletti<br />

7:42am – 7:45am<br />

Discussion<br />

7:45am – 7:49am<br />

Chimeric Stacked Deep Inferior Epigastric Per<strong>for</strong>ator Flap Breast<br />

Reconstruction: A New Solution to an Old Problem<br />

Institution where the work was prepared: The Center <strong>for</strong> Restorative Breast<br />

Surgery, New Orleans, LA, USA<br />

Frank J. DellaCroce, MD; Scott Keith Sullivan, MD, FACS<br />

46<br />

7:49am – 7:53am<br />

*Outcome of Microvascular Complications after Free Flap Breast Reconstruction<br />

Institution where the work was prepared: UCLA Medical Center/David Geffen<br />

School of Medicine at UCLA, Los Angeles, CA, USA<br />

Brian Carlsen, MD; Peter Ashjian, MD; Brian P. Dickinson, MD; Jaco Festekjian,<br />

MD; Andrew L. Da Lio; James P. Watson, MD; Christopher A. Crisera, MD<br />

7:53am – 7:57am<br />

*Simultaneous Bilateral Breast Reconstruction with In-the-Crease Inferior<br />

Gluteal Artery<br />

Institution where the work was prepared: Louisiana State University Department<br />

of Plastic Surgery, New Orleans, LA, USA<br />

Quintessa Miller, MD; Robert J. Allen; M. Whitten Wise; Joshua Levine<br />

7:57am – 8:00am<br />

Discussion<br />

8:00am – 8:04am<br />

*Functional MRI to Evaluate “Sense of Self” Following Deep Inferior Epigastric<br />

Per<strong>for</strong>ator Flap Breast Reconstruction<br />

Institution where the work was prepared: Beth Israel Deaconess Medical Center,<br />

Boston, MA, USA<br />

Stephanie A. Caterson, MD; Sharon Fox, BS; Adam M. Tobias; Bernard T. Lee, MD<br />

8:04am – 8:08am<br />

Utilization of the Internal Mammary Intercostal Per<strong>for</strong>ator Instead of the True<br />

Internal Mammary Vessels as the Recipient Vessels <strong>for</strong> Breast Reconstruction<br />

Institution where the work was prepared: Johns Hopkins University, Baltimore,<br />

MD, USA<br />

Gedge D. Rosson, MD; Eduardo D. Rodriguez; Jaime I. Flores; Michele A.<br />

Manahan; Nia D. Banks; Navin K. Singh<br />

8:08am – 8:12am<br />

*Microvascular Free Tissue Transfer <strong>for</strong> Breast Reconstruction in the Elderly: A<br />

Safe and Effective Option<br />

Institution where the work was prepared: Georgetown University Hospital,<br />

Washington, DC, USA<br />

Jeffrey M. Jacobson, MD; Maurice Y. Nahabedian, MD<br />

8:12am – 8:15am<br />

Discussion<br />

8:15am – 9:15am ASRM/ASPN Panel: Treatment of the Mangled <strong>Hand</strong>:<br />

A Multidisciplinary Approach<br />

Michael W. Neumeister, MD, Moderator<br />

L. Scott Levin, MD, FACS<br />

Michael Sauerbier, MD, PhD<br />

9:15am – 9:45am Break with Exhibitors<br />

9:45am – 10:45am Panel: Basic Science <strong>for</strong> Clinical Microsurgeons<br />

Current Status and Clinical Relevance<br />

This panel will cover stem cells, gene therapy, tissue engineering<br />

and trans<strong>plan</strong>t.<br />

William Zamboni, MD, Moderator<br />

Gregory R. D. Evans, MD<br />

Geoffrey Gurtner, MD<br />

Wayne Morrison, MD, PhD<br />

Maria Siemionow, MD, PhD<br />

9:45am – 10:45am Panel: GU Reconstruction<br />

Lawrence Gottlieb, MD, Moderator<br />

Lawrence Colen, MD<br />

David Gilbert, MD<br />

Milomir Ninkovic, MD<br />

Joseph Serletti, MD<br />

10:45am – 11:45am Panel: Voodoo in Microsurgery?<br />

This panel will discuss anti coagulation - do's and don'ts,<br />

the HIT phenomenon, flap training and flap protection<br />

and upper and lower extremity flaps.<br />

Michael Neumeister, MD, Co-Moderator<br />

Peter Neligan, MD, Co-Moderator<br />

William C. Pederson, MD<br />

Randy Sherman, MD<br />

Alexander Shin, MD


11:45am – 12:15pm Presidents Address<br />

12:15pm – 1:00pm<br />

Lawrence B. Colen, MD<br />

Lunch with Exhibitors<br />

12:15pm – 1:00pm Mentor Luncheon (Invitation Only)<br />

1:00pm – 2:00pm Instructional Courses<br />

205 Reconstruction of a Weight Bearing Sole<br />

Sole defect may arise from trauma, tumor excision or neurotrophic<br />

ulcer. Regarding to the caveat of weight bearing,<br />

the reconstruction had better provide stable post with<br />

adequate soft tissue and protective sensation.<br />

B. Battiston, MD<br />

Marco Innocenti, MD<br />

Chi-Hung Lin, MD<br />

206 Pedicled and Microsurgical Flaps in Lower<br />

Extremity Reconstruction – What has Evolved<br />

as the Routine State of the Art<br />

Chris Attinger, MD<br />

Detlev Erdmann, MD<br />

Steve Moran, MD<br />

207 Monitoring Free Flaps - What should be the<br />

standard of care?<br />

During this instructional course discussion will cover the<br />

outline of techniques available, pros, con’s and limitations<br />

of monitoring free flaps as well as survey results of practice<br />

patterns.<br />

William Swartz, MD<br />

Joan Lipa, MD<br />

208 Head and Neck Reconstruction-What’s New<br />

in Hard and Soft Tissue Transfer?<br />

This course will cover refinements and tailoring of the free<br />

and pedicled flaps, including prelaminated and pre-fabricated<br />

flaps to maximize the aesthetic outcome in complex<br />

head and neck reconstruction. In addition this course<br />

will present technical refinements to optimize aesthetic<br />

and functional results in jaw reconstruction.<br />

Giorgio de Santis, MD<br />

Julian Pribaz, MD<br />

E. Rodriguez, MD<br />

2:00pm – 3:00pm Concurrent Scientific Paper Presentations:<br />

Other<br />

*Designates resident/fellow paper presentations<br />

Moderator: Charles Lee, MD<br />

2:00pm – 2:04pm<br />

An Anatomical Study of the Superficial Peroneal Nerve Accessory Artery and<br />

Its Per<strong>for</strong>ators, and Clinical Application of Superficial Peroneal Nerve<br />

Accessory Artery Per<strong>for</strong>ator Flaps<br />

Institution where the work was prepared: Gyeongsang National University<br />

Hospital, Jinju, South Korea<br />

Tae Hyun Choi, MD, PhD; Jun Sik Kim; Nam Gyun Kim; Kyung Suk Lee<br />

2:04pm – 2:08pm<br />

Tissue Oximetry, A Reliable Technique <strong>for</strong> Non-Invasive Free Flap Monitoring<br />

Institution where the work was prepared: Long Island Jewish Medical Center,<br />

New Hyde Park, NY, USA<br />

Alex Keller, MD<br />

2:08pm – 2:12pm<br />

20 Years Experience In Pediatric Microsurgery<br />

Institution where the work was prepared: Sheba Medical Center, Tel Hashomer, Israel<br />

Batia Yaffe, MD; Eyal Winkler; Haim Kalpan<br />

2:12pm – 2:15pm<br />

Discussion<br />

2:15pm – 2:19pm<br />

A Reconstruction Algorithm to Encounter No Sizable Skin Per<strong>for</strong>ator during<br />

Anterolateral Thigh Flap Dissection<br />

Institution where the work was prepared: Chang Gung Memorial Hospital -<br />

Kaohsiung Medical Center, Kaohsiung, Taiwan<br />

Ching-Hua Hsieh, MD; Seng -Feng Jeng, MD; Yur-Ren Kuo, MD, PhD, FACS;<br />

Pao-Yuan Lin, MD; Johnson C. Yang, MD<br />

47<br />

2:19pm – 2:23pm<br />

*Early Results of a Prospective, Randomized Cost and Outcome Analysis of<br />

ICU vs. Surgical <strong>Floor</strong> Monitoring in Free Flap Breast Reconstruction<br />

Institution where the work was prepared: University of Chicago Medical Center,<br />

Chicago, IL, USA<br />

Charles Y. Tseng, MD; David H. Song, MD<br />

2:23pm – 2:27pm<br />

Partial Muscle Trans<strong>plan</strong>tation: Strategy <strong>for</strong> Preservation of Form and Function<br />

at the Donor Site<br />

Institution where the work was prepared: Cali<strong>for</strong>nia Pacific Medical Center, San<br />

Francisco, CA, USA<br />

Darrell Brooks; Rudolf F. Buntic<br />

2:27pm – 2:30pm<br />

Discussion<br />

2:30pm – 2:34pm<br />

*Microvascular Venous Coupler Reduces the Rate of Venous Anastomosis Failure<br />

Institution where the work was prepared: University of Manitoba, Winnipeg, MB,<br />

Canada<br />

Matthew Choi, MD; Edward Wayne Buchel; Thomas E.J. Hayakawa<br />

2:34pm – 2:38pm<br />

Strategic Approaches to Salvage the Venous Compromised Deep Inferior<br />

Epigastric Per<strong>for</strong>ator Flap<br />

Institution where the work was prepared: Chang Gung Memorial Hospital,<br />

Taipeh, Taiwan<br />

Rozina Ali, MD; Ming-Huei Cheng, MD, MHA; Christina Bernier, MD; Yt Lin;<br />

Alexander Cardenas-Mejia, MD; Rachel Bluebond-Cangner, MD; Eduardo P.<br />

Rodriguez, MD; We-Chen Ching, MD<br />

2:38pm – 2:42pm<br />

13 Years Experience with Free Fibula Flap Phalloplasty<br />

Institution where the work was prepared: Gulhane Military Medical Academy,<br />

Ankara, Turkey<br />

Mustafa Sengezer; Serdar Ozturk; Mustafa Deveci; Fatih Zor<br />

2:42pm – 2:45pm<br />

Discussion<br />

2:45pm – 2:49pm<br />

Outcomes of Immediate VRAM Flap Reconstruction versus Primary Closure in<br />

Patients Undergoing Chemoradiation and Abdominoperineal Resection <strong>for</strong><br />

Anorectal Cancer<br />

Institution where the work was prepared: The University of Texas M. D. Anderson<br />

Cancer Center, Houston, TX, USA<br />

Charles E. Butler, MD; Õzlem Gûndeslioglu, MD; Miguel A. Rodriguez-Bigas, MD<br />

2:49pm – 2:53pm<br />

*Comparison of Surgical Outcomes Using VRAM Flaps vs. Thigh-based Flaps <strong>for</strong><br />

Reconstruction of Abdominoperineal Resection and Pelvic Exenteration Defects<br />

Institution where the work was prepared: The University of Texas M. D. Anderson<br />

Cancer Center, Houston, TX, USA<br />

Rebecca A. Nelson, MD; Charles E. Butler, MD<br />

2:53pm – 2:57pm<br />

*Microangiosomes: a New Concept<br />

Institution where the work was prepared: University of Chicago Hospitals,<br />

Chicago, IL, USA<br />

Eric A. Odessey, MD; Charles Y. Tseng, MD; Amir H. Dorafshar, MD; Lisa Spiguel,<br />

MD; Lawrence J. Gottlieb, MD, FACS<br />

2:57pm – 3:00pm<br />

Discussion<br />

2:00pm – 3:00pm Concurrent Scientific Paper Presentations:<br />

Upper Extremity<br />

*Designates resident/fellow paper presentations<br />

Moderator: James Higgins, MD<br />

2:00pm – 2:04pm<br />

Total and Subtotal Amputations with Destruction of the Proximal Interphalangeal<br />

and Metacarpal Phalangeal Joint: a Paradigm Shit Towards Salvage<br />

Institution where the work was prepared: Cali<strong>for</strong>nia Pacific Medical Center, San<br />

Francisco, CA, USA<br />

Darrell Brooks, MD; Rudolf F. Buntic, MD


2:04pm – 2:08pm<br />

*Single-Stage Reconstruction of the Mutilated <strong>Hand</strong> Using Bilobed and Trilobed<br />

Free Flaps Based on the Anterior Tibial Artery<br />

Institution where the work was prepared: Duke University, Durham, NC, USA<br />

Keith E. Follmar; Yi Xin Zhang; Danru Wang; Detlev Erdmann; L. Scott Levin<br />

2:08pm – 2:12pm<br />

Complications Associated With Specific Types of Intrinsic Pedicle Flaps Used<br />

to Reconstruct Digital Trauma Defects<br />

Institution where the work was prepared: <strong>Hand</strong> & Wrist Center of Houston,<br />

Houston, TX, USA<br />

Mark Henry, MD<br />

2:12pm – 2:15pm<br />

Discussion<br />

2:15pm – 2:19pm<br />

Refinement of Arterialized Venous Flaps in Finger Reconstructions<br />

Institution where the work was prepared: Chang Gung Memorial Hospital, Tao-<br />

Yuan, Taiwan<br />

Yu-Te Lin, MD, MS; Chih-Hung Lin; Cheng-Hung Lin; Fc Wei, MD, FACS<br />

2:19pm – 2:23pm<br />

*Arterialized Venous Instep Flap: A New Alternative <strong>for</strong> Reconstruction of<br />

Palmar Contracture Release<br />

Institution where the work was prepared: Gulhane Military Medical Academy,<br />

Ankara, Turkey<br />

Fatih Zor; Selçuk Isik; Muhidtin Eski; Serdar Ozturk<br />

2:23pm – 2:27pm<br />

*Long-Term Functional Outcome of the Upper Extremity following<br />

Osteocutaneous Radial Forearm Free Flap Harvest<br />

Institution where the work was prepared: University of Pittsburgh Medical Center,<br />

Pittsburgh, PA, USA<br />

Justin M. Sacks, MD; Kia M. McLean, MD; Ernest K. Manders, MD; James M.<br />

Russavage, MD, DMD; Frederic W.-B. Deleyiannis, MD, MPhil, MPH<br />

2:27pm – 2:30pm<br />

Discussion<br />

2:30pm – 2:34pm<br />

*Vascularized Scapular Grafts: An Excellent Option <strong>for</strong> Humeral Nonunions<br />

Institution where the work was prepared: Denver Clinic <strong>for</strong> Extremities at Risk,<br />

Denver, CO, USA<br />

Jerrod Keith, MD; David P. Schnur, MD; William Brown; Ross Wilkins; Ronald<br />

Hugate, MD; Cynthia Kelly<br />

2:34pm – 2:38pm<br />

The Aesthetic Mini Wrap - around Technique <strong>for</strong> Thumb Reconstruction<br />

Institution where the work was prepared: Department of Orthopaedics University<br />

of Modena, Modena, Italy<br />

Roberto Adani, MD<br />

2:38pm – 2:42pm<br />

*Radical Reduction of Upper Extremity Lymphedema with Preservation of<br />

Per<strong>for</strong>ators: A Preliminary Report<br />

Institution where the work was prepared: E-DA Hospital, I-Shou University,<br />

Kaohsiung, Taiwan<br />

Paolo Sassu, MD; Christopher Salgado; Samir Mardini, MD; Hung-Chi Chen, MD,<br />

FACS<br />

2:42pm – 2:45pm<br />

Discussion<br />

2:45pm – 2:49pm<br />

Vascularized Groin Lymph Node Transfer <strong>for</strong> Postmastectomy Upper Extremity<br />

Lymphedema<br />

Institution where the work was prepared: Cheng-Hung Lin, Taipei, Taiwan<br />

Cheng-Hung Lin; Rozina Ali; Chris Wallace; Hung-Chi Chen; Ming-Huei Cheng<br />

2:49pm – 2:53pm<br />

*Use of Nerve Conduits as an Adjunct to Brachial Plexus Micro-Neurorraphy<br />

Institution where the work was prepared: Hospital <strong>for</strong> Special Surgery, New York,<br />

NY, USA<br />

Helene L. Strauss, BA; Richard Cheng, BS; Scott Wolfe, MD; Joseph Feinberg, MD<br />

48<br />

2:53pm – 2:57pm<br />

The Extended Lower Trapezius Flap <strong>for</strong> the Reconstruction of Shoulder Tip<br />

Defects<br />

Institution where the work was prepared: Singapore General Hospital, Singapore,<br />

Singapore<br />

Kok-Chai Tan, MBBS, FRCS; Bien-Keem Tan, MBBS, FRCS, (Ed); Mohamed Z.<br />

Rasheed, MBBS, MRCS(Ed)<br />

2:57pm – 3:00pm<br />

Discussion<br />

3:00pm – 3:30pm Break with Exhibitors<br />

3:30pm – 4:30pm Presidents Invited Lecture<br />

4:30pm – 5:30pm Godina Lecture<br />

Luis Vasconez, MD<br />

“Complex Reconstructive Surgery:<br />

An Increasing Need”<br />

The presentation will illustrate one medical center’s<br />

approach to complex reconstruction involving multiple<br />

specialties, and where a plastic surgeon plays a key role.<br />

Dr. Luis O. Vasconez currently is the Chief of the Division<br />

of Plastic Surgery at the University of Alabama in<br />

Birmingham. Prior to taking his position in Alabama, Dr.<br />

Vasconez was the Chief of the Division of Plastic Surgery<br />

at the University of Cali<strong>for</strong>nia in San Francisco. As a<br />

Captain in the United States Air Force, Dr. Vasconez<br />

served as the Chief of Surgery at the James Connally<br />

AFB Hospital in Waco, Texas from 1964–1966. Dr.<br />

Vasconez has been involved in the resurrection of reconstructive<br />

surgery, including microsurgery, from the very<br />

beginning.<br />

Peirong Yu, MD<br />

“Marko Godina was distinguished by his tireless energy,<br />

his impeccable logic, his boundless optimism, and his<br />

constant good humor and courtesy” – G. Lister<br />

It is these qualities that are sought after in choosing the<br />

ASRM Godina Lecturer, honoring Dr. Marko Godina, an<br />

unrivaled leader and innovator in reconstructive microsurgery<br />

whose life was tragically cut short at the young<br />

age of 43. Established by the trustees of the Marko<br />

Godina Fund, this distinguished lectureship highlights a<br />

young, upcoming microsurgeon who has demonstrated<br />

leadership, innovation and ongoing commitment to our<br />

field in the best traditions of Dr. Godina. It is a pleasure to<br />

introduce Peirong Yu, MD as the 2007 Godina Traveling<br />

Fellow.<br />

MY JOURNEY, THE LAND OF OPPORTUNITIES<br />

America is known as the land of opportunities. Born in a<br />

small village and received medical education in China, I<br />

came to the United States in 1989 to search <strong>for</strong> the<br />

opportunities <strong>for</strong> my career development. I will share<br />

with you my journey to the world of microsurgery and<br />

my contributions in this field, particularly in head and<br />

neck, and tracheal esophageal reconstruction.<br />

Dr. Peirong Yu is currently an Associate Professor in the<br />

Department of Plastic Surgery at the University of Texas,<br />

MD Anderson Cancer Center. Dr. Yu received a degree<br />

in medicine from Suzhou Medical College in Suzhou,<br />

China and a degree in Immunology from the Peking<br />

Union Medical College in Beijing, China. His post graduate<br />

training was done at Peking Union Medical College,<br />

Massachusetts General Hospital (Harvard Medical<br />

School), Brown University and the Medical College of<br />

Wisconsin.


ASRM<br />

DAY-AT-A-GLANCE<br />

Monday, January 14, 2008<br />

6:30am – 3:30pm Speaker Ready Room Cali<strong>for</strong>nia Showroom<br />

6:30am – 3:00pm <strong>Meeting</strong> Services Cali<strong>for</strong>nia Lounge<br />

6:30am – 7:00am Coffee Cali<strong>for</strong>nia Lounge<br />

7:00am – 4:00pm Patient Safety Computerized Presentations Cali<strong>for</strong>nia Showroom<br />

7:00am – 8:00am ASRM Instructional Courses<br />

209 Innovative Nerve Transfers/Conduits Palisades<br />

210 Concept of A-V Loops in Critical Pacific<br />

Reconstructive Situations<br />

211 Free Flaps in Seriously Ill Patients Sherman Oaks<br />

212 Transfer of Engineered Tissue – Research Westwood<br />

Status and Clinical Applicability<br />

8:00am – 8:30am Past Presidents Breakfast (Invitation Only) Encino<br />

8:00am – 8:30am Continental Breakfast in Exhibit Hall Cali<strong>for</strong>nia Showroom<br />

8:30am – 9:30am Buncke Lecture: Berish Strauch, MD Los Angeles<br />

9:30am – 10:15pm PANEL: The Big Debate – Is there still a Place Los Angeles<br />

<strong>for</strong> Flaps in Lower Leg Reconstruction?<br />

10:15am – 11:15am Concurrent Scientific Paper Presentations: Lower Extremity Los Angeles<br />

10:15am - 11:40am Concurrent Scientific Paper Presentations: Research Beverly Hills<br />

11:15am – 12:00pm Lunch with Exhibitors Cali<strong>for</strong>nia Showroom<br />

11:15am Departure <strong>for</strong> Golf Tournament: Mountain Gate CC<br />

Mountain Gate Country Club<br />

12:00pm – 4:30pm Master Series in Microsurgery Los Angeles<br />

12:30pm – 5:00pm ASRM Composite Tissue Allotrans<strong>plan</strong>tation Update Session Beverly Hills Room<br />

6:30pm – 8:00pm <strong>Meeting</strong> Services Cali<strong>for</strong>nia Lounge<br />

7:00pm – 10:30pm ASRM Cocktail Reception & Dinner-Theater Cali<strong>for</strong>nia Lounge / Los Angeles<br />

of the Imagination<br />

49


ASRM<br />

Monday, January 14, 2008<br />

6:30am – 7:00am Coffee<br />

7:00am – 4:00pm Patient Safety Computerized Presentations<br />

7:00am – 8:00am Instructional Courses<br />

209 Innovative Nerve Transfers / Conduits<br />

During this course the instructors will discuss past, present<br />

and future biologic, alloplastic and bioartificial peripheral<br />

nerve conduits<br />

Paul Cederna, MD<br />

Alexander Shin, MD<br />

Michael Klebuc, MD<br />

210 Concept of A-V Loops in Critical<br />

Reconstructive Situations<br />

Guenter Germann, MD<br />

M. Pelzer, MD<br />

211 Free Flaps in Seriously Ill Patients<br />

Koenraad Landuyt, MD<br />

L. Scott Levin, MD, FACS<br />

Michael Sauerbier, MD<br />

212 Transfer of Engineered Tissue – Research Status<br />

and Clinical Applicability<br />

Michael Neumeister, MD<br />

Gregory R. D. Evans, MD<br />

8:00am – 8:30am Past Presidents Breakfast (invitation only)<br />

8:00am – 8:30am Continental Breakfast in Exhibit Hall<br />

8:30am – 9:30am Buncke Lecture<br />

Berish Strauch, MD<br />

The Harry Buncke Lectureship has been created with the<br />

support of the Cali<strong>for</strong>nia Pacific Medical Center to honor<br />

Dr. Buncke’s remarkable contributions to the field of<br />

microsurgery. Dr. Harry Buncke has played a major role<br />

in the development of our specialty and has helped<br />

develop several microsurgical laboratories across the<br />

globe. He has influenced countless residents and fellows<br />

as well as numerous department chairs throughout<br />

the world. It is with great appreciation that we are able<br />

to honor Dr. Harry Buncke with this lectureship due to the<br />

sponsorship of the Cali<strong>for</strong>nia Pacific Medical Center. It is<br />

our pleasure to introduce Berish Strauch, MD as the 2008<br />

Harry Buncke Lecturer.<br />

“Reflection of Microsurgery”<br />

During this lecture Dr. Strauch will reflect on microsurgery<br />

from the early beginnings to current time both in the<br />

USA and around the world.<br />

Dr. Berish Strauch recently retired as the chairman of the<br />

Department of Plastic and Reconstructive Surgery and<br />

Professor of Plastic Surgery at the Albert Einstein College<br />

of Medicine and Montefiore Medical Center. Dr. Strauch<br />

is Board-certified in both general and plastic surgery, and<br />

holds a certificate of added qualification in hand surgery<br />

from the <strong>American</strong> Board of Plastic Surgery.<br />

In 1984, Dr. Strauch founded the Journal of Reconstructive<br />

Microsurgery and has been Editor In Chief since that time.<br />

His bibliography contains over 90 items, including the<br />

three-volume Grabb’s Encyclopedia of Flaps (with Drs.<br />

Vasconez and Hall-Findley), the Atlas of Microvascular<br />

Surgery: Anatomy and Operative Approaches (with Dr. Yu),<br />

and the Textbook on Microsurgery (with Dr. Daniller).<br />

Dr. Strauch is a founding president of the <strong>American</strong><br />

Society <strong>for</strong> Reconstructive Microsurgery, International<br />

Society of Reconstructive Microsurgery and the <strong>American</strong><br />

Society <strong>for</strong> the Peripheral Nerve, and served as president<br />

of the New York Society <strong>for</strong> Surgery of the <strong>Hand</strong>.<br />

9:30am – 10:15am Panel: The Big Debate – Is there still a Place<br />

<strong>for</strong> Flaps in Lower Leg Reconstruction?<br />

Allen Van Beek, MD, Moderator<br />

Dennis Orgill, MD<br />

Randy Sherman, MD<br />

50<br />

10:15am – 11:15am Concurrent Scientific Paper Presentations<br />

Lower Extremity<br />

*Designates resident/fellow paper presentations<br />

Moderator: Rudy Buntic, MD<br />

10:15am – 10:19am<br />

Vascularized Fibula Flap Onlay <strong>for</strong> Salvage of Pathologic Long-Bone Fracture<br />

Institution where the work was prepared: Mayo Clinic, Rochester, MN, USA<br />

Jeffrey B. Friedrich, MD; Steven L. Moran; Allen T. Bishop; Christina M. Wood;<br />

Alexander Y. Shin<br />

10:19am – 10:23am<br />

*Microvascular Bone Flap Prefabrication: Preliminary Results in an Animal<br />

Experimental Model<br />

Institution where the work was prepared: Div of Plastic Surgery - University of<br />

Modena and Reggio Emilia, Modena, Italy<br />

Alessio Baccarani; Giovanna Petrella; Pietro Loschi; Massimo Pinelli; Giorgio De Santis<br />

10:23am – 10:27am<br />

The Use of Corticoperiosteal Flaps in Recalcitrant Distal Tibial Nonunions<br />

Institution where the work was prepared: Fundación Pedro Cavadas, Valencia, Spain<br />

Pedro C. Cavadas, MD, PhD; Luis Landin<br />

10:27am – 10:30am<br />

Discussion<br />

10:30am – 10:34am<br />

How Do Free Muscle Flap Reconstruction Effect Gait Analysis in Landmine<br />

Injury Patients?<br />

Institution where the work was prepared: Gulhane Military Medical Academy,<br />

Ankara, Turkey<br />

Serdar Ozturk; Mustafa Sengezer; Haydar Mohur; Fatih Zor<br />

10:34am – 10:38am<br />

*Complex Perineal and Groin Wound Reconstruction Using the Extended<br />

Dissection Technique of the Gracilis Flap<br />

Institution where the work was prepared: Georgetown University Hospital,<br />

Washington, DC, USA<br />

Joseph H. Dayan, MD; Patrick Curry; Chris E. Attinger, MD; Ivica Ducic, MD, PhD<br />

10:38am – 10:42am<br />

*Vascularization of the Flexor Hallucis Longus Muscle and Its Implication in<br />

Free Fibula Flap Transfer<br />

Institution where the work was prepared: KleinertKutz Institute, louisville, KY, USA<br />

Paolo Sassu, MD; Samir Mardini, MD; Tuna Ozyurekoglu, MD; J. Christopher<br />

Salgado, MD; Steven Moran; Robert D. Acland, MD<br />

10:42am – 10:45am<br />

Discussion<br />

10:45am – 10:49am<br />

*The Distal Superficial Femoral Arterial (SFA) Branch to the Sartorius Muscle<br />

as Recipient Vessels <strong>for</strong> Peri-Knee Soft Tissue Reconstruction: Anatomic Study<br />

and Clinical Applications<br />

Institution where the work was prepared: University of Cali<strong>for</strong>nia, San Francisco,<br />

San Francisco, CA, USA<br />

Fernando Herrera, MD; Charles K. Lee, MD; Mark W. Kiehn, MD; Scott Lee<br />

Hansen, MD<br />

10:49am – 10:53am<br />

Trends in the Treatment of Severe Open Tibial Fractures<br />

Institution where the work was prepared: BG Trauma Center Ludwigshafen,<br />

Ludwigshafen, Germany<br />

Christoph Czermak; Emilios Nalbantis; Guenter Germann; Christoph Heitmann<br />

10:53am – 10:57am<br />

Free Tissue Transfer <strong>for</strong> Complex Extremity War Injuries<br />

Institution where the work was prepared: The Microsurgery Unit, The Department<br />

of Plastic Surgery, Tel-Av, Tel-Aviv, Israel<br />

Arik Zaretski, MD; A. Amir; E. Arad; Y. Barnea; E. Miller; D. Leshem; J. Weiss; E. Gur<br />

10:57am – 11:00am<br />

Discussion<br />

11:00am – 11:04am<br />

Pedicled Per<strong>for</strong>ator Flaps of the Lower Leg: Cluster Analysis of Per<strong>for</strong>ator<br />

Locations and Clinical Application<br />

Institution where the work was prepared: UT Southwestern Medical Center at<br />

Dallas, Dallas, TX, USA<br />

M. Saint-Cyr, MD; Mark Schaverien; Gary Arbique; Spencer A Brown; Rod J Rohrich


11:04am – 11:08am<br />

Aesthetic Per<strong>for</strong>ator Free Flap <strong>for</strong> Soft Tissue Restoration<br />

Institution where the work was prepared: Samsung Medical Center, Seoul, South<br />

Korea<br />

Goo-Hyun Mun, MD; Jai-Kyung Pyon<br />

11:08am – 11:12am<br />

Reconstruction of Segmental Femoral Defects with Living Bone Allografts<br />

Combined with Host-derived Neoangiogenesis: Mechanical, Histologic and<br />

Radiographic Analysis<br />

Institution where the work was prepared: Dept. of Orthopedic Surg., Microvasc.<br />

Research Lab., Mayo Clinic, Rochester, MN, USA<br />

Goetz A. Giessler, MD; Patricia F. Friedrich; Allen T. Bishop, MD<br />

11:12am – 11:15am<br />

Discussion<br />

10:15am – 11:40am Concurrent Scientific Paper Presentations<br />

Research<br />

*Designates resident/fellow paper presentations<br />

Moderator: William Zamboni, MD<br />

10:15am – 10:19am<br />

*Reduction of the Immunological Rejection in Composite Tissue<br />

Allotrans<strong>plan</strong>tation by Heat Stress Preconditioning<br />

Institution where the work was prepared: <strong>Hand</strong>-, Plastic and Reconstructive<br />

Surgery, BG Trauma Center, Ludwigshafen, Germany<br />

Nina Ofer, resident; Michael Sauerbier; Guenter Germann<br />

10:19am – 10:23am<br />

*Investigation of Allograft Tolerance in Non-Human Primate Composite Facial<br />

Trans<strong>plan</strong>tation Model<br />

Institution where the work was prepared: University of Maryland School of<br />

Medicine, Baltimore, MD, USA<br />

Rachel Bluebond-Langner, MD; Rolf Barth, MD; Eduardo D. Rodriguez, DDS,<br />

MD; Stephen Shipley; Stephen T. Bartlett<br />

10:23am – 10:27am<br />

Swine Hemi-facial Composite Tissue Trans<strong>plan</strong>tation: A Preclinical Large<br />

Animal Model<br />

Institution where the work was prepared: Chang Gung Memorial Hospital<br />

–Kaohsiung Medical Center, Kaohsiung, Taiwan<br />

Yur-Ren Kuo, MD, PhD, FACS; Nai-Siong Kueh, MD; Wen-Sheng Wu; Chien-Chih<br />

Lin; Chong-Wei Huang; Yuan-Cheng Chiang<br />

10:27am – 10:30am<br />

Discussion<br />

10:30am – 10:34am<br />

Comparison between Cyclosporine A and Tacrolimus in Vascularized Bone<br />

Marrow Trans<strong>plan</strong>tation <strong>for</strong> Inducing Composite Tissue Allotrans<strong>plan</strong>tation<br />

Tolerance with Non-Myeloablative Conditioning<br />

Institution where the work was prepared: Wei-Chao Huang, Taoyuan, Taiwan<br />

Wai-Chao Huang; Nai-Jen Chang, yes; Jeng-Yee Lin, MD; Christopher Glenn<br />

Wallace, MD; Fu-Chan Wei<br />

10:34am – 10:38am<br />

*In Vivo and In Vitro Evidence that Intrajejunal Administration of Fresh Donor<br />

Splenocytes Delays the Onset of Rejection of Hindlimb Composite Tissue<br />

Allotrans<strong>plan</strong>ts by Regulating Th1/Th2 Cytokines in Rats<br />

Institution where the work was prepared: Chang Gung Memorial Hospital and<br />

Chang Gung University, Taipei, Taiwan<br />

Christopher Glenn Wallace, MB, ChB, MRCS; Chia-Hung Yen, PhD; Hsiang-Chen<br />

Yang, MSc; Chun-Yen Lin, MD, PhD; Wei-Chao Huang; Jeng-Yee Lin; Fu-Chan<br />

Wei, MD, FACS<br />

10:38am – 10:42am<br />

*The Gene Expression Profiling of Ischemia-Reperfusion Injury in Rat Kidney,<br />

Small Intestine, and Cremasteric Muscle Model by DNA Microarray<br />

Institution where the work was prepared: Chang Nai-Jen, Taoyuan, Taiwan<br />

Nai-Jen Chang, yes; See-Tong Pang; Fu-Chan Wei<br />

10:42am – 10:45am<br />

Discussion<br />

10:45am – 10:49am<br />

Aged Donor Bone Marrow Influcences Mixed Chimerism and Donor-specific<br />

Tolerance to Composite Tissue Allotrans<strong>plan</strong>tation with Nonmyeloablative<br />

Conditioning<br />

Institution where the work was prepared: Chang Gung Memorial Hospital, Taipei, Taiwan<br />

Jeng-Yee Lin, MD; Wei-Chao Huang; David C.C. Chuang; Fu-Chan Wei<br />

51<br />

10:49am – 10:53am<br />

*Quantitative Evaluation of the Dilation of Rat Femoral Vessels Following<br />

Application of Topical Botulinum Toxin<br />

Institution where the work was prepared: University of Virginia, Charlottesville, VA, USA<br />

Peter B. Arnold, MD, PhD; Christopher A. Campbell; David B. Drake; Wyndell H.<br />

Merritt, MD; George T. Rodeheaver; Raymond F. Morgan<br />

10:53am – 10:57am<br />

*A Modification of Neural-Island Flap: “Split Neural-Island Flap”<br />

Institution where the work was prepared: Hacettepe University Hospital, Plastic<br />

and Reconst Surg Dept, Ankara, Turkey<br />

Erhan Sonmez, MD; Hakan Ozdemir; Tunc Safak; Abdullah Kecik<br />

10:57am – 11:00am<br />

Discussion<br />

11:00am – 11:04am<br />

*Impact of Hypertonic and Hyperoncotic Saline Solutions on Ischemia-<br />

Reperfusion Injury in Free Flaps in Rats<br />

Institution where the work was prepared: Aesthetic and Plastic Surgery Institute,<br />

UCI, Orange, CA, USA<br />

Thomas Scholz, MD; Gregory R. D. Evans<br />

11:04am – 11:08am<br />

*The Effect of Ischaemia Time on Acute Rejection of Composite Tissue<br />

Allotrans<strong>plan</strong>tation in Rat Model<br />

Institution where the work was prepared: Duke University Medical Center,<br />

Durham, NC, USA<br />

Yee Siang Ong, MRCS, (Edin); Yi Xin Zhang; Alessio Baccarani; Keith E. Follmar;<br />

Caroline Messmer; Bruce Klitzmann; Detlev Erdmann; L. Scott Levin<br />

11:08am – 11:12am<br />

*Targeted Motor Reinnervation of the Rabbit Rectus Abdominis: a Single<br />

Muscle Can Receive and Distinguish Three Independent Nerve Inputs<br />

Institution where the work was prepared: Northwestern University, Feinberg<br />

School of Medicine, Chicago, IL, USA<br />

Peter S. Kim, MD; Kristina O'Shaughnessy, MD; Todd A. Kuiken, MD, PhD;<br />

Gregory A. Dumanian<br />

11:12am – 11:15am<br />

Discussion<br />

11:15am – 11:19am<br />

*Donor-Recipient Bone Marrow Cells Fusion as a Novel Therapy <strong>for</strong> CTA Trans<strong>plan</strong>ts<br />

Institution where the work was prepared: Cleveland Clinic, Cleveland, OH, USA<br />

Maria Siemionow, MD, PhD; Earl Poptic; Serdar Nasir; Aleksandra Klimczak;<br />

Lukasz Krokowicz; Wioleta Luszczek, PhD<br />

11:19am – 11:23am<br />

Tissue Expression of The Beta-Chemokine, RANTES (CCL5), is Upregulated in<br />

Acutely Rejecting, Fully MHC-Mismatched Vascularized Skin Allotrans<strong>plan</strong>ts in<br />

Rats<br />

Institution where the work was prepared: From the Department of Plastic and<br />

Reconstructive Surgery1 and t, Taipei, Taiwan<br />

Arik Zaretski, MD; Chia-Hung Yen; Christopher Glenn Wallace; Ren-Chin Wu; Fu-<br />

Chan Wei<br />

11:23am – 11:27am<br />

*The Role of Thymus in Chimerism Induction on Composite Osseomusculocutaneous<br />

Sternum, Ribs, Thymus, Pectoralis Muscles, Skin Allotrans<strong>plan</strong>tation Model<br />

Institution where the work was prepared: Cleveland Clinic, Cleveland, OH, USA<br />

Mehmet Bozkurt, MD; Serdar Nasir; Aleksandra Klimczak; Lukasz Krokowicz;<br />

Christopher Grykien; Maria Siemionow<br />

11:27am – 11:30am<br />

Discussion<br />

11:30am – 11:34am<br />

*Acute and Delayed Effects of Pulsed Acoustic Cellular Therapy (PACE) on<br />

Capillary Perfusion and Microcirculatory Hemodynamics of Muscle Flaps<br />

Institution where the work was prepared: Cleveland Clinic, Cleveland, OH, USA<br />

Lukasz Krokowicz; Christopher Grykien; Mariusz Mielniczuk; Aleksandra Klimczak;<br />

Maria Siemionow<br />

11:34am – 11:38am<br />

Three-and Four-Dimensional Arterial and Venous Anatomies of the<br />

Thoracodorsal Artery Per<strong>for</strong>ator Flap<br />

Institution where the work was prepared: UT Southwestern Medical Center at<br />

Dallas, Dallas, TX, USA<br />

Michel Saint-Cyr, MD; Mark Schaverien; Gary Arbique; Spencer A Brown; Rod J Rohrich<br />

11:38am – 11:40am<br />

Discussion


11:15am – 12:00pm Lunch with Exhibitors<br />

11:15am Departure <strong>for</strong> Golf Tournament:<br />

Mountain Gate Country Club<br />

12:00pm – 4:30pm Master Series in Microsurgery<br />

Milan Stevanovic, MD, Chairperson<br />

Pre-registration is required.<br />

12:00pm – 12:05pm Introductory Remarks<br />

Milan V. Stevanovic, MD, Chair<br />

12:06pm – 12:21pm Vascularized Bone Pedicle Flaps in the<br />

Upper Extremity<br />

Allen T. Bishop, MD<br />

12:22pm – 12:37pm Vascularized Bone Grafts <strong>for</strong> Long Bone Defects<br />

L. Scott Levin, MD, FACS<br />

12:38pm – 12:53pm Mandibular Reconstruction<br />

Giorgio DeSantis, MD<br />

12:54pm – 1:09pm Free Vascularized Fibular Graft <strong>for</strong> the Treatment<br />

of Osteonecrosis of the Femoral Head<br />

James Urbaniak, MD<br />

1:10pm – 1:30pm Discussion<br />

1:31pm – 1:46pm Nerve Transfer<br />

Robert Spinner, MD<br />

1:47pm – 2:02pm The Best Flaps <strong>for</strong> Small Defects of the <strong>Hand</strong><br />

Roberto Adani, MD<br />

2:03pm – 2:18pm The Best Flaps <strong>for</strong> Small Defects of the Foot<br />

Randy Sherman, MD<br />

2:19pm – 2:34pm Discussion<br />

2:35pm – 2:50pm Break<br />

2:50pm – 3:05pm Prefabricated Flaps <strong>for</strong> Head And Neck<br />

Reconstruction<br />

Julian Pribaz, MD<br />

3:06pm – 3:21pm Best Free Flaps in Pediatrics<br />

Joseph Upton, MD<br />

3:22pm – 3:37pm Microsurgical Reconstruction of the Pediatric Thumb<br />

Neil F. Jones, MD<br />

3:38pm – 3:53pm Single and Double Functional Muscle Transfer<br />

Alexander Shin, MD<br />

3:54pm – 4:14pm Discussion<br />

4:15pm – 4:30pm Closing Remarks and Adjournment<br />

Milan Stevanovic, MD<br />

52<br />

12:30pm – 4:30pm ASRM Composite Tissue Allotrans<strong>plan</strong>tation<br />

Update Session<br />

Course is complimentary to ASRM registrants,<br />

but pre-registration is required.<br />

12:30pm – 12:40pm Welcome and Introduction<br />

Warren C. Breidenbach III, MD and Sue McDiarmod, MD<br />

12:40pm – 12:50pm A Historical Perspective of CTA Over the<br />

Last 50 Years<br />

Gordon R. Tobin, MD<br />

12:50pm – 1:05pm Status of Clinical CTA<br />

W.P. Andrew Lee, MD<br />

1:05pm – 1:20pm Chronic Rejection<br />

Anthony J. Demetrius, MD<br />

1:20pm – 2:20pm Immunological Risks of CTA<br />

Moderator: Warren C. Breidenbach III, MD<br />

Presenters: Mark A. Hardy, MD<br />

Neil F. Jones, MD<br />

Gerhard Opelz, MD<br />

Thomas H. Tung, MD<br />

2:20pm – 2:35pm Break<br />

2:35pm – 3:35pm T Regulatory Cells and CTA<br />

Moderator: Suzanne T. Ildstad, MD<br />

Presenters: Carla C. Baan, MD<br />

Haval Shirwan, MD<br />

Assia Eljaafari, MD<br />

Flavio G. Vincenti, MD<br />

3:35pm – 5:00pm Presentation of Abstracts<br />

Moderator: Linda C. Cendales, MD<br />

7:00pm – 10:30pm ASRM Cocktail Reception & Dinner<br />

Theater of the Imagination<br />

The ASRM would like to thank ASSI <strong>for</strong> their<br />

sponsorship of this evenings cocktail reception.


ASRM<br />

DAY-AT-A-GLANCE<br />

Tuesday, January 15, 2008<br />

6:30am – 7:30am Coffee Cali<strong>for</strong>nia Lounge<br />

6:30am – 11:30am Speaker Ready Room Cali<strong>for</strong>nia Showroom<br />

6:30am – 9:30am <strong>Meeting</strong> Services Cali<strong>for</strong>nia Lounge<br />

7:00am – 12:00pm Patient Safety Computerized Presentations Cali<strong>for</strong>nia Showroom<br />

7:00am – 8:00am ASRM Instructional Courses<br />

213 Innovative Concepts in Vascularized Bone Transfer Palisades<br />

214 Functional Muscle Transfer Pacific<br />

215 Complex Chest and Trunk Reconstructions Sherman Oaks<br />

216 Microsurgical Reconstructions of Burn Injuries Westwood<br />

7:30am – 8:30am Breakfast Cali<strong>for</strong>nia Lounge<br />

8:15am – 9:00am Business <strong>Meeting</strong> (members only) Encino<br />

9:00am – 10:30am Concurrent Scientific Paper Presentations: Head and Neck Los Angeles<br />

9:00am - 10:35am Concurrent Scientific Paper Presentations: Miscellaneous Beverly Hills<br />

10:30am – 10:45am Coffee Break Cali<strong>for</strong>nia Lounge<br />

10:45am – 12:30pm Scientific Paper Presentations and Lecture: Hans Steinau, MD Los Angeles<br />

12:30pm Adjourn<br />

1:00pm – 2:00pm ASRM Council <strong>Meeting</strong> Encino<br />

53


ASRM<br />

Tuesday, January 15, 2008<br />

6:30am – 7:30am Coffee<br />

7:00am – 12:00pm Patient Safety Computerized Presentations<br />

7:00am – 8:00am Instructional Courses<br />

213 Innovative Concepts in Vascularized Bone Transfer<br />

L. Scott Levin, MD, FACS<br />

M. Pelzer, MD<br />

P. Pinal, MD<br />

214 Functional Muscle Transfer<br />

Allen Bishop, MD<br />

K. Doi, MD<br />

215 Complex Chest and Trunk Reconstructions<br />

Milomir Ninkovic, MD - Bladder<br />

Charles Butler, MD - Abdomen<br />

Michael Sauerbier, MD – Complex Chest Reconstruction<br />

Lawrence Gottlieb, MD<br />

216 Microsurgical Reconstructions of Burn Injuries<br />

During this course the instructors will cover indications,<br />

timing and choices <strong>for</strong> microsurgical reconstruction in<br />

pediatric and adult burn injuries<br />

P.Vogt, MD<br />

Kevin Yakuboff, MD<br />

Elliott Rose, MD<br />

7:30am – 8:30am Breakfast<br />

8:15am – 9:00am Business <strong>Meeting</strong> (members only)<br />

9:00am – 10:30am Concurrent Scientific Paper Presentations:<br />

Head and Neck<br />

*Designates resident/fellow paper presentations<br />

Moderator: R. Jobe Fix, MD<br />

9:00am – 9:04am<br />

*The Incidence of Venous Thromboembolism in Head and Neck Reconstruction<br />

Institution where the work was prepared: Memorial Sloan-Kettering Cancer<br />

Center, New York, NY, USA<br />

Constance M. Chen, MD, MPH; Joseph J. Disa; Babak J. Mehrara<br />

9:04am – 9:08am<br />

Microsurgical Correction of Craniofacial Mal<strong>for</strong>mations: A Fifteen-Year<br />

Experience<br />

Institution where the work was prepared: New York University School of<br />

Medicine, New York, NY, USA<br />

Pierre Saadeh; Chris Chang, BA; Evan Garfein; Otway Louie; John Siebert<br />

9:08am – 9:12am<br />

Rehabilitation after Mandibular Reconstruction with Fibula Free Flap: Clinical<br />

(Outcome) and Quality of Life Assessment<br />

Institution where the work was prepared: Erasmus University Medical Center,<br />

Rotterdam, Netherlands<br />

Stefan O.P. Hofer; Alessandra C. Hundepool; Antoine G. Dumans; Nico Fokkens;<br />

Sukh S. Rayatt; Erik H. van der Meij; Kees P. Schepman<br />

9:12am – 9:15am<br />

Discussion<br />

9:15am – 9:19am<br />

*Evaluation of Cortical Reorganization in Facial Trans<strong>plan</strong>tation<br />

Institution where the work was prepared: University of Pittsburgh, Pittsburgh, PA, USA<br />

Kia M. McLean, MD; Mario G. Solari; Justin M. Sacks; Anjey Su; Vijay S. Gorantla;<br />

Jignesh V. Unadkat; Stefan Schneeberger; George E. Carvell; Daniel J. Simons;<br />

W.P. Andrew Lee<br />

9:19am – 9:23am<br />

*Le Fort I Osteotomy with Interpositional Free Fibula Flap <strong>for</strong> Maxillary<br />

Augmentation<br />

Institution where the work was prepared: R Adams Cowley Shock Trauma Center,<br />

Baltimore, MD, USA<br />

Rachel Bluebond-Langner, MD; Lisa Witkin; Eduardo D. Rodriguez<br />

9:23am – 9:27am<br />

*Maxilla Trans<strong>plan</strong>tation<br />

Institution where the work was prepared: Cleveland Clinic Foundation Plastic<br />

Surgery Department, Cleveland, OH, USA<br />

Ilker Yazici; Kevin Carnevale, MD; Ayhan Comert, MD; Tarik Cavusoglu, MD;<br />

Aleksandra Klimczak, PhD; Ibrahim Vargel, MD, PhD; Ibrahim Tekdemir, MD;<br />

Maria Z. Siemionow<br />

54<br />

9:27am – 9:30am<br />

Discussion<br />

9:30am – 9:34am<br />

Microvascular Free Appendix Transfer For Reconstruction Of Various Purposes<br />

Institution where the work was prepared: E-Da Hospital, Kaohsiung, Taiwan<br />

Hung-Chi Chen, MD, FACS; Samir Mardini, MD; Yueh-Bih Tang, MD, PhD;<br />

Christopher Salgado; Guan-Ming Feng, MD<br />

9:34am – 9:38am<br />

*Does the Ischemia Time Affect the Outcome of Free Fibula Flaps <strong>for</strong> Head<br />

and Neck Reconstruction? A Review of 117 Fibular Flaps<br />

Institution where the work was prepared: Chang Gung Memorial Hospital, Taoyuan,<br />

Taipeh, Taiwan<br />

Shu-ying Chang, MD; Huang-Kai Kao, MD; Jung-Ju Huang, MD; Holger Engel,<br />

MD; Betul Ulusal; Ming-Huei Cheng, MD, PhD<br />

9:38am – 9:42am<br />

*Harnessing the Potential of the Free Fibula Osteoseptocutaneous Flap in<br />

Mandible Reconstruction: How to Attain Adequate Functional and Esthetic<br />

Height <strong>for</strong> the Reconstructed Segment<br />

Institution where the work was prepared: Chang Gung Memorial Hospital, Taipei, Taiwan<br />

Christopher Glenn Wallace, MB, ChB, MRCS; Yang-Ming Chang; Chi-Ying Tsai;<br />

Ming-Huei Cheng; Chung-Kan Tsao; Fu-Chan Wei, MD, FACS<br />

9:42am – 9:45am<br />

Discussion<br />

9:45am – 9:49am<br />

*Autolgous Fat as an Alternative to Microvascular Free Tissue Transfer <strong>for</strong> the<br />

Treatment of Severe Facial Soft Tissue De<strong>for</strong>mities<br />

Institution where the work was prepared: University of Pennsylvania, Philadelphia, PA, USA<br />

Suhail Kanchwala, MD; Louis P. Bucky<br />

9:49am – 9:53am<br />

*Radial Forearm Free Flap Pre-lamination with Acellular Dermal Matrix <strong>for</strong><br />

Repair of Subtotal Glossectomy Defects<br />

Institution where the work was prepared: Fox Chase Cancer Center, Philadelphia, PA, USA<br />

Fernando Cordera, MD; Neal S. Topham, MD<br />

9:53am – 9:57am<br />

*Management of Life Threatening Tracheaesophageal Fistulae, Leaks, and Defects<br />

Institution where the work was prepared: MD Anderson cancer Center, Houston,<br />

TX, USA<br />

John Nigriny, MD, DMD; Peirong Yu<br />

9:57am – 10:00am<br />

Discussion<br />

10:00am – 10:04am<br />

*Chronic Deep Venous Thrombosis in the Peroneal Veins of a Fibula Flap:<br />

Strategies <strong>for</strong> Salvage and Avoidance<br />

Institution where the work was prepared: Brigham and Women's Hospital,<br />

Boston, MA, USA<br />

Amir Taghinia, MD; Julian J. Pribaz, MD; Lifei Guo, MD, PhD<br />

10:04am – 10:08am<br />

Go <strong>for</strong> the Jugular – A 10-year Experience with End-to-Side Anastomosis to<br />

the Internal Jugular Vein in 320 Head and Neck Free Flaps<br />

Institution where the work was prepared: Memorial Sloan-Kettering Cancer<br />

Center, New York, NY, USA<br />

Eric Halvorson, MD; Peter G. Cordeiro<br />

10:08am – 10:10am<br />

Discussion<br />

9:00am – 10:35am Concurrent Scientific Paper Presentations<br />

Miscellaneous<br />

*Designates resident/fellow paper presentations<br />

Moderator: Neil F. Jones, MD<br />

9:00am – 9:04am<br />

*Using Stereolithographic Models to Plan Mandibular Reconstruction <strong>for</strong><br />

Advanced Oral Cavity Cancer<br />

Institution where the work was prepared: Fox Chase Cancer Center, Philadelphia, PA, USA<br />

Eric Y. Ro, MD; John A. Ridge, MD, PhD, FACS; Neal S. Topham, MD


9:04am – 9:08am<br />

*Timing of Microsurgical Reconstruction of Lower Extremity: Is It Really<br />

Important In Flap Failure<br />

Institution where the work was prepared: Gulhane Military Medical Academy,<br />

Ankara, Turkey<br />

Fatih Zor; Mustafa Sengezer; Murat Turegun; Selcuk ˘sik; Mustafa Nisanci;<br />

Muhidtin Eski<br />

9:08am – 9:12am<br />

*Buried Flap Monitoring Using a Novel Non-Invasive Simultaneous<br />

Microcirculatory Perfusion, Oxygenation and Venous Outflow Monitor<br />

Institution where the work was prepared: Hannover Medical School, Hannover,<br />

Germany<br />

Karsten Knobloch, MD, PhD; Andreas Gohritz; Niels C. Gellrich; Peter M. Vogt<br />

9:12am – 9:15am<br />

Discussion<br />

9:15am – 9:19am<br />

Local Per<strong>for</strong>ator Flaps Around the Elbow<br />

Institution where the work was prepared: Recovery Hospital, Cluj-Napoca,<br />

Romania<br />

Alexandru Georgescu, Prof, MD, PhD; Ileana Matei; Filip Ardelean, MD<br />

9:19am – 9:23am<br />

The Use of Free Medial Pedis Per<strong>for</strong>ator Flap in The Treatment of Chron˘c<br />

Postburn Palmar Contractures<br />

Institution where the work was prepared: GATA Haydarpa?a E?itim Hastanesi<br />

dept. of Plastic Surgery, Istanbul, Turkey<br />

Haluk Duman, Assoc, Prof, MD; Fatih Uygur; Ersin ülkür; Sinan öksüz; Bahattin<br />

çeliköz<br />

9:23am – 9:27am<br />

The Effect of Preoperative Radiotherapy on the Free Jejunum Flap Transfer<br />

Institution where the work was prepared: E-Da Hospital, Kao-hsiung, Taiwan<br />

Hung-Chi Chen, MD, FACS; Yueh-Bih Tang, MD, PhD; Samir Mardini, MD;<br />

Christopher Salgado; Chung-chen Hsu, MD<br />

9:27am – 9:30am<br />

Discussion<br />

9:30am – 9:34am<br />

*Further Esthetic Refinement <strong>for</strong> Great Toe Transfers in Pursuit of an Ideal Thumb<br />

Reconstruction<br />

Institution where the work was prepared: Chang Gung Memorial Hospital, Taipei,<br />

Taiwan<br />

Christopher Glenn Wallace, MB, ChB, MRCS; Chih-Hung Lin; Yu-Te Lin; Fu-Chan Wei<br />

9:34am – 9:38am<br />

V-Y Advancement Adductor Magnus Per<strong>for</strong>ator Flap <strong>for</strong> Reconstruction of<br />

Scrotal/Perineal Defects<br />

Institution where the work was prepared: UMass Plastic Surgery, Worcester, MA, USA<br />

Mustafa Akyurek, MD; Marjorie R. Chelly, MD; Raymond M. Dunn, MD<br />

9:38am – 9:42am<br />

*Resurfacing of a Complex Upper Extremity Injury: An Excellent Indication <strong>for</strong><br />

the Dorsal Thoracic Fascial Flap<br />

Institution where the work was prepared: The Buncke Clinic, San Francisco, CA, USA<br />

Ron Hazani, MD; Darrell Brooks, MD; Rudolf F. Buntic, MD<br />

9:42am – 9:45am<br />

Discussion<br />

9:45am – 9:49am<br />

The Pedicled FHL Flap: A Good Option When Options Aren't Good<br />

Institution where the work was prepared: New York University School of<br />

Medicine, New York, NY, USA<br />

Otway Louie; Evan Garfein; Jamie P. Levine; Pierre Saadeh<br />

55<br />

9:49am – 9:53am<br />

Achieving Aesthetic Results in Facial Reconstructive Microsurgery: Planning<br />

and Executing Secondary Refinements<br />

Institution where the work was prepared: New York University School of<br />

Medicine, New York, NY, USA<br />

Pierre Saadeh; Otway Louie; Evan Garfein; Jamie P. Levine; John W. Siebert<br />

9:53am – 9:57am<br />

*Immediate Nipple-Areolar Complex Reconstruction with Inner Thigh (TUG)<br />

Flap Microvascular Breast Reconstruction<br />

Institution where the work was prepared: Cali<strong>for</strong>nia Pacific Medical Center, Ralph<br />

K. Davies Campus, San Francisco, CA, USA<br />

Matthew J. Trovato, MD; Karen M. Horton, MD, MSc, FRCSC; Rudolf F. Buntic,<br />

MD, FACS; Darrell Brooks, MD<br />

9:57am – 10:00am<br />

Discussion<br />

10:00am – 10:04am<br />

Using Free Style Proximal Radial Forearm Free Flaps while Preserving Radial<br />

Artery <strong>for</strong> Reconstructions of Burn hand and Head and Neck Defects<br />

Institution where the work was prepared: Chang Gung Memorial Hospital, Taipei,<br />

Taiwan<br />

Jeng-Yee Lin, MD; Wei-Chao Huang; David C.C. Chuang; Fu-Chan Wei<br />

10:04am – 10:08am<br />

Voice Reconstruction Utilizing the Free Ileo-Ileocecal Valve Free Flap with a<br />

Patch of Cecum<br />

Institution where the work was prepared: E-Da Hospital/I-Shou University,<br />

Kaohsiung, Taiwan<br />

Samir Mardini, MD; Hung-Chi Chen, MD, FACS; Christopher J. Salgado, MD<br />

10:08am – 10:12am<br />

*Modified Tibial Turn-up Fillet flap <strong>for</strong> Repair of Extensive Composite Defects<br />

of the Thigh<br />

Institution where the work was prepared: The University of Texas, M. D. Anderson<br />

Cancer, Houston, TX, USA<br />

Yoav Barnea; Patrick Lin, MD; Gregory Reece, MD<br />

10:12am – 10:15am<br />

Discussion<br />

10:15am – 10:19am<br />

Partial Breast Reconstruction with Free Autologous Tissue Transfers<br />

Institution where the work was prepared: university of Manitoba, winnipeg,<br />

Canada<br />

Edward Wayne Buchel; Thomas E.J. Hayakawa<br />

10:19am – 10:23am<br />

Imaging Techniques in Preoperative Planning of the Abdominal Per<strong>for</strong>ator<br />

Flaps: Our Experience Using the MRI<br />

Institution where the work was prepared: Hospital de la Santa Creu i Sant Pau,<br />

Barcelona, Spain<br />

Jaume Masia, MD, PhD; Jm Monill; Ja Clavero; G. Pons; J. Larrañaga; L. Vives<br />

10:23am – 10:27am<br />

*Innervation Improves Patient-rated Quality of Life in free TRAM Breast<br />

Reconstruction<br />

Institution where the work was prepared: University of Western Ontario, London,<br />

ON, Canada<br />

Claire LF Temple, MD, FRCSC; Sharon Kim, MD, FRCSC; Douglas C. Ross, MD,<br />

FRCSC; Raymond Tse, BSc, MD; Margo Bettger-Hahn, BScN, MScN; Bing Siang<br />

Gan, MD, PhD, FRCSC; Joy MacDermid, PhD, PT<br />

10:27am – 10:31am<br />

*End-to-Side Anastomosis to the Internal Mammary Artery in Free Flap Breast<br />

Reconstruction: Preserving the Internal Mammary Artery <strong>for</strong> Coronary Artery<br />

Bypass Grafting<br />

Institution where the work was prepared: Union Memorial Hospital, Baltimore,<br />

MD, USA<br />

Amani Hemphill, MD; Ramon De Jesus, MD; Nathaniel McElhaney; Jonathan<br />

Ferrari<br />

10:31am – 10:35am<br />

Discussion<br />

10:30am – 10:45am Coffee Break


10:45am – 11:15am Scientific Paper Presentations and Lecture<br />

Hans Steinau, MD – Introductional Lecture<br />

11:15am – 12:45pm Scientific Paper Presentation<br />

Tumor Reconstruction<br />

*Designates resident/fellow paper presentations<br />

Moderator: Howard Langstein, MD<br />

11:15am – 11:19am<br />

Free Vascularized Fibula Graft Salvage of Complications of Long-Bone<br />

Allograft Post-Tumor Reconstruction<br />

Institution where the work was prepared: Mayo Clinic, Rochester, MN, USA<br />

Jeffrey B. Friedrich, MD; Steven L. Moran; Allen T. Bishop; Christina M. Wood;<br />

Alexander Y. Shin<br />

11:19am – 11:23am<br />

*Vascularized Bone Grafts – An Effective Tool <strong>for</strong> Limb Salvage in Long Bone<br />

Malignancies and Non-unions<br />

Institution where the work was prepared: Devner Clinic <strong>for</strong> Extremities at Risk,<br />

Devner, CO, USA<br />

Alex Colque, MD; David P. Schnur, MD; William C Brown; Ross M Wilkins; Ronald<br />

R. Hugate; Cynthia Kelly<br />

11:23am – 11:27am<br />

Limiting Complications and Complexity of the Transverse Upper Gracilis Flap<br />

in Breast Reconstruction<br />

Institution where the work was prepared: University of Manitoba, Winnipeg, Canada<br />

Edward Wayne Buchel; Thomas E.J. Hayakawa<br />

11:27am – 11:30am<br />

Discussion<br />

11:30am – 11:34am<br />

*Outcome of Radical Excision and Microsurgical Reconstruction in Patients<br />

with Recurrent Oromucosal Cancer and Secondary Primary Cancer<br />

Institution where the work was prepared: Chang Gung Memorial Hospital, Tao-<br />

Yuan, Taiwan<br />

Emre Gazyakan, MD, MSc; Holger Engel, MD; Jung-Ju Huang, MD; Huang-Kai<br />

Kao, MD; Ming-Huei Cheng, MD, PhD<br />

11:34am – 11:38am<br />

The Use of Thromboelastography as a Guide to Tailor the Anticoagulation<br />

Management in the Microvascular Surgical Patient<br />

Institution where the work was prepared: The Methodist Hospital, Institute <strong>for</strong><br />

Reconstructive Surgery, Houston, TX, USA<br />

Aldona J. Spiegel, MD; Hector Salazar-Reyes, MD<br />

11:38am – 11:42am<br />

Free-style Proximal Lateral Leg Per<strong>for</strong>ator Flaps <strong>for</strong> Head and Neck<br />

Reconstruction<br />

Institution where the work was prepared: Chang Gung Memorial Hospital,<br />

Taoyuan, Taiwan<br />

Wei-Chao Huang; Christopher Glenn Wallace; Robert EH Ferguson, MD; Fu-<br />

Chan Wei; Jeng-Yee Lin<br />

11:42am – 11:45am<br />

Discussion<br />

11:45am – 11:49am<br />

*The SIEA, DIEP and Free TRAM flaps: A Comparison of Abdominal Wall and<br />

Flap Complications and a Surgical Algorithm<br />

Institution where the work was prepared: University of Pennsylvania, Philadelphia,<br />

PA, USA<br />

Jesse Creed Selber, MD, MPH; Fares Samra, BA; Lauren Hill, BA; Mirar Bristol;<br />

Seema Sonnad; Joseph Serletti<br />

11:49am – 11:53am<br />

A New Composite Flap: Rectus Abdominis Muscle Flap Harvested with Pubic<br />

Bone Segment (Anatomic Considerations)<br />

Institution where the work was prepared: Gulhane Military Medical Academy,<br />

Ankara, Turkey<br />

Serdar Ozturk; Mustafa Sengezer; Unsal Coskun; Fatih Zor<br />

56<br />

11:53am – 11:57am<br />

*Extended Anterolateral Thigh Flap in Oncological Reconstruction<br />

Institution where the work was prepared: Memorial Sloan Kettering, New York,<br />

NY, USA<br />

Afshin Mosahebi; Martin Jugenburg, MD; Pravin Reddy; Andrea L. Pusic; Joseph<br />

J. Disa; Peter G. Cordeiro; Babak J. Mehrara<br />

11:57am – 12:00pm<br />

Discussion<br />

12:00pm – 12:04pm<br />

*Fat Necrosis in Microvascular Breast Reconstruction: An Assessment and<br />

Comparison of SIEA, DIEP and Muscle-Sparing Free TRAM Methods<br />

Institution where the work was prepared: University of Pennsylvania, Philadelphia,<br />

PA, USA<br />

Alison E. Kaye, MD; Liza C. Wu; Joseph M. Serletti<br />

12:04pm – 12:08pm<br />

*A Ten-Year Experience of Free Flaps in Head and Neck Surgery. How Necessary<br />

is a Second Venous Anastomosis?<br />

Institution where the work was prepared: University of Toronto, Toronto, ON,<br />

Canada<br />

Gary L. Ross, MD, FRCS(plast); Erik Ang; Declan Lannon; Patrick Addison; Alex<br />

Golger; Christine Novak; Joan Lipa; Patrick Gullane; Peter Neligan<br />

(Laura Snell presenting)<br />

12:08pm – 12:12pm<br />

The Longitudinal Gracilis Myocutaneous Flap: Another Option in Breast<br />

Reconstruction<br />

Institution where the work was prepared: Cali<strong>for</strong>nia Pacific Medical Center and<br />

UCSF Medical Center, San Francisco, CA, USA<br />

Gabriel M. Kind, MD; Robert D. Foster, MD<br />

12:12pm – 12:16pm<br />

*Ultrasound-Assisted Liposuction as a Novel Treatment <strong>for</strong> Fat Necrosis after<br />

Autologous Breast Reconstruction<br />

Institution where the work was prepared: Beth Israel Deaconess Medical Center,<br />

Boston, MA, USA<br />

Stephanie A. Caterson, MD; Adam M. Tobias; Bernard Lee<br />

12:16pm – 12:20pm<br />

Discussion<br />

12:30pm Adjourn<br />

1:00pm ASRM Council <strong>Meeting</strong>


ABSTRACT TABLE OF CONTENTS<br />

AAHS/ASPN/ASRM Abstract Author Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58-59<br />

AAHS Abstracts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60-97<br />

AAHS Outstanding Nerve Paper Presentations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98-99<br />

AAHS Poster Presentations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100-102<br />

AAHS/ASRM/ASPN Outstanding Nerve Paper Presentations . . . . . . . . . . . . . . . . . . . . . . 103-104<br />

ASPN Abstracts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105-131<br />

ASPN Poster Presentations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132-135<br />

ASRM Abstracts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136-206<br />

ASRM Poster Presentations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 207-214<br />

57


ABSTRACT AUTHOR INDEX<br />

58<br />

A<br />

Abrams, Reid . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81<br />

Abtahi, Fatemeh . . . . . . . . . . . . . . . . . . . . . . . . . 76<br />

Ackerman, Duncan B.. . . . . . . . . . . . . . . . . . . . . 65<br />

Acland, Robert D. . . . . . . . . . . . . . . . . . . . . . . . 166<br />

Adams, Brian D.. . . . . . . . . . . . . . . . . . . . . . . . . . 84<br />

Adani, Roberto . . . . . . . . . . . . . . . . . . . . . 161, 211<br />

Addison, Patrick. . . . . . . . . . . . . . . . . . . . . . . . . 205<br />

Agro, Deborah. . . . . . . . . . . . . . . . . . . . . . . . . . 119<br />

Ahn, Hee-Chang . . . . . . . . . . . . . . . . . . . . . . . . . 75<br />

Aita, Marcio A. . . . . . . . . . . . . . . . . . . . . . . . . . . . 68<br />

Akyurek, Mustafa. . . . . . . . . . . . . . . . . . . . . . . . 193<br />

Ali, Rozina. . . . . . . . . . . . . . . . . . . . . . . . . . 154, 162<br />

Allen, Robert J. . . . . . . . . . . . . . . . . . . . . . . . . . 147<br />

Alon, Malvina . . . . . . . . . . . . . . . . . . . . . . . . . . . 130<br />

Alton, Timothy . . . . . . . . . . . . . . . . . . . . . . . . . . 109<br />

Alvey, Dallas . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79<br />

Amako, Masatoshi. . . . . . . . . . . . . . . . . . . . . . . 126<br />

Amir, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 168<br />

Amrami, Kimberly K. . . . . . . . . . . . . . . 84, 86, 108<br />

An, Kai-Nan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86<br />

Anastakis, Dimitri J.. . . . . . . . . . . . . . . . . . . . . . 112<br />

Anderson, Aaron . . . . . . . . . . . . . . . . . . . . . . . . . 74<br />

Ang, Erik . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 205<br />

Anthony, Smith. . . . . . . . . . . . . . . . . . . . . . . . . . . 83<br />

Arad, E. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 168<br />

Arbique, Gary . . . . . . . . . . . . . . . . . . . . . . 169, 181<br />

Ardelean, Filip. . . . . . . . . . . . . . . . . . . 71, 191, 209<br />

Arino, Hiroshi . . . . . . . . . . . . . . . . . . . . . . . . . . . 126<br />

Arnold, Peter B. . . . . . . . . . . . . . . . . . . . . . . . . . 175<br />

Ashjian, Peter. . . . . . . . . . . . . . . . . . . . . . . . . . . 147<br />

Asko-Seljavaara, Sirpa . . . . . . . . . . . . . . . . . . . 138<br />

Attinger, Chris E. . . . . . . . . . . . . . . . . . . . . . . . . 166<br />

Aubá, Cristina . . . . . . . . . . . . . . . . . . . . . . . . . . 107<br />

B<br />

Baccarani, Alessio . . . . . . . . . . . . . . . . . . . 164, 176<br />

Badalamente, Marie . . . . . . . . . . . . . . . . . . . . . . 70<br />

Bain, James R.. . . . . . . . . . . . . . . . . . 111, 115, 119<br />

Banks, Nia D. . . . . . . . . . . . . . . . . . . . . . . . . . . . 149<br />

Baratz, Mark E.. . . . . . . . . . . . . . . . . . . . . . . . . . . 98<br />

Barker, Allison R. . . . . . . . . . . . . . . . . . . . . . . . . 129<br />

Barnea, Yoav . . . . . . . . . . . . . . . . . . . . . . . 168, 197<br />

Barth, Rolf. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 171<br />

Bartlett, Stephen T. . . . . . . . . . . . . . . . . . . . . . . 171<br />

Bates, Steven . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75<br />

Batt, Jane AE . . . . . . . . . . . . . . . . . . . . . . . . . . . 115<br />

Beckenbaugh, Robert D. . . . . . . . . . . . . . . . . . . 65<br />

Bekler, Halil I. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91<br />

Bengtson, Keith A. . . . . . . . . . . . . . . . . . . . . . . 127<br />

Berger, Richard A. . . . . . . . . . . . . . . . . . . . . . 84, 86<br />

Bernier, Christina . . . . . . . . . . . . . . . . . . . . . . . . 154<br />

Berry, Nada . . . . . . . . . . . . . . . . . . . . . . . . . 73, 117<br />

Bettger-Hahn, Margo . . . . . . . . . . . . . . . . . . . . 198<br />

Bindra, Randy R. . . . . . . . . . . . . . . . . . . . . . . . . . 68<br />

Bishop, Allen T.. . . . . . . . . . . . . 127, 164, 170, 200<br />

Blount, Andrew . . . . . . . . . . . . . . . . . . . . . . . . . 118<br />

Bluebond-Langner, Rachel . . . 136, 171, 184, 207<br />

Borschel, Gregory H. . . . . . . . . 114, 119, 120, 133<br />

Boyce, Brandon M. . . . . . . . . . . . . . . . . . . . . . . . 63<br />

Boyd, Brian 145<br />

Bozkurt, Mehmet . . . . . . . . 97, 104, 128, 139, 179<br />

Bristol, Mirar. . . . . . . . . . . . . . . . . . . . . . . . 203, 211<br />

Brooks, Darrell . . . . . . . . . . . . . 153, 157, 194, 195<br />

Brown, Spencer A. . . . . . . . . . . . . . . . . . . . . 77, 79<br />

Brown, William C. . . . . . . . . . . . . . . . . . . . . . . . 160<br />

Buchel, Edward Wayne . . . . . . . . . . 153, 197, 201<br />

Bucky, Louis P. . . . . . . . . . . . . . . . . . . . . . . . . . . 187<br />

Bueno, Rebuen . . . . . . . . . . . . . . . . . . . . . . . . . 117<br />

Buntic, Rudolf F. . . . . . . . . . . . . 153, 157, 194, 195<br />

Busch, Kay H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97<br />

Butler, Charles E. . . . . . . . . . . . . . . . . . . . . . . . . 155<br />

Butler, Erin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93<br />

Butler, Richard G.. . . . . . . . . . . . . . . . . . . . . . . . 111<br />

C<br />

Campbell, Christopher A. . . . . . . . . . . . . . . . . 175<br />

Capo, John. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64<br />

Capota, Irina . . . . . . . . . . . . . . . . . . . . . . . . 71, 209<br />

Cardenas-Mejia, Alexander . . . . . . . . . . . . . . . 154<br />

Carlsen, Brian. . . . . . . . . . . . . . . . . . . . . . . . . . . 147<br />

Carnevale, Kevin . . . . . . . . . . . . . . . . . . . . . . . . 185<br />

Carney, Joseph R. . . . . . . . . . . . . . . . . . . . . . . . . 80<br />

Carvalho, Alex . . . . . . . . . . . . . . . . . . . . . . . . . . . 78<br />

Carvell, George E.. . . . . . . . . . . . . . . . . . . . . . . 184<br />

Catalano, Francesco . . . . . . . . . . . . . . . . . . . . . 125<br />

Caterson, Stephanie A. . . . . . . . . . . 144, 148, 206<br />

Cavadas, Pedro C.. . . . . . . . . . . . . . . . . . . . . . . 165<br />

Cavusoglu, Tarik . . . . . . . . . . . . . . . . . . . . . . . . 185<br />

Cederna, Paul S. . . . . . . . . . . . . . . . . 101, 106, 134<br />

Chambers, Chris . . . . . . . . . . . . . . . . . . . . . 61, 140<br />

Champion, Hunter C. . . . . . . . . . . . . . . . . . . . . 136<br />

Chang, Chris . . . . . . . . . . . . . . . . . . . . . . . . . . . 183<br />

Chang, Edward I.. . . . . . . . . . . . . . . . . . . . . . . . 137<br />

Chang, Nai-Jen . . . . . . . . . . . . . . . . . . . . . 172, 174<br />

Chang, Shu-ying . . . . . . . . . . . . . . . . . . . . . . . . 186<br />

Chang, Yang-Ming . . . . . . . . . . . . . . . . . . . . . . 187<br />

Chelly, Marjorie R. . . . . . . . . . . . . . . . . . . . . . . . 193<br />

Chen, Constance M.. . . . . . . . . . . . . . . . . . . . . 182<br />

Chen, Gary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90<br />

Chen, Hung-Chi. . . . . . . . 161, 162, 185, 192, 196<br />

Cheng, Ming-Huei . 154, 162, 186, 187, 201, 212<br />

Cheng, Richard . . . . . . . . . . . . . . . . . . . . . . . . . . 162<br />

Chiang, Yuan-Cheng. . . . . . . . . . . . . . . . . . . . . . 172<br />

Ching, We-Chen . . . . . . . . . . . . . . . . . . . . . . . . . 154<br />

Cho, Alvaro B. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68<br />

Choi, Matthew . . . . . . . . . . . . . . . . . . . . . . . . . . . 153<br />

Choi, Tae Hyun. . . . . . . . . . . . . . . . . . . . . . . . . . . 150<br />

Chojnowski, Adrian J. . . . . . . . . . . . . . . . . . . . . . . 71<br />

Chollet, André . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96<br />

Chow, Pk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 142<br />

Chuang, David C.C. . . . . . . . . . . . . . . . . . . . . . . 174<br />

Cindy, Ivy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83<br />

Ciocanel, Despina E.. . . . . . . . . . . . . . . . . . . . . . . 67<br />

Clark, Ian M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71<br />

Clarke, Howard M. . . . . . . . . . . . . . . . . . . . . . . . 100<br />

Clavero, Ja . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 198<br />

Cobb, Tyson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99<br />

Coert, J.H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108<br />

Collins, Evan. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87<br />

Colque, Alex . . . . . . . . . . . . . . . . . . . . . . . . . . . . 200<br />

Comert, Ayhan. . . . . . . . . . . . . . . . . . . . . . . . . . . 185<br />

Conaway, Danielle A. . . . . . . . . . . . . . . . . . . . . . . 84<br />

Cooney, Damon . . . . . . . . . . . . . . . . . . . . . . 61, 140<br />

Cordeiro, Peter G.. . . . . . . . . . . . . . . . . . . . 189, 204<br />

Cordera, Fernando . . . . . . . . . . . . . . . . . . . . . . . 188<br />

Coskun, Unsal . . . . . . . . . . . . . . . . . . . . . . . . . . . 203<br />

Cote, Daniel . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90<br />

Crisera, Christopher A.. . . . . . . . . . . . . . . . 145, 147<br />

Culp, Randall . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86<br />

Curry, Patrick. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 166<br />

Czermak, Christoph . . . . . . . . . . . . . . . . . . . . . . 167<br />

D<br />

Da Lio, Andrew L. . . . . . . . . . . . . . . . . . . . . 145, 147<br />

Danker, Timm. . . . . . . . . . . . . . . . . . . . . . . . . . . . 122<br />

Darlis, Nickolaos A. . . . . . . . . . . . . . . . . . . . . . . . 69<br />

Day, Joseph Paul . . . . . . . . . . . . . . . . . . . . . . . . . 128<br />

Dayan, Joseph H. . . . . . . . . . . . . . . . . . . . . . . . . 166<br />

De Boer, Ralph. . . . . . . . . . . . . . . . . . . . . . . . . . . 123<br />

De Jesus, Ramon . . . . . . . . . . . . . . . . . . . . 133, 199<br />

De Santis, Giorgio . . . . . . . . . . . . . . . . . . . . . . . . 164<br />

De Vitis, Rocco. . . . . . . . . . . . . . . . . . . . . . . . . . . 125<br />

DeAngelis, Nicola . . . . . . . . . . . . . . . . . . . . . . . . . 76<br />

DeBoer, Johannes F. . . . . . . . . . . . . . . . . . . . . . . 110<br />

Deleyiannis, Frederic W. B. . . . . . . . . . . . . . . . . 160<br />

DellaCroce, Frank J. . . . . . . . . . . . . . . . . . . . . . . 146<br />

DeMatteo, Carol . . . . . . . . . . . . . . . . . . . . . . . . . 119<br />

Demir, Yavuz . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140<br />

Dennison, David . . . . . . . . . . . . . . . . . . . . . . . . . . 60<br />

Derwin, Kathleen . . . . . . . . . . . . . . . . . . . . . . . . . . 74<br />

Deveci, Mustafa . . . . . . . . . . . . . . . . . . . . . . . . . . 154<br />

Dexter, Erika . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118<br />

Dhar, Sanjay. . . . . . . . . . . . . . . . . . . . . 105, 118, 130<br />

Di Scipio, Federica . . . . . . . . . . . . . . . . . . . . . . . 122<br />

Dickinson, Brian P. . . . . . . . . . . . . . . . . . . . . . . . . 147<br />

Disa, Joseph J. . . . . . . . . . . . . . . . . . . . . . . 182, 204<br />

Donnelly, S. Chase. . . . . . . . . . . . . . . . . . . . . . . . . 74<br />

Dorafshar, Amir H.. . . . . . . . . . . . . . . . . . . . 156, 213<br />

Drake, David B. . . . . . . . . . . . . . . . . . . . . . . . . . . 175<br />

Drake, Richard . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74<br />

Ducic, Ivica. . . . . . . . . . . . . . . . . . . . . . 107, 114, 166<br />

Duman, Haluk . . . . . . . . . . . . . . . . . . . . . . . . . . . 192<br />

Dumanian, Gregory A . . . . . . . . . . . . . 78, 117, 177<br />

Dumans, Antoine G. . . . . . . . . . . . . . . . . . . . . . . 183<br />

Duncan, Scott F. M. . . . . . . . . . . . . . . . . . . . . . . . . 72<br />

Dunn, Raymond M. . . . . . . . . . . . . . . . . . . . . . . . 193<br />

E<br />

Echo, Anthony . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88<br />

Edwards, Michael Charles . . . . . . . . . . . . . . . . . 128<br />

Elsohemy, Amal S.. . . . . . . . . . . . . . . . . . . . . . . . 111<br />

Engel, Holger. . . . . . . . . . . . . . . . . . . . . . . . 186, 201<br />

Erdmann, Detlev . . . . . . . . . . . . . . . . . . . . . 158, 176<br />

Eskander, Jonathan . . . . . . . . . . . . . . . . . . . . . . . . 76<br />

Eskander, Mark. . . . . . . . . . . . . . . . . . . . . . . . . . . . 76<br />

Eski, Muhidtin . . . . . . . . . . . . . . . . . . . . . . . 159, 190<br />

Evans, Gregory R. D.. . . . . . . . . . . . . . . . . . 130, 176<br />

F<br />

Fahnestock, Margaret. . . . . . . . . . . . . . . . . . . . . 111<br />

Faillace, John . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83<br />

Fang, Xin-Hua . . . . . . . . . . . . . . . . . . . . . . . . . . . 141<br />

Fankhauser, Grant . . . . . . . . . . . . . . . . . . . . . . . . . 72<br />

Faria, Fabiano N. . . . . . . . . . . . . . . . . . . . . . . . . . . 68<br />

Farkas, Jordan . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77<br />

Feinberg, Joseph . . . . . . . . . . . . . . . . . . . . 117, 162<br />

Feng, Guan-Ming . . . . . . . . . . . . . . . . . . . . . . . . 185<br />

Ferguson, Robert E.H. . . . . . . . . . . . . . . . . . . . . 202<br />

Ferrari, Jonathan . . . . . . . . . . . . . . . . . . . . . 133, 199<br />

Festekjian, Jaco. . . . . . . . . . . . . . . . . . . . . . 145, 147<br />

Finnerty, Edward . . . . . . . . . . . . . . . . . . . . . . . . . . 67<br />

Fiore II, Nicholas A. . . . . . . . . . . . . . . . . . . . . . . . . 88<br />

Firoozbakhsh, Keikhosrow . . . . . . . . . . . . . . . . . . 78<br />

Fitzgerald, Brian. . . . . . . . . . . . . . . . . . . . . . . . . . . 80<br />

Fletcher, Joel G.. . . . . . . . . . . . . . . . . . . . . . . . . . . 84<br />

Flores, Jaime I.. . . . . . . . . . . . . . . . . . . . . . . . . . . 149<br />

Fokkens, Nico . . . . . . . . . . . . . . . . . . . . . . . . . . . 183<br />

Follmar, Keith E. . . . . . . . . . . . . . . . . . . . . . 158, 176<br />

Foster, Robert D. . . . . . . . . . . . . . . . . . . . . . . . . . 205<br />

Fox, Sharon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 148<br />

Friedrich, Jeffrey B. . . . . . . . . . . . . . . . . . . . 164, 200<br />

Friedrich, Patricia F. . . . . . . . . . . . . . . . . . . . . . .170<br />

Froimson, Jill . . . . . . . . . . . . . . . . . . . . . . .104, 128<br />

Fukushima, Walter Y . . . . . . . . . . . . . . . . . . . . . .68<br />

Furey, M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .121<br />

G<br />

Gajendran, Varun . . . . . . . . . . . . . . . . . . . . . . . .81<br />

Galvez, Michael G. . . . . . . . . . . . . . . . . . . . . . .137<br />

Gan, Bing Siang . . . . . . . . . . . . . . . . . . . . . . . .198<br />

Gannon, Caitlin . . . . . . . . . . . . . . . . . . . . . . . . . .98<br />

Garcia-Cepeda, Ignacio . . . . . . . . . . . . . . . . . . .64<br />

Garfein, Evan . . . . . . . . . . . . . . . . . . .183, 194, 195<br />

Gauvin, Jean . . . . . . . . . . . . . . . . . . . . . . . . . . . .62<br />

Gazyakan, Emre . . . . . . . . . . . . . . . . . . . . . . . . .201<br />

Gelfand, Mark . . . . . . . . . . . . . . . . . . . . . . . . . .145<br />

Gellrich, Niels C. . . . . . . . . . . . . . . . . . . . . . . . .191<br />

Georgescu, Alexandru . . . . . . . . . . . .71, 191, 209<br />

Germann, Güenter . . . . . . . . . . . . . . .82, 167, 171<br />

Geuna, Stefano . . . . . . . . . . . . . . . . . . . . . . . . .122<br />

Giessler, Goetz A. . . . . . . . . . . . . . . . . . . . . . . .170<br />

Glenn Wallace, Christopher . .172, 173, 178, 187, 193, 202<br />

Gohritz, Andreas . . . . . . . . . . . . . . . . . . . . . . . .191<br />

Goitz, Robert . . . . . . . . . . . . . . . . . . . . . . . . . . . .62<br />

Golger, Alex . . . . . . . . . . . . . . . . . . . . . . . . . . . .205<br />

Gonzalez-Hernandez, Eduardo . . . . . . . . . . . . .64<br />

Gorantla, Vijay S. . . . . . . . . . . . . . . . . . . . . .95, 184<br />

Gordon, T . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .121<br />

Gorria, Oscar . . . . . . . . . . . . . . . . . . . . . . . . . . .107<br />

Gottlieb, Lawrence J. . . . . . . . . . . . . . . . . . . . .156<br />

Grykien, Christopher . . . . . . . .104, 128, 179, 180<br />

Guenther, Elke . . . . . . . . . . . . . . . . . . . . . . . . . .122<br />

Gullane, Patrick . . . . . . . . . . . . . . . . . . . . . . . . .205<br />

Guo, Lifei . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .189<br />

Gur, E. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .168<br />

Gurtner, Geoffrey C. . . . . . . . . . . . . . . . . . . . . .137<br />

Gustin, Jason . . . . . . . . . . . . . . . . . . . . . . . . . . .114<br />

Gûndeslioglu, Õzlem . . . . . . . . . . . . . . . . . . . .155<br />

H<br />

Hadlock, Tessa A. . . . . . . . . . . . . . . . . . . . . . . .103<br />

Haerle, Max . . . . . . . . . . . . . . . . . . . . . . . . . . . .122<br />

Halvorson, Eric . . . . . . . . . . . . . . . . . . . . . . . . . .189<br />

Hamou, Cynthia D. . . . . . . . . . . . . . . . . . . . . . .137<br />

Hanasono, Matthew M. . . . . . . . . . . . . . . . . . .139<br />

Hansen, Scott L. . . . . . . . . . . . . . . . . . . . . . . . . . .75<br />

Hansen, U. D. . . . . . . . . . . . . . . . . . . . . . . . . . . .116<br />

Harris, Patrick . . . . . . . . . . . . . . . . . . . . . . . . .94, 96<br />

Hartley, Craig J. . . . . . . . . . . . . . . . . . . . . . . . . .139<br />

Hartmann, Emily . . . . . . . . . . . . . . . . . . . . . . . .107<br />

Hatef, Daniel A. . . . . . . . . . . . . . . . . . . . .77, 79, 96<br />

Hautz, Theresa . . . . . . . . . . . . . . . . . . . . . . . . . . .95<br />

Hayakawa, Thomas E.J. . . . . . . . . . .153, 197, 201<br />

Hayashi, Ayato . . . . . . . . . . . . . . . . . . . . . . . . . .113<br />

Hayton, M. J. . . . . . . . . . . . . . . . . . . . . . . . . . . . .85<br />

Hazani, Ron . . . . . . . . . . . . . . . . . . . . . . . . . . . .194<br />

Heaton, James T. . . . . . . . . . . . . . . . . . . . . . . . .103<br />

Heitmann, Christoph . . . . . . . . . . . . . . . . . . . .167<br />

Hemphill, Amani . . . . . . . . . . . . . . . . . . . . . . . .199<br />

Henry, Francis Patrick . . . . . . . . . . . . . . . . .90, 110<br />

Henry, Mark . . . . . . . . . . . . . . . . . . . . . . . . . . . .158<br />

Hermanns, Susanne . . . . . . . . . . . . . . . . . . . . .122<br />

Hermenau, Shawn . . . . . . . . . . . . . . . . . . . . . . . .83<br />

Herrera, Fernando . . . . . . . . . . . . . . . . . . . . . . .167<br />

Herron, Margo . . . . . . . . . . . . . . . . . . . . . . . . . .117<br />

Hill, Lauren . . . . . . . . . . . . . . . . . . . . . . . . . . . . 203<br />

Hirase, Yuichi . . . . . . . . . . . . . . . . . . . . . . . . . . . .74<br />

Hitzigrath, Christiane . . . . . . . . . . . . . . . . . . . . .82<br />

Hofer, Stefan O. P . . . . . . . . . . . . . . . . . . . . . . .183<br />

Hofmeister, Eric . . . . . . . . . . . . . . . . . . . . . .80, 100<br />

Hogue, William R. . . . . . . . . . . . . . . . . . . . . . . . .68<br />

Holt, Gary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .67<br />

Hontanilla, Bernardo . . . . . . . . . . . . . . . . . . . . .107<br />

Horibe, Elaine K. . . . . . . . . . . . . . . . . . . . . . . . . .95<br />

Horton, Karen M. . . . . . . . . . . . . . . . . . . . . . . . .195<br />

Horton, Todd . . . . . . . . . . . . . . . . . . . . . . . . . . . .81<br />

Hovius, Steven E. R. . . . . . . . . . . . . . . . . . . . . . .85<br />

Hsieh, Ching-Hua . . . . . . . . . . . . . . . . . . . . . . .152<br />

Hsu, Chung-Chen . . . . . . . . . . . . . . . . . . . . . . .192<br />

Huang, Chong-Wei . . . . . . . . . . . . . . . . . . . . . .172<br />

Huang, Jung-Ju . . . . . . . . . . . . . . . .186, 201, 212<br />

Huang, Wai-Chao . . . . . . . . . . . . . . . . . . . . . . .172<br />

Huang, Wei-Chao . . . . . . . . . . . . . . . . . . .173, 174<br />

Hugate, Ronald R. . . . . . . . . . . . . . . . . . . .160, 200<br />

Hundepool, Alessandra C. . . . . . . . . . . . . . . .183<br />

Hunter, Daniel A. . . . . . . . . . . .113, 120, 132, 133<br />

Hurst, Lawrence C. . . . . . . . . . . . . . . . . . . . . . . .70<br />

I<br />

Iba, Kousuke . . . . . . . . . . . . . . . . . . . . . . . . . . . . .83<br />

Ikegami, Hiroyasu . . . . . . . . . . . . . . . . . . . . . . . .60<br />

Imbriglia, Joseph E. . . . . . . . . . . . . . . . . . . .62, 66<br />

Isaacs, Jonathan . . . . . . . . . . . . . . . . . . . . . . . .111<br />

Isik, Selçuk . . . . . . . . . . . . . . . . . . . . . . . . . . . . .159<br />

J<br />

Jacobson, Jeffrey M. . . . . . . . . . . . . . . . . . . . . .149<br />

Janz, Brian A. . . . . . . . . . . . . . . . . . . . . . . . . . . . .88<br />

Jeng, Seng - Feng . . . . . . . . . . . . . . . . . . . . . .152<br />

Johnston, Phillip . . . . . . . . . . . . . . . . . . . . . . . . .71<br />

Jones, Neil F. . . . . . . . . . . . . . . . . . . . . . . . . . . . .75<br />

Jugenburg, Martin . . . . . . . . . . . . . . . . . . . . . . 204<br />

K<br />

Kalpan, Haim . . . . . . . . . . . . . . . . . . . . . . . . . . .151<br />

Kanchwala, Suhail . . . . . . . . . . . . . . . . . . . . . . .187<br />

Kao, Huang-Kai . . . . . . . . . . . . . . . . .186, 201, 212<br />

Kaufmann, Robert W. . . . . . . . . . . . . . . . . . . . . .69<br />

Kauhanen, M Susanna C. . . . . . . . . . . . . . . . . .138<br />

Kawamura, David H. . . . . . . . . . . . . . . . . .113, 119<br />

Kaye, Alison E. . . . . . . . . . . . . . . . . . . . . . . . . . .204<br />

Kecik, Abdullah . . . . . . . . . . . . . . . . . . . . . . . . .175<br />

Keirstead, Hans S. . . . . . . . . . . . . . . . . . . . . . . .118<br />

Keith, Jerrod . . . . . . . . . . . . . . . . . . . . . . . . . . .160<br />

Keller, Alex . . . . . . . . . . . . . . . . . . . . . . . . . . . . .151<br />

Kelly, Cynthia . . . . . . . . . . . . . . . . . . . . . . .160, 200<br />

Kemp, Stephen W. P. . . . . . . . . . . . . . . . . . . . .106<br />

Kenney, Christina B. . . . . . . . . . . . . . . . . . . . . .113<br />

Kevin, Renfree . . . . . . . . . . . . . . . . . . . . . . . . . . .83<br />

Khiabani, Kayvan T. . . . . . . . . . . . . . . . . . . . . . .141<br />

Khouri, Roger K. . . . . . . . . . . . . . . . . . . . . . . . . .85<br />

Kiehn, Mark W. . . . . . . . . . . . . . . . . . . . . . . . . .167<br />

Kim, Elizabeth M. . . . . . . . . . . . . . . . . . . . . . . .146<br />

Kim, Jun Sik . . . . . . . . . . . . . . . . . . . . . . . . . . . .150<br />

Kim, Nam Gyun . . . . . . . . . . . . . . . . . . . . . . . . .150<br />

Kim, Peter S. . . . . . . . . . . . . . . . . . . . . . . .117, 177<br />

Kim, Sharon . . . . . . . . . . . . . . . . . . . . . . . . . . . .198<br />

Kinchelow, Tosca . . . . . . . . . . . . . . . . . . . . . . . . .64<br />

Kind, Gabriel M. . . . . . . . . . . . . . . . . . . . . . . . .205<br />

Kipke, Daryl R. . . . . . . . . . . . . . . . . . . . . . .106, 134<br />

Kircher, Michelle . . . . . . . . . . . . . . . . . . . . . . . .127<br />

Aleksandra, Klimczak . . . .97, 104, 128, 139, 140, 177, 179, 185<br />

Klitzmann, Bruce . . . . . . . . . . . . . . . . . . . . . . . .176<br />

Klomp, Aaron . . . . . . . . . . . . . . . . . . . . . . . . . . . .72<br />

Knight, Andrew M. . . . . . . . . . . . . . . . . . . . . . .123<br />

Knobloch, Karsten . . . . . . . . . . . . . . .97, 101, 191<br />

Kochevar, Irene E. . . . . . . . . . . . . . . . . . . . . . . . .90<br />

Korvenoja, Antti . . . . . . . . . . . . . . . . . . . . . . . . .138<br />

Kosins, Aaron M. . . . . . . . . . . . . . . . . . . . . . . . .118<br />

Kowaleski, Jeffrey . . . . . . . . . . . . . . . . . . . . . . .103<br />

Kraus, Armin . . . . . . . . . . . . . . . . . . . . . . .112, 122<br />

Kremer, Thomas . . . . . . . . . . . . . . . . . . . . . . . . .82<br />

Krichev, Alisa . . . . . . . . . . . . . . . . . . . . . . . . . . .130<br />

Krokowicz, Lukasz . . . . . . . . . . . 97, 104, 128, 139, 177, 179, 180<br />

Kronowitz, Steven J. . . . . . . . . . . . . . . . . . . . . .143<br />

Kryger, Zol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .78<br />

Kueh, Nai-Siong . . . . . . . . . . . . . . . . . . . . . . . .172<br />

Kuiken, Todd A. . . . . . . . . . . . . . . . . . . . . .117, 177<br />

Kumar, Sivathan . . . . . . . . . . . . . . . . . . . . . . . . . .68<br />

Kuo, Yur-Ren . . . . . . . . . . . . . . . . . . .152, 172, 212<br />

Kuzon Jr, William M. . . . . . . . . . . . . . . . . . . . . .106<br />

L<br />

Ladak, A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .131<br />

Ladd, Amy L. . . . . . . . . . . . . . . . . . . . . . . . . . . . .93<br />

Lanaras, Tatjana . . . . . . . . . . . . . . . . . . . . . . . . .122<br />

Landes, Geneviève . . . . . . . . . . . . . . . . . . . .94, 96<br />

Landin, Luis . . . . . . . . . . . . . . . . . . . . . . . . . . . .165<br />

Lannon, Declan . . . . . . . . . . . . . . . . . . . . . . . . .205<br />

Lao, Zhen Guo . . . . . . . . . . . . . . . . . . . . . . . . . . .90<br />

Larrañaga, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . .198<br />

Larson, Debbie . . . . . . . . . . . . . . . . . . . . . . . . . .71<br />

Larson, Ethan . . . . . . . . . . . . . . . . . . . . . . . . . . .114<br />

Lawton, Jeffrey N. . . . . . . . . . . . . . . . . . . . . . . . .74<br />

Lee, Bernard T. . . . . . . . . . . . . . . . . . . . . .144, 148<br />

Lee, Charles K. . . . . . . . . . . . . . . . . . . . . . . . . . .167<br />

Lee, Kyung Suk . . . . . . . . . . . . . . . . . . . . . . . . .150<br />

Lee, W.P. Andrew . . . . . . . . . . . . . . . . . . . . . . . .184<br />

Lemaine, Valerie . . . . . . . . . . . . . . . . . . . . . .94, 96<br />

Lemke, Jon . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .99<br />

Leshem, D. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .168<br />

Levin, L. Scott . . . . . . . . . . . . . . . . . . . . . .158, 176<br />

Levine, Jamie . . . . . . . . . . . . . . . . . . . . . . .141 214<br />

Levine, Jamie P. . . . . . . . . . . . . . . . . . . . . .194, 195<br />

Levine, Joshua . . . . . . . . . . . . . . . . . . . . . . . . . .147<br />

Li, Zhongyu . . . . . . . . . . . . . . . . . . . . . . . . . . . . .109<br />

Lim, Gale . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .73<br />

Lin, Charles P. . . . . . . . . . . . . . . . . . . . . . . . . . . . .90<br />

Lin, Cheng-Hung . . . . . . . . . . . . . . . . . . .159, 162<br />

Lin, Chien-Chih . . . . . . . . . . . . . . . . . . . . . . . . .172<br />

Lin, Chih-Hung . . . . . . . . . . . . . . . . . . . . .159, 193<br />

Lin, Chun-Yen . . . . . . . . . . . . . . . . . . . . . . . . . . .173<br />

Lin, Jeng-Yee . . . . . . . . . .172, 173, 174, 196, 202<br />

Lin, Pao-Yuan . . . . . . . . . . . . . . . . . . . . . . . . . . .152<br />

Lin, Patrick . . . . . . . . . . . . . . . . . . . . . . . . . . . . .197<br />

Lin, Yt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .154<br />

Lin, Yu-Te . . . . . . . . . . . . . . . . . . . . . .159, 193, 212<br />

Lineaweaver, William C. . . . . . . . . . . . . . . . . . .105<br />

Lino Jr, W. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .68<br />

Lipa, Joan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .205<br />

Liu, Xiao Lin . . . . . . . . . . . . . . . . . . . . . . . . . . . . .90<br />

Lo, David . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .103<br />

Longaker, Michael T. . . . . . . . . . . . . . . . . . . . . .137<br />

Loschi, Pietro . . . . . . . . . . . . . . . . . . . . . . . . . . .164<br />

Louie, Otway . . . . . . . . . .141, 183, 194, 195, 214<br />

Louie, Stephanie . . . . . . . . . . . . . . . . . . . . . . . . .93


59<br />

ABSTRACT AUTHOR INDEX<br />

Luciano, Janina P. . . . . . . . . . . . . . . .113, 120, 133<br />

Luginbuhl, Ryan D. . . . . . . . . . . . . . . . . . . . . . .114<br />

Luria, Shai . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .91<br />

Luszczek, Wioleta . . . . . . . . . . . . . . . . .89, 97, 177<br />

M<br />

MacDermid, Joy . . . . . . . . . . . . . . . . . . . . . . . .198<br />

Mackinnon, Susan . . . . . . . . . . . . . . . . . . .103, 133<br />

Malessy, Martijn J.A. . . . . . . . . . . . . . . . . . . . . .124<br />

Manahan, Michele A. . . . . . . . . . . . . . . . . . . . .149<br />

Manders, Ernest K. . . . . . . . . . . . . . . . . . . . . . .160<br />

Mardini, Samir . . . . . . . . .161, 166, 185, 192, 196<br />

Marianne, Merritt . . . . . . . . . . . . . . . . . . . . . . . .83<br />

Masannek, Carmen . . . . . . . . . . . . . . . . . . . . . .122<br />

Masia, Jaume . . . . . . . . . . . . . . . . . . . . . . . . . . .198<br />

Matei, Ileana . . . . . . . . . . . . . . . . . . . .71, 191, 209<br />

Mathes, David W. . . . . . . . . . . . . . . . . . . . . . . . .96.<br />

Matloub, Hani S. . . . . . . . . . . . . . . . . . . . . . . . .124<br />

McCollough, Cynthia H. . . . . . . . . . . . . . . . . . . .84<br />

McConnell, Michael P. . . . . . . . . . . . . . . . . . . .118<br />

McDaniel, Candice O. . . . . . . . . . . . . . . . . . . .111<br />

McElhaney, Nathaniel . . . . . . . . . . . . . . . . . . . .199<br />

McKean, Jason M. . . . . . . . . . . . . . . . . . . . . . . .91<br />

McLean, Kia M. . . . . . . . . . . . . . . . . . .95, 160, 184<br />

Mehrara, Babak J. . . . . . . . . . . . . . . . . . . .182, 204<br />

Mendoza, Charles . . . . . . . . . . . . . . . . . . . . . . .118<br />

Mercer, Deana . . . . . . . . . . . . . . . . . . . . . . . . . . .78<br />

Merolli, Antonio . . . . . . . . . . . . . . . . . . . . . . . . .125<br />

Merritt, Wyndell H. . . . . . . . . . . . . . . . . . . . . . .175<br />

Messmer, Caroline . . . . . . . . . . . . . . . . . . . . . .177<br />

Midha, Raj . . . . . . . . . . . . . . . . . . . . . . . . . . . . .127<br />

Midha, Rajiv . . . . . . . . . . . . . . . . . . . . . . . . . . . .106<br />

Mielniczuk, Mariusz . . . . . . . . . . . . . . . . . . . . . .180<br />

Milbrandt, Jeffery . . . . . . . . . . . . . . . . . . . . . . .114<br />

Miller, Blake . . . . . . . . . . . . . . . . . . . . . . . . . . . . .67<br />

Miller, E. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .168<br />

Miller, Michael J. . . . . . . . . . . . . . . . . . . . . . . . .139<br />

Miller, Quintessa . . . . . . . . . . . . . . . . . . . .147, 214<br />

Mirza, M. Ather . . . . . . . . . . . . . . . . . . . . . . .63, 89<br />

Mithani, Suhail K. . . . . . . . . . . . . . . . . . . .136, 207<br />

Mohur, Haydar . . . . . . . . . . . . . . . . . . . . . . . . . .165<br />

Moneim, Moheb S. . . . . . . . . . . . . . . . . . . . . . . .78<br />

Monill, JM . . . . . . . . . . . . . . . . . . . . . . . . . . . . .198<br />

Monsivais, Jose . . . . . . . . . . . . . . . . . . . . . .92, 113<br />

Moon, Wong . . . . . . . . . . . . . . . . . . . . . . . . . . .137<br />

Moradzadeh, Arash . . . . . . . . .113, 114, 132, 133<br />

Moran, Steven L. . . . . . . . . . . . .60, 164, 166, 200<br />

Morgan, Raymond F. . . . . . . . . . . . . . . . . . . . .175<br />

Mosahebi, Afshin . . . . . . . . . . . . . . . . . . . . . . .204<br />

Mueller, Daniela . . . . . . . . . . . . . . . . . . . . . . . .122<br />

Mueller, Hans-Werner . . . . . . . . . . . . . . . . . . . .122<br />

Mueller, Miriam . . . . . . . . . . . . . . . . . . . . . . . . . .82<br />

Mun, Goo-Hyun . . . . . . . . . . . . . . . . . . . . . . . .170<br />

Muriuki, Muturi . . . . . . . . . . . . . . . . . . . . . . . . . .62<br />

Myckatyn, Terence M. . . . . . . . . . . .113, 114, 133<br />

N<br />

Nagle, Raymond . . . . . . . . . . . . . . . . . . . . . . . .118<br />

Nahabedian, Maurice Y . . . . . . . . . . . . . . . . .149.<br />

Nair, Dileep . . . . . . . . . . . . . . . . . . . . . . . .104, 128<br />

Nakamichi, Noriaki . . . . . . . . . . . . . . . . . . . . . . .60<br />

Nakamura, Toshiyasu . . . . . . . . . . . . . . . . . . . . .60<br />

Nakanishi, Kuniaki . . . . . . . . . . . . . . . . . . . . . . .126<br />

Nalbantis, Emilios . . . . . . . . . . . . . . . . . . . . . . .167<br />

Nasir, Serdar . . . . . . . . . . . .97, 128, 139, 177, 179<br />

Neligan, Peter . . . . . . . . . . . . . . . . . . . . . . . . . .205<br />

Nelson, Rebecca A. . . . . . . . . . . . . . . . . . . . . .155<br />

Nemoto, Koichi . . . . . . . . . . . . . . . . . . . . . . . . .126<br />

Neumeister, Michael W. . . . . . . .61, 73, 117, 140<br />

Newman, Martin I. . . . . . . . . . . . . . . . . . . . . . .144<br />

Ng, Damon . . . . . . . . . . . . . . . . . . . . . . . . . . . . .64<br />

Ngov, Li . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .79<br />

Nguyen, Minh-Doan . . . . . . . . . . . . . . . . . . . . .140<br />

Nigriny, John . . . . . . . . . . . . . . . . . . . . . . . . . . .188<br />

Nikolis, Andreas . . . . . . . . . . . . . . . . . . . . . .94, 96<br />

Nisanci, Mustafa . . . . . . . . . . . . . . . . . . . . . . . .190<br />

Noble, Debby . . . . . . . . . . . . . . . . . . . . . . . . . . .77<br />

Norris, Morgan E. . . . . . . . . . . . . . . . . . . . . . . . .88<br />

Novak, Christine B. . . . . . . . . . . . . . . . . . .112, 205<br />

O<br />

O’Shaughnessy, Kristina . . . . . . . . . . . . . .117, 177<br />

Odessey, Eric A. . . . . . . . . . . . . . . . . . . . . . . . .156<br />

Ofer, Nina . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .171<br />

Ogunleye, Olubunmi . . . . . . . . . . . . . . . . . . . .139<br />

Olson, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .131<br />

Ong, Yee Siang . . . . . . . . . . . . . . . . . . . . . . . . .176<br />

Orbay, Jorge L. . . . . . . . . . . . . . . . . . . . . . . . . . .85<br />

Osterman, A. Lee . . . . . . . . . . . . . . . . . . . . . . . .86<br />

Oswald, Tanya M. . . . . . . . . . . . . . . . . . . . . . . .105<br />

Otto, Andre . . . . . . . . . . . . . . . . . . . . . . . . . . . . .82<br />

Owen, John R. . . . . . . . . . . . . . . . . . . . . . . . . . .111<br />

Ozdemir, Hakan . . . . . . . . . . . . . . . . . . . . . . . . .175<br />

Ozturk, Serdar . . . . . . . . . . . . . .154, 159, 165, 203<br />

Ozyurekoglu, Tuna . . . . . . . . . . . . . . . . . . . . . .166<br />

P<br />

Pang, See-Tong . . . . . . . . . . . . . . . . . . . . . . . . .174<br />

Park, Hyle Boris . . . . . . . . . . . . . . . . . . . . . . . . .110<br />

Parrett, Brian M. . . . . . . . . . . . . . . . . . . . . . . . . 144<br />

Patish, Hagar . . . . . . . . . . . . . . . . . . . . . . . . . . 130<br />

Payatakes, Alexander H. . . . . . . . . . . . . . . . . . . 69<br />

Peled, Ziv. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118<br />

Pennock, Andrew. . . . . . . . . . . . . . . . . . . . . . . . 81<br />

Peramo, Antonio P. . . . . . . . . . . . . . . . . . 106, 134<br />

Peterson, Brett . . . . . . . . . . . . . . . . . . . . . . . . . . 81<br />

Petrella, Giovanna . . . . . . . . . . . . . . . . . . . . . . 164<br />

Pfaeffle, Jamie . . . . . . . . . . . . . . . . . . . . . . . . . . 62<br />

Pinelli, Massimo . . . . . . . . . . . . . . . . . . . . . . . . 164<br />

Pirela-Cruz, Miguel . . . . . . . . . . . . . . . . . . . . . 116<br />

Plant, Pam . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115<br />

Pondaag, Willem . . . . . . . . . . . . . . . . . . . . . . . 124<br />

Pons, G.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 198<br />

Poptic, Earl . . . . . . . . . . . . . . . . . . . . . . . . . . . . 177<br />

Pribaz, Julian J.. . . . . . . . . . . . . . . . . . . . . . . . . 189<br />

Primak, Andrew N.. . . . . . . . . . . . . . . . . . . . . . . 84<br />

Pusic, Andrea L. . . . . . . . . . . . . . . . . . . . . . . . . 204<br />

Pyon, Jai-Kyung . . . . . . . . . . . . . . . . . . . . . . . . 170<br />

R<br />

Randolph, M. A.. . . . . . . . . . . . . . . . . . . . . 90, 110<br />

Rasheed, Mohamed Z. . . . . . . . . . . . . . . . . . . 163<br />

Rawlani, Vinay. . . . . . . . . . . . . . . . . . . . . . . . . . . 78<br />

Rayatt, Sukh S. . . . . . . . . . . . . . . . . . . . . . . . . . 183<br />

Rebecca, Alanna . . . . . . . . . . . . . . . . . . . . . . . . 72<br />

Reddy, Pravin . . . . . . . . . . . . . . . . . . . . . . . . . . 204<br />

Reece, Gregory . . . . . . . . . . . . . . . . . . . . . . . . 197<br />

Reinblatt, Maura. . . . . . . . . . . . . . . . . . . . . . . . 145<br />

Reinhart, Mary Kate. . . . . . . . . . . . . . . . . . . 63, 89<br />

Rhue, John Paul . . . . . . . . . . . . . . . . . . . . . . . . . 80<br />

Rizzo, Marco . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65<br />

Ro, Eric Y. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 190<br />

Robinson, Kris . . . . . . . . . . . . . . . . . . . . . . 92, 113<br />

Rocchi, Lorenzo . . . . . . . . . . . . . . . . . . . . . . . . 125<br />

Rochkind, Shimon . . . . . . . . . . . . . . . . . . 130, 132<br />

Rodeheaver, George T.. . . . . . . . . . . . . . . . . . 175<br />

Rodgers, Jeff. . . . . . . . . . . . . . . . . . . . . . . . . . . . 67<br />

Rodrigues, Robert . . . . . . . . . . . . . . . . . . . . . . . 65<br />

Rodriguez, Eduardo D. . . . . . . . . . . 136, 149, 171, 184, 207<br />

Rodriguez, Eduardo P.. . . . . . . . . . . . . . . . . . . 154<br />

Rodriguez-Bigas, Miguel A. . . . . . . . . . . . . . . 155<br />

Rodway, Ian. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67<br />

Rogers, Andrew . . . . . . . . . . . . . . . . . . . . . . . . . 93<br />

Rogers, James M. . . . . . . . . . . . . . . . . . . . . . . 130<br />

Roggy, David . . . . . . . . . . . . . . . . . . . . . . . . . . . 75<br />

Rohrich, Rod J. . . . . . . . . . . . . . . . . . 79, 169, 181<br />

Rose, Jessica. . . . . . . . . . . . . . . . . . . . . . . . . . . . 93<br />

Rosenwasser, Melvin P. . . . . . . . . . . . . . . . . . . . 91<br />

Ross, Douglas C. . . . . . . . . . . . . . . . . . . . . . . . 198<br />

Ross, Gary L. . . . . . . . . . . . . . . . . . . . . . . . . . . . 205<br />

Rosson, Gedge D. . . . . . . . . . . . . . . . . . . . . . . 117<br />

Rossum, A. D.. . . . . . . . . . . . . . . . . . . . . . . . . . 116<br />

Roy, Niloy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85<br />

Ruggiero, Gustavo M.. . . . . . . . . . . . . . . . . . . . 68<br />

Russavage, James M. . . . . . . . . . . . . . . . . . . . 160<br />

Rust, Esther A. Z. . . . . . . . . . . . . . . . . . . . . . . . 110<br />

Ryu, Jaiyoung . . . . . . . . . . . . . . . . . . . . . . . . . . . 63<br />

Ryuichi, Morishita. . . . . . . . . . . . . . . . . . . . . . . 126<br />

S<br />

Saadeh, Pierre . . . . . . . . . . . . . 141, 183, 194, 195<br />

Sacks, Justin M. . . . . . . . . . . . . . . . . . 95, 160, 184<br />

Safak, Tunc . . . . . . . . . . . . . . . . . . . . . . . . . . . . 175<br />

Saint-Cyr, Michel. . . . . . . . . . 77, 79, 96, 169, 181<br />

Salazar-Reyes, Hector . . . . . . . . . . . . . . . . . . . 202<br />

Salgado, Christopher J.. . . . . . . . . . 161, 166, 185, 192, 196<br />

Samra, Fares . . . . . . . . . . . . . . . . . . . . . . . . . . . 203<br />

Samson, Michel C.. . . . . . . . . . . . . . . . . . . . . . 144<br />

Sanger, James R. . . . . . . . . . . . . . . . . . . . . . . . 124<br />

Sassu, Paolo . . . . . . . . . . . . . . . . . . . . . . . . . . . 161<br />

Sato, Kazuki. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60<br />

Sauerbier, Michael. . . . . . . . . . . . . . . . . . . 82, 171<br />

Schaller, Hans-Eberhard. . . . . . . . . 112, 122, 123<br />

Schaverien, Mark . . . . . . . . . . . . . . . . . . . 169, 181<br />

Schembri, P. . . . . . . . . . . . . . . . . . . . . . . . . . . . 131<br />

Schepman, Kees P. . . . . . . . . . . . . . . . . . . . . . 183<br />

Schmidt, Bernhard. . . . . . . . . . . . . . . . . . . . . . . 84<br />

Schneeberger, Stefan . . . . . . . . . . . . . . . . 95, 184<br />

Schnur, David P. . . . . . . . . . . . . . . . . . . . . 160, 200<br />

Schoenle, Philip . . . . . . . . . . . . . . . . . . . . . . . . 122<br />

Scholz, Thomas . . . . . . . . . . . . . . . . . . . . 130, 176<br />

Selber, Jesse Creed . . . . . . . . . . . . . . . . 203, 211<br />

Sengezer, Mustafa . . . . . . . . . 154, 165, 190, 203<br />

Serletti, Joseph M. . . . . . . . . . 146, 203, 204, 211<br />

Shafi, Mohamed. . . . . . . . . . . . . . . . . . . . . . . . 130<br />

Shaw, William . . . . . . . . . . . . . . . . . . . . . . . . . . 145<br />

Shepard, Brandon . . . . . . . . . . . . . . . . . . . . . . 118<br />

Shin, Alexander Y. . . . . . . 60, 101, 127, 164, 200.<br />

Shipley, Stephen . . . . . . . . . . . . . . . . . . . . . . . 171<br />

Siebert, John W. . . . . . . . . . . . . . . . . . . . 183, 195<br />

Siemionow, Maria Z. . . . 89, 97, 104, 128, 139, 140, 177, 179, 180<br />

Simon, Rainer . . . . . . . . . . . . . . . . . . . . . . . . . . . 82<br />

Simons, Daniel J. . . . . . . . . . . . . . . . . . . . . . . . 184<br />

Singh, Navin K. . . . . . . . . . . . . . . . . . . . . . . . . .149<br />

Sinis, Nektarios . . . . . . . . . . . . . . . .112, 122, 123<br />

Skie, Martin C. . . . . . . . . . . . . . . . . . . . . . . . . . .67<br />

Slater, Robert R. . . . . . . . . . . . . . . . . . . . . . . . . .81<br />

Smith, Anthony . . . . . . . . . . . . . . . . . . . . . . .72, 83<br />

Solari, Mario G. . . . . . . . . . . . . . . . . . . . . .95, 184<br />

Song, David H. . . . . . . . . . . . . . . . . . . . . .152, 213<br />

Sonmez, Erhan . . . . . . . . . . . . . . . . . . . . .128, 175<br />

Sonnad, Seema . . . . . . . . . . . . . . . . . . . .203, 211<br />

Sood, Rajiv . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .75<br />

Sorenson, Eric J. . . . . . . . . . . . . . . . . . . . . . . . .116<br />

Sotereanos, Dean G. . . . . . . . . . . . . . . . . . . . . .69<br />

Spiegel, Aldona J. . . . . . . . . . . . . . . . . . . . . . .202<br />

Spies, Marcus . . . . . . . . . . . . . . . . . . . . . . . . . . .97<br />

Spiguel, Lisa . . . . . . . . . . . . . . . . . . . . . . . . . . .156<br />

Spinelli, Maria Silvia . . . . . . . . . . . . . . . . . . . . .125<br />

Spinner, Robert J. . . . . . . . . . .108, 116, 123, 127<br />

Staines, Kimberly . . . . . . . . . . . . . . . . . . . . . . . .87<br />

Stanley, John K. . . . . . . . . . . . . . . . . . . . . . . . . .85<br />

Stephenson, Linda L. . . . . . . . . . . . . . . . . . . . .141<br />

Sterbank, Patrick . . . . . . . . . . . . . . . . . . . . . . . . .99<br />

Strauss, Helene L. . . . . . . . . . . . . . . . . . . . . . . .162<br />

Strickland, Justin . . . . . . . . . . . . . . . . . . . . . . . . .60<br />

Su, Anjey . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .184<br />

Sullivan, Scott Keith . . . . . . . . . . . . . . . . . . . . .146<br />

Suominen, Sinikka . . . . . . . . . . . . . . . . . . . . . .138<br />

Szabo, Robert . . . . . . . . . . . . . . . . . . . . . . . . . . .81<br />

T<br />

Taghinia, Amir . . . . . . . . . . . . . . . . . . . . . . . . . .189<br />

Tahiri, Youssef . . . . . . . . . . . . . . . . . . . . . . . .94, 96<br />

Talwalkar, Sumedh C. . . . . . . . . . . . . . . . . . . . . .85<br />

Tan, Bien-Keem . . . . . . . . . . . . . . . . . . . .142, 163<br />

Tan, Kok-Chai . . . . . . . . . . . . . . . . . . . . . . . . . .163<br />

Tan, Virak . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .64<br />

Tang, Peter . . . . . . . . . . . . . . . . . . . . . . . . . .62, 66<br />

Tang, Yueh-Bih . . . . . . . . . . . . . . . . . . . . .185, 192<br />

Tay, Shian Chao . . . . . . . . . . . . . . . . . . . . . .84, 86<br />

Tekdemir, Ibrahim . . . . . . . . . . . . . . . . . . . . . . .185<br />

Temple, Claire L. F. . . . . . . . . . . . . . . . . . . . . . . .98<br />

Teoh, Lam Chuan . . . . . . . . . . . . . . . . . . . .73, 101<br />

Terreros, D. A. . . . . . . . . . . . . . . . . . . . . . . . . . .116<br />

Thompson, Michael . . . . . . . . . . . . . . . . . . . . . .80<br />

Thomson, Angus W. . . . . . . . . . . . . . . . . . . . . .95<br />

Thornby, John . . . . . . . . . . . . . . . . . . . . . . . . . . .87<br />

Tobias, Adam M. . . . . . . . . . . . . . . .144, 148, 206<br />

Tomaszek, Sandra . . . . . . . . . . . . . . . . . . . . . . .97<br />

Tomita, Kazunari . . . . . . . . . . . . . . . . . . . . . . . . .86<br />

Tong, Alice Y. . . . . . . . . . . . . . . . . . .113, 114, 133<br />

Tontz, William . . . . . . . . . . . . . . . . . . . . . . . . . . .81<br />

Topham, Neal S. . . . . . . . . . . . . . . . . . . .188, 190<br />

Toyama, Yoshiaki . . . . . . . . . . . . . . . . . . . . . . . .60<br />

Tra, W. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .108<br />

Trail, Ian A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .85<br />

Trovato, Matthew J. . . . . . . . . . . . . . . . . . . . . .195<br />

Trumble, Thomas E. . . . . . . . . . . . . . . . . . . . . . .91<br />

Tsai, Chi-Ying . . . . . . . . . . . . . . . . . . . . . . . . . .187<br />

Tsao, Chung-Kan . . . . . . . . . . . . . . . . . . . . . . .187<br />

Tse, Raymond . . . . . . . . . . . . . . . . . . . . . . . . . .198<br />

Tseng, Charles Y. . . . . . . . . . . . . . . .152, 156, 213<br />

Tsuchihara, Toyokazu . . . . . . . . . . . . . . . . . . . .126<br />

Tuffaha, Sami H. . . . . . . . . . . .113, 114, 120, 133<br />

Tukiainen, Erkki . . . . . . . . . . . . . . . . . . . . . . . . .138<br />

Tung, Thomas H. . . . . . . . . . . . . . . .113, 119, 133<br />

Turegun, Murat . . . . . . . . . . . . . . . . . . . . . . . . .190<br />

Tyler, Jennifer . . . . . . . . . . . . . . . . . . . . . . . . . . .99<br />

Tyreman, N. . . . . . . . . . . . . . . . . . . . . . . . .121, 131<br />

U<br />

Udina, E. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .121<br />

Ulusal, Betul . . . . . . . . . . . . . . . . . . . . . . . . . . .186<br />

Unadkat, Jignesh V. . . . . . . . . . . . . . . . . . .95, 184<br />

Unal, Mehmet Bekir . . . . . . . . . . . . . . . . . . . . .140<br />

Urbanchek, Melanie G. . . . . . . . . . . . . . .106, 134<br />

Uygur, Fatih . . . . . . . . . . . . . . . . . . . . . . . . . . . .192<br />

V<br />

Vaca, Luis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .145<br />

van der Meij, Erik H. . . . . . . . . . . . . . . . . . . . .183<br />

Van Neck, J. . . . . . . . . . . . . . . . . . . . . . . . . . . .108<br />

Van Riet, Roger P. . . . . . . . . . . . . . . . . . . . . . . . .86<br />

Vargel, Ibrahim . . . . . . . . . . . . . . . . . . . . . . . . .185<br />

Vives, L. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .198<br />

Vogt, Peter M. . . . . . . . . . . . . . . . . . .97, 101, 191<br />

Vroemen, Joy Christiane . . . . . . . . . . . . . . . . . .91<br />

W<br />

Waitayawinyu, Thanapong . . . . . . . . . . . . . . . .91<br />

Wallace, Chris . . . . . . . . . . . . . . . . . . . . . . . . . .162<br />

Wallace, Christopher Glenn . . . . . .172, 173, 178<br />

Walsh, Sarah K. . . . . . . . . . . . . . . . . . . . . . . . . .127<br />

Wang, Danru . . . . . . . . . . . . . . . . . . . . . . . . . . .158<br />

Wang, Huan . . . . . . . . . . . . . . . . . . .108, 116, 123<br />

Wang, Wei Z. . . . . . . . . . . . . . . . . . . . . . . . . . .141<br />

Watson, James P. . . . . . . . . . . . . . . . . . . .145, 147<br />

Wayne, Jennifer S. . . . . . . . . . . . . . . . . . . . . . .111<br />

Webb, Aubrey A. . . . . . . . . . . . . . . . . . . . . . . .106<br />

Wei, Fu-Chan . . . . . . . . .159, 172, 173, 174, 178<br />

Weiss, Douglass . . . . . . . . . . . . . . . . . . . . . . . . .76<br />

Weiss, J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .168<br />

Wendt, Michael . . . . . . . . . . . . . . . . . . . . . . . . .82<br />

Werdin, Frank . . . . . . . . . . . . . . . . . . . . . .112, 122<br />

West, P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .116<br />

Wijdicks, Coen . . . . . . . . . . . . . . . . . . . . . . . . . .60<br />

Wilkins, Ross . . . . . . . . . . . . . . . . . . . . . . . . . . .160<br />

Williams Eric H. . . . . . . . . . . . . . . . . . . . . . . . . .117<br />

Windebank, Anthony J. . . . . . . . . . . . . . .116, 123<br />

Winkler, Eyal . . . . . . . . . . . . . . . . . . . . . . . . . . .151<br />

Winograd, Jonathan M. . . . . . . . . . . . . . .90, 110<br />

Wise, M. Whitten . . . . . . . . . . . . . . . . . . .147, 214<br />

Witkin, Lisa . . . . . . . . . . . . . . . . . . . . . . . . . . . . .184<br />

Wolfe, Scott . . . . . . . . . . . . . . . . . . . . . . . . . . . .162<br />

Wong, Wendy . . . . . . . . . . . . . . . . . . . . . . . . . . .93<br />

Woo, Eky . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .142<br />

Woo, Minna . . . . . . . . . . . . . . . . . . . . . . . . . . . .115<br />

Wood, Christina M. . . . . . . . . . . . . . . . . .164, 200<br />

Wu, Liza C. . . . . . . . . . . . . . . . . . . . . . . . . .146, 204<br />

Wu, Ren-Chin . . . . . . . . . . . . . . . . . . . . . . . . . .178<br />

Wu, Wen-Sheng . . . . . . . . . . . . . . . . . . . . . . . .172<br />

Y<br />

Yaffe, Batia . . . . . . . . . . . . . . . . . . . . . . . . . . . . .151<br />

Yam, Andrew . . . . . . . . . . . . . . . . . . . . . . . . . . . .73<br />

Yan, Ying . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .120<br />

Yan, Yu-Hui . . . . . . . . . . . . . . . . . . . . . . . . . . . . .124<br />

Yan, Ji-Geng . . . . . . . . . . . . . . . . . . . . . . . . . . .124<br />

Yang, Hsiang-Chen . . . . . . . . . . . . . . . . . . . . . .173<br />

Yang, Johnson C. . . . . . . . . . . . . . . . . . . . . . . .152<br />

Yaszemski, Michael J. . . . . . . . . . . . . . . . . . . . .123<br />

Yazici, Ilker . . . . . . . . . . . . . . . . . . . . . . . . . . . . .185<br />

Yen, Chia-Hung . . . . . . . . . . . . . . . . . . . . .173, 178<br />

Ylä-Kotola, Tuija M. . . . . . . . . . . . . . . . . . . . . . .138<br />

Z<br />

Zamboni, William A. . . . . . . . . . . . . . . . . . . . . .141<br />

Zaretski, Arik . . . . . . . . . . . . . . . . . . . . . . .168, 178<br />

Zhang, Feng . . . . . . . . . . . . . . . . . . . . . . . . . . .105<br />

Zhang, Lin-Ling . . . . . . . . . . . . . . . . . . . . . . . . .124<br />

Zhang, Yi Xin . . . . . . . . . . . . . . . . . . . . . . . . . . .176<br />

Zhu, Jia Kai . . . . . . . . . . . . . . . . . . . . . . . . . . . . .90<br />

Zhu, Qing Tang . . . . . . . . . . . . . . . . . . . . . . . . . .90<br />

Zieger, Madeline . . . . . . . . . . . . . . . . . . . . . . . . .75<br />

Zor, Fatih . . . . . . . . . . . . . .154, 159, 165, 190, 203<br />

Zuijdendorp, H. M. . . . . . . . . . . . . . . . . . . . . . .108<br />

Zuker, Ronald . . . . . . . . . . . . . . . . . . . . . . . . . . .117<br />

çeliköz, Bahattin . . . . . . . . . . . . . . . . . . . . . . . .192<br />

öksüz, Sinan . . . . . . . . . . . . . . . . . . . . . . . . . . . .192<br />

ülkür, Ersin . . . . . . . . . . . . . . . . . . . . . . . . . . . . .192


AAHS Concurrent Scientific Paper Session A<br />

Long Term Outcome Following Scaphoidectomy and Four-Corner Fusion<br />

Institution where the work was prepared: Mayo Clinic, Rochester, MN, USA<br />

David Dennison, MD; Coen Wijdicks; Justin Strickland; Steven Moran; Alexander Shin; Mayo Clinic<br />

INTRODUCTION:<br />

The long term outcome following scaphoidectomy and four-corner fusion (FCF) has received limited investigation and few studies have<br />

included patient rated outcome measures. The purpose of this study was to examine the long-term outcome following FCF with respect<br />

to patient rated outcome measures and to investigate the effect that the method of fixation, age, follow-up period, and radiographic<br />

parameters, have upon outcome measures.<br />

METHODS:<br />

A retrospective review identified patients that underwent a scaphoidectomy and FCF between February 1976 and August 2003. The<br />

Disabilities of the Arm, Shoulder and <strong>Hand</strong> (DASH), Patient Rated Wrist Evaluation (PRWE), and a pain survey were completed by 84 patients.<br />

The mean outcome measure follow-up was 9.6 ± 5.7 years. Outcome measures were compared to method of fixation, age, follow-up period,<br />

and postoperative capitolunate angle. The correlation between outcome scores was examined. Union rates were evaluated and compared<br />

based upon fixation type. Statistical analysis was per<strong>for</strong>med with significance set at alpha less than or equal to 0.05<br />

RESULTS:<br />

The mean DASH score was 23 (SD 19) and the mean PRWE score was 27 (SD 22). Eighty-four per cent of patients reported decreased<br />

pain while 62% still had some degree of pain. There was a significantly higher PRWE score (more impairment) associated with dorsal<br />

circular plate fixation compared to non-plate fixation. There was also a significant decrease in PRWE score with longer follow-up time.<br />

The DASH and PRWE scores correlated well. There were no significant differences in nonunion rates with respect to type of fixation.<br />

CONCLUSION:<br />

Although higher PRWE scores were significantly associated with circular plate fixation, we were not able to detect a difference in union<br />

rates between circular plate fixation and other methods of fixation. The PRWE was able to detect significant findings compared to the<br />

DASH, and should be considered when evaluating patients with isolated wrist dysfunction.<br />

Reconstruction of the TFCC Using ECU Half-Slip and Interference Screw<br />

Institution where the work was prepared: Department of Orthopaedic Surgery, Keio University, Tokyo, Japan<br />

Toshiyasu Nakamura, MD, PhD; Kazuki Sato; Noriaki Nakamichi; Yoshiaki Toyama; Hiroyasu Ikegami; Keio University<br />

PURPOSE:<br />

Since 1998, we treated 33 wrists of ulnar detachment of the TFCC by reconstruction technique using half-slip of the extensor carpi<br />

ulnaris (ECU) tendon with the very small interference screw. We described the technique of the reconstruction and examined our clinical<br />

results of the procedure.<br />

TECHNIQUE:<br />

This technique was indicated to the severe DRUJ instability cases with the avulsion of the TFCC from the ulnar fovea. The ECU half-slip<br />

was harvested and was induced inside the TFCC from the dorsodistal artificial slit of the TFCC to the fovea area. The half-slip was tightly<br />

sutured to the remnant TFCC, then pulled out through the bone tunnel that was made at the center of the fovea by 2.5 mm diameter<br />

drill. The ECU half-slip was subsequently anchored to the ulnar fovea with the small interference screw (Figure). Two weeks long arm<br />

cast was occurred, followed by three weeks of short arm cast.<br />

PATIENTS AND METHODS:<br />

There were 21 right, 10 left and 1 bilateral wrist with an average age of 35.8 years (range 13-68). All complained ulnar sided wrist pain<br />

and severe distal radioulnar joint (DRUJ) instability. The neutral ulnar variance was indicated in 26 wrists and positive in 7. In the positive<br />

variance wrists, the ulnar shortening equalized the abutment be<strong>for</strong>e the reconstruction. Periods from initial injury were 1 month to 48<br />

years. Diagnosis of the TFCC avulsion was done by arthrogram and MRI. Radiocarpal arthroscopy could demonstrate loss of trampoline<br />

effect in all wrists. DRUJ arthroscopy revealed detachment of the radioulnar ligament origin at the fovea in recent 13 cases. Clinical<br />

results were evaluated by pain, range of rotation and DRUJ instability.<br />

RESULTS:<br />

At final follow-up (average 21.5months), 26 wrists indicated no pain and slight pain remained in 7 wrists. Complete re-stabilization of<br />

the DRUJ was noted in 30 wrists, however there remained moderate DRUJ instability in 2 wrists. Severe DRUJ instability remained in 1<br />

wrist. There were 21 excellent, 8 good, 2 fair and 2 poor results. CONCLUSION: This reconstruction technique represented real anatomical<br />

reattachment of the TFCC to the ulnar fovea, which induced excellent DRUJ stability and clinical result. When the TFCC was<br />

detached from the fovea completely and condition of the distal remnant TFCC was relatively secured, this technique is promising.<br />

60


Expression of TGF beta and IL-10 in Rat Hindlimb Composite Tissue Allografts<br />

Institution where the work was prepared: Plastic Surgery, Southern Illniois University School of Medicine, P.O. Box<br />

19653, Sprignfield, IL, USA<br />

Damon Cooney MD, PhD; Chris Chambers; Michael Neumeister<br />

Composite-tissue allografting is in many ways an ideal solution to many of the problems of reconstructive surgery. The major drawback<br />

of this technique is the need <strong>for</strong> immunosuppression and the possibility of rejection. The induction of immunological tolerance has<br />

been seen as critical step in the protection of allogenic tissue from rejection. We propose a novel approach to the induction of allograft<br />

tolerance by modifying the allograft itself. In vitro experiments have demonstrated the ability of cytokines including IL-10 and TGF beta<br />

to produce CD4+, CD25+, foxp3 expressing cells T “regulatory” cells (Treg). These cells may be able to reduce or stop the rejection of<br />

the trans<strong>plan</strong>ted material. By expressing these molecules in the composite tissue allograft we will promote the production of Treg cells<br />

specific to the allograft without disturbing the function of the immune system in the rest of the host animal.<br />

The long term goal of this project is to determine the effect of the over-expression of the cytokines TGF beta and IL-10 on the rejection<br />

of hind limb trans<strong>plan</strong>tation in rats. The first step necessary to achieve this goal is the generation of adenoviral expression vectors<br />

and expression in a composite tissue allograft model. We have created vectors containing GFP alone, TGF beta, IL-10, and TGF beta<br />

and IL-10 combined using the AdEasy adenoviral expression system. The transfection conditions are optimized by establishing a timecourse<br />

of GFP expression. Conditions which yield optimal GFP expression are utilized <strong>for</strong> the remainder of the experiments. Using these<br />

conditions the viral vectors containing the TGF beta and IL-10 genes are expressed and expression verified with immuno-histochemical<br />

staining of biopsies taken from the transduced limbs. We demonstrate the expression levels and location of GFP, TGF beta and IL-<br />

10 using immuno-histochemistry. This demonstrates the ability to over express cytokines of interest within the trans<strong>plan</strong>ted hindlimb<br />

and describes the tissue distribution of expression.<br />

With the ability to express our target cytokines within the trans<strong>plan</strong>ted hind limb future studies will determine the effect they have on<br />

allograft rejection. Trans<strong>plan</strong>ts will involve trans<strong>plan</strong>tation of a limb from a donor Lewis rat onto a Brown Norway recipient rat. The effect<br />

of over-expression of TGF beta and IL-10 on tolerance and rejection will be investigated. The ultimate goal of these studies is the development<br />

of a means of inducing composite tissue allograft tolerance in humans.<br />

61


Is There More Translational Motion after Proximal Row Carpectomy?<br />

Institution where the work was prepared: University of Pittsburgh Medical Center, Pittsburgh, PA, USA<br />

Peter Tang, MD, MPH1; Jean Gauvin, PhD2; Muturi Muriuki, PhD2; Jamie Pfaeffle, MD, PhD2; Joseph Imbriglia, MD2;<br />

Robert Goitz, MD2; (1)Columbia University Medical Center, (2)University of Pittsburgh Medical Center<br />

HYPOTHESIS:<br />

After proximal row carpectomy (PRC) contact pressure increases, contact area decreases and translational motion increases.<br />

METHOD:<br />

• N=6 cadaveric wrists<br />

• Sealed UltraSuperLow Fuji Contact Film was inserted in the radiocarpal joint of the intact wrist and a total <strong>for</strong>ce of 200 N was applied<br />

<strong>for</strong> 60 seconds<br />

• The specimens were tested in neutral, flexion (45 deg) and extension (45 deg)<br />

• The specimens then underwent PRC and the experiment was repeated with SuperLow and Low Fuji film<br />

• The film was scanned and analyzed with a customized MATLAB program to determine contact pressure, area and location<br />

• Multivariable ANOVA with multiple contrast testing as well as t-tests were per<strong>for</strong>med<br />

RESULTS:<br />

• Average pressure significantly increased 320 to 400% after PRC. (p


A Novel Approach <strong>for</strong> Treating Fractures of the Distal Radius<br />

Institution where the work was prepared: Dr Ather Mirza, Smithtown, NY, USA<br />

M. Ather Mirza, MD; M. Ather Mirza, MD, PC; Mary Kate Reinhart, CNP; M. Ather Mirza, MD<br />

INTRODUCTION:<br />

This study reports the outcome of distal radius fractures (DRF) treated with cross pin fixation and a non-bridging external fixator; the CPX System.<br />

METHODS:<br />

Thirty-eight patients (27 females, 11 males) with 40 displaced DRF were treated with the CPX System. Average age was 57 years (range<br />

22-87y). There were 32 intra- and 8 extra-articular fractures. A removable custom splint was applied two to five days post-op. Grip and<br />

pinch strengths and radiologic measurements; radial height, radial inclination, and palmar tilt, were recorded post-operatively at designated<br />

intervals. The Patient Rated Wrist <strong>Hand</strong> Evaluation (PRWHE) and DASH were used <strong>for</strong> subjective outcome analysis.<br />

RESULTS:<br />

Radiologic measurements were maintained throughout healing. Mean wrist ROM at four weeks post-op revealed dorsiflexion 53%,<br />

volarflexion 41%, pronation 85%, supination 55% and at one year; dorsiflexion 95%, volarflexion 87%, pronation 97% and supination<br />

96% compared to the contralateral side. Mean grip strength at six months was 79% of the contralateral side and 100% at one year.<br />

Lateral and precision strengths were 87.5% and 80% at 6 months and 100% and 89% at one year respectfully compared to the contralateral<br />

side. DASH scores revealed a clinically significant improvement in physical function at 4 weeks, 12 weeks, and 1 year. Mean PRWHE<br />

was 21 at 6 months and 10.8 at one year.<br />

CONCLUSION:<br />

The CPX System is a minimally invasive surgical technique <strong>for</strong> stabilization of extra- and intra-articular displaced reducible or non-displaced<br />

DRF. This technique af<strong>for</strong>ds the patient a removable splint <strong>for</strong> early wrist ROM and ADL with maintenance of radiologic measurements.<br />

Radiographic Evaluation of the Distal Radius Using Two Novel Bi<strong>plan</strong>ar "Pitch-And-Roll" Views:<br />

A Cadaveric Study<br />

Institution where the work was prepared: West Virginia University Department of Orthopaedics, Morgantown, WV, USA<br />

Brandon M. Boyce, MD; Jaiyoung Ryu; West Virginia University<br />

PURPOSE:<br />

To compare the use of two bi<strong>plan</strong>ar angled radiographs versus standard posterioanterior (PA) and lateral radiographs in determining<br />

preservation of the articular space with regard to pin placement in the distal radius.<br />

METHODS:<br />

A series of five cadaveric <strong>for</strong>earms were evaluated radiographically at various combinations of inclination (pitch) and clockwise/counterclockwise<br />

rotation (roll) to determine which provided the best view of the distal radius articular surface. Then, smooth k-wires were placed<br />

into the distal radii, stopping proximally to penetrating the subchondral bone, and the radiographic series was repeated. Optimum visualization<br />

of the articular surface presented at 12? inclination plus 15? counterclockwise rotation <strong>for</strong> the PA view and 22? inclination and 15?<br />

counterclockwise rotation <strong>for</strong> the lateral view. Finally, ten cadaveric <strong>for</strong>earms were dissected and ten k-wires were placed at specific surfaces<br />

of the distal radius. The articular surface was penetrated, then each k-wire was countersunk 2mm below the chondral surface so all<br />

k-wires resided within the subchondral bone. Each <strong>for</strong>earm was radiographed in four views; PA, lateral, pitch-and-roll PA (PR-PA), and pitchand-roll<br />

lateral (PR-lateral). Four blinded reviewers evaluated these radiographs; a board certified orthopaedic hand surgeon, a board certified<br />

orthopaedic surgeon, and a fifth year and a third year orthopaedic resident. For each radiograph, reviewers marked whether they<br />

were certain (value=1), relatively certain (value=2), or uncertain (value=3) that the k-wires did not penetrate into the articular space. The data<br />

were then analyzed using logistic fit of uncertainty <strong>for</strong> each view and intraobserver reliability was calculated using contingency Chi-square.<br />

RESULTS:<br />

Reviewers demonstrated significantly less uncertainty about intraarticular penetration (p


Repair of Distal Radial Malunions with Intramedullary Fixation<br />

Institution where the work was prepared: UMDNJ- NJ Medical School, Newark, NJ, USA<br />

John Capo; Damon Ng, MD; Tosca Kinchelow, MD; Virak Tan, MD; UMDNJ- NJ Medical School<br />

PURPOSE:<br />

To evaluate the effectiveness of using an intramedullary im<strong>plan</strong>t combined with osteotomy and grafting <strong>for</strong> treatment of distal radial malunions.<br />

METHODS:<br />

Eleven patients with healed distal radial malunions had surgical correction of their wrist de<strong>for</strong>mities at an average of 7.6 months after<br />

the date of the original fracture. They were all treated with osteotomy, grafting, and fixation with an intramedullary im<strong>plan</strong>t. The im<strong>plan</strong>t<br />

is available in varying sizes, contains three fixed angle screws distally and two locking bolts proximally. Bone graft was taken from the<br />

iliac crest in six patients, locally from the distal radius callous in four patients, and was an injectable calcium-sulfate paste in one. There<br />

were ten dorsal malunions and one volar malunion. Radiographic exam be<strong>for</strong>e the osteotomy revealed an average radial inclination of<br />

20 degrees and an ulnar length of + 3.5mm. The volar tilt <strong>for</strong> the dorsal malunions averaged -13.1 degrees (apex volar), while the volar<br />

malunion measured +28 degrees (apex dorsal). Post-procedure the patients were immobilized with a short arm cast or splint <strong>for</strong> an average<br />

of 4 weeks and then range-of-motion exercises were begun.<br />

RESULTS:<br />

All eleven of the patients healed their osteotomies at an average time period of 7.8 weeks following surgery. Physical exam, at an average<br />

follow-up of 6.1 months, showed wrist flexion of 46 degrees, extension of 59 degrees, <strong>for</strong>earm supination of 75 degrees, and pronation<br />

of 80 degrees. Radiographs post-procedure showed a correction of alignment to the following average values: volar tilt of 2.2<br />

degrees, radial inclination of 22.6 degrees and an ulnar length of 0.4 mm ulnar positive. There were no cases of nerve injury or tendon<br />

irritation, and grip strength averaged 67 % of the contralateral side.<br />

CONCLUSION:<br />

Treatment of distal radial malunions with an intramedullary im<strong>plan</strong>t combined with osteotomy and bone grafting is a viable treatment option.<br />

The intramedullary position of the im<strong>plan</strong>t aids in realigning the anatomy and appears to minimize tendon and hardware problems.<br />

Transosseous Repair of the Triangular Fibrocartilage Complex in Ulnar Sided Lesions; Cadaver<br />

Model and Clinical Series<br />

Institution where the work was prepared: Miami <strong>Hand</strong> Center, Miami, FL, USA<br />

Eduardo Gonzalez-Hernandez, MD; Miami <strong>Hand</strong> Center; Ignacio Garcia-Cepeda, MD; Universidad de Salamanca<br />

INTRODUCTION:<br />

The purpose of this study is to evaluate a technique <strong>for</strong> surgical repair of ulnar sided triangular fibrocartilage complex tears. We produce<br />

a cadaver model <strong>for</strong> complete tears of the TFCC at its insertion into the distal ulna.<br />

MATERIALS/ METHODS:<br />

Our model includes a complete detachment of the triangular fibrocartilage complex from the fovea and the ulnar styloid. The lesion is<br />

repaired using two different techniques: standard arthroscopic technique <strong>for</strong> repair of peripheral TFCC tear and transosseous pull-out<br />

technique <strong>for</strong> reattachment of the TFCC into the fovea and the base of the ulnar styloid. Biomechanical testing consists of measuring<br />

the AP translation of the radius with respect to the ulna when a load of 10 lb. is applied to the specimen reproducing the well known<br />

piano-key test. Testing is done in the intact specimen, and is repeated in the same specimen after the TFCC has been released entirely<br />

from its ulnar insertion. Mechanical testing is then repeated following standard arthroscopically assisted repair and finally in the specimen<br />

following a transosseous repair. Translation of the radius with respect to the ulna was measured in three positions of <strong>for</strong>earm rotation:<br />

neutral, full pronation and full supination. A stability index is developed to reflect the amount of AP translation of the radius with<br />

respect to the ulna. The clinical series consists of 12 patients followed prospectively <strong>for</strong> a minimum of 12 months post operatively. There<br />

is no comparison made to a similarly matched group undergoing a standard repair. All patients had an MRI diagnosis of ulnar sided<br />

avulsion of the TFCC confirmed on arthroscopic evaluation.<br />

RESULTS:<br />

In all instances of our laboratory testing, the stability index was higher following the transosseous repair. The stability index was 10 to<br />

30% higher following transosseous repair than standard repair. In our clinical series, all patients, except one, were asymptomatic and<br />

had returned to their pre-morbid activity. There was one failure in a college athlete who developed recurrent symptoms four months<br />

after returning to competitive swimming. This particular patient has a very significant ulnar minus variant (-4mm) and that anatomic variant<br />

may limit our ability to repair the TFCC.<br />

CONCLUSION:<br />

In the cadaver model we were able to demonstrate significantly improved stability with a transosseous repair and our clinical series show<br />

consistently good outcomes sufficient to warrant further investigation.<br />

64


Wrist Arthrodesis as a Salvage Operation <strong>for</strong> Failed Wrist Im<strong>plan</strong>t Arthroplasty<br />

Institution where the work was prepared: Mayo Clinic, Rochester, MN, USA<br />

Duncan B. Ackerman, MD; Marco Rizzo; Robert Rodrigues; Robert D. Beckenbaugh; Mayo Clinic<br />

INTRODUCTION:<br />

The purpose of this study was to evaluate the clinical utility of wrist arthrodesis as a salvage procedure <strong>for</strong> failed total wrist arthroplasty<br />

(TWA). Arthrodesis can be a successful salvage procedure <strong>for</strong> failed wrist im<strong>plan</strong>t arthroplasty.<br />

METHODS:<br />

Between 1980 and 2006, twenty patients were identified as having undergone wrist arthrodesis <strong>for</strong> salvage of a failed TWA. Data collected<br />

included: im<strong>plan</strong>t type, mode of im<strong>plan</strong>t failure, revisions prior to arthrodesis, method of fusion, the use of allograft or autograft<br />

bone at the time of fusion, rate of union, clinical outcome, and patient satisfaction.<br />

RESULTS:<br />

Twenty wrists in twelve females (80%) and 4 males (20%) underwent TWA at an average age of 56 years (range, 40-78). The average time from<br />

the index arthroplasty to wrist arthrodesis was 8.4 years (range, 7 months-20 years). The average follow-up was 4.1 years (range, 2 months-<br />

21 years). The mode of failure in the majority of wrists were loosening, migration, or instability (n=12, 70%). Three patients (15%) underwent<br />

removal of the components due to infection. Three wrists had undergone a total of 4 revisions prior to the index salvage procedure. The<br />

method of fixation <strong>for</strong> arthrodesis included: Steinmann pins in 10 (50%) wrists, plates and screws in 6 (30%), staples in 2 (10%), external fixation<br />

in one (5%), Steinmann pins and staples in one (5%). Allograft bone was utilized in 11 (55%) wrists and autogenous bone in 9 (45%).<br />

Overall 10 (50%) wrists achieved radiographic union, 7 (35%) had a pseudarthrosis with minimal to no pain, and 3 (15%) had a nonunion.<br />

DISCUSSION:<br />

Bony union was achieved in only 50% of patients who underwent attempted arthrodesis as a salvage procedure <strong>for</strong> a failed wrist arthroplasty.<br />

Despite a relatively low union rate, most patients had clinical improvement with little/no pain at last followup.<br />

65


Osteochondral Resurfacing of Capitate Chondrosis in Proximal Row Carpectomy<br />

Institution where the work was prepared: Western Pennsylvania <strong>Hand</strong> and UpperEx Center, Wex<strong>for</strong>d, PA, USA<br />

Peter Tang, MD, MPH; Columbia University Medical Center; Joseph E. Imbriglia, MD; Western Pennsylvania <strong>Hand</strong> and<br />

UpperEx Center<br />

HYPOTHESIS:<br />

Osteochondral resurfacing of capitate chondrosis in proximal row carpectomy (PRC) can give equal results to standard PRC.†<br />

METHODS:<br />

Patients undergoing PRC who had grade 2 and higher capitate chondrosis, underwent osteochondral resurfacing of the capitate with<br />

grafts harvested from normal cartilage from resected carpal bones.(Fig. 1-3)† Demographic in<strong>for</strong>mation, pre- and post-operative pain,<br />

employment status, ROM, grip strength and modified Mayo wrist scores were assessed.† MRI's were done to evaluate graft incorporation.†<br />

Student's t-test was utilized to detect statistical significant between the pre- and post-operative state.<br />

RESULTS:<br />

N = 8 patients, average age 53.1 years, follow-up 17.7 mos<br />

Pain ñ Pre-op - 87.5% moderate to severe; Post-op - 87.5% mild to no pain (p=0.0005)<br />

Employment - Pre-op - 62.5% regular employment; Post-op - 75.0% regular employment (p>0.05)<br />

ROM ñ Pre-op - 84 degrees (74.0% of the contralateral); Post-op - 75 degrees (66% of the contralateral) (p>0.05)<br />

ROM in previous studies ñ DiDonna 72 deg, Imbriglia 84 deg, Jebson 77 deg, Tomaino 74 deg (1,2,3,4)<br />

Grip Strength ñ Pre-op - 65 lbs or 62% of the contralateral; Post-op - 74 lbs or 71% of the contralateral (p>0.05)<br />

Grip Strength in previous studies ñ DiDonna 91%, Imbriglia 80%,† Jebson 83%, Tomaino 79%. (1,2,3,4)<br />

Mayo wrist score ñ Pre-op ñ 51 = poor result; Post-op - 68 = fair result (p=0.01)<br />

Radiographic degeneration - 75% of patients had mild to no degeneration.<br />

MRI's showed graft incorporation (Fig. 4)<br />

SUMMARY:<br />

Our results compare favorably to the literature on PRC, showing that osteochondral grafting in PRC per<strong>for</strong>ms as well as standard PRC<br />

in terms of pain relief, employment status, ROM and grip strength.† Autogenous osteochondrondral grafting is a proven technique<br />

which we have applied to the PRC wrist <strong>for</strong> the first time.† If this procedure proves effective, the hand surgeon will have another option<br />

to treat wrist arthritis, specifically PRC when there is capitate chondrosis.<br />

REFERENCES:<br />

1. DiDonna ML. J Bone Joint† Surg 2004;86A:2359-2365.<br />

2. Imbriglia JE. J <strong>Hand</strong> Surg 1990;15A:426-430.<br />

3. Jebson PJL. J <strong>Hand</strong> Surg 2003;28A:561-569.<br />

4. Tomaino MM. J <strong>Hand</strong> Surg 1994;19A:694-703.<br />

Fig. 1 Capitate chondrosis found on capitate after PRC.<br />

Fig. 2 Graft pictured next to lunate.<br />

Fig. 4 Post-operative MRI at 21.3 mos from surgery reveals<br />

graft incorporation. Arrow indicates graft.<br />

Fig. 7 Capitate after osteochondral graft placement.<br />

66


Post-Operative Complications Of Arthroscopic TFCC Repair<br />

Institution where the work was prepared: University of Toledo, Toledo, OH, USA<br />

Ian Rodway, MD; Martin C Skie; Despina E Ciocanel; University of Toledo<br />

PURPOSE:<br />

Wrist arthroscopy is frequently used in the diagnosis and treatment of traumatic injuries to the wrist, including repair of the triangular<br />

fibrocartilage complex (TFCC) tears. Our purpose was to determine the incidence of complications after arthroscopic repair of Palmer<br />

1B TFCC tears and to compare the results with data from the literature.<br />

METHODS:<br />

In order to determine the incidence of complications after arthroscopic repair <strong>for</strong> Palmer 1 B TFCC tears, we retrospectively reviewed<br />

the records of 67 consecutive patients, 35 males and 32 females. All patients underwent arthroscopic repair using zone specific cannula<br />

and the inside-out repair method. The mean patient age was 34 years, with a range of 14 to 59 years. The mean follow-up <strong>for</strong> these<br />

67 patients was 17 months.<br />

RESULTS:<br />

The results of arthroscopic repair were compared and analyzed based on their complications. Transient paresthesis within the distribution<br />

of the dorsal sensory branch of the ulnar nerve was the most frequent complication (49 %). Six patients (9%) were complicated with<br />

ulnar nerve irritation (3 sensory paresthesia involving the ring and small fingers, 2 mild cubital tunnel syndromes and 1 ulnar motor neuropathy).<br />

9 patients had residual instability of DRUJ ( distal radio-ulnar joint) and one patient had infection. 12 patients (18%) underwent<br />

ulnar shortening following arthroscopic TFCC repair <strong>for</strong> treatment of continued pain, one of them having bilateral ulnar shortening.<br />

CONCLUSION:<br />

82% of our reported complications following TFCC tears arthroscopic repair were minor or transient. No previous study described transient<br />

paresthesia as a complication of arthroscopic TFCC repairs. This complication was related to the suture knots near dorsal branches<br />

of the sensory branch of ulnar nerve. Our results confirm similar findings (Hulsizer et al) that recommend an ulnar-shortening osteotomy<br />

<strong>for</strong> unsuccessful arthroscopic debridement in eliminating ulnar-sided wrist pain. Overall the success rate of arthroscopic repair in our<br />

study was similar with previous studies.<br />

Scaphoid Excision and Limited Wrist Fusion: A Comparison of K-wire and Circular Plate Fixation<br />

Institution where the work was prepared: Des Moines Orthopaedic Surgeons, West DesMoines, IA, USA<br />

Jeff Rodgers, MD1; Gary Holt, MD2; Edward Finnerty, PhD3; Blake Miller, BS3; (1)Des Moines Orthopaedic Surgeons,<br />

(2)Iowa Radiology, (3)Des Moines University<br />

HYPOTHESIS:<br />

Recent reports suggest that circular plate fixation <strong>for</strong> Scaphoid excision and limited wrist fusion is inferior to traditional methods. While<br />

implicating the circular plate im<strong>plan</strong>t as the major cause of complications and failure, these studies failed to control <strong>for</strong> important variables<br />

including the source of bone graft, surgical technique of multiple surgeons and patient factors that may have influenced the selection<br />

of the im<strong>plan</strong>t.<br />

The purpose of this study is to compare the clinical outcome, union rate and complications of Scaphoid excision and limited wrist<br />

arthrodesis per<strong>for</strong>med by a single surgeon using distal radius bone graft and k-wires or distal radius bone graft and circular plate fixation.<br />

METHODS:<br />

A sequential series of 12 wrists (eleven patients) that were stabilized with temporary k-wires were compared to 12 patients who were stabilized<br />

with a circular plate. Minimum follow up was 1 year. One patient in the K-wire group was converted to a wrist fusion. 6 of the remaining<br />

10 patients in the K-wire fixation group and 8 of the 12 patients in the Circular Plate fixation group returned <strong>for</strong> the following blinded<br />

evaluations: Quick DASH, Analog Pain Scale, Range of Motion, Strength measurement, plain x-ray and Multi Detector CT evaluation.<br />

RESULTS/STATISTICS:<br />

Data was analyzed using SPSSÆ 14.0. The independent measures t-test was used <strong>for</strong> functional tests, two-factor ANOVA procedure <strong>for</strong><br />

ROM and Strength parameters and Pearson correlation was used to assess the CL-angle with ROM. Power and appropriate measures<br />

of size effect were determined where indicated.<br />

One non-union occurred in the K-wire group. There were no non-unions in the circular plate fixation group. There was no difference in<br />

any of remaining measures or rate of complications.<br />

Cost analysis assuming a return to the OR <strong>for</strong> k-wire removal reveals an overall cost of care savings of $1975 using circular plate fixation.<br />

SUMMARY POINT:<br />

Based on this Sequential Cohort with careful control of non-im<strong>plan</strong>t related variables, the use of a Circular Plate Device is equivalent in<br />

efficacy and more cost effective than K-wires <strong>for</strong> Scaphoid excision and limited wrist fusion.<br />

67


The volar aproach <strong>for</strong> fractures of the distal radius: 100 patients analysis<br />

Institution where the work was prepared: Faculdade de Medicina do ABC, Santo Andre, Brazil<br />

Marcio A. Aita, MD1; Gustavo M. Ruggiero, MD1; Alvaro B. Cho, MD1; Walter Y. Fukushima, MD1; W. Lino Jr, MD2;<br />

Fabiano N. Faria, MD2; (1)Faculdade de Medicina do ABC, (2)Beneficencia Portuguesa Hospital<br />

ABSTRACT<br />

We review the results of 100 patients with distal radius fractures treated surgically by the volar aproach and fixation with fixed-angle volar<br />

plate, since march 2002 to december 2005. The indications were: instability only (17%), instability and articular displacement (72%), articular<br />

displacement only (5%) , contralateral upper limb fracture (3%) and refusal of non-operative treatment by the patient (3%). There was<br />

58% female and 42% male, age was 46,8 years (11 to 81 years). Radiographic averages results after surgery shows Dorsal Tilt of ñ 8o (2o<br />

to -18o), Radial Inclination of 19o (-8o to 24o), Radial Shortening of 0,5mm (0mm to 6mm) and articular surface displacement of 0,13mm<br />

(0mm to 1mm). Compared to the contralateral wrist we found the Dorsal Tilt correction of 97% (70% to 100%) and Radial Inclination correction<br />

of 95% (65% to 100%). The flexion-extension range of motion was 144o again 147o of oppositive side (98% of normal ROM), pronation-supination<br />

ROM was 176o again 177o of contralateral limb (99% of normal ROM) and radial-ulnar deviation of 41o again 45o of other<br />

wrist (91% of normal ROM). According Gartland score we found 86% of excellent, 10% good and 4% fair results. There were 2 infections,<br />

and 2 patients with loosening of reduction. Fracture healing occurs at an average 8 weeks time in all patients. We consider the volar<br />

aproach and fixation with volar fixed-angle plates the best treatment choice <strong>for</strong> fractures of the distal radius when surgical treatment is<br />

indicated. This can lead to lower rates of complications and improved functional and radiographic results compared to other techniques.<br />

Mechanical Effect of Metaphyseal Plate Stand-off in Radius Volar Plates<br />

Institution where the work was prepared: University of Arkansas, Little Rock, AR, USA<br />

Randy R. Bindra, MD, FRCS; Sivathan Kumar; William R Hogue; University of Arkansas <strong>for</strong> Medical Sciences<br />

PURPOSE:<br />

Volar fixation with a locking plate has become the standard of care <strong>for</strong> operative management of dorsally unstable distal radius fractures.<br />

Traditional locking plates are based on screws locking into the plate upon tightening ñ the plate is not compressed against the<br />

metaphysis and may stand off. The purpose of this study was to examine the mechanical effect of plate stand-off from the radius metaphysis<br />

in an unstable radius fracture model. To our knowledge, this has not been previously examined.<br />

METHODS:<br />

An unstable extra-articular distal radial fracture was simulated using a Sawbones foam model by excising a 5mm dorsal wedge 2 cm<br />

from the distal articular surface. Group 1 specimens (n=5) were fixed with a locking volar plate (DVO, IN) with the plate flush against the<br />

specimen. In Group 2 (n=5),the plate was fixed with a 4mm standoff from the distal metaphysis. The specimens were vertically loaded<br />

to failure at the rate of 0.1 mm/s using a servo-hydraulic machine (MTS Systems MN) and the stiffness, yield point and load to ultimate<br />

failure were recorded.<br />

RESULTS:<br />

Axial loading resulted in fracture collapse followed by fixation failure at the most proximalscrew hole. The point of initial yield was similar<br />

in both groups(group 1: 562 (+26) N; group 2: 549 (+48) N). The specimens in group I failed at a higher ultimate load of 1337 (+162)<br />

N compared to 1179 (+246) N in group II but this difference did not reach statistical significance. The specimens in group 1 were significantly<br />

stiffer at 485 (+79) N/mm versus 366 (+55) N/mm in group 2 where the plate had a 4 mm standoff (p=0.026).<br />

SUMMARY:<br />

Failure to seat a volar plate flush against the radius metaphysis reduces stiffness and may clinically result in fracture collapse with early<br />

mobilization. Newer plate designs that utilize alternative locking technology instead of threaded plate holes such as the "CoverLoc"<br />

plate may be advantageous as they allow plate compression against the metaphysis during screw insertion.<br />

68


Surgical Management of Post-traumatic Elbow Contractures in the Adolescent Patient<br />

Population: Principles and Outcome<br />

Institution where the work was prepared: Allegheny General Hospital, Pittsburgh, PA, USA<br />

Alexander H. Payatakes, MD; Nickolaos A Darlis; Robert W Kaufmann; Dean G Sotereanos; Allegheny General Hospital<br />

INTRODUCTION:<br />

Contracture is a common sequela of elbow trauma which often responds poorly to conservative management, even in the pediatric<br />

and adolescent patient population. The literature concerning results of surgical management in this group is limited and has suggested<br />

a less favorable outcome compared to adults.<br />

PURPOSE:<br />

To present our experience with surgical treatment of post-traumatic elbow contractures in adolescents using a consistent management<br />

protocol.<br />

MATERIALS/ METHODS:<br />

Our records were retrospectively reviewed to identify adolescent patients that underwent open release of post-traumatic elbow contractures.<br />

Charts were reviewed <strong>for</strong> data concerning age, initial injury, prior management, and surgical procedure per<strong>for</strong>med. A modified<br />

lateral column approach was utilized in all cases to per<strong>for</strong>m an anterior joint release, as well as additional posterior release if necessary.<br />

Medial-sided pathology was addressed through a separate medial approach. Supervised therapy was initiated within the first<br />

postoperative week. Prophylaxis <strong>for</strong> heterotopic ossification was not routinely administered. Preoperative and postoperative evaluation<br />

included range of motion, pain, other associated symptoms, radiographic findings, and complications.<br />

RESULTS:<br />

Twelve adolescent patients (mean age 16.7 years, range 13-21) with open release of elbow contractures secondary to fracture and/or<br />

dislocation were evaluated. Mean preoperative flexion and extension was 113? and -51? respectively, with severely limited rotation in 4<br />

cases. Anterior release was per<strong>for</strong>med in all cases, with supplemental posterior release in four. Radial head excision was per<strong>for</strong>med in<br />

three cases to improve <strong>for</strong>earm rotation. An additional medial approach was necessary in three patients. Mean follow-up was 25.8<br />

months (range 18-42 months). All patients obtained a functional arc of at least 100? (mean 114?), with a mean gain of 56? in the flexionextension<br />

arc (p


AAHS Concurrent Scientific Paper Session B<br />

Injectable Collagenase Enzyme (AA4500) in Dupuytren's Contracture: Clinical Success in<br />

Patients with Concomitant Diabetes<br />

Institution where the work was prepared: SUNY at Stony Brook, Stony Brook, NY, USA<br />

Marie Badalamente, PhD; Lawrence C. Hurst; SUNY-Stony Brook<br />

INTRODUCTION:<br />

In phase II and III controlled clinical trials, injectable collagenase enzyme (AA4500, Auxilium Pharmaceuticals, Inc.) has been shown to<br />

be an effective nonsurgical treatment <strong>for</strong> improving finger joint function in patients with Dupuytren's contracture (DC), a progressive<br />

fixed flexion de<strong>for</strong>mity associated with abnormal collagen synthesis. The prevalence of DC is 3 to 4 times greater in diabetic patients<br />

than in nondiabetic patients. In the US, diabetes occurs in almost 10% of people aged 20 years and older, and increases to nearly 21%<br />

after age 60.<br />

METHODS:<br />

A post hoc analysis was per<strong>for</strong>med to compare efficacy and safety of AA4500 in the treatment of DC in diabetic (n=17) and nondiabetic<br />

(n=108) patients in one phase II trial and one phase III clinical trial. Clinical success was defined as correction of metacarpophalangeal<br />

(MP) and/or proximal interphalangeal (PIP) joint contractures to 0 to 5 degrees extension (normal=0 degrees) following treatment with<br />

1 to 3 injections of 0.58 mg AA4500 into the cords affecting MP or PIP joints. Tolerability was evaluated from adverse events (AEs) recorded<br />

<strong>for</strong> diabetic and nondiabetic patients with DC receiving AA4500 or placebo injections.<br />

RESULTS:<br />

Overall clinical success rates were 58.3% <strong>for</strong> 24 joints treated in 17 diabetic patients with DC, and 74.7% <strong>for</strong> 146 joints treated in 108<br />

nondiabetic patients with DC. Success rates were lower <strong>for</strong> diabetic patients than <strong>for</strong> nondiabetic patients (64.3% vs 87.3% <strong>for</strong> the MP<br />

joint; 50% vs 62.7% <strong>for</strong> the PIP joint). In diabetic patients, success rates were 33.3% (n=3), 61.5% (n=13), and 62.5% (n=8) <strong>for</strong> middle, ring<br />

and little finger joints, respectively, and 87.5% (n=16), 75% (n=44), and 70.4% (n=81) <strong>for</strong> middle, ring and little finger joints, respectively,<br />

in nondiabetic patients. Treatment-related AEs were similar <strong>for</strong> diabetic and nondiabetic patients who received at least 1 injection of<br />

AA4500. The 5 most common AEs were hand edema (76.5% vs 84.3%), ecchymosis (58.8% vs 62%), tenderness (58.8% vs 50%), injection<br />

site pain (35.3% vs 31.5%), and elbow and/or axillary lymphadenopathy (23.5% vs 25.9%) <strong>for</strong> diabetic and nondiabetic patients,<br />

respectively.<br />

DISCUSSION:<br />

Marked improvements in correction of joint contractures and joint function were achieved <strong>for</strong> diabetic and nondiabetic patients with<br />

DC following treatment with AA4500. Although the clinical success rate was lower <strong>for</strong> diabetic than nondiabetic patients, this nonsurgical<br />

approach provides an important alternative in a population more prone to surgical complications. AA4500 had the same tolerability<br />

profile in both groups in this study.<br />

70


Clinical Outcome in Dupuytren's Disease Correlates with Proteinase Gene Expression<br />

Institution where the work was prepared: University of East Anglia and Norfolk & Norwich Hospital, Norwich, United Kingdom<br />

Phillip Johnston, MA, MRCS1; Debbie Larson2; Adrian J. Chojnowski, MA, FRCS, (Orth)2; Ian M. Clark, PhD3;<br />

(1)Addenbrooke's Hospital, (2)Norfolk & Norwich University Hospital, (3)University of East Anglia<br />

INTRODUCTION:<br />

We have previously demonstrated that gene expression levels of matrix metalloproteinases (MMPs), related metalloproteinases<br />

ADAMTSs and tissue inhibitors of metalloproteinases (TIMPs) differ when comparing palmar fascia from 20 patients with Dupuytren's<br />

Disease (DD) to 20 disease-free controls (carpal tunnel syndrome) [1].<br />

MATERIALS/METHODS:<br />

All of the patients with DD were followed up <strong>for</strong> at least 12 months from their primary fasciectomy. Clinical outcome was scored by<br />

measuring range of movement to assess total extension deficit (fixed flexion de<strong>for</strong>mity of the affected digit), total further flexion and<br />

grip strength. Three validated outcome scores, the DASH (disability of arm, shoulder and hand), MHQ (Michigan <strong>Hand</strong> Questionnaire)<br />

and the Vancouver Scar Scale were also used.<br />

RESULTS:<br />

There was a significant correlation between levels of gene expression of several of the MMPs and ADAMTSs and the change in total extension<br />

deficit. Interestingly, all of these genes were up-regulated in DD samples compared with controls. In particular, greater expression levels<br />

of MMP-13 (Collagenase 3), MMP-14 and ADAMTS-14 (procollagen N-propeptidase) were correlated with greater extent of recurrence.<br />

CONCLUSION:/ CLINICAL RELEVANCE:<br />

These findings suggest that gene expression levels of certain key MMPs and ADAMTSs could be used to predict the recurrence of fixed<br />

flexion de<strong>for</strong>mity of the affected finger following fasciectomy <strong>for</strong> DD at one-year follow-up. This study there<strong>for</strong>e provides further evidence<br />

to support the link between metalloproteinase activity and DD progression.<br />

REFERENCE:<br />

1. Johnston P, Chojnowski AJ, Davidson RK, Riley GP, Donell ST, Clark IM. A complete expression profile of matrix-degrading metalloproteinases<br />

in Dupuytren's disease. J <strong>Hand</strong> Surg [Am]. 2007; 32 (3): 343 - 51<br />

Amputation Versus Reconstruction in Severe Crush Injuries of the Upper Limb<br />

Institution where the work was prepared: UMF Iuliu Hatieganu, Plastic and Reconstructive Microsurgery Clinic, Cluj<br />

Napoca, Romania<br />

Alexandru Georgescu, Prof, MD, PhD; Filip Ardelean MD; Ileana Matei; Irina Capota MD<br />

INTRODUCTION:<br />

Severe crush traumas, un<strong>for</strong>tunately still happening very frequently, are in many cases accompanied by great tissue defects. The question<br />

that naturally rises is: when and how can we decide to conserve a completely destroyed limb segment? Certainly, there are cases<br />

in which the amputation per primam is much more profitable from economical point of view. The problem is whether a patient will benefit<br />

more in the future from a more or less per<strong>for</strong>ming prosthesis or from conserving a segment, even with the price of a reduction in<br />

functionality. Because the majority of patients choose the second possibility, in our service we established a protocol concerning the<br />

when we should try to preserve the crushed segment. The study in this paper is based on our experience on more then 450 cases.<br />

MATERIAL AND METHOD:<br />

In the last 10 years we treated in our service more then 450 cases with severe crush injuries of the upper limb, including complete and<br />

incomplete amputations, large soft tissue destructions and extensive bone defects. We per<strong>for</strong>med amputation from the beginning in<br />

only 5 cases. In the remaining cases we tried to preserve the crushed segments. In more then half of them we proceeded to emergency<br />

all-in-one reconstruction, and in the remaining cases we reconstructed and covered the tissue defects after 24-48 hours. In covering the<br />

tissue defects we used different types of free or local flaps, mostly per<strong>for</strong>ator flaps.<br />

RESULTS:<br />

The post-surgery evolution of the 5 cases when we amputated per primam was without incidents. We lost only 2 re<strong>plan</strong>ted segments,<br />

the rest being fully integrated; the sooner we per<strong>for</strong>med the reconstruction, the better the results were and the lower the degree of<br />

bacterial contamination.<br />

CONCLUSIONS:<br />

Although there are still many discussions regarding the abandonment or the preservation of the severely crushed limbs, considering<br />

the modern techniques of reconstruction and covering with flaps, we think that even when we are dealing with highly destroyed segments,<br />

we should try first to preserve them.<br />

71


A Comparison Study of Preliminary Soft Tissue Distraction vs. Check Rein Ligament Release<br />

in the Treatment of Dupuytren's PIP Joint Contracture<br />

Institution where the work was prepared: Mayo Clinic Hospital Arizona, Phoenix, AZ, USA<br />

Aaron Klomp, MD; Grant Fankhauser; Anthony Smith; Alanna Rebecca; Scott Duncan; Mayo Clinic Arizona<br />

HYPOTHESIS:<br />

Check rein ligament release (CRLR), the standard treatment <strong>for</strong> PIP joint contracture in Dupuytren's disease, does not address: 1) the<br />

shortened neurovascular bundle, and 2) the insufficient skin envelope, particularly in re-operated cases. The Digit-WidgetÆ (DW) uses<br />

soft-tissue distraction to overcome these problems. The purpose of this study is to compare our operative experience in treating<br />

Dupuytren's PIP joint contractures with a CRLR to treating Dupuytren's PIP joint contractures with preliminary placement of the Digit-<br />

WidgetÆ followed by operative release.<br />

METHODS:<br />

Twenty-three patients (29 digits) were treated. There were 19 men and 4 women. Age ranged from 45 to 81 years. Twenty digits underwent<br />

CRLR <strong>for</strong> flexion contractures from 10-80 degrees (mean=52.4). Six (30%) were re-operations. Five of these six required full thickness<br />

skin grafts (FTSG). Nine digits were treated with DW distraction <strong>for</strong> flexion contractures from 30-90 degrees (mean=66.7). Three<br />

(33%) were re-operations<br />

RESULTS:<br />

Twenty CRLR digits had an average of 27.7 (range -48 to 70) degrees of improvement in active PIP joint extension. Digits treated with<br />

DW distraction and release had an average of 44.1 (range 12-73) degrees of improvement in active PIP joint extension. Two DW-treated<br />

digits improved to full PIP extension without residual contracture and were not released. Mean improvements <strong>for</strong> re-operated digits<br />

treated by CRLR or DW distraction were 32 and 52 degrees respectively. Two of the CRLR re-operated digits had partial loss of the<br />

FTSG. Primarily treated digits with CRLR or DW distraction improved PIP extension by means of 16 and 34 degrees. For contractures<br />

under 30 degrees, CRLR worsened the contracture by a mean of 13 degrees while DW distraction improved the contracture by a mean<br />

of 12 degrees. Contractures between 30 and 60 degrees treated by CRLR or Digit-Widget distraction improved by means of 30 and 28<br />

degrees, respectively. Contractures over 60 degrees treated by CRLR or DW distraction improved extension by means of 30 and 55<br />

degrees respectively.<br />

SUMMARY:<br />

Digit-WidgetÆ soft tissue distraction followed by operative release showed greater correction of the contractures than CRLR <strong>for</strong> both<br />

primarily treated and re-operated groups. ï Preliminary soft tissue distraction is particularly effective in contractures greater than 60<br />

degrees. ï In re-operated digits the CRLR technique is more likely to worsen than improve the PIP joint contracture. ï Use of the Digit<br />

WidgetÆ obviated the need <strong>for</strong> a FTSG <strong>for</strong> wound closure in re-operated digits.<br />

72


The Spiral Flap <strong>for</strong> Fingertip Resurfacing: Short- and Long-Term Results<br />

Institution where the work was prepared: Singapore General Hospital, Singapore, Singapore<br />

Gale Lim, MBBS, MRCS, MMed; Andrew Yam, MBBS, MRCSEd, MM; Jonthan YL Lee, MBBS, MRCSEd, MM; Lc Teoh,<br />

MBBS, FRCS, FAMS; Singapore General Hospital<br />

PURPOSE:<br />

We describe a new homodigital neurovascular island flap <strong>for</strong> reconstructing large pulp defects of the fingertips and review the shortand<br />

long-term appearance and function of the reconstructed fingertips.<br />

METHODS:<br />

The ìspiral flapî is a homodigital neurovascular island flap with a unique spiral advancement and transposition design that allows pulp reconstruction<br />

using sensate glabrous skin while restricting donor morbidity to the injured digit. 32 fingertips were resurfaced using this flap. All<br />

had large volar unfavourable pulp defects averaging 1.2 cm wide x 2.0 cm long (1.0 to 2.0 by 1.5 to 2.5cm). Short-term results <strong>for</strong> all patients<br />

at a minimum of 6 months and long-term results <strong>for</strong> 10 patients with a follow-up of 13.4 years were reviewed. Objective outcome measures<br />

included static two-point discrimination, degree of nail de<strong>for</strong>mity (beaking), total active motion and hypersensitivity or cold intolerance.<br />

Subjective outcome measures included patient satisfaction with function and aesthetics, using a visual analog scale.<br />

RESULTS:<br />

All flaps achieved primary healing with no complications. There was initially mild extension deficit in the PIP and DIP joints, which<br />

improved to full range of motion in the long term. Sensory recovery was excellent with an average 2-point discrimination of 5 mm initially,<br />

improving to 3.7mm in the long term. Nail beaking was minimal initially, but increased significantly in the long-term. These results<br />

may be explained by soft tissue remodeling. All patients on long-term follow up were highly satisfied with both aesthetic and functional<br />

outcome. There was no hypersensitivity or cold intolerance at either the short term or long term follow up assessments.<br />

CONCLUSION:<br />

The spiral advancement-transposition flap is suitable <strong>for</strong> resurfacing large pulp defects with excellent short- and long-term functional<br />

and aesthetic results, and high patient satisfaction.<br />

Analysis of Limited Wyndell Merritt Splint <strong>for</strong> Extensor Tendon Injuries to <strong>Hand</strong> Immobilization<br />

Institution where the work was prepared: SIU School of Medicine, Springfield, IL, USA<br />

Nada Berry, MD; Michael Neumeister; SIU School of Medicine<br />

INTRODUCTION:<br />

The Wyndell-Merritt (relative motion) splint has been used effectively <strong>for</strong> extensor tendon lacerations. We have been treating extensor<br />

tendon injuries with the yoke splint without wrist immobilization with good clinical results. This study compares range of motion (ROM)<br />

of the injured finger to previously published results, as well as ROM <strong>for</strong> the digits treated with a traditional Wyndell-Merritt splint<br />

METHODS:<br />

A retrospective chart review was per<strong>for</strong>med <strong>for</strong> two groups of patients treated over the last six years <strong>for</strong> complete extensor lacerations.<br />

Group A was treated with a relative motion hand splint only, while group B was immobilized at the wrist. Both groups of patients were<br />

treated with the same method of tendon repair, and were initially placed in a static splint. On follow-up, a controlled relative motion<br />

splint was fabricated and hand therapy commenced. The ROM figures were collected and analyzed. Two patients in group A were<br />

excluded and one patient was excluded from group B<br />

RESULTS:<br />

Fourteen patients were included in group A and 7 patients in group B. The average duration of treatment <strong>for</strong> both groups was 45 days.<br />

The average time of motion splint application <strong>for</strong> group A was 8.8 days post-operatively and 9.8 days <strong>for</strong> group B. Group A had 5 index,<br />

7 long, 1 ring, and 2 small finger injuries that included 1 zone IV, 11 zone V, and 2 zone VI injuries. Group B had 3 index, 3 long, and 1<br />

ring finger that included 2 zone IV, 3 zone V and 2 zone VI tendon lacerations. The ROM at conclusion of hand therapy was 230.4 and<br />

230.7 degrees of flexion <strong>for</strong> groups A and B respectively. The average extensor lag <strong>for</strong> group A was 7.5 and 10.7 degrees <strong>for</strong> group B.<br />

One patient in each group required tenolysis <strong>for</strong> the complaint of skin adhesion.<br />

CONCLUSION:<br />

Limiting the Wyndell-Merritt splint to the hand and not immobilizing the wrist has produced good clinical results <strong>for</strong> patients with complete<br />

EDC injuries in zones IV through VI. ROM <strong>for</strong> the patients treated with yoke splint only is the same as those treated with wrist<br />

splinting, and is comparable to previous studies with a traditional Wyndell-Merritt splint. The extensor lag is better <strong>for</strong> patients with a<br />

mobile wrist. These results support the use of a hand-based relative motion splint <strong>for</strong> treatment of zone IV, V, and VI extensor tendon<br />

lacerations.<br />

73


Comparison of FiberLoop and Supramid in Zone II Flexor Tendon Repair Using a Cyclic Protocol<br />

Institution where the work was prepared: Cleveland Clinic, Cleveland, OH, USA<br />

Aaron Anderson, MD; S. Chase Donnelly; Richard Drake, PhD; Kathleen Derwin, PhD; Jeff Lawton, MD; Cleveland Clinic<br />

INTRODUCTION:<br />

Many suture methods and materials are used <strong>for</strong> zone II flexor tendon repairs. The ideal repair should be strong enough to allow early<br />

range of motion while facilitating tendon glide through the pulley system. The purpose of this study was to investigate the differences<br />

in gap <strong>for</strong>mation and failure load between FiberLoop (Arthrex Inc., Naples, FL) and Supramid (S. Jackson Inc., Alexandria, VA) sutures<br />

in zone II flexor tendon repairs using a human cadaveric model under cyclic loading.<br />

METHODS:<br />

Twenty paired flexor tendons from human, cadaveric hands were used to test the repair strength of FiberLoop versus Supramid suture.<br />

FDP Tendons were obtained from the ring, middle, and index fingers, transected in zone II, and repaired with either 4-0 FiberLoop or<br />

4-0 looped Supramid suture using a standard 8-strand cruciate repair technique followed by a running epitendinous 6-0 prolene suture.<br />

The repaired tendons were then clamped and mounted on a material testing system (MTS, Eden Prairie MN) preloaded to 2N and<br />

cycled 8000 times between 2N and 25N at a frequency of 1 Hz. Specimens were then pulled at a rate of 12mm/min until failure, defined<br />

as either the maximum load or a point corresponding to a drop in load of 10% or more of maximum during the failure test. Suture markers<br />

were placed on both sides of the repair site to analyze gap <strong>for</strong>mation across the repair during testing with an optical system.<br />

Outcome measures included gap <strong>for</strong>mation at 8000 cycles and failure load. Statistical differences were analyzed using a paired t-test<br />

(p


Deep Inferior Epigastric Artery Graft <strong>for</strong> Raynaud's Disease<br />

Institution where the work was prepared: Hee Chang Ahn, Seoul, South Korea<br />

Hee-Chang Ahn, MD1; Steven Bates, MD2; Scott L. Hansen2; Neil F. Jones2; (1)Hanyang University Hospital, (2)UCLA<br />

HYPOTHESIS:<br />

To examine the use of the deep inferior epigastric artery (DIEA) graft <strong>for</strong> reconstruction of occluded ulnar or radial arteries in patients<br />

with Raynaud¢ÆØs disease.<br />

METHODS:<br />

We evaluated eight patients (6 female, 2 male) who had undergone digital sympathectomy and interposition of a DIEA graft <strong>for</strong> ulnar<br />

or radial artery occlusion from August 2004 to July 2006.† The mean age was 39.2 y.o. (range 31 to 58). Three patients underwent arterial<br />

grafts on bilateral hands (11 grafts).† 10 grafts were <strong>for</strong> ulnar artery and 1 <strong>for</strong> radial artery reconstruction.<br />

We evaluated subjective symptom improvement such as ischemic pain and Raynaud¢ÆØs phenomena, and objective measures such<br />

as angiograms, pre- and postoperative color Doppler vascular flow, thermoscan and ulceration on the finger tips.† All patients received<br />

periarterial sympathectomy.† The DIEA graft was harvested through a 10 cm transverse incision on the lower abdomen. Vascular anastomosis<br />

was per<strong>for</strong>med with 10-0 ethilon sutures.<br />

RESULTS:<br />

Following arterial reconstruction, immediate perfusion of the digits was obvious. Patients were evaluated at 6 and 12 months <strong>for</strong> symptom<br />

relief and vascular flow using a Doppler.† All patients showed the improvement in the subjective symptoms and wound healing.† Doppler<br />

evaluation revealed excellent vascular reflow through grafted artery in 7 cases, moderate flow in 2 cases, and scant flow in 2 cases.<br />

SUMMARY:<br />

Vascular reconstruction with a DIEA graft provided vascular reflow and improved wound healing. Two of 11 (18%) arterial grafts seemed<br />

to be narrowed or occluded in post operative follow-up, although subjective symptoms were improved with rapid wound healing in all<br />

cases. We suggest that the DIEA graft has several advantages in donor site morbidity including scar location, good match in size <strong>for</strong><br />

arterial reconstruction at wrist (proximal) and common digital arteries at the palmar arch (distal), and good long-term patency rates.<br />

Fig. 1. Deep inferior epigastric artery with several braches<br />

that can be used <strong>for</strong> palmar arch and common digital artery<br />

The Use of Dermal Substitutes in Burn Scar Contracture Releases to the <strong>Hand</strong> and Upper Extremity<br />

Institution where the work was prepared: Indiana University, Indianapolis, IN, USA<br />

Madeline Zieger, PA1; David Roggy, RN2; Rajiv Sood, MD, FACS1; (1)Indiana University, (2)Richard M. Fairbanks Burn Center<br />

Numerous options exist <strong>for</strong> soft tissue coverage of the upper extremity following contracture release. Recently, a number of dermal substitutes<br />

have become available <strong>for</strong> coverage of wounds in the upper extremity obviating the need <strong>for</strong> more complex reconstruction.<br />

We report our experience, with the use of AlloDerm and Integra dermal substitutes, in 40 patients (32 adults and 8 children) from 1998<br />

to the present. AlloDerm is freeze-dried dermal homograft, which provides an acellular matrix of dermal elements (collagen and GAGs).<br />

Integra is bilaminar structure with cross-link bovine collagen with an overlying silicone epidermis. Thick AlloDerm is applied to the soft<br />

tissue release site and simultaneously covered with a thin autograft (.006-.008 inches). Integra is applied directly to the wound bed and<br />

the patient is returned to the operating room <strong>for</strong> delayed autografting. Both dermal substitutes are covered with a VAC device. Forty<br />

patients had AlloDerm (55 sites) and Integra (19 sites) applied following hand and upper extremity contracture release (see table 1).<br />

Thirty-five of the <strong>for</strong>ty patients had successful wound healing with increased active range of motion to the contracture release site (see<br />

table 1). Four patients required additional surgical procedures due to re-contracture caused by non-compliance with physical and occupational<br />

therapy (2 axillas, 1 elbow, and 1 wrist) and one patient required additional skin grafting due to a non-healing wound to an<br />

elbow release site. The use of dermal substitutes provides a useful reconstructive option <strong>for</strong> coverage of the hand and upper extremity<br />

and prevents the use of other potentially useful donor sites <strong>for</strong> future reconstructive needs. The use of dermal substitutes also allows<br />

an excisional approach to be used, and is also useful <strong>for</strong> coverage of denuded muscle, tendon, or bone.<br />

75<br />

Fig. 2. Deep inferior artery graft from the ulnar<br />

artery to common digital artery


Treatment of Distal Biceps Ruptures Using a One-Incision Technique and Biotenodesis Screw<br />

Fixation: A Preliminary Report on Patient-Oriented Outcomes<br />

Institution where the work was prepared: UMass Memorial Medical Center, Worcester, MA, USA<br />

Mark Eskander, MD; Jonathan Eskander; Douglass Weiss; Nicola DeAngelis; UMass Medical School<br />

OBJECTIVES:<br />

Complete distal biceps brachii tendon ruptures are uncommon injuries. This type of injury can be approached by either a one or twoincision<br />

method. Un<strong>for</strong>tunately, both have associated risks. Moreover, there are a variety of fixation techniques to choose from including<br />

biotenodesis screws. The purpose of this study is to evaluate the patient outcomes of a one-incision technique coupled with biotenodesis<br />

screws <strong>for</strong> treatment of distal biceps tendon ruptures.<br />

METHODS:<br />

We prospectively followed all patients who underwent surgery with this technique. Data from ten surgeries on nine patients coupled<br />

with postoperative questionnaires (DASH and SF-12) were collected and analyzed. The surgeries took place from 2005-2006 by the<br />

same surgeon. The cohort group consisted of employed males at an average age of 44 ranging from 31 to 56 years old. Eight out of<br />

the nine patients were right-hand dominant, six were manual laborers, and four out of the ten ruptures were on the right side and the<br />

other six were on the left. There were no intra-operative complications during the ten surgeries.<br />

RESULTS:<br />

The patients were all seen back at regular postoperative intervals and our DASH and SF-12 scores were collected at one year after surgery.<br />

All patients demonstrated a normal range of motion (ROM) with flexion, extension, pronation, and supination except <strong>for</strong> one. The<br />

postoperative mean flexion and supination strength were 5.0±0 and 4.9±0.21 respectively. The postoperative mean DASH, SF-12<br />

Physical Component (PC), and SF-12 Mental Component (MC) scores were 9.91±13.88, 50.65±9.21, and 51.26±9.38 respectively. These<br />

values are similar to the normative DASH (10.10±14.68) as well as SF-12 PC and MC (51.22±8.80, and 50.72±9.31) values <strong>for</strong> the US male<br />

population. One patient in our group has additional medical problems affecting overall outcomes. If this patient is excluded, the DASH,<br />

SF-12 PC, and MC are 7.68±12.68, 53.36±3.62, and 50.57±9.67 respectively. We noted an overall complication rate of 30% (three of the<br />

ten surgeries). The complications included calcific tendonitis with decreased ROM after a partial re-rupture, decreased strength, and<br />

numbness along the distribution of the radial sensory nerve.<br />

CONCLUSION:<br />

There is no consensus in the literature on the best way to treat distal biceps tendon ruptures. Our DASH and SF-12 scores imply the oneincision<br />

approach and biotenodesis screw fixation provide excellent outcomes. Our complications are similar to those reported by other<br />

authors and thus demonstrate the safety and effectiveness of this technique <strong>for</strong> patients who present with distal biceps tendon ruptures.<br />

76


Flexor Tendon Repair with Barbed Suture<br />

Institution where the work was prepared: UT SouthWestern Medical center, Dallas, TX, USA<br />

Fatemeh Abtahi, MD1; Michel Saint-Cyr2; Spencer A. Brown2; Debby Noble, BS3; Dan Hatef, MD4; Jordan Farkas,<br />

MD3; (1)UT SouthWestern Medical Center, (2)University of Texas Southwestern Medical Center, (3)UTSW medical center,<br />

(4)UT Southwestern<br />

PURPOSE:<br />

This study evaluated the tensile strength properties (maximum tensile load, gapping at the repair site, and the pattern of failure) of flexor<br />

tendon repaired with barbed sutures.<br />

INTRODUCTION:<br />

According to Strickland an ideal tendon repair should permit easy placement of sutures in the tendon, would allow smooth gliding,<br />

have secure suture knots with a smooth junction of tendon ends without gapping at the repair site, create minimal interference with<br />

tendon vascular, and have sufficient strength throughout healing to permit early motion of the tendon. The difficulty in satisfying all<br />

these criteria by any repair technique is probably reflected in the multitude of repairs described and currently utilized by practitioners.<br />

There are many variations in the suture technique of placing core sutures. The described technique include Bunnel, Strikland, Kessler,<br />

modified Kessler, Becker, modified Becker, repair. Tendon repair ruptures usually occur at the suture knots. Adhesion <strong>for</strong>mation remains<br />

the most common complication after flexor tendon repair, despite the widespread use of early-motion protocols. With these factors<br />

related to tendon repair failure considered, our department per<strong>for</strong>med a pilot study using barbed sutures to repair lacerated flexor digit<br />

rum tendons. Barbed sutures (self-anchoring)have been developed by Quill Medical, in which bidirectional barbs are introduced into a<br />

suture that eliminates the need <strong>for</strong> tying a knot to obtain suture closure. The barbs are designed to grip tissue and obviate the need<br />

<strong>for</strong> tying a knot during tissue approximation. They can pass easily through tissue in one direction, but can not be reversed, there<strong>for</strong>e<br />

providing knot security.<br />

MATERIALS/ METHODS:<br />

160 cadaveric and porcine flexor tendons were harvested and cut. Repairs were per<strong>for</strong>med using 0 or 2-0 barbed Nylons and same sizes<br />

standard Nylon. Modified Bunnell and Modified Kessler techniques were used.All repairs have been done without epitendonous<br />

suture.The repaired tendons were then tested <strong>for</strong> Maximum Load, Gap Strength, and Initial Gap, using a Tensiometer. Result:Overall<br />

mean Maximum Load <strong>for</strong> barbed sutures was 41.12 N. Mean Maximum Load <strong>for</strong> 0 barbed Nylon was 55.90 N. Mean Maximum Load<br />

<strong>for</strong> 2-0 barbed Nylon was 37.46 N,and mean Maximum Load <strong>for</strong> 2-0 Nylon was 53.76. Mean Maximum Load <strong>for</strong> conventional 3-0<br />

Ethibond was 31.25 N. These data are fairly consistent with what has been seen previously in the literature.<br />

SUMMARY:<br />

Overall,barbed sutures gave a stronger repair, especially when 0 barbed Nylons were used. Conventional 0 barbed Nylons would be<br />

clinically unfeasible,as the knots would be far too bulky.The ability to use this size of suture without the need <strong>for</strong> knot tying gives hand<br />

surgeons this option in repair of flexor tendon injuries.<br />

77


Management of the Central Extensor Tendon on the Surgical Approach <strong>for</strong> Exposure of the<br />

Proximal Interphalangeal Joint: A Biomechanical Study<br />

Institution where the work was prepared: University of New Mexico, Department of Orthopaedics, Albuquerque,<br />

NM, USA<br />

Deana Mercer; Keikhosrow Firoozbakhsh; Alex Carvalho; Moheb S. Moneim; University of New Mexico<br />

PURPOSE:<br />

Since 1966 silicone im<strong>plan</strong>t arthroplasty has been used to treat arthritis of the PIP joint as an alternative to fusion. The volar approach<br />

to expose this joint spares the extensor mechanism at the cost of increased risk to neurovascular structures. In the dorsal approach, the<br />

extensor mechanism must be carefully handled, reattached and then protected during rehabilitation. Several surgical techniques have<br />

been used to handle the extensor mechanism. Swanson et al. recommended midline incision of the central tendon followed by release<br />

of the lateral insertion on the middle phalanx and then reattachment to the base of the middle phalanx. Our clinical experience led us<br />

to a new surgical technique; splitting then repairing the extensor mechanism without bone reattachment as recommended by Swanson.<br />

The purpose of this study was to biomechanically compare strength and function of this technique with that of Swanson.<br />

METHODS:<br />

Four pairs of fresh-frozen cadaveric hands were used. The index, long and ring finger were harvested <strong>for</strong> testing. Twelve digits (3 digits<br />

x 4 hands) were designated as control and were used to measure the fixation strength of Swanson's procedure. The other 12 digits of<br />

the paired hands were designated as experimental and were used to measure the fixation strength of the proposed new technique.<br />

RESULTS:<br />

The fixation strength mean ± SD were 4.74 ± 0.46 N/mm <strong>for</strong> the control group and 4.62 ± 0.30 <strong>for</strong> the experimental group. The results<br />

were not statistically different, p=0.45.<br />

DISCUSSION:<br />

The simple repair of the central slip without the bone reattachment preserves the function of the extensor mechanism on the PIP joint.<br />

In our clinical cases we haven't noticed any increase in the incidence of extensor lag or boutonniËre de<strong>for</strong>mity as a result of that. This<br />

technique can also be applied <strong>for</strong> fracture fixation in the area.<br />

Treatment of Chronic Digital Ischemia with Direct Microsurgical Revascularization<br />

Institution where the work was prepared: Northwestern University, Chicago, IL, USA<br />

Zol Kryger, MD; Vinay Rawlani; Gregory A. Dumanian; Northwestern University<br />

INTRODUCTION:<br />

Chronic digital ischemia of the fingers is a painful debilitating condition that untreated can progress to functional loss and even amputation.<br />

Direct revascularization techniques require microsurgery, however, these procedures are quite distinct from free tissue transfer and re<strong>plan</strong>tation.<br />

The literature is lacking an adequate description of how best to per<strong>for</strong>m this uncommon procedure. The authors present their technique<br />

<strong>for</strong> treating digital ischemia using a radial to digital artery bypass graft per<strong>for</strong>med in a bloodless field under tourniquet and microscope.<br />

METHODS:<br />

This procedure was per<strong>for</strong>med in six consecutive patients (four with occlusive collagen vascular disease, one with diabetic peripheral<br />

vascular disease, one with hypercoagulable state), all of whom had ischemic digits with ulceration, pain, and dry gangrene and who<br />

were unmanageable under conservative medical or surgical therapy. The outcomes were resolution of fingertip ulcers, avoidance of<br />

more proximal amputations, and elimination of ischemic pain.<br />

RESULTS:<br />

Successful outcomes were obtained in all six patients, and the grafts have remained patent with an average follow up 17 months as<br />

confirmed by a hand-held Doppler examination. All patients had salvage of the revascularized finger, and resolution of the ulcers and<br />

rest pain. The mean tourniquet time was 100 minutes.<br />

CONCLUSION:<br />

Digital revascularization using a radial to digital artery bypass is a straight<strong>for</strong>ward, reproducible technique <strong>for</strong> the treatment of patients<br />

suffering from refractory chronic digital ischemia.<br />

78


Modified Allen's Test Using Near Infrared Spectroscopy: Clincal and Anatomic Study<br />

Institution where the work was prepared: University of Texas Southwestern Medical Center, Dallas, TX, USA<br />

Daniel A. Hatef, MD; Dallas Alvey; Li Ngov; Michel Saint-Cyr; Spencer A. Brown; Rod J. Rohrich; University of Texas<br />

Southwestern Medical Center<br />

INTRODUCTION:<br />

A dogma of hand surgery instructs that the dominant arterial supply to the hand is the ulnar artery. This has some serious clinical implications,<br />

as reconstructive surgeons use the radial <strong>for</strong>earm flap to repair defects all over the body, and cardiac surgeons often harvest<br />

the radial artery <strong>for</strong> use as a graft in coronary bypass surgery.<br />

METHODS:<br />

Near Infrared Spectroscopy was used to assess tissue oxygen saturation (St02) in the second and fifth digit, while per<strong>for</strong>ming the modified<br />

Allen's test, in 30 hands of 15 subjects. Measurements were recorded and statistically analyzed. A cadaveric study was undertaken<br />

using 6 upper extremities, to confirm the findings of this and previous studies. Radiopaque barium was injected into the brachial<br />

artery to demonstrate the vasculature of the <strong>for</strong>earm and hand. The arms were then scanned using a CT scanner, and the images were<br />

reconstructed and analyzed using TeraRecon Æ imaging software.<br />

RESULTS:<br />

Baseline St02 readings were variable (range 39 to 90; Mean = 64.43; St. Dev. = 13.07). Two hands, of the same patient, demonstrated<br />

clear ulnar dominance; one hand demonstrated radial dominance. Of note, two hands had normal Allen's tests, but appeared to have<br />

radial dominance to the index. The results of the cadaveric investigation demonstrate that 2 of the 10 upper extremities had incomplete<br />

filling of the superficial arch. The ulnar digital artery was seen to be dominant in every index digit; this was a branch of the palmar<br />

metacarpal artery off of the superficial palmar arch in 8 specimens, and the terminal branch of the radial artery in 2 specimens.<br />

DISCUSSION:<br />

This study shows that there is no one dominant blood supply to the hand. This study demonstrates the importance of diligent use of<br />

the Allen's test preoperatively, and in any patient with questionable result, it is recommended that the radial artery not be sacrificed.<br />

Some hands may have radial dominance to the index, but an anatomical reason <strong>for</strong> this was not confirmed through cadaveric investigation.<br />

Near infrared spectroscopy demonstrated extremely variable St02 readings. It cannot be concluded that use of near infrared<br />

spectroscopy aids in improving the sensitivity of the Allen's test.<br />

79


AAHS Concurrent Scientific Paper Session C<br />

Evaluating the Efficacy of Combining Clinical Signs of Scaphoid Fracture to Decrease<br />

Unnecessary Immobilization: A Prospective Multi-Institutional Study Supporting the<br />

Early Use of Advanced Imaging<br />

Institution where the work was prepared: Naval Medical Center San Diego, San Diego, CA, USA<br />

Joseph R. Carney, MD; Eric Hofmeister; John Paul Rhue; Brian Fitzgerald; Michael Thompson; Naval Medical Center<br />

San Diego<br />

BACKGROUND:<br />

The initial clinical examination <strong>for</strong> scaphoid fracture is inaccurate leading to unnecessary immobilization in a large percentage of<br />

patients suspected of occult fracture. An exam with improved accuracy in patients suspected of scaphoid fracture can potentially lead<br />

to the cost effective use of advanced diagnostic imaging modalities to further guide treatment and decrease unnecessary immobilization.<br />

METHODS:<br />

An IRB approved, prospective, multi-institutional study was per<strong>for</strong>med in adults with suspected scaphoid fractures. An initial examination<br />

documenting the presence or absence of seven described clinical signs of scaphoid fracture was per<strong>for</strong>med and patients followed<br />

until a scaphoid fracture was determined to be present or absent. Initial exam findings, initial and final diagnosis, diagnostic studies<br />

used to exact a final diagnosis, number of follow up visits needed to exact a final diagnosis, and length of immobilization were determined.<br />

Statistical measures of test validity <strong>for</strong> the seven clinical signs used in multiple combinations were determined. The mean number<br />

of positive signs in patients with a final diagnosis of scaphoid fracture was compared to patients with a final diagnosis of scaphoid<br />

nonfracture in an ef<strong>for</strong>t to further evaluate the accuracy of the initial clinical examination when using multiple signs of fracture. A cost<br />

analysis <strong>for</strong> patients unnecessarily immobilized was compared to a proposed model utilizing early use of bone scintigraphy to decrease<br />

periods of over treatment.<br />

RESULTS:<br />

From June 2004 to June 2006 eighty-three patients were enrolled. Four were lost to follow up (95% retained). Clinical examination accuracy<br />

did not improve when clinical signs were combined (p>0.05). Furthermore, suspected occult fracture patients found to be without<br />

fracture possessed a significantly higher number of positive signs than patients found to have fractures (p


Long-term Outcomes of Dorsal Intercarpal Ligament Capsulodesis <strong>for</strong> Chronic Scapholunate<br />

Dissociation<br />

Institution where the work was prepared: University of Cali<strong>for</strong>nia, Davis, Sacramento, CA, USA<br />

Varun Gajendran, MS1; Brett Peterson, MD1; Robert R. Slater, MD, FACS2; Robert Szabo, MD, MPH1; (1)University of<br />

Cali<strong>for</strong>nia, Davis, (2)The Permanente Medical Group<br />

PURPOSE:<br />

Chronic scapholunate dissociation is a common cause of symptomatic wrist instability. In an attempt to restore normal carpal mechanics<br />

and prevent wrist arthrosis, we developed and tested biomechanically the dorsal intercarpal ligament capsulodesis (DILC). Previously,<br />

we reported good early clinical results <strong>for</strong> this procedure. Here, we report on the functional and radiographic outcomes of these<br />

patients at long-term follow-up.<br />

METHODS:<br />

After IRB approval, records of patients undergoing the DILC <strong>for</strong> chronic (greater than 6 weeks), flexible, static scapholunate dissociation<br />

were reviewed. Only patients with follow-ups of greater than 60 months were included. Physical examination, radiographs, and validated<br />

outcome instruments were used to evaluate the patients.<br />

RESULTS:<br />

Twenty-one patients (22 wrists) met the inclusion criteria. Fifteen of these 21 patients (16 wrists) were available <strong>for</strong> follow-up. After an average<br />

follow-up period of 86 months, physical examination revealed an average wrist flexion and extension of 50Ña and 55Ña respectively,<br />

radial and ulnar deviation of 17Ña and 36Ña respectively, and grip strength of 61 kgf. DASH, SF-12, and Mayo wrist scores averaged<br />

19, 78, and 78 respectively. Radiographs revealed an average scapholunate angle and gap of 62Ña and 3.5 mm respectively. Eight of the<br />

16 wrists in our study demonstrated arthritic changes on radiograph, including one patient who developed Stage IV arthritis of the wrist.<br />

CONCLUSION:<br />

Our results show that the DILC does not prevent radiographic deterioration and the development of arthrosis in the long term.<br />

However, the level of functionality and patient satisfaction remained high in the majority of our patients, suggesting a lack of correlation<br />

between the radiographic findings and development of arthritis on one hand and functional outcomes and patient satisfaction on<br />

the other hand. Based on these findings, we believe that the DILC is still a good choice <strong>for</strong> treating flexible static scapholunate dissociation<br />

in carefully selected patients. Prevention of radiographic deterioration and arthrosis, however, remains an unsolved problem.<br />

Treatment of Scaphoid Fractures and Nonunions with a Cannulated AO Screw and Threaded<br />

Washer: Report of 99 Cases<br />

Institution where the work was prepared: University of Cali<strong>for</strong>nia San Diego, San Diego, CA, USA<br />

Andrew Pennock, MD1; Todd Horton, MD2; William Tontz, MD1; Reid Abrams, MD3; (1)University of Cali<strong>for</strong>nia San<br />

Diego, (2)Naval Medical Center, (3)University of Cali<strong>for</strong>nia, San Diego<br />

PURPOSE:<br />

Several im<strong>plan</strong>t designs have been utilized <strong>for</strong> the rigid internal fixation of scaphoid fractures. To date, no study in the literature has<br />

reported surgical outcomes using the 3.0 mm cannulated AO screw lagged through a threaded washer. The purpose of this study was<br />

to evaluate union rates in a consecutive series of patients who had internal fixation of a scaphoid fracture or nonunion using this device.<br />

WITHDRAW<br />

METHODS:<br />

From September 1996 to September 2006, 68 consecutive scaphoid waist fractures requiring surgical stabilization were treated with a<br />

3.0 mm cannulated AO screw and threaded washer by a single surgeon. Nondisplaced fractures were treated through a mini-volar<br />

approach while displaced fractures and nonunions were treated with an open volar approach. At the time of surgery, if nonunions were<br />

unstable, bone graft from the iliac crest or distal radius was harvested, but if stable, graft was not utilized. Charts and radiographs were<br />

reviewed from all patients and pertinent demographic and clinical data were recorded. Postoperative radiographs were reviewed to<br />

assess fracture union and screw position.<br />

RESULTS:<br />

The union rate <strong>for</strong> the 21 nondisplaced fractures was 100% with an average time to union of 15.5 weeks. The union rate <strong>for</strong> the 23 displaced<br />

fractures was 96% with an average time to union of 17.1 weeks. In none of the acute fractures was it necessary to remove symptomatic<br />

hardware. The union rate <strong>for</strong> the 24 nonunions was 92% with an average time to union of 22 weeks. In two instances, symptomatic<br />

hardware had to be removed which had migrated into the scapho-trapezio-scaphoid joint.<br />

CONCLUSION:<br />

The 3.0 mm AO cannulated screw and threaded washer can be used reliably and safely to treat both scaphoid waist fractures and<br />

nonunions. A theoretic advantage of this device is that it enables the controlled compression of the scaphoid if resorption occurs across<br />

the fracture site, increasing the probability of successful union. This benefit is not without risk of distal screw migration, which was<br />

observed in two cases in this study. We there<strong>for</strong>e recommend close radiographic follow-up in all cases until bony union is achieved.<br />

81


Outcome Assessment after Treatment of Scaphoid Nonunion in the Middle Third (Herbert<br />

Type D2) with Conventional Bone Grafting and Screw Fixation from a Palmar Approach<br />

Institution where the work was prepared: Department of <strong>Hand</strong>, Plastic and Reconstructive Surgery, Ludwigshafen, Germany<br />

Miriam Mueller, MD; Andre Otto; Christiane Hitzigrath; Rainer Simon; Guenter Germann; Michael Sauerbier;<br />

Heidelberg University<br />

OBJECTIVES:<br />

This study was designed to assess the clinical and radiological outcomes after treatment of scaphoid nonunion of the middle third<br />

(Herbert D2) with bone graft and screw fixation.<br />

MATERIALS/ METHODS:<br />

Eighty patients were treated <strong>for</strong> scaphoid nonunions in the middle third between 05/98 and 10/05 and were retrospectively reviewed.<br />

Average follow-up time was 41.5 months. 73 patients were male, 7 female with a mean age of 32 years. The right hand was affected in<br />

55 %, the left in 45 % of the cases. Mean delay to surgery was 9,7 months. All patients were treated by resection of the nonunion from<br />

a palmar approach, interposition of a nonvascularized bone graft from the radius or iliac crest, stabilization by screw fixation and immobilization.<br />

All patients received pre- and postoperative CT-scans to assess osseous union. Apart from demographic data range of<br />

motion, grip strength, pain relief (VAS score) and DASH-score were obtained.<br />

RESULTS:<br />

Average time of immobiliazation was 8,7 weeks. Osseous union could be achieved in 73 (91 %) patients at this time. The average DASHscore<br />

(range 0-100 points) was 11,8 points (range 0-53). The average range of motion were: Ext./Flexion 116.4?, Ulnaabd./Radialadd.<br />

65.4?, Pronation/Supination 164.4? and grip strength was 40.7 kg. The pain relief (VAS range 0-100) was 4.3 at rest and 21.4 during stress<br />

activities in average. Complications occurred in 5 patients (6,25 %) and consisted of necessary further operation like four corner fusion<br />

(2), proximal row carpectomy (1) or re-operation with iliac crest bone graft (2)<br />

DISCUSSION:<br />

Our study demonstrates that excellent union rates can be achieved with using a conventional bone graft and screw fixation <strong>for</strong> scaphoid<br />

nonunion in the middle third. For reliable assessment of bony union CT-scans are necessary; radiological osseous union is highly predictive<br />

<strong>for</strong> patientxs satisfaction and functional outcome.<br />

Open Reduction <strong>for</strong> Perilunate Injuries - Long Term Results and Patients Content<br />

Institution where the work was prepared: BG Trauma Center Ludwigshafen, Ludwigshafen, Germany<br />

Thomas Kremer, MD; Michael Wendt; Michael Sauerbier; Guenter Germann; BG Trauma Center Ludwigshafen<br />

INTRODUCTION:<br />

Perilunate injuries lead to severe destruction of the carpal integrity. Optimal treatment is mandatory to avoid poor results in terms of<br />

pain and function. However, the patientsx outcome is still unsatisfying in a subset of patients. Moreover, these injuries are frequently<br />

overlooked. This study evaluates the long term results after open reduction and treatment with K-wires.<br />

PATIENTS/METHODS:<br />

Patients, who were treated <strong>for</strong> perilunate dislocations / fractures (Mayfield 3/4) in our institutiuon (1995-2004) were included in this retrospective<br />

analysis. The evaluation focussed on postoperative radiologic results and on development of arthrosis, range of motion,<br />

pain, sensitivity, grip strength, Mayo - and Krimmer wrist scores and the patients content (DASH-score).<br />

RESULTS:<br />

72 patients were treated at our institution <strong>for</strong> perilunate injuries from 1995-2004. 54% (n=39 [2 females/37 males]) were evaluated <strong>for</strong><br />

functional results and patientsx satisfaction (median follow-up 65, 5 months). Blue collar workers dominated (n=26). Two thirds (61%) of<br />

the patients suffered from perilunate fracture dislocations and the dominant hand was affected in one third. Postoperative reduction<br />

was successful in the majority of patients (89.7% normal scapholunate angles, normal Gilula arcs in 64.1%). At follow-up, pain was rated<br />

1.8 at rest and 4.8 under stress conditions (visual analogoue scale). Average extension/flexion was 76.7? (62.3% of the opposite side)<br />

and radial-/ulnarabduction was reduced to 60% of the unaffected side. Sensitivity was normal in all patients. Average grip strength was<br />

36.6 kg (51.6 kg opposite side). 17 patients were diagnosed with significant radiocarpal arthrosis at follow-up, a pathologic scapholunate<br />

angle was found in 14 patients, whereas 6 patients developed an ulnar shift of the carpus. 69.2% of the patients worked in their<br />

<strong>for</strong>mer occupation. Average Mayo- and Krimmer wrist scores were 70.4 and 70.3, respectively. The average DASH-score was 23.2, which<br />

is low with respect to the severe injury pattern.<br />

DISCUSSION:<br />

Open reduction is the treatment of choice <strong>for</strong> perilunate injuries. However, long term results show significant functional impairment and<br />

arthrosis even after ideal treatment course. Furthermore, radiologic changes and functional results demonstrate no correlation. The<br />

high patientsx individual satisfaction shows, that treatment in specialized hand surgery units is mandatory.<br />

82


Thumb Metacarpal Phalangeal Joint Capsulodesis at the Time of Basal Joint Arthroplasty:<br />

a Surgical Technique Utilizing Suture Anchors<br />

Institution where the work was prepared: Mayo Clinic, Phoenix, AZ, USA<br />

Scott F.M. Duncan, MD, MPH1; Smith Anthony, MD1; Merritt Marianne, RNFA1; Ivy Cindy, OT, CHT1; Renfree Kevin,<br />

MD1; Kousuke Iba, MD2; (1)Mayo Clinic - Scottsdale, (2)Sapporo University<br />

PURPOSE:<br />

Metacarpal-phalangeal joint capsulodesis is considered a technically demanding procedure with a recognized risk of digital nerve injury<br />

and tendon adhesions. Additionally, there is no uni<strong>for</strong>m surgical approach <strong>for</strong> the procedure or agreed upon method of volar plate fixation<br />

to allow the procedure to be considered routine. The use of capsulodesis <strong>for</strong> the treatment of the hyperextended MPC joint at<br />

the time of basal joint arthroplasty is well established. The purpose of this study was to examine the results of a unique surgical approach<br />

to MCP joint capsulodesis that utilizes suture anchors.<br />

METHODS:<br />

This was a retrospective chart review examining the results consecutive patients undergoing thumb MCP joint capsulodesis between<br />

2003 and 2006. Indications <strong>for</strong> surgery were thumb MCP joint hyperextension de<strong>for</strong>mity of at least 30 degrees with radiographic evidence<br />

of stage III basal joint arthritis. Variables examined included pre/post operative range of motion and complications. The surgical<br />

technique involves making a Bruner incision on the volar aspect of the MPJ. Both digital nerves are identified and protected. The A1<br />

pulley is released and the FPL retracted. The volar plate is released proximally and the joint is placed in 30 degrees of flexion. A Kirshner<br />

wire is then directed obliquely across the joint. A mini-mitek suture anchor is placed in the distal metacarpal. The volar plate is then<br />

mobilized and secured with the mitek sutures. The K-wire is pulled at 6 weeks. <strong>Hand</strong> therapy was initiated at the first post operative visit<br />

and a strict 16 week protocol followed.<br />

RESULTS:<br />

The average patient age was 62.4 years (55-79). Twenty-one thumbs in 19 patients were treated with the above technique. The average<br />

range of motion at the thumb MPJ after capsulodesis was 0 degrees of extension (range -5 to 5) and 40 degrees of flexion (range 20<br />

to 70). There were no cases of residual hyperextension at the last follow up (6-38 months). There were 4 complications: two superficial<br />

pin tract infection treated with oral antibiotics and two cases of complex regional pain syndrome. One patient complained of pain at<br />

the thumb MCP joint post operatively, and was considering arthrodesis.<br />

CONCLUSION:<br />

Thumb metacarpal phalangeal joint capsulodesis at the time of CMC arthroplasty can easily and effectively be per<strong>for</strong>med utilizing this<br />

technique of suture anchors, joint pinning <strong>for</strong> 6 weeks, and a strict hand therapy protocol.<br />

Biotenodesis Screw in Basilar Thumb Arthritis: A Biomechanical Study<br />

Institution where the work was prepared: Tripler Army Medical Center, Honolulu, HI, USA<br />

John Faillace, MD; Hillcrest Baptist Medical Center; Shawn Hermenau, MD; Tripler Army Medical Center<br />

A number of procedures have been developed to reconstruct incompetent volar ligaments and to relieve pain in patients with CMC<br />

arthritis. Volar beak ligament reconstruction with local tendon grafts, tendon interpositions, and resection arthroplasties have all been<br />

described with success in the literature. More recent literature has shown that ligament reconstruction without tendon interposition provides<br />

reproducible relief to patients with CMC arthritis without loss of range of motion, pinch strength, or the ability to per<strong>for</strong>m ADLs.<br />

Biotenodesis screws have been used with marked success in the knee and sports literature as well as the foot and ankle literature to<br />

aide in the reconstruction of ligaments. We have applied these principles to the reconstruction of the thumb volar beak ligament. The<br />

purpose of this cadaver study is to test load to failure and method of failure of volar beak ligament reconstruction with biotenodesis<br />

screw reconstruction compared to the standard tendon to tendon technique i.e. the modified ligament reconstruction of Eaton and<br />

Littler.<br />

Ten matched pairs of cadaveric hands of average age 60 years had ligament reconstruction with biotenodesis screw randomized to<br />

right or left and suture on the other. The specimens were tested first with 10 cycles of load <strong>for</strong> preconditioning then loaded to failure.<br />

The data was tabulated and analyzed with a One-Way ANOVA.<br />

The load at failure <strong>for</strong> both groups surpassed that expected <strong>for</strong> light pinch. The Biotenodesis screw was stiffer but did not reach statistical<br />

significance. The suture repair had a statistically significant higher load to failure (p=0.007).<br />

83


Partial Ulnar Head Resurfacing Im<strong>plan</strong>t Arthroplasty<br />

Institution where the work was prepared: University of Iowa, Iowa City, IA, USA<br />

Danielle A. Conaway, MD; Brian D. Adams; University of Iowa<br />

Although complete im<strong>plan</strong>t replacement of the distal ulna has become a popular and accepted procedure, in many cases it sacrifices<br />

normal portions of a distal ulna and important soft tissue attachments. Consequences of resecting unaffected portions of the distal ulna<br />

include a higher risk of distal radioulnar joint instability, im<strong>plan</strong>t prominence, soft tissue irritation, and ulnocarpal instability. To minimize<br />

the resection and to optimize the functional result of im<strong>plan</strong>t arthroplasty of the distal ulna <strong>for</strong> the treatment of distal radioulnar arthritis,<br />

a partial ulnar head replacement was developed, which only replaces the articular surfaces. The im<strong>plan</strong>t allows retention of the ulnar<br />

neck, ulnar styloid, extensor carpi ulnaris grove, ulnocarpal ligament attachments, extensor carpi ulnaris sheath, and the triangular fibrocartilage<br />

complex attachments to the ulnar styloid. It is intended <strong>for</strong> patients who have good skeletal alignment and functioning soft<br />

tissue stabilizers surrounding the distal ulna. To assess the design's replication of the natural anatomy, a study was per<strong>for</strong>med on 10<br />

cadavers. A number of radiographic parameters were compared between the natural state of the distal ulna and the state after im<strong>plan</strong>tation.<br />

In addition, the results of the first 10 patients treated by 3 surgeons were reviewed to assess its clinical efficacy. Plain radiographs<br />

demonstrated a good match (within 7%) between the size and shape of the natural ulna and the im<strong>plan</strong>t, as well as ulnar variance, ulnar<br />

offset, and ulnar height at the distal radioulnar joint. Distal radioulnar joint stability was maintained by subjective assessment, and there<br />

was no loss of <strong>for</strong>earm rotation. Of the 10 clinical patients, 7 were treated <strong>for</strong> osteoarthritis and 3 <strong>for</strong> posttraumatic arthritis. In a retrospective<br />

chart review at an average 6 month follow up, there were no intraoperative or postoperative complications. Pain relief was satisfactory<br />

in all, though none were pain free. Motion was improved in all, with all patients achieving at least 75 degrees of pronation and<br />

65 degrees of supination. Wrist flexion and extension was unaffected. There were no cases of distal radioulnar joint instability. In conclusion,<br />

this preliminary report suggests that surface, ìconservativeî, im<strong>plan</strong>t replacement of the distal ulna may offer advantages over<br />

complete distal ulna replacement in selected patients.<br />

Dynamic (4D) Computed Tomography of the Wrist : Proof of Feasibility in a Cadaveric Model<br />

Institution where the work was prepared: Mayo Clinic College of Medicine, Rochester, MN, USA<br />

Shian Chao Tay, MBBS, FRCS, FAMS1; Andrew N. Primak, PhD2; Joel G. Fletcher, MD2; Bernhard Schmidt, PhD3;<br />

Kimberly K. Amrami, MD1; Cynthia H. McCollough, PhD1; Richard A. Berger, MD, PhD4; (1)Mayo Clinic, (2)Mayo Clinic<br />

College of Medicine, (3)Siemens Medical Solutions, (4)Mayo Clinic Foundation<br />

PURPOSE:<br />

High resolution real-time 3D imaging of the moving wrist may provide novel insights into the pathophysiology of dynamic joint instability.<br />

The purpose of this work was to assess the feasibility of using retrospectively-gated spiral computed tomography to per<strong>for</strong>m<br />

dynamic (4D) imaging of the moving wrist joint.<br />

METHODS:<br />

A cadaver <strong>for</strong>earm from below the elbow was mounted on a motion simulator which per<strong>for</strong>med periodic radioulnar deviation of the<br />

wrist at 30 cycles per minute. An electronic trigger from the simulator provided the "electrocardiogram" (ECG) signal required <strong>for</strong> gated<br />

reconstructions. The wrist was scanned on a 64-slice CT scanner (Sensation 64, Siemens Medical Solutions) using a retrospectively-gated<br />

CT protocol with a special low pitch of 0.1 provided by the manufacturer. Scanning was per<strong>for</strong>med from the distal radius and ulna to<br />

the proximal metacarpals to ensure adequate coverage of the carpal bones. The first condition scanned was during periodic radioulnar<br />

deviation and was designated the 4D condition. The second scan served as a control where the wrist was precisely moved to four<br />

designated static positions and scanned. This control scan was designated the 3D condition. Both the 4D and 3D images were then<br />

compared by two blinded observers <strong>for</strong> image quality and presence of artifacts. The displacement of the distal pole of the scaphoid<br />

during radioulnar deviation was also calculated from the dynamic 4D phase after appropriate image segmentation and thresholding.<br />

RESULTS:<br />

Image quality of 4D images was rated by both observers to be excellent at the extremes of radial and ulnar deviation (end-motion phases).<br />

Mid-motion phases were rated by both observers to be fair due to the presence of motion and band artifacts. However, in all phases,<br />

carpal joint spaces remain well resolved. The centroid of the distal pole of the scaphoid was found to undergo a displacement magnitude<br />

of 12.4 mm.<br />

CONCLUSION:<br />

In conclusion, a method using retrospectively-gated CT <strong>for</strong> dynamic 4D imaging in the wrist is feasible. In the near future, this may provide<br />

hand surgeons a new diagnostic tool in which dynamic carpal instabilities can be assessed.<br />

84


Preliminary Experience with Fat Grafting of Dupuytren's Contracture Following Complete<br />

Percutaneous Release<br />

Institution where the work was prepared: Miami <strong>Hand</strong> Center, Miami, FL, USA<br />

Roger K. Khouri, MD1; Jorge L. Orbay, MD1; Steven E.R. Hovius2; (1)Miami <strong>Hand</strong> Center, (2)Erasmus University<br />

Medical Center Rotterdam<br />

INTRODUCTION:<br />

Fat atrophy is inherent to the pathology of Dupuytren's contracture. Graft interposition after simple fasciotomy is widely believed to<br />

change the biology of the disease and to prevent recurrences. We hereby report our preliminary experience with lipografting<br />

Dupuytren's contracture following a novel minimally invasive release technique that safely cuts up the diseased cord and separates it<br />

from the dermis.<br />

PURPOSE:<br />

A strong steady extension <strong>for</strong>ce is applied on the digit using a lead hand retractor. Then progressing in an orderly fashion from proximal<br />

to distal, we make a series of palmar puncture wounds with a sharp tipped 1mm blade equipped with a T-bar stop which prevents<br />

from penetrating more than 3mm proximal to the transverse palmar crease, 2 mm over the distal palm, and 1 mm over the digits.<br />

Working along a wide area around the contracture, the cords are progressively and extensively severed through transverse oscillations<br />

at each puncture point. Skin wrinkles or pits are released with another dissecting instrument that severs dermal attachments of the cord.<br />

Following full contracture release, full skin separation from the cord, and full morcelization of the nodules, we fill the surgical site with<br />

lipoaspirate harvested from the flanks. An extension splint is incorporated in the dressing.<br />

CLINICAL RESULTS:<br />

We per<strong>for</strong>med this incision-less minimally invasive procedure in 12 hands, four had four digital rays released and six had three. Three<br />

had recurrent disease, four had 90? PIP contractures and six had 60?MP contractures. Full complete extension was achieved in 9 and<br />

the remaining had less than 15? lag at the completion of the procedure. There were no complications and no morbidity. One week post<br />

op the patients were allowed to use the hand and wear an extension splint at night. At 2 weeks, all patients recovered full use of the<br />

hand. At one month, most striking findings were softness of the hand and absence of scarring. All patients were satisfied with the result<br />

and had no evidence of recurrence at an average of 6 months follow-up.<br />

CONCLUSION:<br />

We hereby describe a safe and minimally invasive approach to the treatment of Dupuytren's contracture that departs from the standard<br />

of cord excision and adds padding to the already fat-deficient hand. Fat grafting after extensive percutaneous superficial fasciotomy<br />

seems to prevent the flare reaction and to change the biology of the disease.<br />

Ulnohumeral Arthroplasty in the Management of the Arthritic Elbow<br />

Institution where the work was prepared: Wrightington Hospital Centre For Upper Limb Surgery, Wigan, United Kingdom<br />

M. J. Hayton; Sumedh C Talwalkar; Ian A Trail; Niloy Roy; John K Stanley; Wrightington Hospital<br />

Purpose:<br />

To present the long term follow-up of patients who underwent Ulohumeral arthroplasty <strong>for</strong> symptomatic elbow arthritis.<br />

METHODS:<br />

81patients were who underwent ulnohumeral arthroplasty between 1994 and 2002 were included in the study. All patients were sent a<br />

questionnaire with a request to attend a clinical evaluation. 40 patients replied and 34 attended <strong>for</strong> clinical examination. There were 6<br />

females and 34 males with an average age of 63 years (32-80) and a mean follow-up of 6years (2-10). There were 22(55%) patients with<br />

primary osteoarthritis, 14(35%) with osteoarthritis secondary to trauma, two patients with rheumatoid arthritis and one patient each with<br />

arthrogryphosis multiplex congenital and post-septic arthritis of the elbow.<br />

RESULTS:<br />

Using the VAS(0-10), the pain score was seen to improve from a mean pre-operative score of 8(6-10) to 4(0- 9). 21 patients (50%) were<br />

on minimal or no analgesia and 31(75%) patients felt they would have the surgery again <strong>for</strong> the same problem. The arc of motion as<br />

regards flexion/extension was found to increase by 19% while prono-supination was found to increase by 30%.There was one patient<br />

each with superficial infection, anterior interosseous nerve neuropathy and myositic ossificans while two patients had triceps rupture.<br />

Radiological examination showed that in 12 cases the trephine hole was partially obliterated while in 4 cases it was completely obliterated.<br />

This could not be correlated clinically. Patients with loose bodies seemed to do better in the post-operative phase.<br />

CONCLUSION:<br />

Ulnohumeral arthroplasty has a role in the management of the arthritic elbow as it provides pain relief in the post-operative period;<br />

however the improvement in the range of movement is limited particularly as regards the arc of extension.<br />

85


Isolated Proximal Pole Hamate Arthritis<br />

Institution where the work was prepared: Thomas Jefferson University, Philadelphia, PA, USA<br />

A. Lee Osterman, MD; Randall Culp; Thomas Jefferson University<br />

Proximal pole hamate arthritis is a common cause of ulnar wrist pain. Anatomic studies have shown increased lunato-hamate load <strong>for</strong>ces<br />

and a consequent high association of proximal hamate arthritis with Type II lunates.Burgess first defined the association of lunato-triquetral<br />

instability and proximal pole arthritis. Palmer noted an incidence of 91% and defined the syndrome HALT,hamate arthrosis lunato-triquetral<br />

ligament tear. This study introduces a new entity-isolated hamate impaction --and its treatment. Between 1997-2000 we<br />

arthroscopically identified 57 consecutive patients with proximal pole hamate arthritis, of which 18 were isolated as defined by Grade<br />

II-IV Outerbridge changes and the absence of LT instability. 18 consecutive pts (19 wrists) 13 ?â 5 ?ä; 48yrs (27-66) Dominant wrist 50%;<br />

Acute injury event 50%; Work related 5, 2 WC. The onset of symptoms was often related to sports, especially those with ulnar loading<br />

such as golf (55%).Average symptom duration 11 months. All pts activity related pain. 74% had grip strength weakness in UD. Xray findings:<br />

All had Type II Lunate Facets averaging 2.7mm (1-5);Prox Pole Erosions in 37% Ulnar variance: 5+ avg 1.4mm; 10 neutral; 5- avg<br />

1.6mm.MRI findings: Proximal Pole changes 53%; 7 TFC tears (only 5 @ arthro)1 Hook Hamate Nonunion. Arthroscopic findings:Prox<br />

Pole Hamate Arthritis 100%; Midcarpal Synovitis 100%; TFC Tear IA---2 IIC---3; Pisotriquetral Arthritis 1 LT Instability none . Treatment<br />

was arthroscopic proximal pole hamate excision in all. An avg of2.6 mm Hamate resected (1-4mm). Concommitant surgery: Midcarpal<br />

synovectomy 100%; TFC debridement 5; Open Hook Hamate excision 1. Follow-up 7.0 years (3.1-9.3).1 lost to Fu @ 3.1 yrs 1 died, Last<br />

FU @ 5.1yrs. 94% very satisfied and would repeat surgery :RTW 15 days (2-84); RT Sports 3 months No radiographic evidence of progressive<br />

arthritis or collapse de<strong>for</strong>mity. Wrist evaluation scores: Preop 73.1(Fair) to Postop 94.7 (Excellent). No Complications. In summary,Isolated<br />

proximal pole hamate arthritis does occur, and is another cause of ulnar wrist pain. It has an association with type II Lunates<br />

and a high incidence in golfers. Arthroscopic Proximal pole resection of 2.5 mm provides a reasonable solution with excellent results @<br />

moderate FU interval.<br />

In-vivo Kinematic Analysis of the Forearm<br />

Institution where the work was prepared: Mayo Clinic College of Medicine, Rochester, MN, USA<br />

Shian Chao Tay, MD, MS1; Kazunari Tomita, MD1; Roger P. Van Riet, MD2; Kimberly K. Amrami2; Kai-Nan An, PhD3;<br />

Richard Berger, MD, PhD4; (1)Mayo Clinic College of Medicine, (2)Mayo Clinic, (3)Orthopedic Biomechanics<br />

Laboratory, (4)Mayo Clinic/Mayo Foundation<br />

PURPOSE:<br />

Controversy still exists regarding the location and nature (static or dynamic) of the <strong>for</strong>earm joint axis. This might be due to inconsistent<br />

results from in-vitro data and less precise methods of analysis. We present the first in-vivo kinematic analysis of normal <strong>for</strong>earm joint<br />

rotation described by helical axis analysis.<br />

METHODS:<br />

Data obtained from computed tomography images of both <strong>for</strong>earms of five healthy volunteers was used to calculate finite helical axis<br />

(FHA) parameters from trans<strong>for</strong>mation matrices. Four positions were analyzed: maximum pronation, maximum supination, 60? pronation,<br />

60? supination. Registration of the image data were per<strong>for</strong>med using Analyze 7.0. Kinematic analysis focused on the motion of the<br />

radius around the ulna.<br />

RESULTS:<br />

FHAs were located near the center of the radial head biased towards the proximal radioulnar joint (PRUJ), extending towards the ulnar<br />

head just dorsal to its center at the distal radioulnar joint (DRUJ), moving in a linear motion at the radial and ulnar heads during <strong>for</strong>earm<br />

rotation. Magnitude of FHA rotation during pronation was larger than in supination. Proximo-distal translation of the radius during<br />

<strong>for</strong>earm rotation was a mean of 0.98 mm. A significant linear relationship was found between translation and rotation.<br />

CONCLUSION:<br />

The in-vivo <strong>for</strong>earm joint axis was precisely located. This new in<strong>for</strong>mation of the <strong>for</strong>earm joint axis defined by FHA analysis, may be useful<br />

in im<strong>plan</strong>t design, and in guiding surgeons in their reconstruction of instabilities of the DRUJ or PRUJ.<br />

86


Mesh Im<strong>plan</strong>t Arthroplasty <strong>for</strong> Treatment of Basilar Joint Arthritis<br />

Institution where the work was prepared: Methodist Hospital, Houston, TX, USA<br />

Evan Collins, MD; Kimberly Staines; John Thornby; The Methodist Hospital<br />

PURPOSE:<br />

Multiple surgical approaches have been per<strong>for</strong>med <strong>for</strong> advanced stage thumb basilar joint osteoarthritis (OA). This study assesses initial<br />

results of a new surgical approach utilizing a biodegradable polycaprolactone-based mesh im<strong>plan</strong>t as a spacer following a trapezium<br />

and base metacarpal resurfacing osteotomy.<br />

METHODS:<br />

A prospective convenience design was used to assess 15 patients between the ages of 42 and 66, who suffered from OA limited to the<br />

carpometacarpal (CMC), or basilar, joint of the thumb nonresponsive to conservative treatment over a 4 to 6 month period. Data collection<br />

included x-rays of the hand and thumb, posterior anterior, oblique, lateral and basil joint stress views, along with DASH and VAS<br />

scores and ROM ñ bilateral evaluation. The same surgeon treated all subjects and per<strong>for</strong>med a surgical technique utilizing an approach<br />

to the capsule as described by Eaton. A biodegradable mesh T-shaped spacer of woven construction was used as im<strong>plan</strong>t. The outpatient<br />

procedure was per<strong>for</strong>med using an intrascalene block. The surgeon began by dividing the capsule as a metacarpal based tongue<br />

flap, exposing the CMC joint. An osteotome and rasp resurfaced the joint, creating a parallel space. The im<strong>plan</strong>t was inserted and<br />

affixed to the metacarpal or trapezium ñ depending on the quality of bone stock ñ and secured with a Mitek suture anchor.<br />

Intraoperative imaging confirmed results. The capsule was closed with a running double loop supramid suture and the metacarpophalangeal<br />

(MP) joint was then assessed <strong>for</strong> laxity. Following 4-week immobilization, the same CHT per<strong>for</strong>med postoperative follow-up at<br />

10 days, 4, 6, 8, 12 and 24 weeks. Pre and postoperative data was recorded.<br />

RESULTS/STATISTICS:<br />

Mean data normalized as percentage change from pre to postoperative measures and compared to uninvolved side revealed significant<br />

improvement of 39% <strong>for</strong> Disability Assessment <strong>for</strong> Shoulder/<strong>Hand</strong> (DASH), p=0.0194(54.17 ± 24 preoperative; 32.96 ± 25 postoperative)<br />

and 54% improvement in Visual Analogue Scale <strong>for</strong> Pain (VAS), p=0.0212 (8.51 ± 2.6 preoperative; 3.38 ± 2.5 postoperative).<br />

Total Active Motion(TAM) in the involved thumb increased by 9% postoperative and was 96% of values in the uninvolved thumb. Tripod<br />

Pinch strength was 68% of uninvolved side preoperatively and improved to 81% postoperatively. Grip strength improved by 22% postoperatively<br />

and was 77% of values in the uninvolved thumb.<br />

CONCLUSION:<br />

Mean values and early results reflected improvement and indicate that this procedure leads to high patient satisfaction with low complications<br />

and should be considered <strong>for</strong> CMC basilar joint OA.<br />

87


Combining a Clinical Software Program, Research Databases, and Novel Teaching Software<br />

with the Use of Medical In<strong>for</strong>matics in a Resource Limited Environment<br />

Institution where the work was prepared: Baylor College of Medicine, Houston, TX, USA<br />

Brian A. Janz, MD; Anthony Echo; Morgan E. Norris, MD, DDS; Nicholas A. Fiore II; Baylor College of Medicine<br />

Combining a clinical software program and research databases in a resource limited environment can be advantageous to clinicians<br />

because of the ability to efficiently store patient in<strong>for</strong>mation <strong>for</strong> both patient caring and later retrieval <strong>for</strong> research studies. The same<br />

user-interface, if linked to a repository of medical in<strong>for</strong>mation can assist with streamlining teaching while caring <strong>for</strong> patients (Figure 1).<br />

The goals of the project included capturing patient data that was readily available at the point of care and utilize it <strong>for</strong> both tracking<br />

patients within the hospital and storing the data <strong>for</strong> research purposes; while at the same time linking the user-interface to a database<br />

of medical in<strong>for</strong>mation <strong>for</strong> teaching purposes.<br />

SETTING:<br />

The software was designed to be utilized on a plastic surgery hand service at a major level one trauma center.<br />

METHODS:<br />

To accomplish this goal, a software program was designed to track hand surgery patients and serve as a large repository <strong>for</strong> key in<strong>for</strong>mation<br />

that can be utilized to assist with retrospective research projects. The user-interface was also designed to allow in<strong>for</strong>mation to<br />

be stored <strong>for</strong> prospective studies. A database of high yield upper extremity in<strong>for</strong>mation was compiled by topic which could be linked<br />

to patient diagnoses. The clinical-user interface and research tools were both designed using the Visual Studio.NET © environment<br />

coupled with a relational database to store in<strong>for</strong>mation. The standard demographic in<strong>for</strong>mation along with major diagnoses <strong>for</strong> each<br />

patient was linked to both DRG and ICD-9 codes to allow <strong>for</strong> efficient access when evaluating and querying the databases. Patient data<br />

was recorded during the time period from March 2006 until April 2007 <strong>for</strong> this study.<br />

RESULTS:<br />

The database currently stores in<strong>for</strong>mation <strong>for</strong> 184 patients. 64.2 % (n = 118) of the patients who underwent an operation were male. The<br />

major injury was related to trauma in 71.1 % (n = 131) of the cases. 48% of the trauma cases involved multiple injuries. Four-hundred<br />

and eighty three high yield clinical in<strong>for</strong>mation summaries were compiled and separated into twenty-one categories.<br />

CONCLUSION:<br />

The software program allows <strong>for</strong> the entry of data to assist with the tracking of patients on a hand surgery service. Concurrently, the software<br />

program allows <strong>for</strong> retrieval of stored data to assist with clinical research projects either prospectively or retrospectively. The quick<br />

links between diagnoses and medical in<strong>for</strong>mation summaries allows <strong>for</strong> a teaching module to assimilate with clinical and research userinterfaces.<br />

88


AAHS Concurrent Scientific Paper Session D<br />

Chimerism Induction and Maintenance in Composite Tissue Allograft Trans<strong>plan</strong>ts after<br />

Augmentation with Donor Specific BMT<br />

Institution where the work was prepared: Cleveland Clinic, Cleveland, OH, USA<br />

Wioleta Luszczek, PhD; Aleksandra Klimczak, PhD; Maria Siemionow, MD, PhD; Cleveland Clinic<br />

INTRODUCTION:<br />

Impact of donor bone marrow trans<strong>plan</strong>tation (BMT) on chimerism induction in different composite tissue allograft (CTA) models was<br />

investigated. Methods: Four CTA models were studied: (1) limb allograft (n=36), (2) composite hemiface trans<strong>plan</strong>t (n=26), (3) vascularized<br />

bone (n=10) and (4) composite vascularized skin allograft (n=10) trans<strong>plan</strong>ts. Trans<strong>plan</strong>ts were per<strong>for</strong>med across MHC barrier<br />

between ACI(RT1a, LBN(RT1l+n) or BN(RT1n) donors and LEW(RT1l) recipients under 7-day protocol of ??-TCR/CsA. All CTA allografts<br />

(except limb allografts) were augmented with donor BMT (70x106). Flow cytometry evaluated donor specific chimerism <strong>for</strong> MHC class<br />

I antigens in peripheral blood. Chimerism was evaluated as a contribution of donor T-(CD4, CD8) and B-lymphocytes (CD45RA).<br />

Immunohistochemistry determined engraftment of donor cells into lymphoid organs.<br />

RESULTS:<br />

In long-term survivals (over 100 days) chimerism levels were as follows: (1) limb allograft <strong>for</strong> T-cells 7.6% of CD4/RT1n, 1.3% of CD8/RT1n<br />

and 16.5% of CD45RA/RT1n <strong>for</strong> B-cells. (2) hemiface allograft trans<strong>plan</strong>ts T-cells chimerism revealed 2.8% <strong>for</strong> CD4/RT1n and 1.9% <strong>for</strong><br />

CD8/RT1n and 6.8% <strong>for</strong> CD45RA/RT1n B-cells population (3) vascularized bone allografts T-cells chimerism was assessed at 5.1% <strong>for</strong><br />

CD4/RT1n and 1.9% <strong>for</strong> CD8/RT1n and at 5.2% <strong>for</strong> CD45RA/RT1n B-cells. (4) In vascularized skin allografts T-cell chimerism was: 8.0%<br />

<strong>for</strong> CD4/RT1a, 2.6% <strong>for</strong> CD8/RT1a and 0.4% <strong>for</strong> CD45RA/RT1a <strong>for</strong> B-cells linage. In all CTA models immunochemistry confirmed presence<br />

of donor-origin cells in the lymphoid organs of recipients.<br />

CONCLUSION:<br />

The best engraftment of donor cells was achieved in limb allograft trans<strong>plan</strong>t model as confirmed by stable chimerism level in T-cells<br />

population at early post-trans<strong>plan</strong>t and was maintained by B-cells lineage. The lowest level of chimerism was found in vascularized skin<br />

allografts confirming importance of bone marrow compartment as an integral part of the graft. This data indicate that constant source<br />

of BM delivery in limb allograft model is permissive <strong>for</strong> chimerism induction and its maintenance at stable level. This mechanism would<br />

apply and be permissive in acceptance of hand allograft trans<strong>plan</strong>ts.<br />

Fifteen Year Follow-up of the Distal Single Scope Assisted Carpal Tunnel Release<br />

Institution where the work was prepared: Dr Ather Mirza, Smithtown, NY, USA<br />

M. Ather Mirza, MD; Mary Kate Reinhart, CNP; M. Ather Mirza, MD, PC<br />

TITLE:<br />

Fifteen Year Follow-up of the Distal Single Scope Assisted Carpal Tunnel Release<br />

INTRODUCTION:<br />

This study reports the fifteen-year follow-up (1855 cases) of the distal single incision scope assisted carpal tunnel release technique.<br />

METHODS:<br />

A 1.5 cm longitudinal distal single incision in the palm allows direct visualization of the distal edge of the transverse carpal ligament,<br />

median nerve, the superficial palmar arch, and any abnormal structures. A specially designed knife/sleeve unit mounted on a standard<br />

4mm endoscope allows division of the transverse carpal ligament with a distal-to-proximal pass.<br />

RESULTS:<br />

Among those in whom the interthenar fascia is preserved, high lateral pinch strength was reported. Postoperative pinch and grip<br />

strength were near or greater than preoperative levels by eight weeks. The mean overall return to work time was 21 days. Among the<br />

patients reporting analgesic usage, 27% required no postoperative analgesics. Patients reported minimal scar, ulnar and radial pillar<br />

tenderness. There were no permanent injuries to the median nerve or superficial palmar arch.<br />

CONCLUSION:<br />

This technique allows <strong>for</strong> a small cosmetically appealing scar, direct identification of key anatomy, higher strength and function in early<br />

postoperative periods, and an overall early return to work and activities of daily living. This technique has shown excellent long- and<br />

short-term results.<br />

89


A Simple Method to Demonstrate Collateral Sprouting of An Intact Axon at End-to-side Neurorrhaphy Site<br />

Institution where the work was prepared: The First Affilated Hospital of Sun Yat-Sen University, Guangzhou, China<br />

Qing Tang Zhu, MD, PhD1; Jia Kai Zhu, MD2; Zhen Guo Lao, MD2; Xiao Lin Liu, MD, PhD2; Gary Chen, MD1;<br />

(1)Cali<strong>for</strong>nia Hospital Medical Center, (2)The First Affilicated Hospital of Sun Yat-Sen University<br />

Recent experimental studies had suggested the successful nerve regeneration of an injured nerve repaired with end-to-side neurorrhaphy<br />

technique. However, the origin of the regenerating axons is still controversial. Some studies demonstrated that regenerating axons<br />

emerged at sites far proximal to the coaptation site. Some studies indicated nerve damage was a prerequisite <strong>for</strong> axonal regeneration<br />

through end-to-side neurorrhaphy, the regenerating axons originated from terminal sprouting of the proximal stump of the injured<br />

donor nerve. Most studies supported that the regenerating axons sprouted collaterally from the donor nerve at the neurorrhaphy site.<br />

Considering retrograde tracing or electrophysiological study only provided indirect evidences of collateral sprouting from the donor<br />

nerve, we presented a simple method to directly demonstrate collateral sprouting of an intact axon at end-to-side neurorrhaphy site.<br />

5 Wistar adult rats were used in this study. The common peroneal nerves at one side were sectioned and their distal ends were sutured<br />

laterally to the tibial nerves after removal of a 1-mm-diameter window in the epineurium. 3 months postoperatively, the nerve segments<br />

at neurorrhaphy site and the contralateral normal tibial nerves were harvested. The specimens were fixed in 10% <strong>for</strong>maldehyde and<br />

postfixed in 1% osmium tetroxide, then macerated in glycerol. Single nerve fiber was teased out with microsurgical instruments in pure<br />

glycerol under an operative microscope, then transferred to a slide and observed under light microscope. We found that small nerve<br />

fibers sprouted collaterally from a donor nerve fiber near nodes of Ranvier (Fig 1). However, such phenomena could not be found in<br />

normal tibial nerve without end-to-side neurorraphy. This study provided a direct evidence of collateral sprouting of an intact axon at<br />

end-to-side neurorraphy site. Nerve fiber micro-tease technique is a simple method to demonstrate such a phenomenon.<br />

Real Time in Vivo Imaging of Neural Microarchitecture with Coherent Anti-stokes Raman<br />

Scattering (CARS) Microscopy<br />

Institution where the work was prepared: Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA<br />

Francis Patrick Henry, MD; Daniel Cote, PhD; M.A. Randolph, MAS; Irene E. Kochevar, PhD; Charles P. Lin, PhD;<br />

Jonathan M. Winograd, MD; Massachusetts General Hospital, Harvard Medical School<br />

INTRODUCTION:<br />

Current analysis of nerve injury and repair relies largely on electrophysiological and ex vivo histological techniques. In vivo architectural<br />

assessment of a nerve without removal or destruction of the tissue would greatly assist in the grading of nerve injury and in the monitoring<br />

of nerve regeneration over time. CARS Microscopy is a nonlinear optical process using ultrashort laser pulses to probe molecular<br />

vibrational structures and con<strong>for</strong>mations in tissue with a particular sensitivity <strong>for</strong> high lipid containing molecules such as myelin. This<br />

minimally invasive, non-thermal technique offers high resolution images of neural microarchitecture, which we aim to evaluate in both<br />

normal and injured nerve.<br />

METHODS:<br />

A standard demyelinating crush injury was reproduced in the sciatic nerves of male Sprague Dawley rats. Animals were randomized into<br />

groups and CARS microscopy was undertaken at Day 1 and weeks 2, 3 and 4 following injury. The uninjured nerve was used as a control.<br />

Functional analysis was undertaken weekly with standardized walking track analysis. Histomorphometry of both control and injured<br />

nerve was undertaken following imaging to allow verification of our findings.<br />

RESULTS:<br />

All animals demonstrated loss of sciatic nerve function following nerve injury. Recovery was documented with sciatic functional index<br />

data approaching normal at three weeks. Demyelination was confirmed in nerves up to three weeks post injury. Remyelination was<br />

observed in the three week group and beyond (fig. 1). Imaging of the control nerves revealed structured myelin bundles as shown in<br />

fig. 2. These results were consistent with histological findings.<br />

CONCLUSION:<br />

We conclude that CARS Microscopy has the ability to image the peripheral nerve following demyelinating crush injury. This technology<br />

which permits in vivo, real time microscopy of nerves at a resolution of 5-10 microns could provide invaluable diagnostic and prognostic<br />

in<strong>for</strong>mation about intraneural preservation and recovery following injury.<br />

90


Innervations of the Medial Head of the Triceps by the Ulnar Nerve<br />

Institution where the work was prepared: Department of Orthopaedic Surgery Columbia Uni. Medical Cen., New York, NY, USA<br />

Halil I. Bekler, MD; Joy Christiane Vroemen; Jason M. McKean; Melvin P Rosenwasser; Columbia University Medical<br />

Center<br />

INTRODUCTION:<br />

Surgical observations suggested that ulnar nerve give some motor branches to medial head just proximal to Cubital tunnel. Material<br />

and Methods: Seventeen fresh frozen human cadaver upper limbs from eleven cadavers were used. Nine of cadavers used were male,<br />

two female with an average age of 61.9 years. The medial head of the triceps (MHT) and ulnar nerve were exposed by a long medial<br />

incision over the upper arm and the soft tissue was dissected under 3.5 loupe magnification. For each dissection we measured how far<br />

the origin of the motor branch of the MHT was from the Cubital tunnel. Specimens of nerve branches from the ulnar nerve innervating<br />

the medial head of the triceps were taken, fixed in <strong>for</strong>malin, embedded in paraffin, sectioned at nerve-muscle connection and impregnated<br />

with silver nitrate to visualize axons and end-plates.<br />

RESULTS:<br />

Nerve branches from ulnar nerve were observed proximal to the cubital tunnel. These branches entered in the medial head of triceps<br />

muscle. The branches from the ulnar nerve comprised two or three separated fascicle that usually accompanied by vascular tissues.<br />

Discussion: A consistent presence of the motor branch to MHT arising from the ulnar nerve was observed. Branches are from the ulnar<br />

collateral branches of radial nerve having anatomical integrity with ulnar nerve.<br />

CONCLUSION:<br />

On the basis of cadaver specimen dissection and in vivo motor nerve stimulation, the ulnar nerve gives motor branches to the MHT.<br />

Figure 1: Ulnar nerve motor branch to the medial head of the triceps.<br />

Endoscopic Revision of Carpal Tunnel Release<br />

Institution where the work was prepared: University of Washington, Seattle, WA, USA<br />

Shai Luria, MD; Thanapong Waitayawinyu; Thomas E. Trumble; University of Washington<br />

BACKGROUND:<br />

Open revision with or without internal neurolysis has been the standard approach <strong>for</strong> treatment of recurrent carpal tunnel syndrome<br />

(CTS). Our hypothesis was that endoscopic revision without neurolysis will result in comparable results to open revision.<br />

METHODS:<br />

Forty-one patients with unilateral recurrence were prospective analyzed be<strong>for</strong>e and after endoscopic revision <strong>for</strong> a period of one year.<br />

All had clinical signs or symptoms, a positive response to a steroid injection and electrodiagnostic findings consistent with CTS after<br />

primary open release and had failed to improve after an average of 16 months. Follow-up evaluations were per<strong>for</strong>med with validated<br />

outcome instruments and quantitative measurements of strength and sensation. Results - Thirty-seven of the 41 patients reported<br />

improvement after the endoscopic revision. Significant improvement was seen at 3 and 12 months after the procedure in the CTS<br />

Symptom Severity Scores (SSS), the CTS Functional Status Scores (FSS), the UW satisfaction score, pinch strength and sensation and a<br />

decrease in scar sensitivity. An improvement in grip strength was measured after 12 months. The satisfaction score was found to be significantly<br />

correlated to the SSS and FSS.<br />

CONCLUSION:<br />

Endoscopic release of recurrent CTS may be per<strong>for</strong>med safely using standard technique with good results without the per<strong>for</strong>mance of<br />

neurolysis. The advantage of the procedure is the ability to approach the tunnel while avoiding the scaring related to the previous open<br />

approach. This technique is not adequate <strong>for</strong> cases after several open revisions, suspected nerve injury or extension of the previous<br />

open approach proximal to the wrist crease.<br />

91


Practical Clinical Guide <strong>for</strong> the Management of Chronic Pain Secondary to Neuropathic<br />

Conditions<br />

Institution where the work was prepared: <strong>Hand</strong> and Microsurgery Center of El Paso and UTEP, El Paso, TX, USA<br />

Jose Monsivais, MD; <strong>Hand</strong> & Microsurgery Center; Kris Robinson, PhD, FNP; University of Texas at El Paso<br />

INTRODUCTION:<br />

Chronic pain secondary to peripheral neuropathic conditions is frequently seen in clinical practice. However, precipitous surgical treatment<br />

in the presence of undiagnosed psychosocial dysfunction will end up in frustration <strong>for</strong> both the surgeon and the patient.<br />

MATERIALS/METHOD:<br />

Psychosocial dysfunction was recognized through clinical acumen and the use of multidimensional assessment of pain (VAS, Wong-<br />

Baker, and BPI). The clinical diagnosis of neuropathy was determined using standard sensory-motor evaluations and electrodiagnostic<br />

and imaging studies (MRI). An archival review of records from 91 patients treated <strong>for</strong> neuropathic pain over a ten-year period in a specialty<br />

clinic were included. Inclusion criteria were individuals with proven nerve dysfunction experiencing pain > 3 months. Surgical candidates<br />

were determined by the severity of sensory-motor abnormalities and showed evidence of improved psychosocial functioning<br />

as measured by the Brief Pain Inventory (BPI). Surgical procedures included nerve decompressions, reconstruction, neurolysis, and excision<br />

of neuromas. Medical treatment included analgesics, adjuvants, and neuroleptic medications. Psychosocial treatment included a<br />

prescription to remain or return to work on a predetermined date and daily exercise. Patient progress was monitored by pain diary, BMI,<br />

pulse, and biological markers when applicable. Participants received periodic clinical evaluation of sensory and motor function, and<br />

assessment of pain.<br />

RESULTS:<br />

Over 93% (85/91) of patients returned to work and reported lower levels of pain up to 5 years after onset of nerve injury/ condition. In<br />

addition, no differences were noted between individuals treated medically or surgically on a variety of psychosocial measures after treatment<br />

including pain level (p=.2), litigation status (p > .5), and return to work (p>.05). The majority of individuals expected total relief of<br />

pain with surgical treatment. This issue needs to be addressed to insure that patients have a realistic expectation of the treatment,<br />

whether surgical or medical.<br />

CONCLUSION:<br />

With psychosocial assessment, support, and adequate pain treatment, there seems to be no difference in functional outcomes on several<br />

levels between those patients receiving surgical and non-surgical treatment. Patients' expectations of total pain relief with surgery<br />

are unrealistic and must be addressed prior to treatment. In summary, early recognition and treatment of psychosocial dysfunction leads<br />

to improved outcomes as measured by improvement in pain, neurological signs/symptoms, and functionality.<br />

92


An Upper Limb Reach and Grasp Cycle <strong>for</strong> Children<br />

Institution where the work was prepared: Stan<strong>for</strong>d University, Stan<strong>for</strong>d, CA, USA<br />

Amy L. Ladd, MD; Erin Butler; Stephanie Louie; Wendy Wong; Andrew Rogers; Jessica Rose; Stan<strong>for</strong>d University<br />

Medical Center<br />

SUMMARY:<br />

We developed a ìReach and Graspî Cycle to evaluate upper limb motor per<strong>for</strong>mance in children, with consistent kinematic patterns<br />

emerging among control subjects <strong>for</strong> seven specified joint motions. The low coefficient of variation (CV) <strong>for</strong> elbow flexion/extension in<br />

each of the five phases of the Reach and Grasp cycle suggests a repeatable upper limb cycle <strong>for</strong> object evaluation of functional motor<br />

per<strong>for</strong>mance.<br />

INTRODUCTION:<br />

While a normative protocol exists <strong>for</strong> evaluating lower limb gait deficits [Schutte], kinematic analysis of the upper limb is more challenging<br />

and only recently examined [Mosqueda, Fitoussi]. We propose a ìReach and Graspî Cycle that is defined by upper limb kinematics<br />

and is consistent among children and adolescents.<br />

MATERIALS/METHODS:<br />

Three-dimensional kinematic data were recorded from 17 children (9 males and 8 females, ages 5-18 years) during a single Reach and<br />

Grasp cycle. We divided the upper limb ìReach and Graspî Cycle into five phases: 1) initial position, 2) reach and grasp an object placed<br />

at 75% total reach, 3) retract arm, bring object toward self, 4) reach and replace object, and 5) return arm to initial position (Figure 1).<br />

Light-reflective markers were placed on the children's torso and upper limbs, and a 3-D motion analysis system captured and processed<br />

upper limb kinematics <strong>for</strong> seven primary joint motions of the dominant arm and trunk (Motion Analysis Corportation, Santa Rosa, CA).<br />

We calculated the mean ± 1 standard deviation (SD) <strong>for</strong> every 2% increment of the cycle, and determined the coefficient of variation<br />

(CV) <strong>for</strong> elbow flexion/extension. We also evaluated upper limb kinematics <strong>for</strong> one child, age 6.5 years, with mild hemiplegic cerebral<br />

palsy (CP).<br />

RESULTS:<br />

Consistent normal kinematic patterns emerged <strong>for</strong> each of the seven motions: trunk flexion/ extension; shoulder elevation/ extension;<br />

shoulder rotation; elbow flexion/ extension; Forearm pronation/ supination; wrist flexion/ extension; and ulnar/ radial deviation. The<br />

mean ± 1 SD (CV) <strong>for</strong> peak elbow flexion/ extension in each of the five phases were: 82±13 (16%), 53±12 (22%), 127±6 (5%), 54±12 (22%),<br />

and 82± 14 (18%). The child with mild CP demonstrated decreased shoulder elevation, increased shoulder internal rotation, and<br />

reduced elbow extension, compared to the normative data. DISCUSSION The defined Reach and Grasp cycle has potential to provide<br />

an effective classification system <strong>for</strong> upper limb kinematics based on 3-D motion analysis. Such a system is necessary to advance our<br />

understanding of upper limb motor disorders and improve therapeutic modalities <strong>for</strong> the upper limb.<br />

93


Anticoagulation in Digital Revascularization and Reim<strong>plan</strong>tation Surgery: a Complete Analysis<br />

of Beneficial and Detrimental Effects<br />

Institution where the work was prepared: Montreal University Health Care Center, Montreal, Canada<br />

Youssef Tahiri, medical, student; Patrick Harris, MD; Genevieve Landes, MD; Valerie Lemaine, MD; Andreas Nikolis,<br />

MD; UniversitÈ de MontrÈal, HÙpital Notre-Dame<br />

INTRODUCTION:<br />

Anticoagulation administration in digital re<strong>plan</strong>tation microsurgery is not without serious consequences. Furthermore, no consensus exists<br />

among microsurgeons regarding indications, timing and duration of medication administration. The aim of the study is to better establish<br />

the efficacy and risks associated with three different thromboprophylaxis regimens commonly used in digital re<strong>plan</strong>tation microsurgery.<br />

MATERIALS/METHODS:<br />

All patients consecutively treated at a specialized microsurgical re<strong>plan</strong>tation center from April 2004 to April 2006 were evaluated. All<br />

traumatically severed digits revascularized or reim<strong>plan</strong>ted over the study period were included. Demographic data, injury characteristics,<br />

as well as type, dosage, duration and timing of medication administration <strong>for</strong> thromboprophylaxis were assessed. Primary endpoints<br />

with respect of thromboprophylaxis regimens efficacy and risks were i) the proportion of successfully re<strong>plan</strong>ted digits at the<br />

moment of patient discharge and ii) the incidence of complications in the immediate and short term post-operative periods.<br />

Proportions were compared by using X≤ tests and multivariate analyses were conducted with logistic regression.<br />

RESULTS:<br />

Over a 2-year period, 151 digits were treated: 91 revascularization and 60 reim<strong>plan</strong>tation procedures. Sixty-five percent of digits received<br />

pre-operative aspirin at dosing of 325 mg. Overall, 98.0% of the digits received post-operative thromboprophylaxis regimens: 51,0%<br />

received aspirin 80 mg once daily plus subcutaneous heparin 5000 U twice daily (group A; n=77) <strong>for</strong> a mean duration of 4.8 days (±1.4<br />

days), 33.1% received aspirin 80 mg once daily plus IV heparin (group B; n=50) <strong>for</strong> a mean duration of 5.3 days (±1.9 days), and 13.9%<br />

received two weeks of aspirin 80 mg once daily (group C; n=21). Success rates at discharge were as following: group A 96.1%, group B<br />

90.0%, and group C 85.7% (p=0.191). Short term complication rates in groups A, B, and C were similar at 24.7%, 42.0%, and 33.3%<br />

respectively (p=0.121). Controlling <strong>for</strong> age, smoking status and the intervention per<strong>for</strong>med, the type of anticoagulation regimen was<br />

not significantly related to success rates, whereas digits on IV heparin had a 2.4 times greater risk of complication than digits on subcutaneous<br />

heparin (95% CI, 1.5-5.4).<br />

CONCLUSION:<br />

Important discrepancies were outlined in the administration of anticoagulation regimens in digital re<strong>plan</strong>tation surgery. When considering<br />

short-term outcomes following microsurgical digital reim<strong>plan</strong>tation and revascularization interventions, no significant survival differences<br />

were identified based on the type of regimen used. Digits receiving IV heparin had a significantly greater risk of post-operative<br />

complications than those receiving subcutaneous heparin.<br />

94


Local Immunotherapy Inhibits Skin Rejection in Composite Tissue Allotrans<strong>plan</strong>tation<br />

Institution where the work was prepared: University of Pittsburgh, Pittsburgh, PA, USA<br />

Mario G. Solari, MD; Kia M. McLean; Justin M. Sacks; Theresa Hautz; Jignesh V. Unadkat; Elaine K. Horibe; Vijay S.<br />

Gorantla; Stefan Schneeberger; Angus W. Thomson; W.P. Andrew Lee; University of Pittsburgh<br />

INTRODUCTION:<br />

Skin is the most immunogenic component of a composite tissue allograft (CTA). Clinically this has manifested as multiple acute skin<br />

rejection episodes in most of the human CTA per<strong>for</strong>med to date. Intravenous steroids and increased systemic immunosuppression have<br />

been used to mitigate these rejection episodes. These drugs cause direct organ toxicity and are associated with metabolic dysfunction,<br />

opportunistic infection, and malignancy. Topical immunotherapy is an attractive and practical therapeutic option to provide local<br />

immunosuppression with minimal systemic toxicity. Topical tacrolimus is known to reduce the stimulatory activity of antigen presenting<br />

cells (APC) toward autologous T cells in atopic dermatitis. The present study applies these properties to CTA. It investigates the potential<br />

of topical tacrolimus to maintain a CTA after total withdrawal of a short course of systemic therapy.<br />

METHOD:<br />

Wistar Furth to Lewis (full MHC mismatch) orthotopic hind limb trans<strong>plan</strong>ts were per<strong>for</strong>med. Groups included: I- topical tacrolimus<br />

alone, II- anti-lymphocyte serum (ALS) (0.5mL x2 doses) + 21 days cyclosporine (CsA) (10/mg/kg/day), III- ALS (2 doses) + 21 days CsA<br />

+ topical tacrolimus once daily. The endpoint of the study is grade 3 rejection, defined by epidermolysis, or 100 days (long term survival).<br />

Biopsies of skin, muscle, and bone were taken <strong>for</strong> immunohistochemistry and H&E.<br />

RESULTS:<br />

All animals in Group I (n=7) developed grade 3 clinical rejection by postoperative day (POD) 9, similar to controls without treatment. The<br />

mean onset of grade 3 rejection was POD 40 with a range of 34-44 in Group II (n=7). In Group III (n=6), two animals developed grade 3<br />

rejection on POD 35 and 56. The remaining 4 experimental animals reached the 100 day endpoint without grade 3 rejection (Fig 1).<br />

CONCLUSION:<br />

This study demonstrates the feasibility of maintaining a CTA on topical tacrolimus therapy alone after induction therapy. The induction<br />

protocol in this model mirrors what is currently per<strong>for</strong>med clinically where recipients undergo lymphoid depletion be<strong>for</strong>e organ trans<strong>plan</strong>tation,<br />

followed by systemic immunosuppression. Preoperative depletion of T cells with ALS, along with a short course of systemic<br />

immunosuppression, prevents acute rejection, while topical tacrolimus may inhibit immune cell activation and multiplication in the skin<br />

component of the CTA. This novel regimen could reduce or eliminate the morbidity associated with systemic immunosuppression in<br />

clinical CTA.<br />

95


Rate of reoperation following digital re<strong>plan</strong>tation and revascularization surgery in a designated<br />

Provincial University Re<strong>plan</strong>tation Program<br />

Institution where the work was prepared: Centre hospitalier de l'Universite de Montreal, Montreal, QC, Canada<br />

Valerie Lemaine, MD; GeneviËve Landes; Patrick Harris; André Chollet; Youssef Tahiri; Andreas Nikolis; UniversitÈ de<br />

MontrÈal, HÙpital Notre-Dame<br />

PURPOSE:<br />

The Quebec Provincial Re<strong>plan</strong>tation Program (QPRP) is comprised of a core group of twelve microsurgeons who cover the entire<br />

province of Quebec, Canada <strong>for</strong> all microsurgical emergencies (n=120 patients/year). The impetus <strong>for</strong> creation of the program included<br />

centralizing surgeon expertise to one designated center, increasing the surgeons' exposure to infrequent surgical traumas, and<br />

developing and refining protocols <strong>for</strong> this trauma population. As our outcomes <strong>for</strong> successful re<strong>plan</strong>tation or revascularization have<br />

reached approximately 90%, our next step in the evolution of the program is the evaluation of secondary procedures. Further surgery<br />

following digital re<strong>plan</strong>tation or revascularization is frequently necessary in improving function, this in conjunction with a tailored rehabilitation<br />

program. The goals of this study were first, to determine the rate of reoperation in a unique patient population; second, to identify the<br />

type and frequency of procedures per<strong>for</strong>med; and finally, to establish which factors predisposed patients to reoperation.<br />

METHOD:<br />

An observational study was conducted from April 2004 to March 2005. Patients who underwent successful digital microsurgery were<br />

included. Data was abstracted from hospital and office charts, as well as through patient interviews conducted in the follow-up period.<br />

In<strong>for</strong>med consent was obtained from all study participants.<br />

RESULTS:<br />

A total of 68 patients who suffered hand trauma requiring digital microsurgery were included. The combined digital survival rate in these<br />

patients was 88.9%. Twenty-five of these patients (41.7%) had one or more secondary procedures. Secondary procedures in patients<br />

who had successful digital microsurgery were divided into an early group (< 2 months after the initial surgery) and a late group (> 2<br />

months after the initial surgery). In the early group, approximately half of the procedures were per<strong>for</strong>med <strong>for</strong> anastomotic problems (all<br />

within 10 days). In the late group, 37.5% of procedures were bone-related surgeries <strong>for</strong> functional improvement, followed by joint-related<br />

procedures (25%). Avulsion injury, multiple-digit trauma and zone II injuries were significantly associated with a higher rate of reoperation.<br />

No significant association was found between the incidence of secondary procedures and smoking, alcohol consumption,<br />

patient age, or the digit traumatized.<br />

CONCLUSION:<br />

This study reports a rate of reoperation of 41.7% within 24 months following successful digital microsurgery, which is comparable to<br />

published data. Early procedures were predominantly emergency surgeries <strong>for</strong> anastomotic problems while late procedures were mainly<br />

bone grafts and arthrodesis <strong>for</strong> functional improvement.<br />

Survey of The Current State of Upper Extremity Re<strong>plan</strong>tation in North America<br />

Institution where the work was prepared: University of Texas Southwestern, Dallas, TX, USA<br />

David W. Mathes, MD1; Dan Hatef2; Michel Saint-Cyr2; (1)University of Washington, (2)University of Texas Southwestern<br />

Medical Center<br />

INTRODUCTION:<br />

Re<strong>plan</strong>tation is the standard of care <strong>for</strong> treatment of selected upper extremity amputations. While many technical steps central to successful<br />

re<strong>plan</strong>tation have been standardized, significant variations in their management exist. We sought to examine the frequency, success,<br />

and the technical variations in digital re<strong>plan</strong>tation per<strong>for</strong>med at re<strong>plan</strong>t centers in North America.<br />

METHODS:<br />

In 2006, a 3-page survey on the current management of upper extremity re<strong>plan</strong>ts was sent to 58 centers that have an active <strong>Hand</strong> surgery<br />

training program. Surveys were mailed to each program and results were evaluated in a blinded fashion. The survey examined the<br />

pre-operative, intra-operative and post-operative management of the upper extremity re<strong>plan</strong>ts.<br />

RESULTS:<br />

Of the 58 surveys sent out, we received 31 responses (55.4% response rate). The majority of programs per<strong>for</strong>m 1 to 10 re<strong>plan</strong>ts per<br />

month (84.6) while one program reported 31 to 40 re<strong>plan</strong>ts per month. The success rate of these re<strong>plan</strong>ts was high in all programs with<br />

32% of them reporting 100% success rate. Sixty percent of the program surveyed stated that they were per<strong>for</strong>ming single digit re<strong>plan</strong>ts<br />

(excluding thumb) with 17 of the programs re<strong>plan</strong>ting single digits amputated in zone 1. Most hand surgeons employed intra-operative<br />

heparin (96.2%) but the dosage varied. However, only 57.6% of the programs used post-operative heparin while and even smaller<br />

group (36%) use Dextran. The most common method of post-operative monitoring was oxygen saturation monitoring (50%). <strong>Hand</strong> held<br />

Doppler was used in only 26.9% of the programs. The majorities of the centers keep their patients hospitalized <strong>for</strong> an average of 5 days<br />

(42.3%) and begin post-operative mobilization at 2 weeks (44.4%).<br />

CONCLUSION:<br />

This survey indicates that variations in re<strong>plan</strong>t management mostly involve post-operative medical care. The liberal use of aspirin, vein<br />

grafts, and K wire fixation were found in most training programs. The survey provides a cross sectional assessment of digital re<strong>plan</strong>tation<br />

practices in North America and could provide the basis <strong>for</strong> further multi-institutional examination of what constitutes the best management<br />

of the digital re<strong>plan</strong>t.<br />

96


The Effect of Donor Presensitization on the Immunotolerance in Composite Tissue<br />

Trans<strong>plan</strong>tation in Rat Groin Flap Model<br />

Institution where the work was prepared: Cleveland Clinic, Cleveland, OH, USA<br />

Mehmet Bozkurt, MD; Serdar Nasir; Aleksandra Klimczak; Lukasz Krokowicz; Wioleta Luszczek; Maria Siemionow;<br />

Cleveland Clinic<br />

INTRODUCTION:<br />

New protocols are needed <strong>for</strong> tolerance induction in composite tissue allograft (CTA) such as human hand. It is well documented that<br />

bone marrow trans<strong>plan</strong>tation induces donorñspecific immune-tolerance through the creation of mixed chimerism. Donor sensitization<br />

with the recipient bone marrow be<strong>for</strong>e trans<strong>plan</strong>tation is a new approach to induce immuntolerance. We demonstrated the effect of<br />

donor sensitization on the immune response to vascularized skin allografts.<br />

METHODS:<br />

Fourty trans<strong>plan</strong>tations were per<strong>for</strong>med in 8 experimental groups of 5 animals each. Allograft trans<strong>plan</strong>ts were per<strong>for</strong>med between presentisized<br />

ACI donors and Lewis recipients. In each experimental group ACI (RT1a) donor rats were presentisized with Lewis (RT1l) bone<br />

marrow (80x106 cells) 24 hours (group I, III, V, VII) or 72 hours (group II, IV, VI, VIII) be<strong>for</strong>e trans<strong>plan</strong>tation. In groups I, II, V, VI donors<br />

received ??-TCR and cyclosporine (CSA) treatment therapy be<strong>for</strong>e trans<strong>plan</strong>tation. Animals in groups III, IV, VII, and VIII did not receive<br />

??-TCR. After groin flap trans<strong>plan</strong>tation Lewis (RT1l) recipients in groups V, VI, VII, VIII were under 7 day protocol of ??-TCR and CSA.<br />

Recipients in groups I, II, III, IV did not receive any kind of immunosupression. Be<strong>for</strong>e trans<strong>plan</strong>tation bone morrow cells (BMC) were<br />

stained with PKH dye to evaluate migratory process of donor BMC. Assessment included flap viability, flow cytometry <strong>for</strong> donor<br />

chimerism, and immunohistochemistry.<br />

RESULTS:<br />

In the control groups VSA were acutely rejected within 5 to 9 days. The mean survival of VSA was 82 days in Group V, 73 days in group<br />

VI, 75 day in Group VII and 54 day in group VIII. Donor specific chimerism in peripheral blood was estimated by presence of T and B<br />

cells. Total chimerism levels <strong>for</strong> Group V at day 7, 21, 35 and 63 were 4.93%, 1.75%, 2.46%, 1.45% respectively and Group VI 3.6%, 2.37%,<br />

1, 87%, and 0.48% respectively. Chimerism level <strong>for</strong> Group VI (24 hour after bone marrow trans<strong>plan</strong>tation) were at 7th 21st 35th 63rd are<br />

3.92%, 1.26%, 1.64%, 1.42% respectively and <strong>for</strong> group VIII were 4.82%,2.29%, 2.37%, 2.25% at respective days.<br />

CONCLUSION:<br />

Donor sensitization with recipient BM modified the recipient's responsiveness to VSA. This study proved that immunomodulation is not<br />

required <strong>for</strong> donor presensitization however is mandatory during allograft trans<strong>plan</strong>tation. Significant extension of skin allograft survival<br />

is encouraging and in future boosting dosage of BM may facilitate tolerance induction in composite allograft allotrans<strong>plan</strong>tation.<br />

Pedicled Radial Artery Removal Does Not Compromise Palmar Microcirculation Among<br />

Arteriosclerotic Patients<br />

Institution where the work was prepared: Hannover Medical School, Hannover, Germany<br />

Karsten Knobloch, MD, PhD; Sandra Tomaszek; Marcus Spies; Kay H. Busch; Peter M. Vogt; Hannover Medical School<br />

BACKGROUND:<br />

Radial artery <strong>for</strong>earm flaps are used <strong>for</strong> reconstruction of soft tissue defects. However, the functional consequences of removal of the<br />

radial artery <strong>for</strong> hand perfusion remain unclear. There<strong>for</strong>e, we determined palmar microcirculation in a long-term follow-up among arteriosclerotic<br />

patients following removal of the radial artery <strong>for</strong> revascularisation.<br />

METHODS:<br />

A total number of 114 patients (100 males, 61.7±6.7 years) were included undergoing elective coronary revascularization using the radial<br />

artery of the non-dominant <strong>for</strong>earm with non-pathological Allen-Test. Palmar microcirculatory mapping was applied regarding capillary<br />

flow, finger tip oxygenation as well as postcapillary venous filling pressures throughout both hands at a mean 25±5months following<br />

removal of the radial artery using combined non-invasive real-time Laser-Doppler flowmetry & spectrophotometry (Oxygen-to-see,<br />

LEA Medizintechnik, Giessen, Germany).<br />

RESULTS:<br />

25±5months following radial artery removal only 2/56 positions revealed a difference beyond a 5% threshold. Superficial capillary blood<br />

flow decreased by 13% at the hypothenar eminence (242.0±153.6 vs. 275.6±169.2, p=0.009). Deep postcapillary venous filling pressure<br />

(8mm) was significantly increased by 9% only at the fingertip of the fifth finger (112.4±49.7 vs. 103.0±25.0, p=0.033). No clinical signs of<br />

malperfusion were found following radial artery removal and no patient was impaired in his daily palmar motor activity.<br />

CONCLUSION:<br />

Pedicled removal of the radial artery does not compromise superficial or deep palmar capillary blood flow, finger tip oxygenation or<br />

postcapillary venous filling pressures in a long-term perspective in arteriosclerotic patients. No clinical relevant signs of malperfusion or<br />

any deterioration of palmar motor function was encountered. The blood flow via the ulnar artery and the interosseal artery compensates<br />

palmar perfusion without microcirculatory deterioration even more than two years following removal of the radial artery.<br />

97


AAHS Outstanding Nerve Paper Presentations<br />

Aberrant Anatomy Does Not Preclude Safe Carpal Tunnel Release Via a Limited-Open<br />

Approach<br />

Institution where the work was prepared: Allegheny General Hospital, Pittsburgh, PA, USA<br />

Caitlin Gannon, BS; Mark E. Baratz; Allegheny General Hospital<br />

HYPOTHESIS:<br />

The presence of aberrant anatomy during a limited-open carpal tunnel release does not require conversion to an open procedure.<br />

Patients with aberrant anatomy who undergo a limited-open approach can have successful and safe outcomes.<br />

MATERIALS/METHODS:<br />

One thousand three hundred sixty-nine patients underwent carpal tunnel release (CTR) between January 2000 and April 2007 were<br />

identified and 1,091 patients were included in the study. Patients were excluded if their surgical record could not be found. There were<br />

709 women and 381 men. Anomalies were categorized by those involving the median nerve, anomalous muscles or tendons, and aberrant<br />

arteries or veins. Anomalous nerves were often seen in the presence of anomalous fibers of thenar muscle that crossed the midline<br />

of the palm. In each case the nerve was dissected back to the main trunk of the median nerve. When the nerve could be traced to<br />

the median nerve in the distal 25% of the carpal canal, limited open release using a knife and guide proceeded in a typical fashion.<br />

Otherwise, we per<strong>for</strong>med a <strong>for</strong>mal open carpal tunnel release tracing the motor branch until it rejoined the median.<br />

RESULTS:<br />

Of the 1,091 carpal tunnel releases, 66 (6%) showed aberrant anatomy of the motor branches, muscle, or a combination of motor<br />

branches and muscle. The anomalies included thirty-five (54%) transligamentous aberrant motor branches of the median nerve, 1 (2%)<br />

subligamentous aberrant motor branch, 1 (2%) intraligamentous anomalous nerve branch, and 1 (2%) median nerve was aberrant to the<br />

radial leaflet. Of the other anomalies found 34 patients (52%) had anomalous muscles, 8 (12%) hands contained an aberrant motor<br />

branch and anomalous muscle, 1 had a palmaris longus tendon within the carpal canal and 1 patient (2%) had an aberrant median artery<br />

and vein passing superficial to the transverse carpal ligament. Sixty-five of the procedures were able to proceed safely through a limited-open<br />

approach using a knife and guide designed to facilitate limited open release. One procedure, where the aberrant motor<br />

branch was intra-ligamentous, required conversion to an open release.<br />

SUMMARY:<br />

In our experience, most aberrant branches of the median nerve split the distal fibers of the transverse carpal ligament on the ulnar side<br />

of the median nerve and cross the field to enter the thenar musculature. In all but one instance the nerve could be safely dissected<br />

through the small distal incision, allowing the release to proceed via a limited-open approach.<br />

98


Efficacy of Endoscopic Cubital Tunnel Release<br />

Institution where the work was prepared: Orthopaedic Specialists, PC, Davenport, IA, USA<br />

Tyson Cobb, MD1; Jon Lemke, PhD2; Jennifer Tyler, PA1; Patrick Sterbank, PA1; (1)Orthopaedic Specialists, PC, (2)Genesis<br />

Medical Center<br />

HYPOTHESIS:<br />

Endoscopic cubital tunnel release is as efficacious as open release based on resolution of preoperative paresthesias in the ulnar nerve<br />

distribution.<br />

METHODS:<br />

Records from 113 consecutive cases of endoscopic cubital tunnel releases per<strong>for</strong>med in 99 patients were retrospectively reviewed.†<br />

Patients were queried as to the presence or absence of numbness and tingling in the ulnar nerve distribution.† There were 104 of the<br />

113 cases of endoscopic cubital tunnel release who had preoperative paresthesia.† The 9 who did not have preoperative paresthesia<br />

underwent the endoscopic cubital tunnel release as a prophylactic measure due to the nature of concomitant surgery.† Preoperative<br />

severity was classified using Dellon's classification.† Two control groups (submuscular transposition and simple decompression) were<br />

<strong>for</strong>mulated from a meta-analysis of published reports.† Logistic regression was used to compare resolution rates of paresthesia following<br />

endoscopic versus open cubital tunnel release while controlling <strong>for</strong> Dellon's scores.<br />

RESULTS:<br />

Of the 104 cases, 42 (40.4%) received endoscopic cubital tunnel release only.† Concomitant surgeries included 49 (47.1%) endoscopic<br />

carpal tunnel releases and the other 13 surgeries included trigger finger releases, elbow arthroscopy, and mass excision.† Evaluation<br />

based on Dellon's classification revealed 5 cases of mild, 41 cases of moderate, and 58 cases of severe cubital tunnel syndrome.† There<br />

was resolution following endoscopic cubital tunnel release in 100.0% of mild, 80.5% of moderate, and 65.5% of the severe cases.† In<br />

the simple decompression control group, paresthesias resolved in 91.1% of mild, 60.8% of moderate, and 33.8% of severe cases.<br />

Controlling <strong>for</strong> Dellon's scores, the odds ratio was 3.38 (p


AAHS Poster Presentations<br />

Management of Open Wounds with Exposed Vital Structures<br />

Institution where the work was prepared: UMDNJ - New Jersey Medical School, Newark, NJ, USA<br />

Ulysses Scarpidis, MD, MPA; Ramazi O. Datiashvili, MD, PhD; UMDNJ - New Jersey Medical School<br />

Primary wound closure in extremity re<strong>plan</strong>tation is frequently impossible due to significant post ischemic and post traumatic edema<br />

and/or tissue loss. In many instances, despite local tissue rearrangement, there remain open wounds with exposed vital structures such<br />

as repaired vessels, nerves, and tendons at the site of re<strong>plan</strong>tation. This threatens the survival of re<strong>plan</strong>ted segments as well as the functional<br />

outcome of the surgery. Immediate skin grafting of these wounds risks thrombosis of the vessels, creation of neuromas, and tendon<br />

adhesions. We report our experience in managing post-re<strong>plan</strong>tation open wounds with exposed vital structures using a biosynthetic<br />

skin substitute (Biobrane, Bertek Pharmaceuticals, NC) and subsequent skin grafting of the wound. This experience is based on<br />

two cases of <strong>for</strong>earm re<strong>plan</strong>tations and one case of thumb re<strong>plan</strong>tation. All re<strong>plan</strong>ted segments survived, and patients have good long<br />

term functional results.<br />

Our experience shows that temporary wound closure with biobrane provides reliable protection of vital structures, prevents thrombosis<br />

of the vessels and prevents tendon adhesions. It facilitates in the <strong>for</strong>mation of a fine granulation tissue envelope around these structures<br />

providing optimal conditions <strong>for</strong> subsequent skin grafting of the wounds without interfering with vital structure function.<br />

Large Fragment Coronal Split Fractures of the Hamate<br />

Institution where the work was prepared: Naval Medical Center San Diego, San Diego, CA, USA<br />

Eric Hofmeister; Leo T. Kroonen; Michael G. Clarke; Naval Medical Center San Diego<br />

INTRODUCTION:<br />

Coronal split fractures of the hamate are rare injuries caused by axial loads, often as a result of a clenched fist striking a solid object.<br />

Only case reports and small case series are found in the literature. The purpose of this study was to examine the methods of diagnosis,<br />

treatment, and outcomes of a cohort of seven patients with this rare injury.<br />

METHODS:<br />

From December 2004 to June 2005, all patients with large coronal split fractures of the hamate were treated at our institution. A retrospective<br />

review of the clinical data and radiographs was conducted. Demographics, radiographic studies, associated injuries, time to<br />

definitive treatment, treatment methods, and rate and time to return to full activities were reviewed.<br />

RESULTS:<br />

Seven cases of this injury were indentified and five elected operative fixation. Four of the cases were initially misdiagnosed. Computed<br />

tomography was used <strong>for</strong> injury characterization in six of seven cases, and revealed a significant articular ìdie-punchî fragment in three<br />

cases. Average diastasis of major fragments in the sagittal <strong>plan</strong> was 7.5mm (range 5.2-10.7mm). Associated injuries included 4th<br />

metacarpal fractures in six cases, capitate fractures in two cases, and 3rd and 5th metacarpal fractures in two cases each. Five of seven<br />

patients returned to full active duty status in an average of 58 days and 2 cases were lost to followup.<br />

DISCUSSION:<br />

In the largest series of coronal fractures of the hamate, only 4/17 were Type III injuries (described as coronal split fractures of the hamate<br />

described here) and other case reports describe the rarity of this injury. Injuries to the body of the hamate should be suspected any time<br />

a patient presents with significant ulnar sided hand or wrist pain after a closed fist injury as in our series four of seven injuries were initially<br />

misdiagnosed. Computed tomography is useful in characterizing the intraarticular component of this injury, as die-punch fragments<br />

and significant diastasis can be associated with these fractures. Two of our cases were successfully treated with closed reduction<br />

and casting, but the majority required surgical fixation. While closed reduction and casting of these injuries can be attempted, often<br />

adequate reduction cannot be achieved. In these cases, surgical stabilization should be per<strong>for</strong>med in order to prevent early arthrosis,<br />

muscle imbalance, loss of grip strength and chronic pain. With appropriate treatment, these injuries heal well, and patients are usually<br />

able to return to full duty in 6-12 weeks.<br />

100


Wrist Arthroscopy: Correlation of Clinical Findings, Imaging with Arthroscopic Findings and<br />

Outcome Results<br />

Institution where the work was prepared: Singapore General Hospital, Singapore, Singapore<br />

Siau Woon Jacqueline Tan, MBBS, MRCS, MMED; Lam Chuan Teoh; Soo Heong Tan; Siew Weng Ng; Singapore General<br />

Hospital<br />

This is a retrospective review of 70 consecutive wrist arthroscopies per<strong>for</strong>med at our institution between January 2000 and July 2005. All<br />

the patients complained of wrist pain, which often interfered with their daily activities, work or sports. The mean duration of symptoms<br />

was 8 months. Preoperative arthrograms and MRIs were per<strong>for</strong>med in 50 and 15 patients, respectively. A standard arthroscopic technique<br />

was employed in all. Any triangular fibrocartilage complex (TFCC), scapholunate (SL) or lunotriquetral (LT) tears found were debrided.<br />

There were 42 patients with TFCC tears, 62 with SL tears and 51 with LT tears. Clinical findings were found to correlate well with arthroscopic<br />

findings. Using wrist arthroscopy as a standard reference, arthrography was found to have high sensitivities <strong>for</strong> the detection of<br />

TFCC tears (0.96), SL tears (1.00) and LT tears (0.94) but low specificities of 0.63, 0.14 and 0.27, respectively. MRI was neither sensitive nor<br />

specific. At follow-up examination at an average of 16.2 months, 85.8% reported an improvement in symptoms and 20% had improved<br />

range of motion. Grip strength improved by 11%. On the average, the patients rested <strong>for</strong> 2.6 months be<strong>for</strong>e returning to work. Outcome<br />

following arthroscopic debridement was determined using the Mayo Modified Wrist Score. Based on the postoperative wrist scores of<br />

50 patients, 23 patients (46%) were rated excellent, 20 (40%) good, 5 (10%) fair and 2 (4%) poor. By comparing preoperative and postoperative<br />

wrist scores of 37 patients, we were able to demonstrate significant improvement in patients who underwent wrist arthroscopies.<br />

Outcomes <strong>for</strong> Limb-Salvage Surgery <strong>for</strong> Osteosarcoma of the Distal Radius:<br />

Institution where the work was prepared: University of Michigan Hospitals, Ann Arbor, MI, USA<br />

Asheesh Bedi, MD1; Peter J. L. Jebson1; Peter M. Murray, MD2; Edward A. Athanasian, MD3; Alexander Y. Shin, MD4;<br />

Paul S. Cederna, MD1; (1)University of Michigan, (2)The Mayo Clinic, (3)Hospital <strong>for</strong> Special Surgery & Memorial Sloan<br />

Kettering Cancer Center, (4)Mayo Clinic; J. Erickson, MD<br />

Osteosarcoma of the distal radius is an extremely rare lesion, accounting <strong>for</strong> less than 1% of all primary osteosarcomas. Limited in<strong>for</strong>mation<br />

on the outcome of different treatment strategies is available in the literature. The purpose of our study is to present the diagnostic<br />

challenges, imaging features, and treatment principles of limb salvage surgery <strong>for</strong> these rare lesions through illustrative case examples.<br />

A multi-center case series of patients treated with limb-salvage surgery <strong>for</strong> osteosarcoma of the distal radius is presented. All patients<br />

were treated using a multidisciplinary approach and underwent preoperative, neo-adjuvant chemotherapy. Surgical management<br />

included wide resection and vascularized or non-vascularized fibular autograft reconstruction with fibulo-capitate fusion. Serial radiographs<br />

and adjunct imaging studies were reviewed <strong>for</strong> tumor staging, progression to union, and hardware complications. Chart review<br />

was per<strong>for</strong>med to define patient demographics, preoperative chemotherapy regimen, tumor response, surgical margins, postoperative<br />

complications, tumor recurrence, metastatic disease, and patient satisfaction.<br />

We determined that an osteosarcoma of the distal radius is rare and that misdiagnosis is common. A successful outcome defined by a<br />

functional limb, patient life expectancy, and high patient satisfaction is feasible with a multidisciplinary treatment strategy of neoadjuvant<br />

chemotherapy and wide resection with fibula autograft reconstruction.<br />

Sclerosing Therapy and Eccentric Training in Flexor Carpi Radialis Tendinopathy in a Tennis Player<br />

Institution where the work was prepared: Hannover Medical School, Hannover, Germany<br />

Karsten Knobloch, MD, PhD; Peter M. Vogt; Hannover Medical School<br />

Tendinopathy of the flexor carpi ulnaris tendon is a rare entity. Recent research revealed the role of a neurovascular ingrowth at the point<br />

of pain in various tendinopathic locations, such as at the Achilles and patellar tendon, in <strong>plan</strong>tar fasciitis as well as in supraspinatus and<br />

tennis elbow tendinopathy. However, beyond the elbow no such neovascularisation has been reported yet. We present a 35-year old tennis<br />

player suffering tremendous pain (VAS 9/10) at the flexor carpi ulnaris tendon with adjacent calcification in close proximity to the pisi<strong>for</strong>m<br />

bone. Laser-Doppler flowmetry incorporated in the Oxygen-to-see system (LEA Medizintechnik, Giessen, Germany) revealed an<br />

increased capillary blood flow in 8mm tissue depths at three distinct positions at the distal flexor carpi radialis tendon in 1cm distances<br />

in contrast to the healthy contralateral side (from distal to proximal: 146/240/232rU at the symptomatic side vs. 93/74/70rU at the asymptomatic<br />

side). Tendon oxygen saturation was slightly elevated at the corresponding three symptomatic vs. the asymptomatic positions<br />

(81%/79%/88% vs. 66%/65%/67%). However, postcapillary venous filling pressures at the FCU tendon were within the same range<br />

(46/39/50rU vs. 38/55/41rU). Using combined Power and Laser-Doppler spectrophotometry a targeted sclerosing therapy was per<strong>for</strong>med<br />

using 0.25% polidocanol in 0.1ml titration volumes at the area of neovascularisation until resolution of the flow signal using the Power-<br />

Doppler, which was achieved with 1.5ml of polidocanol. Capillary blood flow using the Oxygen-to-see system declined immediately at<br />

all three positions in the flexor carpi radialis tendon (113rU vs. 146rU (distal), 219rU vs. 240rU (middle), and 175rU vs. 232rU (proximal).<br />

Tendon oxygenation was slightly elevated following sclerosing from 81%/79%/88% to 97%/99%/91% associated with slightly elevated<br />

postcapillary venous filling pressures by 20%. Pain immediately following the initial sclerosing was decreased to 4/10 with further resolution<br />

of pain following a 12 week interval of daily eccentric training of the <strong>for</strong>earm muscles using the Thera-BandÆ Flex-BarÆ <strong>for</strong> eccentric<br />

training with 6x15 repetitions per day to VAS 0/10. Neovascularisation is evident beyond the elbow at the wrist level such as in flexor<br />

carpi ulnaris tendinopathy. Power-Doppler ultrasound associated with quantitative combined Laser-Doppler & spectrophotometry are<br />

capable to detect the area of neovascularisation in flexor carpi ulnaris tendinopathy, where selective sclerosing therapy using polidocanol<br />

was per<strong>for</strong>med. Immediately following sclerosing therapy the patient's pain level was reduced by 50% with further reduction within the<br />

next 2 weeks. Painful eccentric <strong>for</strong>earm training was initiated <strong>for</strong> a substantial and sustained modification of the wrist tendons.<br />

101


“A Well-Structured Induction Program in Plastic Surgery”: A Strategy to Effective Integration<br />

of Surgical Trainees into a Plastic Surgery Unit <strong>for</strong> the Benefits of Patients' Care<br />

Institution where the work was prepared: University College Hospital, Galway, Galway, Ireland<br />

Fuan Chiang Chan, AFRCSI, MD; C. O'Boyle, MD; J. Kelly; University College Hospital Galway<br />

INTRODUCTION:<br />

High quality patient care and smooth integration of junior trainees into a plastic surgery department is an issue during the changeover<br />

periods of plastic surgical trainees. This study aims to address both of the above issues with a well-structured, clinically orientated induction<br />

program in plastic surgery.<br />

MATERIALS/METHODS:<br />

A half-day induction program which includes history taking and clinical examination, management of common plastic surgical emergencies,<br />

and consultants' preferences of dressings and suture materials was held at week 2 of starting of job in our department. Surgical<br />

trainees (n=10) were asked to answer a set of clinical and non-clinical questionnaires be<strong>for</strong>e and after the induction program.<br />

RESULTS:<br />

It was clinically useful and essential to include clinical components in the induction program (p < 0.05). There was a significant improvement<br />

in term of approach and management of common plastic surgical emergencies be<strong>for</strong>e and after the induction program (p < 0.02).<br />

CONCLUSION:<br />

A well-structured and clinically orientated induction program ensures not only effective integration of surgical trainees into a surgical<br />

unit but also improves the effectiveness of the management of plastic surgical patients.<br />

Crystal Deposition Disease Masquerading as Stenosing Tenosynovitis and its Associated Sequelae<br />

Institution where the work was prepared: Baylor College of Medicine, Houston, TX, USA<br />

Cara R. Downey, MD; Jamal M. Bullocks, MD; David Dice, MD; David T. Netscher, MD; Baylor College of Medicine<br />

Extra-articular crystalline deposition secondary to gout, and less commonly, pseudogout is a well known phenomenon. Tophacious<br />

deposits into the soft tissues are the manifestation of biochemical metabolic derangements. Despite this well documented entity of<br />

extra-articular deposition, there have been few reports of infiltration of the flexor tendon sheath of the hand. Here we present a case<br />

series of this unique occurrence, including surgical techniques, pathology and the clinical outcomes of 5 patients treated at the affiliated<br />

hospitals of the Texas Medical Center at Baylor College of Medicine in Houston, Texas. Between the years 2002 and 2007 we encountered<br />

2 cases of calcium pyrophosphate, and 3 cases of uric acid deposition into the flexor tendon sheath masquerading as common<br />

tendonopathies. These include cases of carpal tunnel syndrome, non-suppurative flexor tenosynovitis, trigger finger and attrition rupture<br />

of the flexor tendons. While most patients presented with a known history of metabolic disease undergoing standard medical therapy,<br />

one case marked the initial presenting symptom of the disease. Although, medical therapy is the cornerstone of treatment <strong>for</strong> diseases<br />

that result in crystal deposition, these cases emphasize the potential need <strong>for</strong> surgical therapy in the armamentarium of their management.<br />

This case series demonstrates the importance of inclusion of crystal deposition into the flexor tendon sheath in the differential<br />

diagnosis in patients that present with uncharacteristic symptomatology of common flexor tendonopathies.<br />

102


AAHS/ASPN/ASRM OUTSTANDING<br />

NERVE PAPER PRESENTATIONS<br />

Rodent Facial Nerve: a Model <strong>for</strong> the Study of Synkinesis<br />

Institution where the work was prepared: Massachusetts Eye and Ear Infirmary, Boston, MA, USA<br />

Tessa A. Hadlock, MD1; Jeffrey Kowaleski1; David Lo1; Susan Mackinnon2; James T. Heaton, PhD3; (1)Massachusetts<br />

Eye and Ear Infirmary and Harvard Medical School, (2)Washington University in St. Louis, (3)Massachusetts General<br />

Hospital<br />

INTRODUCTION:<br />

Rodent whisker movement has been measured after facial nerve manipulation, in an attempt to quantify functional recovery. We have<br />

recently established a method of simultaneously monitoring both whisking movement and induced ocular closure, <strong>for</strong> the purpose of<br />

studying aberrant regeneration. Herein we describe normal bilateral whisking movement and air puff-induced eye closure, and the relationship<br />

between these two distinct facial movements, in a group of normal rats.<br />

MATERIALS / METHODS:<br />

80 female Wistar rats underwent im<strong>plan</strong>tation of a head fixation device, followed by quantitative facial movement testing in an apparatus<br />

designed to measure vibrissial movement and ocular closure <strong>for</strong> each side independently. Animals were handled daily, and then<br />

conditioned to the apparatus. On the day of testing, each animal underwent a 300 second recording session, in which right and left C-<br />

1 whisker positions were continuously recorded, and infrared (IR) emitter/detectors positioned in front of each eye recorded changes<br />

in the IR detection corresponding to eye closure were continuously recorded. An olfactory stimulus was delivered in 10 second pulses<br />

three times at random during the run, and three separate 20 millisecond air puffs were delivered to each eye at random to elicit a blink.<br />

All whisks greater than 15 degrees were analyzed via the method of Bermejo et al, and all eye closures with greater than a 100mV<br />

change in IR detection were counted as blinks.<br />

RESULTS:<br />

Animals tolerated the testing apparatus well. Average whisking amplitude was 35 degrees (sd = 7), consistent with literature values, and<br />

there was no significant difference between whisking frequency, amplitude, velocity, or acceleration between the right and left sides.<br />

Air puff delivery elicited an ipsilateral blink 97% of the time, and a contralateral blink 34% of the time. Olfactory stimulus delivery prompted<br />

a distinct change in whisking behavior 69% of the time, and prompted at least one meaningful eye closure 20% of the time. Air puff<br />

delivery to the eye produced a bilateral whisking burst 85% of the time, indicating that most often air puff delivery elicits whisking as<br />

well as eye closure.<br />

CONCLUSION:<br />

Our study establishes normative data <strong>for</strong> assessing cranial nerve VII-controlled facial movement in four separate facial regions. We<br />

demonstrate the capability of animals to move their orbicularis oculi muscles independently of and simultaneously with their midfacial<br />

muscles. This model provides an excellent tool <strong>for</strong> the study of aberrant regeneration following facial nerve injury in the rodent.<br />

103


Enhancement of Regeneration of Peripheral Nerve Defects by Application of Epineural Tubes<br />

Filled with Donor Derived Bone Marrow Stromal Cells<br />

Institution where the work was prepared: Cleveland Clinic, Cleveland, OH, USA<br />

Mehmet Bozkurt; Christopher Grykien; Lukasz Krokowicz; Aleksandra Klimczak; Jill Froimson; Dileep Nair; Maria<br />

Siemionow; Cleveland Clinic<br />

INTRODUCTION:<br />

Supportive therapy with bone marrow stromal cells (BMSCs) has shown enhancement of nerve regeneration. This study was per<strong>for</strong>med<br />

to asses the effect of BMSCs in nerve gaps repaired with isogenic epineural tubes filled with isogenic and allogenic BMSCs.<br />

METHODS:<br />

Total of 54 isogenic epineural tubes were trans<strong>plan</strong>ted in 3 experimental groups (18 animals each). Group 1 control saline, Group 2 isogenic<br />

BMSCs (Lewis (RT1l)) and Group 3 allogenic BMSCs (ACI (RT1a)). Trans<strong>plan</strong>tation in Group 2 and 3 was supported with BMSCs<br />

therapy (2x106) delivered directly into trans<strong>plan</strong>ted epineural tube. Be<strong>for</strong>e trans<strong>plan</strong>tation BMSCs were stained with PKH-dye to assess<br />

migratory potential and ability <strong>for</strong> neural differentiation. Evaluation at 6, 12 and 24 weeks post-trans<strong>plan</strong>t included Gastrocnemius<br />

Muscle Index (GMI), sensory and motor recovery was evaluated by pinprick, toe-spread and Somato-Sensory Evoked Potentials (SSEP).<br />

Toluidin blue staining determined number of regenerated axons. Immunostaining with NGF and Laminin B2 assessed the migration<br />

and presence of BMSCs in regenerating epineural tubes.<br />

RESULTS:<br />

Functional assessment by pin prick test, 6 weeks after trans<strong>plan</strong>tation, showed in all groups score 3. Toe spread <strong>for</strong> groups 1, 2 and 3<br />

was respectively 1.7; 2; 1. SSEP in groups 1, 2 and 3 (P1, N2-latencies; P1, N2 % of normal values) was respectively (20.2; 23.6; 113; 95),<br />

(17.5; 18.1; 98; 73) and (15.7; 21.65; 88; 87). GMI in groups 1,2 and 3 respectively (0.45; 0.48; 0.47). Histology revealed first signs of axonal<br />

regeneration in all groups at 6 weeks. Group 2 showed higher number per measured field of regenerated axons (90.6 ± 26.9) compared<br />

to Group 1 (71.4 ± 3.0) and 3 (76.4 ± 5.4). In group 2 and 3 (with BMSCs) PKH positive cells were found in proximal part of trans<strong>plan</strong>ted<br />

tube. Immunostaining with NGF confirmed upregulation of NGF in proximal segment of tube compared to middle and distal<br />

parts. Moreover, NGF-staining in combination with PKH-staining confirmed that BMSCs differentiated into neural tissue. Differentiation<br />

efficacy was greater after trans<strong>plan</strong>tation in isogenic (Lewis) BMSCs compared to allogenic (ACI) BMSCs. NGF upregulation in groups<br />

2 and 3 correlated with upregulation of Laminin B2 in both groups, indicating active nerve regeneration.<br />

CONCLUSION:<br />

In this study co-trans<strong>plan</strong>tation of BMSCs with epineural tube enhanced regeneration of peripheral nerve defects, confirmed by<br />

increased expression of NGF and Laminin B2. Better functional recovery and axonal regeneration was seen in BMSCs supported<br />

epineural tube grafts. Finally we have proven differentiation of BMSCs into neural tissue.<br />

104


ASPN SCIENTIFIC PAPER SESSION A<br />

Maintainance of Neuronal Differentiated Adipose-derived Stem Cells in Long Term Culture<br />

Institution where the work was prepared: University of Cali<strong>for</strong>nia, Irvine Medical Center, Orange, CA, USA<br />

Suraj Kachgal, MS; Sanjay Dhar, PhD; Eul Sik Yoon, MD; Gregory R.D. Evans, MD; University of Cali<strong>for</strong>nia, Irvine<br />

INTRODUCTION:<br />

Adipose-derived stem cells (AdSCs) have documented great potential to differentiate into cells of a neural phenotype. These cells provide<br />

a great source <strong>for</strong> autologus trans<strong>plan</strong>tation into in vivo models of peripheral nervous system disorders. The present study investigates<br />

the efficacy of a new neuronal induction media and whether it can maintain human AdSCs in a differentiated state in vitro <strong>for</strong> a<br />

period of time that would correspond with nerve regeneration in vivo.<br />

METHODS:<br />

Human lipoaspirate was processed by standard methodologies and AdSCs from the product were extracted into culture. AdSCs were<br />

briefly expanded in control medium and then subjected to culture in our neural induction media (DE-1) <strong>for</strong> periods of 1 day, 1, 2, 4, 6,<br />

and 8 weeks. Cultures were probed <strong>for</strong> expression of neural-specific markers: NeuN, nestin, GFAP, vimentin, NSE, trk-A, and MAP2 via<br />

immunocytochemistry, RT-PCR, and Western blot.<br />

RESULTS:<br />

Immunocytochemical staining of the neural-induced cells was positive <strong>for</strong> the markers GFAP, trk-A, nestin, and NeuN. Western blot<br />

analysis revealed expression of early neural markers NSE and NeuN was found in control AdSCs and showed decreasing expression in<br />

our neural-induced AdSCs, suggestive of a developing neural phenotype. Expression of the early glial marker vimentin was not present<br />

in the control blot but was expressed in neural-induced AdSCs at day one. Vimentin expression tapered off to zero by week eight<br />

while expression of the mature astrocyte marker GFAP expressed from day one to week eight. RT-PCR results indicate that all markers<br />

except trk-A are transcribed in control and experimental groups, but Western blot analysis shows not all are transcribed.<br />

CONCLUSION:<br />

We have successfully established a medium which promotes neural differentiation of AdSCs and holds them in the differentiated state<br />

<strong>for</strong> a period of time longer than previously reported. The media was successful in promoting the development of cells of a glial phenotype<br />

as shown by expression profiles of vimentin and GFAP.<br />

Repair of Partial Nerve Injury by Bypass Nerve Grafting with End-to-side Neurorrhaphy<br />

Institution where the work was prepared: University of Mississippi Medical Center, Jackson, MS, USA<br />

Tanya M. Oswald, MD; Feng Zhang; William C Lineaweaver; University of Mississippi Medical Center<br />

BACKGROUND:<br />

The peripheral nerve injury without disruption of the anatomic continuity of the nerve often results in <strong>for</strong>mation of neuromas-in-continuity.<br />

Management of this partial nerve injury is notoriously difficult. The purpose of this study was to determine the efficacy of bypass<br />

nerve grafting with end-to-side neurorrhaphy in repair of partial nerve injury in a rabbit model.<br />

METHODS:<br />

Thirty-six adult male New Zealand rabbits were divided into three groups. The partial nerve injury was created by removal of a segment<br />

of the lateral fascicle of the left peroneal nerve. In Group one, the injured nerve was repaired with a nerve graft bypassing the injury site<br />

in an end-to-side fashion 4 weeks after injury. In Group two, the injured nerve was repaired with an end-to-end interposition nerve grafting<br />

6 weeks after injury. The injured nerve without repair was used as the control. At the 16th week after nerve repair in groups one and<br />

two, and 20 weeks after the initial nerve injury in the control group, the nerves were dissected <strong>for</strong> electrophysiological examination and<br />

biopsied <strong>for</strong> histology and molecular marker expressions.<br />

RESULTS:<br />

The nerve repair with interposition nerve grafting achieved maximal functional recovery. However, the motor nerve conduction velocity<br />

(MCV) and compound motor action potential (CMAP) in nerve repair with the bypass nerve grafting were significantly higher than<br />

that in the nerve injury without repair. Histologically, the regenerated myelinated axons and unmyelinated axons were present in the<br />

distal peroneal nerves in the bypass nerve grafts. The axon counts in nerve repair with bypass nerve grafting were also significantly higher<br />

than that in the nerve injury without repair. The comparisons of the ciliary neurotrophic factor (CNTF) and the calcitonin gene related<br />

peptide (CGRP) gene expressions between nerves with and without repair were significantly different.<br />

CONCLUSION:<br />

End-to-side bypass nerve grafting can significantly improve the functional recovery in the nerve with partial injury and may be a useful<br />

repair strategy in neuroma-in-continuity.<br />

105


The Effect of In Vivo Delivery of Nerve Growth Factor (NGF) Through a Novel T-tube<br />

Chamber on Behavioural Recovery in a Rat Model of Peripheral Nerve Injury<br />

Institution where the work was prepared: University of Calgary, Calgary, AB, Canada<br />

Stephen W.P. Kemp, BSc(Hons), MSc; Aubrey A. Webb; Rajiv Midha; University of Calgary<br />

Various behavioural measurements have traditionally been used to assess recovery following peripheral nerve transection, including the<br />

sciatic functional index (SFI), video gait analysis and ankle rotation measures. However, direct measures that objectively and sensitively<br />

assess the return of sensorimotor function in peripheral nerve injured animals are currently lacking. We sought to assess the extent of<br />

behavioural recovery in both skilled and unskilled sensorimotor tasks, especially locomotion, in normal rats both be<strong>for</strong>e and after unilateral<br />

injury to the right sciatic nerve. In addition to traditional methods of sciatic nerve repair, the effect of in vivo delivery of nerve growth<br />

factor (NGF) was evaluated using a novel T-tube chamber nerve conduit. Animals were randomly assigned to one of five treatment<br />

groups: nerve crush (Group 1); direct suture repair (Group 2); transection and T-tube repair with saline administration (Group 3); transection<br />

and T-tube repair with NGF (800 pg/day) administration (Group 4), and; sham-operated controls (Group 5). Locomotor measurements<br />

consisted of (1) ladder rung; (2) tapered beam with crutch; (3) quantitative kinematics, and; (4) ground reaction <strong>for</strong>ce determination.<br />

Ground reaction <strong>for</strong>ce determination, in particular, provides a sensitive assessment of behavioural recovery by allowing the analysis<br />

of each limb's contribution to vertical (body weight support), <strong>for</strong>e-aft (braking and propulsion), and mediolateral <strong>for</strong>ces during locomotion.<br />

Sensory testing consisted of two parts: (1) a traditional measure of tactile allodynia was assessed via von Frey filament testing, and;<br />

(2) thermal nociception was evaluated using a modified thermal <strong>plan</strong>tar test. Following serial and final endpoint behavioural measures (3<br />

months), EMG measurements assessed both nerve and muscle conduction velocities. Animals were subsequently sacrificed and final outcome<br />

measures consisted of (1) gastrocnemius muscle weights, and; (2) morphometry (axon/myelination) of EPON embedded section<br />

tissue. Preliminary results indicate that our battery of locomotor tests provide a sensitive, comprehensive, and objective means by which<br />

to evaluate peripheral nerve regeneration. Ongoing evaluation aims to further determine whether animals directly administered NGF<br />

within a T-tube environment show improved sensorimotor behavioural recovery compared to animals administered saline.<br />

Nerve Repair with Introduction of a MEMS-Based Neural Electrode is Not Detrimental to<br />

Muscle Reinnervation<br />

Institution where the work was prepared: University of Michigan, Ann Arbor, MI, USA<br />

Melanie G. Urbanchek, MS, PhD; Antonio P. Peramo, PhD; Daryl R. Kipke, PhD; William M. Kuzon Jr, MD, PhD; Paul S.<br />

Cederna, PhD; University of Michigan<br />

Bioengineers are constructing Micro-Electro-Mechanical Systems (MEMS) that contain integrated sensors, actuators, and electronics on<br />

a common silicon microelectrode substrate. MEMS devices can per<strong>for</strong>m complex functions in small areas such as peripheral nerves.<br />

MEMS could be im<strong>plan</strong>ted within a severed peripheral nerve to detect efferent signals <strong>for</strong> powering prostheses or providing afferent<br />

signals <strong>for</strong> sensory feedback. This closed-loop neural control of a prosthesis would provide a dramatic increase in functionality <strong>for</strong> upper<br />

extremity amputees. To achieve this goal, we designed a series of experiments testing the compatibility of MEMS electrodes on axonal<br />

sprouting, regeneration and subsequent muscle reinnervation following neurorrhaphy.<br />

We studied F344 rat peroneal nerve reinnervation of the extensor digitorum longus (EDL) muscle. Our 3 experimental groups received<br />

either no peroneal nerve surgery (Normal), division and repair surgery (Repair), or division and repair with a MEMS electrode introduced<br />

into the distal end of the neurorrhaphy (Repair+Electrode). Each silicon electrode was 10mm X .4mm X 15um with 16 shanks and<br />

embedded inactive wiring. Operated rats recovered <strong>for</strong> 58-87 days which is early in the postoperative recovery prior to achievement of<br />

maximal reinnervation. EDL maximum tetanic isometric <strong>for</strong>ce (Fo) was measured in situ by supramaximal stimulation of the peroneal<br />

nerve proximal to the nerve repair. Peroneal nerve conduction velocity was measured. The EDL muscle was then harvested, weighed,<br />

and the specific <strong>for</strong>ce (sFo) was calculated based upon the muscle cross sectional area.<br />

The EDL muscles of the Repair (-43%) and the Repair+Electrode (-33%) groups produced less maximal <strong>for</strong>ce when compared with the<br />

Normal group but did not differ from each other. There were no significant differences between the Repair and Repair+Electrode<br />

groups in muscle mass, Fo, sFo, or nerve conduction velocity indicating that the presence of the MEMS probe did not adversely effect<br />

nerve regeneration or muscle reinnervation based upon these outcome measurements.<br />

This study demonstrates that decreased maximal <strong>for</strong>ces early in the reinnervation process discriminate repaired nerve/muscle from normal<br />

<strong>for</strong> both nerve repair groups. Most importantly the lack of a significant difference between repair groups indicates that intraneural<br />

placement of a MEMS silicon electrode within the peroneal nerve did not adversely effect muscle reinnervation early in recovery.<br />

106


Nerve Regeneration through Nerve Autografts after Local Administration of Brain Derived<br />

Neurotrophic Factor (Bdnf) with Osmotic Pumps<br />

Institution where the work was prepared: Clinica Universitaria. Universidad de Navarra, Pamplona, Spain<br />

Bernardo Hontanilla, MD, PhD; Cristina Aubá; Oscar Gorria; Clínica Universitaria, Universidad de Navarra<br />

OBJECTIVE:<br />

To determine if administration of brain-derived neurotrophic factor (BDNF) with osmotic pumps at the site of the proximal stump of a<br />

peripheral nerve autograft can improve the peripheral nerve regeneration.<br />

METHODS:<br />

Tibialis branch of sciatic nerves were transected and grafted with a 20 mm nerve autografts. Wistar rats (n=70) were divided into four<br />

groups: a non-grafted control group (group I, n=10), a grafted but non-treated control group (group II, n=20), a grafted saline-treated<br />

group (group III, n=20), and finally a grafted and BDNF-treated group (group IV, n=20). BDNF was delivered at a rate of 6 µg/day <strong>for</strong> 2<br />

weeks after nerve repair, using osmotic pumps subcutaneously im<strong>plan</strong>ted with a connecting tube, the distal end of which faced the<br />

proximal stump of the nerve graft. The animals were sacrificed at 6 weeks. Spinal motoneurons were quantified as well as axons at the<br />

tibialis branch 5 mm distal to the distal nerve repair site. Neuron size was categorised as large (>25 µm) or small (0.1). Finally, there were no statistically significant differences between groups II, III and IV regarding the number of<br />

distal axons.<br />

CONCLUSION:<br />

BDNF delivered through osmotic pumps demonstrates a significant capacity <strong>for</strong> improving the presence of motoneurons in the ventral<br />

spinal horn and then the capacity to improve nerve regeneration thorough nerve autografts. However, in this study BDNF does not specially<br />

protect from injury to motoneurons depending of the soma size.<br />

Peripheral Nerve Surgery: Pre-Operative Variables Associated with Outcome Failures<br />

Institution where the work was prepared: Georgetwon University Hospital, Washington, DC, USA<br />

Ivica Ducic, MD, PhD; Emily Hartmann; Georgetown University Hospital<br />

A wide range of outcomes in peripheral nerve surgery are reported and are linked to the type of nerve injury or neuropathy and the<br />

type of surgery designed to address the cause. Even with proper meta-analysis of available data, it is still not possible to normalize<br />

specifics to each reported outcome, so rather false conclusions about variables associated with post-operative failures are commonly<br />

encountered. In order to address these issues, controlling the patient selection criteria, type of surgeries and follow-up, a single surgeon<br />

outcome failures were analyzed identifiying what is common had patients that failed the same type of the surgery when compared<br />

to the one with success.<br />

Fifteen hundred consecutive patients that underwent peripheral nerve surgery by a single surgeon were identified. Patients were sent<br />

a survey asking them about their outcome (reduction in pain, return to pre-injury daily function – sensory/motor improvement, quality<br />

of life improvement). Only patients who had less then 50% of improvement with surgery were then analyzed (n = 425; 28.3%). Outcomes<br />

were measured with minimum of one year follow up (range 1-3 years).<br />

Out of 425 patients, 41 (9.6%) were on methadone, 350 (82%) had pain longer then 3 years pre-op, 429 (88.2%) had depression, 330<br />

(77%) had workmen's compensation, 220 (52%) had surgery on more then 3 nerves at the same time. Each of 425 patients had one variable<br />

present, 69% had two and 31% three or more variables. Complete failure of surgery <strong>for</strong> patients with three of more variables (131)<br />

was the outcome.<br />

Although we often present our best results, it is important to consider these findings when evaluating and consenting patients <strong>for</strong><br />

peripheral nerve surgery.<br />

107


The Dynamic Phases of Peroneal and Tibial Intraneural Ganglion Formation: A New<br />

Dimension Added to the Unifying Articular Theory<br />

Institution where the work was prepared: Mayo Clinic, Rochester, MN, USA<br />

Robert J. Spinner, MD; Huan Wang; Kimberly K. Amrami; Mayo Clinic<br />

OBJECT:<br />

The pathogenesis of intraneural ganglia has been controversial <strong>for</strong> more than a century. Recently we have identified a stereotypic pattern<br />

of occurrence of peroneal and tibial intraneural ganglia and based on an understanding of their pathogenesis, provided a unifying ex<strong>plan</strong>ation.<br />

Atypical features occasionally observed have offered an opportunity to further verify and expand upon our proposed theory.<br />

METHODS:<br />

Ten unusual cases are reviewed to introduce the dynamic features of peroneal and tibial intraneural ganglia. In part I, we analyzed 2 of<br />

our own patients who shared the essential principles common to peroneal intraneural ganglia: namely a) connections to the anterior<br />

portion of the superior tibiofibular joint, and b) intraepineurial dissection of the cyst along the articular branch of the peroneal nerve<br />

and proximally. These patients also demonstrated unusual MRI findings: a) the presence of a cyst within the tibial and sural nerves in<br />

the popliteal fossa region, and b) spontaneous regression of the cysts on serial examinations per<strong>for</strong>med weeks apart. We then identified<br />

a clinical outlier that could not be understood in terms of our previously reported unified theory. Reported 32 years ago, this patient<br />

had a tibial neuropathy and was found to have tibial, peroneal and sciatic intraneural cysts without a joint connection at operation. Our<br />

hypothesis, based on our initial experience was that this reported patient had a primary tibial intraneural ganglion with proximal extension,<br />

sciatic cross-over and then distal descent, and that a joint connection to the posterior aspect of the superior tibiofibular joint with<br />

remnant cyst within the articular branch would be present, a finding that would help us explain the <strong>for</strong>mation of the different cysts by a<br />

single mechanism. We proved this by careful inspection of a recently obtained postoperative MRI. In part II, we retrospectively reviewed<br />

20 additional cases of our own and identified 7 examples with subtle unrecognized MRI features of sciatic cross-over (as well as several<br />

examples in the literature).<br />

CONCLUSION:<br />

These cases provide firm evidence <strong>for</strong> mechanisms underlying intraneural ganglia <strong>for</strong>mation and allow us to expand our unified articular<br />

theory to elucidate unusual presentations of intraneural cysts. Whereas an articular connection and fluid following the path of least<br />

resistance was pivotal, we now incorporate dynamic aspects of cyst <strong>for</strong>mation due to pressure fluxes. These principles explain new patterns<br />

of primary ascent, sciatic cross-over and terminal branch descent when cyst fills the sciatic nerve's common epineurial sheath.<br />

Delay of Denervation Atrophy by Sensory Protection in an End-to-Side Neurorrhaphy Model<br />

Institution where the work was prepared: Erasmus MC, Rotterdam, Netherlands<br />

H.M. Zuijdendorp; W. Tra; J. van Neck; J.H. Coert; Erasmus MC<br />

OBJECT:<br />

Temporary sensory innervation delays the atrophy process. A major disadvantage of most experimental models is that sensory protected<br />

muscles must be denervated a second time to allow reinnervation by the affected nerve. The aim of this study was to assess the<br />

effect of sensory protection on denervated gastrocnemius muscle in an end-to-side neurorrhaphy model, in which denervated muscles<br />

may be preserved until axons of the native nerve reach their target without the necessity <strong>for</strong> a second operation.<br />

METHODS:<br />

The tibial nerve of 24 female Lewis rats was transected. Twelve animals acted as the controls. In the other 12 animals, the end of the<br />

sural nerve was connected to the side of the distal tibial nerve stump (sensory protection group). At 5 and 10 weeks, wet gastrocnemius<br />

muscle weight was reported as a ratio of the operated to the unoperated side. For histological analysis, muscle samples were rapidly<br />

frozen and sections were stained with hematoxylin and eosin, Oil Red O stain and modified Gomori Trichrome stain.<br />

RESULTS:<br />

The difference between the sensory protection group and the control group was statistically significant at 5 (0.36 ± 0.01 and 0.29 ± 0.01<br />

respectively; p < 0.001) and 10 weeks postoperatively (0.28 ± 0.01 and 0.19 ± 0.00 respectively; p < 0.001). Histological observations<br />

revealed that sensory protected muscles underwent less atrophy.<br />

CONCLUSION:<br />

Sensory protection delays atrophy in an end-to-side neurorrhaphy model.<br />

108


Insulin-Like-Growth Factor 1 Improves Nerve Regeneration in Aged Rats<br />

Institution where the work was prepared: Wake Forest University, Winston-Salem, NC, USA<br />

Peter Apel, MD; Timothy Alton, BS; Jianjun Ma, MD, PhD; Zhongyu Li, MD, PhD; Wake Forest Univeristy<br />

INTRODUCTION:<br />

Increasing age significantly impairs neuromuscular recovery following injury via an unknown etiology. Previous studies indicate a<br />

decrease in circulating trophic and anabolic factors with age, such as insulin-like growth factor-1(IGF-1), which may contribute to agerelated<br />

impairments. HYPOTHESIS: Locally delivered IGF-1 will improve the quality of nerve regeneration and in aged rats.<br />

MATERIALS/METHODS:<br />

Twenty-four rats were divided into two groups: Young adult (8 months) and Aged (24 months). The tibial nerve was transected, nerve<br />

stumps were placed in opposing ends of a T-tube, and the middle arm was attached to a mini-pump. In half of the animals, 0.10Ìg/ÌL<br />

IGF-1 in saline was delivered at 0.25 Ìl/hr. Control animals received saline. After 3 months, compound motor action potential (CMAP) of<br />

the gastrocnemius was recorded. The regenerated nerve was examined by both light and electron microscopy. Axon number, density,<br />

average diameter, nerve area and myelin thickness were measured. The gastrocnemius muscle was harvested and gene expression<br />

of GAP-43, myogenin, MyoD, MYF5, MYF6 (MRF4) and the ·, ‚, Á, ‰, and Â-subunits of the nicotinic acetlycholinergic receptor(nAChR)<br />

were examined.<br />

RESULTS:<br />

For control animals, 83% of Young showed evidence of regeneration vs. 50% of Aged. For IGF-1 treated animals, 100% of Young and<br />

75% of Aged showed evidence of regeneration. Of regenerated animals, there was no difference in conduction delay or amplitude. In<br />

aged animals, IGF-1 significantly increased a) axons per nerve (13025 vs. 3062; p


ASPN SCIENTIFIC PAPER SESSION B<br />

In Vivo Microscopy of the Peripheral Nerve, a Quantitative Analysis Following Injury using<br />

Optical Coherence Tomography (OCT)<br />

Institution where the work was prepared: Massachusetts General Hospital, Harvard Medical School, Boston, MA,<br />

USA<br />

Francis Patrick Henry, MD; Hyle Boris Park, PhD; Esther A. Z. Rust; M.A. Randolph, MAS; Johannes F. DeBoer, PhD;<br />

Jonathan M. Winograd, MD; Massachusetts General Hospital, Harvard Medical School<br />

INTRODUCTION:<br />

Electrophysiological and invasive ex vivo histological techniques remain the current gold standard method <strong>for</strong> assessing nerve injury<br />

and regeneration. In vivo assessment of a nerve without destruction of the tissue would greatly advance both grading and monitoring<br />

following neural injury. Optical Coherence Tomography (OCT) is a minimally-invasive optical tomographic imaging technique which<br />

uses coherent light to offer good penetration with micrometer axial and lateral resolution in tissues. Using a multifunctional OCT system<br />

we <strong>plan</strong> to quantitatively and qualitatively assess changes in optical density and birefringence of nerve following injury.<br />

METHODS:<br />

A standard demyelinating crush injury was reproduced in the sciatic nerves of male Sprague Dawley rats. Animals were randomized into<br />

groups (n=8) and nerve exposure with OCT imaging was undertaken at day 1 and weeks 1, 2, 3 and 4 following injury. The uninjured<br />

nerve was used as a control. Functional analysis was undertaken weekly with standardized walking track analysis. Histomorphometry of<br />

both control and injured nerve was undertaken following imaging to allow verification of our findings.<br />

RESULTS:<br />

All animals demonstrated loss of sciatic nerve function following nerve injury. Recovery was documented with sciatic functional index<br />

data approaching normal at four weeks. OCT imaging revealed a quantifiable change in birefringence of the nerve (as measured by<br />

phase retardation graphs) following a simple crush injury. These changes can be characterized both visually and in graph <strong>for</strong>m to indicate<br />

definitive injury and recovery in a longitudinal pattern. Figures below are examples of a normal nerve and samples 2 and 3 weeks<br />

following injury. Regeneration can be assessed with the recovery of phase retardation versus depth over time as characterized by a<br />

change in the slope of the graph (red line). The initial decrease and subsequent increase following injury represents recovery and reorganization<br />

of the nerve fibers.<br />

CONCLUSION:<br />

We conclude that OCT has the ability to image the peripheral nerve revealing quantitative and qualitative changes in composition<br />

which may be used to grade injury and regeneration over time. This technology which permits in vivo, real time imaging of nerves could<br />

provide invaluable diagnostic and prognostic in<strong>for</strong>mation following neural injury.<br />

110


Comparative Analysis of Holding Strength of Available ìNerve Gluesî<br />

Institution where the work was prepared: Candice McDaniel, Richmond, VA, USA<br />

Jonathan Isaacs, MD1; Candice O. McDaniel, MD2; John R. Owen, PE3; Jennifer S. Wayne3; (1)VCU Medical Center,<br />

(2)Medical College of Virginia at VCUHS, (3)Virginia Commonwealth University<br />

HYPOTHESIS:<br />

A variety of potentially useful artificial and biological sealants applied to a sutured nerve decrease gapping at the repair site.<br />

METHODS:<br />

Fifty-seven cadaveric nerve specimens were transected and repaired with two 8-0 nylon epineural sutures placed 180 degrees apart.<br />

The specimens were divided into five groups. Four groups received augmentation of the repair with application of either autologous<br />

fibrin glue, Tisseel fibrin glue (Baxter Healthcare Corporation), Evicel fibrin glue (Ethicon, Inc.), or DuraSeal polyethylene glycol based<br />

hydrogel sealant (Confluent Surgical, Inc.). Each nerve construct was mounted in a servohydraulic materials testing machine (Instron<br />

Corporation; MTS Systems Corporation) and stretched at a constant 5mm/min displacement rate until failure. A noncontact video analysis<br />

permitted normalization of stretch within the repair region. Statistical analysis was per<strong>for</strong>med via ANOVA followed by Tukey-Kramer<br />

post-hoc pairwise comparison, if indicated.<br />

RESULTS:<br />

There was no statistical difference <strong>for</strong> the peak load at failure between any of the groups (p>0.4, Fig. 1). Resistance to gapping as measured<br />

through normalized stiffness (N/mm/mm) was greater <strong>for</strong> the Tisseel group (p


The Efficacy of Subcutaneous Transposition of the Ulnar Nerve in Surgical Treatment of<br />

Cubital Tunnel Syndrome<br />

Institution where the work was prepared: Dept. of Plastic Surgery,University of Tuebingen, Tuebingen, Germany<br />

Armin Kraus, MD; Nektarios Sinis; Frank Werdin; Hans-Eberhard Schaller; University of Tuebingen<br />

PURPOSE:<br />

In surgical treatment of cubital tunnel syndrome, subcutaneous transposition of the ulnar nerve is controversial. It is aim of this study to evaluate<br />

the efficacy of subcutaneous transposition of the ulnar nerve in cubital tunnel syndrome in comparison to nerve decompression alone.<br />

MATERIALS/METHODS:<br />

54 patients undergoing surgery <strong>for</strong> neurologically proven cubital tunnel syndrome between 2000 and 2006 at our institution were scheduled<br />

<strong>for</strong> a postoperative examination with standardized history taking, examination and grip strength measurement with Jamar<br />

dynamometer and pinchmeter. Patients undergoing ulnar nerve decompression alone were assigned to group 1, patients undergoing<br />

additional subcutaneous transposition of the nerve were assigned to group 2.<br />

RESULTS:<br />

12 patients were operated with decompression alone, 42 patients underwent additional subcutaneous nerve transposition. There were<br />

no differences between the groups concerning age, sex, preoperative nerve conduction velocitiy and the presence of Froment`s sign.<br />

Postoperatively, there was no significant difference between group 1 and group 2 concerning overall amelioration of symptoms (83%<br />

ìyesî vs 81% ìyesî, p=0.33), subjective usage property of the operated hand rated on a scale 1 to 10 (mean 8.1 vs 7.9, p=0.81), presence<br />

of paresthesia (50% ìyesî vs 52% ìyesî, p=0.79) and duration of disability (24 vs 26 days, p=0.77). Comparison of grip strength between<br />

groups showed no significant difference <strong>for</strong> both the right hand and the left hand measured with the Jamar dynamometer (p=0.91 and<br />

p=0.62, respectively). Pinchmeter measurement of finger <strong>for</strong>ce revealed no significant difference between groups <strong>for</strong> the right and the<br />

left hand either (p=0.90, p=0.73, respectively). 2-point discrimination ability of the 8th, 9th and 10th finger nerve was not significantly<br />

different between group 1 and 2 (p=0.36, p=0.14, p=0.66 respectively).<br />

CONCLUSION:<br />

In our patient collective, subcutaneous transposition of the ulnar nerve revealed no advantages concering symptom amelioration, duration<br />

of disability, improvement of grip strength and improvement of 2-point discrimination ability.<br />

Health Related Quality of Life and Disability in Patients Following Peripheral Nerve Injury<br />

Institution where the work was prepared: University Health Network, Toronto, ON, Canada<br />

Christine B. Novak, PT, MS, PhD(c); Dimitri J. Anastakis; University Health Network<br />

BACKGROUND:<br />

Most outcome studies following peripheral nerve lesions of the upper extremity have focused on functional recovery. There have been<br />

few studies examining long-term outcomes related to health related quality of life and disability. A quantitative examination of these<br />

factors would provide a valuable and comprehensive understanding of upper extremity impairments due to nerve lesions.<br />

PURPOSE:<br />

The objective of this study was to determine the relative level of disability, pain and health related quality of life in patients following<br />

peripheral nerve injury in the upper extremity.<br />

METHODS:<br />

Following Research Ethics Board approval, prospectively collected data from patients with nerve injury were reviewed from a larger<br />

database. There were 187 patients who had sustained a traumatic nerve injury and were at least 6 months following nerve injury/repair.<br />

At the final office visit, patients completed the Disabilities of the Arm, Shoulder and <strong>Hand</strong> (DASH) questionnaire and the Medical<br />

Outcomes Study 36-Item Short-Form Health Survey (SF-36). Independent variables assessed included nerve injured, dominant arm<br />

affected, gender and workers' compensation involvement. Data were analyzed using SPSS. For the SF-36, comparisons were made<br />

between the Canadian norms and the nerve injured patients. Patients were grouped as having increased pain if they exceeded 2 standard<br />

deviations from the normative data and the DASH scores were compared to patients who had pain versus no pain.<br />

RESULTS:<br />

There were 187 patients (134 men, 53 women) with a mean age of 43 years (sd 15 years). The mean time from injury to final assessment<br />

was 4 years (sd 5 years). As reported on the SF-36, the mean bodily pain was 45 (sd 26) and indicated significantly more pain than the<br />

reported SF-36 normative data (p < 0.001). Similarly, patients with nerve injury had significantly decreased physical function, vitality, social<br />

function, general health and mental health (p< 0.001). The mean DASH score was 39 (sd 24), which indicated a high level of impairment<br />

in these patients. Significantly more impairment as indicated by a lower score on the DASH was found in patients with abnormal bodily<br />

pain (p = 0.016) and with brachial plexus nerve injuries (p = 0.047).<br />

CONCLUSION:<br />

Peripheral nerve injuries are associated with increased chronic neuropathic pain and impairment as reported on the SF-36 and the<br />

DASH. Recognition of chronic pain and the associated factors may permit more efficacious treatment and better health related quality<br />

of life in these patients.<br />

112


The Mechanisms of Axonal Sprouting With End-to-Side Neurorrhaphy<br />

Institution where the work was prepared: Washington University in St Louis, St Louis, MO, USA<br />

Ayato Hayashi, MD, PhD; Daniel A. Hunter, RA; Alice Y. Tong, MS; David H. Kawamura, MD; Arash Moradzadeh, MD;<br />

Sami H. Tuffaha, BA; Christina B. Kenney, MD; Janina Luciano, BS; Thomas H. Tung, MD; Susan E. Mackinnon, MD;<br />

Terence M. Myckatyn, MD; Washington University in St. Louis<br />

BACKGROUND:<br />

Nerve injuries are usually reconstructed by end-to-end neurorrhaphy. However, end-to-side neurorrhaphy is an alternative procedure<br />

that may be used in certain situations. Since the reintroduction of this technique in 1992, significant controversy remains regarding how<br />

end-to-side neurorrhaphy results in axonal sprouting and whether it provides any functional benefit. To investigate these issues, we used<br />

transgenic mice with fluorescently-labeled axons to visualize this process.<br />

METHODS:<br />

We used transgenic mice in which a few motor axons (Thy1-GFPS) or all axons, including sensory, (Thy1-YFP16) were labeled with GFP<br />

or YFP. Animals were randomized into three groups: 1) end-to-side neurorrhaphy was per<strong>for</strong>med by opening an epineurial window with<br />

partial neurectomy, 2) the nerve graft was wrapped around the donor nerve to keep the donor nerve completely uninjured while endto-side<br />

coaptation was achieved, and 3) chronic compression to the donor nerve was applied by wrapping the proximal donor nerve<br />

with a tight fitting silicon tube. All animals were evaluated using a fluorescent live imaging system at multiple time points to monitor<br />

<strong>for</strong> regenerating axons. At a 3 or 5 month endpoint, the site of anastomosis was harvested and evaluated with immunohistochemistry,<br />

confocal whole mount imaging, histomorphometry, and western blot. In addition, the functional connections of the regenerating axons<br />

were characterized with muscle end plate staining and an evaluation of cutaneous innervation.<br />

RESULTS:<br />

With partial neurectomy, abundant regenerating axons were seen projecting from the stump of the injured donor nerve into the graft at<br />

early time points. The non-injury model using thy1-GFPS mice showed no motor axonal regeneration throughout the experiment.<br />

However, YFP16 mice showed new axons projecting into the graft at late time points. The compression injury group using thy1-GFPS mice<br />

also showed regenerating motor axons at late time points, appearently due to induction of collateral sprouting from the donor nerve.<br />

CONCLUSION:<br />

Our results demonstrate that some type of injury, such as compression or epineurotomy, is required to trigger motor axonal regeneration<br />

through an end-to-side neurorrhaphy. In contrast, sensory axonal regeneration can take place with end-to-side neurorrhaphy without<br />

any injury to the donor nerve as evidenced by the different results seen with the YFP16 and thy1-GFPS mice. This study represents<br />

a novel model <strong>for</strong> studying end-to-side neurorrhaphy over time and provides further insights into the mechanism by which axonal<br />

regeneration occurs in this setting.<br />

Comparison of Psychosocial Outcomes of Patients with Neuropathic Conditions Treated With<br />

and Without Surgery<br />

Institution where the work was prepared: <strong>Hand</strong> and Microsurgery Center of El Paso, El Paso, TX, USA<br />

Jose Monsivais, MD; <strong>Hand</strong> & Microsurgery Center; Kris Robinson, PhD, FNP; University of Texas at El Paso<br />

PURPOSE:<br />

To evaluate psychosocial outcome after surgical and non-surgical treatment of neuropathies and nerve injuries in chronic pain patients.<br />

METHODS:<br />

Archival review of records from 91 patients (1995-2005). Inclusion criteria included nerve dysfunction and pain >3 months. Diagnosis was<br />

established by history, P/ E, sensory/motor evaluation, electrodiagnostics and imaging. Surgical candidates were determined by severity<br />

of sensory -motor abnormalities and had no evidence of uncontrolled depression/psychological distress. Pain was not used as an<br />

indicator <strong>for</strong> any <strong>for</strong>m of treatment. Surgical procedures included nerve decompressions, reconstruction, neurolysis, and excision of<br />

neuromas. Medical treatment included analgesics, adjuvants, and neuroleptic medications. Psychological reports included psychological<br />

diagnosis, results of Oswestry Pain Questionnaire, GAF, and PSS. Statistician conducted correlational analysis using SAS statistical<br />

program. A sample size of 85 is required to detect a medium effect size with alpha set at .05 and power of .80.<br />

RESULTS:<br />

The majority of patients returned to work and reported lower levels of pain ~5 years after onset of nerve injury/ condition. No differences<br />

were noted between groups on a variety of measures including pain level (p=.2), litigation status (p>.5), and return to work<br />

(p>.05). The majority of individuals expected total relief of pain with surgical treatment.<br />

CONCLUSION:<br />

With psychosocial assessment, support, and adequate pain treatment, no difference was detected in psychosocial outcomes between those<br />

patients receiving surgical and non ñsurgical treatment. Patients' expectations of surgery are unrealistic and must be addressed prior to treatment.<br />

113


Delivery Strategy Significantly Affects the Number and Phenotype of Schwann Cells in<br />

Seeded Decellularized Allografts<br />

Institution where the work was prepared: Washington University School of Medicine, Saint Louis, MO, USA<br />

Arash Moradzadeh, MD; Sami H. Tu faha, BA; Ryan D. Luginbuhl; Jason Gustin; Gregory H. Borschel; Alice Y. Tong; Je fery<br />

Milbrandt, MD, PhD; Susan E. Mackinnon, MD; Terence M. Myckatyn, MD; Washington University School of Medicine<br />

BACKGROUND/PURPOSE:<br />

Nerve regeneration is impaired when non-native constructs are used to bridge long nerve gaps. Ef<strong>for</strong>ts have been made to improve<br />

regeneration through decellularized nerve grafts by adding stem cells, Schwann cells (SC) and/or growth factors. The goal of the current<br />

study is to compare the commonly used SC injection technique to a SC co-culture delivery mechanism in 2 different types of decellularized<br />

nerve grafts.<br />

METHODS:<br />

Adult Brown-Norway rat sciatic nerves were harvested and decellularized using either 7 weeks of cold-preservation with University of<br />

Wisconsin solution or using a proprietary graft processing method from AxoGen Inc. This method removes antigens and degrades molecules<br />

that inhibit neuroregeneration while leaving laminin intact. Nerves from each group were treated with either (1) injection of 1 X<br />

105/20 µl fluorescent labeled SCs (GFP) or (2) nerves were co-cultured with 1 X 105 GFP-labeled SCs in growth media. Nerves were sectioned<br />

and labeled with S100 (marker <strong>for</strong> mature SCs), DAPI (nuclear stain), and p75 (marker <strong>for</strong> immature SCs). Confocal microscopy<br />

was used to evaluate the quantity and maturity of viable SCs delivered into the grafts. For the SC injection group, evaluation was conducted<br />

immediately after injection and at a 3 day time-point (<strong>for</strong> this group nerves were injected and then incubated in growth media<br />

<strong>for</strong> 3 days). In the co-culture group evaluation was done following 3 days of incubation.<br />

RESULTS:<br />

SC injection and co-culture are both effective <strong>for</strong> delivering SCs into nerve grafts. A greater number of cells are found in grafts using<br />

the injection technique, with the location of SCs closer to the middle of the graft. Nerves decellularized using the AxoGen Inc. method<br />

appear to be more receptive to SC delivery by the co-culture technique and demonstrate a greater number of mature SCs as demonstrated<br />

by immunolabeling and confocal microscopic quantification of SC processes.<br />

CONCLUSION:<br />

SC co-culture is a possible alternative to SC injection <strong>for</strong> the delivery of SCs into decellularized nerve grafts. Both grafts support the<br />

adherence of SCs, however, AxoGen Inc. processed nerve grafts appear to be more receptive to the co-culture delivery technique and<br />

demonstrate a greater number of mature SCs. We are now staining the laminin and extracellular matrix of AxoGen Inc. and cold-preserved<br />

nerve grafts, to identify possible differences. Decellularized nerve grafts supplemented with SCs via the injection or co-culture<br />

are also being evaluated in vivo to study the impact of SC delivery technique on nerve regeneration.<br />

Saphenous Nerve Neuropathy: Treatment Options and Outcomes<br />

Institution where the work was prepared: Georgetwon University Hospital, Washington, DC, USA<br />

Ethan Larson, MD; Ivica Ducic, MD, PhD; Georgetown University Hospital<br />

PURPOSE:<br />

There is not much reported about leg pain and paresthesia related to saphenous nerve neuropathy. Extending from the groin area to<br />

the dorso-medial foot, the saphenous nerve is exposed to a number of possible danger zones. It can be compressed, due to trauma<br />

or other conditions, at the adductor canal causing mid-thigh pain and distal paresthesia, or can be damaged as a result of previous surgeries<br />

(vascular surgery saphenous vein harvest, orthopaedic knee surgery or foot and ankle surgery). Despite the number of opportunities<br />

to cause saphenous nerve neuropathy, its involvement remains under diagnosed primarily due to lack of recognition of the problem<br />

by other specialties. We reviewed 20 consecutive patients and present their outcomes.<br />

METHODS:<br />

Common to all 20 patients is that their pain was present <strong>for</strong> at least 9 months (9m-2.7y) and that all conservative pain modalities failed<br />

to provide relief. Three patients had nerve compression at the adductor canal (one idiopathic, two following blunt trauma). Two patients<br />

had nerve exposed in open wound (sickle cell), five patients had pain due to orthopaedic procedures in the lower extremity and foot,<br />

while ten had pain following knee surgery. All patients had moderate to major quality of life issues due to the pain. Patients who had<br />

nerve compression at the adductor canal were decompressed, while patients with post-op neuroma along the course of the nerve had<br />

excision of the nerve proximal to the site of the injury and im<strong>plan</strong>tation to the muscle.<br />

RESULTS:<br />

Patient's had an average 2-year follow up (range 1.4-2.9 years). Pre-operative average VAS pain level was 7.4 (with ten on direct stimulation<br />

of the neuroma site), while post-operatively it dropped to an average of 2.3 (p


Caspase 3 Knockout Mice Show Partial Protection of Skeletal Muscle Atrophy following<br />

Denervation<br />

Institution where the work was prepared: McMaster University, Hamilton, ON, Canada<br />

James Bain, MD, MSc1; Jane AE Batt, MD, PhD, FRCPC2; Pam Plant2; Minna Woo2; (1)Hamilton Health Sciences and<br />

McMaster University, (2)University Health Network, University ofToronto<br />

Early functional reinnervation is the goal following peripheral nerve injury and denervation. However, profound and eventually irreversible<br />

muscle denervation atrophy is a barrier to this goal. The ubiquitin proteasomal pathway is the predominant protein degradation<br />

pathway activated following denervation that results in denervation muscle atrophy. However, the proteasome is not able to<br />

degrade intact actinomyosin myofibrils. Capsase-3 has been purported to be a key enzyme that degrades intact actinomyosin complexes,<br />

into substrates upon which the ubiquitin proteasome subsequently acts.<br />

HYPOTHESIS:<br />

The absence of the caspase-3 protein will protect muscle from denervation atrophy.<br />

PURPOSE:<br />

To explore the muscle denervation atrophy in caspase-3 knockout mice and evaluate both the downstream ubiquitination pathways,<br />

and apoptotic pathways in this animal model.<br />

METHODS/MATERIALS:<br />

Caspase-3 knockout mice and heterozygote and wild type controls were anesthetized and had the sciatic nerve transected under institutionally<br />

guided ethics approval. Animals were sacrificed after 2 or 4 weeks of denervation. Animal and wet Gastrocnemius muscle<br />

weights were recorded <strong>for</strong> experimental and contralateral sides. Muscle was then either snap frozen in liquid nitrogen and maintained<br />

at ñ80, or fixed in para<strong>for</strong>maldehyde <strong>for</strong> subsequent histological analysis. RNA and protein were isolated. Real time RT PCR and western<br />

blotting determine mRNA and protein expression levels respectively of key mediators of the ubiquitin proteasome pathways.<br />

RESULTS:<br />

Although experimental and control animals demonstrated muscle atrophy, significantly less muscle loss was observed in the homozygous<br />

animals at both 2 weeks and 4 weeks (p


ASPN SCIENTIFIC PAPER SESSION C<br />

Grip Strength and CMAP Amplitude in Median Nerve Injury of the Rats<br />

Institution where the work was prepared: Mayo Clinic, Rochester, MN, USA<br />

Huan Wang, MD, PhD; Eric J. Sorenson; Robert J. Spinner; Anthony J. Windebank; Mayo Clinic<br />

INTRODUCTION:<br />

Grip strength is a measurement of finger flexor power and there<strong>for</strong>e reflects motor function of the median nerve which innervates finger<br />

flexors in rats. The aim of the study is to develop atraumatic recording of compound muscle action potential (CMAP) of median<br />

nerve and validate its reliability by correlating CMAP amplitude with grip strength.<br />

METHODS:<br />

12 Sprague Dawley rats were used. In one group median nerve transection and repair was done. Transection and direct coaptation of<br />

both median and ulnar nerves was done in the other group. CMAP was recorded by placing a subcutaneous needle electrode at the<br />

thenar muscle while the median nerve was percutaneously stimulated at the cubital fossa. A grasping task was carried out to measure<br />

grip strength. These measurements were conducted preoperatively and postoperatively after 1, 3, 4, 6, 8, 10, 12, and 16 weeks.<br />

Relationship between recovery of CMAP amplitude and recovery of grip strength was assessed by plotting grip strength against CMAP<br />

amplitude. To further determine if there is any correlation between this pair of variables, correlation coefficient was examined by nonlinear<br />

regression curve fit of these two sets of data.<br />

RESULTS:<br />

Reproducible median nerve CMAP was recorded in both groups. Following nerve transection CMAP disappeared and did not return<br />

until 4 weeks after nerve repair. CMAP dispersion, amplitude deterioration, area deterioration and prolonged onset latency were seen<br />

during early regeneration period. The amplitude gradually increased as post-operative time passed and did not reach pre-operative<br />

level until 16 weeks. Following median nerve transection, flexion of <strong>for</strong>epaw digits was lost and grip strength was not measurable. Digit<br />

flexion was observed 3 weeks postoperatively and grip strength gradually recovered and returned to pre-operative level 12 weeks postoperatively.<br />

Visual correlation between grip strength and median nerve CMAP amplitude in both groups showed similar pattern of<br />

recovery with time. Recovery of CMAP amplitude lagged behind recovery of grip strength. Nonlinear regression of CMAP amplitudegrip<br />

strength curve followed a hyperbolic shape. R squared of the curve fit in median nerve injury group was 0.91 while r squared of the<br />

curve fit in combined median and ulnar nerve injury group was 0.93. This demonstrated a strong correlation between grip strength and<br />

median nerve CMAP amplitude.<br />

CONCLUSION:<br />

CMAP is a valid parameter that shows typical time course of nerve regeneration and motor function recovery. To our knowledge it is<br />

the first report of conducting CMAP measurement in rat <strong>for</strong>elimb.<br />

Nerve Transfers For Paralysis Of The Tibialis Anterior Muscle (Foot-Drop)óA Cadaveric<br />

Feasibility Study<br />

Institution where the work was prepared: Teaxs Tech University Health Science Center, El Paso, TX, USA<br />

Miguel Pirela-Cruz, MD; D.A. Terreros; U.D. Hansen, MD; P. West, MD; A.D. Rossum, MD; Texas Tech University HSC, El Paso<br />

INTRODUCTION:<br />

Nerve transfers <strong>for</strong> upper extremity neurological problems is now an accepted treatment option <strong>for</strong> addressing some motor and sensory<br />

deficits. However this treatment option <strong>for</strong> reconstructing peripheral lesions of the lower extremity is limited. This study is an<br />

attempt to explore the possibility of restoring motor function of the tibialis anterior (TA) muscle following an irreparable traumatic injury<br />

to the common peroneal nerve that results in a foot-drop.<br />

MATERIALS/METHODS:<br />

Eight caderveric legs, disarticulated at the hip, were studied. Specimens included 4 male and 4 female with an average age 51 and 47<br />

years respectively. Three nerves were evaluated as possible donors; the branch to the soleus muscle, branch to the medial and to the<br />

lateral gastrocnemius muscle.<br />

RESULTS:<br />

Nerve transfer using the interosseous route could be accomplished <strong>for</strong> each of the donor nerves. The average working length of the<br />

branch to the tibialis anterior (BTA) was 96 mm +/- 8.9. All nerve transfers with the exception of one could be per<strong>for</strong>med without an<br />

interpositional nerve graft. The average repair site to TA was 73.5 mm, 66.6 mm, 46.6 mm <strong>for</strong> the medial gastrocnemius, lateral gastrcnemius<br />

and soleus respectively.<br />

CONCLUSION:<br />

Successful mobilization of the BTA can be accomplished through a fibula and interosseus windows to reach to potential donor nerves.<br />

These finding may have significant clinical benefits pertaining treatment <strong>for</strong> traumatic foot drop.<br />

116


Soleus Arch as Compression Site <strong>for</strong> Proximal Tibial Nerve: Cadaver Study<br />

Institution where the work was prepared: Union Memorial Hospital, Baltimore, MD, USA<br />

Eric H. Williams, MD; Dellon Institute <strong>for</strong> Peripheral Nerve Surgery: Baltimore. Clinical Instructor; Johns Hopkins<br />

University School of Medicine; Gedge D. Rosson, MD; Johns Hopkins School of Medicine; A. Lee Dellon, MD; Dellon<br />

Institute <strong>for</strong> Peripheral Nerve Surgery: Baltimore. Professor; Johns Hopkins University School of Medicine<br />

TITLE:<br />

Soleus Arch as Compression Site <strong>for</strong> Proximal Tibial Nerve: Cadaver Study<br />

PURPOSE:<br />

As the Pronator Syndrome represents a site of proximal compression of the median nerve that can be symptomatic by itself or be the<br />

etiology of ìfailed carpal tunnel syndromeî, so too may a site of proximal compression of the tibial nerve beneath the aponeurotic arch<br />

of the origin of the soleus muscle be a source of symptoms <strong>for</strong> patients with pain in the calf or who complain of pain or numbness in<br />

their toes. The setting <strong>for</strong> the syndrome of proximal compression of the tibial nerve may be in patients with previous lumbosacral spine<br />

surgery, ìfailed tarsal tunnel syndromeî, compartment syndrome, of it may exist on its own.<br />

METHOD:<br />

25 limbs from 18 embalmed cadavers were dissected using 3.5X loupe magnification. There were 12 right and 13 left cadaver limbs; the<br />

sex was unknown. The distance from the medial femoral epicondyle to the soleus arch and the length of the leg was measured. The<br />

ratio of limb length to location of the soleus arch was calculated. The thickness of the fibrous soleus arch, its relationship to the tibial<br />

nerve, and any narrowing of the tibial nerve in this location were noted.<br />

RESULTS:<br />

The average limb length was 46.8 cm (40-55 cm). The tibial nerve traveled under the soleus arch 9.4 cm (7-13 cm) below the medial<br />

femoral epicondyle. This location measured approximately 1/5 the total length of the leg. The soleus arch demonstrated a thick deep<br />

layer of fascia in 64% of the specimens. The tibial nerve was narrowed in 52% of the specimens; 48% demonstrated slight narrowing<br />

over several centimeters, but 4% demonstrated a tight focal constriction across the nerve at the level of the soleus arch.<br />

CONCLUSION:<br />

The soleus arch represents an anatomic site of potential compression of the proximal tibial nerve.<br />

Anatomical Landmarks <strong>for</strong> the Nerve Branch to the Masseter Muscle in Facial Reanimation<br />

Institution where the work was prepared: SIU School of Medicine, Springfield, IL, USA<br />

Nada Berry, MD1; Margo Herron1; Rebuen Bueno1; Ronald Zuker, MD2; Michael W. Neumeister3; (1)SIU School of<br />

Medicine, (2)The Hospital <strong>for</strong> Sick Children, (3)Southern Illniois University School of Medicine<br />

The nerve branch to the masseter muscle has been used as the donor nerve in facial reanimation surgery <strong>for</strong> the Moebius syndrome<br />

patient. It is located on the undersurface of the masseter usually coursing downward at the posterior margin of the muscle below the<br />

zygomatic arch. As the nerve enters the muscle, it divides into smaller branches. An anatomical study has not been done to map out<br />

the location and course of the nerve as in enters the muscle. This study defines the course of the nerve in relation to anatomical landmarks<br />

and measures the length of the nerve be<strong>for</strong>e branching. Total of 15 nerves were dissected and examined. The following landmarks<br />

were selected: superior pole of the tragus, point A at superior border of the zygoma, oral commisure, and the first branch emerging<br />

from the muscle. The average length from the tragus to point A is 29.4mm (STD 3.4), and the average distance to the first branch<br />

is 18mm (STD 2.1). When using the nerve branch to the masseter muscle as the donor nerve <strong>for</strong> reanimation with a reinnervated gracilis<br />

muscle, the results from this study will help identify the nerve during the reanimation procedure.<br />

Novel Model <strong>for</strong> End-Neuroma Formation in the Amputated Rabbit Forelimb<br />

Institution where the work was prepared: Northwestern University, Feinberg School of Medicine, Chicago, IL, USA<br />

Peter S. Kim, MD1; Kristina O'Shaughnessy, MD1; Todd A. Kuiken, MD, PhD2; Gregory A. Dumanian1; (1)Northwestern<br />

University, Feinberg School of Medicine, (2)Rehabilitation Institute of Chicago<br />

The <strong>for</strong>elimb amputee poses many reconstructive challenges in the clinical setting, and there is a paucity of established surgical models<br />

<strong>for</strong> study. To further elucidate the pathogenic process in amputation neuroma <strong>for</strong>mation, we created a reproducible, well-tolerated<br />

rabbit <strong>for</strong>elimb amputation model. Upon approval from the institutional Animal Care and Use Committee, 5 New Zealand white rabbits<br />

underwent left <strong>for</strong>elimb disarticulation. During this initial surgery the median, radial and ulnar nerves were transected 1.6-2.5 (mean<br />

2.0) cm distal to the brachial plexus, transposed onto the anterior chest wall and preserved at length. Six weeks subsequent to the<br />

amputation, the distal 5 mm of each neuroma was excised and the remaining stump underwent histomorphometric analysis. The nerve<br />

cross sectional areas increased by factors of 1.99, 3.17, and 2.59 in the median (p=0.059), radial (p=0.001) and the ulnar (p=0.012) nerves<br />

respectively. At the axonal level, the number and cross sectional area of axons demonstrated an inverse relationship whereby the number<br />

of axons in the median, radial and ulnar nerves increased by factors of 5.13 (p=0.096), 5.25 (p=0.037) and 5.59 (p=0.046) and the<br />

cross sectional areas of the axons decreased by factors of 4.62 (p


Antibodies to Galactocerebroside Enhance Nerve Regeneration after Acute Contusion and Transection Injuries<br />

in the Adult Rat Sciatic Nerve<br />

Institution where the work was prepared: University of Cali<strong>for</strong>nia, Irvine, Orange, CA, USA<br />

Aaron M. Kosins, MD, MBA; Charles Mendoza; Michael P. McConnell, MD; Brandon Shepard; Sanjay Dhar, PhD;<br />

Gregory RD Evans, MD, FACS; Hans S. Keirstead, PhD; University of Cali<strong>for</strong>nia, Irvine<br />

INTRODUCTION:<br />

To improve the regenerative potential of PNS axons in vivo, we utilize a novel therapy in the adult rat sciatic nerve in which nerve regeneration<br />

is enhanced following contusion and transection injuries. We demonstrate that 1) Axon regeneration within a region of injury<br />

increases in the presence of immunological demyelination, and 2) Regenerated axons are derived from the proximal motor axons.<br />

METHODS:<br />

Adult female Sprague-Dawley sciatic nerves were contused and injected with the demyelinating agent. The sciatic nerves were harvested<br />

14 and 28 days following the onset of demyelination. The lesion containing length of nerve was cut into 1mm transverse blocks and<br />

processed to preserve the cranio-caudal orientation. In a second group, the sciatic nerves were exposed, transected, repaired, and<br />

injected with the demyelinating agent. These animals were similarly euthanized at 1 and 2 months and processed to examine the extent<br />

of axon regeneration. Specimens were fixed and evaluated using structural and immunohistochemical analysis. A Mini-Ruby Tracer was<br />

included to determine the source and direction of axonal re-growth.<br />

RESULTS:<br />

A single epineural injection of complement proteins plus antibodies to galactocerebroside (the major myelin sphingolipid) resulted in<br />

demyelination followed by Schwann cell remyelination that enhanced nerve regeneration in the injured (contusion and transection) animals.<br />

At each time point <strong>for</strong> both contused and transected animals, nerve regeneration was enhanced following demyelination therapy.<br />

Tracers demonstrated that nerve regeneration arose from proximal motor axons, and not the distal branching of sensory axons.<br />

CONCLUSION:<br />

These studies demonstrate a new method to enhance nerve regeneration in the PNS using experimental immunological demyelination.<br />

Our findings indicate that peripheral nerve regeneration within a region of contusion or transection injury in the adult rat sciatic<br />

nerve can be enhanced using a demyelinating agent. This data can be applied in the creation of tissue-engineered constructs, cellbased<br />

therapy systems, and even nerve transfers to improve the outcome of critical nerve injuries in the PNS.<br />

Sympathetic Nerves in the Tarsal Tunnel: Implications <strong>for</strong> Blood Flow in the Diabetic Foot<br />

Institution where the work was prepared: University of Arizona School of Medicine, Tucson, AZ, USA<br />

Andrew Blount, BS; Erika Dexter; Raymond Nagle; Christopher Maloney; Lee Dellon; Ziv Peled; University of Arizona<br />

BACKGROUND:<br />

Peripheral nerve decompression has been shown to alter the natural history of lower extremity peripheral neuropathy by reducing the<br />

incidence of ulceration and amputation. One method by which this occurs is an increase in protective sensation in the decompressed<br />

foot. Another possible method, which has yet to be evaluated, is an improvement in blood flow resulting from sympathectomy of the<br />

tibial vasculature which takes place during tarsal tunnel decompression surgery.<br />

METHODS:<br />

Seven consecutive patients evaluated at our clinic were enrolled in this pilot study which was approved by the Institutional Review Board<br />

of our university. All patients had neuropathy as documented by their clinical history, physical exam, and by neurosensory testing using<br />

the Pressure Specified Sensory Device (PSSD) (Sensory Management Services L.L.C., Baltimore, MD). During tarsal tunnel decompression,<br />

all patients had a partial epineurectomy of the tibial nerve, a portion of which was sent as a specimen. Connective tissue bridging<br />

the tibial nerve and vessels was also harvested and sent <strong>for</strong> evaluation. Specimens were analyzed by immunohistochemistry using an<br />

anti-tyrosine hydroxylase antibody, which is specific <strong>for</strong> sympathetic nerves.<br />

RESULTS:<br />

Five of seven tibial epineurial specimens stained positively with TH. Six of seven connective tissue specimens stained positively with TH.<br />

In those specimens that were negative, no nerve tissue of any type was identified. Staining was especially apparent surrounding the<br />

microvasculature in each specimen (Fig 1).<br />

CONCLUSION:<br />

Sympathetic nerves are present adjacent to the tibial vessels and microvasculature within the tarsal tunnel. Sympathectomy occurring<br />

during tarsal tunnel decompression may account <strong>for</strong> increased blood flow to the foot, a concept supported by our identification of sympathetic<br />

nerve fibers along the local microvasculature in our specimens. This mechanism has several implications. One, it may help<br />

explain how tarsal tunnel decompression functions in preventing future ulceration and amputation. Furthermore, if blood flow is<br />

improved after decompression and epineurectomy, perhaps our tarsal tunnel release procedure could be considered an adjunct to<br />

bypass surgery in patients with lower extremity peripheral vascular disease. In the future, we <strong>plan</strong> to per<strong>for</strong>m more direct blood flow<br />

measurements and correlate these data with similar immunohistochemical findings.<br />

118


A Study of Modality Specific Nerve Regeneration in the Rat Femoral Nerve<br />

Institution where the work was prepared: Washington University, St. Louis, MO, USA<br />

David H. Kawamura, MD; Gregory H Borschel; Daniel A Hunter; Susan E Mackinnon; Thomas HH Tung; Washington<br />

University in St. Louis<br />

BACKGROUND/HYPOTHESIS:<br />

Today, autologous sensory nerve grafting is the standard of care <strong>for</strong> the repair of peripheral nerve gaps. Motor nerve defects are frequently<br />

reconstructed with grafts harvested from superficial sensory nerves due to the morbidity associated with motor nerve harvest.<br />

However, some investigators have suggested that modality matching, i.e. repairing motor nerves with motor grafts and sensory nerves<br />

with sensory grafts, may improve nerve regeneration. The aim of this study is to compare nerve regeneration between modality<br />

matched and modality mismatched grafts in a clinically-representative scenario utilizing unifascicular nerve grafts in a rodent model.<br />

MATERIALS AND METHODS:<br />

Isogeneic nerve grafts were harvested from the quadriceps branch of the femoral nerve (motor), femoral cutaneous branch (sensory),<br />

and peroneal nerve (mixed). Grafts were 10mm in length and were used to reconstruct a 5mm defect in the quadriceps branch or cutaneous<br />

branch of a recipient rat. A total of 48 Sprague-Dawley rats were randomized to six groups of eight animals each. The groups<br />

represented six different combinations of donor and recipient nerves, as follows: 1) motor/motor, 2) sensory/motor, 3) mixed/motor, 4)<br />

sensory/sensory, 5) motor/sensory, 6) mixed/sensory. Animals were sacrificed after 7 weeks and nerves were harvested <strong>for</strong> analysis. The<br />

recipient nerve distal to the graft was fixed, stained, and sectioned <strong>for</strong> histomorphometry.<br />

RESULTS:<br />

Histologic sections revealed robust regeneration through the graft and into the distal nerve in all groups. Histomorphometric analysis<br />

of nerve sections distal to the graft revealed no significant difference between any of the six experimental groups with regard to nerve<br />

fiber count, fiber density, fiber width, nerve area, or percent nerve. Assessment of fiber size revealed that sensory and motor grafts supported<br />

regeneration of a similar number of large-diameter axons when grafted into motor nerve.<br />

CONCLUSION:<br />

Our data demonstrate that injured peripheral axons do not regenerate in a manner specific to motor or sensory modality. On the contrary,<br />

motor and sensory nerve regeneration occurs to an equal degree in motor, sensory, and mixed nerve grafts. In addition, equal<br />

numbers of large-diameter fibers regenerated through sensory and motor grafts in the quadriceps branch. This indicates that sensory<br />

grafts are equal to motor in their ability to support regenerating motor axons. Our findings support the continued use of nerve grafts<br />

derived from sensory nerves when reconstructing motor nerve defects in human patients. Further studies will be undertaken to compare<br />

end organ reinnervation and functional recovery between modality matched and mismatched grafts.<br />

Limb Length Discrepancy in Obstetrical Brachial Plexus Injury<br />

Institution where the work was prepared: McMaster Children's Hospital, Hamilton, ON, Canada<br />

James Bain, MD, MSc; Carol DeMatteo; Deborah Agro; Hamilton Health Sciences and McMaster University<br />

Obstetrical brachial plexus injury (OBPI) has a variable natural history depending upon severity of nerve trauma. Approximately 50 % of<br />

children will completely recover, many will be left with a functional but short, impaired arm.<br />

PURPOSE:<br />

To determine if OBPI results in differences in limb length comparing the affected to unaffected limbs.<br />

METHODS:<br />

A prospective database of OBPI patients from 1998-2007 has been reviewed. Limb lengths were manually measured by the same investigator<br />

at standard times in new patients and at 3 and 12 month follow-up. Arm length was measured from the acromion to the olecranon<br />

and <strong>for</strong>earm length from the olecranon to the ulnar styloid. Inclusion criteria included those with full records and early presentation<br />

to our clinic. Comparisons were made between affected and unaffected limbs, and results correlated with total active motion scale<br />

scores (AMS) using SAS statistical software.<br />

RESULTS:<br />

Twenty-four children had complete scores at 3 months and there was a significant reduction in the limb length of the affected side<br />

(p


Regeneration in an Enzyme-Treated Decellularized Nerve Allograft<br />

Institution where the work was prepared: Washington University School of Medicine, St. Louis, MO, USA<br />

Sami H. Tuffaha, BA; Daniel A. Hunter; Ying Yan; Janina P. Luciano; Susan E. Mackinnon; Gregory H. Borschel;<br />

Washington University in St. Louis<br />

INTRODUCTION:<br />

Peripheral nerve injuries are currently reconstructed using nerve autografts. The very limited supply of autologous nerve grafting material<br />

combined with the morbidity associated with nerve autograft harvest, such as sensory loss and painful neuroma <strong>for</strong>mation, necessitate<br />

a suitable substitute to autografting. AxoGenô nerve allografts are manufactured by decellularizing human nerves with a process<br />

that removes antigens and degrades molecules that inhibit neuroregeneration while leaving laminin intact. We designed a study to<br />

compare the neuroregenerative capacities of the AxoGenô nerve graft to those of an autograft and the NeuraGenô conduit (the leading<br />

hollow tube nerve conduit).<br />

METHODS:<br />

To obtain processed nerve grafts, sciatic nerves from Brown Norway rats were harvested and sent to AxoGenô <strong>for</strong> proprietary processing.<br />

Three groups (Avanceô, NeuraGenô and isograft) were im<strong>plan</strong>ted into the sciatic nerve of Lewis rats at two different lengths (14mm<br />

and 28mm). Grafts were harvested at either a 6 or 12 week endpoint and evaluated <strong>for</strong> neuroregeneration using histomorphometry.<br />

Retrograde labeling, motor endplate staining, walking track analysis, and wet muscle mass were used to analyze functional recovery.<br />

RESULTS:<br />

Midgraft histomorphometric data of the 14mm grafts at 6 weeks showed significantly greater regeneration in AxoGenô processed<br />

grafts, as compared to NeuraGenô conduits.† Fiber distribution patterns resembled those of an isograft as demonstrated by electron<br />

micrographs of midgraft sections.<br />

CONCLUSION:<br />

The AxoGenô grafts were well-tolerated by all animals. The 6 week histomorphometric data suggest that the neuroregenerative capacities<br />

of AxoGenô processed grafts are comparable to those of an isograft and significantly better than those of the leading biosynthetic<br />

conduit. Pending functional outcome measures and data from the 12 week endpoint, it appears that AxoGenô grafts could provide<br />

a much needed substitute <strong>for</strong> autografts.<br />

Graft Type<br />

Total fiber number ±<br />

std dev<br />

Percent Nerve<br />

± std dev<br />

* or †: significant difference between groups; p < 0.05 by ANOVA.<br />

Fiber width (µm)<br />

± std dev<br />

120<br />

Nerve density<br />

(fibers/mm 2 )<br />

± std dev<br />

Isograft 13649 ± 4967*† 23.5 ± 11.0* 3.0 ± 0.2* 23191 ± 9616*<br />

AxoGen TM<br />

Processed<br />

Nerve Graft<br />

6041 ± 1515† 16.5 ± 3.4† 3.3 ± 0.2† 14749 ± 3512†<br />

NeuraGen TM 1427 ± 2018* 1.3 ± 1.8*† 1.6 ± 2.2*† 1278 ± 1821*†


Increase of Neuronal Camp by Electrical Stimulation or Rolipram Administration and/or<br />

Local Application of Chonodrioitinase ABC Accelerates Motor Axon Outgrowth Across the<br />

Surgical Repair Site of Sectioned Rat Peripheral Nerve<br />

Institution where the work was prepared: University of Alberta, Edmonton, AB, Canada<br />

T. Gordon; M Furey; N Tyreman; E Udina; University of Alberta<br />

Inhibitory proteins associated with myelin and the proteoglycans of the extracellular matrix play a major role in the failure of the central<br />

axons to regenerate after injury. Although also present in the peripheral nervous system (PNS), these molecules do not block PNS<br />

regeneration mainly due to the effective Wallerian degeneration after a nerve lesion. Nevertheless, these molecules could play an<br />

important role in the delay in the onset of axonal regeneration observed after the repair of a transected peripheral nerve. By accelerating<br />

the onset of axonal regeneration the detrimental consequences of long periods of chronic axotomy and Schwann cell denervation<br />

would be diminished and the functional recovery would be improved. In this study we wanted to elucidate the role of cAMP in PNS<br />

regeneration, since its elevation in neurons can overcome inhibition of myelin associated proteins. Electrical stimulation (ES) of the<br />

peripheral nerve accelerates the onset of regeneration and its effect has been linked to increased levels of cAMP in the neuron, there<strong>for</strong>e<br />

we also wanted to compare the similarities between ES with systemic administration of an agent that increase cellular cAMP levels<br />

in PNS regeneration. We repaired the transected common peroneal (CP) nerve in rats and increased levels of cAMP in the axotomized<br />

neurons with subcutaneous administration of rolipram, a specific inhibitor of the phosphodiesterase, the enzyme that degrades<br />

cAMP. Moreover, we investigated if combination of rolipram treatment with local degradation of the proteoglycans by application of<br />

chondroitinase ABC (cABC) in the distal stump, would elicit an additive enhancement in nerve regeneration. Rolipram treatment significantly<br />

increased the mean (± SE) number of motor (but not sensory) neurons that regenerated their axons across the repair site at 1w<br />

and 2w with 194±14 of a total of 336±19 CP motoneurons regenerating their axons a 10mm distance into the distal nerve stump at 2w<br />

as compared to 109±20 motoneurons that regenerated their axons after saline treatment. This effect mimicked the effect of 1h of ES<br />

(at 20Hz) applied to the proximal stump of the transected and repaired femoral nerve in accelerating axon outgrowth. Both rolipram<br />

and ES significantly increased the number of motor axons crossing the lesion site at earlier time points by ~3-fold when compared to<br />

the control groups. Local application of cABC also accelerated axonal outgrowth but the effect was not additive when combined with<br />

rolipram. We conclude that pharmacological elevation of cAMP accelerates PNS axonal outgrowth similar to ES.<br />

121


Suppression of Fibrous Scar Improves Peripheral Nerve Regeneration After Primary Nerve Suture<br />

Institution where the work was prepared: University of Tuebingen and University of Duesseldorf, Tuebingen and<br />

Duesseldorf, Germany<br />

Nektarios Sinis, MD1; Philip Schoenle1; Tatjana Lanaras1; Frank Werdin, MD1; Armin Kraus, MD1; Max Haerle, MD2;<br />

Timm Danker, PhD1; Elke Guenther, Phd1; Federica Di Scipio, Phd3; Stefano Geuna, MD3; Hans-Werner Mueller,<br />

PhD4; Daniela Mueller5; Carmen Masannek5; Susanne Hermanns, Phd5; Hans-Eberhard Schaller, MD1; (1)University of<br />

Tuebingen, (2)Orthopaedische Klinik Markgroeningen, (3)University de Torino, (4)Heinrich-Heine-University of<br />

Duesseldorf, (5)Neuraxo Biopharmaceuticals GmbH<br />

BACKGROUND:<br />

Despite the progress of microsurgical techniques the outcome of repaired nerves after primary nerve suture remains incomplete in a<br />

lot of cases. One reason that explains these results is the development of a fibrous collagen scar at the site of coaptation with expression<br />

of different growth inhibiting substances. This collagen scar prevents axons from passing the lesion and reaching the end organ.<br />

The aim of this study was to analyze the impact of a scar inhibiting substance, namely a potent iron chelator on peripheral nerves after<br />

transection and primary nerve suture.<br />

MATERIAL/ METHODS:<br />

In a rat median nerve model four experimental groups were operated. Group I ñ transection of the median nerve and primary nerve<br />

suture (N = 12). Group II ñ transection and venous ensheatment of the median nerve at the coaptation site (external jugular vein) (N =<br />

12). Group III ñ transection of the nerve, venous ensheatment and filling the vein with a lipid carrier (N = 12). Group IV ñ transection,<br />

venous ensheatment, filling of the vein with the iron chelator combined with the lipid carrier (N = 12). The observation† Axon number,<br />

density, average diameter, nerve area and myelin thickness were measured. The gastrocnemius muscle was harvested and gene expression<br />

of GAP-43, myogenin, MyoD, MYF5, MYF6 (MRF4) and the ?, ?, ?, ?, and ?-subunits of the nicotinic acetlycholinergic<br />

receptor(nAChR) were examined.<br />

RESULTS:<br />

For control animals, 83% of Young showed evidence of regeneration vs. 50% of Aged. For IGF-1 treated animals, 100% of Young and<br />

75% of Aged showed evidence of regeneration. Of regenerated animals, there was no difference in conduction delay or amplitude. In<br />

aged animals, IGF-1 significantly increased a) axons per nerve (13025 vs. 3062; p


ASPN SCIENTIFIC PAPER SESSION D<br />

Brachial Plexus Surgery in a German Center <strong>for</strong> Peripheral Nerve Surgery<br />

Institution where the work was prepared: University of Tuebingen, Tuebingen, Germany<br />

Nektarios Sinis, MD; Tatjana Lanaras; Hans-Eberhard Schaller, MD; University of Tuebingen<br />

Brachial plexus lesions are still associated with complete or partial plegia of affected muscles even though the microsurgical concepts<br />

and treatment options were improved during the past twenty years. This work should provide an overview of strategies and outcomes<br />

of 42 patients operated in a center <strong>for</strong> peripheral nerve surgery in the southwest of Germany. The patients were followed after surgery<br />

and examined <strong>for</strong> muscle strength of different muscle groups following the classification introduced by Loved et al. (M0 ñ no function<br />

to M5 ñ full function) and sensitivity (differentiation of blunt and sharp touch in different dermatomes). They were asked with a short<br />

questionnaire about their experiences and daily life after surgery. The longest follow-up was 96 months while the shortest was four.<br />

Mean time past between trauma and operation was 7.1 months. 93% of the patients received a grafting procedure using the sural nerve.<br />

Different procedures were applied referring to the underlying pathology: Intercostal nerve transfer, end-to-side coaptation of donor and<br />

recipient nerves (one case of phrenic nerve to axillary nerve), direct grafting between roots, cords and trunks to different recipient<br />

nerves. At the time of examination 27 patients had a follow-up time of at least 36 months. Only these patients presented a measurable<br />

function in the affected extremity. In general the results <strong>for</strong> reconstruction of proximal muscle groups were more satisfactory than those<br />

in distally located muscles (e. g. short muscles of the hand, exception the deltoid muscle). Elbow ñ flexion was restored in 56 % of cases<br />

(i. e. muscle strength of at least M3). Triceps function was successfully reconstructed in 26 % of cases. <strong>Hand</strong> function was in contrast poor<br />

except of one case with full regeneration after neurolyisis. Nevertheless, some developed an acceptable <strong>for</strong>ce of the <strong>for</strong>earm muscle<br />

groups with the ability to flex the wrist in 37 % and <strong>for</strong> wrist extension in 17 %. Results were estimated as acceptable <strong>for</strong> biceps reconstruction<br />

but poor <strong>for</strong> the other muscle groups. Some treatment strategies which are today under frequent discussion (contralateral C7transfer,<br />

banked autografts, Oberlin procedure) were not applied. However, some of these techniques may provide a key to improve<br />

the results, there<strong>for</strong>e frequent exchange in <strong>for</strong>m of specialist meetings <strong>for</strong> different concepts and surgical techniques should be per<strong>for</strong>med<br />

by centers operating brachial plexus lesions in order to share their experiences with the others.<br />

Effect Of Nerve Growth Factor (NGF) Releasing Polylactic-Co-Glycolic Acid (PLGA)<br />

Microspheres On Peripheral Nerve Regeneration<br />

Institution where the work was prepared: Mayo Clinic, Rochester, MN, USA<br />

Ralph De Boer, MD1; Huan Wang, MD, PhD1; Andrew M. Knight, PhD1; Robert J. Spinner1; M.J.A. Malessy2; Michael<br />

J. Yaszemski, MD, PhD1; Anthony J. Windebank, MD1; (1)Mayo Clinic, (2)Leiden University Medical Center<br />

INTRODUCTION:<br />

Autologous nerve grafting is the standard method <strong>for</strong> repair of a peripheral nerve when direct coaptation is not feasible. Optimization<br />

of artificial nerve conduits by incorporation of trophic factors may enhance nerve regeneration and improve outcomes <strong>for</strong> patients.<br />

Consistent delivery of trophic factors <strong>for</strong> a prolonged period of time is there<strong>for</strong>e required. We have characterized the long term release<br />

of nerve growth factor, using a microsphere delivery system and evaluated the effect on functional regeneration in a rat sciatic nerve<br />

injury model.<br />

METHODS:<br />

In vitro: 125I-NGF was incorporated into PLGA microspheres with lactic to glycolic acid ratios of 50:50 (1A - inherent viscosity 0.1 dL/g);<br />

50:50 (4A - inherent viscosity 0.4 dL/g); 50:50 (7A - inherent viscosity 0.7 dL/g); 75:25 and 85:15. Microspheres were placed in a transwell<br />

and continuously shaken at 37'C <strong>for</strong> 10 weeks. Release of radioactivity into the medium was measured weekly by ?-counting. Biological<br />

activity of released NGF was established using the E15 rat dorsal root ganglion (DRG) assay In vivo: An animal study has been initiated<br />

with PLGA nerve conduits loaded with NGF releasing microspheres bridging a 10 mm gap in the rat sciatic nerve. An autologous nerve<br />

graft and a conduit filled with saline were used as the positive and negative control respectively. Electrophysiological (CMAP, SEP), sensory<br />

(Hargreaves) and motor testing (motion analysis) were carried out at baseline and at two week intervals after surgery. Retrograde<br />

tracing will be per<strong>for</strong>med be<strong>for</strong>e sacrificing the rats at 17 weeks. Sciatic nerves, along with appropriate spinal cord segments and dorsal<br />

root ganglia will be harvested and analyzed <strong>for</strong> cell counting and nerve morphometric measurements.<br />

RESULTS:<br />

In vitro: Microspheres could be designed to gradually release NGF at a rate of 0.2-2.5% of total per day. There was a small (


Nerve Transfers to Reanimate Elbow Flexion in Obstetric Brachial Plexus Lesions<br />

Institution where the work was prepared: Leiden University Medical Center, Leiden, Netherlands<br />

Willem Pondaag, MD; Martijn J.A. Malessy; Leiden University Medical Center<br />

INTRODUCTION:<br />

In obstetric brachial plexus lesions with avulsion injury, nerve grafting is not possible due to the lack of a proximal stump as lead-out. In<br />

such cases, intercostal nerves (ICN) and pectoral (PEC) nerves can serve as donor <strong>for</strong> a nerve transfer to the musculocutaneous nerve<br />

(MCN) to restore elbow flexion. Reports are scarce on the results of ICN-MCN and PEC-MCN transfers. In the present study the results<br />

of both techniques are reported from a single institution.<br />

METHODS:<br />

Patients We analyzed 30 consecutive patients (1995-2005) in whom nerve transfers <strong>for</strong> biceps reanimation had been applied. From 1995-<br />

2000 only ICN-MCN transfers were per<strong>for</strong>med, from 2001-2005 both techniques were applied. 8 of the 16 patients with ICN-MCN transfer<br />

had a flail arm. The PEC-MCN was applied in 10 cases of avulsion injury to both C5 and C6, which had often resulted from breech<br />

delivery. Alternatively, the PEC-MCN transfer was applied in 4 patients because shoulder innervation had recovered spontaneously but<br />

recovery of the biceps muscle had not taken place.<br />

RESULTS:<br />

Surgical Technique In all but one ICN-MCN patients three intercostal nerves were coaptated directly to the musculocutaneous nerve; in<br />

one patient a 1 cm graft proved necessary. In the patients with PEC-MCN transfer, in half of the patients the musculocutaneous was significantly<br />

bigger in diameter than the pectoral nerves. In these cases the MCN was sectioned only partially, leaving half of the nerve intact.<br />

Results Elbow flexion > MRC 3 was achieved in 26/30 patients (87%) after a mean follow-up of 40 months. The results in the PEC-MCN<br />

group were somewhat better than in the ICN-MCN group (93% vs. 81%). In the ICN-MCN group once secondary surgery was per<strong>for</strong>med<br />

(Steindler flexor-plasty). No adverse effects were noted in both groups, especially no rib cage de<strong>for</strong>mity.<br />

DISCUSSION:<br />

The overall success rate was satisfying. The observed difference in results between the PEC-MCN and ICN-MCN transfers may be<br />

explained by the more severe brachial plexus lesions that were included in the ICN-MCN group.<br />

Specialty of the Phrenic Nerve <strong>for</strong> Modified End-to-Side Nerve Repair - Experiment and<br />

Clinical Implications<br />

Institution where the work was prepared: Medical College of Wisconsin, Milwaukee, WI, USA<br />

ji-Geng Yan, MD; Lin-Ling Zhang; Hani S Matloub; James R Sanger; Yu-Hui Yan; Medical College of Wisconsin<br />

INTRODUCTION:<br />

End-to-side neurorrhaphy has had limited use clinically due to its few and small donor side sprouts. Phrenic nerve possesses a continuous<br />

firing rhythm that enhances side sprouting.<br />

METHODS:<br />

Laboratory phase: 18 SD rats were divided into 3 groups of 6. Group I: Phrenic side with wide oblique window was sutured with 1.5-cm<br />

saphenous nerve graft, then musculocutaneous nerve; Group II: Phrenic nerve was transected, its proximal end sutured to1.5-cm saphenous<br />

nerve graft, then to musculocutaneous nerve; Group III: Musculocutaneous nerve was transected without any repair. Clinical phase:<br />

From 1999 to 2007, a total 46 patients (15 adults, 32 children) with brachial plexus injury underwent modified end-to-side neurorrhaphy<br />

in which the phrenic side was widely opened, one or two nerve grafts were interpositioned and sutured between the phrenic nerve side<br />

and the recipient nerve end, which included various recipient ends on different nerve injuries (musculocutaneous nerve, anterior or posterior<br />

division of the upper trunk, axillary nerve, suprascapular nerve, etc.) 34 patients have been followed postoperatively from 3 months<br />

to 69 months (mean:25.5).<br />

RESULTS:<br />

Laboratory phase: Group I was superior to Groups II and III. by histology and electrophysiologic study. Side sprouting behavior was<br />

studied by various histology and molecular methods that showed that sprouting growth of the phrenic nerve was easy and extensive.<br />

Clinical phase: 17/34 (50%) patients had muscle grade 4; 10/34 (30%) patients had muscle grade 3; 4/34 (11%) patients had muscle grade<br />

2; 3/34 (9%) patients had muscle grade 1.<br />

CONCLUSION:<br />

1. Both laboratory and clinical surgery showed excellent results can be obtained if the phrenic nerve side is widely opened to allow one<br />

or more nerve grafts by oblique repair methods. 2. The special suitability of the phrenic nerve <strong>for</strong> this type of repair is evidenced by<br />

easy, fast and intense side sprouting, probably due to its continuous firing rhythm.<br />

124


Spontaneous gait recovery in denervated rats may impair the evaluation of artificial nerve guides<br />

Institution where the work was prepared: The Catholic University, Rome, ItalyAntonio Merolli, MD; Lorenzo Rocchi;<br />

Maria Silvia Spinelli; Rocco De Vitis; Francesco Catalano; The Catholic University<br />

PURPOSE:<br />

The study of the morphology of the in-vivo regeneration of a nerve, made by purely histological methods, may require such a high number<br />

of animals to pose serious problems of technique, ethics and funding and, then, a cheaper analysis like the evaluation of gait recovery<br />

is viewed with favour. The purpose of this study is to evaluate the reliability of this approach with the future perspective of studying<br />

artificial nerve guides im<strong>plan</strong>tation.<br />

METHODOLOGY:<br />

The study of peripheral nerve regeneration makes a widespread use of the rat sciatic nerve model where an artificial nerve guide may be<br />

im<strong>plan</strong>ted to bridge the gap in the eventually ablated segment of the nerve. In this work, 4 mm of the left sciatic nerve were ablated in<br />

inbred male Wistar rats; the retraction of the stumps led to a final gap of about 8 mm; nothing was interposed to bridge the gap. Twice a<br />

week the animals where individually taken out of their cage and let walk freely on a 0,5*2,0 m board <strong>for</strong> about 4 minutes; their walking was<br />

video-recorded. After 8 weeks the animal were sacrificed and a macroscopic examination of the operated site was per<strong>for</strong>med.<br />

RESULTS:<br />

Two rats exhibited a partial recovery in gait within the first week after surgery; additional three exhibited it within the second week. Only<br />

one rat dragged the opertated limb during the first two weeks, mostly because of a deficit in extension of the foot, but afterwards a<br />

partial gait recovery ensued. As time passed, improving in gait recovery was documented; at the same time the operated limb<br />

appeared more hypotrophic and abducted.<br />

CONCLUSION:<br />

A cheaper analysis per<strong>for</strong>med on the same animal along the duration of the experiment is seeked with favour and several studies in<br />

the literature contemplate the evaluation of gait pattern, and its eventual recovery after trauma, to avoid the use of more animals. The<br />

present study highlights that in the male Wistar rat sciatic model a spontaneous recovery in gait pattern occurs very early. This will impair<br />

any possible subtle discrimination, by qualitative visually-based analysis alone, about a possible benefit derived from the use of an artificial<br />

nerve guide since a recovery in gait is likely to ensue even without a device.<br />

125


ASPN SCIENTIFIC PAPER SESSION E<br />

Nonviral HVJ (Hemagglutinating Virus of Japan) Liposome Mediated Retrograde Gene<br />

Transfer of Human Hepatocyte Growth Factor Improves Neuropathic Pain-Related<br />

Phenomena in Rats<br />

Institution where the work was prepared: National Defense Medical College, Tokorozawa, Japan<br />

Toyokazu Tsuchihara1; Koichi Nemoto1; Hiroshi Arino1; Masatoshi Amako1; Kuniaki Nakanishi1; Morishita Ryuichi2;<br />

(1)National Defense Medical College, (2)Osaka University Medical School<br />

INTRODUCTION:<br />

Peripheral nerve injury is relatively common and sometimes may cause chronic neuropathic pain characterized by hyperalgesia and allodynia.<br />

However, neuropathic pain is extremely difficult to treat because of poor understanding of the underlying mechanisms. The purpose<br />

of this study is to investigate the therapeutic effect of Human hepatocyte growth factor (HGF) delivered into the nervous system<br />

by retrograde axonal transport using liposomes containing the hemagglutinating virus of Japan (HVJ).<br />

MATERIAL/METHODS:<br />

Male Wistar rats, approximately 6 weeks old were used (n=228). Chronic constriction injury (CCI) model in rats was made as an experimental<br />

neuropathic pain model. HGF gene was delivered into the nervous system by retrograde axonal transport following its repeated<br />

intramuscular transfer, using liposomes containing the HVJ. Evaluation methods were as follows: (a) the withdrawal threshold of the<br />

hind paw in response to non-noxious mechanical stimuli; (b) the thermal threshold in response to noxious heat applied to the <strong>plan</strong>tar<br />

surface of the hind paw; (c) the blood flow of the sciatic nerve and the hind paw; (d) mRNA levels <strong>for</strong> P2X and P2Y receptors. P2X and<br />

P2Y receptors, which are activated by extracellular ATP, may play important roles as nociceptive purinoceptors on sensory nerve terminals,<br />

and (e) imaging study using light- and electron-micrographs.<br />

RESULTS:<br />

CCI (control) rats exhibited marked mechanical allodynia and thermal hyperalgesia, and decreased blood flow in sciatic nerve and hind<br />

paw. All these changes were significantly reversed by HGF-gene transfer. In the sciatic nerve in HGF-transferred rats, the histgram of the<br />

axons showed rightward shifts, the number of myelinated axons more than 5ìm in diameter was significantly increased, and the mean<br />

diameter of unmyelinated axons was significantly increased (versus CCI rats). Levels of P2X3, P2X4, and P2Y1 receptor mRNAs were elevated<br />

in the ipsilateral dorsal root ganglia and/or sciatic nerves by CCI, and these levels were decreased by HGF-gene transfer.<br />

CONCLUSION:<br />

We have demonstrated that transfer the human HGF gene into the nervous system via repeated intramuscular injection of nonviral<br />

HGF-HVJ liposomes is an efficient way of preventing or limiting sensory nerve degeneration in a rat model of neuropathic pain. On this<br />

basis, HGF gene transfer via retrograde transport may become a novel useful therapeutic tool <strong>for</strong> the treatment of neuropathic pain.<br />

126


Repairing Peripheral Nerve Injuries Using Skin-Derived Precursor Cells<br />

Institution where the work was prepared: University of Calgary, Hotchkiss Brain Institute, Calgary, AB, Canada<br />

Sarah K. Walsh, BSc; Raj Midha, MD, MSc; University of Calgary<br />

Previous work has shown that clones of progenitor cells isolated from the dermis of the neonatal and adult murine skin have the ability<br />

to differentiate in vitro into neural crest cell types, including peripheral neurons and glia. These cells, termed skin-derived precursors<br />

(SKPs), also respond to the milieu of the regenerating nerve in vivo and are able to differentiate into GFAP/S-100‚ positive Schwann cells<br />

when trans<strong>plan</strong>ted distal to a nerve injury. In our ongoing study, we are exploring the viability and differentiation of SKPs in various nerve<br />

injury models to ascertain their role in promoting nerve regeneration. To this end, the sciatic nerves of CD-1 mice were transected and<br />

chronically denervated. SKPs or SKP-SCs were injected into the subepineurium distal to the transection either immediately following<br />

injury or after 8 weeks of denervation. Immunohistochemical analysis 2-8 weeks following trans<strong>plan</strong>tation revealed survival and differentiation<br />

of both naïve and pre-differentiated SKPs, with 73% of the surviving cells injected after established chronic denervation<br />

expressing Schwann cell markers. Eight weeks following SKP trans<strong>plan</strong>t, survival of pre-differentiated SKPs was significantly higher than<br />

that of the naïve preparation. This study also examined the potential <strong>for</strong> SKPs to improve nerve regeneration across a gap bridged by<br />

a freeze-thawed nerve graft. Donor sciatic nerves were collected from adult Lewis rats and decellularized by repeated cycles of freezing<br />

in liquid nitrogen and thawing in warm water bath. These syngeneic grafts were then used to bridge a 12 mm nerve injury gap in<br />

Lewis rat recipients and SKPs-SCs or cultured Schwann cells were injected into the grafted area. Immunohistology after 4 weeks showed<br />

survival of both cell types and early regeneration in SKP seeded grafts (as deemed by NF-stained axon counts) was comparable to those<br />

seeded with Schwann cells. We expect that morphometrical and electrophysiological measurements of cell-treated nerve segments<br />

after 8 weeks survival will show a similar contribution to regeneration. We there<strong>for</strong>e conclude that SKPs represent an accessible, autologous<br />

source of Schwann cells <strong>for</strong> trans<strong>plan</strong>tation therapies that have the potential to survive over long time periods and improve<br />

regeneration outcomes.<br />

DASH as a Measurement of Outcome in Adult Brachial Plexus Reconstruction<br />

Institution where the work was prepared: Mayo Clinic, Rochester, MN, USA<br />

Keith A. Bengtson; Alexander Shin; Robert Spinner; Allen Bishop; Michelle Kircher; Mayo Clinic<br />

No clear consensus exists on how to measure outcomes after adult brachial plexus reconstruction. The BMRC muscle strength scale is<br />

the most popular measuring tool used to date. Un<strong>for</strong>tunately, this method has many shortcomings including its imprecision, lack of<br />

inter-rater reliability, as well as the wide range of strength that is covered by the grade of 4/5. The DASH, however, “is the most validated<br />

measure of upper extremity function in upper extremity disorders. The instrument's ease of use in a heterogeneous sample is possibly<br />

its greatest advantage.” (Dowrick 2005). No studies have been published that measure DASH scores both be<strong>for</strong>e and after brachial<br />

plexus reconstruction. The purpose of this study is to illustrate the usefulness of the DASH as an outcome measure in adult brachial<br />

plexus reconstruction. Between the dates of November 2004 and October 2006, 34 patients underwent reconstruction of brachial<br />

plexus injuries and completed both pre-operative and post-operative DASH questionnaires. Time of follow-up questionnaire ranged<br />

from 5 months to 26 months (average of 15.4 months) depending on type of surgery and expected time period <strong>for</strong> neurologic recovery.<br />

Improvement in DASH scores ranged from -27.5 (greater disability) to +29.2 with an average improvement of 11.2. Five different<br />

patient groups were included based on type of neurologic injury. Each group showed a significant change in DASH score be<strong>for</strong>e and<br />

after surgical intervention. Such responsiveness to change would indicate that the DASH is a sensitive outcome tool <strong>for</strong> the study of<br />

adult brachial plexus reconstruction.<br />

REFERENCE:<br />

Dowrick AS. Gabbe BJ. Williamson OD. Cameron PA. Outcome instruments <strong>for</strong> the assessment of the upper extremity following trauma:<br />

a review. Injury. 36(4):468-76, 2005 Apr.<br />

127


Reversal of Distal Symmetric Polyneuropathy by Microsurgical Decompression of Localized<br />

Nerve Entrapments<br />

Institution where the work was prepared: International Neuropathy Microsurgery Institute, Sonora, CA, USA<br />

Michael Charles Edwards, MD/PhD; Joseph Paul Day, PhD; International Neuropathy Microsurgery Institute<br />

BACKGROUND:<br />

Current medical guidelines recommend non-surgical care of distal symmetric polyneuropathy (Chaudhry, Stevens et al. 2006). We<br />

hypothesize that intra-operative electromyography to identify localized nerve entrapments will validate nerve decompression surgery<br />

(Dellon 2006; Dyck 2007). The increasing population of neuropathy patients need effective treatments (Papanas, Maltezos et al. 2006).<br />

Lost productivity costs the United States $61 billion annually (Henig, Ephron et al. 2007).<br />

METHODS:<br />

Our 1.5 year study integrated intra-operative electromyography with standard nerve decompression techniques of the lower extremity<br />

treating a wide population of patients with well defined distal symmetric polyneuropathy (England, Gronseth et al. 2005). Placebo surgeries<br />

were considered unethical with 17 years of empirical data (Chaudhry, Stevens et al. 2006) (Siemionow, Alghoul et al. 2006). Nerve<br />

entrapments were objectively identified; in contrast to human studies and on-going clinical application (Dellon 2006; Dyck 2007).<br />

RESULTS:<br />

Distal symmetric polyneuropathy was reversed by nerve decompression surgery at the tarsal tunnel, fibular tunnel, and pedal dorsum.<br />

Intra-operative electromyography objectively identified local entrapments. 433 lower extremity muscle groups in 111 patients were tested<br />

intra-operatively. High post nerve decompression increase in motor unit action potential correlated with an improved post-operative<br />

sensibility (P


Pressure Changes in the Medial and Lateral Plantar and Tarsal Tunnels Related to Ankle<br />

Position: a Prospective Intra-Operative Study in Patients with Underlying Neuropathy<br />

Institution where the work was prepared: Johns Hopkins University School of Medicine, Baltimore, MD, USA<br />

Gedge D. Rosson, MD1; Eric H. Williams, MD2; Allison R. Barker, BA1; A. Lee Dellon, MD3; (1)Johns Hopkins<br />

University School of Medicine, (2)Dellon Institute <strong>for</strong> Peripheral Nerve Surgery: Baltimore. Clinical Instructor; Johns<br />

Hopkins University School of Medicine, (3)Dellon Institute <strong>for</strong> Peripheral Nerve Surgery: Baltimore. Professor; Johns<br />

Hopkins University School of Medicine<br />

BACKGROUND:<br />

Pressure in the tarsal tunnel has been shown to be elevated in pronation. We hypothesized that this result would hold <strong>for</strong> the medial<br />

and lateral <strong>plan</strong>tar tunnels since they are also potential sites of nerve compression. Additionally we hypothesized that decompression<br />

surgery would decrease these pressures. We have previously presented that these pressures are decreased by surgery in a cadaver<br />

model. We further hypothesized that the pressures in symptomatic patients would be higher than in our cadaver study. Thus, we sought<br />

to study the pressure changes in the medial and lateral <strong>plan</strong>tar and tarsal tunnels in actual symptomatic patients with co-existing peripheral<br />

neuropathy and evidence of superimposed nerve compressions.<br />

METHODS:<br />

10 patients were enrolled. Intra-operative pressure measurements were made in the medial and lateral <strong>plan</strong>tar and tarsal tunnels be<strong>for</strong>e<br />

and after decompression surgery, including excision of the septum between the medial and lateral <strong>plan</strong>tar tunnels, in a variety of foot<br />

positions. Approval <strong>for</strong> this prospective study was obtained from The Johns Hopkins Medicine IRB.<br />

RESULTS:<br />

Pronation and pronation with <strong>plan</strong>tar flexion gave significantly higher pressures than the other foot positions in the medial and lateral<br />

<strong>plan</strong>tar tunnels. This was the same as seen in the cadaver study. Surgery significantly decreased the pressures in the three tunnels in all<br />

foot positions except pronation in the tarsal tunnel and supination in the lateral <strong>plan</strong>tar tunnel. Significant decreases in pressure were<br />

seen with simple roof incision in all tunnels in all positions except the two mentioned above. Septum excision gave further significant<br />

decreases in pressure in the medial and lateral <strong>plan</strong>tar tunnels when compared with roof incision alone. These patients did have significantly<br />

higher pressures in several foot positions in the medial and lateral <strong>plan</strong>tar tunnels than the cadaver study limbs.<br />

CONCLUSION:<br />

Pressures within the medial and lateral <strong>plan</strong>tar tunnels, and the tarsal tunnel, increase significantly with changes in ankle position. These<br />

pressure changes are significantly decreased by surgical release of these three tunnels, including excision of the septum between the<br />

medial and lateral <strong>plan</strong>tar tunnels. Pressures within the medial and lateral <strong>plan</strong>tar tunnels are significantly higher in living symptomatic<br />

patients versus presumably asymptomatic cadaver limbs.<br />

CLINICAL RELEVANCE:<br />

Symptoms related to chronic compression of the tibial nerve and its branches may potentially be relieved by custom orthotics and proper<br />

gait mechanics, and, when necessary, by a surgical strategy targeting release of multiple anatomic regions rather than focusing upon<br />

the tarsal tunnel alone.<br />

129


Inducible Nerve Growth Factor Delivery by HEK-293 Cells <strong>for</strong> Peripheral Nerve Regeneration<br />

in Vivo<br />

Institution where the work was prepared: University of Cali<strong>for</strong>nia, Irvine, CA, USA<br />

Thomas Scholz, MD; James M. Rogers; Alisa Krichev; Sanjay Dhar; Gregory R. D. Evans; University of Cali<strong>for</strong>nia, Irvine<br />

INTRODUCTION:<br />

Autologous nerve grafts are currently the treatment of choice <strong>for</strong> peripheral nerve injury, but are limited by availability and related morbidity.<br />

Tissue engineered nerve constructs have the potential to improve peripheral nerve regeneration following nerve injury. We have<br />

previously demonstrated that HEK-293 cells can be genetically tripel transfected to release and regulate nerve growth factor (NGF) in<br />

vitro. The aim of this study was to evaluate the efficacy of the NGF delivery system in vivo and its impact on nerve regeneration and<br />

functional recovery.<br />

MATERIALS/METHODS:<br />

HEK-293 cells were tripel transfected with a regulatory vector, NGF cDNA, and HSV-TK. The NGF production by this stable cell line is<br />

induced by Ponasterone A (Pon A) and stopped by ganciclovir (GCV). A total of 120 nude rats were used to create a 15mm sciatic nerve<br />

gap with both nerve ends sutured into a silastic conduit. Conduits were filled with the transfected HEK-293 cells diluted in culture media<br />

and assigned to one of the following treatment groups (n=20): A) non-induced, B) induced with Pon A, C) non-induced and treated with<br />

GCV at day 7, 14, 21, D) induced with Pon A and boostered with Pon A at day 7, 14, 21, E) induced with Pon A and treated with GCV at day<br />

7, 14, 21. An additional group was implemented using trans<strong>plan</strong>ted nerve isografts from donor animals as a control. Animals were harvested<br />

at day 7, 14, 21, 60, and 120. Macroscopic nerve growth was measured during the first month. Functional assessment was per<strong>for</strong>med by<br />

walking track analysis, extensor postural thrust, gastrocnemius and soleus muscle weight, and sensory evaluation. Nerves were fixed <strong>for</strong> histomorphology<br />

and media was harvested from conduits <strong>for</strong> analysis of NGF expression by ELISA and its bioactivity by PC-12 differentiation.<br />

RESULTS:<br />

The induction of the cell line by Pon A and additional booster (Group D) demonstrated significantly the highest levels of bioactive NGF<br />

(ELISA and PC-12 differentiation), enhanced nerve growth, improved functional recovery as well as histological regeneration when compared<br />

to control groups. The treatment with GCV resulted in suppression of the NGF production and decreased functional and histological<br />

outcome.<br />

CONCLUSION:<br />

Transfected HEK-293 cells can be regulated to inducibly produce bioactive NGF in vivo over prolonged periods of time. This tissue<br />

engineered nerve construct including the NGF delivery system is able to improve peripheral nerve regeneration and functional recovery<br />

and is superior to nerve isografts.<br />

Restoration of Elbow Function Using Inverse End-to-Side Anastomosis between Ulnar<br />

Fascicles and Musculocutaneous Nerve in Late Incomplete Obstetrical Erb's Palsy<br />

Institution where the work was prepared: Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel<br />

Shimon Rochkind, MD; Mohamed Shafi; Malvina Alon; Hagar Patish; Tel-Aviv Sourasky Medical Center, Tel-Aviv<br />

University<br />

PURPOSE:<br />

Improvement of elbow flexion using inverse end-to-side anastomosis, where intact fascicles of the ulnar nerve are im<strong>plan</strong>ted into a barely<br />

functional musculocutaneous nerve, has been clinically investigated in cases of late obstetrical Erb's palsy.<br />

METHODS:<br />

The study was conducted on 2 patients suffering from severe elbow flexion disability resulting from late obstetrical Erb's palsy (operated<br />

on at the ages of 5 and 14.5 years old). Clinical and electrophysiological motor function data were compared be<strong>for</strong>e and after surgery.<br />

Using intraoperative electrophysiological monitoring 2 intact fascicles of the ulnar nerve were im<strong>plan</strong>ted (end-to-side) into a barely<br />

functional musculocutaneous nerve (at the connection point between musculocutaneous nerve and its branch to the biceps) through<br />

an epineural window, using 10-0 sutures. Follow up periods after the operation were 1 year and 6 months respectively.<br />

RESULTS:<br />

Prior to the surgery, the first patient's strength of elbow flexors (using MRC grading system) was M2 and improved 1 year after surgery<br />

to M4-. The second patient's strength of elbow flexor improved from M1 (prior to the surgery) to M3 six months after surgery.<br />

Postoperative electrophysiological analysis showed improvement in amplitude of compound muscle action potentials and recruitment<br />

compared to be<strong>for</strong>e surgery.<br />

CONCLUSION:<br />

The study suggests that inverse end-to-side anastomosis can be considered as a viable microsurgical technique <strong>for</strong> patients suffering<br />

from incomplete long-term brachial plexus injuries.<br />

130


The Feasibility of Using Side-to-Side Nerve Grafts to “Protect” Nerve Pathways during Axon<br />

Regeneration from Surgically Repaired Proximal Nerve Injuries<br />

Institution where the work was prepared: University of Alberta, Edmonton, AB, Canada<br />

P. Schembri, BSc, MD; A Ladak; N. Tyreman; J Olson; T. Gordon; University of Alberta<br />

The goal in the surgical repair of peripheral nerve injuries is the precise union of the proximal and distal stumps of the transected nerve<br />

such that optimal nerve function is achieved. It has been established that there is a narrow window of opportunity <strong>for</strong> axonal regeneration<br />

so that with high ulnar nerve lacerations <strong>for</strong> example, long-term neuronal axotomy and chronic denervation of distal nerve stumps<br />

will progressively reduce regenerative potential to almost zero. In this study we used side-to-side nerve bridges on the distal nerve<br />

stump as a means to “protect” the distal nerve stumps and counted the number of motoneurons that regenerated their axons through<br />

the bridge(s). Sprague Dawley rats (n=43) were divided into 4 groups, all of which were subjected to unilateral excision of a 6mm segment<br />

of the common peroneal (CP) nerve to use as a side-to-side nerve bridge in Groups II and III. In the Group I, an 18mm contralateral<br />

CP nerve graft (cCPgraft) was harvested to bridge between the ipsilataral CP nerve stumps using end-to-end anastomoses. In<br />

Group II, a cCPgraft was again inserted between the ipsilateral CP nerve stumps AND a side-to-side ipsilateral CP nerve graft joined<br />

the tibial and CP distal nerve stumps. In Groups III and IV, the CP nerve was transected and NOT bridged end-to-end by the cCP graft;<br />

one (Group III) or 3 (Group IV) side-to-side nerve CP graft(s) joined the tibial (TIB) and CP distal nerve stumps. All anastomoses were<br />

per<strong>for</strong>med using Tisseel fibrin glue and rats convalesced prior to backlabelling of TIB and CP regenerated axons 4 months later with<br />

fluorescent retrograde dyes. Axonal regeneration through the contralateral CP nerve graft in Groups I and II showed exceptional recovery:<br />

~90% of CP motoneurons regenerated axons through the cCP graft. In Group III, there was minimal TIB axon regeneration with<br />

8±3 (mean ± SE) labeled motoneurons in 8 out of 15 rats in contrast to the significantly better regeneration of 76±30 backlabelled<br />

motoneurons in 7 out of 7 rats in Group IV. There was only one case of sprouting in 32 rats in Groups II, III and IV. Our data demonstrate<br />

the feasibility of using multiple rather than single side-to-side nerve bridges to “protect” the distal nerve stump after surgical repair of<br />

proximal nerve injuries.<br />

131


ASPN POSTER PRESENTATIONS<br />

Increase of Neuronal Sprouting and Migration Using 780mn Laser Phototherapy<br />

Institution where the work was prepared: Tel Aviv Medical Center, Tel Aviv University and NVR Lab., Tel Aviv, Ness<br />

Ziona, Israel<br />

Shimon Rochkind, MD1; Dalia El-Ani, PhD2; Tami Hayun, MA2; Zvi Nevo, PhD3; Abraham Shahar, PhD2; (1)Tel-Aviv<br />

Medical Center, Tel-Aviv University, (2)NVR Labs, (3)Tel Aviv University<br />

PURPOSE:<br />

The present study focuses on the effect of 780 nm laser irradiation on the growth of embryonic rat brain cultures embedded in neurogel<br />

(cross-linked hyaluronic acid with adhesive molecule laminin). Neuronal cells attached to microcarriers (MCs) were laser treated, and<br />

their growth in stationary cultures was detected.<br />

METHODS:<br />

Whole brains were dissected from rat embryos. Cells were seeded directly in neurogel on DE-53 positively charged cylindrical MCs. After 14 days<br />

of suspension, the <strong>for</strong>med floating cell-MC aggregates were sub-cultured in neurogel. Single cell-MC aggregates were either irradiated with nearinfrared<br />

780 nm laser beam <strong>for</strong> 1, 3, 4 or 7 min, or cultured without irradiation. Laser powers were 10, 30, 50, 110, 160, 200 and 250 mW.<br />

RESULTS:<br />

780 nm laser irradiation accelerated migration and fiber sprouting of neuronal cells aggregates. The irradiated cultures contained a<br />

higher number of large neurons than the controls. Significant differences in cell size were obtained following 1 min irradiation of 50mW.<br />

Neurons in the irradiated cultures developed a dense branched interconnected network of neuronal fibers.<br />

CONCLUSION:<br />

780 nm laser treatment of embryonic rat brain cultures embedded in neurogel and attached to positively charged cylindrical MCs, stimulated<br />

migration and fiber sprouting of neuronal cells aggregates and, there<strong>for</strong>e, can be considered as potential therapy <strong>for</strong> neuronal injury.<br />

Ropivacaine-Induced Nerve Injection Injury in the Rodent Model<br />

Institution where the work was prepared: Washington University School of Medicine, St Louis, MO, USA<br />

Elizabeth L. Whitlock, BA; Arash Moradzadeh, MD; Michael J. Brenner; Daniel A. Hunter; Susan E. Mackinnon;<br />

Washington University School of Medicine<br />

BACKGROUND/HYPOTHESIS:<br />

Ropivacaine is a long-acting local anesthetic which has gained recognition <strong>for</strong> its reduced potential <strong>for</strong> CNS and cardiac toxicity as compared<br />

to racemic bupivacaine. Because of its milder toxicity profile, ropivacaine is indicated when a large quantity of local anesthetic is<br />

given, such as in major peripheral nerve block. Iatrogenic intraneural administration of certain local anesthetics has been associated<br />

with severe nerve damage. Because ropivacaine is injected in high concentrations <strong>for</strong> peripheral nerve blockade, we undertook the<br />

present study to investigate histologic changes induced by ropivacaine injection into rat sciatic nerve.<br />

METHODS:<br />

Forty-five adult male Lewis rats were randomly distributed to 9 groups, 5 animals per group. Fifty microliters of normal saline, 10% phenol<br />

or 0.75% ropivacaine was administered by intrafascicular injection, extrafascicular injection, or as a drip in close proximity to the sciatic<br />

nerve. At a two-week endpoint, animals were sacrificed and the sciatic nerve at the injection site was evaluated with light<br />

microscopy, histomorphometry and electron microscopy.<br />

RESULTS:<br />

Injection with saline was associated with mild intraneural edema and no significant damage to nerve fibers. Injection with phenol resulted<br />

in severe demyelination and axonal degeneration. Intrafascicular injection of ropivacaine resulted in a wedge-shaped region of<br />

demyelination with relative sparing of axons, bordered by a region of normally-myelinated axons in a background of edematous<br />

endoneurium. The area most distant from the administration site was uninjured. Extrafascicular injection and ropivacaine drip were both<br />

associated with damage to the perineurium, with an area of local demyelination surrounded by edematous endoneurium. Nerve tissue<br />

distant to the site of ropivacaine contact was uninjured. Extrafascicular injection resulted in more significant damage than ropivacaine<br />

drip, but less than intrafascicular injection as shown with quantitative histomorphometry.<br />

CONCLUSION:<br />

Unlike bupivacaine, from which it is derived, ropivacaine is associated with marked nerve damage when injected into or dripped in close<br />

proximity to a nerve. Because extrafascicular and drip injury were associated with similar, although milder, histological damage than<br />

intrafascicular injection, we suggest that extrafascicular injection or extraneural drip of ropivacaine is associated first with disruption of<br />

the perineurium, permitting the anesthetic to enter and damage the nerve fibers themselves. These results suggest that great care<br />

should be taken when administering large volumes of concentrated ropivacaine near a nerve, since injury may occur even without<br />

mechanical damage to the nerve itself.<br />

132


Subperiosteal Approach: A New, Safe Technique <strong>for</strong> Suprascapular Nerve Decompression<br />

Institution where the work was prepared: Union Memorial Hospital, Baltimore, MD, USA<br />

Jie Xu, HBSc1; Ramon De Jesus, MD2; Jonathan Ferrari, BS1; (1)Union Memorial Hospital, (2)Johns Hopkins<br />

Decompression of the suprascapular nerve by excision of the superior transverse scapular ligament (STSL) can be a curative approach<br />

<strong>for</strong> suprascapular neuropathy. Current methods of suprascapular nerve release include the superior, anterior, and posterior approach.<br />

We suggest a new variation of the more commonly used posterior approach. Subperiosteal dissection of the supraspinatus enables<br />

easier and safer access to the STSL to decompress the suprascapular nerve. Advantages of the subperiosteal approach includes minimization<br />

of intraoperative muscle injury, early rehabilitation, increased safety, and an unobstructed view of the STSL as compared to the<br />

conventional posterior approach. This case report describes the technique per<strong>for</strong>med on a 62-year-old mechanic with a history of extensive<br />

overhead work <strong>for</strong> thirty years. Presenting symptoms included chronic right shoulder pain with difficulty abducting and flexing the<br />

right shoulder <strong>for</strong> nine months.<br />

Effects of Bipolar Electrocautery on Regeneration of Rat Sciatic Nerve<br />

Institution where the work was prepared: Washington University School of Medicine, St Louis, MO, USA<br />

Arash Moradzadeh, MD; Michael J. Brenner; Vinay K. Puppula; Alice Y. Tong; Thomas T. Tung; Terence M. Myckatyn;<br />

Daniel A. Hunter; Susan E. Mackinnon; Washington University School of Medicine<br />

While bipolar electrocautery was developed to decrease the risk of iatrogenic nerve injury, bipolar nerve damage remains a potential<br />

source <strong>for</strong> significant functional impairment. Although a rare injury, the prognosis is difficult to predict, partly because of the lack of experimental<br />

data comparing cautery injuries against better studied nerve injury models. For example, the nerve crush model reliably produces<br />

a Sunderland III axonotmetic nerve injury. The present study investigates the morphologic, immunohistochemical, and functional outcomes<br />

following bipolar nerve injury. Sixteen Lewis rats were randomized to sciatic nerve injury from bipolar electrocautery or nerve crush.<br />

Assessment at 21 days shows greater disruption of myelin and neurofilament architecture at the bipolar versus crush injury sites. Distal<br />

nerve histomorphometry demonstrates significantly decreased total nerve fiber count, nerve density, and percent neural tissue (all p<br />


Compatibility of Myoblast Growth with Bio, Synthetic, and Biosynthetic Materials Used as<br />

Components <strong>for</strong> an Endoprosthetic Nerve Interface<br />

Institution where the work was prepared: University of Michigan, Ann Arbor, MI, USA<br />

Melanie G. Urbanchek, MS, PhD; Michael S Wellington; Lisa M Larkin; Antonio P Peramo; Cynthia L Marcelo; Daryl R<br />

Kipke; David C Martin; William M Kuzon, Jr; Paul S Cederna; University of Michigan<br />

Tissue engineers are growing functional miniature tissue constructs in vitro from adult derived mammalian donor cells with the goal to<br />

ultimately im<strong>plan</strong>t the constructs in vivo during limb reconstruction or prosthetic rehabilitative surgery. Neural prostheses could incorporate<br />

engineered muscle as an intermediary between native nerve and myoelectric micro-electro-mechanical systems (MEMS). An<br />

endoprosthesis with nerve interface would contain engineered muscle where transected nerve stumps could quickly sprout and innervate<br />

unoccupied neuromuscular junctions, perhaps permanently halting neuroma <strong>for</strong>mation while powering the muscle. Additional biocompatible<br />

materials are needed to support, stabilize, contain and perhaps enhance signaling along components of the endoprosthesis.<br />

We tested compatibility of myocyte growth in the presence of materials being considered <strong>for</strong> incorporation into the endoprosthesis<br />

design. The groups tested were cells alone or cells plus: conductive polymer poly (3,4-ethylenedioxythiophene) (PEDOT); smooth<br />

or rough silicone; Biobrane, a bilayer biosynthetic skin substitute; acellular muscle; acellular nerve, acellular muscle coated with iron<br />

chloride (FeCl3), an oxidizer in the polymerization of PEDOT; silicon MEMS electrodes with PEDOT coated recording sites; and PEDOT<br />

covered acellular muscle. Robust myoblast growth of mononuclear progenitor satellite cells in the presence of these materials would<br />

confirm compatibility. A primary culture of myoblasts and fibroblasts was grown from adult rat soleus muscles. Each culture plate was<br />

prepared with a silicone elastomer layer. A test material was pinned to the elastomer. The plate was sterilized, coated with laminin, dried,<br />

rinsed, filled with growth medium, and UV treated. Cells were then plated and grown in growth medium until proliferation achieved<br />

confluence and then were switched to differentiation medium. Myoblast growth was observed daily to determine compatibility with the<br />

materials. Myoblast proliferation rates were compared <strong>for</strong> cells grown in the presence of select materials. Small undifferentiated cells<br />

developed into multinucleated myocytes and fibroblasts with cells becoming confluent on all plates regardless of material. By day 14<br />

<strong>for</strong> each material, multinucleated myocytes fused into myotubes, as confirmed by desmin staining. Many myotubes contracted spontaneously.<br />

Proliferation presently shows no significant difference <strong>for</strong> the groups (Table 1). Myoblast compatibility was confirmed by<br />

myotube <strong>for</strong>mation <strong>for</strong> all plates tested: bio (myoblasts alone), synthetic (Silicone and PEDOT), and biosynthetic (Acellular muscle, acellular<br />

nerve, PEDOT coated acellular muscle, FeCl3 coated acellular muscle, Silicon electrode with PEDOT and Biobrane). Primary<br />

myoblasts grown in the presence of bio, synthetic, and biosynthetic materials were also successfully passaged indicating the ability to<br />

keep myocytes alive and growing <strong>for</strong> extended periods.<br />

Cord Encasing Lipoma of the Brachial Plexus: A Case Report with One Year Follow-Up<br />

Institution where the work was prepared: Albany Medical Center, Albany, NY, USA<br />

Benjamin J. Schalet, MD, MS, Joseph A. Wolf, MD and Jerome D. Chao, MD, Albany Medical Center<br />

Brachial plexus region tumors are relatively rare, comprising less than 5% of tumors of the hand and upper extremity. Both intrinsically<br />

derived tumors and tumors extrinsic to the peripheral nervous system (PNS) can affect the brachial plexus. Tumors that originate from<br />

the PNS include schwannoma, neurofibroma and malignant peripheral nerve sheath tumor (MPNST). Tumors of non-neural origin<br />

include sarcoma and lipoma among others. These tumors may affect the brachial plexus and peripheral nerves by direct extension or<br />

compression. There are reports of lipomas affecting peripheral nerves of the brachial plexus and portions of the proximal plexus, causing<br />

selective neuropathy. We present a case of a lipoma encasing the entire brachial plexus at the cord level. This 56 year old patient<br />

initially presented with dysesthesia in her hand, <strong>for</strong>earm, chest, and back. The lipoma surrounding the brachial plexus was resected<br />

using standard incisions <strong>for</strong> brachial plexus exploration without disrupting neural tissue. At her two week postoperative visit she was<br />

noted to have a median neuropathy with loss of sensation to the radial thumb, index, and middle finger as well as loss of flexor pollicis<br />

longus and flexor digitorum profundus to the index finger. By one year postoperatively, the patient has had improvement of motor<br />

and sensory function both clinically and by electromyographic studies.<br />

134


The Use of Ultrasound to Identify the Position of the Digital Nerves of the Thumb<br />

Institution where the work prepared: Henry Ford Hospital, Detroit, MI, USA<br />

Kanye Willis, MD; Henry Ford Hospital; Donald Ditmars; Henry Ford Hospital<br />

Purpose:<br />

Trigger finger, also known as stenosing tenosynovitis, occurs when a digital flexor tendon sheath becomes constricted at the A-1 pulley.<br />

The constriction is usually due to scar tissue or a nodule of the tendon sheath and results in pain, clicking of the finger with movement<br />

and a digit that becomes locked in the flexed position. Surgical treatment consisting of dividing the A-1 pulley has a significantly<br />

lower recurrence rate than medical treatment. Surgical treatment consists of a traditional open technique and a percutaneous<br />

approach. The percutaneous approach employs the use of an 18 gauge needle guided anatomic landmarks to divide the A-1 pulley.<br />

Several authors have discouraged per<strong>for</strong>ming percutaneous trigger finger release in the thumb due to the increased risk of injuring the<br />

digital nerves. Our study uses ultrasound to identify the in vivo position of the digital nerves of the thumb in both flexed and extended<br />

positions. We hypothesized that extending the thumb causes the digital nerves to move more laterally decreasing the risk of injuring<br />

them during percutaneous trigger finger release.<br />

Methods:<br />

The study included 15 healthy subjects (7 male, 8 female) with a mean age of 29.5 years. An 8-megahertz frequency ultrasound probe<br />

was used to identify the digital nerves of the right thumb. The distance between the digital nerves was measured with the thumb in<br />

both flexed and extended positions. A single operator per<strong>for</strong>med all ultrasound examinations using the same ultrasound equipment.<br />

A comparison of the distance between the digital nerves with the thumb in flexion and extension was made.<br />

Results:<br />

On average there was a 1.4mm increase in the distance between the digital nerves when the thumb was placed in extension. This represents<br />

a 12.6% increase in overall distance and reached statistical significance with a p-value of 0.01 using a T-test. Two subjects had a<br />

decrease in the distance between the digital nerves when the thumb was extended, however the nerves appeared to be located more<br />

inferiorly.<br />

Conclusions:<br />

Placing the thumb in extension results in lateral movement of the digital nerves in most patients, which may protect them during percutaneous<br />

trigger finger release. Because individual variability exists, ultrasound may be a useful guide in identifying and protecting the<br />

digital nerves when per<strong>for</strong>ming trigger finger release percutaneously. Future investigations may include using ultrasound to identify the<br />

position of the digital nerve in multiple dimensions and in patients with comorbidities such as connective tissue disorders.<br />

Peroneal Nerve Regeneration after End-to-Side Repair in Rat<br />

Institution where the work was prepared: Poznan University of Medical Sciences, Poznaƒ, Poland<br />

Piotr Czarnecki, MD; Aleksandr Astapov; Leszek Romanowski; <strong>Hand</strong> Surgery, Poznan University of Medical Sciences<br />

Background:<br />

En-to-side neuroraphy can be a solution <strong>for</strong> injuries with nerve gap when en-to-end or grafting techniques are not applicable. Current<br />

experiences leave a lot of questions to this method of treatment.<br />

Aim:<br />

The aim of research is to evaluate: - effectiveness of end-to-side nerve repair, - the need of epineural window, - possible donor nerve damage.<br />

Material and Method:<br />

45 Wistar rats were divided into 3 equal groups: • end-to-side repair without epineural window, • end-to-side repair with epineural window,<br />

• nerve graft reconstruction Right peroneal nerve were cut and then repaired according to the group investigated. Follow-up period<br />

was 24 weeks and the regeneration was checked by: • footprint analysis after 1, 2, 4, 6, 8, 10, 12, 24 weeks, • electroneurography<br />

after 24 weeks months using direct sciatic stimulation, magnetic field stimulation and both tibial and peroneal direct probing. Both<br />

sides: operated and nonoperated were tested, • microscopic evaluation of tibial and peroneal nerve specimens after 24 weeks.<br />

Results:<br />

Footprint analysis Calculated factors prove on regeneration in every group investigated: SFI (A – -18,37, B – -15,15, C – -14,75); PFI (A -<br />

-20,95, B - -21,17, C - -20,8); TSI (A – 0,08, B – 0,06, C – 0,06) after 3 months, values has decreased after 6 months. The highest values<br />

were in graft repair group, the lowest in the group without epineural window. Electroneurography In both direct and magnetic stimulation<br />

amplitude, latency and conduction velocity were in normal range in every group investigated. Amplitude and latency of peroneal<br />

nerve were higher on operated side.<br />

135


ASRM SCIENTIFIC PAPER PRESENTATION: RESEARCH II<br />

Changes in the Nitric Oxide Pathway During Free Flap Failure<br />

Institution where the work was prepared: R Adams Cowley Shock Trauma Center, Baltimore, MD, USA<br />

Rachel Bluebond-Langner, MD1; Suhail K. Mithani, MD1; Hunter C. Champion, MD, PhD2; Eduardo D. Rodriguez1;<br />

(1)R Adams Cowley Shock Trauma Center, (2)Johns Hopkins School of Medicine<br />

INTRODUCTION:<br />

Despite advances in microsurgery, free flap failure or flap salvage re-exploration range from 5-20%. Nitric Oxide (NO) has been shown<br />

to play a role in free flap failure and up-regulation of NO has been targeted with varying success. The purpose of this study was to look<br />

at changes in the NO pathway, specifically the downstream effector of NO and cyclic guanosine monophosphate (cGMP).<br />

MATERIALS AND METHODS<br />

Twenty Sprague-Dawley rats underwent harvest of a free flap based on the inferior epigastric vessels. In ten rats (group 1) the flap was<br />

havested, stored sterile <strong>for</strong> 20 minutes to simulate warm ischemia time and then anastomosed to the femoral vessels under the microscope<br />

using 10-0 nylon. To simulate flap failure, in ten rats (group 2) the flap was raised, arterial anastomosis per<strong>for</strong>med and the vein was occluded<br />

with 10-0 nylon <strong>for</strong> 12 hours and then released. Rats were euthanized at three days. Serum, flap tissue and vascular pedicle were collected.<br />

cGMP levels were measured in the serum and tissue. eNOS, iNOS, arginase and PDE-5 activity was measured in the flap tissue.<br />

RESULTS:<br />

All flaps in group 1 survived and 85% of flaps in group 2 survived. PDE5 activity in flaps that survived increased by 17% compared to<br />

controls, while flaps that failed had 59%* increased activity. eNOS activity was halved in free flap tissue compared with controls, and<br />

reduced an additional 2 fold* in free flap failure. iNOS activity was comparable in free flaps compared to controls, but doubled in free<br />

flap failure*. Arginase activity increased modestly in flaps which survived compared to controls; however, activity increased almost 2 fold<br />

in flaps which failed. cGMP levels were 20%* higher in the vascular pedicles and plasma of free flaps that survived compared with those<br />

that failed. (*=p


Regenerative Acellular Collagen Tube Matrix as a Microvascular Conduit<br />

Institution where the work was prepared: Cleveland Clinic Foundation, Cleveland, OH, USA<br />

Wong Moon, MD; Cleveland Clinic Foundation<br />

INTRODUCTION:<br />

Autogenous vein is the only biologic graft available <strong>for</strong> vascular reconstruction. However, autogenous vein is limited by its quality, quantity,<br />

diameter, and length. The purpose of this study is to determine if a human derived Acellular Collagen Matrix (ACM) tube graft can<br />

be used as a microvascular conduit.<br />

METHODS:<br />

In 10 Sprague-Dawley 500g rats, 7mm long segment of aorta was excised. 1.75 to 2.0mm in diameter vascular conduits were created<br />

from human derived ACM. These grafts were interpositioned between the two cut ends of the aorta and anastomosed in an end-toend<br />

fashion using 12-30x magnifying surgical microscope. Animals were given heparin 100IU/kg be<strong>for</strong>e surgery and received daily<br />

LMWH 1.5mg/kg <strong>for</strong> 7 days. Rats were observed daily to detect possible complications. Graft patency was check at 3 and 6 months.<br />

Grafts were sent <strong>for</strong> histological examination.<br />

RESULTS:<br />

Post-operatively, all 10 rats appeared healthy and were active. Their limbs were viable. At the time of harvest, all rats had patent grafts<br />

at 3 and 6 months. There was well incorporation of the graft material into the native aorta. No infections or aneurysms were present<br />

during the follow-up period. The H & E stained graft tissue showed an intact collagen matrix with in-growth of endothelial and smooth<br />

muscle cells.<br />

CONCLUSIONS:<br />

We report the first study that human derived Acellular Collagen Matrix (ACM) tube can be used as a vascular graft preparation. This<br />

material can tolerate the high shear stresses of the aorta, can regenerate into a native artery, and has successful long-term patency.<br />

Thermoreversible Poloxamers and Applications <strong>for</strong> Vascular Biology<br />

Institution where the work was prepared: Stan<strong>for</strong>d University, Stan<strong>for</strong>d, CA, USA<br />

Edward I. Chang, MD; Cynthia D. Hamou; Michael G. Galvez; Michael T. Longaker; Geo frey C. Gurtner; Stan<strong>for</strong>d University<br />

INTRODUCTION:<br />

Conventional suture techniques <strong>for</strong> vascular anastomoses are time consuming and prone to thrombosis and restenosis due to intimal<br />

damage and inflammation. We propose a novel sutureless technique using thermoreversible poloxamers.<br />

METHODS:<br />

Rheological studies determined the <strong>for</strong>mulation of P407/P188 to obtain a phase transition temperature at 42°C. Anastomoses were per<strong>for</strong>med<br />

on Fisher rat aortas using P407/P188 and bioadhesives (n=30) and 10-0 nylon sutures (n=30). CT angiograms, burst strength<br />

assays, histology, and scanning electron microscopy (SEM) were per<strong>for</strong>med at designated timepoints. Tissue factor pathway inhibitor<br />

(TFPI) ELISA was per<strong>for</strong>med on media harvested from HUVECs exposed to heparin and heparinized P407/P188.<br />

RESULTS:<br />

A <strong>for</strong>mulation of 17% P407 and 6% P188 achieved a phase transition temperature of 42°C which was used <strong>for</strong> all future experiments.<br />

The average diameter of the rat aorta used <strong>for</strong> the end-to-end anastomoses in this study was 2.8mm, and the average diameter of the<br />

iliac vessels used in the end-to-side anastomoses was 1.9mm. End-to-end anastomoses per<strong>for</strong>med using P407/P188 were completed<br />

more efficiently than the hand-sewn technique (10.0 ± 4.2min vs. 47.3 ± 5.0 min, p1500mm Hg,<br />

p>0.05). Angiograms demonstrated equivalent patency, and flow through native aorta, hand-sewn anastomoses, and sutureless anastomoses<br />

were not significantly different (26mL/sec vs. 27mL/sec vs. 29mL/sec respectively). Histology and SEM demonstrated less fibrosis<br />

in the sutureless group compared with the traditional technique. End-to-side anastomoses per<strong>for</strong>med with the hand-sewn technique<br />

had 100% failure rate; however, end-to-side sutureless anastomoses were successful in 33% of operations per<strong>for</strong>med (p


Brain Plasticity after Facial Reanimation Imaged by fMRI<br />

Institution where the work was prepared: Dep of Plastic Surgery, Helsinki University Hospital, Helsinki, Finland<br />

Tuija M. Ylä-Kotola, MD; Antti Korvenoja, MD, PhD; M Susanna C Kauhanen; Sinikka Suominen; Erkki Tukiainen; Sirpa<br />

Asko-Seljavaara; Helsinki University Hospital<br />

PURPOSE/INTRODUCTION<br />

The purpose of the study was to investigate cerebral reorganization in patients treated <strong>for</strong> total facial paralysis with cross-facial nerve grafting<br />

and microneurovascular muscle transfer. Long-lasting unilateral facial paralysis is often treated with cross-facial nerve grafting and<br />

microneurovascular muscle transfer. To date, it is not known where in brain the cerebral activation due to the new mimic muscle function in<br />

the trans<strong>plan</strong>t innervated by the contralateral facial nerve occurs. Functional Magnetic Resonance Imaging (fMRI) localizes an increased neuronal<br />

activity in a particular area of the brain in response to voluntary tasks like muscle activity through changes in the blood oxygen.<br />

MATERIALS/METHODS<br />

Four consecutive female patients with unilateral facial paralysis were included in the prospective study. Three imaging sessions were<br />

scheduled. Preoperative fMRI was done to every patient be<strong>for</strong>e the cross-over nerve grafting. The patients were instructed to attempt<br />

a smile as visual cues to smile appeared at approximately 15 s intervals. During the session time series of 730 gradient-echo echo-<strong>plan</strong>ar<br />

images were acquired with a Siemens Sonata 1.5 T scanner. Analysis was carried out using FEAT (FMRI Expert Analysis Tool) Version<br />

5.43. The second session followed six to eight months after the first operation be<strong>for</strong>e the microneurovascular muscle transfer. Two<br />

patients went through the second session. The third session was done approximately one year after microneurovascular muscle transfer.<br />

Three patients have completed the study schedule so far.<br />

RESULTS:<br />

FMRI offers a statistical parametric map showing changes in brain activity seen during smiling. We compared the activation maps taken<br />

be<strong>for</strong>e the operations, between the operations and one year after the operation. Be<strong>for</strong>e surgery, multiple areas of the brain were activated<br />

by the task. After cross facial nerve grafting, activation pattern was not changed. The transferred muscle was clinically functioning<br />

one year after facial reanimation. At this timepoint, brain activity was increased in parietal areas on both sides, and in frontal areas<br />

on the contralateral to the original paralyzed side. Activation was also increased in anterior cingulate cortical areas in all the patients.<br />

CONCLUSION:<br />

We have found changes in brain activity in fMRI after facial reanimation, suggesting that brain plasticity plays a role in the adaption of<br />

microneurovascularly transferred muscle to the face. Increased knowledge of brain plasticity offered by research combining neuroscience<br />

and plastic surgery will benefit patients undergoing various <strong>for</strong>ms of reconstruction.<br />

138


Postoperative Changes in Blood Velocity Following Microvascular Free Tissue Transfer<br />

Institution where the work was prepared: University of Texas M. D. Anderson Cancer Center, Houston, TX, USA<br />

Olubunmi Ogunleye, MD1; Michael J. Miller, MD2; Craig J. Hartley, PhD3; Matthew M. Hanasono, MD1; (1)University<br />

of Texas M. D. Anderson Cancer Center, (2)Ohio State University, (3)Baylor College of Medicine<br />

BACKGROUND:<br />

Microvascular free flap surgery is routine today, but little is known about its physiology. Quantifying blood velocity during the postoperative<br />

period would help in<strong>for</strong>m the surgeon as to when microvascular thrombosis, which is associated with low velocity states, is most likely to occur.<br />

OBJECTIVES:<br />

1. To quantify arterial and venous blood velocity in microvascular free flaps prior to pedicle division and after anastomosis to understand<br />

how free tissue transfer affects blood flow through the flap. 2. To understand how arterial and venous blood velocity change during the<br />

early postoperative period.<br />

METHODS:<br />

Thirty-two free flaps were per<strong>for</strong>med <strong>for</strong> reconstruction of head and neck defects. During surgery, a 20 MHz needle-type Doppler was<br />

held at a 45 degree angle to the flap artery or vein to measure blood velocity prior to pedicle division and 20 minutes after anastomosis.<br />

A Cook-Schwartz (Cook Vascular Incorporated, Vandergrift, PA) im<strong>plan</strong>table Doppler probe was then used to measure arterial<br />

and/or venous blood velocity daily <strong>for</strong> 5 days.<br />

RESULTS:<br />

Free flaps included: 14 anterolateral thigh free flaps, 10 radial <strong>for</strong>earm free flaps, and 8 fibula osteocutaneous free flaps. The arterial blood<br />

velocity was 30.3±16.2 cm/s prior to pedicle division and increased to 36.5±14.7 cm/s 20 minutes after anastomosis (p


Supportive Therapy with Donor Bone Marrow Trans<strong>plan</strong>tation and Role of Regulatory T-cell<br />

<strong>for</strong> Allograft Survival in Facial Allograft Model<br />

Institution where the work was prepared: Cleveland Clinic, Cleveland, OH, USA<br />

Aleksandra Klimczak, PhD; Mehmet Bekir Unal; Yavuz Demir; Maria Siemionow; Cleveland Clinic<br />

PURPOSE:<br />

We have <strong>for</strong>merly achieved functional tolerance in fully MHC mismatched rat hemifacial allotrans<strong>plan</strong>tation model under Cyclosporine-<br />

A (CsA) monotheraphy. In this study we have evaluated the effect of supportive therapy with donor bone marrow trans<strong>plan</strong>tation (DBMT)<br />

under short-term ·‚-TCRmAb and CsA 7-day protocol, on chimerism induction in hemifacial allograft model across MHC barrier.<br />

METHODS:<br />

Thirty six hemiface allotrans<strong>plan</strong>tation were per<strong>for</strong>med between LBN(RT1l+n) donors and LEW(RT1l) recipients in 6 groups of 6 rats<br />

each. Controls: Group 1 isograft and Group 2 allograft recipients without treatment, Group 3 received intraosseous DBMT only. Groups<br />

4, 5 and 6 received ·‚-TCRmAb/CsA 7-day therapy. Additionally Groups 5 and 6 were augmented with intraosseous DBMT of 35x106,<br />

and 100x106 bone marrow cells (BMC) respectively. Be<strong>for</strong>e trans<strong>plan</strong>tation BMC were stained with PKH dye to evaluate migratory<br />

process of donor BMC. Flow cytometry assessed immunodepletion of T–lymphocytes, donor-specific chimerism <strong>for</strong> MHC class I-RT1n<br />

antigens and presence of regulatory T-cells (Treg) CD4/CD25. Histological grading of graft rejection was assessed by H+E staining.<br />

RESULTS:<br />

Isograft controls survived indefinitely, whereas controls without immunosuppression rejected trans<strong>plan</strong>ted allograft within 5 to 8 days.<br />

Group 3 treated with only DBMT accepted trans<strong>plan</strong>t up to 13 days. Median survival time (MST) of facial allograft (Group 4) under ·‚-<br />

TCRmAb/CsA therapy was 35 days. In both Groups 5 and 6 augmented with donor BMC MST was 48 days. However, the longest survival<br />

time in Groups receiving 35x106 or 100x106 BMC was 465 and 498 days respectively. In long-term survaivals split tolerance was<br />

assessed because these animals lose the hair but skin was pliable. PKH-positive cells of donor origin were present within lymphoid<br />

organs and skin of recipients. In rejected allografts T-cell chimerism declined


The Use of Thrombolytics in Microvascular Free Flaps<br />

Institution where the work was prepared: NYU Medical Center, New York, NY, USA<br />

Otway Louie; Pierre Saadeh; Jamie Levine; NYU Medical Center<br />

BACKGROUND:<br />

Microvascular reconstruction has emerged as a highly reliable method of reconstruction, with free flap success rates well over 90%. However,<br />

flap failures do occur, often secondary to venous or arterial thrombosis. The use of thombolytics has been proposed by some to aid in salvage<br />

of compromised flaps. The purpose of this study was to review our experience with thrombolytics in the salvage of microvascular free<br />

flaps.<br />

METHODS:<br />

A retrospective review of all microvascular free flaps per<strong>for</strong>med at NYU Medical Center from 2001 to 2007 was per<strong>for</strong>med. Patients<br />

requiring emergent re-exploration <strong>for</strong> impending flap failure were identified. The findings upon re-exploration were analyzed, as well<br />

as the methods of management and final outcome.<br />

RESULTS:<br />

Over the course of 5 years, 418 microvascular free flaps were per<strong>for</strong>med in 388 patients. Overall flap survival was 96.2%. There were 53<br />

cases (12.7%) where emergent re-exploration was per<strong>for</strong>med. Re-exploration was <strong>for</strong> hematoma in 19 patients, venous congestion or<br />

thrombus in 25 patients, and arterial thrombus in 5 patients. Thrombolytics were used in 14 patients; 10 of these flaps had successful<br />

salvage (71%), whereas 4 resulted in flap failure. Of the 24 patients with pedicle thrombosis treated without thrombolytics, 13 flaps were<br />

salvaged (54%). The majority of flaps salvaged were re-explored in the zero to seven day post-operative interval.<br />

CONCLUSIONS:<br />

Microvascular free flap reconstruction can be per<strong>for</strong>med with high success rates. The use of thrombolytics may offer a slight advantage in<br />

the salvage of thrombosed flaps. Close post-operative monitoring and expeditious re-exploration are essential <strong>for</strong> successful flap salvage.<br />

Ischemia/reperfusion-induced Apoptotic Endothelial Cells Isolated from Rat Skeletal Muscle<br />

Institution where the work was prepared: University of Nevada School of Medicine, Las Vegas, NV, USA<br />

Wei Z. Wang, MD; Xin-Hua Fang, MT; Linda L. Stephenson, MT; Kayvan T. Khiabani, MD; William A. Zamboni, MD;<br />

University of Nevada School of Medicine<br />

BACKGROUND:<br />

Necrosis was considered to be the solo mechanism <strong>for</strong> ischemia/reperfusion (I/R)-induced cell death. Our previous study has demonstrated<br />

that ischemia followed by reperfusion not only causes cell necrosis, but also accelerates cell apoptosis in the cells isolated from<br />

rat skeletal muscle. However, the cell types of these apoptotic cells from skeletal muscle still need to be identified. The purpose <strong>for</strong> the<br />

present study was to investigate I/R-induced apoptotic endothelial cells isolated from rat skeletal muscle.<br />

MATERIALS/METHODS<br />

A vascular pedicle isolated rat gracilis muscle model was used. After surgical preparation, clamps were applied on vascular pedicle to<br />

create 4h of ischemia and released <strong>for</strong> reperfusion (I/R, n=10). Clamping was omitted in sham I/R rats (sham I/R, n=10). The muscle sample<br />

was harvested after 24h of reperfusion and incubated with collagenase IA followed by EDTA and rat's own serum. Cells were filtered<br />

through a sieve and collected by sedimentation. One million cells from each sample were stained by monoclonal anti-CD146-<br />

Fluorescein (a principal marker <strong>for</strong> endothelial cells) and Annexin-V-Phycoerythrin to detect and quantify apoptotic endothelial cells.<br />

Twenty thousand cells from each sample were scanned and analyzed by flow cytometry.<br />

RESULTS:<br />

The average percentage (±SEM) of CD146-Fuorescein-positive cells was 21.0±2.9% suggesting these cells are endothelial cell. In total<br />

isolated cells, the average percentage of apoptotic cells was 18.3±1.8% in I/R group vs. 5.5±0.3% in the sham I/R group that suggesting<br />

there was a statistically significant apoptosis (P=0.001) in the post-I/R cells. In CD146-negative cells, the average percentage of apoptotic<br />

cells was 1.4±0.4% in I/R group vs. 1.3±0.1% in the sham I/R group that suggesting there was no significant apoptosis either in<br />

sham I/R or after I/R in non-endothelial cells. However, in CD146-positive cells, the average percentage of apoptotic cells was 38.6±1.0%<br />

in I/R group vs. 19.4±0.3% in the sham I/R group that suggesting there was a statistically significant apoptosis (P


A Prefabricated Neo-Endocrine Pancreas using a Muscle Flap to Maximize Cell Mass in<br />

Pancreatic Trans<strong>plan</strong>ts – Pilot Study in a Rat Model<br />

Institution where the work was prepared: Singapore General Hospital, Singapore, Singapore<br />

Eky Woo, MBBS, MRCSEd; Bien-Keem Tan, FRCS; Kok Chai Tan, FRCS; Pk Chow, FRCS, PHD; Singapore General<br />

Hospital<br />

AIMS:<br />

Pancreatic trans<strong>plan</strong>t is the treatment of choice in a special subset of diabetic patients e.g type 1 diabetes with worsening complications.<br />

Presently, whole organ pancreatic trans<strong>plan</strong>tation is the procedure of choice. However, the pancreas has a low tolerance <strong>for</strong> surgical<br />

manipulation which makes surgery challenging. Islet cell trans<strong>plan</strong>tation is an emerging technique that suffers from poor yield and<br />

engraftment. This novel technique creates a trans<strong>plan</strong>table muscle-pancreas composite flap which can potentially overcome the above<br />

problems. We aim to demonstrate the viability of this flap.<br />

METHODS:<br />

Using a rat model, a neo-endocrine pancreas was created using a muscle flap to vascularize a segment of pancreas. The experiment<br />

was carried out in 3 phases: Phase 1: Pancreatic vascularization A rectus flap was raised and juxtaposed to the tail of the pancreas Phase<br />

2: Separation of neo-pancreas Once the segment was vascularized by the muscle carrier, it was separated from the rest of the gland<br />

and was thus be available <strong>for</strong> trans<strong>plan</strong>t as a neo pancreas. Phase 3: Assessment of viability The viability of the neo-endocrine organ<br />

was demonstrated through histological examination.<br />

RESULTS:<br />

Histological examination was per<strong>for</strong>med using H&E and immuno-chemical stains specific <strong>for</strong> insulin and vascular endothelium. More<br />

than 75% of specimens showed viable islet cells that stained positive <strong>for</strong> insulin specific stains. The remaining 25% showed poor take<br />

probably attributable to evolving surgical technique.<br />

CONCLUSIONS:<br />

This study proves that a viable prefabricated neo-pancreas can be fashioned. At present, our islet cell yield already compares favourably<br />

to that of free islet cell trans<strong>plan</strong>ts. We anticipate that with further refinement of technique, results can be improved. Ongoing preclinical<br />

studies in diabetic animal models are evaluating its feasibility as a trans<strong>plan</strong>table organ. We hope to showcase these results in your<br />

coming meeting<br />

142


ASRM SCIENTIFIC PAPER PRESENTATIONS: BREAST<br />

Redesigned Gluteal Artery Per<strong>for</strong>ator Flap <strong>for</strong> Breast Reconstruction<br />

Institution where the work was prepared: Univ. of Texas, M.D. Anderson Cancer Center, Houston, TX, USA<br />

Steven J. Kronowitz, MD; M. D. Anderson Cancer Center<br />

BACKGROUND:<br />

The standard elliptical gluteal artery per<strong>for</strong>ator (SE-GAP) flap is an alternative to an autologous tissue flap from the lower abdomen in<br />

patients undergoing breast reconstruction. However, many experienced microsurgeons find use of the SE-GAP flap technically difficult,<br />

and the complication rate with this flap is high.<br />

PURPOSE:<br />

The purpose of this study was to redesign the SE-GAP flap to become a more reliable option <strong>for</strong> breast reconstruction and to improve<br />

the cosmetic outcomes, especially in large-breasted patients. A secondary objective was to compare the outcomes of the R-GAP flap<br />

with those of the SE-GAP flap.<br />

METHODS:<br />

We retrospectively reviewed the records of 12 patients. Four underwent unilateral SE-GAP flap reconstruction; one, bilateral SE-GAP<br />

flap reconstruction; and seven, unilateral R-GAP flap reconstruction. Thus, the study included 13 reconstructed breasts. Differences<br />

between the two breast reconstruction options were assessed using a two-sided Fisher's exact test.<br />

RESULTS:<br />

Indications <strong>for</strong> use of GAP flap included; prior abdominoplasty (R-GAP, 14%; SE-GAP, 17%), prior contralateral breast reconstruction with<br />

a lower abdominal flap (R-GAP, 29%; SE-GAP, 33%), prior ipsilateral breast reconstruction with loss of lower abdominal flap (R-GAP, 14%;<br />

SE-GAP, 0%) or insufficient abdominal adipose tissue (R-GAP, 43%; SE-GAP, 50%). Eighty-six percent of the R-GAP versus only 17% of<br />

the SE-GAP reconstructions had received prior PMRT (p = 0.0291). Seventy-one percent of the R-GAP flaps were based on the superior<br />

gluteal vessels as opposed to 50% of the SE-GAP flaps. Whereas the inferior gluteal vessels were used in 50% of the SE-GAP flaps<br />

and in only 30% of the R-GAP flaps. The complication rate was higher with SE-GAP flaps (67%) than R-GAP flaps (29%). Recipient site<br />

complication rates were 50% with SE-GAP and 14% with R-GAP flaps; donor site complication rates were 17% with SE-GAP and 14%<br />

with R-GAP flaps. Cosmetic outcomes were worse with SE-GAP flaps: in 83% of SE-GAP versus no R-GAP reconstructions there was<br />

insufficient volume to achieve the desired breast size (p = 0.0047); in 67% of SE-GAP versus no R-GAP reconstructions the reconstructed<br />

breast had an irregular contour (p = 0.0210). In 50% of SE-GAP but no R-GAP reconstructions, a major revision of the reconstructed<br />

breast was required (p = 0.0699). In 75% of SE-GAP versus 14% R-GAP reconstructions a contralateral breast symmetry procedure was<br />

required (p = 0.0879).<br />

CONCLUSIONS:<br />

The R-GAP flap is more reliable than the SE-GAP flap and permits successful reconstruction of larger breasts.<br />

143


DIEP Flaps in Patients with Abdominal Scars: Are Complication Rates Affected?<br />

Institution where the work was prepared: Beth Israel Deaconess Medical Center, Harvard Medical School, Boston,<br />

MA, USA<br />

Brian M. Parrett, MD1; Stephanie A. Caterson, MD2; Adam M. Tobias2; Bernard T. Lee2; (1)Harvard Medical School,<br />

(2)Beth Israel Deaconess Medical Center, Harvard Medical School<br />

Previous abdominal surgery in breast cancer patients is common and may affect per<strong>for</strong>ator anatomy and complication rates in deep<br />

inferior epigastric per<strong>for</strong>ator (DIEP) breast reconstruction patients. The purpose of this study is to determine if preexisting abdominal<br />

scars have an effect on flap and donor site complications in DIEP flap breast reconstruction. Over a 3 year period, DIEP flap patients<br />

were divided into a control group with no preexisting abdominal scars, and a scar group with previous abdominal procedures. Postoperative<br />

flap and donor site complications were retrospectively compared between the two groups with statistical analysis per<strong>for</strong>med<br />

with the chi-square test. Of 168 consecutive DIEP flap patients, 90 patients (54%) underwent 114 DIEP flaps in the control group and 78<br />

patients (46%) underwent 104 flaps in the scar group. The most common previous incisions were the Pfannenstiel, the McBurney's<br />

appendectomy incision, and the midline incision. The mean age was 48 years in both groups. There was no significant difference in BMI<br />

(mean 27 kg/m2 in both groups), smoking history, and radiation status between the two groups. There were no significant differences<br />

in flap loss (1.8% in control vs. 2.9% in scar group), partial flap loss (1.8% vs. 1.0%), or fat necrosis (14.9% vs. 14.4%). However, the scar<br />

group had a significantly higher overall rate of abdominal donor site complications (24.4%) when compared to the control group (6.7%;<br />

p = 0.005). The most common complications in the scar group were abdominal wound breakdown (11.5%), seroma requiring operative<br />

drainage (6.4%), and abdominal laxity or bulge (5.1%). With minor technical modifications, DIEP flaps can be per<strong>for</strong>med successfully<br />

without increased flap complications in patients with preexisting abdominal incisions. However, patients should be in<strong>for</strong>med of an<br />

increased risk <strong>for</strong> donor site complications.<br />

Laser-Assisted ICG Angiography; Applications in Per<strong>for</strong>ator Flap Surgery<br />

Institution where the work was prepared: Cleveland Clinic Florida, Weston, FL, USA<br />

Michel C. Samson, MD; Martin I. Newman, MD; Cleveland Clinic Florida<br />

BACKGROUND:<br />

The ability to confirm per<strong>for</strong>ator flap perfusion, be<strong>for</strong>e harvest and following microsurgical anastomosis, is a key factor in intraoperative<br />

decision-making. Previously, clinical assessment combined with adjuncts such as Doppler ultrasound, temperature probes, and other<br />

modalities have served to provide microsurgeons with clues to per<strong>for</strong>ator flow and flap perfusion. Laser-assisted intraoperative indocyanine<br />

green fluorescent-dye angiography (LA-ICGA) has been used <strong>for</strong> decades in the diagnosis and treatment of retinal disorders.<br />

Recently, LA-ICGA has been successfully adopted by cardiac, urologic and liver trans<strong>plan</strong>t surgeons <strong>for</strong> its ability to provide unparalleled,<br />

real time vascular images. We report here the initial experience with the application of this technology in per<strong>for</strong>ator flap surgery.<br />

METHODS:<br />

Following IRB approval, LA-ICGA technology was introduced into our per<strong>for</strong>ator flap protocol. In our practice, deep inferior epigastric<br />

per<strong>for</strong>ator flaps are per<strong>for</strong>med <strong>for</strong> breast reconstruction in breast cancer patients using standard technique. In a prospective fashion,<br />

LA-ICGA was per<strong>for</strong>med prior to harvest and following microsurgical anastomosis. Examined and imaged prior to harvest were the arterial<br />

and venous pedicles as well as the subdermal plexus. Examined and imaged following inset were the arterial and venous anastomoses,<br />

the vascular pedicles and the perfusion of the flaps through both adipose tissue and skin.<br />

RESULTS:<br />

Ten (10) DIEP flaps were per<strong>for</strong>med on eight (8) female breast cancer patients. Flap survival was 100% and one flap (10%) required return<br />

to operating room <strong>for</strong> venous congestion. LA-ICGA imaging helped to identify intraoperatively: one flap (10%) with inadequate subdermal<br />

plexus perfusion leading us to débride the distal portion of the flap prior to harvest; one flap (10%) with inadequate venous<br />

return leading us to seek additional per<strong>for</strong>ators prior to harvest; and, one flap (10%) in which inadequate perfusion of a mastectomy<br />

flap was identified leading us to débride the marginal tissue prior to final inset.<br />

CONCLUSION:<br />

LA-ICGA appears to be a valuable adjunct in per<strong>for</strong>ator flap surgery. It can be used to evaluate arterial, venous and subdermal plexus<br />

perfusion prior to harvest and following anastomosis. As additional data is collected and analyzed, the ability to interpret findings will<br />

develop. A multicenter trial is recommended to evaluate the effect of this new technology on clinical outcome.<br />

144


Comparison Of Superior Gluteal Artery Per<strong>for</strong>ator Flaps and Myocutaneous Flaps For Breast<br />

Reconstruction<br />

Institution where the work was prepared: University of Cali<strong>for</strong>nia at Los Angeles, Los Angeles, CA, USA<br />

Mark Gelfand, MD; Brian Boyd, MD; William Shaw, MD; James Watson, MD; Andrew Da Lio, MD; University Cali<strong>for</strong>nia<br />

Los Angeles<br />

Use of the Superior Gluteal Artery (SGA) myocutaneous flap <strong>for</strong> breast reconstruction was popularized in the US by Shaw in 1983. At<br />

UCLA it was initially the main backup in patients who were not candidates <strong>for</strong> autologous lower abdominal tissue flaps. Later it was<br />

replaced by Superior Gluteal Artery Per<strong>for</strong>ator flap (SGAP). This flap, first introduced by Allen and Tucker in 1995, allowed <strong>for</strong> a much<br />

longer pedicle, leading to a simpler microvascular anastomosis, and obviated the need <strong>for</strong> vein grafts to access the internal mammary<br />

vessels. However, so far there has been no head to head comparison of these two flaps. We per<strong>for</strong>med retrospective chart review of<br />

102 operations in 80 patients. A total of 70 SGA and 32 SGAP flaps were per<strong>for</strong>med over a ten year period. Patients in SGAP group<br />

tended to lose significantly less blood (241 vs. 375 cc) and were less likely to require transfusion (9% vs. 11.4 %). There was no significant<br />

difference in length of surgery (505 min vs. 496 min) or hospital stay (4.4 vs. 4.7 days). Although the overall complication rate was<br />

higher in SGAP group (28% vs. 20%), it failed to achieve statistical significance. Even though the difference in the rate of anastomotic<br />

thrombosis (6 % in SGAP group vs 10 % in SGA group) was not statistically significant, patients in SGA group were prone to thrombosis<br />

at venous site. They were also more likely to require vein grafting and require take-back <strong>for</strong> anastomotic problems, specifically venous<br />

thrombosis. In this group, venous access proved a problem in number of cases even when a vein graft was not required: the external<br />

jugular vein was utilized in 13 cases and the cephalic in 3. Overall, patients in SGAP group had higher rate of utilization of internal mammary<br />

vessels <strong>for</strong> recipient site (100 % vs 66%), a statistically significant difference. To analyze requirements <strong>for</strong> second stage reconstruction<br />

separate analysis was carried out <strong>for</strong> staged bilateral or unilateral breast reconstruction. There was no difference between two<br />

groups with regards to a number of second stage operations, as well as number of procedures required to achieve optimal outcome<br />

at donor site or breast. We believe that our report highlights that SGAP and SGA flaps are very similar. However, SGAP flap appears to<br />

be superior in allowing utilization of internal mammary vessels <strong>for</strong> as recipients, allowing <strong>for</strong> better <strong>plan</strong>ned, smoother and more predictable<br />

operative course.<br />

Advanced Age as a Risk Factor <strong>for</strong> Free Tissue Transfer Breast Reconstructions: A Review of<br />

372 Operations<br />

Institution where the work was prepared: UCLA (University of Cali<strong>for</strong>nia, Los Angeles), Los Angeles, CA, USA<br />

Maura Reinblatt, MD; Luis Vaca; Jaco Festekjian, MD; James Watson, MD; Andrew Da Lio, MD; Christopher Crisera,<br />

MD; University of Cali<strong>for</strong>nia, Los Angeles<br />

BACKGROUND:<br />

Aging is an important risk factor <strong>for</strong> developing breast cancer. As the population ages, surgeons will encounter a growing proportion<br />

of elderly women requiring breast reconstruction after mastectomy. Because free tissue transfer breast reconstruction generally results<br />

in longer operative times and recovery periods, the applicability of microsurgical reconstruction in the aging patient needs further study.<br />

We set out to assess the risks of microvascular breast reconstruction with advancing age.<br />

METHODS:<br />

A prospectively maintained database was utilized to identify microvascular breast reconstructions per<strong>for</strong>med between 2002 and 2006.<br />

Patients were divided into four age groups: less than 50 years of age (Group 1), between 50 and 59 (Group 2), between 60 and 69 (Group<br />

3), and 70 years of age and above (Group 4). Comorbidities (hypothyroidism, diabetes, smoking, hypertension, hypercholesterolemia,<br />

surgical history, body mass index), <strong>American</strong> Society of Anesthesiology (ASA) status, and length of hospital stay (LOS) were examined.<br />

Surgical complications including flap loss, thrombosis, hematoma, abdominal hernia, and fat necrosis were analyzed.<br />

RESULTS:<br />

A total of 372 free flaps were per<strong>for</strong>med on 295 patients, ranging from 24 to 75 (mean 51) years of age. The flap success rate was 99.2%,<br />

with 3 flap losses. 60% of the flaps per<strong>for</strong>med were free transverse rectus abdominis musculocutaneous (TRAM) and muscle-sparing<br />

free TRAM, 34% were deep inferior epigastric artery per<strong>for</strong>ator (DIEP), and 5% were superior gluteal artery per<strong>for</strong>ator (SGAP). The overall<br />

rate of surgical complications was 33%. The most common complication was fat necrosis (21%), followed by abdominal laxity or hernia<br />

(6%). Age was not predictive of any surgical complication. There was no significant difference in the risk of overall surgical complications,<br />

or each individual complication, among the various age groups. ASA designation was the only significant predictor of overall<br />

surgical morbidity (p=0.02), specifically associated with fat necrosis (p=0.001) and hematoma (p


Late Venous Thrombosis in Free Flap Breast Reconstruction<br />

Institution where the work was prepared: Hospital of the University of Pennsylvania, Philadelphia, PA, USA<br />

Elizabeth M. Kim, MD; Liza C. Wu; Joseph M. Serletti; University of Pennsylvania<br />

PURPOSE:<br />

Identify the phenomenon and management of late postoperative venous thrombosis after free flap breast reconstruction.<br />

PATIENTS/ METHODS:<br />

Most venous thromboses occur within 48 hours following free flap surgery. It has been the senior author's experience that in free flap<br />

breast reconstruction, there is a group of patients who develop late venous thrombosis, frequently following discharge. A retrospective<br />

chart review of this surgeon's experience was per<strong>for</strong>med to determine the incidence, management, and outcome of late venous thrombosis.<br />

All patients undergoing free flap breast reconstruction were monitored post-operatively by following a surface arterial Doppler<br />

signal every hour in an ICU <strong>for</strong> a minimum of 48 hours and then every 4 hours until discharge. The skin paddle was examined <strong>for</strong> signs<br />

of congestion; venous flow was not directly monitored. Late venous thrombosis was defined as venous occlusion that occurred 72 hours<br />

or more post-operatively.<br />

RESULTS:<br />

More than 1000 free flap breast reconstructions were per<strong>for</strong>med by the senior surgeon between 1992 and 2007. Ten free flaps in ten<br />

patients were identified with late venous thrombosis. The thromboses occurred on post op day 3 in two patients, day 4 in three patients,<br />

day 5 in one patient, day 6 in two patients, day 8 in one patient, and day 12 in one patient. Two cases were identified on the day of<br />

<strong>plan</strong>ned discharge and three came from home. Eight of these ten patients were urgently taken to the operating room where thrombectomy<br />

and repeat venous anastamosis was per<strong>for</strong>med. In 6 patients, a thrombolytic was infused into the recipient artery following repeat<br />

venous anastomosis. The remaining two patients received heparin infusion only. 7 of these 10 flaps survived. Two patients were not<br />

taken to the OR because the flap changes appeared to be very late. One of these flaps was lost and the other did survive but has developed<br />

significant fat necrosis. Mean follow-up was 21 months.<br />

CONCLUSION:<br />

With only one per cent of our free flap breast reconstruction series suffering a late venous thrombosis, it would appear that this is a rare<br />

entity. The late timing of this thrombosis in free flap breast reconstruction has, <strong>for</strong> us, been the rule and not the exception. Surgeons<br />

who per<strong>for</strong>m free flap breast reconstruction should be made aware of this potential event and instruct patients on the signs of venous<br />

thrombosis. Prompt diagnosis and surgical treatment including thrombolytics increases the likelihood of total flap salvage.<br />

Chimeric Stacked Deep Inferior Epigastric Per<strong>for</strong>ator Flap Breast Reconstruction: A New<br />

Solution to an Old Problem<br />

Institution where the work was prepared: The Center <strong>for</strong> Restorative Breast Surgery, New Orleans, LA, USA<br />

Frank J. DellaCroce, MD; Scott Keith Sullivan, MD, FACS; The Center <strong>for</strong> Restorative Breast Surgery<br />

Breast reconstruction continues to evolve. Autogenous breast reconstruction has proven to provide the most natural and lasting result<br />

over time. The Deep Inferior Epigastric Per<strong>for</strong>ator flap is a well described and increasingly accepted means of providing natural tissue<br />

reconstruction with minimum associated morbidity. For patients with insufficient abdominal fat <strong>for</strong> DIEP breast reconstruction, secondary<br />

options such as GAP flap or im<strong>plan</strong>t reconstruction are usually considered. For patients with need <strong>for</strong> autogenous reconstruction of<br />

a single breast and hereto<strong>for</strong>e insufficient abdominal fatty volume, we present a new option that allows <strong>for</strong> incorporation of the entire<br />

abdominal fatty composite with chimeric linkage and stacked inset of two individual abdominal flaps. The ability to take advantage of<br />

the entirety of the abdominal donor volume allows those with relatively thin body habitus to enjoy candidacy <strong>for</strong> DIEP reconstruction.<br />

Sophisticated microsurgical technique transcends procedures with similar goals such as the bipedicled TRAM flap by avoiding muscle<br />

sacrifice and allowing precise, independent flap inset. We describe our experience with this technique in 50 patients with 100 flaps over<br />

2 years.<br />

146


Outcome of Microvascular Complications after Free Flap Breast Reconstruction<br />

Institution where the work was prepared: UCLA Medical Center/David Geffen School of Medicine at UCLA, Los<br />

Angeles, CA, USA<br />

Brian Carlsen, MD; Peter Ashjian, MD; Brian P. Dickinson, MD; Jaco Festekjian, MD; Andrew L. Da Lio; James P.<br />

Watson, MD; Christopher A. Crisera, MD; University of Cali<strong>for</strong>nia, Los Angeles<br />

BACKGROUND:<br />

Microvascular complications after free flap reconstruction can be devastating, increasing patient morbidity and leading to flap loss. Little<br />

is known about rates of salvage of free flaps after recurrent thrombosis or vascular compromise.<br />

METHODS:<br />

A retrospective review of all patients at a major university medical center undergoing microvascular breast reconstruction from January<br />

1992 to December 2006 was conducted. The incidence of thrombotic and hemorrhagic complications was determined. Rates of flap<br />

salvage and complications were analyzed after a single microvascular revision (Single Event), two revisions (Plural Event), three or more<br />

revisions (Multiple Event), and after a delayed presentation (i.e. > 3days) and attempted salvage (Delayed Event). Fisher's exact test was<br />

used to determine statistical difference among the groups.<br />

RESULTS:<br />

1704 free flaps were per<strong>for</strong>med <strong>for</strong> breast reconstruction between January 1992 and December 2006. Fifty-three flaps (3.1%) suffered a<br />

microvascular complication. Thirteen flaps (0.8%) were lost. The overall salvage rate after any microvascular complication was 75%<br />

(40/53). Salvage rates were determined <strong>for</strong> each of the four groups. Single Events (less than 3 days postoperative) had a salvage rate of<br />

94% (31/33). Plural Events had a salvage rate of 80% (4/5). Multiple Events had a salvage rate of 40% (4/10). Delayed Events (greater than<br />

3 days postoperative) had a salvage rate of 20% (1/5). The salvage rate decreased with repeated microvascular events (p


Functional MRI to Evaluate “Sense of Self” Following Deep Inferior Epigastric Per<strong>for</strong>ator Flap<br />

Breast Reconstruction<br />

Institution where the work was prepared: Beth Israel Deaconess Medical Center, Boston, MA, USA<br />

Stephanie A. Caterson, MD; Sharon Fox, BS; Adam M. Tobias; Bernard T. Lee, MD; Beth Israel Deaconess Medical<br />

Center, Harvard Medical School<br />

INTRODUCTION:<br />

Patient satisfaction following breast reconstruction is an integral component in assessing surgical outcomes. In the past, patient questionnaires<br />

have been the mainstay of satisfaction analysis but are limited by patient bias and subjective answers. In this study, we use<br />

functional MRI (fMRI) to identify changes in patterns of brain activation following deep inferior epigastric per<strong>for</strong>ator flap breast reconstructions.<br />

This method objectively evaluates self-recognition, or “sense of self” in a reconstructed breast compared to a natural breast.<br />

METHODS:<br />

Two patient groups were identified. The first group consisted of four patients scheduled <strong>for</strong> delayed DIEP flap breast reconstruction,<br />

who had undergone a unilateral mastectomy at least two years prior. The second group included four patients who had undergone a<br />

unilateral immediate DIEP breast reconstruction, at least two years prior. Each patient had one unaffected breast, allowing <strong>for</strong> an internal<br />

control of self-recognition. In a block-design fMRI experiment, patients were cued to alternately touch their natural breast, operative<br />

site, or silicone gel models. Regions of interest (ROIs) defined in the literature as being associated with self-recognition (as opposed<br />

to "other") were mapped to averaged patient data using normalized spatial coordinates. A general linear model examining activity in<br />

each ROI was applied to average data from each patient group. In addition, analyses of variance between the two patient populations<br />

were per<strong>for</strong>med. A questionnaire was administered to all patients at the time of the fMRI.<br />

RESULTS:<br />

ROIs in the right superior frontal gyrus, inferior parietal, and medial frontal lobes were identified as breast self-recognition areas. In the<br />

pre-operative group, the self-recognition ROIs had minimal activity when the mastectomy site was stimulated. In contrast, the normal<br />

breast showed increased activity in these areas, as compared to the mastectomy site. In the post-operative group, DIEP flap stimulation<br />

was associated with increased activity in the self-recognition ROIs, and was remarkably similar to the natural breast fMRI signals.<br />

Questionnaire results were examined and found to be consistent with favorable patient satisfaction.<br />

CONCLUSIONS:<br />

Two years following unilateral breast reconstruction with DIEP flap, patients demonstrate an association of the reconstructed breast with<br />

self-recognition regions that are also active upon stimulation of the natural breast. These same areas are not active when the pre-operative<br />

mastectomy site was stimulated. This study provides objective evidence that supports an association of DIEP flap breast reconstruction<br />

with "self". Autologous reconstructions can improve patient satisfaction when compared to no reconstruction.<br />

148


Utilization of the Internal Mammary Intercostal Per<strong>for</strong>ator Instead of the True Internal<br />

Mammary Vessels as the Recipient Vessels <strong>for</strong> Breast Reconstruction<br />

Institution where the work was prepared: Johns Hopkins University, Baltimore, MD, USA<br />

Gedge D. Rosson, MD; Eduardo D. Rodriguez; Jaime I. Flores; Michele A. Manahan; Nia D. Banks; Navin K. Singh;<br />

Johns Hopkins School of Medicine<br />

OBJECTIVE:<br />

Although autologous free tissue transfer has become a mainstay in breast reconstruction, there exist inherent controversies regarding<br />

the procedure, including choice of recipient vessels. For the past few years, our institution has preferred the routine use of the internal<br />

mammary artery and vein <strong>for</strong> DIEP and SGAP flap reconstruction. In an ef<strong>for</strong>t to decrease any potential morbidity at the recipient site<br />

by preserving the internal mammary artery <strong>for</strong> potential use as a coronary artery bypass conduit in the future, we aim to use the internal<br />

mammary intercostals per<strong>for</strong>ator as a recipient vessel if suitable. We have implemented the following protocol: preoperative mapping<br />

of the per<strong>for</strong>ators along the sternal border with a hand-held Doppler, intraoperative exploration to find a suitable per<strong>for</strong>ator, and<br />

costal cartilage resection if necessary to expose the true internal mammary vessels. Our previous cadaver studies showed that the<br />

largest internal mammary intercostal per<strong>for</strong>ator is usually located in the 2nd or 3rd intercostal space. In this study we sought to evaluate<br />

the utility of the internal mammary intercostal per<strong>for</strong>ator <strong>for</strong> microsurgical breast reconstruction.<br />

METHODS:<br />

We retrospectively reviewed a single surgeon's first 101 DIEP flap breast reconstructions, per<strong>for</strong>med during a 1 ? year period from July<br />

2005 through January 2007. Recipient vessel selection, flap failure, and development of fat necrosis were critically analyzed.<br />

RESULTS:<br />

Of these 101 flaps reviewed, 22 DIEP flaps were anastomosed to an internal mammary intercostal per<strong>for</strong>ator in the 2nd or 3rd interspace.<br />

When broken down into groups of 20 flaps, a statistically significant pattern of increasing frequency of usage emerges. In the<br />

first 20 flaps an IM per<strong>for</strong>ator was used <strong>for</strong> only one flap (5%), while in the final 20 flaps an IM per<strong>for</strong>ator was used <strong>for</strong> 9 flaps (45%).<br />

Overall, four flaps had partial flap fat necrosis of less than 5% of the flap volume and one patient had total failure of the flap due to<br />

venous congestion; however none of these were in the flaps using the IM intercostal per<strong>for</strong>ator.<br />

CONCLUSIONS:<br />

The probable need <strong>for</strong> use of the internal mammary artery <strong>for</strong> future coronary artery bypass graft is rare in our breast cancer reconstruction<br />

patients. However, we have implemented an approach to utilize the IM intercostal per<strong>for</strong>ating vessels as the recipient vessels when<br />

suitable. Although the learning curve is steep, use of these vessels can be per<strong>for</strong>med safely without increased fat necrosis and preserve<br />

the internal mammary artery <strong>for</strong> potential future life-saving surgery.<br />

Microvascular Free Tissue Transfer <strong>for</strong> Breast Reconstruction in the Elderly: A Safe and<br />

Effective Option<br />

Institution where the work was prepared: Georgetown University Hospital, Washington, DC, USA<br />

Jeffrey M. Jacobson, MD; Maurice Y. Nahabedian, MD; Georgetown University Hospital<br />

While nearly half of breast cancer cases involve women 65 years of age or older, there is a paucity of literature reviewing microvascular<br />

free tissue transfer <strong>for</strong> breast reconstruction in this age group. The objective of this study was to evaluate the safety and efficacy of<br />

microvascular free tissue transfer <strong>for</strong> breast reconstruction in women 65 years of age and over. Between 1997 and 2007, 890 women<br />

underwent immediate or delayed microvascular breast reconstruction by a single surgeon. Of these, 21 (2.4%) were per<strong>for</strong>med on<br />

women 65 years of age or older (mean age 68, range 65-82). Women were assessed <strong>for</strong> candidacy, evaluated <strong>for</strong> medical co-morbidities,<br />

and cleared <strong>for</strong> surgery by their primary care physician. Reconstructions were unilateral in 18 women and bilateral in 3, immediate<br />

in 17 cases and delayed in 7, and the specific flaps included the DIEP (16), free TRAM (7), and SGAP (1). 14 DIEP flaps were based off<br />

of a single per<strong>for</strong>ator (87.5%) and 2 DIEP flaps were based off of 2 per<strong>for</strong>ators (12.5%). The free TRAM flaps were MS-0 in 1 case (14%),<br />

MS-1 in 2 cases (29%), and MS-2 in 4 cases (57%). Recipient artery and vein included the internal mammary in 14 women (67%) and the<br />

thoracodorsal in 7 women (33%). Co-morbidities included diabetes mellitus (4.8%), tobacco use (4.8%), hypertension (33%), and preoperative<br />

XRT (9.5%). Cancer stage ranged from 0 to 2B. Mean follow-up was 26.6 months (range, 5-84 months). Complete success<br />

without morbidity was achieved in 17 women (81%). Surgical complications occurred in 4 women including failure of 1 DIEP flap secondary<br />

to venous thrombosis, 2 abdominal bulges following unilateral and bilateral DIEP flaps, and fat necrosis (


ASRM SCIENTIFIC PAPER PRESENTATIONS: OTHER<br />

An Anatomical Study of the Superficial Peroneal Nerve Accessory Artery and Its Per<strong>for</strong>ators,<br />

and Clinical Application of Superficial Peroneal Nerve Accessory Artery Per<strong>for</strong>ator Flaps<br />

Institution where the work was prepared: Gyeongsang National University Hospital, Jinju, South Korea<br />

Tae Hyun Choi, MD, PhD; Jun Sik Kim; Nam Gyun Kim; Kyung Suk Lee; Gyeongsang National University<br />

BACKGROUND:<br />

In the 1990s, skin island flaps supplied by the vascular axis of sensitive superficial nerves, like the sural and saphenous nerves, were introduced.<br />

Flaps supplied by the superficial peroneal nerve accessory artery (SPNAA), however, are still not commonly used. The aim of this<br />

study is to understand the anatomical structure of the SPNAA and its per<strong>for</strong>ators, and to utilize SPNAA per<strong>for</strong>ator flaps in the clinic.<br />

METHODS:<br />

We dissected sixteen cadavers and assessed the location and number of the SPNAA, its per<strong>for</strong>ators, and the septocutaneous per<strong>for</strong>ators<br />

originating from the anterior tibial artery. The largest diameter of the SPNAA was also measured. A SPNAA per<strong>for</strong>ator flap was<br />

applied to twelve patients, the free flap was applied to eleven patients, and the pedicled flap was applied to one patient.<br />

RESULTS:<br />

The origin of the SPNAA was 4 to 8 cm (average 5.5 cm) away from the fibular head. The SPNAA was 7 to 16 cm in length (average<br />

12.33 cm), originating from the superior lateral peroneal artery and gradually disappearing between 15 and 22 cm (average 17.06 cm)<br />

from the fibular head. The largest diameter of the SPNAA was between 0.6 and 1.2 mm (average 0.85 mm). The number of per<strong>for</strong>ators<br />

in SPNAA examined ranged from zero to eight (average 4.5). Of these, the number of septocutaneous per<strong>for</strong>ators ranged from zero to<br />

six (average 3.19), and the number of musculocutaneous per<strong>for</strong>ators ranged from zero to three (average 1.31). The size of the flap<br />

ranged from 3.5 x 6 cm to 9 x 12 cm (mean 65.5 cm2). The complete follow-up period ranged from three to 20 months (mean 7.6<br />

months). Although one flap was lost due to arterial thrombosis, the procedure was successful in the remaining eleven patients. The flap<br />

was very thin, comparable in thickness to the recipient site (i.e. foot, ankle, pretibia, knee or hand), and thus, aesthetically appealing.<br />

CONCLUSION:<br />

SPNAA per<strong>for</strong>ator flaps could be an excellent alternative to per<strong>for</strong>ator flaps that use the lower leg as a donor site. Legends Fig. 1.<br />

(Above, left) Preoperative view. (Above, right) Preoperative design of the SPNAA per<strong>for</strong>ator flap. (Below, left) The septocutaneous per<strong>for</strong>ator<br />

of the SPNAA (yellow arrow) is the pedicle of this flap. Black arrow indicates the SPN. EDL: extensor digitorum longus. PL:<br />

Peroneus longus. (Below, right) Post-operative observation six months after surgery.<br />

150


Tissue Oximetry, A Reliable Technique <strong>for</strong> Non-Invasive Free Flap Monitoring<br />

Institution where the work was prepared: Long Island Jewish Medical Center, New Hyde Park, NY, USA<br />

Alex Keller, MD; North Shore Long Island Jewish Health System<br />

INTRODUCTION:<br />

Despite improvements in anastomotic techniques in free tissue transfer or re<strong>plan</strong>tation, anastomotic failure can still plague the microsurgeon.<br />

Clinical evaluation including flap color, capillary refill and bleeding can be hard to interpret and are most valuable when<br />

assessed by an experienced surgeon. Even in specialized units a nurse is usually responsible <strong>for</strong> flap monitoring. It is <strong>for</strong> these reasons<br />

that more objective and reliable flap monitoring techniques have been sought. Range of techniques currently utilized include external<br />

and internal temperature probes, laser Doppler monitoring, intravenous fluorescein, pulse oximetry, transcutaneous oxygen, and surface<br />

and im<strong>plan</strong>table Doppler. An ideal monitor should provide continuous non-invasive monitoring of perfusion or flap metabolism<br />

with rapid detection of arterial or venous occlusion. Tissue oximetry is the only way to measure end organ perfusion. A new device, the<br />

ViOptix Tissue Oximeter (ODISsey) was evaluated. The ODISsey uses an optical tissue characterization based on measuring the scattering<br />

and absorption of near infrared light which is related to the oxygen content of the hemoglobin in that particular tissue.<br />

METHODS & DATA:<br />

133 clinical free flap transfers (either DIEP, SIEA or SGAP) <strong>for</strong> breast reconstruction in 98 patients were monitored continuously during<br />

elevation, transfer, and in the postoperative period both clinically and with the ViOptix Tissue Oximeter. While there were no flap failures,<br />

6 patients were reoperated upon acutely. Early in the series, reoperation occurred only when there was clear evidence of ischemia<br />

and flap compromise. Later in the study, with increased confidence in the ViOptix monitor, a low or falling oxygen saturation reading<br />

was the trigger <strong>for</strong> reoperation. In these instances, reoperation was undertaken be<strong>for</strong>e there was clear clinical evidence of flap compromise.<br />

One patient was reoperated upon <strong>for</strong> hematoma without flap compromise or outflow problems. The findings were consistent<br />

with the monitor prediction of a healthy flap. False negative readings (low or falling tissue oxygen saturation) was related to movement<br />

of the probe. Experience with the monitor and the fixation of the surface probe increased the confidence in the device to pick up early<br />

flap compromise. Most importantly, the ability to follow a flap was now less dependent upon the observer.<br />

CONCLUSION:<br />

The use of the ViOptix Tissue Oximeter is a reliable, noninvasive technique to monitor a cutaneous free flap. Flap compromise can be<br />

identified be<strong>for</strong>e clinically evident. Routine flap monitoring can be per<strong>for</strong>med by individuals less skilled in the clinical evaluation of the<br />

flap.<br />

20 Years Experience In Pediatric Microsurgery<br />

Institution where the work was prepared: Sheba Medical Center, Tel Hashomer, Israel<br />

Batia Yaffe, MD; Eyal Winkler; Haim Kalpan; Sheba Medical Center<br />

Elective microvascular surgery is a routine method of reconstruction of a variety of defects in adults. In pediatric patients this method is<br />

used less frequently. The aim of this presentation is to review our 20 years experience with elective microvascular surgery in children,<br />

addressing the special considerations pertinent to this patient population and stressing both the similarities and differences of microsurgery<br />

in children as opposed to adults. In the last 20 years we per<strong>for</strong>med 96 free tissue transfer procedures in 87 children aged 4<br />

month – 17 years, (mean age 10.5 years) with 97% success rate (93 out of 96 flaps). The most common etiologies were motor vehicleaccident<br />

(31 children), and congenital de<strong>for</strong>mities (19 patients). Other etiologies were post burns de<strong>for</strong>mity, iatrogenic injury, de<strong>for</strong>mities<br />

created by disease or tumor surgery, and firearms injury. In adults during the same period the most common etiology was oncological<br />

resection. The most common recipient area was the lower extremity (44 children). In 35 children the flap was transferred to the upper<br />

extremity and in 15 to the head and neck region. For reconstruction of soft tissue defects latissimus dorsi muscle covered with skin graft<br />

was the most frequently used flap (29 flaps) followed by the scapular free flap (19 flaps). Other less frequently used flaps were radial<br />

artery <strong>for</strong>earm flap (7 flaps), lateral arm free flap (6 flaps), groin flap based on SCIA (5 flaps), posterior interosseous free flap (2), 1 anterolateral<br />

thigh flap and 1 gracilis muscle with skin graft. For restoration of muscle function we used gracilis neurovascular free flap 5 times<br />

and latissimus dorsi neurovascular free flap twice. For bony defects osteocutaneous or osseous fibula flap was used in 8 children and<br />

vascularized iliac crest in 5. For replacement of missing digits 5 toes were transferred. The operative time and recovery time in children<br />

was shorter than in same flaps in adults. Heparin was used in 2 cases only. The post operative regime included axillary block in surgery<br />

on the upper extremity, keeping the room temperature and blood pressure stable, and good pain management. Although we use<br />

aspirin routinely in microsurgery in adults, it was not used in children. Follow up period ranged between 1 - 20 years (mean – 10 years).<br />

In conclusion, although often technically challenging, free flaps in children are safe and usually provide the best possible reconstruction<br />

in a variety of conditions.<br />

151


A Reconstruction Algorithm to Encounter No Sizable Skin Per<strong>for</strong>ator during Anterolateral<br />

Thigh Flap Dissection<br />

Institution where the work was prepared: Chang Gung Memorial Hospital - Kaohsiung Medical Center, Kaohsiung, Taiwan<br />

Ching-Hua Hsieh, MD1; Seng -Feng Jeng, MD2; Yur-Ren Kuo, MD, PhD, FACS3; Pao-Yuan Lin, MD1; Johnson C. Yang,<br />

MD4; (1)Chang Gung Memorial Hospital in Kaohsiung, (2)Chang Gung Memorial Hospital - Kaohsiung Medical Center,<br />

Chang Gung University, (3)Chang Gung Memorial Hospital- Kaohsiung Medical Center, Chang Gung University,<br />

(4)Chang Gung Memorial Hospital at Kaohsiung<br />

PURPOSE:<br />

The free anterolateral thigh (ALT) flap is becoming the preferred option <strong>for</strong> soft-tissue reconstruction in most clinical situations. If no sizable<br />

skin per<strong>for</strong>ators are found or if they are inadvertently divided during flap dissection in the ALT region, we propose a reconstruction<br />

algorithm with modified options to facilitate a successful reconstruction.<br />

MATERIALS & METHODS:<br />

A Doppler flowmeter was used preoperatively to detect the location of the per<strong>for</strong>ator. After incision being made down to the deep fascia,<br />

the per<strong>for</strong>ator to the skin was visualized first to determine which per<strong>for</strong>ator was preferred <strong>for</strong> skin perfusion. If there was no sizable<br />

skin per<strong>for</strong>ator at all, the reconstruction algorithm was followed in this order: 1. More proximal exposure of the lateral circumflex femoral<br />

artery system to harvest a tensor fascia lata flap. 2. Detection of a promising skin vessel medial to the incision with audible Doppler, and<br />

proceeded dissection in a medial direction to elevate an anteromedial thigh flap. 3. Elevation of a free vastus lateralis muscle with coverage<br />

of full-thickness skin graft (FTSG) harvested from ALT skin portion. 4. Abandon the donor site and sought <strong>for</strong> another donor region.<br />

RESULTS:<br />

Between August of 1995 and December of 2006, 923 patients received ALT flaps elevation at Chang Gung Memorial Hospital in<br />

Kaohsiung. There were ten patients had no any adequate skin per<strong>for</strong>ator in the ALT region during the initial dissection. There were three<br />

patients, who had no per<strong>for</strong>ator in one thigh, received dissection in contralateral thigh but still had no any sizable per<strong>for</strong>ator <strong>for</strong> reconstruction.<br />

In total, four patients received reconstruction with a free tensor fascia lata flap, three with an anteromedial thigh flap, two with<br />

a free muscle flap and FTSG, and one with a radial <strong>for</strong>earm flap. There was one postoperative venous thrombosis in a tensor fascia lata<br />

flap which was finally salvaged.<br />

DISCUSSION:<br />

With sizable per<strong>for</strong>ator in 99% of the designed area, ALT flap is a very reliable flap <strong>for</strong> reconstruction. If there is no adequate skin per<strong>for</strong>ator<br />

in one thigh, dissection per<strong>for</strong>med in another thigh is not suggested, because similarity of the vascular condition would be<br />

encountered. When there is no sizable skin per<strong>for</strong>ator in ALT dissection, an acceptable successful rate to complete the reconstruction<br />

could be achieved by following the above algorithm according to our experience, which might be the largest series in dealing with such<br />

kind of problem.<br />

Early Results of a Prospective, Randomized Cost and Outcome Analysis of ICU vs. Surgical<br />

<strong>Floor</strong> Monitoring in Free Flap Breast Reconstruction<br />

Institution where the work was prepared: University of Chicago Medical Center, Chicago, IL, USA<br />

Charles Y. Tseng, MD; David H. Song, MD; University of Chicago Medical Center<br />

PURPOSE:<br />

At present, it is standard practice to admit all patients who undergo free flap reconstruction to the ICU or an equivalent flap recovery<br />

unit <strong>for</strong> monitoring on an hourly basis. The ICU remains a large user of hospital resources, accounting <strong>for</strong> 25% to 30% of total hospital<br />

costs, despite the fact that these beds represent only 5 to 10% of total hospital beds. To date, there have been no studies documenting<br />

an improvement in free flap outcomes or cost-savings based solely on ICU level flap monitoring. The purpose of this study is to per<strong>for</strong>m<br />

a cost comparison of free flap monitoring in the ICU versus surgical floor using standard clinical criterion, external Doppler probe,<br />

and Near Infrared Spectroscopy (NIRS) in patients who have undergone free flap breast reconstruction.<br />

METHODS:<br />

Since August 2006, 14 patients underwent free flap breast reconstruction using MS-TRAM, DIEP, or SIEA free flaps. 8 patients (10 flaps)<br />

were randomized to the ICU and 6 patients (7 flaps) to the standard surgical floor <strong>for</strong> post-operative monitoring using standard clinical<br />

criteria, external Doppler probe, and continuous NIRS monitoring. Patient demographics, procedure type, diagnosis, adjuvant treatment,<br />

and complications were recorded.<br />

RESULTS:<br />

6 MS-TRAM, 6 DIEP, and 5 SIEA free flaps breast reconstructions were per<strong>for</strong>med. There was no difference in flap loss, fat necrosis, or<br />

venous congestion. Average total length of stay (LoS) and cost of stay (CoS) in patients randomized to recover in the ICU was 4.25 days<br />

and $18,122. Average LoS and CoS in patients recovering on the surgical floor was 4 days and $7,564.<br />

CONCLUSION:<br />

This randomized, prospective study compares the cost and early (30-day) results of post-operative recovery and free-flap breast reconstruction<br />

monitoring in an ICU versus surgical floor setting at a single institution using external doppler probe and near-infrared spectroscopy<br />

(NIRS) as adjunctive monitoring devices. Current monitoring devices fall short of the ideal and none have gained widespread<br />

acceptance. A monitoring tool that could detect disturbances in vascular flow early, reliably, and independent of level of care and experience<br />

of nursing staff could potentially generate tremendous cost savings to both the institution and to the patient. Easy to use and<br />

accurate, NIRS technology has the potential to lower hospital costs by allowing patients to recover on a standard surgical floor while<br />

receiving continuous free flap monitoring. Long term outcomes data are needed to corroborate our early findings.<br />

152


Partial Muscle Trans<strong>plan</strong>tation: Strategy <strong>for</strong> Preservation of Form and Function at the Donor Site<br />

Institution where the work was prepared: Cali<strong>for</strong>nia Pacific Medical Center, San Francisco, CA, USA<br />

Darrell Brooks; Rudolf F. Buntic; Buncke Clinic<br />

INTRODUCTION:<br />

Selection of the best tissue trans<strong>plan</strong>t requires striking a balance between the potential benefit <strong>for</strong> the recipient site and risk to the<br />

donor site. There has been a recent trend towards trans<strong>plan</strong>tation of per<strong>for</strong>ator flaps and away from muscle flaps given the attendant<br />

loss of function with muscle harvest. Although we acknowledge the attributes of the per<strong>for</strong>ator flap, we continue to recognize significant<br />

advantages of muscle trans<strong>plan</strong>tation in selected patients.<br />

PURPOSE:<br />

The purpose of this study is to describe the design and trans<strong>plan</strong>tation of the partial superior latissimus dorsi(PSL) and partial medial<br />

rectus abdominis(PMR) muscle flaps while preserving <strong>for</strong>m and function at the donor sites.<br />

METHODS:<br />

A retrospective review of partial muscle flaps trans<strong>plan</strong>ted between 2003-2006 was conducted. Charts were reviewed to define indications<br />

<strong>for</strong> tissue trans<strong>plan</strong>tation, characteristics of trans<strong>plan</strong>ted tissue, outcome analysis, maintenance of donor site <strong>for</strong>m/function, as well<br />

as, patient satisfaction. The PSL flap is designed along the superior edge of the latissimus dorsi muscle, medial or lateral depending<br />

on recipient site requirements such as pedicle length and flap dimension. The descending branch of the thoracodorsal nerve is preserved<br />

maintaining function in the residual latissimus. The majority (>70%) of the latissimus muscle is left intact with adequate blood<br />

supply and persistent innervation from the descending branch of the thoracodorsal nerve. Depending on the required pedicle length<br />

and flap dimension, the PMR flap is designed up or down the medial edge of the muscle. Care is taken to protect the arcade of intercostal<br />

nerves and arteries. Branches from the deep inferior epigastric vessels (DIEVs) going to the medial aspect of the rectus muscle<br />

are identified and followed back to the DIEVs. The majority (>50%) of the rectus width is preserved with adequate blood supply and<br />

innervation by intercostals arteries and nerves.<br />

RESULTS:<br />

Thirty-seven PSL muscle flaps were per<strong>for</strong>med <strong>for</strong> arm/hand(12), leg/foot(16), and head/neck(9) defects. Twenty-five PMR muscle flaps<br />

have been per<strong>for</strong>med <strong>for</strong> chest wall(1), arm/hand(11), and leg/foot(13) defects. All flaps survived. Examination revealed preservation of<br />

function of the residual muscle without associated hernia after PMR or early arm fatigue or changes in strength related to activities<br />

involving arm extension after PSL harvest. The lateral thoracic silhouette was maintained in all PSL cases.<br />

CONCLUSION:<br />

The partial latissimus dorsi and rectus abdominis muscle flaps are reliable techniques <strong>for</strong> muscle trans<strong>plan</strong>tation. The minimal donor<br />

site morbidity and versatility in flap design make them excellent options in reconstructing a range of defects.<br />

Microvascular Venous Coupler Reduces the Rate of Venous Anastomosis Failure<br />

Institution where the work was prepared: University of Manitoba, Winnipeg, MB, Canada<br />

Matthew Choi, MD; Edward Wayne Buchel; Thomas E.J. Hayakawa; University of Manitoba<br />

PURPOSE:<br />

To compare venous anastomosis complication rates between hand sewn anastomoses and those using a venous coupler device.<br />

METHODS:<br />

We retrospectively reviewed a single surgeon experience using Deep Inferior Epigastric Per<strong>for</strong>ator (DIEP) flaps and Superficial Inferior<br />

Epigastric Artery (SIEA) free flaps <strong>for</strong> breast reconstruction. The surgeon per<strong>for</strong>med hand-sewn venous anastomoses exclusively in his<br />

practice be<strong>for</strong>e changing his technique to using a venous coupler exclusively (Synovis coupling device). The consecutive series of handsewn<br />

cases was then compared to the consecutive series where the venous coupling device was used. Only DIEP and SIEA free flaps<br />

were considered <strong>for</strong> this analysis. In all cases, end-to-end anastomosis were per<strong>for</strong>med to internal mammary vessels, with one exception<br />

where these recipient vessels were matted down by diseased lymph nodes and the thoracodorsal vessels were used instead.<br />

Outcomes measured were takebacks to the operating room <strong>for</strong> venous insufficiency or venous occlusion.<br />

RESULTS:<br />

A total of 141 cases of DIEP and SIEA free flaps were per<strong>for</strong>med with the hand-sewn technique. Bilateral surgeries were per<strong>for</strong>med in<br />

60 cases totaling 201 flaps. Fifteen (7.4%) patients were taken back to the operating room <strong>for</strong> venous congestion or venous occlusion.<br />

A total of 81 cases of DIEP and SIEA free flaps were per<strong>for</strong>med using a venous coupler. Bilateral surgeries were per<strong>for</strong>med in 29 cases<br />

totaling 110 flaps. One (0.9%) patient was taken back to the operating room <strong>for</strong> venous occlusion. This significant difference in anastomosis<br />

complication rate (p = 0.036) represents an absolute risk reduction of 6.5% and a relative risk reduction of 88%.<br />

DISCUSSION:<br />

Published series of coupler experiences to date have reviewed cases where the authors have selected cases as appropriate <strong>for</strong> coupler<br />

use. This exposes results to a bias which may reflect the use of the coupler in ideal circumstances. Furthermore, reported series do not<br />

have direct comparison of failure rates to hand-sewn controls. Our study addresses these shortcomings by reporting large consecutive<br />

cohorts where the same operative technique is used repeatedly without a decision to abandon the coupler in favor of hand-sewing, or<br />

vice versa. By reviewing a single surgeon experience per<strong>for</strong>ming a single operative procedure, we also achieve reasonable comparison<br />

to a hand-sewn control group.<br />

CONCLUSION:<br />

The use of a venous coupler reduces the complication rate associated with the venous anastomosis.<br />

DISCLOSURE:<br />

The authors have no conflicts of interest.<br />

153


Strategic Approaches to Salvage the Venous Compromised Deep Inferior Epigastric<br />

Per<strong>for</strong>ator Flap<br />

Institution where the work was prepared: Chang Gung Memorial Hospital, Taipeh, Taiwan<br />

Rozina Ali, MD; Ming-Huei Cheng, MD, MHA; Christina Bernier, MD; Yt Lin; Alexander Cardenas-Mejia, MD; Rachel<br />

Bluebond-Cangner, MD; Eduardo P. Rodriguez, MD; We-Chen Ching, MD; Chang Gung Memorial Hospital<br />

INTRODUCTION:<br />

Venous congestion in deep inferior epigastric per<strong>for</strong>ator (DIEP) flap is not infrequent and is the major cause of flap loss and fat necrosis.<br />

The conservative managements of venous congestion include the use of leech, anticoagulants, vasodilators, arteriovenous shunt, keeping<br />

bleeding, and release wound tension. The congested flap may need re-exploration and sometimes require another venous anastomosis<br />

<strong>for</strong> augmentation of venous drainage. The objective of the study was to find the strategic approaches to salvage the venous compromised<br />

DIEP flap.<br />

MATERIALS/METHODS:<br />

Between March 2000 and December, there were 158 DIEP flaps per<strong>for</strong>med <strong>for</strong> breast reconstruction at Chang Gung Memorial Hospital.<br />

Twenty-nine DIEP flap developed venous congestion. Mean age was 48.5 years. Right breast was in 15 cases, and left breast in 14 cases.<br />

Risk factors including pre-op radiation in 5 cases, and longitudinal abdominal scar in 4 cases, transverse cesarean scar in 1 case. The managements<br />

include conservative treatment in 10 cases, post-operative re-exploration in 7 cases and intra-operative salvage in 12 cases.<br />

RESULTS:<br />

There were two total flap failures, giving a success rate of 98.7%. Partial flap loss developed in 3 flaps, and fat necrosis in 4 flaps. The<br />

venous congestion rate was 18.3% (29/158) in this series. The complication rate was 31% (9/29) in the venous congestion group. The<br />

complication rate was statistically significant in post-operative group compared to the conservative and intra-operative groups. The<br />

complication rate was also higher in one-per<strong>for</strong>ator than 2- or 3-per<strong>for</strong>tors groups. There were more than 10 methods in this study to<br />

augment the superficial venous system to the deep venous system <strong>for</strong> salvaging the congested DIEP flap.<br />

DISCUSSION:<br />

Preservation of the superficial inferior epigastric vein, both ipsilateral and contralateral during the flap harvest will provide a helpful tool<br />

to salvage the flap in case of venous congestion. The timing <strong>for</strong> salvage of venous congested DIEP flap may be shifted from post-operative<br />

re-exploration to intra-operative salvage to decrease the possible complications. In conclusion, strategic approaches <strong>for</strong> the management<br />

of venous congested DIEP flaps may salvage the flap and minimize the complication rate.<br />

13 Years Experience with Free Fibula Flap Phalloplasty<br />

Institution where the work was prepared: Gulhane Military Medical Academy, Ankara, Turkey<br />

Mustafa Sengezer; Serdar Ozturk; Mustafa Deveci; Fatih Zor; Gülhane Military Medical Academy<br />

PURPOSE:<br />

Surgical reconstruction of the is challenging because of the many cosmetic and functional requirements such as ual and voiding.<br />

MATERIALS/METHODS<br />

Since 1994, 25 patients were treated with free sensate osteocutaneous fibula flaps. Of the patients, 23 were biological males and the<br />

remaining 2 were operated <strong>for</strong> transsexuals. The ages of the patients ranged between 20 and 27 years (mean, 23,5 years). The average<br />

follow-up period was 7 years (range, 1 to 12 years). Patient satisfaction was evaluated by a questionnaire regarding ual , and daily activities.<br />

Conventional radiographic imaging, magnetic resonance imaging, and bone mineral densitometry were per<strong>for</strong>med to evaluate<br />

the fate of the bony component. Sensibility was evaluated by bulbocavernous reflex and penile somatosensory evoked potentials.<br />

RESULTS:<br />

Eight patients married, and six of them had eight children. Most patients and their parents reported pleasurable ual and . Conventional<br />

radiographs of the fibular bone in neophallus showed robust, calcified bone structure without any evidence of bone resorption or fracture.<br />

The magnetic resonance imaging showed the cortical substance and spongiosum of the bone marrow, which are characteristic<br />

signs of bone viability. Viability of neophallus bone was shown even at 12-year follow-up (the longest in the literature). Dual energy xray<br />

absorbtiometry measurements of the penile bone grafts showed that fibular components in the had bone mineral density values<br />

that were close to the normal subjects. These results were considered as evidence of viability of bone grafts. Neural integrity was found<br />

between the nerves of the neophallus and the residual penile bodies.<br />

CONCLUSION:<br />

Free sensate fibula flap phalloplasty provides cosmetic and functional requirements that an ideal should have. All results put an end to<br />

the discussion that the fibular component of the neophallus could resorb. Constitution of neural integrity is important in terms of pleasurable<br />

ual .<br />

154


Outcomes of Immediate VRAM Flap Reconstruction versus Primary Closure in Patients<br />

Undergoing Chemoradiation and Abdominoperineal Resection <strong>for</strong> Anorectal Cancer<br />

Institution where the work was prepared: The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA<br />

Charles E. Butler, MD; Õzlem Gûndeslioglu, MD; Miguel A. Rodriguez-Bigas, MD; The University of Texas M.D.<br />

Anderson Cancer Center<br />

BACKGROUND & PURPOSE:<br />

Perineal wound complications occur in up to 60% of patients who undergo chemoradiotherapy and abdominoperineal resection (APR)<br />

<strong>for</strong> anorectal cancer. The most common and problematic wound complications are perineal abscess and wound dehiscence owing to<br />

the poor vascularity of surrounding tissues, a large, non-collapsible pelvic dead space, and bacterial contamination. Vertical rectus<br />

abdominis myocutaneous (VRAM) flaps, transferred from the abdomen to the perineum, have been used in an attempt to minimize<br />

these complications by obliterating the dead space and closing the perineal skin defect with non-irradiated, vascularized tissue. The<br />

purpose of this study was to compare the surgical outcomes of anorectal cancer patients who underwent chemoradiotherapy and APR<br />

with immediate VRAM flap reconstruction or primary closure.<br />

METHODS:<br />

We retrospectively reviewed the records of all patients who underwent chemoradiotherapy and APR <strong>for</strong> anorectal cancer from 1993 to 2005<br />

at a major cancer center. Patient, tumor, and treatment characteristics and surgical outcomes in patients who underwent VRAM flap reconstruction<br />

(flap group, n = 35) were compared with those in patients who had primary closure (control group, n = 76) of the perineal wound.<br />

RESULTS:<br />

There were no differences in radiation dose, patient age, medical comorbidities, body mass index, or tumor stage between the groups.<br />

Overall, there was no significant difference in the incidence of perineal wound complications between the groups; however, severe complications<br />

were less frequent in the flap group. The flap group had a significantly lower incidence of perineal abscess (9% vs. 37%, p =<br />

0.002), major wound dehiscence (3% vs. 30%, p = 0.014), and need <strong>for</strong> drainage procedures <strong>for</strong> perineal/pelvic fluid collections (3% vs.<br />

25%, p = 0.003) than the control group. Despite flap harvest and donor site closure in the flap group, there was no difference in the incidence<br />

of abdominal wall complications between the groups during the study's mean patient follow-up of 3.8 years.<br />

CONCLUSIONS:<br />

VRAM flap reconstruction of irradiated APR tissue defects reduces the incidence of severe perineal wound complications without<br />

increasing the incidence of postoperative abdominal wall complications. Strong consideration should be given to immediate VRAM<br />

flap reconstruction following chemoradiotherapy and APR <strong>for</strong> anorectal cancer. Prospective studies may help identify preoperative<br />

and/or intraoperative factors that affect the risk of perineal complications and thus identify patients who would benefit the most from<br />

VRAM flap reconstruction.<br />

Comparison of Surgical Outcomes Using VRAM Flaps vs. Thigh-based Flaps <strong>for</strong><br />

Reconstruction of Abdominoperineal Resection and Pelvic Exenteration Defects<br />

Institution where the work was prepared: The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA<br />

Rebecca A. Nelson, MD; Charles E. Butler, MD; The University of Texas M.D. Anderson Cancer Center<br />

BACKGROUND & PURPOSE:<br />

Pelvic/perineal defects following abdominoperineal resection (APR) and pelvic exenteration (PE) are commonly repaired with regional<br />

flaps from the thigh or abdomen. Previous studies have described the use of these flaps but have not compared outcomes between<br />

flaps from the two donor sites. This study compared the surgical outcomes with vertical rectus abdominis musculocutaneous (VRAM)<br />

flaps and thigh-based flaps used <strong>for</strong> immediate reconstruction of APR and PE defects.<br />

METHODS:<br />

The study included all consecutive patients with a primary colorectal or urogynecologic malignancy who underwent APR or PE and<br />

immediate reconstruction with a VRAM or thigh-based (gracilis, anterolateral thigh, or posterior thigh) flap at a major cancer center from<br />

1993 to 2007. Data were obtained from a prospectively maintained database, and surgical outcomes were retrospectively compared<br />

between patients in the VRAM and thigh flap groups. Patient, tumor, and treatment characteristics were entered into a stepwise logistic<br />

regression model to identify predictors of donor and recipient site complications.<br />

RESULTS:<br />

A total of 133 patients (114 VRAM, 19 thigh) were included. The mean follow-up was 23 months. There were no significant differences<br />

in patient demographics, tumor pathology or stage, adjuvant therapy, or co-morbid conditions between the groups. Patients in the<br />

thigh group had a significantly greater incidence of superficial donor site infection (26% vs. 6% in the VRAM group) and recipient site<br />

complications (cellulitis, 21% vs. 4%; pelvic abscess <strong>for</strong>mation, 32% vs. 6%; and major wound dehiscence, 21% vs. 5%). There were no<br />

differences in abdominal wall complications (including dehiscence, incisional or parastomal hernia, seroma, and infection), despite flap<br />

harvest from the abdominal wall in the VRAM group. Patients in the thigh group had a significantly greater incidence of prolonged (>2<br />

weeks) donor site wound healing (37% vs. 16% in the VRAM group), had a longer mean hospital stay (20 days vs. 12.4 days), and required<br />

more time <strong>for</strong> healing of donor and recipient site wounds (79% and 61% longer, respectively). Obesity (body mass index ? 30) was an<br />

independent predictor of major donor site complications (odds ratio (OR), 3.3), and previous abdominal surgery (OR, 3.5) and tobacco<br />

use (OR, 1.7) were predictors of major recipient site complications.<br />

CONCLUSIONS:<br />

Reconstruction of APR and PE defects with VRAM flaps results in fewer donor and recipient site complications than reconstruction<br />

using thigh-based flaps, without increased abdominal wall morbidity. If available, abdominal flaps should be considered the primary<br />

flap choice to repair these defects.<br />

155


Microangiosomes: a New Concept<br />

Institution where the work was prepared: University of Chicago Hospitals, Chicago, IL, USA<br />

Eric A. Odessey, MD; Charles Y. Tseng, MD; Amir H. Dorafshar, MD; Lisa Spiguel, MD; Lawrence J. Gottlieb, MD,<br />

FACS; University of Chicago Hospitals<br />

BACKGROUND:<br />

The concept of angiosomes has been monumental to the furthering of reconstructive surgery. Such detailed, 3-dimensional knowledge<br />

of soft tissue vascularity has helped shape reconstruction of nearly every part of the human body. The advent of per<strong>for</strong>ator-based flaps<br />

has created a new degree of freedom to reconstructive design. Whereas named vessels supply angiosomes, these per<strong>for</strong>ators supply<br />

what may be called microangiosomes. In search of a consistent source of reliable cutaneous per<strong>for</strong>ators, we have discovered some commonalities.<br />

METHODS:<br />

Corroborated by our literature's description of various individual per<strong>for</strong>ator flaps, we present here a case series designed to further<br />

three hypotheses: 1) There are reliable per<strong>for</strong>ators both proximal and distal to all extremity joints; 2) In general, the direction of blood<br />

flow within these microangiosomes extends away from the joint; and 3) Predictions of flap size can be anticipated depending on the<br />

location of adjacent per<strong>for</strong>ators (and by definition, adjacent microangiosomes).<br />

RESULTS:<br />

Each microangiosome has a self contained circulation with reliable arterial flow and venous drainage. Many flaps previously considered<br />

“distally based” are actually proximally based (from a blood flow point of view) although the base of the pedicle might be distal on the<br />

extremity.<br />

CONCLUSION:<br />

A new concept of microangiosomes has been developed by combining the principles and knowledge of macroangiosomes and per<strong>for</strong>ator<br />

flaps. Using this microangiosome concept, free style pedicled and free per<strong>for</strong>ator flaps can be reliably designed and transferred<br />

<strong>for</strong> a variety of defects. Further defining the soft tissue extent of per<strong>for</strong>ator-based microangiosomes will greatly broaden the spectrum<br />

of reconstructive surgery.<br />

156


ASRM SCIENTIFIC PAPER PRESENTATIONS:<br />

UPPER EXTREMITY<br />

Total and Subtotal Amputations with Destruction of the Proximal Interphalangeal and<br />

Metacarpal Phalangeal Joint: a Paradigm Shit Towards Salvage<br />

Institution where the work was prepared: Cali<strong>for</strong>nia Pacific Medical Center, San Francisco, CA, USA<br />

Darrell Brooks, MD; Rudolf F. Buntic; Buncke Clinic<br />

INTRODUCTION:<br />

Beneficial function can be obtained utilizing a staged approach <strong>for</strong> salvage of digital amputations through the proximal interphalangeal<br />

(PIP) and metacarpal phalangeal (MCP) joints. Completion amputation is currently recommended <strong>for</strong> these injuries. 1,2<br />

METHODS:<br />

Between 2002 and 2006 we treated 14 patients <strong>for</strong> total and subtotal amputations characterized by destruction of their PIP (12) and<br />

MCP (4) joints in a staged approach. In the initial stage, patients underwent restoration of joint height, reconstruction of joint supporting<br />

joint structures, as well as repair of tendons, vessels and nerves. Tissue was transferred or trans<strong>plan</strong>ted as needed <strong>for</strong> soft tissue coverage.<br />

In a subsequent stage, pyrolytic carbon two-piece arthroplasty (Ascension Austin, Texas) was per<strong>for</strong>med through a dorsal<br />

approach. Outcome evaluation involved range of motion (ROM), grip strength, pain, and analysis of the joint characteristics such as lateral<br />

stability, stem loosening, and subsidence.<br />

RESULTS:<br />

All patients completed 18 months follow-up evaluation. Mechanisms of injury included crush, ring avulsion, and saw. An average of 2.8<br />

(PIP group) and 2.0 digits (MCP group) were injured per hand. Range was 1-4 and 2-3 digits per hand respectively. All digits undergoing<br />

staged reconstruction survived. Outcome analysis is illustrated in table 1. Video documentation of function will be provided at presentation.<br />

CONCLUSION:<br />

In selected patients rewarding function can be obtained in cases previously thought to be a contraindication <strong>for</strong> salvage.<br />

Table 1.<br />

Patients Joint ROM (degrees)<br />

11<br />

3<br />

PIP (12)<br />

MCP (4)<br />

60-95<br />

65-90<br />

ROM<br />

(% of nl)<br />

60-95<br />

70-100<br />

157<br />

Avg. %<br />

Reference 1: Soucacous PN. Indications and selection <strong>for</strong> digital amputation and<br />

re<strong>plan</strong>tation. J <strong>Hand</strong> Surg [Br]. 2001 Dec;26(6):572-81.<br />

Reference 2: Allen DM, Levin LS. Tech <strong>Hand</strong> Up Exterm Surg. 2002<br />

79<br />

86.2<br />

Grip<br />

(% of nl)<br />

39-70<br />

12-66<br />

Avg. injured<br />

digits/hand<br />

2.8<br />

2.0


Single-Stage Reconstruction of the Mutilated <strong>Hand</strong> Using Bilobed and Trilobed Free Flaps<br />

Based on the Anterior Tibial Artery<br />

Institution where the work was prepared: Duke University, Durham, NC, USA<br />

Keith E. Follmar; Yi Xin Zhang; Danru Wang; Detlev Erdmann; L. Scott Levin; Duke University<br />

BACKGROUND:<br />

Reconstruction of the mutilated hand remains a challenging clinical problem. Due to the complex shape of the hand, multiple flaps or<br />

staged procedures are often necessary to resurface the hand with an acceptable outcome. Furthermore, involvement of the thumb or<br />

other fingers often complicates reconstruction. The authors describe our experience with bilobed and trilobed free flaps based on the<br />

anterior tibial artery system <strong>for</strong> single-stage reconstruction of the mutilated hand.<br />

METHODS:<br />

Five patients with mutilated hands (two traumatic injuries, three burn injuries) underwent soft tissue coverage with a bilobed (N=2) or<br />

trilobed (N=3) free flap based on the anterior tibial vessel system, including the anterior tibial, dorsalis pedis, and, in the trilobed cases,<br />

the first dorsal metatarsal vessels. The flaps consisted of a lateral leg lobe, a dorsalis pedis lobe, and the great toe as the third lobe.<br />

The sensatory nerve was also anastomosed in all cases. All donor sites were resurfaced by thick-split skin grafts.<br />

RESULTS:<br />

All flaps survived. Functional and aesthetic outcome was acceptable at 3 to 12 months of follow up. Some recovery of protective thermal<br />

sensation was observed in all patients. In the three cases where a great toe was included in the flap, this allowed the reconstructed<br />

thumb to act as an opposable post and provide some pinching action. All donor sites were free from major disability.<br />

CONCLUSION:<br />

Bilobed and trilobed free flaps based on the anterior tibial artery are a robust reconstructive option <strong>for</strong> resurfacing of the mutilated hand,<br />

especially in cases where the thumb or another digit has been lost. It allows <strong>for</strong> excellent results in a single stage. Figure Legend: A 36year-old<br />

female presented with severe burn contractures three years after a burn to her right hand. (A) Preoperative view showing severe<br />

contractures involving the wrist, dorsum, and thenar regions. Also note partial loss of the thumb. (B) Preoperative flap design showing the<br />

three lobes of the flap. (C) Intraoperative view after raising the three lobes of the flap, prior to pedicle division. (D) Postoperative view,<br />

showing the three lobes of the flap used to reconstruct the first web and palm area, the thenar area, and the thumb respectively.<br />

Complications Associated With Specific Types of Intrinsic Pedicle Flaps Used to Reconstruct<br />

Digital Trauma Defects<br />

Institution where the work was prepared: <strong>Hand</strong> & Wrist Center of Houston, Houston, TX, USA<br />

Mark Henry, MD; University of Texas<br />

One hundred and seventy-five consecutive pedicle flaps of the hand and wrist per<strong>for</strong>med over a 4 year period were reviewed, eliminating<br />

5 cases <strong>for</strong> inadequate patient follow-up and 61 cases <strong>for</strong> recipient sites proximal to the metacarpophalangeal joints. The remaining<br />

108 intrinsic hand vessel based pedicle flaps were per<strong>for</strong>med in 98 males and 10 females averaging 36 years of age <strong>for</strong> digit level<br />

trauma in 19 thumbs, 27 index fingers, 50 long fingers, 8 ring fingers, and 4 small fingers. Specific flaps employed were 79 antegrade<br />

flow homodigital proper digital artery, 10 reverse flow homodigital proper digital artery, 3 reverse flow second dorsal metacarpal artery,<br />

5 antegrade flow first dorsal metacarpal artery, 6 reverse flow dorsal ulnar artery of thumb, and 2 dorsal middle phalangeal flaps based<br />

on a dorsal branch of the proper digital artery. The final average total active motion in the fingers was 235 degrees. Complications<br />

occurred in 42 cases in which 39% of the patients were actively smoking post-operatively. Complications included 10 partial flap losses,<br />

13 cases of superficial epidermolysis, 4 cases of venous congestion, 4 superficial infections, 3 deep infections, and 8 cases of delayed<br />

healing at the wound margin. Second surgeries were required to manage these complications in 15 cases: 3 debridements of deep<br />

wound infections, 3 revisions of the distal fingertip amputation profile <strong>for</strong> partial flap loss, 5 full-thickness skin grafts <strong>for</strong> partial flap loss,<br />

and 4 full-thickness skin grafts <strong>for</strong> wound breakdown at the flap margin. Specific associations of complications with flap type were that<br />

the antegrade homodigital proper digital artery flaps used to preserve length in digital amputations experienced partial flap loss, epidermolysis,<br />

delayed wound healing, and infections involving the portion of the flap bordering the amputation margin in a secondary<br />

zone of crush but no cases of venous congestion. Reverse flow proper digital artery flaps of the finger and reverse flow dorsal ulnar<br />

artery flaps of the thumb experienced venous congestion and epidermolysis but no partial flap losses or infection. Whether the skin<br />

taken as part of the flap has experienced direct trauma itself and the direction of flow in the pedicle may play a role in determining what<br />

type of complications can be expected when using pedicle flaps intrinsic to the hand in the reconstruction of digital trauma defects.<br />

158


Refinement of Arterialized Venous Flaps in Finger Reconstructions<br />

Institution where the work was prepared: Chang Gung Memorial Hospital, Tao-Yuan, Taiwan<br />

Yu-Te Lin, MD, MS; Chih-Hung Lin; Cheng-Hung Lin; Fc Wei, MD, FACS; Chang Gung Memorial Hospital<br />

INTRODUCTION:<br />

Venous flaps had been broadly applied in hand/finger reconstruction and been classified according to different afferent vessels. Though<br />

arterialized venous flap was proposed superior to other styles of venous flaps in the literatures, venous congestion seemed to be predestinated<br />

in most observations. Partial loss of the flap was considered a “normal” finding during the first few days after arterialization.<br />

The unfavorable results may not affect the general outcomes of wound healing. Nevertheless, scarring and fibrosis does affect the functional<br />

outcomes of reconstructed fingers/hands. Refinement of the arterialized venous flaps was intended.<br />

MATERIALS/METHODS:<br />

From May 2005 to Apr 2006, seven arterialized venous flaps were used <strong>for</strong> six acutely traumatized fingers and one reconstruction after<br />

release of a finger contracture. All venous flaps were arterialized in an orthodromic pattern. One to two veins were repaired according<br />

to the veins included in the flaps. Technique of refinement was to decrease intravascular pressure of the drainage vein by interfering<br />

arterial flow-through with a hemoclip. Clipping the communicating branch of H-shaped veins was per<strong>for</strong>med in 3 patients; Clipping a<br />

limb ofë-shaped vein at the bifurcation or clipping at the midway of a flow-through arterialized vein were done in 4 patients. Flaps were<br />

monitored in the Microsurgical Intensive Care Unit <strong>for</strong> 5 to 7 days. The patients received hand therapies and were followed in the clinics<br />

<strong>for</strong> 6 months.<br />

RESULTS:<br />

No venous congestion of the flap was detected during the early postoperative course. Flaps were observed mimicking conventional<br />

arterial flaps in color and texture. Scarce congestion was noted in one case during postoperative 3rd to 7th day, and subsided without<br />

any loss. One vasospasm with arterial insufficiency was detected in one case and re-do arterial anastomosis was done. Mild to moderate<br />

venous congestion was relieved in 10 days with superficial loss on the margin. No contraction of flap was observed and adequate<br />

hand function was obtained in all cases.<br />

DISCUSSION:<br />

A vein with diversion of arterial blood provided a venous blood pressure <strong>for</strong> venous drainage, which decreased the venous congestion<br />

of the flaps. Expression of scarce venous congestion starting at 3rd postoperative day may be due to dilatation of choke vessels after<br />

arterialization. Flap survival mimicking an arterial flap makes the refined flaps reliable in hand and finger reconstructions.<br />

Arterialized Venous Instep Flap: A New Alternative <strong>for</strong> Reconstruction of Palmar Contracture<br />

Release<br />

Institution where the work was prepared: Gulhane Military Medical Academy, Ankara, Turkey<br />

Fatih Zor; Selçuk Isik; Muhidtin Eski; Serdar Ozturk; Gülhane Military Medical Academy<br />

Palmar contractures cause great difficulty in per<strong>for</strong>ming the tasks required in daily life. A wide variety of flaps have been used <strong>for</strong> hand<br />

reconstruction and each has its own advantages and disadvantages. As a general rule of plastic surgery, all losses must be replaced by<br />

kind. So <strong>plan</strong>tar region seems to be a good alternative. Medial <strong>plan</strong>tar flap has been used in the literature but, it is a bulk flap and sacrifices<br />

a major artery. In this study, arterialized venous instep flap is described, and used in a clinical series. The amount of tissue loss is<br />

first determined, and the appropriate dimensions of the skin island of the flap are designed on the non-weight bearing area of the foot.<br />

The skin island of the flap resembles medial <strong>plan</strong>tar flap. The thin skin flap is then elevated by preserving the subdermal plexus. At the<br />

distal edge of the skin island, 2or3 subcutaneous veins are preserved and harvested. At the proximal edge of the flap, saphenous vein<br />

is preserved and included in the flap. Following subcutaneous dissection the skin island is transferred to the defect. Following preparation<br />

of the digital arteries, one of the veins at the distal edge of the flap is anastomosed to the digital arteries and the vein at the proximal<br />

edge is anastomosed to the dorsal veins of the hand. Between January 2006-June 2007, 5 arterialized venous instep flaps were<br />

per<strong>for</strong>med. The flap dimensions were averagely 3x 5 cm. All flaps survived without any significant problem. The mean follow-up period<br />

was 6 months. Functional results were satisfactory in all cased. Protective sensation was recognized about 3-6 months postoperatively.<br />

None of the flaps required defatting in follow-up period. Arterialized venous instep flap is very thin as it lacks fascia, it is easily<br />

harvested and no major artery is sacrificed. Moreover characteristics of <strong>plan</strong>tar skin is very similar to palmar skin which causes a great<br />

advantage to this flap. Although further studies are required, we think that the use of arterialized venous instep flap is a very useful<br />

method <strong>for</strong> reconstruction of the palm.<br />

159


Long-Term Functional Outcome of the Upper Extremity following Osteocutaneous Radial<br />

Forearm Free Flap Harvest<br />

Institution where the work was prepared: University of Pittsburgh Medical Center, Pittsburgh, PA, USA<br />

Justin M. Sacks, MD1; Kia M. McLean, MD1; Ernest K. Manders, MD2; James M. Russavage, MD, DMD1; Frederic W.-<br />

B. Deleyiannis, MD, MPhil, MPH2; (1)University of Pittsburgh Medical Center, (2)University of Pittsburgh<br />

BACKGROUND/INTRODUCTION:<br />

The osteocutaneous radial <strong>for</strong>earm free flap (ORFFF) represents a versatile modality in the reconstruction of composite tissue defects of<br />

the head and neck. Poor cosmetic outcomes and the possibility of pathologic fractures have been cited as the primary disadvantages.<br />

The purpose of this study was to determine any long-term functional morbidity of the donor upper extremity following flap harvest.<br />

METHODS:<br />

A prospective cross-sectional analysis was per<strong>for</strong>med on twelve patients who were at least one-year post-operative. Patient, injury and<br />

tumor variables were obtained. Clinical outcomes included donor site appearance, size and any history of wound complications.<br />

Functional capacity was quantified by comparing range of motion (ROM) of the thumbs, digits and wrists along with pronation and<br />

supination of bilateral <strong>for</strong>earms. Pinch and grip strengths were obtained. Neurovascular assessment using two-point discrimination in<br />

the median, ulnar and radial nerve distribution along with digital plethysmography of the thumb and index fingers was assessed.<br />

Disability of the Arm, Shoulder and <strong>Hand</strong> (DASH) questionnaires were elicited at long-term post-operative evaluation. Radiographs of<br />

bilateral <strong>for</strong>earms were utilized to evaluate <strong>for</strong> de<strong>for</strong>mity and occult fracture.<br />

RESULTS:<br />

All radial <strong>for</strong>earm donor sites were healed with no evidence of tendon exposure. The mean ROM of full active wrist flexion, wrist extension,<br />

and thumb flexion measured respectively 83% (p =0.01), 82% (p=0.01), and 89% (p=0.03) of the non-flap arm. Forearm supination<br />

was reduced 83% (p=.03). Three of the patients (25%) were unable to fully oppose their thumb to their little finger (p=0.08). No significant<br />

differences were found between <strong>for</strong>earm pronation, full composite grip, pinch or grip strength, digital plethysmography, or twopoint<br />

discrimination. Five of the 12 patients (41.6%) reported a DASH score greater than 10, and 3 (25%) patients indicated that harvest<br />

of the ORFFF created a disability. Radiographs revealed one malunion secondary to post-operative pathological fracture.<br />

CONCLUSION:<br />

Harvest of the ORFFF is associated with a significant reduction in ROM of the wrist, <strong>for</strong>earm, and thumb. Patients frequently reported<br />

upper extremity limitations. The ORFFF, although versatile and reliable, is associated with long-term functional morbidity of the upper<br />

extremity. Surgeons should pre-operatively counsel their patients about these possible risks.<br />

Vascularized Scapular Grafts: An Excellent Option <strong>for</strong> Humeral Nonunions<br />

Institution where the work was prepared: Denver Clinic <strong>for</strong> Extremities at Risk, Denver, CO, USA<br />

Jerrod Keith, MD1; David P. Schnur, MD2; William Brown2; Ross Wilkins2; Ronald Hugate, MD2; Cynthia Kelly2;<br />

(1)University of Colorado Health Science Center, (2)Denver Clinic <strong>for</strong> Extremities at Risk<br />

Posttraumatic humeral nonunions are uncommon, ranging from 0% to 13% in published series, yet this is a problematic complication,<br />

challenging to surgeons and debilitating to patients. A variety of conventional techniques have been described to treat nonunions,<br />

including intramedullary nailing, plating with and without bone grafting, and external fixation. These methods can be successful, as<br />

reports of bony union range from 22 % to 95%. An attractive alternative to these traditional methods <strong>for</strong> humeral reconstruction is the<br />

addition of vascularized bone grafts, which are especially advantageous in patients with local devascularization and infection. Most<br />

microvascular surgeons utilize the free fibula graft to treat humeral nonunions. Only a few case reports and small case series, the largest<br />

being 3 patients, describe the use of lateral boarder of scapula bone grafts to treat this problem. We retrospectively reviewed 23<br />

patients from a single institution treated with vascularized bone graft <strong>for</strong> humeral nonunion using the lateral border of the scapula. Our<br />

mean population age was 59, and patients underwent an average of 3 prior operations. The length of time from injury to grafting averaged<br />

33.4 months. Healing occurred in 21/23 patients (91.3%), with an average time of 18 weeks to bony union. 19/23 grafts were pedicled,<br />

and the remaining 4 were free grafts. Three of the four free grafts included skin paddles. Fracture locations involved the entire<br />

length of the humerus, although the majority was in the middle third (61%). There were three distal nonunions that were successfully<br />

treated with osteocutaneous free grafts. Three complications occurred in only 2 patients. One patient developed an infection and ulnar<br />

nerve entrapment, while the other <strong>for</strong>med thrombosis in the graft vein. Both complications resolved after operative revisions and these<br />

patients achieved union of their fractures. Throughout follow-up, patients completed a modified MSTS upper extremity functional evaluation<br />

score. The average length of follow up was 30 months and the average MSTS functional score was 80%. Based on these results,<br />

we believe that the lateral border of the scapula as a vascularized bone graft is an excellent option <strong>for</strong> humeral nonunions. The majority<br />

of grafts can be per<strong>for</strong>med on a pedicle, obviating the need <strong>for</strong> lengthy operations and complications associated with vascular anastamoses.<br />

Additionally, the operative field is limited to one region of the body, which may aid in patient com<strong>for</strong>t and hasten recovery.<br />

160


The Aesthetic Mini Wrap - Around Technique <strong>for</strong> Thumb Reconstruction<br />

Institution where the work was prepared: Department of Orthopaedics University of Modena, Modena, Italy<br />

Roberto Adani, MD; University of Modena and Reggio Emilia<br />

INTRODUCTION:<br />

Free flaps from the great toe are an established method <strong>for</strong> reconstruction of absent or partially amputated thumbs. However, opinions<br />

differs as to which technique represents the ideal solution <strong>for</strong> each level of amputation. In addition, there may be some controversy<br />

<strong>for</strong> distal thumb reconstruction, i.e. distal to the IP joint. This work reflects our experience in using the great toe mini wrap-around<br />

flap <strong>for</strong> distal thumb reconstruction.<br />

MATERIALS/METHODS:<br />

In the period between 1990-2005 we have used a great toe mini wrap-around <strong>for</strong> reconstruction of the thumb in 19 patients with traumatic<br />

amputations localized at the distal phalanx of the thumb. A flap including the entire nail and most of the distal phalanx of the<br />

great toe was used. The patients included 15 men and 4 women with a mean age of 25 years (range 17-52 years).The mean interval<br />

between injury and surgery was 98 days (range 7days-13months) with the exception of one patient in whom reconstruction was per<strong>for</strong>med<br />

13 years after injury. In 6 cases ,the amputation was through the base of the distal phalanx, in 11cases it was at the level of the<br />

IP joint and finally in two cases it was at the MP joint (in these cases the bone was initially lengthened with an external fixator and later<br />

reconstruction was per<strong>for</strong>med using a mini wrap around flap).<br />

RESULTS:<br />

18 of the grafts survived. Four of the 6 patients with amputation distal to the IP joint had a functional IP joint with a mean range of motion<br />

of 30° (range 25-°-45°); the other cases had a non functional IP joint.Arthrodesis at the IP level was per<strong>for</strong>med in the remaining cases<br />

.The mean 2sPD was 10 mm (range, 5-15) and there were no complaints of cold intolerance. There was minimal morbidity of the donor<br />

foot and only 3 patients complained of mild foot discom<strong>for</strong>t when walking without shoes.<br />

CONCLUSION:<br />

The mini wrap-around flap has several advantages: it restores adequate thumb length, achieves good pulp reconstruction and the cosmetic<br />

appearance of the nail is very similar to the contra lateral thumb. The disadvantages are complete loss of the nail at the donor<br />

site and loss of the “nail-to-nail pinch” if the IP joint of the thumb cannot be salvaged The great toe mini wrap-around flap is an excellent<br />

reconstruction technique in selected patients.<br />

Radical Reduction of Upper Extremity Lymphedema with Preservation of Per<strong>for</strong>ators: A<br />

Preliminary Report<br />

Institution where the work was prepared: E-DA Hospital, I-Shou University, Kaohsiung, Taiwan<br />

Paolo Sassu, MD1; Christopher Salgado2; Samir Mardini, MD3; Hung-Chi Chen, MD, FACS2; (1)KleinertKutz Institute,<br />

(2)E-da/I-I Shou University Hospital, (3)Mayo clinic Rochester<br />

HYPOTHESIS:<br />

Excisional procedures have been successfully utilized by different authors in multi-stage treatment of upper extremity lymphedema. In<br />

the last five years we have combined microsurgical principles of per<strong>for</strong>ator flap surgery in order to develop a one-stage procedure that<br />

enables a radical reduction of the lymphedematous tissue with preservation of the vascular supply to the overlying skin.<br />

METHODS:<br />

Between March 2000 and November 2005 seven patients were treated by Radical Reduction of the subcutaneous tissue with<br />

Preservation of Per<strong>for</strong>ators (RRPP). Per<strong>for</strong>ator vessels from the radial and posterior interosseous arteries were identified with a doppler<br />

probe and marked. Through medial and lateral <strong>for</strong>earm incisions, skin flaps as thin as 5 mm were raised off the underlying lymphedematous<br />

tissue and the affected tissue was removed off the deep fascia. During the dissection, 3 cm of soft tissue was preserved around<br />

the per<strong>for</strong>ators in order to avoid their injury and guarantee adequate perfusion of the skin flaps. Medial and lateral antebrachial cutaneous<br />

nerves were preserved during the dissection.<br />

RESULTS:<br />

At a mean follow-up of 9.1 months all patients showed a significant reduction of the entire extremity and satisfaction from our evaluation.<br />

Measurements were evaluated from above and below the elbow joint, at the wrist and the hand. At each of these regions the average<br />

percentage reduction was 11.7%, 21.5%, 3.4%, and 5.4% respectively. There were no cases of wound breakdown, skin necrosis or<br />

cellulitis in the postoperative period.<br />

CONCLUSION:<br />

Even though further evaluations will be necessary, microvascular principles applied to the radical excision of the subcutaneous tissue<br />

seems to offer a new promising one-stage surgical procedure in patients affected by upper extremity lymphedema<br />

161


Vascularized Groin Lymph Node Transfer <strong>for</strong> Postmastectomy Upper Extremity Lymphedema<br />

Institution where the work was prepared: Cheng-Hung Lin, Taipei, Taiwan<br />

Cheng-Hung Lin1; Rozina Ali1; Chris Wallace1; Hung-Chi Chen2; Ming-Huei Cheng1; (1)Chang Gung Memorial<br />

Hospital, Chang Gung University, (2)E-Da Hospital, I-Shou University<br />

OBJECTIVE:<br />

The objective of this study was to evaluate the outcome of vascularized groin lymph node (VGLN) transfer in patients with postmastectomy<br />

upper extremity lymphedema (PMUEL).<br />

SUMMARY BACKGROUND DATA:<br />

Microlymphatic surgery <strong>for</strong> obstructive lymphedema was introduced in 1977. Based on results observed in an experimental canine<br />

model, VGLN transfer has been per<strong>for</strong>med in place of microlymphatic surgery in our hospital as the first-line treatment <strong>for</strong> PMUEL<br />

refractory to non-operative therapies. This shift has been fueled by the drive <strong>for</strong> less technically demanding and more physiological procedures.<br />

METHODS:<br />

Between January 1997 and June 2005, 13 consecutive patients with refractory PMUEL underwent VGLN transfer. Superficial inguinal<br />

nodes supplied by the superficial circumflex iliac vessels, were harvested within a lympho-cutaneous flap measuring 10 cm by 5 cm and<br />

transferred to the dorsal wrist of the lymphedematous limb. The superficial branch of the radial artery at the anatomical snuffbox and<br />

the cephalic vein were used as recipient vessels. Outcome was assessed by reduction in upper limb girth, increased functional usage,<br />

decrease in infection rate and improved lymphatic drainage on lymphoscintigraphy.<br />

RESULTS:<br />

All flaps survived although one flap required early re-exploration. No donor site morbidity was encountered. A postoperative reduction<br />

in arm circumference was documented in eleven (84.6%) patients, with a mean percentage reduction in arm circumference of 53.2%. A<br />

marked postoperative reduction in the incidence of cellulitis was noted in eleven patients. Postoperative technetium-labeled sulfur colloid<br />

lymphoscintigraphy indicated improved lymph drainage of the affected arm, revealing decreased lymph stasis and more rapid lymphatic<br />

clearance.<br />

CONCLUSION:<br />

VGLN transfer is a technically simple, reliable and safe procedure that significantly improves refractory PMUEL as assessed by objective<br />

measures and clinical parameters.<br />

Use of Nerve Conduits as an Adjunct to Brachial Plexus Micro-Neurorraphy<br />

Institution where the work was prepared: Hospital <strong>for</strong> Special Surgery, New York, NY, USA<br />

Helene L. Strauss, BA1; Richard Cheng, BS2; Scott Wolfe, MD3; Joseph Feinberg, MD3; (1)UMDNJ, (2)Dartmouth<br />

Medical School, (3)Hospital <strong>for</strong> Special Surgery<br />

HYPOTHESIS:<br />

The use of nerve conduits in level I clinical trials shows improvement in sensory recovery when compared with direct repair. While primate<br />

studies on major mixed motor-sensory nerves have also documented significant improvements over direct repair with nerve conduits,<br />

no clinical data analyzing motor recovery following nerve conduit repair has been reported. We hypothesize that the recovery of<br />

nerves repaired with conduits surpasses that of nerves repaired with end-to-end neurorraphy.<br />

METHODS:<br />

17 patients had one or multiple nerve-to-nerve transfers <strong>for</strong> adult traumatic brachial plexus palsy using the operative microscope, with<br />

some patients undergoing multiple procedures. 7 transfers were per<strong>for</strong>med by advancing the nerve ends into a semi-permeable Type I<br />

cross-linked collagen conduit and 24 nerve transfers were per<strong>for</strong>med utilizing standard end-to-end neurorraphy. No repairs involved interposition<br />

grafts. Postoperative rehabilitation and follow-up were identical between groups. The following three criteria were analyzed: clinical<br />

evaluation using the Medical Research Council grading scheme of muscle function at one year, at two years, and postoperative EMG.<br />

31 and 21 transfers were available <strong>for</strong> one- and two-year follow-up testing, respectively. Two-tailed unpaired t-tests were completed.<br />

RESULTS/STATISTICS:<br />

For all three evaluation criteria, no significant differences existed between the conduit and standard end-to-end neurorraphy. Notably,<br />

all transfers per<strong>for</strong>med with nerve conduits demonstrated clinical and electromyographic reinnervation at one year and all 6 muscles<br />

with two year follow-up data demonstrated M3 or M4 clinical function.<br />

CONCLUSION:<br />

Functional muscle recovery is equivalent <strong>for</strong> nerve transfers per<strong>for</strong>med with collagen nerve conduits and by traditional micro-neurroraphy.<br />

Successful conduit usage <strong>for</strong> motor neuron repair in humans as documented here and previous studies of conduit usage in animals<br />

and sensory neurons warrant continued investigation into conduit repair efficacy and potential improvements in operative time,<br />

precision of repair, and speed of nerve recovery.<br />

162


The Extended Lower Trapezius Flap <strong>for</strong> the Reconstruction of Shoulder Tip Defects<br />

Institution where the work was prepared: Singapore General Hospital, Singapore, Singapore<br />

Kok-Chai Tan, MBBS, FRCS; Bien-Keem Tan, MBBS, FRCS, (Ed); Mohamed Z. Rasheed, MBBS, MRCS(Ed); Singapore<br />

General Hospital<br />

BACKGROUND:<br />

Defects of the shoulder tip expose the glenohumeral and acromioclavicular joints and lead to scarring and contractures. Well vascularised<br />

cover is required to restore function and appearance, yet few pedicled flaps are able to reach the shoulder tip. The latissimus<br />

dorsi flap is commonly employed, but its sacrifice affects glenohumeral function, which is undesirable in a patient with a shoulder weak<br />

from an underlying pathological condition.<br />

METHODS:<br />

We describe the extended lower trapezius flap <strong>for</strong> reconstructing the shoulder tip defects of three patients. This pedicled flap is based<br />

on the dorsal scapular artery and includes the lower trapezius muscle and a long inferior fasciocutaneous extension.<br />

RESULTS:<br />

All flaps healed without complications and all patients regained good shoulder function with full range of motion. One patient who<br />

developed tumor recurrence was treated with re-excision and latissimus dorsi flap reconstruction.<br />

CONCLUSION:<br />

The extended lower trapezius flap is well suited <strong>for</strong> reconstructing shoulder defects. Based on the dorsal scapular artery, the flap has a<br />

long inferior fasciocutaneous extension that is able to reach the shoulder tip. Shoulder morbidity is low as only the lower trapezius is<br />

released minimizing disruption to scapulothoracic function. And as the latissimus dorsi is spared, glenohumeral function is not affected<br />

and the option of the latissimus dorsi flap remains available <strong>for</strong> future use.<br />

Figure 1a:<br />

Figure 1b:<br />

Tz – Trapezius, RM – Rhomboid Major, Rm – Rhomboid Minor, LD – Latissimus Dorsi, DSA – Dorsal Scapular Artery, Arrow – Protraction<br />

of Scapula.<br />

Figure 2:<br />

Post-operative appearance at one month.<br />

163


ASRM SCIENTIFIC PAPER PRESENTATIONS:<br />

LOWER EXTREMITY<br />

Vascularized Fibula Flap Onlay <strong>for</strong> Salvage of Pathologic Long-Bone Fracture<br />

Institution where the work was prepared: Mayo Clinic, Rochester, MN, USA<br />

Jeffrey B. Friedrich, MD; Steven L. Moran; Allen T. Bishop; Christina M. Wood; Alexander Y. Shin; Mayo Clinic<br />

INTRODUCTION:<br />

Long bone pathologic fractures, especially when radiation-induced, represent a significant and difficult entity to treat. The ultimate goal<br />

of treatment is limb salvage, however, there are no treatment methods that guarantee bony healing. Frequently, immobilization or open<br />

reduction and fixation are unsuccessful. In recent decades, the vascularized fibula flap has revolutionized skeletal reconstruction, including<br />

that of the long bones. One treatment option <strong>for</strong> long-bone pathologic fracture is an onlay free vascularized fibula flap spanning<br />

the fracture site. The purpose of this study is to report the results of onlay vascularized fibula flaps <strong>for</strong> pathologic long bone fractures,<br />

and to determine the clinical outcomes, postoperative functional status, and complications of this method of reconstruction.<br />

MATERIALS/METHODS:<br />

A tumor registry review was conducted to search <strong>for</strong> patients who underwent long bone pathologic fracture reconstruction with the<br />

onlay vascularized fibula flap. These patients' records were analyzed <strong>for</strong> details of reconstruction; time to bony union; subsequent surgeries;<br />

clinical and functional outcomes; and complications associated with flap harvest and reconstruction.<br />

RESULTS:<br />

Twenty-five patients met criteria <strong>for</strong> this study. Twenty-one patients demonstrated bony fracture union at an average of 11 months following<br />

fibula flap onlay reconstruction. All 4 of the patients whose fibular flap failed to demonstrate bony healing later obtained limb salvage<br />

following subsequent procedures. Two patients who had experienced bony union ultimately required amputations <strong>for</strong> reasons unrelated<br />

to the fibular reconstruction. Overall limb salvage was possible in 23 patients (92%). Twelve of 25 patients achieved a good or excellent<br />

functional outcome as judged by a common oncologic reconstruction functional outcome scale. Thirteen patients had a fair or fail outcome.<br />

Post-surgical complications were common in this group of patients, with a total of 22 distinct complications (88% incidence).<br />

CONCLUSION:<br />

This study demonstrates that pathologic long bone fracture salvage with an onlay vascularized fibula flap enables limb salvage in a majority<br />

of patients. The incidence of postoperative complications is high, and must be weighed against the potential morbidity of limb loss.<br />

Microvascular Bone Flap Prefabrication: Preliminary Results in an Animal Experimental Model<br />

Institution where the work was prepared: Div of Plastic Surgery - University of Modena and Reggio Emilia, Modena,<br />

Italy<br />

Alessio Baccarani; Giovanna Petrella; Pietro Loschi; Massimo Pinelli; Giorgio De Santis; University of Modena and<br />

Reggio Emilia<br />

INTRODUCTION:<br />

Bone defects still represent a significant challenge to the reconstructive surgeon. Despite major advancements in the field of biomaterials,<br />

autologous bone grafts are to be considered the gold standard <strong>for</strong> reconstructing extended bony defects. Our study was designed<br />

to develop a pre-fabricated bone flap in an animal model, starting from a predetermined-shape biocompatible scaffold (BS), a vascular<br />

pedicle and different types of autologous stem cells.<br />

METHODS:<br />

Thirty New Zealand rabbits (male, weight range from 1.8 to 2.4 kg) were used and divided in three groups (10 rabbits each). In group 1<br />

(control group) a 7 mm diameter biocompatible scaffold (xenogenic decellularized and deproteinized bone) was inset across the rabbit's<br />

femoral pedicle and then wrapped into a silicon sheet. In group 2 the same BS was inset and 0.5 cc of autologous bone marrow<br />

(BM) were added. In group 3 the same BS system was added with 1.5*106 autologous rabbit adipose-derived stem cells (ASCs) in 0.5<br />

cc hyaluronic acid matrix suspension. After 16 weeks all im<strong>plan</strong>ts were harvested as micro-flaps and then analized with microradiograms<br />

(Micro X-Ray, Italstructure, Como, Italy) and by histology (5 mm sections, Toluidine Blue and Gomori staining).<br />

RESULTS:<br />

At microradiographic analysis all the inset scaffolds showed decreased density with respect to the same pre-operatory non-im<strong>plan</strong>ted<br />

scaffolds. Group 2 im<strong>plan</strong>ts showed additionally a significant change in the finest trabecular morphology. Histological analysis showed<br />

in group 1 im<strong>plan</strong>ts an abundant connective tissue deposition with angiogenesis, and frequent bone resorption sites. In group 2<br />

im<strong>plan</strong>ts, osteogenesis was found. Active osteoblasts were assessed together with vital osteocytes. Group 3 im<strong>plan</strong>ts did not differ<br />

much histologically from the control group, but were characterized by a more intense granulocytic inflammatory reaction.<br />

CONCLUSIONS:<br />

Bone marrow derived stem cells are able to promote a faster osteogenesis process in this microsurgical experimental model. Adipose<br />

derived stem cells (ASCs) may promote the same process with longer latency. Microsurgical bone prefabrication may represent a possibile<br />

reconstructive option in the future.<br />

164


The Use of Corticoperiosteal Flaps in Recalcitrant Distal Tibial Nonunions<br />

Institution where the work was prepared: Fundación Pedro Cavadas, Valencia, Spain<br />

Pedro C. Cavadas, MD, PhD; Luis Landin; Fundación Pedro Cavadas<br />

Recalcitrant nonunions of the distal tibia without bone defect are severe problems difficult to treat. Vascularized corticoperiosteum can<br />

provide osteogenesis The thin corticoperiosteal flap based on the descending genicular artery has been previously described to treat<br />

nonunions in the upper extremity without bone defect. The use of this flap to treat distal tibial nonunions is reported. Twentyone<br />

patients with recalcitrant nonunion of the distal tibial metaphysis without segmental bone defect or evidence of infection were treated<br />

with revision of the internal fixation and a corticoperiosteal free flap from the medial condyle of the femur. The number of previous surgical<br />

procedures was 2-5. The flaps were compound, including muscle or fat, <strong>for</strong> wound coverage in seven cases. All compound flaps<br />

survived. Bony union was achieved in all cases, with substantial bone <strong>for</strong>mation at the nonunion site by the fourth month in all cases but<br />

one. In this case bone union took seven months. Donor morbidity was negligible. Two tibiotalar arthrodeses were per<strong>for</strong>med secondarily<br />

<strong>for</strong> posttraumatic osteoarthritis. Treatment of recalcitrant distal tibial nonunions without bone defect with removal of previous hardware,<br />

stable internal fixation and free corticoperiosteal flap transfer is safe and effective in noninfected cases.<br />

How Do Free Muscle Flap Reconstruction Effect Gait Analysis in Landmine Injury Patients?<br />

Institution where the work was prepared: Gulhane Military Medical Academy, Ankara, Turkey<br />

Serdar Ozturk; Mustafa Sengezer; Haydar Mohur; Fatih Zor; Gülhane Military Medical Academy<br />

INTRODUCTION:<br />

Landmine explosion results in severe composite soft tissue and bone defects especially on the heel area. Such injuries bring a <strong>for</strong>midable<br />

challenge to both patients and reconstructive surgeons. Here, we present gait analysis of the patients in one of the largest series in<br />

the literature. We discuss our experience and give important points in gait analyses of these patients.<br />

MATERIAL AND METHODS:<br />

Eighty four patients who had heel defects treated with muscle flaps in Department of Plastic and Reconstructive Surgery at GMMA were<br />

examined objectively. Type of injury, localization of the wounds, tissue defects and timing of the definitive treatment were included in<br />

the study. Treatment modalities according to the severity and localization of the wounds were defined. Our preference <strong>for</strong> reconstruction<br />

of large complex defects was free muscle flaps covered by split-thickness skin grafts. Among these, we used free latissimus dorsi<br />

muscle flaps in 48 patients, and rectus abdominis muscle flaps in 36 patients. Outcomes of free muscle flap surgery were evaluated<br />

mainly by use of three dimensional gait analysis as well as dynamic podography and dynamic EMGs. The mean follow-up of these<br />

patients was 7.2 years ranging from 1 to 13 years. The values were compared with both the results of the intact foot of the patient and<br />

with the ones obtained from 20 healthy volunteer men (control group).Statistical analysis were per<strong>for</strong>med by Mann-Whitney U and<br />

Wilcoxon (non-parametric) tests.<br />

RESULTS:<br />

Most of the patients declared their satisfaction of having their own feet instead of prosthesis. 41 patients are still working without any<br />

difficulty <strong>for</strong> a mean of 3.4 years (range, 1 to 8 years). Chronic and repetitive ulcerations (24patients, 33%) and chronic discharge through<br />

the ulcer (20 patients, 27.8%) were found. The mean time of standing or walking per day was 2.85 hours <strong>for</strong> the rest of the patients.<br />

Dynamic pressure distribution tests revealed significantly higher pressure and load values on the injured feet of the patients than the<br />

control group(p


Complex Perineal and Groin Wound Reconstruction Using the Extended Dissection<br />

Technique of the Gracilis Flap<br />

Institution where the work was prepared: Georgetown University Hospital, Washington, DC, USA<br />

Joseph H. Dayan, MD; Patrick Curry; Chris E. Attinger, MD; Ivica Ducic, MD, PhD; Georgetown University Hospital<br />

BACKGROUND:<br />

The purpose of this paper is to review the applications of the extended dissection technique of the gracilis flap in a high risk patient<br />

population with complex wounds requiring more coverage than a standard gracilis flap may provide. To our knowledge, this is the first<br />

study applying the extended dissection technique as described by Hasen, et al, to pedicled gracilis flaps.<br />

METHODS:<br />

A chart review conducted from 2003 to 2006 identified 19 consecutive patients as having undergone an extended gracilis dissection.<br />

The technical details of this procedure are described.<br />

RESULTS:<br />

All reconstructions were successful. There was one complication presenting as a late infection at the donor site. Mean patient age was<br />

66 years old and nearly all patients had multiple significant comorbidities including diabetes, peripheral vascular disease, and/or radiation<br />

therapy.<br />

CONCLUSIONS:<br />

The extended-dissection technique <strong>for</strong> gracilis harvest has significant benefits <strong>for</strong> use in pedicled flaps including greater arc of rotation<br />

and no restriction on post-op ambulation or thigh abduction. These factors are particularly important in the challenging patient population<br />

represented in this study and add to the reliability and versatility of the gracilis flap. Anatomic illustrations <strong>for</strong> technical guidance<br />

in this procedure are also provided.<br />

Vascularization of the Flexor Hallucis Longus Muscle and Its Implication in Free Fibula Flap<br />

Transfer<br />

Institution where the work was prepared: KleinertKutz Institute, Louisville, KY, USA<br />

Paolo Sassu, MD1; Samir Mardini, MD2; Tuna Ozyurekoglu, MD1; J. Christopher Salgado, MD3; Steven Moran4;<br />

Robert D. Acland, MD5; (1)KleinertKutz Institute, (2)Mayo clinic Rochester, (3)Cooper University Hospital / U.M.D.N.J,<br />

(4)Mayo Clinic, (5)University of Louisville<br />

INTRODUCTION:<br />

Contracture as well as weakness of the flexor hallucis longus (FHL) are possible complications following harvest of the fibula flap.<br />

Clinically significant contracture when it occurs represents a major problem. Possible causes have been related to fibrotic change of the<br />

muscle either due to devascularization or compartment-like syndrome after a tight wound closure. Blood supply to the FHL is partially<br />

disturbed during harvest of the fibula flap. To what degree this occurs is not clear. The purpose of this study is to study the anatomy,<br />

vascularization, and nerve supply of the FHL muscle after fibula flap harvest in a fresh cadaver model.<br />

MATERIALS/METHODS:<br />

A vascularized fibula bone flap was harvested through a lateral approach in twenty fresh limbs. The popliteal artery was isolated and<br />

injected with 40cc of silicone injection compound. . Twenty-four hours later the FHL muscle was isolated and marked into four sections<br />

(one quarter of the entire length) using a marking pen. The vessels supplying the FHL and the nerve to the muscle were studied under<br />

microscopic visualization.<br />

RESULTS:<br />

The distal third and fourth part of the FHL muscle was always found to be located in a tight deep compartment.. The distal part of the<br />

peroneal artery was refilled by the silicone compound in 19 legs. In all specimens at least one branch was found to supply the distal<br />

fourth of the FHL. In all legs the posterior tibialis artery was refilled and an average of two branches were found to supply the muscle.<br />

In all dissections the nerve supplying the FHL originated from the tibialis nerve and its course was strictly close to the tibialis nerve with<br />

an average of three branches per<strong>for</strong>ating the muscle.. No branches of the nerves were injured during the dissection.<br />

CONCLUSIONS:<br />

After harvest of a fibula flap, the FHL muscle maintains adequate vascular supply through the distal portion of the peroneal artery and<br />

the posterior tibialis artery. Since there was no injury to the nerves supplying the FHL, this is unlikely to be a cause of any problems in<br />

clinical cases. The FHL is enclosed in a tight compartment and this may explain the occasional contracture seen in clinical cases. The<br />

results of this study require clinical correlation and lead us to believe that if contracture does occur it is most likely to be related to an<br />

increase in compartment pressure causing some ischemia of the muscle.<br />

166


The Distal Superficial Femoral Arterial (SFA) Branch to the Sartorius Muscle as Recipient<br />

Vessels <strong>for</strong> Peri-Knee Soft Tissue Reconstruction: Anatomic Study and Clinical Applications<br />

Institution where the work was prepared: University of Cali<strong>for</strong>nia, San Francisco, San Francisco, CA, USA<br />

Fernando Herrera, MD; University of Cali<strong>for</strong>nia, San Diego; Charles K. Lee, MD; University of Cali<strong>for</strong>nia, San Francisco<br />

(UCSF); Mark W. Kiehn, MD; University of Wisconsin; Scott Lee Hansen, MD; University of Cali<strong>for</strong>nia at San Francisco<br />

(UCSF)<br />

BACKGROUND:<br />

Soft tissue defects around the peri-knee and upper-third open tibial wounds present a significant challenge, particularly <strong>for</strong> large defects<br />

which frequently require free tissue transfer. Recipient vessels <strong>for</strong> this region include the femoral, popliteal, and other distal branches.<br />

Often times, these vessels are not optimal because of location or zone of injury. We describe a consistent recipient vessel choice <strong>for</strong><br />

microsurgical anastomosis, the distal SFA branch to the sartorius muscle (saphenous artery).<br />

MATERIALS/METHODS:<br />

4 fresh cadaver legs were dissected to identify the SFA branch to the sartorius muscle. Anatomic landmarks and measurements were<br />

taken to identify the takeoff point of the distal sartorius branch and caliber of vessel. A case series of peri-knee reconstruction is<br />

described to demonstrate its clinical utility<br />

RESULTS:<br />

The distal SFA branch was identified in all 4 cadaver specimens. The vessel takes off at 13cm (mean) proximal to the medial epicondyle<br />

of the femur. Mean diameter was 1.5mm. The vessel can be found through an incision over the adductor hiatus. Dissection is taken<br />

down to the superior border of the sartorius muscle and then posterior to the muscle. The branch to the muscle can be seen originating<br />

from the SFA and enters the muscle from its deep side, accompanying the saphenous nerve. 3 cases of successful lower extremity<br />

reconstruction with free tissue transfer and use of the distal SFA branch to the sartorius as recipient vessels are described. Venous outflow<br />

was established with the sartorius branch or saphenous vein.<br />

DISCUSSION:<br />

Vessel choices <strong>for</strong> free tissue transfer around the knee include the popliteal, the descending geniculate artery, the superior medial<br />

geniculate artery, the superficial femoral artery, and others. Recently, we have preferentially used the descending genicular vessels. In a<br />

number of cases these vessels were absent or inadequate and compelled us to search <strong>for</strong> another vessel option which gave similar<br />

advantages: consistent anatomy, good caliber vessels (>1.5mm diameter), proximal to the zone of injury, and a nearby saphenous vein<br />

<strong>for</strong> outflow. The distal SFA branch to the sartorius gives these advantages and appears to be more consistent.<br />

Trends in the Treatment of Severe Open Tibial Fractures<br />

Institution where the work was prepared: BG Trauma Center Ludwigshafen, Ludwigshafen, Germany<br />

Christoph Czermak; Emilios Nalbantis; Guenter Germann; Christoph Heitmann; University of Heidelberg<br />

INTRODUCTION:<br />

Treatment of severe open tibial fractures (Gustilo IIIb, IIIc) represent the classic interface between orthopedic and plastic surgery. This<br />

“orthoplastic” approach is currently considered the Standard of Care. “Fix and flap” within the first 72-96 hours has been postulated<br />

as “golden window“ in the treatment of these type of injuries. This retrospective study addresses the following questions: 1. Is the postulated<br />

“golden window” practicable in a Level III Trauma Center? 2. How does the interval between trauma and reconstruction influence<br />

the final outcome with respect to limb salvage? 3. Is limb salvage correlated to the type of flap employed? 4. Patient satisfaction<br />

with the functional and aesthetic result. 5. Options of secondary othopedic correction in correlation to the flap type.<br />

PATIENTS/METHODS:<br />

During a five year period, 92 patients with severe open tibial fractures underwent reconstruction using different types of free flaps.<br />

Twenty-five patients were primarily treated in our institution, 67 were secondary referrals after bone-reconstruction on outlying orthopedic<br />

units. There were 72 men and 20 women, mean age 46 years (10-79). Study parameters were: Interval between trauma and reconstruction,<br />

type of free flap, Hannover Functional Ability Questionaire, patient satisfaction, VAS, complications, limb salvage, secondary<br />

orthopedic approach, Cybex.<br />

RESULTS:<br />

The following free flaps were used <strong>for</strong> reconstruction: Latissimus dorsi (39), Gracilis muscle (16), Rectus abdominis muscle (2), ALT (32),<br />

Parascapular (2), Radial <strong>for</strong>earm (1), Lateral arm (1). 66 patients could be evaluated postoperative (71%). Flap survival rate was 91,4%. 5<br />

of 8 patients with total flap loss underwent reconstruction with a second free flap, three patients had lower leg amputation. Average<br />

interval between trauma and definitive wound closure was 18,6 (4-59) days. Mean score of FFbH was 72 (0-100), meaning a normal result.<br />

Regarding the functional results there were no significant differences between musculocutaneous and cutaneous free flaps. Aesthetical<br />

results of cutaneous flaps were superior compared to myocutaneous flaps.<br />

DISCUSSION:<br />

In none of our cases we could stay within the “golden window”. However, our data show that this had no significant influence on the<br />

rate of limb salvage. Complication rate in comparison to the literature is not significantly increased. This may partly due to the fact that<br />

the use of A-V loops to per<strong>for</strong>m the vascular anastomosis remote from the zone of injuy is liberal in our department. Cutaneous per<strong>for</strong>ator<br />

flaps proved to be superior with respect to aesthetics and simplification of secondary orthopedic procedures than myocutaneous<br />

flaps.<br />

167


Free Tissue Transfer <strong>for</strong> Complex Extremity War Injuries<br />

Institution where the work was prepared: The Microsurgery Unit, The Department of Plastic Surgery, Tel-Av, Tel-<br />

Aviv, Israel<br />

Arik Zaretski, MD; A. Amir; E. Arad; Y. Barnea; E. Miller; D. Leshem; J. Weiss; E. Gur; Sackler Faculty of Medicine, Tel-<br />

Aviv University<br />

BACKGROUND:<br />

War injury to the extremities due to blast or gunshot injuries are characterized by severe damage to both bony structures and soft tissue.<br />

The common finding is grade III - IV open fractures where concomitant vascular or neural injuries are frequent. The management<br />

of such complicated injuries remains a multi-disciplinary challenge to the orthopedic, vascular and plastic surgeon. If reconstruction is<br />

delayed <strong>for</strong> more than 48-72 hours, the risk of serious complications rises dramatically. We present a unique group of patients, transferred<br />

from The Palestinian Authority in Gaza Strip to Israel following failed initial treatment in Gaza, with highly complicated and infected<br />

open fractures of the limbs that where treated with free tissue transfer.<br />

PATIENTS/METHODS:<br />

Records were reviewed of patients transferred to our institution from Gaza from February 2006 until April 2007, <strong>for</strong> treatment of war<br />

injuries grade III open fractures of limbs. Included in this study were all patients that underwent limb salvage procedures using free tissue<br />

transfer.<br />

RESULTS:<br />

A total of ten patients were included. The etiology was blast injury in 5 patients (50%), gunshot injury in 4 patients (40%) and one patient<br />

was hit by a bulldozer (10%). Six patients presented with open tibial fractures (60%), Two had sever foot injury with exposed bones (20%),<br />

one (10%) had open fractures of the humerus, and 1 (10%) had palmar soft tissue defect. All patients had been initially treated in hospitals<br />

in Gaza, and were transferred to our hospital 3 days on average (range, 0.5-4 days) following trauma. Delayed reconstruction was<br />

achieved by microsurgical flaps in all patients included in the current study group. The flaps used where Gracilis muscle free flap (4),<br />

fibula osteo-septo-cutaneous flap (2), Latissimus dorsi muscle flap (2), tensor fascia lata muscle with iliac crest bone (1), tensor fascia lata<br />

myo-cutaneous flap (1) and vascularized fascia lata flap covered with full thickness skin graft (1). There where 3 re-explorations during<br />

the first 24 hours after surgery and one flap was lost. No mortalities were recorded.<br />

CONCLUSIONS:<br />

Limb preserving procedures should be considered <strong>for</strong> war injuries and grade III open fractures of limbs, even in cases that present late,<br />

with serious wound complications and osteomyelitis. A multidisciplinary approach focusing on proper revascularization, external skeletal<br />

fixation, debridement and control of infection, can achieve good conditions <strong>for</strong> delayed reconstruction. Microsurgical flaps play a<br />

pivotal role in delayed reconstruction of such complex injuries.<br />

168


Pedicled Per<strong>for</strong>ator Flaps of the Lower Leg: Cluster Analysis of Per<strong>for</strong>ator Locations and<br />

Clinical Application<br />

Institution where the work was prepared: UT Southwestern Medical Center at Dallas, Dallas, TX, USA<br />

M. Saint-Cyr, MD; Mark Schaverien; Gary Arbique; Spencer A Brown; Rod J Rohrich; UT Southwestern Medical Center<br />

at Dallas<br />

BACKGROUND:<br />

Pedicled per<strong>for</strong>ator flaps of the lower leg offer local reconstruction options with minimal donor site morbidity. This study maps all of the<br />

per<strong>for</strong>ators of the lower leg in order to determine predictable per<strong>for</strong>ator locations <strong>for</strong> reconstructive options in this region as well as<br />

further defining the venous drainage and contribution of the fascia to flap vascularity.<br />

METHODS:<br />

Twenty lower limbs harvested from fresh cadavers were used in the study. The popliteal artery was cannulated and injected with red<br />

latex, and dissection was per<strong>for</strong>med in a suprafascial <strong>plan</strong>e and the location of per<strong>for</strong>ators of diameter greater than 0.5mm was recorded.<br />

The location of the anterior tibial, posterior tibial, and peroneal arteries were recorded from the intermalleolar line. Sural artery per<strong>for</strong>ators<br />

were recorded as grid locations from the intersection of the popliteal crease with the septum between the heads of gastrocnemius.<br />

Per<strong>for</strong>ators were followed back to their source arteries, the per<strong>for</strong>ator length was measured. Cluster analysis of the per<strong>for</strong>ator<br />

location was per<strong>for</strong>med.<br />

RESULTS:<br />

Cluster analysis revealed that reliable per<strong>for</strong>ators locations from the posterior tibial, anterior tibial, and peroneal arteries could be found<br />

within 5cm intervals. At 4 to 8cm from the intermalleolar line per<strong>for</strong>ators from the anterior tibial and posterior tibial arteries could be<br />

found. In the 13 to 17cm interval a reliable peroneal artery per<strong>for</strong>ator and posterior tibial artery per<strong>for</strong>ator could be found, and at the<br />

21 to 25cm interval reliable per<strong>for</strong>ators could be found from the anterior tibial and posterior tibial arteries. The posterior tibial artery<br />

per<strong>for</strong>ators were found to be the largest and easiest to dissect. 44 percent of per<strong>for</strong>ators from the medial sural artery were found in a<br />

cluster 7 to 9cm distal to the popliteal crease within 2.5cm of the intermuscular septum. Injection of per<strong>for</strong>ators from each source artery<br />

with dye pre- and post-fascial harvest revealed that the fascia plays a significant role in the perfusion of per<strong>for</strong>ator flaps in the lower leg.<br />

CONCLUSIONS:<br />

The per<strong>for</strong>ators of the arteries of the lower leg can be found in predictable locations, aiding in the design of pedicled per<strong>for</strong>ator flaps.<br />

Of these the posterior tibial artery per<strong>for</strong>ators were found to be the largest and easiest to dissect. Studies of the contribution of the fascia<br />

to vascularity suggest that the fascia is important in the vascularity of per<strong>for</strong>ator flaps of the lower leg.<br />

Figure 1. Latex injection of the posterior tibial artery per<strong>for</strong>ators and venae comitantes.<br />

169


Aesthetic Per<strong>for</strong>ator Free Flap <strong>for</strong> Soft Tissue Restoration<br />

Institution where the work was prepared: Samsung Medical Center, Seoul, South Korea<br />

Goo-Hyun Mun, MD; Jai-Kyung Pyon; Samsung Medical Center<br />

PURPOSE:<br />

By the increased capability of customized flap tailoring and markedly reduced donor site morbidity with the introduction of per<strong>for</strong>ator<br />

flaps, it is now able to fulfill both functional and aesthetical requirements more so than in the past. As previous approaches with this<br />

concept were mostly limited to the reconstruction of the face or the breast, we are now to introduce authors' cases of elective surgery<br />

<strong>for</strong> soft tissue restoration in the non-facial region using the concept of aesthetic free flaps.<br />

METHODS:<br />

From March 2006 to May 2007, 10 free flap transfers were per<strong>for</strong>med in 10 patients <strong>for</strong> aesthetic purposes of the restoration of soft tissue<br />

and/or skin. Reconstruction of the lower extremity was in 6 cases, the upper extremity in 2 cases, the neck and buttock each in 1<br />

case. The patient group was composed of 7 females and 3 males, and age ranged from 14 to 59 years (mean: 31.9 years). After the<br />

utmost important step of recreation of the actual soft tissue defect, precise designing and elevation of the flap was followed by microsurgical<br />

vascular anastomosis and elaborate flap insetting with thickness control.<br />

RESULTS:<br />

Among the 10 cases, the deep inferior epigastric artery per<strong>for</strong>ator (DIEP) free flap was transferred in 6 cases and the thoracodorsal artery<br />

per<strong>for</strong>ator (TDAP) free flap in the 4 cases. Flap sizes ranged from 34 x 20 cm to 18 x 5 cm. All 10 flaps were successfully transferred without<br />

any flap loss. The operative results were able to meet the aesthetic demands of the patients. Further corrections such as debulking<br />

were needed in a patient.<br />

CONCLUSIONS:<br />

With the continuing refinements in per<strong>for</strong>ator flap surgery, microsurgical tissue transfer has become more readily considered armamentarium<br />

in expanded application. Established soft tissue deficit in the non-facial regions developed by the trauma, infection or previous<br />

surgery could be restored to meet the high cosmetic demands of the patients. Aesthetic per<strong>for</strong>ator free flap would be a valuable option<br />

in restoration of soft tissue in various parts of body.<br />

Reconstruction of Segmental Femoral Defects with Living Bone Allografts Combined with<br />

Host-derived Neoangiogenesis: Mechanical, Histologic and Radiographic Analysis<br />

Institution where the work was prepared: Dept. of Orthopedic Surg., Microvasc. Research Lab., Mayo Clinic,<br />

Rochester, MN, USA<br />

Goetz A. Giessler, MD; Patricia F. Friedrich; Allen T. Bishop, MD; Department of Orthopedic Surgery, Mayo Clinic<br />

Living musculoskeletal allografts currently require long-term immunosuppression to maintain viability, impractical due to associated<br />

risks <strong>for</strong> non-life-critical tissue trans<strong>plan</strong>tation. We have previously demonstrated an alternative method using im<strong>plan</strong>ted host-derived<br />

vessels to replace the allogeneic nutrient circulation. These vessels maintain measurable blood flow, generate extensive neoangiogeneic<br />

capillaries and <strong>for</strong>m new bone when combined with short-term immunosuppression. In this study, we have used this method to reconstruct<br />

large segmental femoral defects. A segmental femoral defect was created in Dutch-Belted rabbits. Reconstruction was per<strong>for</strong>med<br />

using a free vascularized allogeneic femoral diaphyseal trans<strong>plan</strong>t from a New Zealand White rabbit. Rigid fixation allowing<br />

immediate full weight-bearing was per<strong>for</strong>med. In addition to microvascular repair of the nutrient artery circulation, a pedicled inferior<br />

epigastric fascial flap was placed within the medullary canal. Survival time was 16 weeks. Five groups of 10 Dutch-Belted rabbits each<br />

included a pedicled autograft control group, and four allograft groups which varied in fascial flap patency (patent or ligated) and<br />

immunosuppression with 0.08 mg/kg Tacrolimus (+ or -). Healing was quantified by X-ray. Microangiography and Spalteholz bone clearing<br />

allowed quantification of neoangiogenesis. Mechanical properties were evaluated using 4-point bending. Quantitative histomorphometry<br />

assessed bone remodeling. X-ray analysis using a grading schema demonstrated an equivalent healing response when autograft<br />

controls were compared to immunosuppressed allografts with patent fascial flaps. The latter group demonstrated<br />

roentgenograms of faster healing as well as the lowest relative ultimate strength and elastic modulus values of all groups. This is an indication<br />

of biologic activity, including a greater blood supply and a higher rate of bone remodeling than other groups. It correlated with<br />

findings from microangiography (the highest amount of neoangiogenesis among all groups) and histomorphometric analysis of bone<br />

turnover. Not surprisingly, the lowest angiogenesis and bone remodeling values were found in the non-immunosuppressed allograft<br />

femurs with a ligated intramedullary flap. Surgical angiogenesis from host-derived fascial flaps can provide greater blood flow and<br />

improved rates/grading of healing in immunosuppressed allogeneic bone trans<strong>plan</strong>ts than other groups. Material properties of this<br />

group were also less than the other groups. Thus, while the vascularized tissue allotrans<strong>plan</strong>ts treated with immunosuppression and fascial<br />

flap im<strong>plan</strong>tation maintained flow and viability at levels higher than other groups, we found this to weaken the graft more as well.<br />

As the demonstrated active bone turnover ultimately replaces the graft with host-derived cells, this process in the long-term may result<br />

in a more stable graft with minor rejection.<br />

170


ASRM SCIENTIFIC PAPER PRESENTATIONS: RESEARCH<br />

Reduction of the Immunological Rejection in Composite Tissue Allotrans<strong>plan</strong>tation by Heat<br />

Stress Preconditioning<br />

Institution where the work was prepared: <strong>Hand</strong>-, Plastic and Reconstructive Surgery, BG Trauma Center,<br />

Ludwigshafen, Germany<br />

Nina Ofer, resident; Michael Sauerbier; Guenter Germann; BG Trauma Center<br />

The outcome of composite tissue allotrans<strong>plan</strong>tations can be improved by reduction of ischemia reperfusion injury and graft rejection.<br />

Heat shock proteins are produced as a reaction of the body during a stress situation. Once elevated they protect against a second stress<br />

event. The purpose of the study was to examine the immunological rejection in a rat model of composite tissue allotrans<strong>plan</strong>tation and<br />

to evaluate the effect of preconditioning by heat stress exposure prior to limb trans<strong>plan</strong>tation. Brown Norway rats were systemically<br />

heated to a body temperature of 43°C in order to upregulate heat shock protein 70 (HSP70). The expression of HSP70 - measured by<br />

western blot analysis - showed a peak after 24 hrs. Hindlimb trans<strong>plan</strong>tations were per<strong>for</strong>med between Brown Norway rats and Lewis<br />

rats. Group 1 (n=10) was exposed to heat stress 24 hrs prior to trans<strong>plan</strong>tation. In group 2 (n=10) the trans<strong>plan</strong>tation was per<strong>for</strong>med<br />

without heat shock pre-conditioning. Postoperatively, the trans<strong>plan</strong>ted hindlimb was evaluated clinically every twelve hours. The beginning<br />

of the immunological rejection was defined when erythema, foot edema and hardening of the hindlimb could be observed at the<br />

same time. At this time the rat was sacrificed and hindlimb muscle samples were taken <strong>for</strong> an histological assessment. The rejection in<br />

group 1 occured after five days on average, whereas the graft rejection in group 2 was observed after four days. The difference was significant<br />

(Whitney-Mann-U-Test: p


Swine Hemi-facial Composite Tissue Trans<strong>plan</strong>tation: A Preclinical Large Animal Model<br />

Institution where the work was prepared: Chang Gung Memorial Hospital –Kaohsiung Medical Center, Kaohsiung,<br />

Taiwan<br />

Yur-Ren Kuo, MD, PhD, FACS; Nai-Siong Kueh, MD; Wen-Sheng Wu; Chien-Chih Lin; Chong-Wei Huang; Yuan-Cheng<br />

Chiang; Chang Gung Memorial Hospital- Kaohsiung Medical Center, Chang Gung University<br />

BACKGROUND:<br />

Partial face composite tissue allo-trans<strong>plan</strong>tation (CTA) was recently achieved in a human subject. However, application of CTA is limited<br />

by the risk of side effects caused by long-term high-dose immunosuppression. This preliminary study investigated the reproducibility<br />

of swine hemi-facial trans<strong>plan</strong>tation <strong>for</strong> pre-clinical studies.<br />

METHODS:<br />

Twelve out-bred miniature swine underwent hemi-facial trans<strong>plan</strong>t. The hemi-facial orthotopic trans<strong>plan</strong>t consisted of ear cartilage,<br />

muscle with surrounding hemi-facial skin paddle supplied by the carotid artery and external jugular vein trans<strong>plan</strong>ted to recipient swine.<br />

Two different experimental designs were studied. Group I: autologous hemi-facial trans<strong>plan</strong>tation as a normal control; group II: hemifacial<br />

allo-trans<strong>plan</strong>tation without treatment. Swine viability and rejection signs of allograft were monitored postoperatively.<br />

RESULTS:<br />

The recipient swine were ambulatory immediately following surgery. Survival following autologous hemi-facial trans<strong>plan</strong>t was 100 percent<br />

and indefinite until sacrifice. The allo-trans<strong>plan</strong>ts showed swelling but no visible signs of rejection over the first four days of observation.<br />

The allo-skin paddle appeared blue–purple and edematous on postoperative days 5 to 7 and progressed to tissue necrosis and<br />

rejection at postoperative days 8 to 14.<br />

CONCLUSION:<br />

The experimental results revealed this swine hemi-facial trans<strong>plan</strong>tation model is reproducible and suitable <strong>for</strong> pre-clinical training and<br />

offers a new immuno-suppression strategy toward human facial allo-trans<strong>plan</strong>tation.<br />

Comparison between Cyclosporine A and Tacrolimus in Vascularized Bone Marrow<br />

Trans<strong>plan</strong>tation <strong>for</strong> Inducing Composite Tissue Allotrans<strong>plan</strong>tation Tolerance with Non-<br />

Myeloablative Conditioning<br />

Institution where the work was prepared: Wei-Chao Huang, Taoyuan, Taiwan<br />

Wai-Chao Huang1; Nai-Jen Chang, yes2; Jeng-Yee Lin, MD1; Christopher Glenn Wallace, MD3; Fu-Chan Wei2;<br />

(1)Chang Gung Memorial Hospital, (2)Chang-Gung Memorial Hospital, (3)Chang Gung Memorial Hospital, Chang<br />

Gung University and Medical College<br />

INTRODUCTION:<br />

Cyclosporine A (CsA) and tacrolimus, both calcineurin inhibitors, are immunosuppressant commonly used <strong>for</strong> trans<strong>plan</strong>tations. Previous<br />

studies showed that tacrolimus combined with anti-lymphocyte serum (ALS) could induce mixed chimerism (MC) and tolerance to composite<br />

tissue allotrans<strong>plan</strong>tation (CTA) with non-myeloablative conditioning. Here we compare the efficiency of CsA and tacrolimus <strong>for</strong><br />

tolerance induction in rat CTA.<br />

METHODS:<br />

Male 8-12 week-old donor Brown Norway rats (RT1An) and recipient Lewis rats (RT1A1l) were divided into 6 Groups. Group I: CsA treatment<br />

but no total body irradiation (TBI); Group II: CsA treatment and 200 cGy TBI; Group III: CsA and 400 cGy TBI; Group IV: tacrolimus<br />

treatment but no TBI; Group V: tacrolimus and 200 cGy TBI; Group VI: tacrolimus and 400 cGy TBI. Groups I, II and III received 16 mg/kg<br />

CsA (Days 0-10; 11 doses) and 5 mg ALS on Days 1 and 10. Groups IV, V and VI received 1mg/kg tacrolimus (Days 0-10; 11 doses) and<br />

5 mg ALS on Days 1 and 10. Groups II, III, V and VI received TBI the day be<strong>for</strong>e CTA. Recipients were trans<strong>plan</strong>ted with heterotopic<br />

hindlimb osteomyocutaneous (HHOMC) CTA on Day 0. Body weight and CTA rejection were assessed postoperatively. Chimerism levels<br />

and multi-lineage cells were determined by flow cytometry, 14, 30, 60, 90, 120 and 150 days post-CTA.<br />

RESULTS:<br />

Graft versus Host disease did not occur. CTA survival in recipients treated with CsA was significantly prolonged compared to receipients<br />

treated with tacrolimus. CTA acceptance rates were: 0% in Group I, 28 % in Group III, 80 % in Group III, 0 % in Group IV, 0 % in<br />

Group V and 16 % in Group VI. Chimerism levels after CTA were proportional to the TBI dose. Hematopoietic stem cells from HHOMC<br />

CTA created MC averaging 2.6 % in Group I, 4.2 % in Group II, 15.9 % in Group III, 1.4 % in Group IV, 3.7 % in Group V and 13.1 % in<br />

Group VI.<br />

CONCLUSIONS:<br />

CsA or tacrolimus with non-myeloablative conditioning created MC without significant difference, but recipients treated with CsA displayed<br />

a higher percentage of CTA acceptance than those treated with tacrolimus. Although tacrolimus is used to prevent CTA rejection,<br />

these findings suggest that CsA is more likely to induce CTA tolerance than tacrolimus.<br />

172


In Vivo and In Vitro Evidence that Intrajejunal Administration of Fresh Donor Splenocytes<br />

Delays the Onset of Rejection of Hindlimb Composite Tissue Allotrans<strong>plan</strong>ts by Regulating<br />

Th1/Th2 Cytokines in Rats<br />

Institution where the work was prepared: Chang Gung Memorial Hospital and Chang Gung University, Taipei, Taiwan<br />

Christopher Glenn Wallace, MB, ChB, MRCS1; Chia-Hung Yen, PhD2; Hsiang-Chen Yang, MSc1; Chun-Yen Lin, MD,<br />

PhD1; Wei-Chao Huang1; Jeng-Yee Lin1; Fu-Chan Wei, MD, FACS1; (1)Chang Gung Memorial Hospital, Chang Gung<br />

University and Medical College, (2)National Pingtung University of Science and Technology<br />

INTRODUCTION:<br />

Jejunal mucosal tolerance was superior to oral tolerance in generating donor-specific hyporesponsiveness to cardiac allotrans<strong>plan</strong>ts in<br />

rats. We previously demonstrated that intrajejunal administration of fresh donor splenocytes (FDS) delayed onset of rejection of semiallogeneic<br />

hindlimb composite tissue allotrans<strong>plan</strong>ts (CTA) in rats, even without concurrent immunosuppressive drug therapy. We now<br />

report our investigations into the underlying mechanism.<br />

METHODOLOGY:<br />

Adult (8-10 weeks) male recipient Lewis (RT1l) and donor Lewis-Brown-Norway (LBN; RT1l+n) rats were used in this study. Percutaneous<br />

gastro-duodeno-jejunostomies were sited in all Lewis rats on Day -12. Lewis rats received either intrajejunal-FDS from LBN donors<br />

(5x107 cells; TREATED Group; n=12) or vehicle alone (HBSS only; SHAM Group; n=11) everyday on Days -9 through -3 (7 doses) and<br />

were sacrificed on Day 0 <strong>for</strong> one-way mixed lymphocyte reaction (MLR). Other Lewis rats received heterotopic LBN hindlimb CTAs on<br />

Day 0, and received intrajejunal-FDS from LBN donors (5x107 cells; TREATED/CTA Group; n=8) or vehicle alone (HBSS only; SHAM/CTA<br />

Group; n=5) everyday from Day -9 until completion of CTA rejection. Immunosuppressive drugs were never administered. Cytokine levels<br />

were determined by ELISA (TGF-beta) or flow cytometric bead arrays (IL4, IL10, IFN-Gamma, TNF-alpha) in one-way MLR supernatants<br />

(obtained after 72 hours co-culture) and in sera obtained from CTA recipients on Day +7 post-trans<strong>plan</strong>t.<br />

RESULTS:<br />

IL10 (p


The Gene Expression Profiling of Ischemia-Reperfusion injury in Rat Kidney, Small Intestine,<br />

and Cremasteric Muscle Model by DNA Microarray<br />

Institution where the work was prepared: Chang Nai-Jen, Taoyuan, Taiwan<br />

Nai-Jen Chang, yes; See-Tong Pang; Fu-Chan Wei; Chang-Gung Memorial Hospital<br />

BACKGROUND:<br />

Ischemia-reperfusion (I/R) injury is inevitable to cause tissue damage and leading to graft failure. Although susceptibility of various tissues<br />

to I/R injury has been demonstrated, the detailed mechanism is not fully elucidated. DNA microarray is a powerful tool to detect<br />

whole genome of the molecular changes during I/R injury. Here we compared the gene expression profile of I/R injury using kidney,<br />

intestine, and cremasteric muscle model in rats.<br />

METHODS:<br />

45 male Lewis rats ranging from 270 to 330 gw were randomly assigned to one of 9 groups with an equal number in each group (n=5)<br />

and prepared <strong>for</strong> the study. Left kidney, small intestine, and cremasteric muscle were prepared <strong>for</strong> I/R pedicle. In each model, the group<br />

I is the time controlled group without ischemic insult. The group II had ischemic <strong>for</strong> 60 minutes. The group III had ischemic <strong>for</strong> 60 minutes<br />

plus 60 minutes reperfusion. Extracted total RNA was used to probe the whole rat genome oligo array and the novel genes were<br />

confirmed by real-time PCR.<br />

RESULTS:<br />

Gene expression profiling of the kidney, small intestine, and cremasteric muscle during I/R injury were per<strong>for</strong>med. 23465 genes included<br />

in our studies. After 60 minutes ischemia plus 60 minutes reperfusion, 654, 162, 776 genes were 2-folds up-regulated whereas 129,<br />

518, 4837 genes 2-folds down-regulated in kidney, small intestine, and cremasteric muscle individually. There were no common gene<br />

2-folds up-regulated in all three models during the reperfusion stage. Among the genes, we further identified activating protein-1(AP-<br />

1), an important transcription factor. We found the expression of the AP-1 subunits were extremely high in renal and intestinal but downregulated<br />

in muscle model, such as Fra-2 (18.75/17.33/0.24 folds), activating transcription factor 3 (ATF3) (13.26/5.77/0.26 folds).<br />

CONCLUSION:<br />

AP-1 expresses during cell stress and mediated in many biological pathways. The activation of AP-1 bases on the shifting conjugation<br />

from [Jun]-[Jun] homodimer to [Jun]-[Fos] and [Jun]-[ATF3] heterodimers and activate the JNK and p38 ERK pathways (belong to MAPK<br />

kinase pathway) individually. The dynamic balance of the two pathways may be important in determining whether a cell survives or<br />

undergoes apoptosis. Ap-1 presented with up-regulation in kidney and intestine whereas down regulation after I/R insult may due to<br />

the longer ischemic-tolerance of skeletal muscle. The specific role and the related pathway related to the I/R injury between these three<br />

organs will be further analyzed.<br />

Aged Donor Bone Marrow Influcences Mixed Chimerism and Donor-specific Tolerance to<br />

Composite Tissue Allotrans<strong>plan</strong>tation with Nonmyeloablative Conditioning<br />

Institution where the work was prepared: Chang Gung Memorial Hospital, Taipei, Taiwan<br />

Jeng-Yee Lin, MD; Wei-Chao Huang; David C.C. Chuang; Fu-Chan Wei; Chang Gung Memorial Hospital<br />

BACKGROUND:<br />

Allogeneic trans<strong>plan</strong>tation with aged donor organ or tissue is associated with a higher acute rejection rate or delayed organ dysfunction.<br />

The purpose of this study is to investigate if composite tissue allotrans<strong>plan</strong>tation (CTA) through mixed chimerism with aged donor<br />

bone marrow trans<strong>plan</strong>tation faces a lower engraftment rate, lower mixed chimerism or higher CTA rejection rate.<br />

MATERIAL/METHODS:<br />

Twelve male (6-to-10-week old) and Lewis (LEW) rats (RTA1l) were equally categorized into two groups as recipients. Male Brown Norway<br />

rats (RTA1c) were the donors. Group I recipients were trans<strong>plan</strong>ted with100 x 106 · ‚ -TCR+ and Á &delta-TCR+ T-cell depleted bone<br />

marrow (BM) cells from 8-to-10-week-old Brown Norway (BN) rats. Group II recipients were trans<strong>plan</strong>ted with same number of T-cell<br />

depleted BM cells from 14-to-16-month-old BN rats. Recipient rats were irradiated with 400cGy total body irradiation one day be<strong>for</strong>e<br />

BMT and treated with one dose of 5 mg antilymphocyte serum (ALS) intraperitoneally (IP) one day be<strong>for</strong>e BMT, cyclosporine 16 mg/kg/d<br />

from days 0 to 10 and one dose of 5 mg ALS, IP ten days after BMT. In both groups, the hindlimb osteomyocutaneous flap allotrans<strong>plan</strong>tation<br />

(BN„? mixed chimera rat) was done 28 days after bone marrow trans<strong>plan</strong>tation (BN„?LEW). Chimerism level and multilineage<br />

were assessed by flowcytometry 15, 30, 60, 120, and 150 days following BMT. The percentage of the facilitating cells (CD8+, · ‚-<br />

TCR-, Á &delta -TCR-), and hemopoietic stem cells (SSClow, ALDFlourbright) in lymphoid gate were checked in donor BM cells.<br />

RESULTS:<br />

Recipients in both groups were 100 % engrafted with donor BM. The chimerism level in each group 28 days after BMT were as follows:<br />

Group I: 50 %. Group II: 7%. The graft tolerance rate in Group I (80%) was significantly higher than in Group II (0%). The percentage of<br />

facilitating cells in lymphoid gate were found to be higher in 6-to-10-week-old donor BM cells than in 12-to-16-month-old BM cells while<br />

the percentage of hemopoietic stem cells were the same in two different age donor BM cells.<br />

CONCLUSION:<br />

Significantly lower mixed chimerism level and allograft tolerance rate were found in CTA through BMT with aged donor BM cells. Lower<br />

mixed chiemrism level is probably associated with a lower percentage of facilitating cells rather than stem cells in the aged donor BM<br />

cells.<br />

174


Quantitative Evaluation of the Dilation of Rat Femoral Vessels Following Application of<br />

Topical Botulinum Toxin<br />

Institution where the work was prepared: University of Virginia, Charlottesville, VA, USA<br />

Peter B. Arnold, MD, PhD1; Christopher A. Campbell1; David B. Drake1; Wyndell H. Merritt, MD2; George T.<br />

Rodeheaver1; Raymond F. Morgan1; (1)University of Virginia, (2)Wyndell H. Merritt, M.D<br />

INTRODUCTION:<br />

The topical application of Botulinum Toxin-A (BTX) to digital blood vessels has been described as a useful, non-surgical adjunct <strong>for</strong> the<br />

treatment of digital pain and ulceration resulting from peripheral vasospastic disease. However, quantitative results of this application<br />

with respect to blood flow or vessel dimensions have not been documented. Our study attempts to demonstrate that topically applied<br />

BTX increases the diameter of blood vessels, potentially increasing flow through the dilated segments.<br />

METHODS:<br />

Bilateral femoral artery and vein cutdowns were per<strong>for</strong>med on six adult Sprague-Dawley rats under inhalational anesthesia. The femoral<br />

artery and vein were identified and individually dissected free from surrounding tissue under the operating microscope. A background<br />

micrometer was placed behind the vessels and two marking sutures were placed to identify the area of treatment. Ten units of BTX,<br />

reconstituted with sterile saline, were then applied to the external surface of the vessels. An equivalent volume of sterile saline was<br />

applied to the contralateral side. Digital images of the vessels were obtained be<strong>for</strong>e and immediately after application of the topical<br />

agents, and again on postoperative days (POD) one and fourteen. The overlying skin was closed with interrupted nonabsorbable suture<br />

and the animals recovered after each anesthetic. Average vessel diameter was measured with an image analysis software package following<br />

calibration to the micrometer in each image. Multivariate analysis of variance was per<strong>for</strong>med <strong>for</strong> average BTX treated vessel<br />

diameter compared to control at individual time points, and <strong>for</strong> each study group over time, with Bonferroni post hoc analysis.<br />

RESULTS:<br />

Average vein and artery diameters were equivalent at baseline and immediately after application of BTX and saline. The BTX treated<br />

artery was visibly larger than the control artery on POD 1, and reached significance by POD 14, (p


Impact of Hypertonic and Hyperoncotic Saline Solutions on Ischemia-Reperfusion Injury in<br />

Free Flaps in Rats<br />

Institution where the work was prepared: Aesthetic and Plastic Surgery Institute, UCI, Orange, CA, USA<br />

Thomas Scholz, MD; Gregory R. D. Evans; University of Cali<strong>for</strong>nia, Irvine<br />

BACKGROUND:<br />

The purpose of this study was to evaluate the influence of hypertonic and hyperoncotic saline solutions on the ischemia/reperfusion<br />

injury after free tissue transfer.<br />

MATERIALS/METHODS:<br />

Twenty eight Sprage Dawley rats were divided into four groups (n = 7). An inferior epigastric flap was designed in the left groin region.<br />

Directly after skin incision microcirculation was investigated using the orthogonal polarization spectral imaging technique. A free tissue<br />

transfer of the inferior epigastric flap was per<strong>for</strong>med to the right groin region. In group A 1ml of 7.5% hypertonic saline solution (HS)<br />

was administered to the flap via the inferior epigastric artery at reperfusion. Group B, C, and D received 6% Dextran-70 (DS), a HS and<br />

DS mixture, and isotonic saline solution respectively. Evaluation of the flap microcirculation was again per<strong>for</strong>med at reperfusion, 10, 20,<br />

and 40 minutes later. Flap survival was determined by measurement of viable area of the flap divided by total flap area at day 2. The<br />

results were analysed with a two tailed Rank Sum Test (Mann-Whitney).<br />

RESULTS:<br />

The control group (group D) showed a decline in blood cell velocity (BCV) to 30 +/- 10% of baseline values within the first 40 minutes<br />

of flap reperfusion. Furthermore, arterial vessel diameter (AVD), venous vessel diameter (VVD), and functional capillary density (FCD)<br />

was decreased in this group by 65 +/- 5%, 71 +/- 9%, and 56 +/- 7% respectively. Group A, B and C demonstrated a BCV of 100 +/-<br />

15%, 67 +/- 22%, and 119 +/- 9%, an AVD of 91 +/- 7%, 51 +/- 5%, and 103 +/- 5%, and a FCD of 91 +/- 6%, 46 +/- 7%, and 97 +/- 4%<br />

respectively when compared to baseline values. At day 2 flap survival was decreased in group A by 12.7 +/- 9.2%, in group B by 32.8<br />

+/- 14.2%, in group C by 3.9 +/- 8.9%, and in group D by 41 +/- 12.2%. Group A and C showed statistically significant differences when<br />

compared to group D <strong>for</strong> BCV, AVD, VVD,FCD, and flap survival.<br />

CONCLUSION:<br />

We assume that local administration of soft tissues with HS combined with DS improves microcirculatory disturbances upon reperfusion<br />

and increases overall flap survival. These data demonstrate that a positive influence on no-reflow mechanisms is possible by extensive fluid<br />

shifts on the level of microcirculation. This procedure is easily applicable in a clinical setting and may hold a high cost effectiveness.<br />

The Effect of Ischaemia Time on Acute Rejection of Composite Tissue Allotrans<strong>plan</strong>tation in<br />

Rat Model<br />

Institution where the work was prepared: Duke University Medical Center, Durham, NC, USA<br />

Yee Siang Ong, MRCS, (Edin); Yi Xin Zhang; Alessio Baccarani; Keith E. Follmar; Caroline Messmer; Bruce Klitzmann;<br />

Detlev Erdmann; L. Scott Levin; Duke University<br />

OBJECTIVE:<br />

Composite tissue allotrans<strong>plan</strong>tation (CTA) has now become a clinical reality but several questions about its immunology remain unanswered.<br />

Ischaemia time is an important determinant of survival of trans<strong>plan</strong>ted tissues. Our study aime to evaluate the effect of<br />

ischaemia time on severity of acute rejection in composite tissue allotrans<strong>plan</strong>ts.<br />

MATERIALS/METHODS:<br />

Vascularised epigastric flaps consistiing of skin, subcutaneous tissue and muscle were trans<strong>plan</strong>ted from male WKY rats to female F344<br />

rats. To keep ischaemia time as the only variable in the study, no immunosupressive theray was given. A total of 10 rats were divided<br />

into 2 groups. Group A (n=5) had ischaemia time of 1 hour while the Group B had ischaemia time of 3 hours. All the flaps were biopsied<br />

at 6 days and 13 days post- trans<strong>plan</strong>tation. They were then stained with hematoxylin and eosin and the severity of the acute rejection<br />

graded using criteria like perivascular lympocytic infiltrates, epidermal infiltrates, stromal infiltrates, eosinophils, spongiosis and<br />

endothelial plumping.<br />

RESULTS:<br />

Gross signs of early rejection like erythema, macular rash and edema were observed as early as 6 days and the flap was completely<br />

rejected by 13 days post- trans<strong>plan</strong>t. Histologically, a moderate acute rejection was seen in both groups at day 6. Greater than 50% of<br />

the vessels showed perovascular infiltrates that were accompanied by epidermal infiltrates and stromal inflammation. There was no<br />

spongiosis, endothelial plumping, eosinophils and large lymphocytes. More lymphocytes were seen at the epidermal and dermal junction<br />

in Group B compared to Group A but the difference was not statistically significant (p>0.05). All the other criteria were similar in<br />

both groups. At day 13, severe acute rejection was seen in both groups and no difference in histological examination.<br />

CONCLUSION:<br />

There is very little correlation between gross signs and histological grade of acute rejection. Based on analysis of these two parameters,<br />

there was no significant difference in severity of acute rejection with 1 and 3 hour ischaemia time in a rat model.<br />

176


Targeted Motor Reinnervation of the Rabbit Rectus Abdominis: a Single Muscle Can Receive<br />

and Distinguish Three Independent Nerve Inputs<br />

Institution where the work was prepared: Northwestern University, Feinberg School of Medicine, Chicago, IL, USA<br />

Peter S. Kim, MD1; Kristina O'Shaughnessy, MD1; Todd A. Kuiken, MD, PhD2; Gregory A. Dumanian1; (1)Northwestern<br />

University, Feinberg School of Medicine, (2)Rehabilitation Institute of Chicago<br />

BACKGROUND:<br />

Current myoelectric prostheses are limited at the patient-prosthetic interface, lacking means <strong>for</strong> intuitive, rapid simultaneous prosthetic<br />

joint movements. Targeted motor reinnervation (TMR) is a new method of rerouting the signals in existing amputated nerves to surrounding<br />

musculature which thereby amplifies these signals. Until now, nerve transfers <strong>for</strong> the improved control of myoelectric prostheses<br />

have only been per<strong>for</strong>med in humans. This study investigates the feasibility of TMR of the rabbit rectus abdominis (RA) as a means<br />

to better study this surgical technique and to investigate areas <strong>for</strong> technical advances.<br />

METHOD:<br />

After approval by our institutional Animal Care and Use Committee, 3 New Zealand white rabbits underwent a <strong>for</strong>elimb amputation<br />

with preservation of the proximal median, radial and ulnar nerves. In a second stage operation, an inferiorly based rectus abdominis<br />

flap was created and transposed onto the ventral chest wall. A neurorrhaphy was made between the median, radial, ulnar nerves and<br />

three motor nerves innervating 3 distinct muscle bellies of the RA. After 10 weeks, the electrophysiologic properties of the reinnervated<br />

flap were investigated prior to harvest. Specific muscle bellies also underwent glycogen depletion to further demonstrate discrete,<br />

segmental innervation of the RA muscle bellies.<br />

RESULTS:<br />

Of the 9 total TMRs per<strong>for</strong>med in 3 rabbits, 7 were grossly successful. Except in one rabbit, each single muscle flap was able to be reinnervated<br />

by three different nerves that previously had served the <strong>for</strong>elimb. Muscle surface electromyographic data demonstrate that<br />

the innervation of the RA retains its segmental nature after TMR. A logarithmic loss of electromyographic amplitude was noted in signals<br />

crossing into adjacent muscle outside the area of the active contraction. These results are similar to those observed in the uninjured<br />

rabbit RA controls. Similarly, prolonged stimulation of a nerve reinnervating the RA results in the loss of glycogen isolated to the<br />

territory of the muscle stimulated by that nerve.<br />

CONCLUSION:<br />

This study demonstrates that the RA can safely and reliably undergo TMR in the rabbit and that the reinnervated muscle bellies are<br />

electrically discrete entities. There<strong>for</strong>e, by using a clinically proven muscle flap, several myoneurosomes may be created to help drive<br />

increasingly complex myoelectric prostheses and to further improve the patient-prosthetic interface.<br />

Donor-Recipient Bone Marrow Cells Fusion as a Novel Therapy <strong>for</strong> CTA Trans<strong>plan</strong>ts<br />

Institution where the work was prepared: Cleveland Clinic, Cleveland, OH, USA<br />

Wioleta Luszczek, PhD; Earl Poptic; Serdar Nasir; Aleksandra Klimczak; Lukasz Krokowicz; Maria Siemionow; Cleveland Clinic<br />

INTRODUCTION:<br />

The aim of this study was to create ex vivo, a new generation of chimeric cells by donor-recipient cell fusion.<br />

METHODS:<br />

Bone marrow cells (BMC) were isolated from ACI (RT1a) donors and LEW (RT1l) recipients. Following harvesting, donor and recipients<br />

BMC were stained respectively with green PKH67-GL and red PKH26-GL dye. ACI (RT1a) and LEW (RT1l) stained BMC were fused by<br />

standard Poly-(ethylene-glycol) method. Ex vivo fused chimeric cells (RT1a/RT1l) were purified by FACS-sorting sorting using doublefluorescent<br />

dye. Efficacy of purification was evaluated by immunofluorescence microscopy. PCR-SSP (polymerase chain reactionsequence<br />

specific primers) method was used to confirm chimerism. Colony-<strong>for</strong>ming-units (CFU) assessed clonogenic potential.<br />

Kariotype analysis was per<strong>for</strong>med to confirm polyploidy of the fused chimertic cells. Purified chimeric cells (1.3x106– 2.0x106) were trans<strong>plan</strong>ted<br />

by direct intraosseous injection to five naïve LEW recipients to assess engraftment and migratory potential.<br />

RESULTS:<br />

Chimerism in peripheral blood was evaluated by flow cytometry. Immunofluorescence proved the presence of fused donor-recipient<br />

chimeric cells characterized by RT1a/RT1l phenotype which morphologicaly resembled heterokaryon and synkaryon. Kariotype confirmed<br />

polyploidy of fused cells and CFU assay established clonogenic capacity. PCR study allowed <strong>for</strong> detection of MHC class I genes<br />

characteristics <strong>for</strong> both the donor and the recipient in genetic material isolated from fused RT1a/RT1l cells. 7 day after trans<strong>plan</strong>tation<br />

of fused chimeric cells total chimerism in blood ranged between 1.2-4.58% and at day 21, between 2.54-4.57%. Engraftment and migratory<br />

potential of fused chimeric cells was confirmed by their presence in a bone marrow compartment of the recipients at day 21 posttrans<strong>plan</strong>t.<br />

CONCLUSION:<br />

Our study confirmed the feasibility of ex vivo creation of chimeric cells. This study reports <strong>for</strong> the first time successful engraftment of ex<br />

vivo fused chimeric cells from fully MHC mismatch donors into naïve recipients. Moreover efficacy of cell fusion was confirmed by cells<br />

engraftment followed by chimerism induction. This approach may be applied as a novel cell-based supportive therapy in solid organ<br />

and CTA trans<strong>plan</strong>ts.<br />

177


Tissue Expression of The Beta-Chemokine, RANTES (CCL5), is Upregulated in Acutely<br />

Rejecting, Fully MHC-Mismatched Vascularized Skin Allotrans<strong>plan</strong>ts in Rats<br />

Institution where the work was prepared: From the Department of Plastic and Reconstructive Surgery1 and t, Taipei,<br />

Taiwan<br />

Arik Zaretski, MD; Chia-Hung Yen; Christopher Glenn Wallace; Ren-Chin Wu; Fu-Chan Wei; Chang Gung Memorial<br />

Hospital, Chang Gung University and Medical College<br />

INTRODUCTION:<br />

Chemokines are homologous small proteins (8-10 kD) that are critical to the overall control of immune cell trafficking. RANTES<br />

(Regulated upon Activation Normal T cell Expressed and Secreted; also known as CCL5), a beta-chemokine, exerts its principle<br />

chemoattractant effects on T lymphocytes that are vital to acute allotrans<strong>plan</strong>t rejection. RANTES levels become significantly elevated<br />

5 days following solid organ allotrans<strong>plan</strong>tation. Monoclonal antibody blockade of RANTES significantly prolonged allograft survival in<br />

several models.<br />

AIM:<br />

To define the tissue-specific expression patterns of RANTES in vascularized skin allotrans<strong>plan</strong>ts during acute rejection. Methodology:<br />

Adult (10-14 weeks) male donor Brown-Norway (BN; RT1n) and recipient Lewis (LEW; RT1l) rats were used throughout. Eight allogeneic<br />

(BN to LEW) and 8 isogeneic (LEW to LEW) groin flaps were per<strong>for</strong>med and graded <strong>for</strong> signs of rejection. Four allogeneic and four<br />

isogeneic flap recipients were sacrificed on Day 4, and the rest were sacrificed on Day 6, <strong>for</strong> standard histology as well as immunohistochemical<br />

staining <strong>for</strong> RANTES to be assessed in a single-blinded fashion by a pathologist.<br />

RESULTS:<br />

Trans<strong>plan</strong>t Rejection (Table 1): Allotrans<strong>plan</strong>t rejection started on mean Day 3.6; rejection became moderately severe by Day 6.<br />

Isogeneic trans<strong>plan</strong>ts never showed signs of rejection. 2) Histology (Figure 1): Isogeneic trans<strong>plan</strong>ts showed moderate edema and a<br />

low density of inflammatory cells only. Allotrans<strong>plan</strong>ts showed severe oedema, focal epidermal/myocytic necrosis and a high density of<br />

inflammatory cells (including macrophages, neutrophils, lymphocytes), each feature of which was more severe on Day 6 than Day 4. 3)<br />

Immunohistochemistry to RANTES (Figure 1): The negative control showed no non-specific staining. Isogeneic trans<strong>plan</strong>ts showed minimal<br />

staining in inflammatory cells in Day 4 and Day 6 tissues. Allotrans<strong>plan</strong>ts showed moderate intensity staining in inflammatory cells<br />

in Day 4 tissue, and Day 6 tissue showed a four-fold increased density of staining in inflammatory cells, particularly of lymphocytes, compared<br />

to that observed on Day 4.<br />

CONCLUSION:<br />

Tissue expression of the beta-chemokine, RANTES (CCL5), is upregulated in acutely rejecting vascularized skin allotrans<strong>plan</strong>ts in rats,<br />

correlating with the clinical and histological severity of rejection. RANTES may there<strong>for</strong>e also be a useful therapeutic target <strong>for</strong> blockade<br />

in the control of vascularized skin allotrans<strong>plan</strong>t rejection. This is, to our knowledge, the first study of chemokine expression in acutely<br />

rejecting vascularized skin allotrans<strong>plan</strong>ts.<br />

178


The Role of Thymus in Chimerism Induction on Composite Osseomusculocutaneous Sternum,<br />

Ribs, Thymus, Pectoralis Muscles, Skin Allotrans<strong>plan</strong>tation Model<br />

Institution where the work was prepared: Cleveland Clinic, Cleveland, OH, USA<br />

Mehmet Bozkurt, MD; Serdar Nasir; Aleksandra Klimczak; Lukasz Krokowicz; Christopher Grykien; Maria Siemionow;<br />

Cleveland Clinic<br />

INTRODUCTION:<br />

Cellular and vascularized bone marrow may supply donor derived hematopoietic cells, and both have been used to induce donor-specific<br />

chimerism in various models of vascularized bone marrow trans<strong>plan</strong>ts. We are introducing a new composite vascularized sternal bone marrow<br />

trans<strong>plan</strong>t model which can be applied <strong>for</strong> augmentation of hematopoietic activity <strong>for</strong> chimerism induction after trans<strong>plan</strong>tation.<br />

METHODS:<br />

Ten allograft trans<strong>plan</strong>tation were per<strong>for</strong>med between Lewis-Brown Norway (LBN,RT11+n) donors and Lewis (RT1l) recipients. Group I<br />

consisted of 5 allograft trans<strong>plan</strong>tation via osseomusculocutaneous sternum, ribs, thymus, pectoralis muscles, skin. In Group II 5 allografts<br />

trans<strong>plan</strong>tation were per<strong>for</strong>med using osseomusculocutaneous sternum, ribs, pectoralis muscles, skin without the thymus (Fig 1).<br />

Sternum and the costal ribs were harvested based on the common carotid artery and internal jugular vein. In the recipient Lewis (RT1<br />

l), harvested isograft trans<strong>plan</strong>ts were transferred into the inguinal region and anastomosis was per<strong>for</strong>med between carotid, jugular and<br />

femoral pedicles (Fig 2). All animals received tapered dose of CsA therapy. Presence of donor orgin cells in the peripheral blood of<br />

recipients was evaluated by flow cytometry using monoclonal antibodies specific <strong>for</strong> donor MHC class I.<br />

RESULTS:<br />

Longest survival is 120 days post trans<strong>plan</strong>ted and are still under observation (Fig 3-4 early/long survival view). All sternal grafts have<br />

survived and flap viability was observed daily via inspection of skin island. This composite graft carried 5x106 of hemoetopeotic cells.<br />

Donor specific chimerism was detected during follow up period and introduced as a sum of donor T cell, B cells and monocyte/<br />

macrophage/ dendiric cells. At day 7 post trans<strong>plan</strong>t total level of chimerism was assessed at 3.8% of RTIn positive cells and increased<br />

to 13.2% at day 63 post trans<strong>plan</strong>t. In contrast in group II (without thymus) initial chimerism at day 7 was evaluated at 0.3% and increased<br />

to 2.4% at day 21 post-trans<strong>plan</strong>t (still under observation). Donor orgin cells were also detected in the bone morrow compartment of<br />

recipient at 4.21% of RTIn positive cell cells. Chimerism will be monitored during follow-up period.<br />

CONCLUSIONS:<br />

We have introduced a new model of composite vascularized bone marrow trans<strong>plan</strong>tation by sternal allograft which does not require<br />

laparotomy <strong>for</strong> the placement of the bone. This graft carries significant amount of bone marrow within intact microanotomical compartment.<br />

In this model long term survival correlated directly with chimerism level. Furthermore long term survival of the composite allograft<br />

via thymus is imperative <strong>for</strong> induction of high level of donor specific chimerism.<br />

179


Acute and Delayed Effects of Pulsed Acoustic Cellular Therapy (PACE) on Capillary Perfusion<br />

and Microcirculatory Hemodynamics of Muscle Flaps<br />

Institution where the work was prepared: Cleveland Clinic, Cleveland, OH, USA<br />

Lukasz Krokowicz; Christopher Grykien; Mariusz Mielniczuk; Aleksandra Klimczak; Maria Siemionow; Cleveland Clinic<br />

PURPOSE:<br />

Despite practical indications of Pulsed Acoustic Cellular Therapy (PACE), its effect on inflammation and flap healing at microcirculatory<br />

level remains unknown. Aim of study was to asses effect of PACE on muscle flap microcirculatory hemodynamics, neovascularization<br />

and improvement of blood-supply and muscle flap healing.<br />

METHODS:<br />

Cremaster muscles were dissected in 34 Lewis rats divided into 5 groups: 1) Non-ischemic baseline controls (n=10); 2) PACE with 500<br />

impulses (n=6) and 3) 200 impulses (n=6) immediately be<strong>for</strong>e dissection; 4) PACE with 500 impulses (n=6) and 5) 200 impulses (n=6) 24h<br />

be<strong>for</strong>e dissection (n=6). Microcirculatory hemodynamics (number of rolling, sticking and transmigrating leukocytes in postcapillary<br />

venule, functional capillary index and RBC velocity) were recorded at 1,2,3,4 hours after dissection. Tissue oxygenation (Licox probe)<br />

and H+E histological evaluation were per<strong>for</strong>med. Mechanism of microcirculatory responses was evaluated by immunostaining with<br />

monoclonal antibodies characteristic <strong>for</strong> cell adhesion molecules such as ELAM-1, and their ligand CD15s and ICAM-1.<br />

RESULTS:<br />

After PACE treatment increase in capillary activation was seen in group 2 compared to groups 4 and 1 immediately after flap dissection<br />

(14.11 ± 3.85 vs. 12.59 ± 3.7 vs. 13.46 ± 3.2 respectively). Average amount of rolling leukocytes during observations was decreased in<br />

groups 2 and 4 comparing to control group (6.68 and 7.0 vs. 9.29 respectively).At same time average number of sticking and transmigrating<br />

leukocytes in groups 2 and 4 was increased comparing to control group (4.49 and 2.49 in group 2 and 4.40 and 2.25 in group 4<br />

vs. 3.1 and 2.16 in group 1). Licox probe showed no significant difference between control group and groups 2, 3, 4 and 5 (18-20 mmHg<br />

vs. 18.03 ± 1.8 mmHg). Histology demonstrated no damage to small vessels and capillaries. We observed increased level of leukocytes<br />

adhering to vessels endothelium. Vessel endothelium showed increased level ELAM-1 in acute phase and significant upregulation in<br />

group 4 compare to control group. In addition we determined significant upregulation of CD15s on rolling leukocytes in group 4. This<br />

phenomenon was not observed in group 2 and control group. In contrast upregulation of ICAM-1 was detected in group 2 compare<br />

to group 4 and control group.<br />

CONCLUSIONS:<br />

This study confirmed that PACE therapy increased capillary perfusion in group 2 and presented stable capillary perfusion over 24h<br />

observations comparable with normal controls. Increased level of transmigrated leukocytes in group 4 correlated with upregulation of<br />

ELAM-1 on vessel endothelium and CD15s on transmigrated leukocytes.<br />

180


Three-and Four-Dimensional Arterial and Venous Anatomies of the Thoracodorsal Artery<br />

Per<strong>for</strong>ator Flap<br />

Institution where the work was prepared: UT Southwestern Medical Center at Dallas, Dallas, TX, USA<br />

Michel Saint-Cyr, MD; Mark Schaverien; Gary Arbique; Spencer A Brown; Rod J Rohrich; UT Southwestern Medical<br />

Center at Dallas<br />

BACKGROUND:<br />

The vascular anatomy of the thoracodorsal artery per<strong>for</strong>ator flap, which has not been previously elucidated, was examined using threeand<br />

four-dimensional computed tomographic angiography and venography.<br />

METHODS:<br />

Twenty-five thoracodorsal artery per<strong>for</strong>ator flaps were harvested from fresh cadavers from the Western population. Dynamic static CT<br />

angiography using iodinated contrast media was per<strong>for</strong>med following cannulation of the largest per<strong>for</strong>ator from the descending branch<br />

of the thoracodorsal artery and its vena comitans in ten flaps. Imaging was repeated subsequent to flap thinning between the deep<br />

and superficial adipose layers. Coloured latex injections and flap dissections were per<strong>for</strong>med in a further fifteen flaps to establish the<br />

location, calibre, and intramuscular length of the per<strong>for</strong>ators from the thoracodorsal artery.<br />

RESULTS:<br />

Two distinct per<strong>for</strong>ator complex types were described. Flap thinning can be safely per<strong>for</strong>med between the deep and superficial adipose<br />

layers without significantly affecting flap vascularity, provided that a safety zone about the per<strong>for</strong>ator is respected. The superficial<br />

venous system consisted of large veins arranged in a polygonal pattern situated at the subdermal level, and was connected to the deep<br />

system by the venae comitantes of the per<strong>for</strong>ators of the thoracodorsal artery. Per<strong>for</strong>ators from the descending branch of the thoracodorsal<br />

artery were found in reliable locations.<br />

CONCLUSIONS:<br />

Using a novel dynamic three-dimensional imaging technique, perfusion of the arterial and venous system of the throracodorsal artery<br />

per<strong>for</strong>ator flap have been elucidated. Although the flap is inherently thin, it can be safely thinned between the superficial and deep adipose<br />

layers. This study has identified important advantages of the thoracodorsal artery per<strong>for</strong>ator flap <strong>for</strong> use in reconstruction. Figure<br />

1. 3D static image following cannulation of the most proximal per<strong>for</strong>ator from the descending branch and injection with a barium sulphate/gelatin<br />

mixture, with illustration. Note the filling of the adjacent dorsal intercostal artery per<strong>for</strong>ators via recurrent flow through the<br />

subdermal plexus, with an absence of a suprafascial plexus. This enables the flap to be thinned without disrupting its vascular supply.<br />

181


ASRM SCIENTIFIC PAPER PRESENTATIONS:<br />

HEAD AND NECK<br />

The Incidence of Venous Thromboembolism in Head and Neck Reconstruction<br />

Institution where the work was prepared: Memorial Sloan-Kettering Cancer Center, New York, NY, USA<br />

Constance M. Chen, MD, MPH; Joseph J. Disa; Babak J. Mehrara; Memorial Sloan-Kettering Cancer Center<br />

BACKGROUND:<br />

Cancer patients undergoing head and neck reconstruction are at high risk <strong>for</strong> venous thromboembolism (VTE). Such patients often<br />

exhibit major risk factors including advanced age, immobility due to a prolonged surgical procedure, malignant disease, and hypercoagulability.<br />

Currently, no published data exist regarding the incidence of VTE in patients undergoing oncologic head and neck reconstruction.<br />

This study evaluates the incidence of symptomatic pulmonary embolism (PE) and deep venous thrombosis (DVT) after head<br />

and neck reconstruction at a single tertiary-care cancer center.<br />

METHODS:<br />

A retrospective review was done of 6759 surgical procedures per<strong>for</strong>med between 1997 and 2006 at Memorial Sloan-Kettering Cancer<br />

Center (MSKCC). Data from a prospectively maintained surgical database was reviewed to identify procedures that resulted in postoperative<br />

PE or DVT.<br />

RESULTS:<br />

From 1997-2006, there were 6759 procedures per<strong>for</strong>med by two surgeons at MSKCC. There were 1583 head and neck operations<br />

(n=1583) and 5176 non-head and neck procedures (n=5176). Non-head and neck procedures included surgeries of the breast, upper<br />

extremity, lower extremity, trunk, and back. When compared to patients undergoing procedures in other parts of the body, patients<br />

undergoing oncologic head and neck reconstruction were older, spent more days in the hospital, and underwent longer anesthesia<br />

times. While the incidence of VTE was less than 1% in both patient populations, there was a six-fold greater incidence of VTE among<br />

patients undergoing head and neck surgery (0.57%) than non-head and neck surgeries (0.09%). The difference between the two groups<br />

was statistically significant (p = 0.001).<br />

CONCLUSIONS:<br />

The incidence of pulmonary embolism was significantly higher in cancer patients undergoing head and neck reconstructions than in all<br />

other types of procedures. Possible reasons include advanced age and prolonged immobility. When possible, anticoagulant therapy<br />

<strong>for</strong> prophylaxis against VTE in cancer patients undergoing head and neck reconstruction is strongly recommended.<br />

182


Microsurgical Correction of Craniofacial Mal<strong>for</strong>mations: A Fifteen-Year Experience<br />

Institution where the work was prepared: New York University School of Medicine, New York, NY, USA<br />

Pierre Saadeh1; Chris Chang, BA2; Evan Garfein1; Otway Louie1; John Siebert1; (1)NYU Medical Center, (2)New York<br />

University School of Medicine<br />

PURPOSE:<br />

Since our initial description of microsurgical correction of facial contour in 19 patients with craniofacial mal<strong>for</strong>mations, we have expanded<br />

our experience by 76 additional patients. We reviewed our experience with staged craniofacial, soft tissue, and microsurgical procedures<br />

to effect both functional and cosmetic improvement in this diverse patient population. We sought to provide a comprehensive<br />

summary of the operative results, complications, and refinements in techniques. A treatment algorithm is also presented.<br />

METHODS:<br />

The medical records of 95 patients (1989 to 2004) were reviewed and included 73 craniofacial microsomia patients, 8 Treacher Collins<br />

syndrome patients, 12 severe orbitofacial cleft patients, and 2 severe micrognathia patients. All underwent microsurgical correction<br />

(superficial inferior epigastric, groin, circumflex scapular flaps with/without bone or muscle, fibula) of facial contour de<strong>for</strong>mities. Flap<br />

revisions, complications, and non-free flap related surgery were tabulated. The patients were followed <strong>for</strong> a minimum of 1 year and post<br />

operative evaluation included physical examination and medical photography.<br />

RESULTS:<br />

63/73 patients with craniofacial mal<strong>for</strong>mations underwent non-free flap-related surgery, usually mandibular/ear reconstruction, whereas<br />

7/8 Treacher Collins syndrome patients, 12/12 severe orbitofacial cleft patients, and 2/2 severe micrognathia patients underwent<br />

additional procedures. 17 patients underwent bilateral flaps (1/17 immediate). The flap of choice was a circumflex scapular variant (105).<br />

Mean age at flap operation was 11 (range 4-27). A two team approach was employed with simultaneous ipsilateral flap harvest and facial<br />

dissection. Complications included 1 flap failure, 1 flap salvage, 1 partial flap loss, 5 cellulitis, 5 hematomas requiring bedside drainage.<br />

All patients had improved facial contour and symmetry. Overlying skin tone and color similarly improved. Short and long-term followup<br />

revealed improvement.<br />

CONCLUSION:<br />

Soft tissue augmentation is a welcome byproduct of distraction osteogenesis. However, long-term midfacial reconstruction with nonvascularized<br />

bone and soft tissue graft may be unpredictable introducing a self-perpetuating cycle of devascularization, scar, and<br />

relapse. The adjunctive use of microsurgical techniques has greatly enhanced our ability to improve craniofacial recontouring. These<br />

techniques have proven safe, well-tolerated, and durable. Refinements of these techniques include the identification of the parascapular<br />

flap as our “workhorse flap”, removal of the flap skin entirely, and redefining the position of microsurgery in the reconstructive<br />

sequence. Microsurgical reconstruction was initially employed late, often as an attempt at salvage. Success with this approach lead to<br />

earlier interventions and, in selected patients, primary augmentation with free vascularized soft tissue can play a major role in midfacial<br />

reconstruction of these craniofacial mal<strong>for</strong>mations.<br />

Rehabilitation after Mandibular Reconstruction with Fibula Free Flap: Clinical (Outcome) and<br />

Quality of Life Assessment<br />

Institution where the work was prepared: Erasmus University Medical Center, Rotterdam, Netherlands<br />

Stefan O.P. Hofer; Alessandra C. Hundepool; Antoine G. Dumans; Nico Fokkens; Sukh S. Rayatt; Erik H. van der Meij;<br />

Kees P. Schepman; Erasmus University Medical Center Rotterdam<br />

BACKGROUND:<br />

Tumors (benign or malignant), osteoradionecrosis, or osteomyelitis sometimes lead to large segmental resections of the mandible.<br />

Osteo(cutaneous) fibula free flaps (OFFF) are used to reconstruct these defects. New anatomical relationships as well as possible irradiation<br />

of oral tissues make dental rehabilitation complicated. The aim was to determine the rate of dental rehabilitation with an<br />

im<strong>plan</strong>t-retained lower denture or fixed appliances, after segmental resection and reconstruction of the mandible with an OFFF.<br />

METHODS:<br />

Data were obtained from 70 patients, who underwent segmental mandibular resection due to various causes followed by reconstruction<br />

of the defect with an OFFF over a 10-year period (1995-2005). Dental rehabilitation was defined as, a patient, who after segmental<br />

mandibular resection and reconstruction with an OFFF, received an im<strong>plan</strong>t-retained lower denture or fixed appliances. Clinical and<br />

functional assessments, as well as quality of life and denture satisfaction were evaluated.<br />

RESULTS:<br />

Twenty-four out of 70 patients received dental im<strong>plan</strong>ts. Eighteen patients received complete dental rehabilitation. Functional assessment<br />

and denture satisfaction were 5.8 and 7.7, respectively on a 10-point visual analogue scale.<br />

CONCLUSIONS:<br />

A relatively small percentage of patients with segmental mandibular reconstructions with an OFFF received complete dental rehabilitation.<br />

Main reason was due to poor survival after treatment of malignant tumors of the oral cavity. The beneficial effects of dental rehabilitation<br />

with an im<strong>plan</strong>t-retained denture or fixed appliances, mainly favored cosmetic aspects, rather than oral function.<br />

183


Evaluation of Cortical Reorganization in Facial Trans<strong>plan</strong>tation<br />

Institution where the work was prepared: University of Pittsburgh, Pittsburgh, PA, USA<br />

Kia M. McLean, MD; Mario G. Solari; Justin M. Sacks; Anjey Su; Vijay S. Gorantla; Jignesh V. Unadkat; Stefan<br />

Schneeberger; George E. Carvell; Daniel J. Simons; W.P. Andrew Lee; University of Pittsburgh Medical Center<br />

INTRODUCTION:<br />

Facial trans<strong>plan</strong>tation must provide effective functional outcome in order to be widely accepted as a reconstructive option.<br />

Understanding cortical reorganization, the brain's functional compensation <strong>for</strong> injury, could be the key to optimizing functional outcome<br />

in facial trans<strong>plan</strong>tation. The specific aims of this study were to establish a functional face trans<strong>plan</strong>t model in the rat and per<strong>for</strong>m a<br />

comprehensive analysis of functional recovery and cortical reorganization.<br />

METHODS:<br />

We per<strong>for</strong>med 5 syngeneic and 5 allogeneic functional hemifacial trans<strong>plan</strong>ts with appositions of donor and recipient infraorbital nerves<br />

and facial nerve branches. Allogeneic trans<strong>plan</strong>ts were given 15 mg/kg/day of cyclosporine <strong>for</strong> immunosuppression. As a control 5 syngeneic<br />

hemifacial trans<strong>plan</strong>ts without nerve appositions were per<strong>for</strong>med. Electromyography (EMG) was completed 12 weeks<br />

post–trans<strong>plan</strong>t. Sensory regeneration, cortical reintegration and reorganization were studied at 20 weeks post-trans<strong>plan</strong>t through stimulation<br />

of the whiskers and microelectrode output recording from the somatosensory cortex.<br />

RESULTS:<br />

All experimental trans<strong>plan</strong>ts showed clinical evidence of motor recovery by movement of the whiskers at 24 days (syngeneic) and 32<br />

days (allogeneic) post-trans<strong>plan</strong>t respectively, while control animals did not exhibit return of whisker movement. All experimental animals<br />

showed presence of conduction potentials on EMG 12 weeks post-trans<strong>plan</strong>t, while no electrical activity was elicited in control animals<br />

(p < .001). Stimulation of whiskers elicited a specific regional response and directional sensitivity of cells in the somatosensory cortex.<br />

Histology of the somatosensory cortex with cytochrome oxidase and horseradish peroxidase staining confirmed cortical reorganization.<br />

CONCLUSION:<br />

We have established a functional model <strong>for</strong> face trans<strong>plan</strong>tation in the rat. This is the first model <strong>for</strong> cortical reorganization in composite<br />

tissue trans<strong>plan</strong>tation. Motor nerve recovery was confirmed clinically and physiologically. The sensory pathway in each whisker was<br />

traced to the corresponding region of the somatosensory cortex, quantified, and visualized by histology. This is the first electrophysiological<br />

and histological evidence of cortical reorganization in face trans<strong>plan</strong>tation.<br />

Le Fort I Osteotomy with Interpositional Free Fibula Flap <strong>for</strong> Maxillary Augmentation<br />

Institution where the work was prepared: R Adams Cowley Shock Trauma Center, Baltimore, MD, USA<br />

Rachel Bluebond-Langner, MD; Lisa Witkin; Eduardo D. Rodriguez; R Adams Cowley Shock Trauma Center<br />

INTRODUCTION:<br />

Severe maxillary deficiency results in functional compromise including altered mastication, speech abnormalities, as well as cosmetic<br />

de<strong>for</strong>mities. Historically this has been treated in one of three ways: augmentation with non-vascularized bone grafts, Le Fort I osteotomy<br />

with interpositional bone graft or LeFort I osteotomy with distraction osteogenesis. We present a novel technique, Le<strong>for</strong>t I osteotomy<br />

with interpostional vascularized bone flap, which is particularly useful in patients who have failed augmentation with conventional<br />

techniques.<br />

MATERIALS/METHODS:<br />

Six patients with maxillary hypoplasia underwent Le Fort I osteotomy with interpositional osteoseptocutaneous fibula flaps.<br />

Osteotomies were made to contour the fibula which was then secured between the down-fractured maxilla and the stable zygomaticomaxillary,<br />

pterygomaxillary and nasomaxillary buttresses. Data collected included age, gender, mechanism of injury, maxillary<br />

advancement operative procedures.<br />

RESULTS:<br />

Maxillary retrusion was due to trauma (n=3), cancer (n=1), chronic maxillary atrophy (n=1) and Crouzon's (n=1). There were 3 females<br />

and 4 males with an average age of 40. Four patients had prior attempts at maxillary advancement or augmentation including onlay<br />

bone grafts, Le<strong>for</strong>t III advancement without bone grafting and distraction osteogenesis. The average skin flap area was 33.7 cm2 and<br />

average bone flap length was 13.7 cm. All flaps survived with no donor site complications. Simultaneous vestibuloplasty was per<strong>for</strong>med<br />

in 3 patients using the fibula skin paddle. Average maxillary advancement was 3mm. One has had complete dental restoration including<br />

endosseous im<strong>plan</strong>ts and a fixed prosthesis. The remaining five are in the process. Average follow up was 9 months.<br />

DISCUSSION:<br />

Classically, non vascularized bone graft is used to bridge the gap between the osteotomized maxilla and stable bone. The advantages<br />

of vascularized bone flaps over non-vascularized bone grafts include transfer of viable bone with significantly less resorption over time<br />

and long term osseous integration of im<strong>plan</strong>ts. Augmentation with a fibula flap has been per<strong>for</strong>med however to our knowledge there<br />

are no reports of the use of the fibula osteoseptocutaneous flap as an interpositional material following LeFort I osteotomy <strong>for</strong> treatment<br />

of severely atrophic maxillas. This technique allows simultaneous repositioning of the maxillary alveolus between stable skeletal<br />

buttresses, augmentation of the midface and creation of a vestibule. Furthermore, the maxillary muscosa is left intact obviating the need<br />

<strong>for</strong> debulking and skin grafting when endosseous im<strong>plan</strong>ts are placed.<br />

184


Maxilla Trans<strong>plan</strong>tation<br />

Institution where the work was prepared: Cleveland Clinic Foundation Plastic Surgery Department, Cleveland, OH, USA<br />

Ilker Yazici1; Kevin Carnevale, MD2; Ayhan Comert, MD3; Tarik Cavusoglu, MD4; Aleksandra Klimczak, PhD5; Ibrahim<br />

Vargel, MD, PhD4; Ibrahim Tekdemir, MD3; Maria Z. Siemionow5; (1)Cleveland Clinic, (2)Cleveland Clinic Foundation,<br />

(3)Ankara University Medical Faculty, (4)Kirikkale University Medical Faculty, (5)The Cleveland Clinic Foundation<br />

INTRODUCTION:<br />

The aim of this paper is to provide and discuss biological and anatomical parameters in order to present the allograft maxilla trans<strong>plan</strong>tation<br />

concept <strong>for</strong> midface reconstruction based on our studies.<br />

MATERIALS/METHODS:<br />

10 rats and 6 human cadavers were used to develope maxilla trans<strong>plan</strong>t model. In the rat study allograft maxilla trans<strong>plan</strong>tations were<br />

per<strong>for</strong>med across the major histocompatibility barrier between 10 Lewis-Brown-Norway (RT1nl) and 10 Lewis (RT1l) rats under<br />

cyclosporin A monotherapy. Maxilla grafts (Le-Fort II resembling) were dissected based on the common carotid artery and external<br />

jugular vein and trans<strong>plan</strong>ted to the anterior abdominal wall via microvascular anastomosis. Allografts were examined by tomography,<br />

flow cytometry, angiography, and histology. Grafts were trans<strong>plan</strong>ted to the abdominal region of recipient rats via microvascular anastomosis<br />

to femoral artery and vein. In the anatomical study 6 human cadavers were used <strong>for</strong> dissection of hemimaxilla grafts (Larger Le-<br />

Fort II) and anatomical data were collected based on graft harvest.<br />

RESULTS:<br />

In the rat study three of the allografts survived up to 105 days without any signs of rejection with high level of donor specific chimerism.<br />

The incisors continued to grow; teeth buds, bone, cartilage, and mucosa remained intact with moderate inflammation of the nasal, oral<br />

mucosa and keratinous metaplasia of the oral mucosa. In the anatomical study, arterial and venous pedicles of the hemimaxilla graft,<br />

the graft dissection algorithm and dissection <strong>plan</strong>es were established. We have found that maxillary venous pedicle can be dissected<br />

by using <strong>plan</strong>es surrounding deep buccal fat pad and masticatory space soft tissue boundaries.<br />

CONCLUSIONS:<br />

Our experience with heterotopic maxilla allotrans<strong>plan</strong>tation in rat model with long term survival and our series of cadaver dissections<br />

bring us closer to human practice of maxilla allograft trans<strong>plan</strong>tation. To justify this approach we are further testing tolerance inducing<br />

and minimal immunosupression protocols <strong>for</strong> maxilla allotrans<strong>plan</strong>tation.<br />

Microvascular Free Appendix Transfer For Reconstruction Of Various Purposes<br />

Institution where the work was prepared: E-Da Hospital, Kaohsiung, Taiwan<br />

Hung-Chi Chen, MD, FACS1; Samir Mardini, MD2; Yueh-Bih Tang, MD, PhD3; Christopher Salgado1; Guan-Ming<br />

Feng, MD4; (1)E-da/I-I Shou University Hospital, (2)E-da Hospital, (3)National Taiwan University Hospital, (4)Army<br />

General Hospital<br />

BACKGROUND:<br />

Appendix can provide a small lumen with motility of its mucosa as well as secretion, which can prevent obstruction when it is used as a<br />

conduit with two ends open. In this institute it has been applied <strong>for</strong> the reconstruction of voice tube, urethra and cervix which connects<br />

the uterus and vagina. PATIENTS AND<br />

METHODS:<br />

There were 7 patients, among them 4 had appendix <strong>for</strong> voice tube reconstruction, 2 <strong>for</strong> urethra, and one had colon with appendix <strong>for</strong><br />

cervico-vaginal reconstruction. The pedicle was the appendiceal artery in 3 patients, and ileocolic artery in 4 patients. In two of them<br />

mini-incisions were used <strong>for</strong> harvesting.<br />

RESULTS:<br />

(1) voice reconstruction as a biological substitute of voice prosthesis: no food reflux to the trachea. One of them had excellent voice,<br />

two had good-fair results. (2)urethra reconstruction: The passage of urine was smooth, but in one patient the appendix was the limit of<br />

penile length. (3) The patient having colon and appendix <strong>for</strong> cervicovaginal reconstruction had excellent long-term result at 3 years follow-up.<br />

She had congenital vaginal dysgenesis, atretic cervix and a functional endometrium. The menstral bleeding commenced at 8<br />

weeks after surgery and the uterovaginal fistula was patent at 3 years follow-up.<br />

CONCLUSION:<br />

Although the appendix is small, it can maintain patency due to its nature as a part of the intestine. It is useful <strong>for</strong> various types of reconstructions.<br />

185


Does the Ischemia Time Affect the Outcome of Free Fibula Flaps <strong>for</strong> Head and Neck<br />

Reconstruction? A Review of 117 Fibular Flaps<br />

Institution where the work was prepared: Chang Gung Memorial Hospital, Tao-yuan, Taipeh, Taiwan<br />

Shu-ying Chang, MD; Huang-Kai Kao, MD; Jung-Ju Huang, MD; Holger Engel, MD; Betul Ulusal; Ming-Huei Cheng,<br />

MD, PhD; Chang Gung Memorial Hospital<br />

INTRODUCTION:<br />

Fibula osteocutaneous flap is a good option <strong>for</strong> reconstruction of segmental mandibular defect. The ischemia time of fibula flap <strong>for</strong><br />

mandibular reconstruction is variable according to surgeon's experiences, osteotomies of fibula and fixation of fibula be<strong>for</strong>e vs. after<br />

division of the pedicle, anastomosis be<strong>for</strong>e vs. after inset of the flap, and artery vs. vein anastomosis first. The purposes of this study<br />

were to investigate the relations between the ischemia time and the outcome of fibula flap including bone and skin paddle, and to<br />

establish the upper limit of ischemia time <strong>for</strong> fibula flap.<br />

MATERIALS/METHODS:<br />

Between February of 2003 and March of 2005, 117 fibula flaps were used <strong>for</strong> mandibular reconstructions. The outcome was compared<br />

in the success rate and the complication rate among different ischemia time, 1~3 (n=29), 3~4 (n=51), 4~5 (n=23), 5~7(n=14) hours<br />

groups. The complications were defined as three categories: acute complications (within a week postoperatively); subacute complications<br />

(between a week and one month postoperatively); and chronic complications (one month after operation).<br />

RESULTS:<br />

The mean ischemia time was 3.6 hours (ranged from 1 to 6.6 hours). The patient's risk factors including smoking, diabetes, pre-operative<br />

radiotherapy, and cancer stage were not statistically different between each group. The re-exploration rate was 7.7%. Mean flap success<br />

rate was 98.3%. Mean partial flap loss rate was 17.1% (ranged from 7.8 to 100 %). There was statistical difference between the ischemia<br />

time shorter and longer than 5 hours groups (P=0.035). There was no statistically significant difference among the 4 groups in success<br />

rate and complication rates in different stages. The number of osteotomies (0~3) of fibula bone did not significantly affect the success<br />

rate, complication (acute, subacute, chronic and overall complications ) rates, partial flap loss rate, and bone loss rate in this series.<br />

DISCUSSION:<br />

Although the ischemia time of fibula flap is critical <strong>for</strong> the microsurgical mandibular reconstruction, surgeons may spend a little more<br />

time <strong>for</strong> shaping the fibula to mandible or even adding the osseointegrated dental im<strong>plan</strong>ts if the longer ischemia time does not compromise<br />

the outcome of this procedure. In conclusion, the longer ischemia time of fibula flap <strong>for</strong> mandibular reconstruction does not<br />

affect the success and complication rates. We suggest the ischemia time of fibula osteocutaneous flap <strong>for</strong> mandibular reconstruction<br />

is better limited to 5 hours to reduce the partial flap loss.<br />

186


Harnessing the Potential of the Free Fibula Osteoseptocutaneous Flap in Mandible<br />

Reconstruction: How to Attain Adequate Functional and Esthetic Height <strong>for</strong> the<br />

Reconstructed Segment<br />

Institution where the work was prepared: Chang Gung Memorial Hospital, Taipei, Taiwan<br />

Christopher Glenn Wallace, MB, ChB, MRCS; Yang-Ming Chang; Chi-Ying Tsai; Ming-Huei Cheng; Chung-Kan Tsao;<br />

Fu-Chan Wei, MD, FACS; Chang Gung Memorial Hospital, Chang Gung University and Medical College<br />

INTRODUCTION:<br />

The free fibula osteoseptocutaneous flap remains the first choice <strong>for</strong> segmental mandible and contiguous soft tissue defect reconstructions<br />

in most situations. We present our techniques and results <strong>for</strong> restoring adequate height <strong>for</strong> the reconstructed segment, both<br />

esthetically and functionally, including the incorporation of primary or secondary osseointegration of dental im<strong>plan</strong>ts.<br />

METHODS:<br />

Three recent advancements that we have found useful when addressing difficulties in height contouring, particularly at the anterior segment,<br />

are as follows: (1) Place an additional reconstruction plate inferior to the fibula-im<strong>plan</strong>t construct and use primary osseointegration of dental<br />

im<strong>plan</strong>ts [11 patients; total 34 fibula-borne im<strong>plan</strong>ts]; (2) Use a double-barrelled fibula construct with primary osseointegration [8 patients; total<br />

19 fibula-borne im<strong>plan</strong>ts]; (3) Use vertical distraction osteogenesis and secondary osseointegration [4 cases; total 13 fibula-borne im<strong>plan</strong>ts].<br />

RESULTS:<br />

All free tissue transfers were successful. Few complications were encountered, as follows: Methods (1) and (2) – no major complications,<br />

all patients have good esthetic results and have completed prosthodontic rehabilitation, one patient from the Method 1 group is mildly<br />

bothered by palpability of the second reconstruction plate; Method (3) – difficulty controlling the distraction direction caused mild<br />

im<strong>plan</strong>t malpositioning, notably in the second premolar region, no other complications. Several important principles that should be<br />

respected when using these three methods will be highlighted as well as patient selection criteria when choosing between them. In<br />

particular, technical tips identified when using vertical distraction of the fibula flap will be a further focus.<br />

CONCLUSION:<br />

When applied appropriately, each of the presented methods can be useful <strong>for</strong> increasing the height of the reconstructed mandibular<br />

segment to provide an optimal mandibular reconstruction that restores mechanical functions, facial esthetics and complete dental competence<br />

with minimal complications. Specific technical steps are critical to each, if optimal outcomes are to be expected. Maintaining<br />

control over the vector of vertical distraction remains a challenge.<br />

Autolgous Fat as an Alternative to Microvascular Free Tissue Transfer <strong>for</strong> the Treatment of<br />

Severe Facial Soft Tissue De<strong>for</strong>mities<br />

Institution where the work was prepared: University of Pennsylvania, Philadelphia, PA, USA<br />

Suhail Kanchwala, MD; Louis P. Bucky; University of Pennsylvania<br />

PURPOSE:<br />

The management of acquired and congenital facial soft tissue de<strong>for</strong>mities poses many challenges to the facial reconstructive surgeon.<br />

The use of free tissue transfer to restore soft tissue contour in patients suffering from severe soft tissue de<strong>for</strong>mities has been the “gold<br />

standard”. We have had extensive experience with the use of autologous facial fat grafting in aesthetic surgery and have applied similar<br />

techniques <strong>for</strong> facial reconstruction. The purpose of our study is to describe the use of autologous facial fat grafting as the primary<br />

treatment <strong>for</strong> patients with severe facial soft tissue de<strong>for</strong>mities.<br />

METHODS:<br />

We per<strong>for</strong>med a retrospective review of all patients who underwent autologous facial fat grafting as the primary method of facial soft<br />

tissue reconstruction between 1995 and 2005. We utilized a modified Coleman technique <strong>for</strong> fat harvest and injection. The number or<br />

fat grafting sessions and volume of fat injected was subsequently recorded. In addition, all complications including infection, fat necrosis,<br />

palpable nodules were recorded.<br />

RESULTS:<br />

Reconstructive facial fat grafting was per<strong>for</strong>med in 36 patients. The conditions treated included Hemifacial Atrophy (12 patients), Hemifacial<br />

Microsomia (6 patients), Treacher-Collins syndrome (7 patients), HIV associated lipodistrophy (5 patients), and post-traumatic de<strong>for</strong>mities (6<br />

patients). The median patient age in our series was 34 yrs. Our average follow-up was 4.2 years (range 2.7-10 years). The overall incidence of<br />

complications was low. There were no infections, two patients suffered prolonged bruising, and palpable nodularity was noted in one patient.<br />

CONCLUSION:<br />

Autologous facial fat grafting can be extremely effective in treating patients with severe facial soft tissue defects. Fat grafting has significantly<br />

decreased morbidity when compared with alternative treatment modalities such as free tissue transfer. Improved techniques<br />

<strong>for</strong> fat harvest and injection have enhanced the reliability of fat grafting. Autologous facial fat grafting is a safe and effective technique<br />

<strong>for</strong> the management of severe soft tissue de<strong>for</strong>mities of the face.<br />

187


Radial Forearm Free Flap Pre-lamination with Acellular Dermal Matrix <strong>for</strong> Repair of Subtotal<br />

Glossectomy Defects<br />

Institution where the work was prepared: Fox Chase Cancer Center, Philadelphia, PA, USA<br />

Fernando Cordera, MD; Neal S. Topham, MD; Fox Chase Cancer Center<br />

BACKGROUND:<br />

The mainstay of treatment <strong>for</strong> advanced resectable squamous cell carcinomas (SCCs) of the tongue is surgery and postoperative radiation<br />

therapy. Free-tissue transfer has become the standard technique <strong>for</strong> tongue reconstruction after hemiglossectomies because of<br />

superior functional results when compared to local flaps. We present a novel technique <strong>for</strong> reconstruction of the tongue that uses a<br />

prelaminated radial <strong>for</strong>earm free flap that can be transferred to reconstruct the tongue and oral cavity.<br />

PATIENTS AND METHODS:<br />

After obtaining Institutional Review Board approval, eight patients requiring subtotal glossectomies <strong>for</strong> tongue malignancy underwent<br />

a two stage procedure to reconstruct the tongue using a pre-laminated radial <strong>for</strong>earm free flap between April 2006 and February 2007.<br />

Using the RRC-149-06 head and neck questionnaire, the results of this group of patients were compared to those of four other patients<br />

with the same diagnosis who underwent similar resections but had their reconstruction per<strong>for</strong>med with a standard radial <strong>for</strong>earm free<br />

flap.<br />

RESULTS:<br />

All patients underwent a successful reconstruction. All patients are alive and with no evidence of disease. The novel technique achieved<br />

comparable results to the control in terms of range of motion, pain strength, speech, swallowing, and appearance with the added<br />

advantages of minimizing donor site morbidity and eliminating the potential transfer of radial <strong>for</strong>earm hair to the tongue.<br />

CONCLUSIONS:<br />

Radial <strong>for</strong>earm free flap pre-lamination with acellular dermal matrix <strong>for</strong> repair of subtotal glossectomy defects is feasible and safe. This<br />

technique improves the appearance of the radial <strong>for</strong>earm donor site, eliminates the need <strong>for</strong> skin grafting, and eliminates the transfer<br />

of hair to the mouth while achieving excellent functional outcomes.<br />

Management of Life Threatening Tracheaesophageal Fistulae, Leaks, and Defects<br />

Institution where the work was prepared: MD Anderson cancer Center, Houston, TX, USA<br />

John Nigriny, MD, DMD; Peirong Yu; MD Anderson Cancer Center<br />

BACKGROUND:<br />

Tracheal and esophageal fistulae, leaks, and defects are life threatening complex reconstructive dilemmas. Contributing factors include prior<br />

surgical procedures or dilation, esophageal stenting, radiation therapy, caustic substance ingestion, medical comorbidity, and malignancy.<br />

PATIENTS/METHODS:<br />

We present our experience with these problems at a tertiary care cancer hospital over a two year period (10/22/04-9/26/06) in 14<br />

patients. Age ranged from 34-78 yrs (mean 62 yrs) and 3/14 were female. Be<strong>for</strong>e reconstructive plastic surgery 86% had prior surgery of<br />

the trachea and/or esophagus, 57% had received chemotherapy, and 64% were treated with external beam radiation (range 45-66 Gy).<br />

64% had two or more medical comorbidities and were previous or current smokers. Ten patients had cancer of the esophagus (squamous<br />

cell carcinoma-5, adenocarcinoma-4, Non Hodgkin's Lymphoma-1). Two patients had cancers adjacent to the esophagus<br />

(parathyroid carcinoma-1, malignant mesothelioma of bronchus-1). Two patients were cancer free (esophageal duplication cyst-1, complications<br />

from Nissen fundoplication-1). Life threatening sequelae included: tracheoesophageal fistula (5), esophageal per<strong>for</strong>ation (2),<br />

esophageal anastomotic leak after Ivor Lewis Esophagectomy (3), acquired esophageal defect (3), tracheobronchial stump leak (1).<br />

RESULTS:<br />

Reconstructive intervention included a free and or pedicled flap. 21% of patients required a secondary flap intervention <strong>for</strong> salvage.<br />

One patient died secondary to ARDS associated with the initial tracheoesophageal fistula. Esophageal leaks, per<strong>for</strong>ations or stumps,<br />

and tracheobronchial fistulae, were covered with pedicled flaps (latissimus (7), serratus (5), pectoralis (1), intercostal (1), and omentum<br />

(1). The esophagus in tracheoesophageal fistulae and large esophageal defects were reconstructed with supercharged jejunal flaps (5).<br />

Two of three patients who required a second operation <strong>for</strong> salvage of a failed pedicled muscle flap received a supercharged jejunal flap<br />

as well. The third patient required a total laryngectomy and subsequent reconstruction with an anterolateral thigh flap due to a severe<br />

neck infection with tracheal necrosis. In total seven patients received supercharged jejunal flap reconstruction of the esophagus, all<br />

except the reported death ultimately tolerated a regular diet.<br />

CONCLUSIONS:<br />

The hostile surgical environment created by an esophageal fistula necessitates the use of a staged reconstruction. Our algorithm <strong>for</strong> reconstruction<br />

of life threatening tracheal and esophageal disasters can be divided into two stages. Stage one is debridement, diversion, and<br />

cover of the tracheal esophageal bed with muscle flaps. In stage two several months later, a supercharged jejunal flap is used to provide<br />

alimentary continuity. This algorithm has resulted in a stable and effective salvage template <strong>for</strong> catastrophic tracheoesophageal disasters.<br />

188


Chronic deep venous thrombosis in the peroneal veins of a fibula flap: strategies <strong>for</strong> salvage<br />

and avoidance<br />

Institution where the work was prepared: Brigham and Women's Hospital, Boston, MA, USA<br />

Amir Taghinia, MD; Harvard Plastic Surgery; Julian J. Pribaz, MD; Brigham and Women's Hospital, Harvard Medical<br />

School; Lifei Guo, MD, PhD; Brigham and Women's Hospital<br />

Thrombosis of free flap vessels is usually a significant concern after micro-anastomosis; however, reports of chronic thrombotic venous<br />

occlusion prior to free flap transfer are rare. We present a case of chronic occlusion of the peroneal veins of a free fibula osteocutaneous<br />

flap and a successful salvage attempt. Prolonged bedrest from a contralateral ankle fracture led to deep venous thrombosis and chronic<br />

occlusion in these veins. Successful flap transfer was possible by using a venous branch from the soleus muscle <strong>for</strong> microanastomosis.<br />

An extensive literature search of 773 cases yielded only one similar example. Discussion with multiple experienced microsurgeons<br />

yielded another anecdotal case. In both of these other cases, flap transfers had to be aborted. Based on our experience, we recommend<br />

early intra-operative identification and preservation of the soleus vein branch in case of similar venous difficulties during free fibula<br />

harvest. The use of pre-operative ultrasound to assess these veins in selected patients with history of lower extremity trauma is also<br />

recommended prior to flap harvest.<br />

Go <strong>for</strong> the Jugular – A 10-year Experience with End-to-Side Anastomosis to the Internal<br />

Jugular Vein in 320 Head and Neck Free Flaps<br />

Institution where the work was prepared: Memorial Sloan-Kettering Cancer Center, New York, NY, USA<br />

Eric Halvorson, MD; University of North Carolina; Peter G. Cordeiro; Memorial Sloan-Kettering Cancer Center<br />

INTRODUCTION:<br />

Venous patency is critical <strong>for</strong> successful free tissue transfer in head and neck reconstruction. Although multiple suitable arteries are often<br />

found, venous recipients are usually limited to the internal jugular vein, stumps of its branches, and/or the external jugular vein. We have<br />

found that preferential use of end-to-side anastomosis to the internal jugular vein whenever possible offers distinct advantages, and<br />

has consistently yielded excellent outcomes. A 10-year experience with 320 cases is presented.<br />

METHODS:<br />

A prospectively maintained database was queried <strong>for</strong> patients who underwent free flap reconstruction of head and neck oncologic<br />

defects from 1996 to 2006 by the senior author. Intravenous heparin was given prior to flap harvest, and aspirin was administered <strong>for</strong> 5<br />

days post-operatively. End-to-side venous anastomosis was per<strong>for</strong>med with 9-0 nylon continuous suture. Patient demographics, donor<br />

and recipient sites, and complications were noted <strong>for</strong> all patients who underwent end-to-side anastomosis to the internal jugular vein.<br />

RESULTS:<br />

Over a 10-year period, a total of 470 patients underwent head and neck reconstruction with free tissue transfer, of which 320 (70%)<br />

underwent end-to-side anastomosis to the internal jugular vein. Mean patient age in this group was 56 years (range 7-88). The most<br />

common flaps employed were the rectus (33%), <strong>for</strong>earm (28%), and fibula (21%) flaps. The most common recipient sites were the<br />

mandible with or without floor of mouth (27%), pharyngoesophagus (25%), and tongue or cheek (17% each). Minor wound healing problems,<br />

infection, hematoma, and death were noted in 5% or less. Partial flap loss was seen in 2%. Total flap loss, arterial thrombosis, and<br />

venous thrombosis all occurred in less than 1% of patients.<br />

CONCLUSION:<br />

Presented is a large series of consecutive cases by a single surgeon at one institution over a 10-year period, with preferential use of endto-side<br />

anastomosis to the internal jugular vein <strong>for</strong> head and neck free flap reconstruction. Excellent outcomes were noted, which compare<br />

favorably with other described techniques. The size, constant anatomy, availability, patency, and possibility <strong>for</strong> multiple anastomoses<br />

of any size at any site along its course in the neck make use of the IJV very advantageous. End-to-side anastomosis to the IJV in<br />

this situation results in high patency rates, and kinking is not observed when the neck is rotated. Theoretical advantages include<br />

increased flow in the IJV (which may promote venous outflow and wash away microthrombi) due to its size and the respiratory venous<br />

pump.<br />

189


ASRM SCIENTIFIC PAPER PRESENTATIONS:<br />

MISCELLANEOUS<br />

Using Stereolithographic Models to Plan Mandibular Reconstruction <strong>for</strong> Advanced Oral<br />

Cavity Cancer<br />

Institution where the work was prepared: Fox Chase Cancer Center, Philadelphia, PA, USA<br />

Eric Y. Ro, MD1; John A. Ridge, MD, PhD, FACS2; Neal S. Topham, MD2; (1)Fox Chase Cancer Center/Temple<br />

University, (2)Fox Chase Cancer Center<br />

INTRODUCTION:<br />

Use of the fibula osteocutaneous free flap in mandibular reconstruction has allowed patients to recover essential aspects of mandibular<br />

function, including oral competence, mastication, and aesthetic appearance. To improve the efficiency, accuracy and outcomes of<br />

such procedures, we present our use of stereo lithographic modeling in fifteen patients with oral cancer that require mandibular reconstruction.<br />

This technique is especially beneficial <strong>for</strong> patients where tumor bulk extends laterally from the mandible.<br />

METHODS:<br />

Fifteen patients underwent computed tomography (CT) scan of the mandible using specific parameters (20 cm FOV, pitch 1.0, 1 mm<br />

slice, 120-280 mA) and the data was sent to ProtoMed (Arvada, CO). A 3-D anatomic epoxy model was returned to the reconstructive<br />

surgeon. A 2.4 mm or 3.0 mm locking reconstruction plate (Synthes, Inc., West Chester, PA) was bent and pre-cut to the patient's model<br />

and then sterilized prior to the procedure. Intra-operatively, the pre-bent titanium plate was used to drill holes needed to secure the<br />

plate to the native mandible prior to per<strong>for</strong>ming the osteotomies. The plate was then sterilized and used as a three-dimensional template<br />

to create an accurate neo-mandible using the fibula flap. If tumor extension inhibited plate alignment, holes were drilled after the<br />

osteotomies were per<strong>for</strong>med. In this scenario, accurate alignment was achieved using landmarks on the mandibular model and plate.<br />

RESULTS:<br />

This technique was especially useful with neoplasms that extend laterally from the mandible because the bulk of the lesion prevented<br />

contouring of the titanium reconstruction plate at the time of surgical resection. Alignment of the pre-bent plate eliminated operating<br />

time typically dedicated to plate contouring. There were no complications attributable to this technique. There were no flap failures.<br />

One patient developed a local recurrence.<br />

CONCLUSIONS:<br />

Use of stereo lithographic models in mandibular reconstruction allows <strong>for</strong> accurate contouring of the plate to the mandible, reduces<br />

operative time, and provides a method to reconstruct patients whose tumors extend laterally to the buccal soft tissues.<br />

Timing of Microsurgical Reconstruction of Lower Extremity: Is It Really Important In Flap<br />

Failure<br />

Institution where the work was prepared: Gulhane Military Medical Academy, Ankara, Turkey<br />

Fatih Zor; Mustafa Sengezer; Murat Turegun; Selcuk ˘sik; Mustafa Nisanci; Muhidtin Eski; Gülhane Military Medical<br />

Academy<br />

Landmine injuries of the lower extremity constitute a challenging problem to the reconstructive surgeon. These injuries create composite<br />

tissue defects which are always contaminated. The transfer of the patient to a well established center generally takes time. All these<br />

factors yield a delay at the definitive treatment of the patient. Here, we want to present patients injured by landmine explosions and<br />

treated at different times and to discuss the effect of timing of the microvascular tissue transfer on success of the procedure. Between<br />

1995-2006, 109 patients were treated by microvascular tissue transfers at Gulhane Military Medical Academy in Department of Plastic<br />

and Reconstructive Surgery. All patients were injured due to landmine explosion and reconstructed with microvascular tissue transfer.<br />

The flap success rate and postoperative complications were evaluated. The average follow-up period was 19 months. Of the 109<br />

patients, 12 were operated between 0-7 days (group I-at the acute period). Forty-two of them were operated at the subacute period<br />

(group II, between 7-14 days) and the remaining 55 were operated at the chronic period (group III, more than 14 days). There was no<br />

flap loss in group I patients. Flap failure rate was 16.7 % and 14.5 % <strong>for</strong> group II and group III, respectively and the difference was not<br />

significant. No postoperative infection was observed at the acute period. Postoperative infection rate was 16.7 % and 7.3 % at subacute<br />

and chronic period respectively, and the difference was statistically significant. Microvascular reconstruction of the lower extremity<br />

at the acute period is preferred but landmine injuries are not always possible to operate at the acute period. Posttraumatic vessel<br />

disease is known to be the most important reason of the flap failure. Although, Godina et al. advocates that the acute period is the first<br />

2 days, we agree with Byrd et al as it is the first 7 days. So we think that the critical period <strong>for</strong> the microvascular surgery should be considered<br />

as the first 7 days. When the surgery is per<strong>for</strong>med according to microvascular principles subacute period does not differs from<br />

chronic period when the flap failure is concerned. Subacute period is associated with a higher infection rate.<br />

190


Buried flap monitoring using a novel non-invasive simultaneous microcirculatory perfusion,<br />

oxygenation and venous outflow monitor<br />

Institution where the work was prepared: Hannover Medical School, Hannover, Germany<br />

Karsten Knobloch, MD, PhD; Andreas Gohritz; Niels C. Gellrich; Peter M. Vogt; Hannover Medical School<br />

INTRODUCTION:<br />

Buried microsurgical flaps into the local skin provide an excellent soft tissue augmentation in facial reconstruction, but is hampered by<br />

the fact that methods of flap monitoring are pending. A method <strong>for</strong> early identification of microcirculatory perfusion complications in<br />

these tissue trans<strong>plan</strong>ts seems indispensable <strong>for</strong> a successful long-term outcome.<br />

OBJECTIVE:<br />

To present the feasibility of real-time microcirculatory mapping <strong>for</strong> capillary flow, tissue oxygen saturation and postcapillary venous filling<br />

pressures using a quantitative non-invasive Laser-Doppler-Spectrophotometry (Oxygen-to-see, 02C) of free flaps .<br />

METHODS:<br />

We report the use of this system in a 24-year-old patient who required complex facial reconstruction following orbital evisceration and<br />

hemifacial atophy caused by radiation therapy during childhood due to retinoblastoma. For soft tissue augementation a split latissimus<br />

dorsi muscle flap was trans<strong>plan</strong>ted to the frontal zygomatic region subcutaneously and anastomosed to the facial vessels.<br />

Microcirculatory parameters of blood flow, flow velocity, postcapillary venous filling pressures (AU, Arbitrary Units) and oxygen saturation<br />

(S02%) were assessed prospectively at five positions around both orbitae.<br />

RESULTS:<br />

Capillary blood flow was increased superficially at all five positions up to the 40-fold preoperative value (3AU/120AU). Deep capillary<br />

blood flow was increased in all five positions more than 4-fold (85AU/354AU). Baseline periorbital microcirculation markedly differed<br />

preoperatively with reduced S02% and capillary blood flow and increased postcapillary venous filling pressures. S02% at a superficial<br />

and deep level was increased up to fivefold level at the 6th day postoperatively (16%/82%). Postcapillary venous filling pressures were<br />

increased in 3/5 positions superficially up to 40% (37AU/61AU) and 3/5 positions at 8mm up to 13% following flap transfer<br />

(162AU/184AU). The flap survival was 100%.<br />

CONCLUSION:<br />

Free flap monitoring using the Oxygen-to-see Laser-Doppler-Spectrophotometry offers quantitative microcirculatory values <strong>for</strong> intraand<br />

postoperative perfusion control. Tissue oxygenation is increased following buried flap transfer with transient increase of postcapillary<br />

venous filling pressure without clinical deterioration of the buried flap.<br />

Local Per<strong>for</strong>ator Flaps Around the Elbow<br />

Institution where the work was prepared: Recovery Hospital, Cluj-Napoca, Romania<br />

Alexandru Georgescu, Prof, MD, PhD; Ileana Matei; Filip Ardelean, MD; UMF Iuliu Hatieganu<br />

INTRODUCTION:<br />

The advancements in knowledge about the blood supply of tissues induced the surgeons to imagine new types of flaps, the last one<br />

described being the per<strong>for</strong>ator flaps. This paper will try to demonstrate that around the elbow it is better to harvest flaps based on brachioradial<br />

musculocutaneous per<strong>for</strong>ators or on the inferior cubital artery. The advantage of using these flaps is the possibility <strong>for</strong> early<br />

post-surgery mobilization.<br />

MATERIALS/METHODS:<br />

In this paper we will present 7 cases of per<strong>for</strong>ator flaps around the elbow, from which 2 harvested on the posterior aspect, one on the<br />

distal third of the <strong>for</strong>earm and the rest on the anterior aspect (on the elbow’s flexion fold and the proximal third of the <strong>for</strong>earm). The<br />

patients were aged between 2 and 35 years. Three flaps were based on musculocutaneous per<strong>for</strong>ators from the brachioradialis muscle,<br />

three were based on the inferior cubital artery (the most important per<strong>for</strong>ator vessel emerging from the radial artery) and one on<br />

the recurrent radial artery. In the absence of the Doppler pre-surgery investigations, the harvesting technique consisted of: - initial incision<br />

on two thirds of the flap’s circumference - subfascial undermining until the per<strong>for</strong>ator is detected - completion of the flap’s incision<br />

and deep dissection - the flap’s pedicle is undermined inside the muscle or septum The flap’s length is 2 cm larger then the defect’s<br />

length. In 5 of the 7 cases the donor site was directly sutured, in 2 cases we used split skin grafts.<br />

RESULTS:<br />

The post-surgery mobilization was early, without affecting the flap’s viability. All the flaps survived without any suffering.<br />

CONCLUSIONS:<br />

The per<strong>for</strong>ators emerging from the proximal third of the <strong>for</strong>earm, especially the musculocutaneous ones and the inferior cubital artery<br />

are able to sustain the blood supply <strong>for</strong> flaps as wide as 100 cmÇ, used to cover anterior and posterior defects in the elbow area.<br />

191


The Use of Free Medial Pedis Per<strong>for</strong>ator Flap in The Treatment of Chron˘c Postburn Palmar<br />

Contractures<br />

Institution where the work was prepared: GATA Haydarpa?a E?itim Hastanesi dept. of Plastic Surgery, ?stanbul, Turkey<br />

Haluk Duman, Assoc, Prof, MD; Fatih Uygur; Ersin ülkür; Sinan öksüz; Bahattin çeliköz; GATA Haydarpa?a E?itim hastanesi<br />

INTRODUCTION:<br />

<strong>Hand</strong> burns are quite important since functional recovery is an obligation. However, inadequate treatment at the very beginning causes<br />

severe functional deficiencies which can be difficult to correct. The unique anatomic characteristics of the hand which are thick, sensate<br />

and glabrous skin provide a cushioning and durability effect. In the present study, we introduce the free medialis pedis per<strong>for</strong>ator<br />

flap in the coverage of palmar defects resulting from radical release of chronic postburn contractures.<br />

METHOD:<br />

Eight patients with palmar contractures were treated with free medialis pedis per<strong>for</strong>ator flap between May 2005 and November 2007.<br />

The flaps were <strong>plan</strong>ned on the medial aspect of the foot and elevated as fasciocutaneous per<strong>for</strong>ator flap. The flap sizes ranging from<br />

1.5 x 3.0 cm to 3.0 x 6.5 cm. The flaps were transferred to the palmar defects resulting from radical release of chronic postburn contractures.<br />

Arterial anastomosis were per<strong>for</strong>med with flap artery and proper digital arteries in all but two cases. Venous anastomosis was<br />

done between superficial vein which included in the flap and the recipient superficial vein.The flap donor sites were closed with splitthickness<br />

skin graft in all patients. The mean follow-up period was 10,5 months.<br />

RESULTS:<br />

The trans<strong>plan</strong>ted flaps survived with satisfactory recovery in function. Grasp function of the hand was dramatically improved. Deep sensation<br />

appeared by the end of the second month, and superficial sensation returned in all cases, as assessed by monofilament testing<br />

(Semmes-Weinstein). In two cases transient venous insufficiency was encountered and resolved with elevation.<br />

CONCLUSION:<br />

We believe that the medialis pedis flaps were a remarkable alternative <strong>for</strong> palmar reconstruction of the hand and digits due to burn<br />

because of its glabrous skin, which is very similar to palmar skin and with low donor site morbidity. Although the main disadvantage of<br />

this flap is non sansate, protective sensation was regained in all cases.<br />

The Effect of Preoperative Radiotherapy on the Free Jejunum Flap Transfer<br />

Institution where the work was prepared: E-Da Hospital, Kao-hsiung, Taiwan<br />

Hung-Chi Chen, MD, FACS1; Yueh-Bih Tang, MD, PhD2; Samir Mardini, MD1; Christopher Salgado1; Chung-chen Hsu,<br />

MD3; (1)E-da/I-I Shou University Hospital, (2)National Taiwan University Hospital, (3)Chang Gung Memorial Hospital<br />

BACKGROUND:<br />

Microvascular free jejunum flap transfer has been widely employed <strong>for</strong> reconstruction of defects following ablation of malignant tumors<br />

in the pharynx and larynx. Preoperative radiation therapy has two effects: (1) tissue fibrosis in the neck, which may interfere with wound<br />

healing, and (2) damage to vascular intima which induced a higher rate of thrombosis after microvascular anastomoses in the animal<br />

studies. However, in the clinical situation it is still not clear whether preoperative irradiation causes more complications including survival<br />

of the flap.<br />

PATIENTS AND METHODS:<br />

From 1998 to 2006, 67 patients with cancers in the pharynx and larynx had been reconstructed with free jejunum flap transfer after wide<br />

excision. Among them 31 cases had preoperative radiation (group I )and 36 (group II) did not have radiation. A retrospective study was<br />

per<strong>for</strong>med with a focus on survival, re-exploration and other complications including leakage, dysphagia and later stricture.<br />

RESULTS:<br />

Reexploration was per<strong>for</strong>med in 2 patients in group I and 3 patients in group II. Among them all flaps were salvaged except <strong>for</strong> one<br />

patient in group II. The other complications were found in 20 % of patients in group I and 22 % in group II. There was no statistically significant<br />

difference in the two groups.<br />

CONCLUSION:<br />

Theoretically, preoperative radiation therapy should pose more problems in microsurgical reconstruction. In this series it did not affect<br />

the results of free jejunum flap transfer. Technical pearls in dealing with this difficult situation are presented.<br />

192


Further Esthetic Refinement <strong>for</strong> Great Toe Transfers in Pursuit of an Ideal Thumb Reconstruction<br />

Institution where the work was prepared: Chang Gung Memorial Hospital, Taipei, Taiwan<br />

Christopher Glenn Wallace, MB, ChB, MRCS; Chih-Hung Lin; Yu-Te Lin; Fu-Chan Wei; Chang Gung Memorial Hospital,<br />

Chang Gung University and Medical College<br />

INTRODUCTION:<br />

The trimmed-great-toe-transfer and the modified Morrison's wrap-around technique are useful methods <strong>for</strong> thumb reconstruction, but<br />

each leaves a prominent tubercle (on the fibular side of the distal phalangeal base) with overlying soft tissue that occasionally bothers<br />

patients. We introduce a simple, effective secondary esthetic refinement that addresses this problem.<br />

METHODS:<br />

Key points of technique that should be adhered to <strong>for</strong> optimal esthetic outcome will be described. Furthermore, necessary technical<br />

modifications required <strong>for</strong> great-toe-transfers that incorporate the interphalangeal joint will be demonstrated. Case selection criteria<br />

will be discussed.<br />

RESULTS:<br />

Patient satisfaction has been high and the improved cosmesis has encouraged each to use the reconstructed thumb more openly in<br />

daily life. Thumb vascularity, stability and nail growth were not affected by the operation.<br />

CONCLUSION:<br />

Self-consciousness regarding the esthetics of a reconstructed thumb, causing concealment and disuse, is an un<strong>for</strong>tunate and frustrating<br />

outcome. We introduce a straight<strong>for</strong>ward, effective outpatient technique that cosmetically refines the thumb reconstructed by a<br />

trimmed-great-toe or modified wrap-around great toe transfer.<br />

V-Y Advancement Adductor Magnus Per<strong>for</strong>ator Flap <strong>for</strong> Reconstruction of Scrotal/Perineal<br />

Defects<br />

Institution where the work was prepared: UMass Plastic Surgery, Worcester, MA, USA<br />

Mustafa Akyurek, MD1; Marjorie R. Chelly, MD2; Raymond M. Dunn, MD2; (1)University of Massachusetts, (2)University<br />

of Massachusetts Medical School<br />

BACKGROUND:<br />

The gracilis myocutaneous flap has been traditionally used to carry skin from the medial thigh region. However, the survival of the skin<br />

paddle is unpredictable and often associated with partial flap necrosis. Adductor magnus per<strong>for</strong>ator flap was described in 2001 as a<br />

safer method of flap transfer in posteromedial thigh area, yet with skin grafting of the donor site in almost all of the cases. Purpose: This<br />

presentation describes the anatomic basis and clinical technique of V-Y advancement flap design <strong>for</strong> the adductor magnus per<strong>for</strong>ator<br />

flap in reconstruction of scrotal and perineal defects.<br />

MATERIAL/METHODS:<br />

A total of 6 fresh cadavers were dissected to identify the musculocutaneous per<strong>for</strong>ators from the adductor magnus muscle that supplies<br />

the posteromedial thigh skin. Pedicle characteristics and possible flap advancement were noted. Technique: The flap was<br />

designed in the medial thigh region as a V-Y advancement flap centered around the per<strong>for</strong>ating vessels. It was raised as a complete<br />

island with 2 or 3 per<strong>for</strong>ator vessels carefully preserved. The flap was advanced toward the defect in V-Y fashion. In one patient, the<br />

adductor magnus per<strong>for</strong>ator flap was raised as a combined flap with the gracilis muscle flap included. A total of 5 flaps were used in 3<br />

patients <strong>for</strong> reconstruction of scrotal (n=1) and perineal (n=2) defects.<br />

RESULTS:<br />

Anatomic studies demonstrated that at least two consistent per<strong>for</strong>ating vessels were noted, originating from the medial branches of<br />

the profunda femoris artery and coursing through the adductor magnus muscle, finally supplying the posteomedial thigh skin about 2<br />

cm posterior to the posterior border of the gracilis muscle and 10 and 14 cm inferior to the inguinal crease, respectively. The length of<br />

the per<strong>for</strong>ator vessels ranged from 6 to 8 cm without major intramuscular dissection. Clinical experience proved that the flaps provided<br />

adequate coverage of the defects. All of the flaps survived completely without any complications. None of the patients required skin<br />

grafting of the flap donor sites.<br />

CONCLUSION:<br />

The V-Y advancement adductor magnus per<strong>for</strong>ator flap has been found to be very simple and effective <strong>for</strong> reconstruction of perineal<br />

defects, offering the following advantages: (a) vascular anatomy is consistent, (b) musculocutaneous per<strong>for</strong>ators have large diameter, (c)<br />

the per<strong>for</strong>ators have ample pedicle length allowing <strong>for</strong> significant flap advancement, (d) a large size skin paddle can be harvested reliably,<br />

(e) flap dissection is easy, and (f) there is no need <strong>for</strong> skin grafting of the donor site.<br />

193


Resurfacing of a Complex Upper Extremity Injury: An Excellent Indication <strong>for</strong> the Dorsal<br />

Thoracic Fascial Flap<br />

Institution where the work was prepared: The Buncke Clinic, San Francisco, CA, USA<br />

Ron Hazani, MD; Darrell Brooks, MD; Rudolf F. Buntic, MD; The Buncke Clinic<br />

INTRODUCTION:<br />

Resurfacing of complex injuries of the upper extremity can pose a challenge to the reconstructive surgeon. Injuries characterized by<br />

skeletonization of structures such as bone or tendon can require circumferential wrap by the trans<strong>plan</strong>ted tissue. Skin graft and fasciocutaneous<br />

flaps are not appropriate and muscle flaps can be excessively bulky. Fascial flaps are an ideal solution but most are small.<br />

We present a case in which the dorsal thoracic fascia was harvested, trans<strong>plan</strong>ted <strong>for</strong> <strong>for</strong>earm coverage, and its distal extent wrapped<br />

around skeletonized extensor tendons.<br />

CASE REPORT:<br />

A 35 year-old right-hand-dominant man sustained a left <strong>for</strong>earm crush injury in an all-terrain-vehicle rollover accident. The patient had<br />

open radius and ulna fractures, with significant muscle loss at the muscle-tendon junction. The resultant defect involved a large circumferential<br />

wound with skeletonized extensor tendons. After serial debridement, ORIF of the comminuted radius and ulna, and cable graft<br />

reconstruction of the ulnar nerve, the contralateral dorsal thoracic fascia was harvested. The flap was thin and well vascularized measuring<br />

8X15 cm in dimension. It was successfully trans<strong>plan</strong>ted to provide vascular cover of the ulnar nerve reconstruction, flexor tendons,<br />

plated fracture sites, and its distal extent was wrapped around the extensor tendons. There were no complications.<br />

CONCLUSION:<br />

The dorsal thoracic fascial flap is an excellent option <strong>for</strong> reconstructing large complex wounds requiring thin, supple, vascular tissue,<br />

which is completely or partially buried. It can be utilized <strong>for</strong> many applications, but is especially suited <strong>for</strong> circumferential wrap of tendons<br />

and/or obliteration of complex dead space. It is one of the largest sources of vascular fascia, its harvest is associated with little<br />

morbidity and its trans<strong>plan</strong>tation does not result in a bulky reconstruction.<br />

The Pedicled FHL Flap: A Good Option When Options Aren't Good<br />

Institution where the work was prepared: New York University School of Medicine, New York, NY, USA<br />

Otway Louie1; Evan Garfein1; Jamie P. Levine2; Pierre Saadeh1; (1)NYU Medical Center, (2)New York University School<br />

of Medicine<br />

INTRODUCTION:<br />

Lower extremity wounds remain challenging problems <strong>for</strong> even the most experienced reconstructive surgeon. Wounds of the distal<br />

third of the tibia and ankle, in particular, frequently require free flap reconstruction, given the paucity of described local flap options.<br />

Additionally, free flaps around the knee are represent difficulty with regard to recipient vessels. We present an anatomical study of the<br />

pedicled flexor hallicus longus (FHL) flap (proximally or distally based) and clinical examples of its use.<br />

METHODS:<br />

The anatomic approach and arc of rotation of the FHL flap was defined in 8 cadavers. The distally and proximally based FHL flaps were<br />

used in lower extremity reconstruction.<br />

RESULTS:<br />

Optimal approach to the FHL was prone, through an incision over the fibula with dissection between the lateral and posterior compartments.<br />

The FHL was dissected off the fibula with its peroneal artery to the tibioperonal bifurcation. Distally, flap dissection proceeded<br />

to just below maleolar level. The flap could be proximally or distally based allowing <strong>for</strong> coverage of defects up to 8x12cm of the distal<br />

tibia and ankle. Anterior defects could be directly accessed via a local opening in the interosseous septum. A distally based FHL flap<br />

was used to reconstruct a 6x8cm distal posterior tibial/calcaneal sarcoma resection defect. The patient had 3 vessel runoff into the foot<br />

and adequate foot /retrograde flap perfusion (tested by peroneal artery occlusion). There was no flap loss and the patient went on to<br />

receive XRT at 6wks post op. A patient with injuries including a posterior knee dislocation required coverage of an open knee wound<br />

<strong>for</strong> which local flap options were precluded due to disruption of local vasculature. A proximally based FHL flap was used to provide a<br />

covered vascular leash with excellent vessel size match <strong>for</strong> reconstruction with a free rectus flap.<br />

CONCLUSIONS:<br />

The pedicled FHL flap is a useful option in lower extremity reconstruction. Caveats <strong>for</strong> its use include the need <strong>for</strong> adequate leg inflow<br />

and foot outflow. Additionally, the distally based flap requires adequate collateral circulation from the posterior/anterior tibial systems.<br />

Supercharging to these vessels may extend the use of this flap in situations of compromised vasculature. Additionally, the flap may be<br />

proximally based effectively allowing <strong>for</strong> an "insulated extension cord" to which donor vessels may be attached.<br />

194


Achieving Aesthetic Results in Facial Reconstructive Microsurgery: Planning and Executing<br />

Secondary Refinements<br />

Institution where the work was prepared: New York University School of Medicine, New York, NY, USA<br />

Pierre Saadeh1; Otway Louie1; Evan Garfein1; Jamie P. Levine2; John W. Siebert1; (1)NYU Medical Center, (2)New York<br />

University School of Medicine<br />

INTRODUCTION:<br />

The use of free tissue transfer to provide bulk and contour in facial de<strong>for</strong>mities including mal<strong>for</strong>mations, trauma, radiation, and iatrogenic<br />

injuries is extensively documented. The reconstructive challenges implicit in these complex abnormalities are almost always<br />

addressed in multiple surgical stages. The refinements which turn an acceptable result into an excellent result are essential to reconstruction,<br />

yet have not been comprehensively elaborated. We reviewed our experience and described these refinements.<br />

METHODS:<br />

The charts of 322 free tissue transfer cases (1989-2006) by the senior author were reviewed. Free tissue transfer of a circumflex scapular<br />

variant flap (97%) was per<strong>for</strong>med <strong>for</strong> the treatment de<strong>for</strong>mities arising from hemifacial atrophy (106), hemifacial microsomia (73), radiation<br />

therapy (39), bilateral mal<strong>for</strong>mations including HIV lipodystophy (24 patients; 44 flaps), other congenital anomalies (22), facial palsy<br />

(16), and burns and trauma (22). Lessons learned and standardization of surgical approaches were identified and outlined.<br />

RESULTS:<br />

The following techniques optimize aesthetic outcomes. Revisional surgery <strong>plan</strong>ning begins at initial flap operation where, prior to inset,<br />

the flap is stretched to maximal dimensions. The dermis is almost always discarded and this must be complete. Qualitatively, more tissue<br />

is required in the malar region, less elsewhere. The borders of the flap must be interdigitated with recipient tissue. Revision is indicated<br />

in all cases but only after 6 months post-operatively. Flap revisions involve liposuction, sharp debulking, and re-elevation with strict<br />

attention to release of tethering or contracture. A frequent trouble spot is the jawline which requires relatively more debulking and elimination<br />

of overhang. Elevation is followed by advancement, rotation, transposition, and/or turnover. Readvancements need to be overcorrected<br />

and re-inderdigitated, especially into the alar-facial junction, oral commisure, lateral and medial canthus, ear, and eyebrow.<br />

Periorbital reconstruction is always combined with lower lid support. The flap is suspended high on the lateral orbit and a lower lid/infraorbital<br />

sling is created. The lateral or medial canthus may require repositioning. Conventional facelift techniques can augment the result<br />

wherein the flap is treated as a SMAS equivalent. Autologous fat injection is useful after stable results have been achieved, particularly<br />

<strong>for</strong> perioral and nasal/alar subtleties; it remains our technique of choice <strong>for</strong> lip augmentation. Severe lip deficiencies are addressed with<br />

a variety of flaps (tongue, lip switch, FAMM, and Abbe [rare]).<br />

CONCLUSIONS:<br />

Often lessons learned the “hard way” were the most instructive. The keys to improving results were continual critical reassessment,<br />

open-mindedness to new approaches, and maintaining aggressive expectations.<br />

Immediate Nipple-Areolar Complex Reconstruction with Inner Thigh (TUG) Flap Microvascular<br />

Breast Reconstruction<br />

Institution where the work was prepared: Cali<strong>for</strong>nia Pacific Medical Center, Ralph K. Davies Campus, San Francisco, CA,<br />

USA<br />

Matthew J. Trovato, MD; Karen M. Horton, MD, MSc, FRCSC; Rudolf F. Buntic, MD, FACS; Darrell Brooks, MD;<br />

Cali<strong>for</strong>nia Pacific Medical Center<br />

INTRODUCTION:<br />

Creation of the nipple-areolar complex (NAC) is the final step in surgical restoration of the breast. Often considered as a complement<br />

to breast reconstruction, NAC reconstruction is usually completed after an interval of several months, making use of local flaps or composite<br />

graft techniques involving the opposite nipple. Because the position of the NAC is defined from the outset in skin-sparing mastectomy,<br />

immediate reconstruction is possible using the skin paddle of the inner thigh flap. The authors report their experience with<br />

immediate NAC reconstruction using the transverse upper gracilis (TUG) inner thigh flap microvascular trans<strong>plan</strong>t.<br />

METHODS:<br />

Once the inner thigh flap has been harvested, the crescentic skin paddle is folded back onto itself to <strong>for</strong>m a standing cone, which is fitted<br />

in the skin-sparing mastectomy pocket. The standing cone is subsequently exaggerated using absorbable horizontal mattress<br />

sutures to create an immediate nipple reconstruction. The upper inner thigh skin naturally has somewhat darker pigmentation than the<br />

skin of the breast. This regularly obviates the need <strong>for</strong> areolar tattoo, and enables immediate areolar reconstruction with the inner thigh<br />

flap. Patients were surveyed by questionnaire, and measurements and photographic documentation was carried out.<br />

RESULTS:<br />

Twelve flaps in 6 patients (mean age 52 years; range 42 to 59 years) were used <strong>for</strong> immediate breast and NAC reconstruction between<br />

2005 and 2007. Retrospective review with a mean follow-up of 6.5 months (range, 3 to 15 months) revealed patient satisfaction by means<br />

of questionnaire and physical examination. One hundred percent of patients were pleased with their breast reconstruction. Eighty-three<br />

percent were satisfied with breast symmetry, 83% with size, 100% with shape, and 100% with softness/quality of the reconstructed breast.<br />

Every patient would recommend this type of breast reconstruction to a friend. Seventy-five percent of patients were pleased with their<br />

nipple and areolar reconstruction. Clinical examples and projection measurements of reconstructed nipples at a minimum of 6 months<br />

postoperatively will be presented.<br />

CONCLUSIONS:<br />

Immediate NAC reconstruction with the inner thigh (TUG) flap produces reliable and aesthetically superior results. Shape and projection<br />

make this flap an excellent choice in selected patients requiring breast reconstruction. NAC reconstruction with the inner thigh flap<br />

offers an additional potential advantage <strong>for</strong> breast reconstruction: completion of the entire reconstruction in a single procedure.<br />

195


Using Free Style Proximal Radial Forearm Free Flaps while Preserving Radial Artery <strong>for</strong><br />

Reconstructions of Burn hand and Head and Neck Defects<br />

Institution where the work was prepared: Chang Gung Memorial Hospital, Taipei, Taiwan<br />

Jeng-Yee Lin, MD; Wei-Chao Huang; David C.C. Chuang; Fu-Chan Wei; Chang Gung Memorial Hospital<br />

PURPOSE:<br />

Although radial <strong>for</strong>earm free flaps are commonly used <strong>for</strong> a variety of reconstructions, the associated morbidity remains a concern. The<br />

most notable problems are related to the conspicuousness of a distal <strong>for</strong>earm skin graft and radial artery sacrifice. In this study, we<br />

describe harvesting a proximal radial <strong>for</strong>earm free flap while preserving radial artery and describe its indications and limitations.<br />

Materials and<br />

METHODS:<br />

From November, 2002 through October, 2006, 4 patients had burn related injuries of the hand and 3 patients had the oral defect after<br />

head and neck surgery that were reconstructed using proximal radial <strong>for</strong>earm free flaps (6 males, 1 female) in the free style fashion. The<br />

per<strong>for</strong>ator pedicle of the flap was confirmed and chosen intraoperatively. The radial artery was preserved in all cases. Either the septocutaneous<br />

or myocutaneous per<strong>for</strong>ator that nourished the flap was chosen <strong>for</strong> microsurgical anastomosis to the recipient vessels. The<br />

average dimension of the flap was 4cm x 8.5 cm. All but one donor site was closed primarily. One patient had intentionally delayed<br />

wound closure 10 days after reconstruction.<br />

RESULTS:<br />

Six flaps survived with good functional and aesthetic outcomes. One flap used <strong>for</strong> buccal reconstruction failed due to arterial thrombosis.<br />

There were only minor complaints regarding the proximal <strong>for</strong>earm donor site.<br />

CONCLUSION:<br />

Proximal radial <strong>for</strong>earm free flaps are suitable <strong>for</strong> reconstruction of both hand and head and neck defects. In highly selected situations,<br />

use of free style proximal radial <strong>for</strong>earm free flap allows preservation of the radial artery and primary donor site wound closure.<br />

Voice Reconstruction Utilizing the Free Ileo-Ileocecal Valve Free Flap with a Patch of Cecum<br />

Institution where the work was prepared: E-Da Hospital/I-Shou University, Kaohsiung, Taiwan<br />

Samir Mardini, MD1; Hung-Chi Chen, MD, FACS2; Christopher J. Salgado, MD2; (1)Mayo Clinic, (2)E-da/I-I Shou<br />

University Hospital<br />

PURPOSE:<br />

Voice reconstruction following laryngectomy has been per<strong>for</strong>med with a variety of methods, many of which divert air from the trachea<br />

to the esophagus or neo-esophagus and subsequently to the mouth where articulation takes place. Intestinal flaps including jejunum,<br />

ileocolon and skin flaps have been utilized <strong>for</strong> this purpose with reasonable outcomes. A newly designed flap from the ileocecal region<br />

has been used <strong>for</strong> the purpose of reconstructing voice with or without reconstruction of a partial esophageal defect.<br />

METHODS:<br />

19 patients between July 2004 and May 2006 with a previous history of laryngectomy underwent voice reconstruction with the ileo-ileocecal<br />

valve flap with a patch of cecum and were included in this study. The ileum was used <strong>for</strong> creation of a voice tube, the ileocecal<br />

valve prevented the occurrence of regurgitation and the patch of cecum was used to reconstruct the esophageal defect. Clinical evaluation,<br />

a chart review and questionnaires were conducted. Voice evaluation was based on a modified version of the 5-point Likert scale,<br />

where 1 indicated the patient could not produce any voice and 5 indicated a very good outcome. Swallowing function was evaluated<br />

using a 7-point Likert like scale, where 1 indicated severe complaints and an inability to swallow, and 7 indicated satisfactory swallowing<br />

without any complaints.<br />

RESULTS:<br />

All flaps survived. One patient developed an esophagocutaneous fistula. Two patients had prolapse of ileal mucosa at the voice tube<br />

trachea junction, and two patients had regurgitation of liquid into the voice tube. All patients were able to produce voice (Mean 3.5;<br />

based on the modified Likert scale). All patients were able to eat a solid diet (Mean 6; based on the modified Likert scale)<br />

CONCLUSIONS:<br />

Utilizing intestinal flaps <strong>for</strong> the reconstruction of voice following laryngectomy is a method that can achieve good outcomes. The ileoileocecal<br />

valve flap with a patch of cecum has the advantages that intestinal flaps have to offer with minimal complications at the donor<br />

site and good results of voice and swallow function.<br />

196


Modified Tibial Turn-up Fillet flap <strong>for</strong> Repair of Extensive Composite Defects of the Thigh<br />

Institution where the work was prepared: The University of Texas, M. D. Anderson Cancer, Houston, TX, USA<br />

Yoav Barnea; Sackler Faculty of Medicine, Tel-Aviv University; Patrick Lin, MD; The University of Texas, M. D. Anderson<br />

Cancer; Gregory Reece, MD; MD Anderson Cancer Center<br />

INTRODUCTION:<br />

Management of sarcomas in the proximal, posterior thigh region can be quite challenging, especially <strong>for</strong> recurrent disease and tissues compromised<br />

by previous treatment. Conventional treatment <strong>for</strong> massive soft tissue loss is hemipelvectomy or hip disarticulation with an anterior<br />

flap. The modified tibial turn-up fillet flap offers an alternative to high amputation and is a novel means <strong>for</strong> reconstructing the lower limb.<br />

PATIENT & METHODS:<br />

We present a case report of a 58-year-old male who previously underwent numerous wide excisions and flap reconstructions <strong>for</strong> multiple<br />

recurrences of malignant fibrous histiocytoma of his left posterior upper thigh. He had received extensive radiation therapy. The current<br />

tumor recurrence required a radical composite resection of the femur, sciatic nerve, and the soft tissues of the posterior upper thigh<br />

and inferior gluteal area (total area, 1000 cm2). Instead of per<strong>for</strong>ming a hip disarticulation, the lower limb was reconstructed using a<br />

modified tibial turn-up fillet flap. The leg and foot of the affected extremity were filleted from the popliteal fossa to the metatarsal-digital<br />

joints and only the tibia with all the soft tissue attached was preserved. The flap was vascularized by the popliteal vessels. After trimming<br />

the ends, the distal tibia was turned up to the hip, converting the medial malleolus to a neo-greater trochanter. The gluteal tendons<br />

were sewn to the deltoid ligament of the medial malleolus laterally and the Achilles tendon posteriorly. The iliopsoas tendon was<br />

reattached to the fibular periosteum anteriorly. A total hip joint prosthesis with a constrained acetabular liner was used to reconstruct<br />

the hip. The skin of the sole of foot was inset to cover the inferior gluteal and the ischial areas. The proximal tibia became the distal end<br />

of the stump and the leg skin covered the posterior side of the thigh.<br />

RESULTS:<br />

Ten months postoperatively, he had a well-healed stump with durable sensate skin covering the ischium. He could actively flex and<br />

abduct the left hip 30 degrees but relied on gravity <strong>for</strong> hip extension. An above-knee-amputation prosthesis with microprocessor-controlled<br />

knee joint (C-Leg, Otto Bock) provided stable ambulation.<br />

CONCLUSION:<br />

The modified tibial turn-up fillet flap is a novel reconstructive option <strong>for</strong> patients who require composite resection of the proximal thigh<br />

that is too extensive <strong>for</strong> free flap coverage. The method offers distinct advantages over hip disarticulation, i.e., better cosmesis and<br />

patient self-image and the technique provides a sensate, functional stump permitting ambulation with a prosthetic leg.<br />

Partial Breast Reconstruction with Free Autologous Tissue Transfers<br />

Institution where the work was prepared: University of Manitoba, Winnipeg, Canada<br />

Edward Wayne Buchel; Thomas E.J. Hayakawa; University of Manitoba<br />

PURPOSE:<br />

Lumpectomy and radiation therapy is the standard of care <strong>for</strong> treatment of early stage breast cancer. Cosmetic results vary significantly<br />

depending on the lumpectomy size, location and the development of a significant seroma pre-radiation. Cosmetic results on many of these<br />

patients are suboptimal resulting in the patient requesting reconstruction surgery to obtain better symmetry and individual breast shape.<br />

We present our initial experience with per<strong>for</strong>ator flap reconstruction of partial breast defects post lumpectomy and radiation treatment.<br />

METHODS:<br />

A retrospective chart review was completed on all patients undergoing a partial breast reconstruction using autologous tissue transfers.<br />

RESULTS:<br />

The review of the University of Manitoba Micorsurgical Data base revealed 48??? Free per<strong>for</strong>ator flap breast reconstructions. Twelve<br />

patient underwent partial breast reconstruction. Eight even were completed using the Deep Inferior Epigastric artery Per<strong>for</strong>ator flap<br />

while the remaining four were completed using the Superficial Inferior Epigastric Artery flap. There were no flap failures. Three patients<br />

required secondary revisions <strong>for</strong> flap debulking and one patient need revision of the nipple and areola complex.<br />

CONCLUSIONS:<br />

Partial breast defects are common problems facing patients post lumpectomy and radiation therapy. Typically, symmetry is obtained by<br />

reducing the contralateral breast, tissue rearrangements of the affected breast or an combination of both. Im<strong>plan</strong>t reconstructions have<br />

also been completed with varying degrees of success. Pedicled flaps <strong>for</strong>m the lateral chest and back have been advocated <strong>for</strong> laterally<br />

placed lumpectomy defects. The use of free per<strong>for</strong>ator flap transfers allows the reconstructive surgeon to replace lost or scarred skin,<br />

while filling the irradiated lumpectomy defects in any position on the chest wall. The long pedicle allows easy access to the IMA vessels<br />

<strong>for</strong> the anastomosis and the per<strong>for</strong>ator anatomy allow the flap to be thinned and shaped to fit the lumpectomy defect. Abdominal<br />

donor morbidity is limited and cosmetics can be excellent. Our patients are now offered the option of breast volume and shape restoration<br />

in addition to the option <strong>for</strong> only breast symmetry.<br />

Learning Objectives:<br />

Review the reconstructive option <strong>for</strong> partial breast reconstruction. Highlight the technique of autologous tissue transfer <strong>for</strong> partial breast<br />

defects.<br />

197


Imaging Techniques in Preoperative Planning of the Abdominal Per<strong>for</strong>ator Flaps: Our<br />

Experience Using the MRI<br />

Institution where the work was prepared: Hospital de la Santa Creu i Sant Pau, Barcelona, Spain<br />

Jaume Masia, MD, PhD1; Jm Monill1; Ja Clavero2; G. Pons1; J. Larrañaga1; L. Vives1; (1)Sant Pau University Hospital<br />

(Universitat Autonoma de Barcelona), (2)Clinica Creu Blanca<br />

INTRODUCTION:<br />

The key to predict the viability <strong>for</strong> any muscle per<strong>for</strong>ator flap is an adequate circulation of the chosen per<strong>for</strong>ator. There<strong>for</strong>e, a reliable<br />

method <strong>for</strong> the precise identification of the dominant per<strong>for</strong>ator with regard to its position, course and calibre would be extremely valuable.<br />

During the last 4 years we have been using the multidetector-row CT (MDCT) <strong>for</strong> the preoperative <strong>plan</strong>ning in DIEP flaps with an<br />

excellent results, it helps us in reducing the operating time and the complication rates. Un<strong>for</strong>tunately, even being less than a conventional<br />

abdominal CT scan, the main drawback <strong>for</strong> the patient still is the radiation. .<br />

METHOD:<br />

Between January 2006 and January 2007 we per<strong>for</strong>med 86 DIEAP flaps <strong>for</strong> breast reconstruction in 76 female patients. The mean age<br />

was 46.7 (range 24-70 years). An preoperative multi-dectector row CT and a MRI were done in the first 36 cases, comparing the results<br />

with the preoperative doppler sonography findings and the intraoperative clinical findings. After the comparative study we have been<br />

using only the MRI as the preoperative <strong>plan</strong>ning method.<br />

RESULTS:<br />

Comparing the MDCT and the MRI with the intraoperative findings, no false positive and no false negative results were found. We can<br />

get the same in<strong>for</strong>mation with both techniques but the MRI gives better 3D reconstruction images of the per<strong>for</strong>ator branching inside<br />

the flap. There<strong>for</strong>e MRI seems to have the same advantages of the MDCT but no radiation.<br />

CONCLUSION:<br />

In conclusion we find that the MRI is a very useful tool which provides a reliable method <strong>for</strong> studying the inferior epigastric artery per<strong>for</strong>ators<br />

of the lower abdomen. MDCT allows an anatomic study of the donor area, very ease of interpretation not only by the radiologist<br />

even by the plastic surgeon. It gives us the possibility to do a virtual anatomy dissection of the patient by the computer because<br />

the pictures obtained are 3 dimensional anatomy reconstructions. There<strong>for</strong>e it help us in reducing the operating time and the complication<br />

rates.<br />

Innervation Improves Patient-Rated Quality of Life in Free TRAM Breast Reconstruction<br />

Institution where the work was prepared: University of Western Ontario, London, ON, Canada<br />

Sharon Kim, MD, FRCSC1; Claire LF Temple, MD, FRCSC2; Douglas C. Ross, MD, FRCSC3; Raymond Tse, BSc, MD4;<br />

Margo Bettger-Hahn, BScN, MScN3; Bing Siang Gan, MD, PhD, FRCSC4; Joy MacDermid, PhD, PT4; (1)Mayo Clinic,<br />

(2)University of Western Ontario, (3)St. Joseph's Health Centre, (4)<strong>Hand</strong> and Upper Limb Centre<br />

BACKGROUND:<br />

Restoring sensory innervation has proven to be a useful adjunct in free flap head and neck reconstruction but as yet, has not been shown<br />

to improve outcomes of breast reconstruction. Our previous study demonstrated objectively improved sensation in a group of innervated<br />

transverse rectus abdominus myocutaneous (TRAM) flap breast reconstruction patients relative to non-innervated flaps. The purpose<br />

of this study is to compare patient-rated outcomes of free TRAM breast reconstruction in innervated versus non-innervated flaps.<br />

METHODS:<br />

Twenty-six women were prospectively randomized to receive either an innervated or a non-innervated free TRAM breast reconstruction.<br />

For innervated flaps, the T10 intercostal nerve was harvested with the TRAM flap and neurotized to the T4 sensory nerve at the<br />

recipient site. Three validated outcome tools were administered pre- and post-surgery. These included the SF-36 Health Survey, the<br />

Breast Cancer Therapy Quality of Life Instrument and the Body Image after Breast Cancer Questionnaire. Results of these outcomes<br />

were correlated with previously reported objective sensibility outcomes.<br />

RESULTS:<br />

Demographic analysis revealed no significant differences in patient age, height, smoking, radiation therapy and nipple-areola reconstruction<br />

between randomized patient groups. Time to average follow-up was 28 months. There was a statistically significant improvement<br />

in all three measures (SF-36, BIBCQ and FACT-B) in patients who were randomized to receiving innervated free TRAM flaps compared<br />

to those receiving non-innervated flaps.<br />

CONCLUSIONS:<br />

This study demonstrates that innervation of free TRAM flaps used <strong>for</strong> breast reconstruction not only improves sensibility but also has a<br />

positive effect upon patient-rated quality of life.<br />

198


End-to-Side Anastomosis to the Internal Mammary Artery in Free Flap Breast Reconstruction:<br />

Preserving the Internal Mammary Artery <strong>for</strong> Coronary Artery Bypass Grafting<br />

Institution where the work was prepared: Union Memorial Hospital, Baltimore, MD, USA<br />

Amani Hemphill, MD1; Ramon De Jesus, MD2; Nathaniel McElhaney1; Jonathan Ferrari1; (1)Union Memorial Hospital,<br />

(2)Johns Hopkins<br />

Myocardial revascularization has become an indispensable tool in the management of ischemic heart disease over the last four<br />

decades. Because of its long-term patency as compared to venous grafts, the left internal mammary artery (LIMA) graft to left anterior<br />

descending artery has been the gold standard in bypass surgery since the mid 1980s. Additionally, the IMA's location, patency, and<br />

favorable diameter have also lead to its routine use by plastic surgeons as the recipient vessel in microvascular breast reconstruction.<br />

Un<strong>for</strong>tunately, when the vascular pedicles of breast flaps used <strong>for</strong> reconstruction are anastomosed to the internal mammary vessels in<br />

an end-to-end fashion, they are rendered too short to reach the coronary artery making them unavailable <strong>for</strong> future myocardial revascularization.<br />

By anastomosing the flap's vascular pedicle to its internal mammary recipient vessels in an end-to-side fashion, we can preserve<br />

the IMA in its distal course <strong>for</strong> future myocardial revascularization. We have per<strong>for</strong>med five deep inferior epigastric per<strong>for</strong>ator<br />

(DIEP) flap reconstructions to date using an end-to-side arterial anastomosis without morbidity or mortality. We know cutaneous per<strong>for</strong>ator<br />

flaps develop rich collateral blood supplies which sustain them after their vascular pedicles are disrupted in the setting of debulking<br />

and recontouring. Considering this, should the need arise <strong>for</strong> coronary artery revascularization in one of our patients, the deep inferior<br />

epigastric pedicle can be safely divided without compromising the viability of the reconstructed breast (DIEP flap). It is <strong>for</strong>eseeable<br />

that patients who have undergone standard DIEP flap reconstructions may require future coronary artery revascularizations. Because of<br />

this, the preservation of the IMA as a bypass conduit in the manner described is an option that should be widely considered in the context<br />

of free flap breast reconstruction.<br />

199


ASRM SCIENTIFIC PAPER PRESENTATIONS:<br />

TUMOR-RECONSTRUCTION<br />

Free Vascularized Fibula Graft Salvage of Complications of Long-Bone Allograft Post-Tumor<br />

Reconstruction<br />

Institution where the work was prepared: Mayo Clinic, Rochester, MN, USA<br />

Jeffrey B. Friedrich, MD; Steven L. Moran; Allen T. Bishop; Christina M. Wood; Alexander Y. Shin; Mayo Clinic<br />

INTRODUCTION:<br />

The surgical reconstruction of long-bone tumors achieved a significant milestone when the practice of intercalary allograft insertion<br />

became common. This method allowed <strong>for</strong> limb salvage in a majority of cases. Un<strong>for</strong>tunately, allograft reconstruction is not a panacea,<br />

and achieves success rates of 70-80% in large series. The complications that are most common are host-allograft junction nonunion,<br />

allograft fractures, and allograft infection. An onlay free vascularized fibula bone graft can be employed to span the host-allograft junction<br />

in cases of host-allograft nonunion or fracture. The purpose of this study is to describe this reconstruction modality <strong>for</strong> the treatment<br />

of complications arising from long-bone allograft reconstruction, and to assess the complications, clinical outcomes, and functional<br />

status following allograft reconstruction salvage with onlay vascularized fibula bone grafting.<br />

MATERIAL/METHODS<br />

A tumor registry review was conducted <strong>for</strong> all patients who had undergone reconstruction with a vascularized fibula graft <strong>for</strong> allograft<br />

reconstruction complications within the last 19 years. These patients' records were analyzed <strong>for</strong> details regarding their neoplasms and<br />

the treatment thereof, details of free vascularized fibula graft reconstruction, time to host-allograft bony union, functional outcome, and<br />

clinical outcome.<br />

RESULTS:<br />

Thirty-three patients met criteria <strong>for</strong> this study. The involved bones were femur (18), tibia (8), and humerus (7). All patients in the series<br />

achieved host-allograft bony union at a mean of 7.7 months. Average followup was 72 months. Twenty-three patients achieved a good<br />

or excellent functional outcome, and 10 had a fair or fail outcome. Ultimately 7 patients had failure of allograft reconstruction due to<br />

subsequent complications, 5 of which resulted in limb loss. Postoperative complications were relatively common in this series, with an<br />

overall complication rate over 50%.<br />

CONCLUSION:<br />

While it is not a perfect limb-salvage modality, onlay vascularized fibula grafting is a procedure that af<strong>for</strong>ds an opportunity <strong>for</strong> limb salvage<br />

in patients who have had host-allograft complications following long-bone allograft reconstruction. When compared to the morbidity<br />

of limb loss following allograft reconstruction failure, the complication rate associated with allograft salvage using onlay vascularized<br />

fibula grafting is acceptable.<br />

Vascularized Bone Grafts – An Effective Tool <strong>for</strong> Limb Salvage in Long Bone Malignancies and<br />

Non-unions<br />

Institution where the work was prepared: Devner Clinic <strong>for</strong> Extremities at Risk, Devner, CO, USA<br />

Alex Colque, MD1; David P. Schnur, MD2; William C Brown2; Ross M Wilkins2; Ronald R. Hugate2; Cynthia Kelly2;<br />

(1)University of Colorado Health Science Center, (2)Devner Clinic <strong>for</strong> Extremities at Risk<br />

Long bone reconstruction <strong>for</strong> malignancies and nonunions are complex and difficult procedures. Vascularized bone grafts are often used<br />

when significant bone loss is encountered or when local tissues prove hostile <strong>for</strong> bone healing. We retrospectively reviewed the results of<br />

vascularized bone grafts from the fibula and scapula to reconstruct long bone defects <strong>for</strong> long bone malignancies and non-unions. All<br />

microsurgical long bone reconstructions were per<strong>for</strong>med in a single institution between May 1987 and March 2006 were reviewed. A total<br />

of 62 patients underwent microvascular bone graft transfer. Thirty-five were free fibular grafts and 27 were lateral boarder of scapula grafts.<br />

The indications were nonunion, tumor resection and bone loss. The patients were analyzed <strong>for</strong> comorbid conditions, complications, rate<br />

of union, need <strong>for</strong> secondary operations and failure requiring amputation. Of the 62 patients, 31 (50.0%) were male and 31 (50.0%) were<br />

female. Fifty (80.6%) patients were treated <strong>for</strong> nonunion or malunion, 11 (17.7%) were treated <strong>for</strong> tumor, and 1 (1.6%) <strong>for</strong> bone loss.<br />

Receipient sites were: tibia 10 (16.1%), ulna 1 (1.6%), femur 13 (21.0%), humerus 31 (50.0%), and radius 7 (11.3%). Nineteen (30.6%) had a<br />

history of previous infection. Mean follow up was 39.9 months. Of the 62 grafts, 23 (36.5%) had complications. 9 (14.5%) had infection, 6<br />

(9.7%) had delayed unions or nonunion, 3 (4.8%) had painful hardware, 2 (3.2%) had fractures, 2 (3.2%) had fixation failure, 1 (1.6%) had recurrence<br />

of tumor, 1 (1.6%) had ulnar neuropathy, 1 (1.6%) had graft thrombosis, and 1 (1.6%) had large hematoma <strong>for</strong>mation. All 23 of the<br />

patients with complications required re-operation. Four (6.5%) patients required subsequent conversion to a total joint arthroplasty and 2<br />

(3.2%) patients required amputation. Of the 4 patients requiring total joint arthroplasties, 2 fibula grafts to the humerus were due to<br />

nonunion, 1 fibula graft to the humerus was due to fracture and 1 scapula graft to the humerus required amputation <strong>for</strong> fracture. Of the<br />

amputations, 1 fibula graft to the tibia was due to nonunion and 1 fibula graft to the femur was due to infection. Overall, 56 (90.3%) patients<br />

achieved union. Our data suggests that vascularized fibula and scapula grafts <strong>for</strong> the reconstruction of long bone defects is a valuable <strong>for</strong>m<br />

of limb salvage with an excellent rate of union and a low rate of subsequent amputation.<br />

200


Limiting Complications and Complexity of the Transverse Upper Gracilis Flap in Breast<br />

Reconstruction<br />

Institution where the work was prepared: University of Manitoba, winnipeg, Canada<br />

Edward Wayne Buchel; Thomas E.J. Hayakawa; University of Manitoba<br />

PURPOSE:<br />

The Transverse Upper Gracilis (TUG) flap has become a reliable second choice <strong>for</strong> autologous breast reconstruction. Complications<br />

associated with the TUG flap still limit it's routine use. Our institution has evolved it's technique over the past several months in an<br />

attempt tp decrease these complications. The purpose is to highlight the complications associated with the Transverse Upper Gracilis<br />

(TUG ) flap in breast reconstruction and suggest changes in technique to limit the complications and complexity of the operation.<br />

METHODS:<br />

A retrospective review of the microsurgical data base over the past 24 months was completed on all patients having a TUG flap <strong>for</strong><br />

breast reconstruction. Complications related to the donor site and reconstruction site were quantified. Video documentation of the harvesting<br />

technique and patient positioning was also completed.<br />

RESULTS:<br />

31 Free TUG flaps in 25 patients were per<strong>for</strong>med <strong>for</strong> immediate and delayed breast reconstruction. All patients did not have abdominal<br />

tissue available <strong>for</strong> autologous tissue transfer. One complete failure occurred secondary to a harvesting error. All other flaps survived.<br />

Fat necrosis was noted in 11 flaps (35.4%) of whom 3 underwent secondary revision of small superior contour irregularities. Donor<br />

site complications occurred in 8 donor sites ( 25.8%) with 1 requiring a return to the operating room <strong>for</strong> closure her wounds.<br />

CONCLUSION:<br />

The TUG flap is quickly becoming an excellent second choice <strong>for</strong> autologous tissue breast reconstruction. While fat necrosis and donor<br />

occurred frequently early on in our experience, changes in technique have limited these complications while decreasing the complexity<br />

of the operation.<br />

LEARNING OBJECTIVES:<br />

Review the harvesting techniques of the TUG flap. Highlight complications specific to the TUG flap and technique changes to decrease<br />

these complications.<br />

Outcome of Radical Excision and Microsurgical Reconstruction in Patients with Recurrent<br />

Oromucosal Cancer and Secondary Primary Cancer<br />

Institution where the work was prepared: Chang Gung Memorial Hospital, Tao-Yuan, Taiwan<br />

Emre Gazyakan, MD, MSc; Holger Engel, MD; Jung-Ju Huang, MD; Huang-Kai Kao, MD; Ming-Huei Cheng, MD, PhD;<br />

Chang Gung Memorial Hospital<br />

INTRODUCTION:<br />

Recurrent oromucosal cancer and secondary primary cancer are predominant destructive cancers with significant morbidity and mortality.<br />

In most cases it leads to major midface- and mandibular-defects. Although the extensive defects are posing a challenge to the<br />

microsurgeon the possibilities <strong>for</strong> reconstruction should outweigh the fear of radical tumor resection to minimize recurrence. In the case<br />

of recurrence most patients are still treated with chemo- and/or radiotherapy alone. This study was to investigate the outcome of radical<br />

excision with microsurgical free tissue coverage <strong>for</strong> recurrent oromucosal cancers.<br />

MATERIAL/METHODS:<br />

Between 1999 and 2005, 45 men and 1 woman with a median age of 49.4 years with oromucosal cancer underwent radical excision with<br />

106 microsurgical free tissue transfers. Indications were recurrence, osteoradionecrosis and plate exposure. Patients with recurrence<br />

who received a second or third radical excision with microsurgical free tissue coverage were included in this study. The outcome was<br />

compared in the rate of recurrence, the overall survival rate and the operative complication rate. A comprehensive follow up was available<br />

<strong>for</strong> a minimum of 48 months.<br />

RESULTS:<br />

The initial TNM staging showed T1 in 7, T2 in 13, T3 in 12 and T4 in 14 cases. N0 was shown in 22, N1 in 13 and N2 in 11 patients respectively.<br />

13 Patients received postoperative radiation. Twenty-nine out of 46 patients (63%) were recurrent. Of these, 18 (39%) had disease<br />

recurrence at primary site and 11 (24%) developed a secondary primary tumor. No patient had distant metastasis in the mean 48 months<br />

of follow up. Most recurrences occurred within the first 12 months. These patients underwent the same surgical approach <strong>for</strong> the second<br />

time (20 anterior lateral thigh flaps (ALT) and 9 radial <strong>for</strong>earm flaps). Of these 29 patients, 3 (10%) developed <strong>for</strong> the second time<br />

recurrence. Two patients had a third tumor and one had local recurrence. In all cases an ALT-flap was per<strong>for</strong>med. 5 patients (17%) were<br />

lost to follow up due to disease related death. The rest of the 24 patients (83%) are currently without recurrence. Surgical complications<br />

included flap failure (3.8%) and anastomosis insufficiency (1.9%) among others.<br />

DISCUSSION:<br />

Microsurgical free tissue transfer <strong>for</strong> recurrent oromucosal cancer and secondary primary cancer had a high success rate, minimal complications<br />

and a survival rate of 83% in 48 months. Aggressive wide tumor excision followed by microsurgical reconstruction after recurrence<br />

is a good option.<br />

201


The Use of Thromboelastography as a Guide to Tailor the Anticoagulation Management in<br />

the Microvascular Surgical Patient<br />

Institution where the work was prepared: The Methodist Hospital, Institute <strong>for</strong> Reconstructive Surgery, Houston, TX, USA<br />

Aldona J. Spiegel, MD; The Methodist Hospital; Hector Salazar-Reyes, MD; Baylor College of Medicine / The<br />

Methodist Hospital, Institute <strong>for</strong> Reconstructive Surgery<br />

PURPOSE:<br />

Thrombo-embolic events are among the most feared complications in plastic surgery. Deep venous thrombosis (DVT) and pulmonary<br />

embolism (PE) remain a small (Incidence: 0.35%-1.4%; 0.02%-1.4%, respectively) but real life-threatening risk in plastic surgery. In<br />

microvascular breast reconstruction DVT incidence ranges from 0.87% -5%. Additionally, flap loss incidence due to local thrombosis<br />

varies from 1%-10%. Microvascular surgeons have to balance thrombo-embolic events and flap losses on one side, and postoperative<br />

bleeding complications on the other. Currently employed tests <strong>for</strong> assessing patients' coagulation status do not reflect the dynamic<br />

process of hemostasis and offer a limited perspective. Assessing patients' hemostasis globally, allows the microsurgeon to promptly<br />

implement preventive measures. Thromboelastography (TEG) monitors hemostasis as well as platelet interaction by measuring the viscoelastic<br />

properties of blood, by assessing the clotting cascade and by evaluating the strength and stability of the newly <strong>for</strong>med clot.<br />

In the last nine months, we have routinely used in our microsurgical practice the TEG as tool to manage the anticoagulation therapy<br />

and to monitor patients' overall coagulation status. Additionally, an algorithm <strong>for</strong> patient management based on the TEG results has<br />

been developed. The purpose of this work is to retrospectively review the outcome in our microsurgical practice, following the proposed<br />

algorithm and to evaluate the impact that TEG had in complication rates.<br />

METHODS:<br />

A retrospective chart review was per<strong>for</strong>med in all patients who underwent autologous breast reconstruction (DIEaP and SIEA flaps) by the<br />

senior author (AJS). Special attention was placed on patients' risk factors <strong>for</strong> developing thrombo-embolic and hemorrhagic events, type<br />

and timing of reconstruction, outcome, complications and their correlation with the TEG values obtained be<strong>for</strong>e, during and after surgery.<br />

RESULTS:<br />

Forty-seven DIEaP and 9 SIEA flaps were per<strong>for</strong>med in 34 patients. Age ranged from 34 to 64 years. The data analysis will be presented<br />

and shows encouraging results in the treatment of these patients. Since TEG has been implemented on routine basis, no thromboembolic<br />

events have occurred; flap loss index has been reduced to zero and hematoma <strong>for</strong>mation has been present only in one case;<br />

drainage of the hematoma was not necessary.<br />

CONCLUSION:<br />

A thorough coagulation evaluation must be per<strong>for</strong>med to avoid complications and guarantee surgical success. In the quest <strong>for</strong> the ideal<br />

test to evaluate the coagulation status in microvascular patients, TEG has demonstrated to be a valuable element, and may have the<br />

potential to become the cornerstone to assess these patients' coagulation status.<br />

Free-style Proximal Lateral Leg Per<strong>for</strong>ator Flaps <strong>for</strong> Head and Neck Reconstruction<br />

Institution where the work was prepared: Chang Gung Memorial Hospital, Taoyuan, Taiwan<br />

Wei-Chao Huang1; Christopher Glenn Wallace1; Robert EH Ferguson, MD2; Fu-Chan Wei1; Jeng-Yee Lin1; (1)Chang<br />

Gung Memorial Hospital, (2)University of Kentucky<br />

INTRODUCTION:<br />

Free-style per<strong>for</strong>ator flap surgery represents a relatively new concept in reconstructive microsurgery that brings potential benefits of<br />

reduced donor site morbidity and improved flexibility in customization of, <strong>for</strong> example, flap orientation, dimensions and composition.<br />

We report harvesting techniques, anatomic variations encountered and clinical applications of free-style proximal lateral leg per<strong>for</strong>ator<br />

(PLLP) flaps in head and neck reconstruction.<br />

MATERIAL:<br />

From January 2000 through May 2007, 17 patients (15 males, 2 females; age range: 32 to 80 years) underwent head and neck reconstruction<br />

with free-style PLLP flaps. Dimensions of skin islands ranged between 4x7 cm and 6.5x18 cm. Three flaps included a small portion of<br />

soleus muscle to provide bulk <strong>for</strong> reconstructing tongue or through-and-through cheek defects. Mean follow-up was 13.6 months.<br />

RESULTS:<br />

Vascular origins of free-style PLLP flaps were noted as follows: 11.7 % from the posterior tibial system, 11.7 % from the common popliteal<br />

system, 76.6 % from the peroneal system. Five flaps were re-explored <strong>for</strong> compromised circulation, of which four required venous reanastomosis<br />

<strong>for</strong> venous thrombosis. Three of these flaps recovered with no sequelae, but one failed completely and required replacement<br />

with a radial <strong>for</strong>earm free flap. The fifth flap suffered arterial pedicle disruption due to accidental <strong>for</strong>ceful hyperextension of the<br />

neck 5 days postoperatively. Revascularization with a 1.5 cm vein graft was per<strong>for</strong>med, but the flap still underwent partial necrosis which<br />

required resection and reconstruction with a pedicled deltopectoral flap. Overall, 15 flaps survived completely, one flap had partial<br />

necrosis and one flap failed completely.<br />

CONCLUSIONS:<br />

When applying the concept of free-style harvest, we were able to exercise considerable flexibility intraoperatively, such as when changing<br />

flap design and when incorporating intraoperatively identified and more substantial per<strong>for</strong>ators to supply the PLLP flap, allowing us<br />

to overcome potential problems of limited pedicle length, vascular variations and small diameter pedicle vessels. Free-style PLLP flaps<br />

offer many advantages, such as versatility in design, appropriate tissue volume, superior texture, diverse tissue types available on one<br />

pedicle, feasibility <strong>for</strong> a two-team approach and negligible donor site morbidity, and we recommend it as a useful addition to the Plastic<br />

Surgeon's armamentarium <strong>for</strong> head and neck reconstruction.<br />

202


The SIEA, DIEP and Free TRAM flaps: A Comparison of Abdominal Wall and Flap<br />

Complications and a Surgical Algorithm<br />

Institution where the work was prepared: University of Pennsylvania, Philadelphia, PA, USA<br />

Jesse Creed Selber, MD, MPH; Fares Samra, BA; Lauren Hill, BA; Mirar Bristol; Seema Sonnad; Joseph Serletti;<br />

University of Pennsylvania<br />

PURPOSE:<br />

Attempts to limit the impact of autogenous breast reconstruction on the abdominal wall have lead to the use of the muscle sparing<br />

free TRAM, the DIEP and more recently, the SIEA flap. These procedures differ in complication profile, particularly with respect to the<br />

abdominal wall, and flap related complications such as fat necrosis and flap loss. The purpose of this study is to compare these three<br />

methods across a spectrum of such clinical outcomes to weigh the relative risks and benefits of each, and better refine their respective<br />

roles in autogenous breast reconstruction.<br />

METHODS:<br />

A retrospective cohort study of 72 SIEA flaps, 50 DIEP flaps, and 569 free TRAM flaps was per<strong>for</strong>med. Outcome variables included<br />

wound infection, hematoma, seroma, fat necrosis, abdominal flap necrosis, mastectomy flap necrosis, abdominal hernia or bulge, vessel<br />

thrombosis, partial flap loss and total flap loss. Chi square and Fisher's Exact tests were used to determine significant differences in<br />

patient population characteristics as well as complication rates among groups.<br />

RESULTS:<br />

There was no difference in age, past medical history, length of follow-up or recipient vessels in the 3 groups. In the SIEA and DIEP<br />

groups, there were higher percentages of obese patients (p = 0.0001), bilateral cases (p = 0.0001), and immediate reconstructions (p =<br />

0.001), and in the DIEP group, there was a higher percentage of smokers (p = 0.0001). The rate of flap loss was 3.0% in the SIEA group,<br />

2% in the DIEP group, and 0.2% in the free TRAM group (p = 0.05). The rate of vessel thrombosis was 17% in the SIEA group, 10% in<br />

the DIEP group, and 6% in the free TRAM group (p < .05). The hernia rate was 0% in both the SIEA and DIEP groups, and 2% in the<br />

free TRAM group.<br />

CONCLUSION:<br />

The SIEA has the highest rate of flap loss and vessel thrombosis, followed by the DIEP, followed by the free TRAM. The SIEA and DIEP<br />

both enjoy less donor site morbidity than the free TRAM. These results are consistent with theoretical risks and benefits in which donor<br />

site morbidity is decreased at the expense of reliability. Because of this relationship, the authors recommend that muscle preserving<br />

techniques be undertaken judiciously by microsurgeons experienced in the successful management of vessel thrombosis. The authors<br />

present a surgical algorithm that leads to consistently successful results in autogenous breast reconstruction.<br />

A New Composite Flap: Rectus Abdominis Muscle Flap Harvested with Pubic Bone Segment<br />

(Anatomic Considerations)<br />

Institution where the work was prepared: Gulhane Military Medical Academy, Ankara, Turkey<br />

Serdar Ozturk; Mustafa Sengezer; Unsal Coskun; Fatih Zor; Gulhane Military Medical Academy<br />

The aim of this study is to incorporate a segment of pubic bone to rectus abdominis muscle(RAM). Eight RAM flaps from four fresh<br />

cadavers were used. During surgical dissection utmost care was paid to enclose the areolar tissue between the main DIE vessels and<br />

the pubic bone. A bone segment, 1.5x5cm in dimension, with an intact periosteum was included in RAM. Surgical dissections revealed<br />

two major vascular branches.The first branch arising from the DIEA at a distance of 5.2±1.4 cm from the origin gave rise to two consistent<br />

sub-branches. The second major branch originated from DIEA at a distance of 8.4±1.8 cm from the origin. The first branch gave<br />

off two sub-branches. The second sub-branch coursed antero-medially and nourished the periosteum of the pubic bone.<br />

Microangiographies showed a similar branching pattern of the vessels that create two significant networks. The x-rays confirmed a rich<br />

vascular network around the periosteum of the pubic bone. This wealthy nourishment of the pubic periosteum comes mainly from the<br />

perpendicular descending branches. In conclusion, a vascularized part of pubic bone can be incorporated to the RAM flap by preserving<br />

the delicate vascular network between the DIE vessels and the pubic periosteum.<br />

203


Extended Anterolateral Thigh Flap in Oncological Reconstruction<br />

Institution where the work was prepared: Memorial Sloan Kettering, New York, NY, USA<br />

Afshin Mosahebi1; Martin Jugenburg, MD2; Pravin Reddy3; Andrea L. Pusic1; Joseph J. Disa1; Peter G. Cordeiro1;<br />

Babak J. Mehrara1; (1)Memorial Sloan-Kettering Cancer Center, (2)University of Manitoba, (3)Memorial Sloan Kettering<br />

INTRODUCTION:<br />

Reconstruction of large cutaneous defects is a challenging problem. Skin grafted muscle flaps have been traditionally used. However,<br />

skin grafted muscle flaps have distinct disadvantages such as contracture, poor aesthetic outcome, and failure after radiation therapy<br />

<strong>for</strong> oncologic management. Although the anterolateral thigh (ALT) flap has been used extensively in reconstruction, the use of large or<br />

extended skin paddles (ie. >240 cm2) is in general thought to be associated with increased risk of partial flap necrosis. This trepidation<br />

is based on cadaver perfusion studies of isolated ALT flaps. The purpose of this report was, there<strong>for</strong>e, to evaluate our experience with<br />

the extended ALT flap <strong>for</strong> reconstruction of oncologic defects.<br />

METHODS:<br />

All consecutive patients who had undergone reconstruction of oncological defects using free ALT flap at a single institution between<br />

2002 and 2006 were identified. The subset of patients in whom extended ALT flaps were used (flap size of at least 240 cm2) were then<br />

evaluated using our prospectively maintained database and chart review. Patient characteristics, number of per<strong>for</strong>ators, flap survival,<br />

and outcome data were analyzed.<br />

RESULTS:<br />

Thirty six patients underwent oncologic reconstruction using the ALT flap during the study period. Of these, 13 patients fitted the minimum<br />

size required of 240 cm2. The average age of the patients was 63 years old & majority male (2:1). The majority of the defects were<br />

<strong>for</strong> head & neck soft tissue reconstruction. The average size of the flap was 322 cm2 (240-480 cm2). All flaps were per<strong>for</strong>ator flaps and<br />

the vast majority had one per<strong>for</strong>ator. In 2 patients, ALT as well as tensor fascia lata (TFL) based per<strong>for</strong>ators were used. There was one<br />

total flap loss on postoperative day 7 due to recipient vessel spasm. Three of the patients had delayed donor site wound healing. One<br />

patient had partial necrosis of the distal portion of the flap, however this healed uneventfully with dressing changes.<br />

CONCLUSIONS:<br />

The ALT flap is an excellent choice <strong>for</strong> large or massive defects requiring skin and soft tissue coverage. The flap can be safely extended<br />

beyond the limit of 240 cm2 as suggested by cadaver perfusion studies. Inclusion of TFL per<strong>for</strong>ators may increase the blood supply<br />

of the flap proximally; however, in general a single per<strong>for</strong>ator is capable of supplying a large area of the lateral thigh.<br />

Fat Necrosis in Microvascular Breast Reconstruction: An Assessment and Comparison of SIEA,<br />

DIEP and Muscle-Sparing Free TRAM Methods<br />

Institution where the work was prepared: University of Pennsylvania, Philadelphia, PA, USA<br />

Alison E. Kaye, MD; Liza C. Wu; Joseph M. Serletti; University of Pennsylvania<br />

PURPOSE:<br />

Free flap options <strong>for</strong> autologous breast reconstruction using abdominal tissue includes the superficial inferior epigastric artery (SIEA)<br />

flap, deep inferior epigastric per<strong>for</strong>ator (DIEP) flap, or muscle-sparing transverse rectus abdominus myocutaneous (ms-TRAM) flap.<br />

Controversy remains as to which of these flaps provides a superior reconstruction in terms of vascular support of the transferred tissue.<br />

One clinical marker <strong>for</strong> the quality of free tissue transfer is the presence or absence of fat necrosis in the reconstructed breast flap. The<br />

purpose of this study is to compare outcomes of SIEA, DIEP, and ms-TRAM free flap breast reconstruction with regard to fat necrosis<br />

and the ability of the donor vessels to perfuse the tissue and provide an adequate and stable breast reconstruction.<br />

METHODS:<br />

34 patients with 53 free tissue autologous breast reconstructions per<strong>for</strong>med by a single surgeon from March 2005 to June 2006 were<br />

enrolled and evaluated <strong>for</strong> clinically evident fat necrosis in the reconstructed breasts. Of the 53 flaps, (15 unilateral and 19 bilateral) there<br />

were 16 SIEA, 16 DIEP, and 21 ms-TRAM flaps. Each of the patients in these groups was variable-matched <strong>for</strong> age, BMI, volume of reconstruction,<br />

tobacco use, post-operative radiation, co-morbidities, and length of follow-up. Each patient was evaluated by an independent<br />

plastic surgeon blinded to the type of flap used <strong>for</strong> each reconstructed breast. Any patient with a palpable mass in the reconstructed<br />

breast received an ultrasound or MRI to confirm the diagnosis of fat necrosis.<br />

RESULTS:<br />

Study patients averaged 49.5 years of age (range 29-67 years) with an average BMI of 28.1 (range 21.3-49.4) and 11 months of postoperative<br />

follow-up (range 4-20 months). Of the 53 flaps evaluated, only 6 flaps (11.3%) demonstrated fat necrosis, all in different<br />

patients. These flaps included 3 SIEA, 1 DIEP, and 2 ms-TRAM flaps. Those with fat necrosis averaged 42.7 years old (range 29-52 years)<br />

with an average BMI of 30.05 (range 22.3-41.9). Two of the SIEA flaps with fat necrosis belonged to tobacco-users and one of these also<br />

received post-operative radiation. The remaining patients were neither radiated nor tobacco users and were without significant co-morbidities.<br />

CONCLUSION:<br />

This data indicates no overwhelming trends towards a higher incidence of fat necrosis in one particular type of autologous free tissue<br />

breast reconstruction. We can deduce that there are no significant differences in vascular stability of the SIEA, DIEP and ms-TRAM flaps<br />

with regard to development of fat necrosis.<br />

204


A Ten-Year Experience of Free Flaps in Head and Neck Surgery. How Necessary is a Second<br />

Venous Anastomosis?<br />

Institution where the work was prepared: University of Toronto, Toronto, ON, Canada<br />

Gary L. Ross, MD, FRCS(plast); Erik Ang; Declan Lannon; Patrick Addison; Alex Golger; Christine Novak; Joan Lipa;<br />

Patrick Gullane; Peter Neligan; University of Toronto<br />

INTRODUCTION:<br />

Successful free flap surgery in the head and neck is dependent on the successful anastomosis of both artery and vein. The success of<br />

all free flaps was analysed to determine the necessity <strong>for</strong> per<strong>for</strong>ming two venous anastomoses.<br />

MATERIALS/METHODS<br />

We retrospectively analysed a single surgeons ten-year experience (August 1993 - August 2003) in free flap reconstruction <strong>for</strong> malignant<br />

tumors of the head and neck. 492 free flaps were primary reconstructions that did not require a vein graft, vein loop or cephalic<br />

turnover procedure. 345 flaps had one venous anastomosis and 147 had two venous anastomoses.<br />

RESULTS:<br />

Overall flap success was 468/492 (95%). Successful flap reconstruction in patients undergoing two venous anastomoses was 145/147<br />

(99%) compared to patients undergoing one anastomosis 323/345 (94%) (P


Ultrasound-Assisted Liposuction as a Novel Treatment <strong>for</strong> Fat Necrosis after Autologous<br />

Breast Reconstruction<br />

Institution where the work was prepared: Beth Israel Deaconess Medical Center, Boston, MA, USA<br />

Stephanie A. Caterson, MD; Adam M. Tobias; Bernard Lee; Beth Israel Deaconess Medical Center, Harvard Medical<br />

School<br />

INTRODUCTION:<br />

Fat necrosis is a common complication following all types of autologous breast reconstruction. While the incidence of fat necrosis has<br />

been broadly reported, treatment options beyond direct excision are limited. Here, we describe a novel utilization of ultrasound-assisted<br />

liposuction (UAL) to address fat necrosis after deep inferior epigastric per<strong>for</strong>ator (DIEP) breast reconstruction. Historically, UAL has<br />

been successfully used in areas with high fibroadipose content such as gynecomastia. In breast reconstruction, this minimally invasive<br />

technique is safe and efficacious, while minimizing contour de<strong>for</strong>mities like those seen after direct excision.<br />

METHODS:<br />

A retrospective review of 250 consecutive per<strong>for</strong>ator flaps per<strong>for</strong>med over a three year period revealed 13 DIEP flaps in which UAL was<br />

per<strong>for</strong>med to treat flap associated fat necrosis. Fat necrosis was diagnosed at three months post reconstruction. A thorough history was<br />

obtained and reports of pain associated with the firm areas were recorded. On physical exam areas of fat necrosis were measured along<br />

the largest diameter. The fat necrosis was then categorized dependant on symptoms and size. All patients underwent UAL using the<br />

Byron LySonix 3000 machine with a 4 mm x 20 cm hollow golf tip cannula on settings of 4 and 70%. Clinical results were assessed on<br />

post operative office visit documentation.<br />

RESULTS:<br />

Data reviewed <strong>for</strong> the 13 patients with fat necrosis treated with UAL revealed an average DIEP flap weight of 635 grams. Three of the<br />

patients underwent preoperative radiation therapy (23%). No patients underwent post-reconstruction radiation therapy. Six of the DIEP<br />

flaps were based on one per<strong>for</strong>ator (46%), three DIEPs were based on two per<strong>for</strong>ators (23%), and the remaining four flaps relied on three<br />

per<strong>for</strong>ators (31%). All post-UAL results were examined in the office by the attending surgeon. All areas of fat necrosis were improved, with<br />

increased suppleness. Most patients had near to complete resolution of firmness. Three patients had some residual rigidity, although<br />

much decreased in size. One patient underwent repeat UAL of the same area previously treated at a third stage operation.<br />

CONCLUSIONS:<br />

Currently there is a paucity of treatment options described <strong>for</strong> fat necrosis. Direct excision is often a major intervention that can result<br />

in aesthetic compromise. In our institution, we have used UAL to successfully soften areas of fat necrosis in DIEP flaps while maintaining<br />

a desirable contour. UAL offers a minimally invasive, effective, and reliable alternative to direct excision.<br />

206


ASRM POSTERS PRESENTATIONS<br />

Concentration of NO in the Postischemic Muscle under Different Levels of Oxygen Free<br />

Radicals<br />

Institution where the work was prepared: Plastic Surgery Charité Campus Mitte Humboldt University, Berlin,<br />

Germany<br />

Rolf Buettemeyer, MD, PhD1; Felix Stoffels1; Moritz Beisenhirtz2; Fred Lisdat, PhD3; (1)Charité, Humboldt University,<br />

(2)University of Potsdam, (3)Wildau University of Applied Sciences<br />

Reperfusion of ischemic skeletal muscle is associated with an alteration of the concentrations of 02- and N0. In this study, the influence<br />

of EGCG, a known radical scavenger, on the balance of 02- and NO has been measured on-line in the skeletal muscle of wistar rats.<br />

The hind limb of 14 male rats had been exposed to ischemic stress <strong>for</strong> 2 h. 7 rats received an infusion of 1,5 µmol EGCG/kg 5 min.<br />

be<strong>for</strong>e reperfusion. 02-, NO and temperature were measured during reperfusion. The concentration of 02- declined under the influence<br />

of EGCG from 156.5 nmol/l to 72.2 nmol/l (p=0.01). The level of NO was found to decrease; this decrease was not significantly<br />

changed by EGCG (-175 nmol/l vs. – 227 nmol/l; p=0.33). Thus the different superoxide concentrations did not correspond to different<br />

levels of NO and the interaction of both radicals is not the only reason <strong>for</strong> the concentration decrease of NO in the reperfusion period.<br />

We conclude that EGCG protects skeletal muscle from I/R-injury without influencing the NO concentration profile to a large extent.<br />

Gene Expression Analysis and Biomarker Discovery in a Rat Model of Free Flap Failure<br />

Institution where the work was prepared: R Adams Cowley Shock Trauma Center, Baltimore, MD, USA<br />

Suhail Mithani; Rachel Bluebond-Langner; Eduardo D. Rodriguez; Johns Hopkins School of Medicine<br />

BACKGROUND:<br />

Free tissue transfer is a potent tool in reconstructive surgery, but has a failure rate of up to 10%. Identification of failure relies on clinical<br />

assessment of flap viability which lacks sensitivity <strong>for</strong> early failure. Flap failure is likely preceded by altered gene expression; however,<br />

use of a broad based genome wide approach to identify potential biomarkers and therapeutic targets has not been described. In this<br />

study, an RNA expression microarray identified genes whose expression is altered in a rat model of free flap failure.<br />

METHODS:<br />

A well described rat model of free tissue transfer, with a pedicle based upon the inferior epigastric artery and microvascular anastomosis<br />

of the femoral vessels, was utilized. To model early failure, the venous pedicle was occluded with a vessel loop after anastomosis to<br />

simulate the most common cause of flap failure. After 6 hours a portion of the flap was excised from both early failure and control groups<br />

and RNA extracted. Gene expression of 3 samples in each of the experimental groups was assessed with the Affymetrix GeneChip Rat<br />

230 v2.0 microarray, yielding expression data <strong>for</strong> over 28,000 genes. Quantitative reverse transcription polymerase chain reaction (qRT-<br />

PCR) was per<strong>for</strong>med on genes identified by microarray analysis on RNA extracted from all harvested tissue.<br />

RESULTS:<br />

890 genes had greater than twofold expression differences between the early failure and control groups. Student's t-test and ANOVA<br />

filtering identified 53 genes with statistically significant expression differences. Hierarchical clustering by gene ontology identified 4<br />

genes with likely involvement in the pathogenesis of flap failure. These are RT1 class II, locus Bb (RT2Bb,58.64 fold upregulation), secreted<br />

frizzled-related protein 1 (SFRP1, 2.06 fold upregulation), platelet/endothelial cell adhesion molecule (PECAM, 2.67 fold downregulation),<br />

Claudin 5 (CLDN5, 3.42 fold downregulation). Validation was per<strong>for</strong>med by qRT-PCR on separate control and early failure animals<br />

(n=7 in each arm). RT2Bb, PECAM, CLDN5 had statistically significant alterations of expression in the early failure group. Utilizing<br />

expression thresholds <strong>for</strong> test positivity of these genes, venous occlusion was predicted with 100% sensitivity and 86% specificity.<br />

CONCLUSIONS:<br />

Using a genome wide expression tool, 3 novel genes were identified with altered expression in an animal model of early free flap failure.<br />

Expression levels of these genes predict early flap failure with high sensitivity and specificity. This pilot study validates this method,<br />

and identifies 3 genes which warrant further study as potential diagnostic and therapeutic targets in free flap failure.<br />

207


Understanding the Physiologic Process Behind VAC®: Comparison of Wound Healing<br />

Markers with Non-VAC® Treated Wounds<br />

Institution where the work was prepared: Penn State College of Medicine, Hershey, PA, USA<br />

Rachel H. Noone, BA; Robert Grunfeld, MA; Sprague W. Hazard, MD; Noel B. Natoli, MD; Justin Zelones, BS; Brad Morrow,<br />

BS; Jason Hancey, MD; Paul Ehrlich, PhD; Donald R. Mackay, MD; Reza Miraliakbari, MD; Penn State College of Medicine<br />

INTRODUCTION:<br />

The success of Vacuum Assisted Closure (VAC®) in treatment of wounds is evidenced by its popularity and wide spectrum of clinical<br />

application. Recent studies have examined the effect of VAC® on the biochemical composition of wound fluids by cytokine assay. No<br />

direct data exist as how these findings are different from the non-VAC treated fluid. We propose to study the effect of VAC by comparing<br />

physiologic assays (fibroblast migration and proliferation) as well as the cytokine profiles of wound fluid from patients treated with<br />

VAC®, to closed wounds treated with closed suction JP (Jackson-Pratt) systems.<br />

METHODS:<br />

Wound fluid was collected from 34 VAC® treated patients, and 11 patients with JP drains. Diabetic patients were purposely excluded.<br />

Wound fluid was collected from VAC® canisters and JP bulbs roughly every two days <strong>for</strong> a period of 7 days (at least three collections).<br />

VEGF, IL-1, MMP-13, collagen type I and EDA-Fibronectin levels were analyzed. Also, effects of wound fluid on cultured fibroblast migration<br />

and proliferation were tested on all samples.<br />

RESULTS:<br />

VAC® treated wound fluid showed a significant increase in IL-1 (p = 0.0027). and VEGF (p = 0.016) levels at all time points compared<br />

to JP drained wounds There were no significances detected when comparing the two wound fluids with respect to collagen, fibronectin,<br />

MMP13, or cultures fibroblast migration or proliferation.<br />

CONCLUSIONS:<br />

The mechanism <strong>for</strong> VAC® treatment's success is undefined. This study reports significant elevation of IL-1 and VEGF in VAC treated<br />

wounds compared to non treated wounds. These findings, viewed in isolation, may speak to VAC®'s success. However, once the larger<br />

picture (wound fluid effects on cultured cells) is taken into account, more questions will be raised, regarding the mechanism <strong>for</strong><br />

VAC®'s success. Non- VAC® treated wounds did not differ from VAC® treated wounds in regard to: cell migration, proliferation, collagen<br />

and fibronectin production, as well as MMP13 levels. Further wound fluid analysis is underway to clarify the physiological processes<br />

underlying VAC®'s effectiveness in promoting wound closure.<br />

Cold Ischemia Facilitates Free TRAM and DIEP Flap Breast Reconstruction<br />

Institution where the work was prepared: Stan<strong>for</strong>d University, Palo Alto, CA, USA<br />

Ali Salim, MD; Gordon K. Lee; Stan<strong>for</strong>d University<br />

INTRODUCTION:<br />

The free TRAM flap is a well-established method of autologous tissue breast reconstruction. A drawback to this and other microvascular-based<br />

approaches is the length of operation, which may be 6 hours <strong>for</strong> unilateral and 8 hours <strong>for</strong> bilateral breast reconstruction.<br />

Longer operative times have been reported <strong>for</strong> per<strong>for</strong>ator-based reconstructions, including the DIEP flap. As this may take a significant<br />

physical toll on the surgical team, we have adopted a two-surgeon protocol in which flaps are placed under cold ischemia immediately<br />

after harvest. We believe this (a) reduces surgeon fatigue by facilitating per<strong>for</strong>mance of the operation and (b) is a safe modification<br />

which does not increase operative time or compromise flap viability.<br />

METHODS:<br />

We per<strong>for</strong>med 84 consecutive breast reconstructions (free TRAM, muscle-sparing TRAM, and DIEP flaps) over 36 months. All flaps were<br />

exposed to post-harvest cold ischemia as follows: immediately after harvest, each flap was wrapped in a moist sponge, sealed in a<br />

bowel bag, and placed in an ice slush bath. With the flap(s) on ice, one member of the team proceeds with closure of the abdominal<br />

fascia while the other member takes a break. The surgeons then alternate roles, such that by the time the microvascular anastomosis is<br />

per<strong>for</strong>med, both surgeons are refreshed mentally and physically <strong>for</strong> this delicate part of the operation. A second assistant can close the<br />

skin layer of the abdomen and per<strong>for</strong>m the umbilicoplasty at the same as the microsurgery. We then retrospectively reviewed flap<br />

ischemia times, operative times, and the rate of complications including flap loss, microvascular thrombosis, and fat necrosis evident<br />

upon physical exam.<br />

RESULTS:<br />

Average cold ischemia time <strong>for</strong> unilateral reconstruction was 1 hour 45 minutes, and <strong>for</strong> bilateral reconstruction was 2 hours 5 minutes<br />

<strong>for</strong> the first flap and 3 hours 35 minutes <strong>for</strong> the second flap. There was 1 flap loss (1.2%) which was due to vascular thrombosis; this complication<br />

was not associated with a statistically significant increase in ischemia time. Fat necrosis rate was 3% and average patient follow-up<br />

was 22 months.<br />

CONCLUSION:<br />

As our operative times and complication rates compare to other large published series, we believe that cold ischemia is well-tolerated<br />

by the free TRAM flap, and in fact facilitates the operation significantly by contributing to decreased surgeon fatigue.<br />

208


Microsurgical Treatment of Chronic Osteomyelitis<br />

Institution where the work was prepared: Careggi University Hospital, Florence, Italy<br />

Marco Innocenti, MD; Luca Delcroix; Amerigo Balatri; A.U.O. Careggi<br />

BACKGROUND:<br />

Long standing osteomyelitis are a difficult challenge in orthopaedics. Neither the conventional surgical procedure nor the pharmacological<br />

treatment are likely to be successful when there is a long lasting massive invasion of the affected bone and surrounding soft tissue.<br />

Aggressive debridment, resection at wide margins of contaminated tissue and coverage by free tissue transfer may be effective in<br />

eradicating the infection and providing optimal tissue reconstruction<br />

METHODS:<br />

Seventeen patients ranging in age between 15 and 68 years affected by chronic osteomyelitis lasting from 5 to 45 years, underwent<br />

microsurgical reconstruction in the past 10 years. Tibia was involved in 12 cases, the foot in 5. All the patients had had previous multiple<br />

operations and several pharmacological attempts without success. The operation consisted of radical debridment of contaminated<br />

tissues including large portions of cortical bone , muscle and skin according to principles similar to the ones adopted in tumor surgery.<br />

The following cavity has been repaired by free vascularized muscle transfer in all cases.<br />

RESULTS:<br />

Fifteen patients are free of disease and two underwent amputation after microsurgical failure and recurrence of the infection. The functional<br />

results depend on the elapsed time from the inset of the infection, on the location of the osteomyelitis and on the amount of<br />

joints involved. In all the fifteen patients , however, the limb was salvaged and acceptable function recovered.<br />

CONCLUSIONS:<br />

The advantages related to the described microsurgical approach may be listed as follows: 1. The microvascular transfer of large amount<br />

of healthy tissue allows <strong>for</strong> wide margin excision of infected and necrotic tissues improving the possibility to sterilize the bone and surrounding<br />

soft tissue . 2. The vascularized muscle can be used to fill the medullary canal in order to eradicate possible residual infection<br />

with a vascularized carrier of antibiotics. 3. In the vast majority of patients no further surgery was needed.<br />

Microsurgical non Microvascular Flaps in Diabetic Lower Limb Reconstruction<br />

Institution where the work was prepared: Recovery Hospital, Cluj-Napoca, Romania<br />

Alexandru Georgescu, Prof, MD, PhD; Irina Capota, MD; Filip Ardelean, MD; Ileana Matei; UMF Iuliu Hatieganu<br />

INTRODUCTION:<br />

Pressure sores and post-traumatic lesions in the diabetic lower limb are extremely challenging from reconstructive point of view,<br />

because of the arterial deficit caused by the diabetic artheriopathy. Generally, these cases are treated through long by-pass loops, needed<br />

to revascularize the limb and vascularize the free flaps. This paper will try to demonstrate that even in diabetic lesions in advanced<br />

stages we can still use local or regional means of reconstruction <strong>for</strong> these defects. That is because the diabetic foot has until very late<br />

in evolution a more or less adequate blood supply through the peroneal artery. Based on it, we can harvest various flaps, with good viability<br />

and very useful in reconstructing the diabetic foot.<br />

MATERIAL/METHODS<br />

We per<strong>for</strong>med 11 reconstructions in patients with diabetic foot. In 5 cases the lesions were trophic ulcers induced by diabetes, and in<br />

6 cases we had chronic post-traumatic lesions on foot and shank, generally accompanied by osteitis or osteomyelitis. For all these<br />

patients we per<strong>for</strong>med peroneal artery per<strong>for</strong>ator flaps, used as transposition or propeller flaps, with dimensions between 75 and 200<br />

cmÇ. The flaps used were 8 fasciocutaneous and 3 adipofascial (2 of them including a muscular segment from the lateral gastrocnemius<br />

muscle).<br />

RESULTS:<br />

We lost one flap, but the rest were successful, even the one with open fracture osteitis and bone defect, resulting also the bone consolidation.<br />

The patients were followed <strong>for</strong> 6 to 24 months and we did not notice any relapse in the operated limb.<br />

CONCLUSIONS:<br />

A very successful alternative to the by-pass loops – free flaps treatment <strong>for</strong> the diabetic foot lesions is using peroneal artery per<strong>for</strong>ator<br />

flaps, method that is not as complicated and achieves comparable results.<br />

209


Buried DIEP Flaps For Complex Head and Neck Contour Defects<br />

Institution where the work was prepared: Georgetown University Medical Center, Washington, DC, USA<br />

Mark W. Clemens, MD; Steven Paul Davison, MD, DDS, FACS; Georgetown University Hospital<br />

BACKGROUND:<br />

As the art of microsurgery advances, the demands are changing. No longer is the emphasis on anastamosis, but rather the focus has<br />

turned to the donor site and the final functional result without aesthetic compromise. A prime example of this is head and neck reconstruction.<br />

The expectation is now <strong>for</strong> a result that no longer fills a hole, but restores shape, dimension, and patient confidence; John<br />

Winston Siebert's longitudinal work with facial atrophy exemplifies this philosophy. The DIEP flap has been presented as a potential<br />

source of tissue <strong>for</strong> head and neck reconstruction. It has been sparingly reported <strong>for</strong> pharyngeal reconstruction and to provide a large<br />

bulk of skin, but is not previously described <strong>for</strong> buried contour defects.<br />

METHODS:<br />

We present a retrospective study of a consecutive series of six buried DIEP flaps, per<strong>for</strong>med between 2005 and 2006 with a review of<br />

their indications, results, and complications. Three patient defects had previous radiation. The DIEP flaps were used <strong>for</strong> both functional<br />

scar repair, bulk fill, and <strong>for</strong> soft tissue fill of contour defects. Five flaps were used in the delay setting, as secondary reconstructions<br />

and one flap was designed with a monitor paddle of skin. Despite buried nature of flaps, postoperative monitoring was possible in all<br />

cases by directed Doppler evaluation of anastamotic vessels.<br />

RESULTS:<br />

Soft tissue defects addressed in this study were the result of a variety of different pathologies including temporal fossa meningioma,<br />

fibrous dysplasia of the skull and orbit, nasopharyngeal carcinoma, neck scar repair, sinus cancer, and osteomyelitis. We report a one<br />

hundred percent success rate with primary flap survival, secondary contouring, minimal donor site, provision of moldable bulk soft tissue<br />

fill, and ability to fillet and redistribute. Patient reported satisfaction at six months and one year was good to excellent in all cases.<br />

CONCLUSIONS:<br />

In select cases, we report the functional and aesthetic advantages of the DIEP flap <strong>for</strong> head and neck reconstruction of soft tissue defects<br />

as superior to im<strong>plan</strong>ts, fillers, and non-vascularized fat grafts. Donor site defects are minimized with no muscle loss. The subcutaneous fat<br />

of the DIEP flap has resilience which tends to last and retain its shape. We observe maintenance of residual volume over muscle flaps.<br />

During revisions, these flaps are amendable to liposuction as a contouring tool with portions that can be redistributed on pedicles.<br />

210


Aesthetic Outcomes in the Free TRAM, DIEP and SIEA: Does Muscle Improve Projection<br />

Institution where the work was prepared: University of Pennsylvania, Philadelphia, PA, USA<br />

Jesse Creed Selber, MD, MPH; Mirar Bristol; Seema Sonnad; Joseph Serletti; University of Pennsylvania<br />

BACKGROUND:<br />

The free TRAM flap differs from the DIEP and SIEA flaps in that it retains a portion of the rectus abdominus muscle in the flap. This muscle<br />

adds bulk in the antero-posterior vector, and some speculate that this bulk improves the projection and overall aesthetic appearance<br />

of the reconstructed breast. This is the first study aimed at comparing the aesthetic characteristics of the TRAM, the DIEP and the<br />

SIEA.<br />

METHODS:<br />

The authors per<strong>for</strong>med a prospective, blinded, cohort study in which consecutive patients having undergone either bilateral or unilateral<br />

autogenous breast reconstruction, were photographed in standard three view fashion. Ninety-two free TRAM flaps, thirty-two DIEP<br />

flaps and sixteen SIEAs were compared. The photographs, devoid of patient identifiers, were evaluated by 2 plastic surgeons, and a<br />

lay person, based on a validated, standardized rating sheet <strong>for</strong> aesthetic attributes. Patients also evaluated their own reconstructions.<br />

Results were compared using Kruskal -Wallis tests <strong>for</strong> significance.<br />

RESULTS:<br />

Areas evaluated included vertical and horizontal positioning, projection, naturalness, quality of the infra-mammary fold, medial fullness<br />

and overall appearance. The results demonstrate no significant difference in aesthetic outcomes among the three techniques based<br />

on patient or physician ratings. The lay person, who was also the only person to see all the reconstructed breasts in person, rated the<br />

free TRAM flap as having more projection (p = 0.02), less of the defect visible (p = 0.05) and better overall appearance (p = 0.08).<br />

CONCLUSIONS:<br />

The aesthetics of the reconstructed breast may be affected by multiple factors. The authors believe that projection is improved by the<br />

muscle included in a free TRAM flap, a benefit not enjoyed by the DIEP and SIEA reconstructions. Out of four blinded evaluators, only<br />

one found this to be the case. Interestingly, it was the only person to evaluate the breasts in three dimensions. Results of this study<br />

demonstrate that the free TRAM flaps may have better projection than muscle sparing procedures. A larger series would help clarify<br />

this question.<br />

Free Fibular Graft <strong>for</strong> Post-Traumatic Upper Extremity Reconstruction :Report on 31 Cases<br />

Institution where the work was prepared: Department of Orthopaedics University of Modena and CTO Florence,<br />

Modena and Florence, Italy<br />

Roberto Adani, MD1; Luca Delcroix, MD2; Luigi Tarallo1; Marco Innocenti, MD2; (1)University of Modena and Reggio<br />

Emilia, (2)CTO Florence<br />

PURPOSE:<br />

Vascularized bone graft is most commonly applied <strong>for</strong> lower extremity reconstruction. However, indications <strong>for</strong> its use in the reconstruction<br />

of the upper extremity have expanded in recent years, as the technique as become increasingly appreciated. The aim of this paper<br />

is to review our experience with the use of vascularized fibular graft(VFG) in the treatment of large bone defects, after trauma or<br />

osteomyelitis, located in the upper extremity.<br />

METHOD:<br />

Between 1993-2005, 31 patients with segmental bone defects following upper extremity trauma were managed with VFG. There were<br />

22 males and 9 females, aged 39 years on average (range,16 to 65 years). The reconstructed site was clavicle(1 case), humerus (13 cases),<br />

radius (11 cases) and ulna (6 cases). The length of bone defect ranged from 6 to 16 cm; in five cases the fibular graft was harvested and<br />

used as a vascularized fibula osteoseptocutaneous flap.<br />

RESULTS:<br />

29 grafts were successful. The mean period to obtain radiographic bone union was 5.4 months(mean time in the humerus 6 months<br />

and in the <strong>for</strong>earm 4.8 months). Three patients required additional bone grafts and two cases showed fractures of the grafted bone.<br />

DISCUSSION:<br />

The results obtained suggest that the use of the VFG to the arm is more complex than application to the <strong>for</strong>earm with a higher rate of<br />

complications. A vascularized fibular graft is indicated in cases were conventional treatment has failed, and <strong>for</strong> reconstruction of bone<br />

defects larger than 6-7 cm in the humerus or <strong>for</strong>earm bones. It is also indicated in cases involving osteomyelitis and infected nonunion.<br />

CONCLUSIONS:<br />

Fibular graft allow the use of a segmental of diaphyseal bone which is structurally similar to the radius and ulna and of sufficient length<br />

to reconstruct skeletal defects of the arm.<br />

211


Prevention of Distal End Pharyngoesophageal Stricture Using Z-pasty of Tubed Skin Flap and<br />

Cervical Esophagus <strong>for</strong> Lower Anastomosed site<br />

Institution where the work was prepared: Chang Gung Memorial Hospital- Kaohsiung Medical Center, Kaohsiung,<br />

Taiwan<br />

Yur-Ren Kuo, MD, PhD, FACS; Seng-Feng Jeng; Johnson Chia-Shen Yang; Chih-Yen Chien; Chih-Ying Su; Chang Gung<br />

Memorial Hospital- Kaohsiung Medical Center, Chang Gung University<br />

BACKGROUND:<br />

Various attempts at reconstruction of pharyngo-esophageal defect after ablative cancer surgery have been made. Skin tubing flap was<br />

the common used to reconstruct the defect. However, distal end circular contracture is a big complication. Herein, we presented a triangular-Z-pasty<br />

suture technique to prevent distal end circular contracture.<br />

MATERIALS/METHODS<br />

Seven patients who had undergone esophagus reconstruction due to circumferential pharyngo-esophageal defect had been applied<br />

this technique. All patients were stage III to IV. All patients were male. Their age ranged from 39 to 63 year-old with a mean of 51 yearold.<br />

Four received free radial <strong>for</strong>earm flap and three received anterolateral thigh per<strong>for</strong>ator flap. The distal end of tubed flap size was<br />

designed at least 2 cm radius. The distal skin tube and cervical esophagus parts were incised at three lower tri-angular parts, respectively.<br />

A Z- plasty triangular suture to increase the diameter of anastomosis site was designed. All patients received modality adjuvant<br />

radiotherapy postoperatively. The follow-up ranged from 10 to 36 months.<br />

RESULTS:<br />

All the flaps were survived except one failed due to venous thrombosis. He redid another tubed radial <strong>for</strong>earm flap uneventfully. There<br />

was no leakage in the cervical esophagus and tubed skin flap anastomosis junction. The barium swallowing study revealed a wide<br />

patent anastomosis postoperatively without stricture after adjuvant radiotherapy. All patients tolerated regular diet smoothly after adjuvant<br />

radiotherapy.<br />

CONCLUSION:<br />

With this modification, there is no apparent stricture in distal-anastomosis site of tubed skin flap. This is a useful technique to prevent<br />

tubed contracture in pharygo-esophageal reconstruction.<br />

Comparisons of Donor Site Morbidity Between Free Fibula Osteocutaneous Flap and<br />

Osteomyocutaneous Peroneal Artery Per<strong>for</strong>ator Flap<br />

Institution where the work was prepared: Chang Gung Memorial Hospital, Taiyuan, Taiwan<br />

Jing-Song Guo; Yu-Te Lin; Huang-Kai Kao; Jung-Ju Huang; Ming-Huei Cheng; Chang Gung Memorial Hospital<br />

BACKGROUND:<br />

Previously published studies have shown that there is only minimal donor site morbidity associated with free fibular osteocutaneous<br />

flaps. A modification of the traditional free osteocutaneous fibula (fibula) flap, the osteomyocutaneous peroneal artery per<strong>for</strong>ator (PAP)<br />

flap includes a segment of soleus muscle to give it greater tissue volume. The PAP flap's versatility and extra volume makes it a good<br />

flap <strong>for</strong> composite mandibular and maxillary reconstructions where there is great tissue loss. The purpose of this study is to compare<br />

donor site morbidities between the PAP and o-fibula groups by per<strong>for</strong>ming functional soleus muscle evaluations.<br />

MATERIALS/METHODS<br />

Between December 1999 and May 2006, eight patients underwent PAP flap and thirteen patients underwent an fibula flap reconstructions<br />

of either composite mandibular or maxillary defects at Chang Gung Memorial Hospital. Subjective evaluations were per<strong>for</strong>med<br />

by interviewing patients <strong>for</strong> donor leg symptoms, such as pain, paresthesia, problems walking, activity restrictions, gait alterations, and<br />

donor site aesthetics. Objective assessments were per<strong>for</strong>med by measuring ankle and big toe range of motion and power.<br />

RESULTS:<br />

The Mann-Whitney Test comparing the subjective questionnaire scores between the two study groups showed no significant differences<br />

(p=0.447). The unpaired t-test comparing ankle and big toe range of motion in the PAP flap group and the fibula flap group also<br />

showed no significant functional impairment from segmental soleus muscle harvesting (p>0.05). Muscle power evaluations also failed<br />

to show any significant differences (p>0.05).However,either fibula or PAP flap dose compromise the donor leg ankle and big toe range<br />

of motion comparing to normal leg(84.78% in fibula and 82.08% in PAP <strong>for</strong> ankle dorsiflexion as example).<br />

CONCLUSION:<br />

Although previous study claimed the donor site morbidity of fibula flap is minimal,the range of motion of ankle and big toe do decrease<br />

after the surgery.Long-term follow up of PAP flap patients showed that donor site morbidity is similar to that of the fibula group. Due<br />

to its greater flap volume, the PAP flap is a good reconstructive option <strong>for</strong> extensive mandibular or maxillary composite tissue which<br />

might otherwise require double free-flaps.<br />

212


The Incorporation of Biologics and Free Flaps in My First One Hundred Lower Extremity<br />

Procedures<br />

Institution where the work was prepared: Medical College of Wisconsin, Milwaukee, WI, USA<br />

Robert Whitfield, MD; Medical College of Wisconsin<br />

Lower extremity reconstruction involves in many instances multiple methods to gain a stable soft tissue envelope. This may involve local<br />

tissue rearrangement, skin grafting, rotational muscle flaps with or without skin grafting and free muscle flap with skin graft. One hundred<br />

lower extremity procedures were per<strong>for</strong>med on 49 patients, 34 males and 15 females. Evaluation of the first 100 lower extremity<br />

procedures in my practice showed that this was not entirely true. Of those patients, eighteen, who required free tissue transfer, 57%<br />

(15/26) of the flaps utilized were per<strong>for</strong>ator flaps, 3 Deep Inferior Epigastric Artery Per<strong>for</strong>ator (DIEAP) flaps and 12 Anterolateral Thigh<br />

(ALT) flaps. There was one complete flap loss due to damage of the per<strong>for</strong>ator during the dissection. Also there were two cases of<br />

venous congestion requiring reoperation and in one case vein grafting. Both of these flaps suffered partial flap necrosis of approximately<br />

25% and 33% respectively. In those patients where muscle flaps were used, 43% (11/26), there were two complete flap failures secondary<br />

to venous thromboses. In both instances the flaps that failed were latissimus dorsi muscle free flaps. In one case the contralateral<br />

latissimus was used <strong>for</strong> salvage. In the other case a free Transverse Rectus Abdominus Myocutaneous (TRAM) flap ultimately was<br />

chosen secondary to the patient's difficulty dealing with the donor site of the initial latissimus flap harvest. In addition the use of biologics,<br />

both Integra and Alloderm, have been usefull in the management of these patients. In 50% (6/12) ALT flaps Integra was used to<br />

cover exposed blood vessels or to use as coverage <strong>for</strong> partially debrided flaps. In 16% (2/12) alloderm was used in addition to an ALT<br />

flap to reconstruct the lower extremity over an orthopedic prosthesis. Integra was used in 45% (5/11) as temporary coverage of muscle<br />

flaps. Based on this early experience per<strong>for</strong>ator flaps and biologics are reliable and can be a useful adjuncts in the algorithm of treating<br />

lower extremity injuries.<br />

Navigating the DIEP SIEA: A Per<strong>for</strong>ator Progression Algorithm <strong>for</strong> Microsurgical Breast<br />

Reconstruction<br />

Institution where the work was prepared: University of Chicago Medical Center, Chicago, IL, USA<br />

Charles Y. Tseng, MD; Amir H. Dorafshar, MD; David H. Song, MD; University of Chicago Medical Center<br />

BACKGROUND:<br />

An increasing number of women are undergoing breast reconstruction due to increased awareness, screening, and improved surgical<br />

technique. SIEA, DIEP, and MS-TRAM free flaps reliably replace and closely approximate the look and feel of lost breast tissue. Among<br />

the alternatives <strong>for</strong> autologous breast reconstruction, the SIEA flap provides the least donor-site morbidity, as dissection of the rectus<br />

abdominis sheath and muscle is not required. However, because of inconsistencies in the existence and size of the SIE artery, its use is<br />

limited. In previous reports, free flap breast reconstruction using the SIEA flap is about 30-40%<br />

PURPOSE:<br />

To per<strong>for</strong>m a prospective study of the reliability and outcomes of SIEA, DIEP, and MS-TRAM free flap reconstruction and develop an<br />

algorithm <strong>for</strong> flap selection in autologous breast reconstruction that the developing reconstructive microsurgeon will find useful.<br />

METHODS:<br />

From January 2005 - 2007, 61 consecutive patients underwent SIEA, DIEP, or MS-TRAM free flap breast reconstruction utilizing a specific<br />

algorithm. 66 flaps were used in 56 unilateral and 5 bilateral breast reconstructions. Patient demographics, procedure type, diagnosis,<br />

adjuvant treatment, and complications were recorded.<br />

RESULTS:<br />

22 SIEA (33%), 35 DIEP (53%), and 9 MS-TRAM (13%) free flap breast reconstructions were per<strong>for</strong>med. Fat necrosis was observed in 2<br />

SIEA (9%), 3 DIEP (8.5%), and 1 MS-TRAM (11%) flap. Other complications included 4 intraoperative anastomotic avulsions in the SIEA<br />

group, 1 complete flap loss in the DIEP group, and 1 hematoma in the MS-TRAM group.<br />

CONCLUSION:<br />

This prospective study compares the reliability and outcomes of SIEA, DIEP, and MS-TRAM free flaps in breast reconstruction. Similar<br />

to previous reports, we find that the SIEA flap can be employed in about 30% of cases to achieve breast reconstruction equal in aesthetic<br />

quality to that achieved with DIEP and MS-TRAM flaps while decreasing abdominal donor-site morbidity. Based on the experience<br />

gained from this study and the data collected, we present an algorithm <strong>for</strong> flap selection in autologous breast reconstruction incorporating<br />

the MS-Free TRAM, DIEP, and SIEA flaps. It is our hope that this algorithm will be useful to the developing microsurgeon.<br />

213


The Versatility of Per<strong>for</strong>ator Flaps in the Reconstruction of Upper Extremity Defects<br />

Institution where the work was prepared: Louisiana State University Health Sciences Center, New Orleans, LA, USA<br />

Jules A. Walters III, MD; Quintessa Miller, MD; Jonathan Boraski, MD, DMD; Charles Louis Dupin, MD; M. Whitten<br />

Wise, MD; Louisiana State University Health Sciences Center<br />

BACKGROUND:<br />

Upper extremity wounds present unique reconstructive challenges. They often require thin covering with pliable tissue over joint surfaces<br />

and necessitate reconstruction of a variety of tissues. Regional flaps are frequently available; however, they are often unreliable in<br />

the face of extensive trauma and carry increased donor site morbidity. Free muscle flaps are alternatives, but fibrosis can often lead to<br />

joint contractures. Per<strong>for</strong>ator flaps provide the ideal solution. They allow long vascular pedicles, carry reduced donor site morbidity, and<br />

can carry specialized structures <strong>for</strong> tendon reconstruction. The purpose of this study was to outline the versatility of per<strong>for</strong>ator flaps to<br />

upper extremity wounds resulting from trauma, malignancy, and burns.<br />

MATERIALS/METHODS<br />

The authors present a retrospective study of 13 free per<strong>for</strong>ator flaps in 12 patients between June 2002 and March 2007. The authors<br />

applied 10 ALT flaps and 3 DIEP flaps <strong>for</strong> reconstruction of a variety of complex soft tissue defects. The recipient site was the hand in 5<br />

patients, elbow in 3 patients, arm in 2 patients, and <strong>for</strong>earm in 2 patients. One patient had reconstruction of his triceps tendon with vascularized<br />

fascia lata as part of his ALT flap.<br />

RESULTS:<br />

Patient follow-up averaged 16 months and ranged from 3 to 62 months. All per<strong>for</strong>ator flaps survived. Complications included venous insufficiency<br />

in one flap treated successfully with leech therapy, distal hand ischemia in another patient requiring a partial finger amputation,<br />

and a periumbilical abscess in one patient. Four patients required flap revisions consisting of liposuction, debridement, and skin grafting.<br />

CONCLUSIONS:<br />

Per<strong>for</strong>ator flaps are indicated in a variety of clinical situations. Their size can easily be shaped to fit the spectrum of three-dimensional<br />

wounds encountered during reconstruction. Due to flap versatility, reduced donor site morbidity, and the ease of revision, per<strong>for</strong>ator<br />

flaps provide safe and effective soft tissue coverage to upper extremity wounds.<br />

Multi-digit Re<strong>plan</strong>tation in Patients with Cardiac Stents<br />

Institution where the work was prepared: NYU Medical Center, New York, NY, USA<br />

Otway Louie; Joe Michaels; Sheel Sharma; Jamie Levine; NYU Medical Center<br />

BACKGROUND:<br />

Multi-digit amputation is an indication <strong>for</strong> digital re<strong>plan</strong>tation. Contraindications to re<strong>plan</strong>tation include amputations in patients with<br />

other severe injuries or medical comorbidities. The number of patients receiving cardiac stents is rising. In those patients receiving P2Yreceptor<br />

antagonists with aspirin, the incidence of stent thrombosis is as low as 1%. Most of these events occur within 10 days after<br />

im<strong>plan</strong>tation. To date, no study have documented multi-digit re<strong>plan</strong>tation in patients with pre-existing cardiac stents.<br />

METHOD:<br />

We present our experience per<strong>for</strong>ming multi-digit re<strong>plan</strong>tation in patients with cardiac stents. The hospital course, management, and<br />

outcome of these patients were reviewed.<br />

RESULTS:<br />

Two patients undergoing multi-digit re<strong>plan</strong>tation had pre-existing cardiac stents. Both developed cardiac stent occlusion requiring<br />

emergent angioplasty. One patient with a 6 month old coronary stent had sustained a severe crush injury to his right 2nd-5th digits and<br />

underwent re<strong>plan</strong>tation. He developed angina POD1 and emergent catheterization revealed occluded LAD and RCA stents. All<br />

re<strong>plan</strong>ted digits eventually failed, likely secondary to inadequate perfusion. The second patient underwent successful re<strong>plan</strong>tation of<br />

his 1st-4th digits but developed complete occlusion of his drug eluting stent POD5. Both patients underwent angioplasty with successful<br />

opening of their occluded stents.<br />

CONCLUSION:<br />

Despite antiplatelet agents, patients with pre-existing cardiac stents are at high risk <strong>for</strong> stent thrombosis when undergoing multi-digit<br />

re<strong>plan</strong>tation. Preoperative discussion regarding the possibility of stent occlusion should be held at length with the patient when considering<br />

proceeding with multi-digit re<strong>plan</strong>tation. Emergent cardiac catheterization should be available <strong>for</strong> stent salvage.<br />

214

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!